Citrus Sinensis ID: 021253
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.568 | 0.458 | 0.446 | 3e-44 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.552 | 0.105 | 0.360 | 1e-30 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.542 | 0.070 | 0.398 | 9e-29 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.580 | 0.199 | 0.342 | 6e-28 | |
| Q66L42 | 940 | Mitogen-activated protein | yes | no | 0.533 | 0.178 | 0.401 | 2e-27 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.555 | 0.107 | 0.313 | 6e-27 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.587 | 0.143 | 0.35 | 1e-26 | |
| Q02779 | 954 | Mitogen-activated protein | yes | no | 0.533 | 0.176 | 0.401 | 2e-26 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.561 | 0.184 | 0.376 | 7e-26 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.536 | 0.156 | 0.376 | 1e-25 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 80/179 (44%), Positives = 120/179 (67%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
+EWT DL +L +G FA GA ++YRG Y VA+K++ P + E +EQQF+ EV
Sbjct: 77 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEV 136
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L+ L H NIV+FI AC+K V+CI+TEY G++R +L +++ ++ ++ ++ ALD+
Sbjct: 137 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDI 196
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+RGM Y+H G IHRDLKS+NLL++ + +K+ADFG + +E Q GTYRWMAP
Sbjct: 197 SRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAP 255
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 134 bits (336), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 66/183 (36%), Positives = 107/183 (58%), Gaps = 9/183 (4%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA--QVMEQQFQQ 185
D+W ID +L +G GAFG++++GT+ G +VA+K++ +P+K + +E+ F+
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMI-----SPDKTITKDIERNFKD 831
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
EV ++ TL+H N+V F+ A K CIV E+ GS+ L +P L VK A
Sbjct: 832 EVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAY 891
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRW 303
++GM ++H G HRDLKS NLL+ ++K++DFG+ + + + + PE GT +W
Sbjct: 892 QASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQW 951
Query: 304 MAP 306
AP
Sbjct: 952 TAP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 127 bits (320), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 80/201 (39%), Positives = 112/201 (55%), Gaps = 30/201 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ ID +L G +G FG++ RG + DVAIKI+ R + + + VM FQ EV
Sbjct: 2107 EYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVM---FQNEVG 2163
Query: 189 MLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAV 241
+L+ L+H N+V+F+GAC CIVTE+ GGS+RQFLT QN + LKL
Sbjct: 2164 ILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKL-- 2221
Query: 242 KQALDVARGMAYVHGL--GFIHRDLKSDNLLIS-------------ADKSIKIADFGVAR 286
ALD+A+GM Y+HG +HRDL S N+L+ D KI+DFG++R
Sbjct: 2222 --ALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSR 2279
Query: 287 IEV-QTEGMTPETGTYRWMAP 306
+++ Q MT G +MAP
Sbjct: 2280 LKMEQASQMTQSVGCIPYMAP 2300
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (313), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 64/187 (34%), Positives = 113/187 (60%), Gaps = 4/187 (2%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
P++ + + + I +L + + +G FG +Y+G + G VAIK ++ E+ QV+
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED--VNNQVL 702
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
E+ F++E+ +L+ L+H NIV + AC C +TEY GGS+ L ++ + + ++L
Sbjct: 703 EE-FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQL 760
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
K A+ +A+GM Y+H G IHRD+KS NLL+ ++KI DFG+++++ ++ MT G
Sbjct: 761 YKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIG 820
Query: 300 TYRWMAP 306
+ WM+P
Sbjct: 821 SPIWMSP 827
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 123 bits (308), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 75/187 (40%), Positives = 101/187 (54%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q +QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDP---AVTAEQVRQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLA---GRRVPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMS-AAG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 104/182 (57%), Gaps = 7/182 (3%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
++W ID +L +G G +G++Y+ + G +VA+K++ ++ ++ ME+ F +EV
Sbjct: 777 NDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI----SSKHVSKDMERSFFEEV 832
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ +L+H N+V F+ A K CIV E+ GS+ L +P L +K A
Sbjct: 833 KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQA 892
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWM 304
++GM ++H G +HRDLKS NLL+ + ++K++DFG+ +++ + + GT W+
Sbjct: 893 SKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWI 952
Query: 305 AP 306
AP
Sbjct: 953 AP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (301), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 70/200 (35%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 116 DHRYPTEGL-------ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILER 168
DH++P + E EW + L ++ +G +G +G+++RG++ G +VA+K+L
Sbjct: 823 DHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFN 882
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
N + + ++EV +L L+H NIV F+GAC + CIVTEY GS+ L
Sbjct: 883 DNVNLK----LISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL 938
Query: 229 RRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVAR 286
++ + L ++ D ARGM Y+H IHRDLK+DNLL+ +K+ADFG+A
Sbjct: 939 -DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLAT 997
Query: 287 IEVQTEGMTPETGTYRWMAP 306
++ T T GT W+AP
Sbjct: 998 VKSHTFAKT-MCGTTGWVAP 1016
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 2e-26, Method: Composition-based stats.
Identities = 75/187 (40%), Positives = 101/187 (54%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPEKDP---AVTAEQVCQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R+ VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLAGRR---VPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMSA-AG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (294), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 101/186 (54%), Gaps = 9/186 (4%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQ 182
GL W I L +G+FG ++RG Y G DVAIK +E+ ++PE + +++
Sbjct: 7 GLPTQAIWDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIEK-ADDPEYLKYIDR- 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
EV ML +L+H IV F G C IVTE+ GG VRQ L ++ + V
Sbjct: 65 ---EVSMLQSLRHPFIVNFSGICVHSSGLYIVTEFVSGGDVRQLL--KKTPPIGWDKRVS 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
A+D+A+ M ++H IHRDLKS N+L+ + I++ DFG AR+ QT+ T GT
Sbjct: 120 IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQRIRLCDFGFARMSEQTKKSRHMTMCGT 179
Query: 301 YRWMAP 306
W+AP
Sbjct: 180 EGWVAP 185
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 117 bits (293), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 105/186 (56%), Gaps = 17/186 (9%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE + A
Sbjct: 132 IDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKLFA 189
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
LKH NI+ G C K C+V E+A+GG + + L+ + +P + V A+ +ARGM
Sbjct: 190 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGM 246
Query: 252 AYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETGT 300
Y+H + IHRDLKS N+LI ++K +KI DFG+AR +T M+ GT
Sbjct: 247 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGT 305
Query: 301 YRWMAP 306
Y WMAP
Sbjct: 306 YAWMAP 311
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| 118488096 | 419 | unknown [Populus trichocarpa] | 0.971 | 0.730 | 0.951 | 1e-171 | |
| 224121260 | 415 | predicted protein [Populus trichocarpa] | 0.958 | 0.727 | 0.950 | 1e-169 | |
| 224115648 | 415 | predicted protein [Populus trichocarpa] | 0.958 | 0.727 | 0.940 | 1e-167 | |
| 255574169 | 414 | serine/thronine protein kinase, putative | 0.955 | 0.727 | 0.930 | 1e-162 | |
| 224121256 | 415 | predicted protein [Populus trichocarpa] | 0.958 | 0.727 | 0.900 | 1e-160 | |
| 255574171 | 418 | serine/thronine protein kinase, putative | 0.968 | 0.729 | 0.928 | 1e-157 | |
| 224115644 | 415 | predicted protein [Populus trichocarpa] | 0.958 | 0.727 | 0.914 | 1e-156 | |
| 225429872 | 417 | PREDICTED: serine/threonine-protein kina | 0.952 | 0.719 | 0.892 | 1e-152 | |
| 297798854 | 412 | kinase family protein [Arabidopsis lyrat | 0.949 | 0.725 | 0.848 | 1e-147 | |
| 334187055 | 307 | protein kinase family protein [Arabidops | 0.949 | 0.973 | 0.844 | 1e-147 |
| >gi|118488096|gb|ABK95868.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 292/307 (95%), Positives = 299/307 (97%), Gaps = 1/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +Y
Sbjct: 61 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKY 120
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGL+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+M
Sbjct: 121 PTEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLM 180
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL
Sbjct: 181 EQQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 240
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 241 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 300
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 301 TYRWMAP 307
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121260|ref|XP_002330783.1| predicted protein [Populus trichocarpa] gi|222872585|gb|EEF09716.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1547), Expect = e-169, Method: Compositional matrix adjust.
Identities = 288/303 (95%), Positives = 295/303 (97%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+MEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115648|ref|XP_002332108.1| predicted protein [Populus trichocarpa] gi|222874928|gb|EEF12059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1530), Expect = e-167, Method: Compositional matrix adjust.
Identities = 285/303 (94%), Positives = 293/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYS + GQSVFRPGKVTHALNDDALAQALM+ +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSGTAGQSVFRPGKVTHALNDDALAQALMNPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVMEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHALGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574169|ref|XP_002528000.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532626|gb|EEF34412.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1484), Expect = e-162, Method: Compositional matrix adjust.
Identities = 282/303 (93%), Positives = 290/303 (95%), Gaps = 2/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTGL+GG+++N NYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGLVGGSDDN-VNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 59
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRP KVTHALN+DALAQALMD RY TEG
Sbjct: 60 VGSSDSLTHILSHPGLKPVSHHNYSVSVGQSVFRPRKVTHALNEDALAQALMDSRYQTEG 119
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYD+WTIDLRKLNMGTAFAQGAFGKLYRG YNGEDVAIKILERPEN EKAQVMEQQF
Sbjct: 120 LDNYDDWTIDLRKLNMGTAFAQGAFGKLYRGAYNGEDVAIKILERPENCHEKAQVMEQQF 179
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQ LTRRQNRAVPLKLAVKQ
Sbjct: 180 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQALTRRQNRAVPLKLAVKQ 239
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 240 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 299
Query: 304 MAP 306
MAP
Sbjct: 300 MAP 302
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121256|ref|XP_002330782.1| predicted protein [Populus trichocarpa] gi|222872584|gb|EEF09715.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1466), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/303 (90%), Positives = 290/303 (95%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGL+ +NNN N+YY FTQGFYQ++G+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGKKFTGLMAPSNNNGNDYYGFTQGFYQEIGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPVRH-NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV H NY+VSVG SVFRPGKVTHALNDDALAQALMD+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHRNYNVSVGASVFRPGKVTHALNDDALAQALMDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENIPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGAC+K MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACQKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574171|ref|XP_002528001.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532627|gb|EEF34413.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1446), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/307 (92%), Positives = 291/307 (94%), Gaps = 2/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG NN+N+NNYYDFTQ FYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTG-ANINNDNENNYYDFTQSFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 59
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTH LNDDALAQALMD RY
Sbjct: 60 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHPLNDDALAQALMDSRY 119
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PT GL NYDEWTIDLRKL+MGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVM
Sbjct: 120 PTVGLANYDEWTIDLRKLSMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVM 179
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFL +RQNRAVPLKL
Sbjct: 180 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLAKRQNRAVPLKL 239
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLG IHRDLKSDNLLI ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 240 AVKQALDVARGMAYVHGLGCIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPETG 299
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 300 TYRWMAP 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115644|ref|XP_002332107.1| predicted protein [Populus trichocarpa] gi|222874927|gb|EEF12058.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 277/303 (91%), Positives = 292/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGLIG +NNN NNYY FTQGFYQ+LG+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGQKFTGLIGASNNNGNNYYGFTQGFYQELGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQAL+D+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALVDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERP N+PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPGNSPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADK+IKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKTIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225429872|ref|XP_002283465.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839316|emb|CAN72362.1| hypothetical protein VITISV_000134 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 274/307 (89%), Positives = 287/307 (93%), Gaps = 7/307 (2%)
Query: 5 MVEGPKFTGLIGGNNNN--DNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDN 62
MVEGPKFTG+IGG N+ DNNY+DFTQGFYQKLGE +NMSIDSLQTSNAG SVSMSVDN
Sbjct: 1 MVEGPKFTGIIGGGGNHNHDNNYFDFTQGFYQKLGEDSNMSIDSLQTSNAGLSVSMSVDN 60
Query: 63 SSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGK--VTHALNDDALAQALMDHRY 119
SSVGSNDSLTHIL+HPGLKPV HNYSV G SV RPGK VTHALN+DALA+ALMD RY
Sbjct: 61 SSVGSNDSLTHILNHPGLKPVATHNYSV--GHSVLRPGKGKVTHALNEDALARALMDTRY 118
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRG YNG+DVAIKILERPEN+PE+AQVM
Sbjct: 119 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGEYNGDDVAIKILERPENSPERAQVM 178
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK + WCIVTEYAKGGSVRQFL RRQNR+VPLKL
Sbjct: 179 EQQFQQEVMMLATLKHPNIVRFIGACRKPLAWCIVTEYAKGGSVRQFLMRRQNRSVPLKL 238
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 239 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETG 298
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 299 TYRWMAP 305
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798854|ref|XP_002867311.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313147|gb|EFH43570.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1360), Expect = e-147, Method: Compositional matrix adjust.
Identities = 257/303 (84%), Positives = 275/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFNLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+SVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSVGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LANYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187055|ref|NP_001190878.1| protein kinase family protein [Arabidopsis thaliana] gi|332660471|gb|AEE85871.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1353), Expect = e-147, Method: Compositional matrix adjust.
Identities = 256/303 (84%), Positives = 274/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.946 | 0.725 | 0.759 | 1.9e-115 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.949 | 0.725 | 0.729 | 1.1e-110 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.590 | 0.522 | 0.455 | 1.6e-38 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.577 | 0.526 | 0.454 | 8e-37 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.590 | 0.526 | 0.433 | 1.3e-36 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.561 | 0.307 | 0.444 | 1.6e-36 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.615 | 0.355 | 0.416 | 1.7e-36 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.301 | 0.242 | 0.479 | 1.2e-35 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.565 | 0.312 | 0.436 | 1.7e-35 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.301 | 0.251 | 0.458 | 1.5e-34 |
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 1.9e-115, P = 1.9e-115
Identities = 230/303 (75%), Positives = 241/303 (79%)
Query: 5 MVEGPKFTGL-IXXXXXXXXXXXXFTQGFYQKLGEGTNMSIDSLQTSNAXXXXXXXXXXX 63
M+EG KF L + FTQ FYQKL EG+NMS++S+QTSNA
Sbjct: 1 MLEGAKFNVLAVGNHHNNDNNYYAFTQEFYQKLNEGSNMSMESMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKPVRH YS+SVGQSVFRPG+VTHALNDDALAQALMD RYPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPVRH-YSLSVGQSVFRPGRVTHALNDDALAQALMDTRYPTEG 116
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NYDEWTIDLRKLNMG AFAQGAFGKLY+GTYNGEDVAIKILERPEN+PEKA
Sbjct: 117 LTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 177 QQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 236
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHG FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 237 ALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 296
Query: 304 MAP 306
MAP
Sbjct: 297 MAP 299
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 221/303 (72%), Positives = 235/303 (77%)
Query: 5 MVEGPKFTGLIXXXXXXXXXXXXFTQGFYQKLGE-GTNMSIDSLQTSNAXXXXXXXXXXX 63
M+E PKF FTQ FYQKLGE GTNMS+DS+QTSNA
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKA
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 1.6e-38, P = 1.6e-38
Identities = 86/189 (45%), Positives = 122/189 (64%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D R L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC++ M+ IVTE GG++R++L + + + ++
Sbjct: 67 RDNRFAREIAMLSKVQHKNLVKFIGACKEPMM-VIVTELLLGGTLRKYLVSLRPKRLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
LAV ALD+AR M +H G IHRDLK +NL++SAD K++K+ADFG+AR E TE MT E
Sbjct: 126 LAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
Identities = 84/185 (45%), Positives = 116/185 (62%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXX 182
G +W ID + L +G +GA K+Y G Y + VAIKI+ R E PE+
Sbjct: 6 GFRMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGET-PEEIAKRDSR 64
Query: 183 XXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
L+ ++H N+V+FIGAC K V IVTE +GG++R++L + + ++A+
Sbjct: 65 FLREVEMLSRVQHKNLVKFIGAC-KEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIG 123
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTY 301
ALD+ARGM +H G IHRDLK +NLL++AD K++K+ADFG+AR E TE MT ETGTY
Sbjct: 124 FALDIARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTY 183
Query: 302 RWMAP 306
RWMAP
Sbjct: 184 RWMAP 188
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
Identities = 82/189 (43%), Positives = 120/189 (63%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D + L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC K + IVTE GG++R++L + ++ ++
Sbjct: 67 RESRFAREVSMLSRVQHKNLVKFIGAC-KEPIMVIVTELLLGGTLRKYLVSLRPGSLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
+AV ALD+AR M +H G IHRDLK ++L+++AD K++K+ADFG+AR E TE MT E
Sbjct: 126 VAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 1.6e-36, P = 1.6e-36
Identities = 84/189 (44%), Positives = 117/189 (61%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL--ERPENNPEKAX 177
P +G D W I+L+ L G A G++G LY+GTY ++VAIK+L ER +++ EK
Sbjct: 276 PNDGT---DVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEF 332
Query: 178 XXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ ++H N+V+FIGAC K CIVTE+ GGSV +L +Q L
Sbjct: 333 AQEVFI------MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKL 385
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
K A+D+ +GM+Y+H IHRDLK+ NLL+ ++ +K+ADFGVAR++ QT MT E
Sbjct: 386 PTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAE 445
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 446 TGTYRWMAP 454
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 393 (143.4 bits), Expect = 1.7e-36, P = 1.7e-36
Identities = 85/204 (41%), Positives = 123/204 (60%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVA 162
H + + L A ++ PT+G DEW ID+ +L + A G++G L+RGTY ++VA
Sbjct: 257 HDKSSNELIPACIE--IPTDGT---DEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVA 311
Query: 163 IKILERPENNPEKAXXXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGS 222
IK L+ N E + ++H N+V+F+GAC + CIVTE+ GS
Sbjct: 312 IKFLKPDRVNNEMLREFSQEVFI----MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGS 367
Query: 223 VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ FL +Q A L+ +K ALDVA+GM+Y+H IHRDLK+ NLL+ +K+ADF
Sbjct: 368 IYDFL-HKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADF 426
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
GVAR+++++ MT ETGTYRWMAP
Sbjct: 427 GVARVQIESGVMTAETGTYRWMAP 450
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 1.2e-35, Sum P(2) = 1.2e-35
Identities = 46/96 (47%), Positives = 72/96 (75%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG++++FL ++ +P+K ++ ALD+ARG++Y+H +HRD+KS+N+L+
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+K++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAP 277
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 385 (140.6 bits), Expect = 1.7e-35, P = 1.7e-35
Identities = 82/188 (43%), Positives = 119/188 (63%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN-NPEKAXX 178
PT+G DEW ID+++L + A G++G+L+RGTY ++VAIKIL +PE N E
Sbjct: 278 PTDGT---DEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKIL-KPERVNAEMLRE 333
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ ++H N+V+FIGAC + CIVTE+ GS+ FL + + ++
Sbjct: 334 FSQEVYI----MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKG-VFKIQ 388
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+K ALDV++GM Y+H IHRDLK+ NLL+ + +K+ADFGVAR++ ++ MT ET
Sbjct: 389 SLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAET 448
Query: 299 GTYRWMAP 306
GTYRWMAP
Sbjct: 449 GTYRWMAP 456
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 1.5e-34, Sum P(2) = 1.5e-34
Identities = 44/96 (45%), Positives = 71/96 (73%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG+++Q+L R + + + K+ V+ ALD++RG++Y+H +HRD+K++N+L+
Sbjct: 169 CVVVEYIPGGTLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLL 228
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 229 DYQRNLKIADFGVARVEAQNPKDMTGETGTLGYMAP 264
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 315 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-50
Identities = 56/169 (33%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 146 GAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG++Y+GT G +VA+K L + ++ ++F +E ++ L H NIV
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +G C + IV EY GG + +L + + + + L + AL +ARGM Y+ F
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG--TYRWMAP 306
IHRDL + N L+ + +KI+DFG++R + + G RWMAP
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 6e-49
Identities = 60/171 (35%), Positives = 95/171 (55%), Gaps = 15/171 (8%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+GT G+ VA+K L E E+ + ++F +E ++ L H NI
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEER---EEFLEEASIMKKLSHPNI 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
VR +G C + IVTEY GG + FL R+ + LK ++ AL +A+GM Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
F+HRDL + N L++ + +KI+DFG++R + + G +WMAP
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-48
Identities = 55/171 (32%), Positives = 92/171 (53%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+G G +VA+K L + ++ ++F +E ++ L H N+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V+ +G C + IV EY +GG + +L R+ + L + AL +ARGM Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
FIHRDL + N L+ + +KI+DFG++R ++ + + G RWMAP
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-43
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG +Y G+ VAIKI+ E + + ++ +E+ +L L H NIV+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKII-----KKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G +V EY +GGS++ L + + + ++ L + G+ Y+H G IHR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 263 DLKSDNLLISADK-SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ +D +K+ADFG+++ + + GT +MAP
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 58/165 (35%), Positives = 93/165 (56%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ + G+ VA+KIL++ +K +Q ++E+ +L L H NIVR I
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK----DQTARREIRILRRLSHPNIVRLI 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V EY +GG + +L + + A K AL + RG+ Y+H G IHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ + +KIADFG+A+ + + +T GT +MAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 28/181 (15%)
Query: 145 QGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+GAFG++Y+G G+ +VA+K L+ + E+ + F +E ++ L H N+V
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-----KDFLKEARVMKKLGHPNVV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-------VPLKLAVKQALDVARGMA 252
R +G C + +V EY +GG + +L + + + LK + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
Y+ F+HRDL + N L+ D +KI+DFG++R +T G P RWMA
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP----IRWMA 175
Query: 306 P 306
P
Sbjct: 176 P 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-42
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+Y G+ VAIK++ +K + ++ +E+ +L LKH NIVR
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVI-----KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V EY +GG + L ++ + A + + Y+H G +HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHR 121
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ D +K+ADFG+AR E +T GT +MAP
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG +Y GE +A+K +E ++ E+ + ++E+ +L++L+H NIVR+
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYY 65
Query: 203 GACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G+ R I EY GGS+ L ++ +P + K + G+AY+H G +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ +D +K+ADFG A+ EG GT WMAP
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 63/175 (36%), Positives = 93/175 (53%), Gaps = 11/175 (6%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
+G +GAFG +Y+G G+ VAIK + E E+A + QE+ +L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEAL---KSIMQEIDLLKNL 56
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH NIV++IG+ I+ EYA+ GS+RQ + + P L V +G+AY
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAY 114
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G IHRD+K+ N+L + D +K+ADFGVA ++ + GT WMAP
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 52/170 (30%), Positives = 95/170 (55%), Gaps = 21/170 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y+ + G++VAIK++ +++ +++ E+ +L KH NIV++
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVI------KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-----VKQALDVARGMAYVHG 256
G+ +K +W IV E+ GGS++ L ++ L + K+ L +G+ Y+H
Sbjct: 64 GSYLKKDELW-IVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELL---KGLEYLHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRD+K+ N+L+++D +K+ DFG++ T+ GT WMAP
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-30
Identities = 59/179 (32%), Positives = 94/179 (52%), Gaps = 11/179 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W ++L+KL +G +G FG + +G Y G+ VA+K + K V Q F +E +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI--------KCDVTAQAFLEETAV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+VR +G ++ IV E G++ FL R V + ++ +LDVA
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSA 308
GM Y+ +HRDL + N+L+S D K++DFG+AR+ + G+ +W AP A
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAPEA 168
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 13/181 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W I+ ++L +G +G FG + G Y G+ VA+K L+ Q F E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ TL+H N+V+ +G + IVTEY GS+ +L R + L + ALDV
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAPS 307
GM Y+ F+HRDL + N+L+S D K++DFG+A+ Q + ++G +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPE 169
Query: 308 A 308
A
Sbjct: 170 A 170
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 48/151 (31%), Positives = 84/151 (55%), Gaps = 14/151 (9%)
Query: 145 QGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FGK+ Y+ GE VA+K L ++ F++E+ +L TL H NI
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENI 68
Query: 199 VRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V++ G C K ++ EY GS+R +L R +++ + LK + + + +GM Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+IHRDL + N+L+ ++ +KI+DFG+A++
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F QE
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------AFLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ C + IVTEY GS+ FL + + + L V A +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 305
GMAY+ +IHRDL + N+L+ + KIADFG+AR+ ++ + T G +W A
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTA 172
Query: 306 PSA 308
P A
Sbjct: 173 PEA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 7/171 (4%)
Query: 139 MGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G G+FG +Y G +G+ A+K + ++ + Q +Q +QE+ +L+ L+H
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVKQLEQEIALLSKLQHP 62
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAYVH 255
NIV+++G R+ I E GGS+ + L + + P+ +L +Q L G+ Y+H
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L+ + +K+ADFG+A+ V+ G+ WMAP
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 48/214 (22%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
EW + +L +G +GAFG++ + G D VA+K+L K E+
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------KDDATEK 57
Query: 182 QFQQEV----MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
V MM KH NI+ +G C + +V EYA G++R FL R R
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGE 115
Query: 238 KLA----------------VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ V A VARGM ++ IHRDL + N+L++ D +KIAD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 282 FGVAR-IEVQ------TEGMTPETGTYRWMAPSA 308
FG+AR I T G P +WMAP A
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLP----VKWMAPEA 205
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 27/192 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
+ + A GAFG++Y G Y G D + + + PE+ E+ E F E ++++
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD---ESDFLMEALIMS 64
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQ----ALD 246
H NIVR IG +R+ I+ E GG ++ FL + R P L +K A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEVQTE-------GMTP 296
VA+G Y+ FIHRD+ + N L++ + KIADFG+AR + M P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 297 ETGTYRWMAPSA 308
+WM P A
Sbjct: 185 ----IKWMPPEA 192
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 15/180 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM-EQQFQQEVMM 189
ID +L G FG ++ G + G+ DVAIK++ + M E F +E +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI--------REGAMSEDDFIEEAKV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+V+ G C K+ IVTEY G + +L R + + + + DV
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
M Y+ GFIHRDL + N L+ D +K++DFG+AR + + T GT +W P
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 11/182 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W + L + G FG+++ G YNG VAIK L++ +PE F E
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-------FLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +VR + ++ I+TEY + GS+ FL + + + + A +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 307 SA 308
A
Sbjct: 173 EA 174
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 39/179 (21%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA G++Y+ T G++VAIK + + N E E++++ KH NIV +
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-------NEILIMKDCKHPNIVDYY 81
Query: 203 GACR-KRMVWCIVTEYAKGGS----VRQF---LTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ +W +V EY GGS + Q + Q V +V +G+ Y+
Sbjct: 82 DSYLVGDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CREVLQGLEYL 132
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-------GTYRWMAP 306
H IHRD+KSDN+L+S D S+K+ADFG A Q +T E GT WMAP
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 62/183 (33%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F +E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------SFLEEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + RA+ L V A VA
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL+S N+L+ KIADFG+AR+ E + + +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 SAG 309
A
Sbjct: 173 EAA 175
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVME-QQFQQEV 187
W ID + + G FG+++ G +N VA+K L K M+ + F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL--------KPGTMDPKDFLAEA 52
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ L+H +++ C IVTE K GS+ ++L RA+ L + A V
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
A GMAY+ +IHRDL + N+L+ + K+ADFG+AR+ + G +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171
Query: 305 APSA 308
AP A
Sbjct: 172 APEA 175
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ +PE F QE
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + + L V A +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ E + + +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 SAG 309
A
Sbjct: 173 EAA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 60/176 (34%), Positives = 92/176 (52%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FG +Y+G G +VA+K R P+ ++++F QE +L H NIV+ IG
Sbjct: 5 KGNFGDVYKGVLKGNTEVAVKTC-RSTLPPD----LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
C ++ IV E GGS+ FL +++NR + +K ++ +LD A GM Y+ IHRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-----------RWMAPSA 308
L + N L+ + +KI+DFG++R E E G Y +W AP A
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREE--------EGGIYTVSDGLKQIPIKWTAPEA 166
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 17/179 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP----ENNPEKAQVMEQQFQQEVMMLATL 193
G +G +G++Y GE +A+K +E P + + + M + + E+ L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGM 251
HLNIV+++G I EY GGS+ L R R ++ +Q L G+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL---EGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
AY+H G +HRDLK+DNLL+ AD KI+DFG+++ I + M+ + G+ WMAP
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 57/173 (32%), Positives = 96/173 (55%), Gaps = 24/173 (13%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIV 199
+GA+G +YRG + G VA+KI+ + + + + Q+EV +L+ L+ NI
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-----QREVALLSQLRQSQPPNIT 65
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK-----LAVKQALDVARGMAYV 254
++ G+ K I+ EYA+GGSVR + +A P+ + +++ L VA + Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVL-VA--LKYI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 306
H +G IHRD+K+ N+L++ ++K+ DFGVA + Q + GT WMAP
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPE-KAQVMEQQFQQEVMMLATLKHL 196
G QGAFG++Y G ++A+K + ++PE K +V + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV--NALECEIQLLKNLQHE 64
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV++ G R I EY GGSV+ L + A+ + K + G+ Y+H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I GM TGT WM+P
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIG 203
+G+FG++Y + VA+K+L + + K ++F +E+ +LA+L H NIV+
Sbjct: 10 EGSFGEVYLARDR-KLVALKVLAKKLESKSKEV---ERFLREIQILASLNHPPNIVKLYD 65
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ L + + A+ + + Y+H G IHR
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125
Query: 263 DLKSDNLLISAD-KSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
D+K +N+L+ D + +K+ DFG+A++ + GT +MAP
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 58/190 (30%), Positives = 89/190 (46%), Gaps = 35/190 (18%)
Query: 145 QGAFGKLYRGT-YNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
+GAFGK++ G Y+ E VA+K L+ E A + F++E +L +H N
Sbjct: 15 EGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDA---RKDFEREAELLTNFQHEN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--------RQNRAVPLKLAVKQ----AL 245
IV+F G C + +V EY + G + +FL + + +L + Q A+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPET 298
+A GM Y+ F+HRDL + N L+ D +KI DFG++R V M P
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187
Query: 299 GTYRWMAPSA 308
RWM P +
Sbjct: 188 --IRWMPPES 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G FG + +G Y +G+ +VA+K L+ E +++F +E ++A L H IV
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R IG C+ +V E A G + ++L ++ R +P+ + A VA GMAY+ F
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMAP 306
+HRDL + N+L+ KI+DFG++R + ++ T +W AP
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 19/169 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++Y+ + VAIK+++ E E + QQE+ L+ + I ++
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI-----QQEIQFLSQCRSPYITKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
G+ K I+ EY GGS L A L+ +V G+ Y+H G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-------EVLLGLEYLHEEG 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S + +K+ADFGV+ ++ GT WMAP
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G +Y+ + G+ VAIK++ E+ Q+ +E+ +L IV++
Sbjct: 13 EGSYGSVYKAIHKETGQVVAIKVVPVEEDL--------QEIIKEISILKQCDSPYIVKYY 64
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G+ K +W IV EY GSV + ++A Q L +G+ Y+H
Sbjct: 65 GSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---KGLEYLHSNKK 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGV+ T GT WMAP
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQ 182
W + K+ + QG+FG +Y G G VAIK + N + +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIE-- 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVP---- 236
F E ++ ++VR +G +V E G ++ +L R + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 237 --LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292
L+ ++ A ++A GMAY+ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 293 -----GMTPETGTYRWMAP 306
G+ P RWMAP
Sbjct: 176 RKGGKGLLP----VRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-24
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 20/180 (11%)
Query: 140 GTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +GA+G +Y G N G+ +A+K +E +N A+ ++ Q+EV +L +LKH+NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV-----KQALDVARGMAY 253
V+++G C I E+ GGS+ L NR PL V KQ LD G+AY
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILD---GVAY 117
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+H +HRD+K +N+++ + IK+ DFG AR + + GT WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-24
Identities = 60/183 (32%), Positives = 91/183 (49%), Gaps = 11/183 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ PE F QE
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V + ++ IVTE+ GS+ FL + + L V A +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL++ N+L+ + KIADFG+AR+ E + + +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 SAG 309
A
Sbjct: 173 EAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQ 184
+ I + +G +G FG +Y+G Y E VA+K + +P + +F
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVRE----KFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
QE ++ H +IV+ IG + VW IV E A G +R +L + + L + +
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--R 302
++ +AY+ F+HRD+ + N+L+S+ +K+ DFG++R G +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 303 WMAP 306
WMAP
Sbjct: 174 WMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-24
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 37/195 (18%)
Query: 142 AFAQGAFGKLYRG---TYNGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+GAFGK+Y+G N VAIK L + P+ ++Q+F+QE +++ L+
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPK----VQQEFRQEAELMSDLQ 66
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALD---- 246
H NIV +G C K C++ EY G + +FL R A VK +LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 247 ------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEG 293
+A GM Y+ F+HRDL + N L+ ++KI+DFG++R VQ++
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 294 MTPETGTYRWMAPSA 308
+ P RWM P A
Sbjct: 187 LLP----VRWMPPEA 197
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L RP+ + + F +EV +L+ L NI R +G C C++ EY +
Sbjct: 49 VAVKVL-RPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQ---------ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL + L K A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R VQ P RWMA
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMA 200
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 7e-24
Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FGK L R +G+ +K ++ + E+ EV +L L H NI+++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-----LNEVKILKKLNHPNIIKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHGL 257
+ ++ CIV EYA GG + Q + +++ P +Q LD + + Y+H
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP--EEQILDWFVQLCLALKYLHSR 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
+HRD+K N+ ++++ +K+ DFG++++ T + GT +++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-24
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 26/172 (15%)
Query: 146 GAFGKLY--RGTYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G +G +Y R GE VAIK+ LE ++ + QQE+ ML +H NIV +
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDD--------FEIIQQEISMLKECRHPNIVAY 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLA--VKQALDVARGMAYVHGLG 258
G+ +R IV EY GGS+ Q + + + L++A ++ L +G+AY+H G
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPET---GTYRWMAP 306
IHRD+K N+L++ D +K+ADFGV A++ T + GT WMAP
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-24
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVME-QQFQQE 186
W ++ + M G +G++Y G + VA+K L K ME ++F +E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFLKE 52
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ +KH N+V+ +G C + + I+TE+ G++ +L + V + + A
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G +W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKW 171
Query: 304 MAP 306
AP
Sbjct: 172 TAP 174
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 146 GAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLN 197
G FG++ RG DVAIK L KA ++Q F E ++ H N
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTL--------KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G K I+TEY + GS+ +FL + +L V +A GM Y+ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLSEM 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAPSA 308
++HRDL + N+L++++ K++DFG++R +E G RW AP A
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 60/171 (35%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 143 FAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++++GT + VA+K + E+ P++ ++ +F E +L H NIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKI---KFLSEARILKQYDHPNIVKL 57
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C +R IV E GG FL R++ + K VK ALD A GMAY+ IH
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG----TYRWMAPSA 308
RDL + N L+ + +KI+DFG++R E +G+ +G +W AP A
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEA 165
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 11/182 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ TYN VA+K ++ P V + F E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSV--EAFLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +V+ K ++ I+TE+ GS+ FL + PL + + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+SA KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 307 SA 308
A
Sbjct: 173 EA 174
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K + K Q F E +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAFLAEASV 52
Query: 190 LATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ F+HRDL + N+L+S D K++DFG+ + E + T +TG +W AP
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAP 168
Query: 307 SA 308
A
Sbjct: 169 EA 170
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 32/187 (17%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
L GAFG +Y+G + E VAIK+L E KA ++ E ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKAN---KEILDEAYVM 63
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD---- 246
A++ H ++VR +G C V ++T+ G + ++ R ++ + + L+
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV--RNHKD---NIGSQYLLNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQ---TEGMTPETG 299
+A+GM+Y+ +HRDL + N+L+ + +KI DFG+A++ E + G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174
Query: 300 TYRWMAP 306
+WMA
Sbjct: 175 -IKWMAL 180
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-23
Identities = 58/169 (34%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ G + N VAIKIL+ ++ K Q FQ+EV L L+H +++
Sbjct: 16 SGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQ----DFQKEVQALKRLRHKHLISLFA 69
Query: 204 AC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
C V+ I+TE + GS+ FL + + +P+ + A VA GMAY+ IHR
Sbjct: 70 VCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-YRWMAPSAGS 310
DL + N+L+ D K+ADFG+AR+ + ++ + Y+W AP A S
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 60/182 (32%), Positives = 88/182 (48%), Gaps = 10/182 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I + + G FG+++ G Y N VA+K L+ P V Q F +E
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSV--QAFLEEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +VR K I+TEY GS+ FL + V L + + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 307 SA 308
A
Sbjct: 174 EA 175
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-23
Identities = 61/188 (32%), Positives = 90/188 (47%), Gaps = 34/188 (18%)
Query: 146 GAFGKLYRGTYNGED--------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
GAFG++Y GT VA+K L + + EK + F +E +++ H N
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFNHPN 60
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFL-----TRRQNRAVPLKLAVKQALDVARGMA 252
IV+ +G C I+ E +GG + +L R + LK + LDVA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 253 YVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVAR-------IEVQTEGMTPETGT 300
Y+ + FIHRDL + N L+S AD+ +KI DFG+AR + EG+ P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP---- 176
Query: 301 YRWMAPSA 308
RWMAP +
Sbjct: 177 VRWMAPES 184
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-22
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 35/194 (18%)
Query: 145 QGAFGKLYR----GTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
QGAFG++++ G E VA+K+L+ E + M+ FQ+E ++A H N
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDHPN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV----------------PLKLA- 240
IV+ +G C C++ EY G + +FL R RA PL L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 241 ---VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GM 294
+ A VA GMAY+ F+HRDL + N L+ + +KIADFG++R +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 295 TPETGTYRWMAPSA 308
+ RWM P +
Sbjct: 190 ENDAIPIRWMPPES 203
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I +L + G FG ++ G + VAIK + + + E+ F +E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C +R C+V E+ + G + +L R Q + + LDV G
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ IHRDL + N L+ ++ +K++DFG+ R V + T TGT +W +P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + G+ DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ IVTEY G + +L R P +L ++ DV G
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ FIHRDL + N L+ +K++DFG++R + E T G+ RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 50/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 141 TAFAQGAFGKLYRGTYNGED-------VAIKILE-RPENNPEKAQVMEQQFQQEVMMLAT 192
T +G FG+++ G + V +K L+ + N ++ +F++E+ M
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN------LQSEFRRELDMFRK 64
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK---LAVKQAL---- 245
L H N+VR +G CR+ ++ EY G ++QFL +++ LK L+ KQ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------GMTPETG 299
+A GM ++ F+HRDL + N L+S+ + +K++ +++ +E + P
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--- 181
Query: 300 TYRWMAPSA 308
RW+AP A
Sbjct: 182 -LRWLAPEA 189
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 33/169 (19%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+KIL P+ + F +EV +L+ LK NI+R +G C C++TEY +
Sbjct: 49 VAVKILR-----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQ--NRAVPLKLAVKQ---------------ALDVARGMAYVHGLGFIHRD 263
G + QFL+ ++ AV AL +A GM Y+ L F+HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 264 LKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
L + N L+ + +IKIADFG++R +Q + P RWMA
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP----IRWMA 208
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-22
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G+FG + RG + G+ VA+K L+ +K + F +E ++ +L H N++
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 200 RFIGACR-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R G ++ +VTE A GS+ L + + A+ +A GM Y+
Sbjct: 60 RLYGVVLTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
FIHRDL + N+L+++D +KI DFG+ R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W +L +G +G FG++ R G D VA+K+L+ + + A ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------ 227
+ E+M L KH NI+ +G C + ++ EYA G++R+FL
Sbjct: 66 SEM---ELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 228 --TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
T+ + K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPSA 308
R + + G P +WMAP A
Sbjct: 182 RGVHDIDYYKKTSNGRLP----VKWMAPEA 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 19/193 (9%)
Query: 127 YDE-WTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD W L+ G GAFGK+ T G D VA+K+L+ ++ E+ +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
M E+ +++ L H NIV +GAC ++TEY G + FL R++ + L
Sbjct: 86 M-----SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+ + + VA+GMA++ IHRDL + N+L++ K +KI DFG+AR ++ +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVV 199
Query: 298 TGTYR----WMAP 306
G R WMAP
Sbjct: 200 KGNARLPVKWMAP 212
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-21
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 18/181 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP---ENNPEKAQVMEQQFQQEVMMLATLK 194
G G+FG +Y G +GE +A+K +E P ++ ++ + M +E+ +L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAY 253
H NIV+++G+ I EY GGSV L L + V+Q L +G+ Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNY 121
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR--------WMA 305
+H G IHRD+K N+L+ IKI+DFG+++ +++ ++ +T R WMA
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 306 P 306
P
Sbjct: 181 P 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
L QG+ G +Y+ + G+ A+K + + + +Q +E+ L + +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRSCE 57
Query: 195 HLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARG 250
+V+ GA ++ + IV EY GGS+ L ++ +P L +Q L G
Sbjct: 58 SPYVVKCYGAFYKEGEI-SIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILK---G 111
Query: 251 MAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+ Y+H IHRD+K NLLI++ +KIADFG++++ T GT +M+P
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-21
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W + +L +G +G FG++ G D VA+K+L+ + + + ++
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------- 231
+ MM KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 66 SEM----EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 232 ------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPSA 308
R + T G P +WMAP A
Sbjct: 182 RDVHNIDYYKKTTNGRLP----VKWMAPEA 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L + + F +E+ +++ LK+ NI+R +G C C++TEY +
Sbjct: 47 VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 221 GSVRQFLTRRQNRA----------VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
G + QFL++R+ + V + + A+ +A GM Y+ L F+HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 271 ISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWMA
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMA 199
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 20/162 (12%)
Query: 135 RKLNMGTAFAQGAFGK--LYR------GTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
R L +G FGK LY GT GE VA+K L+R E Q +++E
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKR-----ECGQQNTSGWKKE 56
Query: 187 VMMLATLKHLNIVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ +L TL H NIV++ G C ++ ++ EY GS+R +L + + L L +Q
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ- 115
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ GMAY+H +IHRDL + N+L+ D+ +KI DFG+A+
Sbjct: 116 --ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 23/177 (12%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ + G+ VAIKI++ E+ E++ ++E +L H NI
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIED-------EEEEIKEEYNILRKYSNHPNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGM 251
F GA K+ +W +V E GGSV + R++ + + + + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
AY+H IHRD+K N+L++ + +K+ DFGV+ ++ + T GT WMAP
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 123 GLENYD-----EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILER 168
G+ Y+ W + +L +G +G FG++ G D VA+K+L+
Sbjct: 1 GVSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS 60
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
+ + ++ + MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 61 DATEKDLSDLISEM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 116
Query: 229 RRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
R+ + K V A VARGM Y+ IHRDL + N+L++ D
Sbjct: 117 ARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176
Query: 275 KSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPSA 308
+KIADFG+AR + T G P +WMAP A
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLP----VKWMAPEA 213
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 11/169 (6%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++ G ++ + + E P ++ +F QE +L H NIVR IG
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264
C ++ IV E +GG FL R + + +K ++ + A GM Y+ IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 265 KSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR-----WMAPSA 308
+ N L++ +KI+DFG++R E +G+ TG + W AP A
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPVKWTAPEA 167
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA +Y N E VAIK + + EK Q + ++EV ++ H N+V++
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V Y GGS+ + R + +V +G+ Y+H G IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-----GTYRWMAP 306
RD+K+ N+L+ D S+KIADFGV+ T + GT WMAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 55/188 (29%), Positives = 94/188 (50%), Gaps = 27/188 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
R L +G FG + Y+ GE VA+K L+ A+ + + F++E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHL-RDFEREIE 57
Query: 189 MLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+L +L+H NIV++ G C R +V EY GS+R +L + + R KL + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPET 298
+ +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ ++ +V+ G +P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP-- 174
Query: 299 GTYRWMAP 306
W AP
Sbjct: 175 --IFWYAP 180
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 143 FAQGAFGKLYRGTYNG----ED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ + +D VA+K L+ E ++ Q FQ+E +L L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTVLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------QNRAVPL-KLAVKQAL- 245
+IVRF G C + +V EY + G + +FL V +L + Q L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMT 295
+A GM Y+ L F+HRDL + N L+ +KI DFG++R V M
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 296 PETGTYRWMAPSA 308
P RWM P +
Sbjct: 187 P----IRWMPPES 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VAIK ++ + + + +E+ +L L H NI++ +
Sbjct: 9 EGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLL 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R + +V E+ + + + + + R +P L + +G+A+ H G +HR
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRW 303
DLK +NLLI+ + +K+ADFG+AR T T RW
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RW 163
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
W KL +G +G FG++ G D VA+K+L+ ++ EK +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKD--LS 65
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------- 227
+ MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 228 -TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
R + + K V VARGM Y+ IHRDL + N+L++ + +KIADFG+AR
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 287 -------IEVQTEGMTPETGTYRWMAPSA 308
+ T G P +WMAP A
Sbjct: 186 DVNNIDYYKKTTNGRLP----VKWMAPEA 210
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FGK+Y GE +A+K + +N+P+ ++ E+ +L LKH N+V++
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----TIKEIADEMKVLELLKHPNLVKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G R I EY GG++ + L R + + L + G+AY+H G +H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-----TGTYRWMAP 306
RD+K N+ + + IK+ DFG A E GT +MAP
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLK-HLN 197
+G+F + ++ AIKIL+ K Q+++++ + V + L L H
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHG 256
I++ + V EYA G + Q++ + + + + L + Y+H
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL---ALEYLHS 120
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
G IHRDLK +N+L+ D IKI DFG A++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 44/171 (25%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR- 200
+G++G +Y+ + A+K ++ + E+ + E+ +LA++ H NI+
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-----NEIRILASVNHPNIISY 64
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVH 255
F+ + CIV EYA G + + +++R+ + +P + + + + RG+ +H
Sbjct: 65 KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLKS N+L+ A+ +KI D G++++ + T + GT +MAP
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202
G FG +Y GE VAIK +++ + E+ + +EV L L H NIV+
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNEHPNIVKLK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARGMAYVHGLGF 259
R+ V EY +G ++ Q + R+ + ++ + Q + +G+A++H GF
Sbjct: 65 EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQ---ILQGLAHIHKHGF 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
HRDLK +NLL+S + +KIADFG+AR + P T Y RW
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT-DYVSTRW 163
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L N + F +E+ +++ LK NI+R + C C++TEY +
Sbjct: 49 VAVKMLREDANKNAR-----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVK---------QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL+R + + K V A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWM+
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMS 200
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R GE VAIK E ++ K + +EV +L L+H NIV
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLRQLRHENIVNL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
A R++ +V EY ++ + L P ++ + Q L + +AY H
Sbjct: 66 KEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLL---QAIAYCHSHNI 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR 286
IHRD+K +N+L+S +K+ DFG AR
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G GAF Y R G +A+K + N + + + + ++E+ ++A L H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R +GA + + + E+ GGSV L++ A + + + RG++Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPE-----TGTYRWMAP 306
IHRD+K NLLI S + ++IADFG A R+ + G E GT +MAP
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 37/194 (19%)
Query: 143 FAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ AFGK+Y+G + + VAIK L + NNP++ +FQQE ++A L H
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWG----EFQQEASLMAELHHP 67
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-----VPLKLAVKQALD----- 246
NIV +G + C++ EY G + +FL R + VK +LD
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 247 -----VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGM 294
+A GM Y+ F+H+DL + N+LI +KI+D G++R VQ + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 295 TPETGTYRWMAPSA 308
P RWM P A
Sbjct: 188 LP----IRWMPPEA 197
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 15/172 (8%)
Query: 146 GAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+++RG G VAIK L+ P + Q F E ++ H NI+R
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G K I+TEY + G++ ++L +L V +A GM Y+ + ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNYV 129
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAPSA 308
HRDL + N+L++++ K++DFG++R+ E EG +G RW AP A
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 47/210 (22%)
Query: 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
L +G +G FGK+ + T VA+K+L+ ++ E ++ E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-----SEFN 55
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------- 232
+L + H ++++ GAC + ++ EYAK GS+R FL +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 ------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
RA+ + + A ++RGM Y+ + +HRDL + N+L++ + +KI+DFG++R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 287 IEV--------QTEGMTPETGTYRWMAPSA 308
+V +++G P +WMA +
Sbjct: 176 -DVYEEDSYVKRSKGRIP----VKWMAIES 200
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-18
Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 15/162 (9%)
Query: 143 FAQGAFGKLY------RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G FGK+ G GE VA+K L +PE+ ++E+ +L L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA----DLKKEIEILRNLYHE 66
Query: 197 NIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
NIV++ G C + I + E+ GS++++L R +N+ + LK +K A+ + +GM Y+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMT 295
++HRDL + N+L+ ++ +KI DFG+ + IE E T
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-18
Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 11/175 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G QGAFG++Y G ++A K ++ +PE ++ + + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65
Query: 198 IVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G R R I EY GGSV+ L + A+ + K + GM+Y+H
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I + G+ TGT WM+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ +GA G +++ GE VA+K + + Q +E+ L +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHP 59
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+V+ + + +V EY + L Q ++ L +G
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL--------KG 111
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
+AY+H G +HRDLK NLLISAD +KIADFG+AR+ + E + + T + AP
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G+FG +++ + A+K ++ N E+ + ++ E +LA L I+R
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAKLDSSYIIR 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + IV EYA+ G + + L ++ R +P + + + G+A++H +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+KS NL + A ++KI D GVA++ T GT +++P
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G FG +Y GT D A+K L R + E Q F +E +++ H N++
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-----FLKEGIIMKDFSHPNVL 59
Query: 200 RFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+G C +V Y K G +R F+ R + +K + L VA+GM Y+
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-----YRWMA 305
F+HRDL + N ++ ++K+ADFG+AR E + T +WMA
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ + + +G +G +Y V I I E PE + Q + +E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL----HEEIA 57
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQA 244
+ + LKH NIV+++G+ + + I E GGS+ L + ++ + KQ
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFG----VARIEVQTEGMTPETG 299
L+ G+ Y+H +HRD+K DN+L++ + KI+DFG +A I TE TG
Sbjct: 118 LE---GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TG 171
Query: 300 TYRWMAP 306
T ++MAP
Sbjct: 172 TLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++Y+G N E VAIKI++ E+A+ + QQE+ +L+ I R+
Sbjct: 13 GKGSFGEVYKGIDNRTKEVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGF 259
G+ K I+ EY GGS L + PL+ + ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 47/175 (26%), Positives = 89/175 (50%), Gaps = 14/175 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPE-NNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG+ LYR T + V K + + E+ + E+++L+ L+H NI+ +
Sbjct: 10 KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
I EYA GG++ + R++ + ++ + + ++Y+H G +H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPSAGSICCG 314
RD+K+ N+ ++ IK+ DFG+++I + +E ET GT +M+P +C G
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSP---ELCQG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 23/175 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R + GE A+KI++ + QQE+ M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVAYFG 73
Query: 204 A--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGL 257
+ R+++ C+ EY GGS++ V L+ Q V R G+AY+H
Sbjct: 74 SYLSREKLWICM--EYCGGGSLQDIY------HVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSAGSI 311
G +HRD+K N+L++ + +K+ADFGV A+I GT WMAP ++
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G++Y+ GE VA+K + R EN E +E+ +L L+H NIVR
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKI-RMENEKEG---FPITAIREIKLLQKLRHPNIVRLK 64
Query: 203 GACRKRMVWCIVTEYAKGG----------SVRQFLTRRQNR--AVPLKLAVKQALDVARG 250
IVT KG + L + + +K +KQ L G
Sbjct: 65 ---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ Y+H G +HRD+K N+LI+ D +K+ADFG+AR
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (198), Expect = 3e-17
Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 29/175 (16%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
+G +G +Y+ GE VA+K + R +N E+ E+ +L LKH NI
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKI-RLDNE-------EEGIPSTALREISLLKELKHPNI 60
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V+ + +V EY ++++L +R P +K + Q L RG+AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK N+LI+ D +K+ADFG+AR I ++T T E T YR AP
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR--AP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ- 181
W + K+ M QG+FG +Y G G VAIK + E A + E+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL----TRRQNRAV-- 235
+F E ++ ++VR +G + ++ E G ++ +L +N V
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 236 --PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
LK ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAPSA 308
G+ P RWM+P +
Sbjct: 175 YRKGGKGLLP----VRWMSPES 192
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G QGAFG++Y G ++A+K ++ +PE ++ + + E+ +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV-NALECEIQLLKNLLHE 64
Query: 197 NIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R M I E+ GGS++ L + A+ + K + G++Y+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ I + GM TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I+ +L G FG ++ G + + VAIK + + + E+ F +E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ IVTE+ + G + +L +RQ + + + DV G
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ FIHRDL + N L+S+ +K++DFG+ R + E + + +W P
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 61/191 (31%), Positives = 90/191 (47%), Gaps = 35/191 (18%)
Query: 143 FAQGAFGKLYRGT-YN---GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ YN +D VA+K L+ +N K F +E +L L+H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK------DFHREAELLTNLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-------PLKLAVKQALDVA 248
+IV+F G C + +V EY K G + +FL AV P +L Q L +A
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 249 R----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------GMTPE 297
+ GM Y+ F+HRDL + N L+ + +KI DFG++R T+ M P
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 185
Query: 298 TGTYRWMAPSA 308
RWM P +
Sbjct: 186 ---IRWMPPES 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L KA E+Q F E ++ H NI+ G K IVTEY
Sbjct: 35 VAIKTL--------KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ GS+ FL + + ++L V +A GM Y+ +G++HRDL + N+L++++
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145
Query: 278 KIADFGVARI-EVQTEGMTPETG---TYRWMAPSA 308
K++DFG++R+ E E G RW AP A
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 38/205 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
I R + + +GAFGK++ T + VA+K L+ P K FQ
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK------DFQ 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--------------TRR 230
+E +L L+H +IV+F G C +V EY K G + +FL R+
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ L + A +A GM Y+ F+HRDL + N L+ A+ +KI DFG++R
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 287 ---IEVQTEGMTPETGTYRWMAPSA 308
V M P RWM P +
Sbjct: 176 TDYYRVGGHTMLP----IRWMPPES 196
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFGK+Y+ G A K++E K++ + + E+ +LAT H IV+ +G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A I+ E+ GG+V + R +++ +Q L+ + Y+H + IH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIH 133
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
RDLK+ N+L++ D IK+ADFGV+ V+T + GT WMAP
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-17
Identities = 57/173 (32%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R GE AIK++ + E + A V QQE++M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVV-----QQEIIMMKDCKHSNIVAYFG 73
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGF 259
+ +R I E+ GGS++ V L+ Q V+R G+ Y+H G
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIY------HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSAGSI 311
+HRD+K N+L++ + +K+ADFGV A+I GT WMAP ++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFI 202
G +G++Y+G + G+ AIK+++ E+ E++ + E+ ML H NI +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYY 79
Query: 203 GACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
GA K+ +W +V E+ GSV + + A+ ++ RG+A++H
Sbjct: 80 GAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSAGSICCG 314
IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP I C
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV--IACD 196
Query: 315 E 315
E
Sbjct: 197 E 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGT----YNGE---DVAIKILERPENNPEKAQVMEQ- 181
W + K+ + QG+FG +Y G GE VA+K + E A + E+
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-------TRRQNRA 234
+F E ++ ++VR +G K +V E G ++ +L R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 235 VP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
P L+ ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAPSA 308
G+ P RWMAP +
Sbjct: 175 YRKGGKGLLP----VRWMAPES 192
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 143 FAQGAFGKLYRGTY--NGEDV----AIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
GAFG +Y+G + GE V AIKIL E KA V +F E +++A++ H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANV---EFMDEALIMASMDHP 69
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
++VR +G C + +VT+ G + ++ ++ + +L + + +A+GM Y+
Sbjct: 70 HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEE 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RWMA 305
+HRDL + N+L+ + +KI DFG+AR +E + + G +WMA
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 21/180 (11%)
Query: 142 AFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G+FGK+Y + + E IK E + K V E++ ++EV++LA +KH NI
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL----DVARGMAYV 254
V F + ++ IV EY GG L +R NR + + Q L ++ G+ ++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSI-KIADFGVAR-IEVQTEGMTPETGTYRWMAPSAGSIC 312
H +HRD+KS N+ +S + + K+ DFG+AR + E GT +++P IC
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP---EIC 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 30/183 (16%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALD 246
L+H N + + G C R+ W +V EY G S L ++ + V + AL
Sbjct: 70 QQLRHPNTIEYKG-CYLREHTAW-LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRW 303
G+AY+H IHRD+K+ N+L++ ++K+ADFG A + ++P GT W
Sbjct: 127 ---GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYW 177
Query: 304 MAP 306
MAP
Sbjct: 178 MAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAK 219
+A+K + N + Q++ +E+ +L IV F GA + I EY
Sbjct: 29 MAVKTIRLEINEAIQKQIL-----RELDILHKCNSPYIVGFYGAFYNNGDIS-ICMEYMD 82
Query: 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278
GGS+ + L Q R +P ++ K A+ V +G+ Y+H IHRD+K N+L+++ IK
Sbjct: 83 GGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141
Query: 279 IADFGVARIEVQTEGMTPETGTYRWMAP 306
+ DFGV+ V + T GT +MAP
Sbjct: 142 LCDFGVSGQLVNSLAKT-FVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAIK + + P+K ++ E++++ KH NIV ++
Sbjct: 29 QGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKHPNIVNYL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + ++ L + + ++H IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIHR 139
Query: 263 DLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 28/173 (16%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ + + A KI++ E E F E+ +L+ KH NIV
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------DFMVEIDILSECKHPNIVGLY 68
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQF-------LTRRQNRAVPLKLAVKQALDVARGMAYV 254
A + +W I+ E+ GG++ LT Q R V +Q L+ + ++
Sbjct: 69 EAYFYENKLW-ILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE---ALNFL 119
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
H IHRDLK+ N+L++ D +K+ADFGV A+ + + GT WMAP
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNI 198
+GA+G +Y+ G VA+K + P + + + +E+ +L L+ H NI
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEHPNI 63
Query: 199 VRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA---- 248
VR + C R+ + +V E+ V Q L ++ L + D+
Sbjct: 64 VRLLDVCHGPRTDRELKLT-LVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
RG+ ++H +HRDLK N+L+++D +KIADFG+ARI
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-16
Identities = 52/191 (27%), Positives = 88/191 (46%), Gaps = 23/191 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQ---F 183
ID+ + + G FG++ RG G+ VAIK L K+ E+Q F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E ++ H NI+ G K I+TE+ + G++ FL + + ++L V
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGM 111
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-- 301
+A GM Y+ + ++HRDL + N+L++++ K++DFG++R T +
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 302 ----RWMAPSA 308
RW AP A
Sbjct: 172 KIPIRWTAPEA 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-16
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 17/169 (10%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQQVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQAL-DVARGMAYVHGLGF 259
G+ K I+ EY GGS L RA P + + L ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ + T GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G FG + +G Y + VA+KIL+ N+P ++ + +E ++ L +
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IVR IG C W +V E A+ G + +FL ++N+ V K + V+ GM Y+
Sbjct: 57 YIVRMIGICEAE-SWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
F+HRDL + N+L+ KI+DFG+++ + +T G P +W AP
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP----VKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 7/143 (4%)
Query: 143 FAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
++GA+G+++ + G+ AIK++++ + K QV Q E +L+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK-ADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + +V EY GG + L ++ +A ++ + Y+H G I
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 261 HRDLKSDNLLISADKSIKIADFG 283
HRDLK DN+LI ++ +K+ DFG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
L +G +G FG + G + +D VA+K ++ + +++ E F E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIEE--FLSEAACMK 56
Query: 192 TLKHLNIVRFIGAC---------RKRMVWCIVTEYAKGGSVRQFL----TRRQNRAVPLK 238
H N+++ IG C K MV + + K G + FL +PL+
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMV---ILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+K +D+A GM Y+ FIHRDL + N ++ D ++ +ADFG+++
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 10/164 (6%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
GAFGK+Y+ ++ +L + K++ + + E+ +LA+ H NIV+ + A
Sbjct: 16 GAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
I+ E+ GG+V + R +++ KQ L+ + Y+H IHRD
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRD 128
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
LK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 23/173 (13%)
Query: 146 GAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FG + +G Y DVAIK+L+ N EK+ E + E+M L + IVR
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMH--QLDNPYIVRM 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C + +V E A GG + +FL+ +++ + + V+ V+ GM Y+ G F+H
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 262 RDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
RDL + N+L+ KI+DFG+++ + ++ G P +W AP
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP----LKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 146 GAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIVRFIG 203
G FGK+ G + G A +++ + A EQ F QEV L H N+++ +G
Sbjct: 6 GWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGLG 258
C + + + +V E+ G ++ +L R NR + + A +VA G+ ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAP 306
FIH DL N ++AD S+KI D+G+A + P RW+AP
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 17/173 (9%)
Query: 145 QGAFGKLYRGT----YNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIV 199
G FGK+ G Y V +K L A V EQ +F +E +L+H N++
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELR------VSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ-ALDVARGMAYVHG 256
+ +G C + + +V E+ G ++ +L R+ P +++ A ++A G+ ++H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
FIH DL N L++AD ++KI D+G++ + + + + RW+AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 42/146 (28%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVME-QQFQQEVMMLATLKHLNIVRF 201
+G+FGK L + +G+ IK E N K E ++ ++EV +L+ +KH NIV++
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIK-----EINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + IV +Y +GG + + + ++ P + + + + +VH +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARI 287
RD+KS N+ ++ D +IK+ DFG+AR+
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARV 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-15
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 34/178 (19%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+FGK+ R G+ A+K+L+ K ++ + E +L+ + H I
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 199 VRFIGACRKRMVWCI--------VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ + + V EYA GG + L + + A A ++
Sbjct: 56 VK--------LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA 105
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ Y+H LG I+RDLK +N+L+ AD IK+ DFG+A+ EG T GT ++AP
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-15
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQKVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G+ K I+ EY GGS L + +++ L +G+ Y+H IH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
RD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-15
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVR 200
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
+ GA K+ +W +V E+ GSV + + + + ++ RG+++
Sbjct: 68 YYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSAGSIC 312
+H IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP I
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV--IA 184
Query: 313 CGE 315
C E
Sbjct: 185 CDE 187
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-15
Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 158 GEDVAIKI-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
G+ VAIK LE ++ K M +E+ ML L+H N+V I R++ +V E
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +V L + N + K + RG+ + H IHRD+K +N+L+S
Sbjct: 81 FVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138
Query: 277 IKIADFGVAR 286
+K+ DFG AR
Sbjct: 139 VKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 48/177 (27%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G +GAFG++Y G ++A+K + ++ E ++ + + E+ +L L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHD 64
Query: 197 NIVRFIGACR--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R + I EY GGS++ L + A+ + + + +G++Y+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-----EGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ +QT G+ TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 61/189 (32%), Positives = 88/189 (46%), Gaps = 40/189 (21%)
Query: 144 AQGAFGKLYRGTY----NGEDVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ R + AIK+L+ EN+ + F E+ +L L H
Sbjct: 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLGHHP 63
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ------------- 243
NI+ +GAC R I EYA G++ FL R++R + A +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 244 ---ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTP 296
A DVA GM Y+ FIHRDL + N+L+ + + KIADFG++R E +T G P
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 297 ETGTYRWMA 305
RWMA
Sbjct: 182 ----VRWMA 186
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 33/203 (16%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG----TYNGED---VAIKILERPENNPEKAQV-MEQQF 183
I+L + + FGK+Y+G T GE VAIK L+ +KA+ + ++F
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK------DKAEGPLREEF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKL 239
+ E MM + L+H NIV +G K ++ Y + +FL R +
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 240 AVKQALD----------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289
VK L+ +A GM ++ +H+DL + N+L+ ++KI+D G+ R EV
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174
Query: 290 QTEGMTPETGT----YRWMAPSA 308
G RWM+P A
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEA 197
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G + +Y+ G VAIK ++ ++A+ + +E+ +L LKH NI+
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQ-ALDVARGMAYVHGLGF 259
+ + +V E+ + + + +++++ L A +K L RG+ Y+H
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETGTYRW 303
+HRDLK +NLLI++D +K+ADFG+AR MT + T RW
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RW 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
L +G +G FG + G N +D +K+ + + + F E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 197 NIVRFIGACRKRM------VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALD 246
N++R IG C + + ++ + K G + FL + +P ++ VK D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 8/161 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G ++ R G+ VAIK E++P V+++ +E+ ML LKH N+V I
Sbjct: 11 EGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R++ +V EY +V L + R VP L K + + + H IHR
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+K +N+LI+ IK+ DFG ARI + RW
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 62/183 (33%), Positives = 91/183 (49%), Gaps = 29/183 (15%)
Query: 132 IDLRKLNMGTAFAQGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
+DL+ + MG AFG + R G++VAIK + +P + P V+ ++ +E+ +
Sbjct: 13 VDLQPVGMG------AFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKL 62
Query: 190 LATLKHLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ-- 243
L L+H NI+ FI VTE G + + LT R PL+ Q
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIY---FVTELL-GTDLHRLLTSR-----PLEKQFIQYF 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
+ RG+ YVH G +HRDLK N+LI+ + +KI DFG+ARI Q MT T +
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYY 171
Query: 304 MAP 306
AP
Sbjct: 172 RAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G ++ G++VAIK + + P+K ++ E++++ LK+ NIV F
Sbjct: 28 GQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII-----NEILVMKELKNPNIVNF 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ +G VA+K ++ E KA+ Q +E+ +L L H N+++++
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIKYL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + ++Q R +P + K + + + ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
G+FG+ L R +G+ A+KIL KA++++ + + V+ +L +++H +
Sbjct: 11 TGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V G+ + +V EY GG + L R++ P +A A V + Y+H
Sbjct: 64 VNLYGSFQDDSNLY--LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
L ++RDLK +NLL+ +D IKI DFG A R++ +T + TPE ++AP
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG + R +G+ + K ++ EK QQ EV +L LKH NIVR+
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPNIVRY 64
Query: 202 IGAC--RKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R IV EY +GG + Q + +++ + + + + + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 258 G-----FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + A+ ++K+ DFG+A+I + + +T GT +M+P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 38/175 (21%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIK-ILERPENN--PEKAQVMEQQFQQEVM 188
LR + +G FG++Y+ G VA+K IL E + P A +E+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-------REIK 59
Query: 189 MLATLKHLNIVRFI--------GACRKRMVWCIVTEYA--------KGGSVRQFLTRRQN 232
+L LKH N+V I + RKR +VT Y + SV+ LT Q
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQ- 116
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+K + Q L+ G+ Y+H +HRD+K+ N+LI +KIADFG+AR
Sbjct: 117 ----IKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 29/159 (18%)
Query: 164 KILERPENNPEKAQVM--------EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215
K++ RP +V+ +Q +E+ +L + H N+V+ ++
Sbjct: 92 KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR----GMAYVHGLGFIHRDLKSDNLL 270
E+ GGS+ + +A +Q L DVAR G+AY+H +HRD+K NLL
Sbjct: 152 EFMDGGSL-------EGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTP---ETGTYRWMAP 306
I++ K++KIADFGV+RI QT M P GT +M+P
Sbjct: 201 INSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 31/190 (16%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME-----QQFQQ 185
+LRKL + G FG +++G + E +IKI P + ++ Q FQ+
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI-------PVAIKTIQDRSGRQTFQE 55
Query: 186 ---EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H IVR +G C + +VT+ + GS+ + + ++ P +L +
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-LN 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMT 295
+ +A+GM Y+ +HR+L + N+L+ +D ++IADFGVA + +E T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 296 PETGTYRWMA 305
P +WMA
Sbjct: 174 P----IKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAFG ++ R + + V IK + + ++ Q E +L L H NI+ +
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EYA GG++ +++ +R N + + + + + +VH +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 263 DLKSDNLLISADKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK+ N+L+ K + KI DFG+++I GT +++P
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + G VAIK + ++ A+ + +E+ +L L+H NI+
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK----RILREIKLLRHLRHENIIGLL 65
Query: 201 --FIGACRKRM--VWCIVTEYAKG--GSV---RQFLTRRQNRAVPLKLAVKQALDVARGM 251
+ V+ IVTE + V Q LT ++ + Q L RG+
Sbjct: 66 DILRPPSPEDFNDVY-IVTELMETDLHKVIKSPQPLTDDH-----IQYFLYQIL---RGL 116
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H IHRDLK N+L++++ +KI DFG+AR E + +T T RW
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT-RW 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIV 214
G A+K + + NP+ +++Q +E+ + + K IV++ GA I
Sbjct: 25 TGMIFALKTITT-DPNPD----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79
Query: 215 TEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
EY +GGS+ +++ + K+ K A V +G++Y+H IHRD+K N+L++
Sbjct: 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+K+ DFGV+ V + T TGT +MAP
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 144 AQGAFGKLYRGTYNGE----DVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ + + D AIK ++ +++ + F E+ +L L H
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------NRAVPLKLAVKQAL- 245
NI+ +GAC R + EYA G++ FL + + + L+ +Q L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTPET 298
DVARGM Y+ FIHRDL + N+L+ + KIADFG++R + +T G P
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 174
Query: 299 GTYRWMA 305
RWMA
Sbjct: 175 --VRWMA 179
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 101 VTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGK--LYRGTYNG 158
VTH AL + ++D P LENY +G+ G + R ++G
Sbjct: 1 VTHEQFKAAL-RMVVDQGDPRSLLENY-------------IKIGEGSTGIVCIAREKHSG 46
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRMVWCIVTEY 217
VA+K+++ K Q E F EV+++ +H N+V + +W ++ E+
Sbjct: 47 RQVAVKMMDL-----RKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELW-VLMEF 99
Query: 218 AKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ ++ Q R ++A V ++ V + + Y+H G IHRD+KSD++L++ D
Sbjct: 100 LQGGALTDIVS--QTRLNEEQIATVCES--VLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
+K++DFG A+I GT WMAP
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
++GAFG +Y + G+ AIK+L + + K QV + ++ +MM+ + +
Sbjct: 5 SKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESP-YVAKL 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + + +V EY GG + + +P A + +V G+ +H G IH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
RD+K +NLLI +K+ DFG++R G+ + GT ++AP
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
++ + +G FG++ + + D AIK ++ + + + F E+
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 58
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--------- 237
+L L H NI+ +GAC R + EYA G++ FL R++R +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANS 116
Query: 238 ---KLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEV 289
L+ +Q L DVARGM Y+ FIHRDL + N+L+ + KIADFG++R EV
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 290 ---QTEGMTPETGTYRWMA 305
+T G P RWMA
Sbjct: 177 YVKKTMGRLP----VRWMA 191
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLKHLNI 198
++GAFGK+Y R N + A+K++++ + N M Q Q E LA K I
Sbjct: 13 SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN------MVHQVQAERDALALSKSPFI 66
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V + + +V EY GG V+ L + AVK +VA + Y+H G
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM--AVKYISEVALALDYLHRHG 124
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
IHRDLK DN+LIS + IK+ DFG++++ + E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 14/154 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G + +Y+G GE VA+K L+ E P A +E+ ++ LKH NIVR
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENIVR 62
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+V EY + T A+ + +G+A+ H +
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQT 291
HRDLK NLLI+ +K+ADFG+AR I V T
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 51/182 (28%), Positives = 94/182 (51%), Gaps = 19/182 (10%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQE 186
+L+K+ + GAFG +Y+G + +GE+ VAIK+L EN KA ++ E
Sbjct: 8 ELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKAN---KEILDE 59
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++A + + R +G C V +VT+ G + ++ ++R L + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RW 303
+A+GM+Y+ + +HRDL + N+L+ + +KI DFG+AR +++ + G +W
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 304 MA 305
MA
Sbjct: 178 MA 179
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 28/185 (15%)
Query: 144 AQGAFGKLYR--GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR 200
+G +GK+++ NG A+KIL+ P ++ ++++ + E +L L H N+V+
Sbjct: 27 GKGTYGKVFKVLNKKNGSKAAVKILD-PIHD------IDEEIEAEYNILKALSDHPNVVK 79
Query: 201 FIGACRKRMV------WCIVTEYAKGGSV----RQFLTRRQNRAVPL-KLAVKQALDVAR 249
F G K+ V W +V E GGSV + FL R + P+ + +AL
Sbjct: 80 FYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---M 135
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSA 308
G+ ++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 309 GSICC 313
I C
Sbjct: 196 --IAC 198
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 20/155 (12%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV----WCI 213
G VA+K + + K Q E F EV+++ +H NIV + +V W +
Sbjct: 44 GRQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSS---YLVGDELW-V 93
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
V E+ +GG++ +T R ++A V A V + ++++H G IHRD+KSD++L++
Sbjct: 94 VMEFLEGGALTDIVT--HTRMNEEQIATVCLA--VLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 273 ADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
+D +K++DFG A++ + GT WMAP
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 23/160 (14%)
Query: 144 AQGAFGKLY---RGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G++Y R G++ AIK + E+ + Q +E+ +L LKH N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGD---KEQYTGISQSACREIALLRELKHENVV 65
Query: 200 RFIGACRKRM---VWCIVTEYAKG--GSVRQFLTRRQNRAVP---LKLAVKQALDVARGM 251
+ + V+ ++ +YA+ + +F + + ++P +K + Q L+ G+
Sbjct: 66 SLVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---GV 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
Y+H +HRDLK N+L+ + +KI D G+AR+
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEV 187
++L KL +G++ +Y+G NG+ VA+K+ ++ E P A +E
Sbjct: 8 LNLEKL------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQAL 245
+L LKH NIV + V EY + Q++ + P ++L + Q L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGTYR 302
RG+AY+HG +HRDLK NLLIS +K+ADFG+AR I QT T YR
Sbjct: 114 ---RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAIK + + P+K ++ E++++ K+ NIV +
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG+++ R + VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 77
Query: 203 GACRKR--------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--D 246
CR + +C E+ G L N+ V L+ + +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC---EHDLAG----LL---SNKNVKFTLSEIKKVMKM 127
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+ G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR ++ P T R
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE---RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K + E P A +E+ +L L H NIV
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-------REISLLKELNHPNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + +V E+ +++F+ +PL L + +G+A+ H
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRDLK NLLI+ + +IK+ADFG+AR V T E T + AP
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YN 157
+V+H AL Q ++ P E L+++ + +G +G+ G + T +
Sbjct: 1 RVSHEQFRAAL-QLVVSPGDPREYLDSF---------IKIG----EGSTGIVCIATEKHT 46
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G+ VA+K ++ K Q E F EV+++ H N+V + +V E+
Sbjct: 47 GKQVAVKKMDL-----RKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100
Query: 218 AKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ +T R N + L V R ++Y+H G IHRD+KSD++L+++D
Sbjct: 101 LEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
IK++DFG A++ + GT WMAP
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAI+ + + P+K ++ E++++ K+ NIV +
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 82
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIH 139
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 24/173 (13%)
Query: 146 GAFGKLYRGTYN--GED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG +Y+G + GE VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHVC 72
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R +G C V ++T+ G + ++ ++ L + + +A+GM Y+
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERRL 130
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARI------EVQTE-GMTPETGTYRWMA 305
+HRDL + N+L+ + +KI DFG+A++ E E G P +WMA
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP----IKWMA 179
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 42/169 (24%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
F + ++Y T V +K L+ ++ E + +F Q+ L+H NI++ +
Sbjct: 8 FGKVLLSEIYTDT-GVARVVVKELKANASSKE-----QNEFLQQGDPYRILQHPNILQCL 61
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFI 260
G C + + + +V EY + G ++ +L++ Q R L L + A ++A G+ ++H F+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
H DL N +++D ++K+ D+G+ + + + E RW+AP
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 36/186 (19%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R N E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA-- 248
L+H N +++ G + +V EY G + ++ PL Q +++A
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL-----QEVEIAAV 120
Query: 249 -----RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GT 300
+G+AY+H IHRD+K+ N+L+S +K+ DFG A I M P GT
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGT 174
Query: 301 YRWMAP 306
WMAP
Sbjct: 175 PYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ T +G A+KIL+ + ++++ + E +L +L H N+V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKILDPISD-------VDEEIEAEYNILQSLPNHPNVVK 83
Query: 201 FIGA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMA 252
F G +W +V E GGSV + + L A+ + G+
Sbjct: 84 FYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPSAGSI 311
++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP I
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV--I 200
Query: 312 CC 313
C
Sbjct: 201 AC 202
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVM----M 189
N G+FG++ TY ED VAIK E K+++++Q+ V +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKI 84
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
L + H V G+ + +V E+ GG FL R+N+ P + A +
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVL 142
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+ L ++RDLK +NLL+ D IK+ DFG A++ V T T GT ++AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT-LCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQ---QEVMMLATLKHLNI 198
G+FG +Y T + E VA+K + + +++Q +EV L LKH N
Sbjct: 30 GHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G K +V EY G + + ++ + V + AL +G+AY+H
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L++ +K+ADFG A GT WMAP
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G++ +Y+G NG+ VA+K+ L+ E P A +E +L LKH NI
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKHANI 65
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V + +V EY + Q++ + P +KL + Q L RG++Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQ 121
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R E VAIK + E N E +++ +E+ ML TLK NIV
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVEL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A R+R +V EY + ++ + L N P K+ + + + + H +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKNDIVH 123
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RD+K +NLLIS + +K+ DFG AR
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T + + VA+K ++ E KA+ Q +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + IV E A G + Q + ++Q R +P + K + + + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 142 AFAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G++G+ L R +G+ IK L N A E++ +QE +L+ LKH NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 199 VRFIGACRKRMVW-------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
V + R W IV + +GG + L ++ + +P V+ + +A +
Sbjct: 62 VAY------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
Y+H +HRDLK+ N+ ++ IK+ D G+AR+ E Q + + GT +M+P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G++ +Y+G G+ VA+K LE E P A +E +L LKH NIV
Sbjct: 15 EGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANIVT 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLG 258
+ +V EY ++Q++ ++L + Q L RG+AY H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR 123
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + IV E A G + + + ++Q R +P K K + + + ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 50/174 (28%), Positives = 89/174 (51%), Gaps = 17/174 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKIL-ERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FG +Y + + +K+L E P E NP + Q QE +L+ L H IV
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIV 65
Query: 200 RFIGACRKRMVWCIVTEYAKGG----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+F + +R +CI+TEY +G + + + + + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAPSA 308
+HRDLK+ N+ + + +KI DFGV+R+ + + + T TGT +M+P A
Sbjct: 124 QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 27/169 (15%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME----QQFQQEV 187
+G +G FG + ED VA+K+L KA + ++F +E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML--------KADIFSSSDIEEFLREA 52
Query: 188 MMLATLKHLNIVRFIG-ACRKRM-----VWCIVTEYAKGGSVRQFL--TR--RQNRAVPL 237
+ H N+++ IG + R R + ++ + K G + FL +R + +PL
Sbjct: 53 ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ V+ +D+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 134 LRKLNMGTAFAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
L MG G+FG++ ++GT GE AIK L++ E K QV Q QE +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK-QV--QHVAQEKSI 71
Query: 190 LATLKHLNIVRFI-GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
L L H IV + + V+ + E+ GG + F R+ P +A ++
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVY-FLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELV 128
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+H I+RDLK +NLL+ +K+ DFG A+ +V + GT ++AP
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KV-PDRTFTLCGTPEYLAP 184
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 32/184 (17%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 29 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVKFL 79
Query: 191 ATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA- 248
+KH N + + G R+ W +V EY G + ++ PL Q +++A
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAW-LVMEYCLGSASDLLEVHKK----PL-----QEVEIAA 129
Query: 249 ------RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+G+AY+H IHRD+K+ N+L++ +K+ADFG A I GT
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPY 186
Query: 303 WMAP 306
WMAP
Sbjct: 187 WMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 23/175 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVR 200
GA+G +Y R ++G VA+K + R + N + + +EV +L L+ NIVR
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPL---STVREVALLKRLEAFDHPNIVR 66
Query: 201 FIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
+ C R+ V +V E+ +R +L + +P K ++Q L RG+
Sbjct: 67 LMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H +HRDLK +N+L+++ +K+ADFG+ARI +TP T + AP
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 2/121 (1%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E M+L + H +++R + C+V + + +LT+R +R +P+ A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIEK 164
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
+ G+ Y+H IHRD+K++N+ I+ + I D G A+ V GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 306 P 306
P
Sbjct: 225 P 225
|
Length = 357 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
V EY GG + F +R R A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 72 FFVMEYVNGGDL-MFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++ IKIADFG+ + E G+T T GT ++AP
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+ L + + + A+K + P K+ + ++E ++LA +KH NIV F
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLP-----KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EY GG + Q + ++ + P ++ + + G+ ++H +HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARI 287
D+KS N+ ++ + +K+ DFG AR+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG ++ T +G+ VA+K + N V ++ +E+ ML KH N++ +
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQN----LVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 204 ACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGL 257
+ + +VTE + + + + Q + +K+ + Q L RG+ Y+H
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSA 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
G +HRD+K NLL++++ +KI DFG+AR+E E MT E T + AP
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 25/59 (42%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
RG+ Y+H +HRDLK NLL++A+ +KI DFG+AR + MT T + AP
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R G A+KIL R E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ R+ C V EYA GG + L+R R + A ++ + Y+H +
Sbjct: 62 YAFQTHDRL--CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+RD+K +NL++ D IKI DFG+ + E ++G T +T GT ++AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
KLN +G +G +YR T +GE VA+K + R +N + + + E+ +L L
Sbjct: 11 KLNR---IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR---EITLLLNL 63
Query: 194 KHLNIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRR-QNRAVPLKLA-VKQ-ALDVA 248
+H NIV + + I V EY + Q L N P + VK L +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
RG+ Y+H IHRDLK NLL++ +KIADFG+AR + + MTP+ T + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
+++Q E+ +L I+ F GA R+ C TE+ GGS+ + R +P
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC--TEFMDGGSLDVY------RKIP 93
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + A+ V +G+ Y+ L +HRD+K N+L++ +K+ DFGV+ V + T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT- 152
Query: 297 ETGTYRWMAP 306
GT +MAP
Sbjct: 153 YVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 37/107 (34%), Positives = 49/107 (45%), Gaps = 26/107 (24%)
Query: 212 CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
C V EYA GG + F R AV A V G+ Y+H ++RDLK
Sbjct: 78 CFVMEYAAGGDLMMHIHTDVFSEPR---------AVFYAACVVLGLQYLHENKIVYRDLK 128
Query: 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
DNLL+ + +KIADFG+ + EGM GT ++AP
Sbjct: 129 LDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAP 170
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN 197
+GAFG+ L R G+ A+K+L K+ ++++ V +LA
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
IV+ + + +V EY GG + L R+ P + A ++ + VH L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA 285
GFIHRD+K DN+LI AD IK+ADFG+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG+++ G E +V +K ++ ++ + QV QE +L L H NI
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQV--TLLLQESCLLYGLSHQNI 70
Query: 199 VRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTR------RQNRAVPLKLAVKQALDVA 248
+ + C V + Y G+++ FL + +A+ + V A+ +A
Sbjct: 71 LPILHVCIEDGEPPFV---LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
GM+Y+H G IH+D+ + N +I + +KI D ++R
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 139 MGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENNPEKAQVME--QQFQQEVMMLATLK 194
+G F L + VA+K L+ + E + QQE++ L+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLD--------SCSKEDLKLLQQEIITSRQLQ 57
Query: 195 HLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR 249
H NI+ FI ++ +V+ GS L +P +LA+ L DV
Sbjct: 58 HPNILPYVTSFI---VDSELY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLN 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ Y+H GFIHR +K+ ++L+S D + ++
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIK---ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +++ E VA+K + + E P A +E+ +L LKH NIV
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REICLLKELKHKNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
R +V EY ++++ P +K + Q L +G+A+ H
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLI+ + +K+ADFG+AR
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 26/179 (14%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK--ILERPENN-PEKAQVMEQQFQQEVMMLATLKHLN-I 198
+G +GK+Y R G+ VA+K LE E P A +E+ +L L I
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-------REISLLQMLSESIYI 63
Query: 199 VRFIGA------CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVAR 249
VR + K ++ +V EY +++F+ R R +P K + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS-IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G+A+ H G +HRDLK NLL+ K +KIAD G+ R + + T E T + AP
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 64/253 (25%), Positives = 98/253 (38%), Gaps = 84/253 (33%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFGK+ + + G VA+K+L+ E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR----MVWCIVTEYAKGG-------SVRQFLTR 229
E+ +L + HLN+V +GAC K MV + EY K G S R+ +
Sbjct: 59 ---TELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEYCKFGNLSNYLRSKRECFSP 112
Query: 230 RQNRAVPLKLAV-----KQALD-------------------------------------- 246
+N++ + KQ LD
Sbjct: 113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172
Query: 247 ---------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ +
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVR 231
Query: 298 TGTYR----WMAP 306
G R WMAP
Sbjct: 232 KGDARLPLKWMAP 244
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ R + A+K++ PE K EQ E +L + H I+R
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLK---QEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ ++ EY GG + +L R + + A ++ + Y+H ++RD
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
LK +N+L+ + IK+ DFG A+ +++ T GT ++AP
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDRTWT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
+G+ VA+K ++ K Q E F EV+++ +H N+V + +V E
Sbjct: 44 SGKLVAVKKMDL-----RKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVME 97
Query: 217 YAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+ +GG++ +T + + + LAV +AL V +H G IHRD+KSD++L++
Sbjct: 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV------LHAQGVIHRDIKSDSILLTH 151
Query: 274 DKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
D +K++DFG A++ + GT WMAP
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 11/132 (8%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI--GACRKRMVWCIVT 215
G +VAIK+L + PE+ +F++E + A L H NIV + G +++ V
Sbjct: 3 GHEVAIKLLR--TDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VF 58
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-- 273
EY G ++R+ L + A+P + L V +A H G +HRDLK N+++S
Sbjct: 59 EYVPGRTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 274 -DKSIKIADFGV 284
K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 64/190 (33%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVM 179
LE Y I L KL GT + +Y+G D VA+K LE E P A
Sbjct: 5 LETY----IKLDKLGEGT------YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-- 52
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPL 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 53 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNV 106
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296
KL + Q L RG+ Y H +HRDLK NLLI+ +K+ADFG+AR + + T+ +
Sbjct: 107 KLFLFQLL---RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 297 ETGTYRWMAP 306
E T W P
Sbjct: 164 EVVTL-WYRP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + C+V EY +GG L + A+P+ +A + + Y+H
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +HRDLK DNLLI++ IK+ DFG+++I
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G+FGK L + +G A+K+L+ K +++++ Q +M +L LKH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQ-------KKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A +VA + Y+H L
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
I+RDLK +N+L+ + + + DFG+ + EG+ PE GT ++AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G +VA+K L RP N Q ++ +E+++L + H NI+ + + + E+
Sbjct: 46 GINVAVKKLSRPFQN----QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS---LEEF 98
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V + + + + ++L ++ + G+ ++H G IHRDLK N+++ +
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D ++KI DFG+AR MTP T + AP
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
+L+ + G AQG Y T G++VAIK L RP N A+ + +++ V+M
Sbjct: 20 NLKPIGSG---AQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMK-L 71
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--- 249
+ H NI+ + + + E+ V + + L ++ LD R
Sbjct: 72 VNHKNIIGLLNVFTPQKS---LEEFQDVYLVMELMDAN------LCQVIQMDLDHERMSY 122
Query: 250 -------GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK L R G+ A+KIL++ E K +V + V+ L +++
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
R+ C V EYA GG + L+R ++RA + AL Y+H
Sbjct: 64 FQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHSCD 115
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + + ++G T +T GT ++AP
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 19/195 (9%)
Query: 124 LENYDEWTIDLRKLNMGT-------AFAQGAFG--KLYRGTYNGEDVAIKILERPENNPE 174
L Y + +R L M +GAFG +L R + A+K+L + E
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
F +E ++A +V+ A + +V EY GG + ++ N
Sbjct: 85 SDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYD 138
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294
VP K A +V + +H +GFIHRD+K DN+L+ +K+ADFG +++ EGM
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGM 197
Query: 295 T---PETGTYRWMAP 306
GT +++P
Sbjct: 198 VRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-I-LE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K I LE E P A +E+ +L L H NIV
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPNIV 61
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + ++ +V E+ +++++ + L + +G+AY H
Sbjct: 62 RLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK NLLI + ++K+ADFG+AR
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 55/253 (21%), Positives = 90/253 (35%), Gaps = 79/253 (31%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G GAFGK+ + G VA+K+L+ E +M
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAK-------------------- 219
E+ +L + HLN+V +GAC + ++ E+ K
Sbjct: 59 ---SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 220 -----------------------GGSVR----QFLTRRQNRAVPLKLA------------ 240
G +F P +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 241 -VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ + VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 300 TYR----WMAPSA 308
+ R WMAP +
Sbjct: 235 SARLPLKWMAPES 247
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 144 AQGAFGKLYRG---TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 10 GEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 201 FIGACR-----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK N+L+++ IK+ADFG+ARI
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHL 196
QG+FGK++ G G+ A+K+L+ KA + + + M +LA + H
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEVNHP 58
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVH 255
IV+ A + ++ ++ +GG + TR + + VK L ++A + ++H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E GT +MAP
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 145 QGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ T G VAIK L RP + A+ + +E+ +L + H N++ +
Sbjct: 25 SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKHMDHENVIGLL 80
Query: 203 GACRKRMVWC------------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ +VT G + + ++ ++ V Q L RG
Sbjct: 81 D------VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL---RG 130
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRW-MAP 306
+ Y+H G IHRDLK N+ ++ D +KI DFG+AR T+ MT T RW AP
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT-RWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 19/147 (12%)
Query: 146 GAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+L RG VAI L ++ ++ + F E + L H NIVR
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-----RGFLAEALTLGQFDHSNIVR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHG 256
G + IVTEY G++ FL + + +L Q + +A GM Y+
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSE 125
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFG 283
+G++H+ L + +L+++D KI+ F
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
AQG Y + +VAIK L RP N Q ++ +E++++ + H NI+ +
Sbjct: 29 AQGIVCAAYDAVLD-RNVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGF 259
+ + E+ V + + + + ++L ++ + G+ ++H G
Sbjct: 84 VFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 57/174 (32%), Positives = 77/174 (44%), Gaps = 27/174 (15%)
Query: 148 FGKLYRGTY----------NGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
KL GTY VA+K LE E P A +EV +L LKH
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKH 62
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAY 253
NIV +V EY ++Q+L N +K+ + Q L RG++Y
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSY 118
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 306
H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T W P
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-WYRP 171
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 40/142 (28%), Positives = 75/142 (52%), Gaps = 9/142 (6%)
Query: 145 QGAFGKLY----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G+++ +GT G+ A+K+L++ E +V +QE+ LATL H +
Sbjct: 11 KGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRN-KVKRVLTEQEI--LATLDHPFLPT 65
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + C+V +Y GG + + L R+ + + ++A A +V + Y+H LG +
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 261 HRDLKSDNLLISADKSIKIADF 282
+RDLK +N+L+ I ++DF
Sbjct: 126 YRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 138 NMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM-----L 190
N +G+FGK+ G D AIKIL K V+ Q E M L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVIIQDDDVECTMVEKRVL 54
Query: 191 ATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A + + +C + M V EY GG + + + P AV A ++A
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH--AVFYAAEIAI 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ A+ IKIADFG+ + E G T T GT ++AP
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 6/63 (9%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWM 304
RG+ Y+H +HRDLK NLL++ + +KI DFG+ARI T +T T RW
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLA 191
+ +G G+FG +Y E VAIK +L+ P Q +E++++
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMK 114
Query: 192 TLKHLNIVRF--------IGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAV 241
L H+NI+ K + +V E+ +V +++ R N A+PL L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286
+ + R +AY+H HRDLK NLLI + ++K+ DFG A+
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 46/164 (28%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ-------QEVMMLATLKH 195
+G +G +YR GE VA+K L+ ME++ + +E+ +L L+H
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK-----------MEKEKEGFPITSLREINILLKLQH 63
Query: 196 LNIVRFIGACRKRMVW-------CIVTEYAKGGSVRQFL-----TRRQNRAVP-LKLAVK 242
NIV K +V +V EY V L T +Q +K +
Sbjct: 64 PNIVTV-----KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
Q L G+A++H +HRDLK+ NLL++ +KI DFG+AR
Sbjct: 114 QLL---SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 37/164 (22%)
Query: 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219
+VAIK L RP N Q ++ +E++++ + H NI+ + +
Sbjct: 51 NVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTP 94
Query: 220 GGSVRQFLTRRQNRAVPLKL-------AVKQALDVAR----------GMAYVHGLGFIHR 262
S+ +F Q+ + ++L ++ LD R G+ ++H G IHR
Sbjct: 95 QKSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-------FAQGAFG--KLYRG 154
AL D AL ++ L Y++ + KL M +GAFG +L R
Sbjct: 5 ALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 155 TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLN---IVRFIGACRKRM 209
+ + A+K+L + E + A E++ ++M H N IV+ A +
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEER---DIM-----AHANSEWIVQLHYAFQDDK 116
Query: 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
+V EY GG + ++ N +P K A +V + +H +GFIHRD+K DN+
Sbjct: 117 YLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 270 LISADKSIKIADFGVARIEVQTEGM 294
L+ +K+ADFG +++ GM
Sbjct: 174 LLDKSGHLKLADFGTC-MKMDANGM 197
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 27/64 (42%), Positives = 34/64 (53%), Gaps = 7/64 (10%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRW 303
RG+ Y+H IHRDLK NLL++ D ++I DFG+AR MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 304 M-AP 306
AP
Sbjct: 177 YRAP 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVA---IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ E +A I++ + E P A +E+ +L ++H NIV
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGNIV 64
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + KR+ +V EY +++ + + A +L + RG+AY H
Sbjct: 65 RLQDVVHSEKRLY--LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 258 GFIHRDLKSDNLLIS-ADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAP 306
+HRDLK NLLI ++K+ADFG+AR I V+T T E T + AP
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP 172
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FGK L + +G+ A+K+L++ N E+ +M ++ ++L +KH +V
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPFLV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + V ++ GG + F ++ R+ P A A ++A + Y+H +
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 306
++RDLK +N+L+ + + + DFG+ + + Q++ T GT ++AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 141 TAFAQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATL 193
+G+FGK+ + + A+K+L+ K +++++ Q+ +M +L +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ-------KKAILKKKEQKHIMAERNVLLKNV 53
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH +V + + V +Y GG + L R R+ P A A ++A + Y
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGY 111
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+H L I+RDLK +N+L+ + + + DFG+ + ++ T GT ++AP
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + P AV A +++ G+ ++H G I+RDLK DN+++ +
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IKIADFG+ + E +G+T T GT ++AP
Sbjct: 137 EGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 43/171 (25%), Positives = 84/171 (49%), Gaps = 17/171 (9%)
Query: 144 AQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHL 196
+G+FGK+ + E+ A+K+L+ K +++++ ++ +M +L +KH
Sbjct: 4 GKGSFGKVLLARHKAEEKFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V + + V +Y GG + L R + P A A ++A + Y+H
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR--ARFYAAEIASALGYLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
L ++RDLK +N+L+ + I + DFG+ + ++ G T GT ++AP
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 60/185 (32%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVMEQQFQ 184
E I L KL GT + +++G + VA+K LE E P A
Sbjct: 6 ETYIKLEKLGEGT------YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------- 52
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVK 242
+EV +L LKH NIV +V EY ++Q++ N +K+ +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTY 301
Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T
Sbjct: 112 QIL---RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 302 RWMAP 306
W P
Sbjct: 169 -WYRP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R +G+ A+KIL++ E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ + R+ C V EY GG + L+R ++R + ALD Y+H
Sbjct: 62 YSFQTKDRL--CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E T+ T +T GT ++AP
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM----- 189
N +G+FGK+ G D AIKIL K V+ Q E M
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVVIQDDDVECTMVEKRV 53
Query: 190 LATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
LA + + +C + M V EY GG + + + P AV A ++A
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH--AVFYAAEIA 111
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ ++ IKIADFG+ + E +G+T +T GT ++AP
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A L +V+
Sbjct: 10 GRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEA--DSLWVVKM 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
+ + ++ ++ E+ GG + L ++ +A + + +H LG
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-----ETVLAIDSIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ + +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 108 DALAQALMDHRYPT--------EGLENYDEWTIDLRKLNMGT-------AFAQGAFG--K 150
D L ++D +P L Y++ +RKL M +GAFG +
Sbjct: 1 DGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210
L R + + A+K+L + E F +E ++A +V+ A +
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKY 117
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + ++ N VP K A +V + +H +G IHRD+K DN+L
Sbjct: 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 271 ISADKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 306
+ +K+ADFG +++ GM GT +++P
Sbjct: 175 LDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+G G+ VA+K + R E+ E + +E+ +L L+H NIV
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG---VPSTAIREISLLKELQHPNIVCLQ 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVHGLGFIH 261
+ ++ E+ + + + + + +L VK L + +G+ + H +H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL-VKSYLYQILQGILFCHSRRVLH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RDLK NLLI IK+ADFG+AR
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L A+K L R ++ + QV + ++++ LA + +V+
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDI--LAEADNEWVVKLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R + P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGV 284
+K DN+LI D IK+ DFG+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIV 199
GAFG+ L R A+K L KA V+ + + E +LA + +V
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLR-------KADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + + V +Y GG + L R LA ++ + VH +GF
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGV 284
IHRD+K DN+LI D IK+ DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 141 TAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQ-----QFQQEVMMLATL 193
T QG +G+++ + GE VA+K + K ++ + E +L T
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTT 58
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K +V+ + A + + EY GG R L + A ++ +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDA 116
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+H LG+IHRDLK +N LI A IK+ DFG++
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + Y+H IHRDLK N+L+++D +K+ADFG+AR
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
W + R N+ + GA+G + T G VA+K L RP ++ + ++ +E+
Sbjct: 13 WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 67
Query: 188 MMLATLKHLNIVRFI-----GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+L +KH N++ + + + + G + + ++ ++ +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
Q L RG+ Y+H IHRDLK NL ++ D +KI DFG+AR + MT T
Sbjct: 128 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 8/125 (6%)
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ- 243
E +L L H +V + + +V + GG +R L+++ V +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKF 104
Query: 244 -ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTY 301
++ + Y+H G IHRD+K DN+L+ + I DF +A V + +T T GT
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTSGTP 163
Query: 302 RWMAP 306
+MAP
Sbjct: 164 GYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + + A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 74 VMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D IKIADFG+ + + EG GT ++AP
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R ++ GA+G + GE VAIK L RP ++++ ++
Sbjct: 7 NKTVWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----QSEIFAKRA 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-- 240
+E+ +L ++H N++ E+ V ++ + + L+
Sbjct: 62 YRELTLLKHMQHENVIGL----LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 241 -----VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
V Q L G+ Y+H G IHRDLK NL ++ D +KI DFG+AR
Sbjct: 118 KVQYLVYQML---CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWM 304
G+ Y+H +HRDLK NLL++AD +KI DFG+AR + G E RW
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF- 201
+G +G++Y R GE VA+K + R +N E + + E+ +L L H NIV
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR---EIKILRQLNHRNIVNLK 72
Query: 202 ---------IGACRKRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ + + + +V EY + G V + ++ +KQ
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSF-----MKQL 125
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
L+ G+ Y H F+HRD+K N+L++ IK+ADFG+AR+
Sbjct: 126 LE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R N+ T GA+G + T + VA+K L RP ++ + ++
Sbjct: 7 NKTVWEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRT 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK- 242
+E+ +L +KH N++ + + T + + L VK
Sbjct: 62 YRELRLLKHMKHENVIGLLD---------VFTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 243 QAL----------DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291
Q L + RG+ Y+H G IHRDLK N+ ++ D ++I DFG+AR Q
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QAD 169
Query: 292 EGMTPETGTYRWMAP 306
+ MT T + AP
Sbjct: 170 DEMTGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L + G A+KIL++ E K +V + V+ + L ++
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGF 259
+ R+ C V EYA GG + L+R R A ++ + Y+H
Sbjct: 62 YSFQTHDRL--CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E +G T +T GT ++AP
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 145 QGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ G D AIK+L++ + + V ++ ++ LA KH +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAA-KHPFLTALH 62
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + F +R +R + A +V + ++H G I+R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL-MFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
DLK DN+L+ A+ K+ADFG+ + E G+T T GT ++AP
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
I+ R + E + Q +E+ +L IV F GA I E+ GGS+
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIAD 281
Q L ++ + +P ++ K ++ V RG+AY+ H + +HRD+K N+L+++ IK+ D
Sbjct: 92 QVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCD 147
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
FGV+ + + + GT +M+P
Sbjct: 148 FGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 22/137 (16%)
Query: 185 QEVMMLATLKHLNIVRF--------------IGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+E+ ++ L H NIV+ +G+ + IV EY + + L +
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFGVARI-- 287
+L + Q L RG+ Y+H +HRDLK N+ I+ + + KI DFG+ARI
Sbjct: 110 PLSEEHARLFMYQLL---RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 288 -EVQTEGMTPETGTYRW 303
+G E +W
Sbjct: 167 PHYSHKGYLSEGLVTKW 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 142 AFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GA+G + G VAIK L RP ++++ ++ +E+ +L +KH N++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVI 77
Query: 200 RFIGACRKRMVWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + ++ G + + + + ++ V Q L +G+ Y+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML---KGLKYI 134
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
H G IHRDLK NL ++ D +KI DFG+AR QT+ MT T + AP
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 13/100 (13%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V EY GG + F +RQ R +P + A A ++ + ++H G I+RDLK DN+L+
Sbjct: 73 LVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
AD IK+ D+G+ + EG+ P GT ++AP
Sbjct: 131 ADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L R A+K L R ++ + QV + ++++ LA + +VR
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDI--LAEADNEWVVRLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGV 284
+K DN+LI D IK+ DFG+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 19/133 (14%)
Query: 184 QQEVMMLATLKHLN---IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
Q + L L N IV F GA I E+ GGS+ Q L ++ +P +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 241 VKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
K ++ V RG+ Y+ +HRD+K N+L+++ IK+ DFGV+ G ++
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSM 154
Query: 299 -----GTYRWMAP 306
GT +M+P
Sbjct: 155 ANSFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 145 QGAFGKLYR-----GTYNGEDVAIKILERPENNPEKAQVMEQQ-----FQQEVMMLATLK 194
+G +GK+++ G G+ A+K+L+ KA ++ Q + E +L +K
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILEAVK 58
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAY 253
H IV I A + ++ EY GG + L R + ++ L +++ + +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEH 115
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G I+RDLK +N+L+ A +K+ DFG+ + + EG T GT +MAP
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A + + F
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWV-VKMF 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
KR ++ I+ E+ GG + L ++ A +A + + +H LG
Sbjct: 68 YSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIA-----ETVLAIDAIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ A +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 18/30 (60%), Positives = 24/30 (80%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+H LG+IHRD+K DNLL+ A IK++DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 25/134 (18%), Positives = 61/134 (45%), Gaps = 10/134 (7%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----FIGACR 206
+Y+G +N ++V I+ ++ +V+ + E+ L + NI++ I
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLK 265
++ EY G +R+ L + + + K + A+D +G+ ++ +++L
Sbjct: 93 DLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 266 SDNLLISADKSIKI 279
S + L++ + +KI
Sbjct: 151 SVSFLVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 143 FAQGAFGKLYRGTYNGED--VAIKILERP----ENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G+FGK++ G + AIK L++ +++ E V ++ V+ LA +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLA-WEHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V EY GG + F + ++ L A A ++ G+ ++H
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + + + T GT ++AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F +RQ R +P + A + +++ + ++H G I+RDLK DN+L+ A
Sbjct: 74 VIEFVSGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IK+ D+G+ + E G T T GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 13/99 (13%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + F +RQ R +P + A + +++ + Y+H G I+RDLK DN+L+ +
Sbjct: 74 VIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
+ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W + L +G GAFG++ T +G VA+K+L+ + EK +
Sbjct: 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +++ L HLNIV +GAC K I+TEY + G + +L R ++
Sbjct: 88 M-----SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 11/167 (6%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++ + G+ A K L++ K EQ E +L + IV
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVSLA 59
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C+V GG ++ + P A+ A + G+ ++H ++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L+ +++I+D G+A V+ +G GT +MAP
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 11/115 (9%)
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
KA + +E+ +L T+ H I+ I A R + C+V K L +R+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD-----LFTYVDRS 179
Query: 235 VPLKLAVKQALDVARGM----AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
PL L +QA+ + R + AY+HG G IHRD+K++N+ + ++ + DFG A
Sbjct: 180 GPLPL--EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 19/32 (59%), Positives = 25/32 (78%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
VH LGFIHRD+K DN+LI IK++DFG++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENN 172
PT+ L ++W L G GAFGK+ T G ED VA+K+L+ +
Sbjct: 24 PTQ-LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82
Query: 173 PEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
E+ +M E+ +L+ L +H NIV +GAC ++TEY G + FL ++
Sbjct: 83 DEREALM-----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
Query: 232 NRAVPLKLAVKQALD 246
+ +A+ + +
Sbjct: 138 ETFLNFVMALPEISE 152
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 175 KAQVMEQQFQQEVMML----ATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTR 229
+A V Q+ ++ +M L ++ V F GA R+ VW I E S+ +F +
Sbjct: 35 RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW-ICMEVMDT-SLDKFYKK 92
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ +P + K A+ + + + Y+H L IHRD+K N+LI+ + +K+ DFG++
Sbjct: 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 287 IEVQTEGMTPETGTYRWMAP 306
V + T + G +MAP
Sbjct: 153 YLVDSVAKTIDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIK---ILERPENNPEKAQVMEQ-- 181
++I R + G +G +GK+ + T G+ VAIK I+E + + Q++
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 182 -QFQ--QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-L 237
F +E+ ++ +KH NI+ + + +V + +++ + R+ +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------- 289
K + Q L G+ +H F+HRDL N+ I++ KIADFG+AR
Sbjct: 122 KCILLQIL---NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 290 -------QTEGMTPETGTYRWMAP 306
+ E MT + T + AP
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAP 202
|
Length = 335 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280
V+ L+ + + + VARGM ++ +HRDL + N+L++ K +KI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 281 DFGVARIEVQTEGMTPETGTY---RWMAPSA 308
DFG+AR + + T+ +WMAP +
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 13/123 (10%)
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
F + +++ L H ++V+ G C R +V EY K G + FL R+
Sbjct: 38 LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFL-HREK 95
Query: 233 RAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKIADFG 283
V L KL V + L A + Y+ +H ++ N+L++ IK++D G
Sbjct: 96 NNVSLHWKLDVAKQL--ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 284 VAR 286
+
Sbjct: 154 IPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNIV 199
G FG++ ++ A+K ++ K ++E Q+ + +L H IV
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ EY GG + L R A V Y+H G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +NLL+ ++ +K+ DFG A+ ++++ T T GT ++AP
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKT-WTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W L +G GAFGK+ GT G VA+K+L+ + EK +
Sbjct: 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVP 236
M E+ ++ L HLNIV +GAC K I+TEY G + +L + R N
Sbjct: 88 M-----SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
Query: 237 LKLAVKQALDV 247
K+ LD+
Sbjct: 143 HPEKPKKDLDI 153
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 19/39 (48%), Positives = 26/39 (66%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
R + Y+H HRDLK N+L +AD +KI DFG+AR+
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + AV A ++ G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + + + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFG++ G D VA+K+L+ + E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
E+ +L + HLN+V +GAC K ++ E+ K G++ +L ++ VP K
Sbjct: 59 ---SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 154 GTYNGEDVAIKILERPEN--------NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
G NG V K+ +P + E + Q +E+ +L IV F GA
Sbjct: 14 GAGNG-GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHR 262
I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ H + +HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 28/133 (21%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
EK ++E++ +L + IV A + C+V GG ++ + R
Sbjct: 37 EKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGER 90
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+ ++ + + + G+ ++H + ++RD+K +N+L+ + +++D G+A +
Sbjct: 91 GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150
Query: 294 MTPETGTYRWMAP 306
+T GT +MAP
Sbjct: 151 ITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 143 FAQGAFGKLYRGTYNG--EDVAIKILERP----ENNPEKAQVMEQQFQQEVMMLAT---- 192
+G+FGK+ G E A+K L++ +++ E V ++ V+ LA
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALAWENPF 57
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
L HL + + V E+ GG + F + + R L A A ++ G+
Sbjct: 58 LTHL-----YCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQ 110
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
++H G I+RDLK DN+++ D IKIADFG+ + V + + GT ++AP
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD +W +L+ G GAFGK+ T G D VA+K+L+ + E+ +
Sbjct: 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +L+ L H+NIV +GAC ++TEY G + FL R+++
Sbjct: 86 M-----SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
VA GM ++ +HRDL + N+LI K +KI DFG+AR ++ + T+ +W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 304 MAPSA 308
MAP +
Sbjct: 308 MAPES 312
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 5/69 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G R
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL 243
Query: 303 ---WMAPSA 308
WMAP
Sbjct: 244 PLKWMAPET 252
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 6/57 (10%)
Query: 233 RAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
R PL LA Q VAR + Y+HG G IHRD+K++N+L++ + I + DFG A
Sbjct: 253 RLRPLGLA--QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 24/181 (13%)
Query: 138 NMGTAFAQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQ----QFQQEVMMLA 191
++ + +G FG ++ R G+ A+K+++ K+ ++ Q F++E +L+
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-------KSVLLAQETVSFFEEERDILS 56
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKLAVKQALDV 247
I + A + + +V EY GG + L R +++ LA ++
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-----EL 111
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG-VARIEV-QTEGMTPETGTYRWMA 305
+ VH +G++HRD+K +N+LI IK+ADFG AR+ + GT ++A
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 306 P 306
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 43/177 (24%), Positives = 86/177 (48%), Gaps = 28/177 (15%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G +G+ A+K+L++ E+ + QV+E Q L
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--FLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
TL + A + ++ +Y GG + L++R+ R ++ + ++ +
Sbjct: 69 TLHY--------AFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSG-EIVLAL 118
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ E + E GT +MAP
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 145 QGAFGKLYRGTYN---GEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G++Y Y+ VA+K I E NP +++++F +E + A L H IV
Sbjct: 12 KGGMGEVYLA-YDPVCSRRVALKKIREDLSENP----LLKKRFLREAKIAADLIHPGIVP 66
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQAL--------DVARGM 251
C Y +G +++ L + Q ++ +LA K ++ + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
YVH G +HRDLK DN+L+ + I D+G A
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ +Q +E+ ++ + IV F GA C+ E+ GS L R + P+
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIP 101
Query: 239 LAV--KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295
+ + K A+ V G+ Y++ +HRD+K N+L+++ IK+ DFGV+ + + T
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161
Query: 296 PETGTYRWMAP 306
GT +M+P
Sbjct: 162 -FVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 28/100 (28%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 213 IVTEYAKGGSVRQFLTRRQN---RAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDN 268
++ +Y GG + L +R++ V + +A + ALD ++H LG I+RD+K +N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLGIIYRDIKLEN 135
Query: 269 LLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+L+ ++ + + DFG+++ + E + GT +MAP
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 28/96 (29%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 273 ADKSIKIADFG--VARIEVQTEGMTPETGTYRWMAP 306
+ I++ADFG + +E T + GT +++P
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 5/66 (7%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR---- 302
VA+GM+++ IHRDL + N+L++ + KI DFG+AR +++ + G R
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281
Query: 303 WMAPSA 308
WMAP +
Sbjct: 282 WMAPES 287
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTY 301
A ++ + ++H G I+RDLK DN+L+ + K+ADFG+ + + G T T GT
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTP 160
Query: 302 RWMAP 306
++AP
Sbjct: 161 DYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E +L + H +I++ G C++ K + +L ++N A+ LA++++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS- 190
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V R + Y+H IHRD+K++N+ I+ + + DFG A
Sbjct: 191 -VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYN-----GE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
QG F K+++G GE +V +K+L++ N E F+ MM + L H
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-----YSESFFEAASMM-SQLSH 58
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++V G C +V EY K GS+ +L + +N + + ++ A +A + ++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE 117
Query: 256 GLGFIHRDLKSDNLLIS---ADKS-----IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G H ++ + N+L+ K+ IK++D G++ I V + + E W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLE--RIPWVPP 173
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 49/176 (27%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 149 GKLYRGTYNGEDVAIKILERPEN-----NPEKAQVMEQQFQQEVMMLATLKHLN---IVR 200
+L +G Y K+L RP + ++ E +F Q +M L L IV
Sbjct: 7 DELGKGNYG---SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAY--VHGL 257
F GA + EY GS+ + +P DV R + Y V GL
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE--------DVLRRITYAVVKGL 115
Query: 258 GF-------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
F IHRD+K N+L++ + +K+ DFGV+ V + T G +MAP
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH LG++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 146 GAFGKLY--RGTYNGED-VAIKILERPENNP-------EKAQVMEQQFQQEVMMLATLKH 195
GAFG +Y R NG++ +A+K E +NP E+ + + + ++ L+H
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALK--EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAY 253
NIVR+ + IV + +G + + + + + + + + + Y
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 254 VHGLGFI-HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H I HRDL +N+++ D + I DFG+A+ + +T GT + P
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 18/39 (46%), Positives = 27/39 (69%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V G+ +H +G +HRD+K +NLL++ D +KI DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 23/67 (34%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRD+ + N+L++ + KI DFG+AR ++ + G R
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276
Query: 303 ---WMAP 306
WMAP
Sbjct: 277 PVKWMAP 283
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 147 AFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206
A GK+Y A K LE+ K + M +Q +L + +V A
Sbjct: 23 ATGKMY---------ACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVSLAYAYE 70
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266
+ C+V GG ++ + N + AV A ++ G+ +H ++RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 267 DNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 131 ENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 40/178 (22%), Positives = 85/178 (47%), Gaps = 30/178 (16%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G G+ A+K+L++ E+ + V+E ++ L
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV--RQSPFLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK-QALDVARG 250
TL + A + ++ +Y GG + L +R N + + V+ + ++
Sbjct: 69 TLHY--------AFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
+ ++H LG ++RD+K +N+L+ ++ + + DFG+++ + + E GT +MAP
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 22/71 (30%), Positives = 43/71 (60%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + +H L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 MNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
+ E+ LA H IV+ + ++ EY GG + + + +R +P +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 244 AL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
L + + VH +HRDLKS N+ + IK+ DFG ++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIADFG 283
L +R +P + K + + + + Y+ HG+ IHRD+K N+L+ A ++K+ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFG 160
Query: 284 VARIEVQTEGMTPETGTYRWMAP 306
++ V ++ T G +MAP
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 153 RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW- 211
+ +GE A+K+++ + + + Q EV L +IV+ C +
Sbjct: 52 KRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVK----CHEDFAKK 103
Query: 212 -----------CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG 258
+V +YA G +RQ + R NR A + V + +VH
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH 163
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291
IHRD+KS N+L+ ++ +K+ DFG +++ T
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196
|
Length = 496 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +G +G +Y+ +G+D L++ E + +E+ +L LKH N+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNV 60
Query: 199 V---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-DVAR 249
+ + + R VW ++ +YA+ + +F + P++L VK L +
Sbjct: 61 IALQKVFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 250 GMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
G +G +G +Y+ + D A+K +E + +E+ +L LKH
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 196 LNIV---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-D 246
N++ + + R VW ++ +YA+ + +F + P++L VK L
Sbjct: 58 PNVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
+ G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M E +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 14/129 (10%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF-----IGAC 205
L R T G V ++I + E + + Q EV++ +H NI+ G+
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKAL----QNEVVLSHFFRHPNIMTSWTVFTTGS- 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
+W +++ + GS L + L RG+ Y+H G+IHR++K
Sbjct: 73 ---WLW-VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128
Query: 266 SDNLLISAD 274
+ ++LIS D
Sbjct: 129 ASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-05
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 26/149 (17%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI----VRF 201
G ++Y ED +KI + ++EV +L L + V
Sbjct: 9 GLTNRVYLLGTKDEDYVLKINPS--------REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---G 258
G ++ E+ +G + L A +A +A +H L
Sbjct: 61 SGESDGWSY--LLMEWIEG----ETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLV 109
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
H DL N+L+ K + I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 11/128 (8%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ 243
E +LA + IV A + + C+V GG +R + +N P A
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-----QTEGMTPET 298
+ G+ ++H I+RDLK +N+L+ D +++I+D G+A +E+ +T+G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGY---A 158
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 159 GTPGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 9/166 (5%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGA 204
GAFG + + + + + EK Q ++ ++ +++ + IV+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ---KRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYV-HGLGFI 260
+ I E S+ +F +P ++ K A+ + + Y+ L I
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ + +IK+ DFG++ V + T + G +MAP
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + ++H G HRD+K +N+LI D +K+ADFG R
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+VT+Y GG + F ++ A ++ + ++H ++RDLK +N+L+
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
A I + DFG+++ + T GT ++AP
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 37/165 (22%), Positives = 75/165 (45%), Gaps = 5/165 (3%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++Y R G+ A+K L++ ++ + + + + +++T IV
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A C + + GG + L+ Q+ K A ++ G+ ++H ++
Sbjct: 63 TYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 31/158 (19%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE------------KAQVMEQQFQQEVMM 189
+GA ++Y G + G IK + + +PE +A++M + + V +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A ++ FI IV EY +G ++ + + L + ++ R
Sbjct: 64 PAVY-FVDPENFI----------IVMEYIEGEPLKDLINSNGMEELEL------SREIGR 106
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+ +H G IH DL + N+++S K I + DFG+A
Sbjct: 107 LVGKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 31/150 (20%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKI-LERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNI--- 198
QGA +Y + G +K + + +PE + + ++ ++E +LA + +
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP 64
Query: 199 -VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
V + IV EY +G ++ L L + V + +H
Sbjct: 65 IVYDVDPDNGL----IVMEYIEGELLKDALEEA-----RPDLLREVGRLVGK----LHKA 111
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +H DL + N+++S + I DFG+
Sbjct: 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 18/63 (28%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A ++ G+ ++H ++RDLK N+L+ ++I+D G+A + + GT+ +
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGY 161
Query: 304 MAP 306
MAP
Sbjct: 162 MAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.85 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.74 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.49 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.48 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.29 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.24 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.91 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.87 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.67 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.02 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.85 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.13 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.61 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.37 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.26 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.23 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.01 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.22 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.86 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=350.63 Aligned_cols=262 Identities=29% Similarity=0.476 Sum_probs=222.8
Q ss_pred hcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Ccee--eeeceeeec--CCceee-ccCchH
Q 021253 36 LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYS--VSVGQSVFR--PGKVTH-ALNDDA 109 (315)
Q Consensus 36 ~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~--i~~~~~~~~--~~~v~~-~~~~~~ 109 (315)
..+|+|++++|++ ..|+|++|+.+...+.. ...++||+|+..+ +.+. ++ ...+|. +..+.+ ..+.++
T Consensus 102 ~~~G~flvR~se~---~~g~yslsv~~~~~~~~---~~~v~hyri~~~~~~~~~~~~~-~~~~F~~l~~lv~~~~~~~~g 174 (468)
T KOG0197|consen 102 NKEGAFLVRESES---DKGDYSLSVREGDSGGL---GAKVKHYRIRQLDGGGLYPYID-ERELFSSLQQLVNYYSKNADG 174 (468)
T ss_pred CCccceeeecccC---CcCCeeEEEEeccccCC---ccceeeeeeeEcCCCCeecCCC-HHHhhhhHHHHHhhhhccCcc
Confidence 3469999999876 88999999999887663 3478999999998 5455 55 445553 555554 789999
Q ss_pred HHHHHhcCCCC------CCCCCCCccccccccccccccceeecccCceEEEEECCe-eEEEEEeeCCCCChhHHHHHHHH
Q 021253 110 LAQALMDHRYP------TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ 182 (315)
Q Consensus 110 l~~~l~~~~~~------~~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~ 182 (315)
++..+..++.. ...-...+.|+|+.+.+++.+.||+|.||+||.|.|++. +||+|.++...+.+ +.
T Consensus 175 l~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-------~~ 247 (468)
T KOG0197|consen 175 LCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-------EA 247 (468)
T ss_pred hhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-------hH
Confidence 99999998863 111112799999999999999999999999999999877 99999998876654 47
Q ss_pred HHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 021253 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (315)
Q Consensus 183 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (315)
|.+|+++|++|+|++||+++++|..+..+|||||||+.|+|.++|+......+.....+.|+.|||+||+||+++++|||
T Consensus 248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR 327 (468)
T KOG0197|consen 248 FLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR 327 (468)
T ss_pred HHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence 88999999999999999999999998899999999999999999998667789999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC---ccccccCccccc
Q 021253 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPSAGSIC 312 (315)
Q Consensus 263 Dlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt---~~y~APE~~~~~ 312 (315)
||.++||||+++..+||+|||+||...++ .++...|. ..|+|||++...
T Consensus 328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 328 DLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred hhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhC
Confidence 99999999999999999999999954443 34444443 799999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.66 Aligned_cols=172 Identities=30% Similarity=0.492 Sum_probs=154.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|.+.+.||.|+|+.||+|++ ++..||||.+........ ..+.+..|+.+|+.++|||||.+++++..++.+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k----~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK----LVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH----HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4677888899999999999987 678999999987655433 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC------CcEEEeeeccee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD------KSIKIADFGVAR 286 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~------~~vkl~DFG~a~ 286 (315)
+|||||.||+|.+|++++. .+++..+..++.||+.||++||+++||||||||.|||++.. -.+||+|||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999998753 59999999999999999999999999999999999999864 468999999999
Q ss_pred eeecCCCccCCCCCccccccCccccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.........+.||+|.|||||++..+
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~ 189 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQ 189 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhc
Confidence 88877667788999999999998644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=302.52 Aligned_cols=182 Identities=45% Similarity=0.807 Sum_probs=165.0
Q ss_pred CCccccccccccccccceeecccCceEEEEECCee-EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
....|.|+..++.+.+.||.|+||+||+|.|.|+. ||||++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 45778999999999999999999999999999998 999999876655443 5789999999999999999999999
Q ss_pred EEeCC-EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCCEEEcCCC-cEEEee
Q 021253 205 CRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLISADK-SIKIAD 281 (315)
Q Consensus 205 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NIli~~~~-~vkl~D 281 (315)
|.++. ..+||||||++|+|.+++.......+++..++.|+.||+.||+|||+.+ ||||||||+|||++.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99988 7899999999999999998755567999999999999999999999999 99999999999999997 999999
Q ss_pred ecceeeeecC-CCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
||+++..... ...+...||+.|||||++..
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcC
Confidence 9999976654 34555789999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.96 Aligned_cols=176 Identities=27% Similarity=0.388 Sum_probs=153.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
.+.|.+.+.||+|+||.|-+|.. +++.||||++++........ ........+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35667889999999999999976 88999999998765543221 1112346799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---CcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~---~~vkl~DFG~a~~ 287 (315)
.|+||||++||+|.+++-.. +.+.+.....++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|++
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999764 457777788899999999999999999999999999999766 6899999999999
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
......+.+.||||.|.|||++..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred cccceehhhhcCCccccChhheec
Confidence 877777899999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=279.48 Aligned_cols=175 Identities=25% Similarity=0.399 Sum_probs=154.9
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|+++++||+|+||+||.++. +++.+|+|++++......+ ..+....|..+|..++||.||.++..|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~---e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK---EVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh---hHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 4467899999999999999999976 7889999999876554332 2357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+|+||+.||.|...|++. ..+++..+..++.+|+.||.|||+.|||||||||+|||+|.+|+++|+|||+|+...
T Consensus 99 kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999999999764 569999999999999999999999999999999999999999999999999999543
Q ss_pred c-CCCccCCCCCccccccCcccc
Q 021253 290 Q-TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~-~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+.|||+.|||||++..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred cCCCccccccCCccccChHHHhc
Confidence 3 334556799999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=277.40 Aligned_cols=173 Identities=31% Similarity=0.437 Sum_probs=154.2
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
.+...+++.++.||+|..|.||++.+ +++.+|+|++...... ...+++.+|+++++.++||+||.+||.|..+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 35667888889999999999999988 6889999999543322 2347899999999999999999999999999
Q ss_pred C-EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 209 M-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 209 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
. .++|+||||++|+|.+++... +.+++....+++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 499999999999999999865 569999999999999999999995 899999999999999999999999999999
Q ss_pred eeecCCCccCCCCCccccccCcccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...+. .-.+.+||..|||||.+.+
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISG 251 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcC
Confidence 76665 4467899999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=288.87 Aligned_cols=171 Identities=29% Similarity=0.450 Sum_probs=155.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+.++.||+|+|+.||+++. +|+.||+|++.+....... ..+.+.+|++|.++|+|||||++|++|++.+.+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~---~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK---QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc---hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 5789999999999999999987 8899999999775443332 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
||+|+|+.++|.+++++ .+.+++.+++.++.||+.||.|||+++|||||||..|++++++.+|||+|||+|.....+
T Consensus 95 ivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999999985 466999999999999999999999999999999999999999999999999999876644
Q ss_pred CCccCCCCCccccccCccc
Q 021253 292 EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~ 310 (315)
+...+.||||.|+|||++.
T Consensus 173 Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cccceecCCCcccChhHhc
Confidence 5667789999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.85 Aligned_cols=173 Identities=25% Similarity=0.386 Sum_probs=154.8
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
..+.+|+..+.||.|+||+|.+++. ++.-+|+|++.+...-..+ ..+...+|..+|+.+.||.++++++.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK---QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK---QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH---HHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3567888999999999999999987 7889999999765443322 2467889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||++||.|..++++. +++++..++.+|.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999999999875 459999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ..+.||||.|+|||++.+
T Consensus 196 ~r--T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred Cc--EEEecCCccccChHHhhc
Confidence 33 667899999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=289.39 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=212.6
Q ss_pred CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCchHHHHH
Q 021253 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (315)
.|+|++++|++ .+|-+|+|++..- -+.||+|.... +..+++ ..+.|+ .++|.| ..-+|+|+..
T Consensus 173 nGSFLVRESEs---SpgQ~sISlRyeG---------RVyHYRINt~~dgK~yvt-~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 173 NGSFLVRESES---SPGQYSISLRYEG---------RVYHYRINTDNDGKMYVT-QESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccceEEeeccC---CCcceeEEEEecc---------eEEEEEeeccCCccEEEe-ehhhhhHHHHHHhhccccccceeEe
Confidence 47788888876 6788888888533 57899999876 777877 566674 456654 6788999988
Q ss_pred HhcCCCCCC------CCCCCccccccccccccccceeecccCceEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHH
Q 021253 114 LMDHRYPTE------GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQ 185 (315)
Q Consensus 114 l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~ 185 (315)
|..|..... .....|+|+.++.++.+..+||-|.||+||.|.|.. -.||||.++...+. .++|+.
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLk 312 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLK 312 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHH
Confidence 876643211 123469999999999999999999999999999954 57999999875554 468999
Q ss_pred HHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 186 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
|+.+|+.++|||+|+|+|+|.....+|||+|||..|+|.+||++-....++.-.++.|+.||..||+||..+++|||||.
T Consensus 313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999999999998777778888889999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC---ccccccCccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPSAGS 310 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt---~~y~APE~~~ 310 (315)
++|+|+.++..|||+|||++|++..+ .++...|. +.|.|||-+.
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCccccc
Confidence 99999999999999999999987655 35666665 7999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=281.21 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=186.9
Q ss_pred CCCCCCcccccccCCCCeE-EEEEeeCCCCCCCcccccccCCCCcccCCceeeeeceeeec--CCceeeccCchHHHHHH
Q 021253 38 EGTNMSIDSLQTSNAGGSV-SMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~-s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~~~~~~~~--~~~v~~~~~~~~l~~~l 114 (315)
.|+|+++.+.......... -+|+.-.. ..-+.|+.++.....++.. ....|. +.++.+.......+.
T Consensus 68 ~GDfLvR~s~~~~~~~~~~~vlSv~~~~-------~~~~~h~vi~~~~~~~~~~-~~~~F~si~~li~~~~~~~~~~~-- 137 (474)
T KOG0194|consen 68 DGDFLVRASEPKEGEKREFVVLSVKWSV-------FKKIKHYVIKRNGNLFFFE-GLRKFPTISELVNYYKFSKLEIT-- 137 (474)
T ss_pred CCceEEEeecccCCcceeEEEEEEEeec-------CCceeEEEEEEcCCeeEEe-ccccCCcHHHHHHHHHhccccee--
Confidence 6899999987754444434 67776431 1123488888777644433 222221 222222111110000
Q ss_pred hcCCCCCCCCCCCccccccccccccccceeecccCceEEEEE---CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHH
Q 021253 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---NG---EDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (315)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~---~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (315)
..+......-....|++.-+++.+.++||+|+||+||+|++ ++ ..||||..+..... ....+.+|.+|++
T Consensus 138 -~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~---~~~~~~e~m~EAr 213 (474)
T KOG0194|consen 138 -GKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL---TKEQIKEFMKEAR 213 (474)
T ss_pred -ccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc---cHHHHHHHHHHHH
Confidence 00111111124678999999999999999999999999987 22 23899988752211 1223578999999
Q ss_pred HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q 021253 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (315)
Q Consensus 189 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 268 (315)
+|+.++|||||++||++.....++||||+|.||+|.++|++..+ .++..+.+.++.+.+.||+|||++++|||||.++|
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 99999999999999999999999999999999999999998653 69999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeeecCCCcc-CCCCCccccccCcccc
Q 021253 269 LLISADKSIKIADFGVARIEVQTEGMT-PETGTYRWMAPSAGSI 311 (315)
Q Consensus 269 Ili~~~~~vkl~DFG~a~~~~~~~~~~-~~~gt~~y~APE~~~~ 311 (315)
+|++.++.+||+|||+++......... ...-..+|+|||.+..
T Consensus 293 cL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~ 336 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT 336 (474)
T ss_pred heecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc
Confidence 999999999999999998543111111 1123489999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=267.41 Aligned_cols=175 Identities=26% Similarity=0.433 Sum_probs=150.8
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE-EEEeCC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG-ACRKRM 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~ 209 (315)
++.+|++.++||.|+||+||+++. ++..||.|.++-..++..+ .+.+..|+.+|++|+|||||++|+ .+.++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 457899999999999999999975 8999999999854444333 468899999999999999999999 454444
Q ss_pred -EEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCCEEEcCCCcEEEeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG--LG--FIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~--iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
.++||||++..|+|.++++. .+.+.+++..+|+++.|+|.||..||+ .. |+||||||.||+++.+|.+||.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 48999999999999999984 345679999999999999999999998 45 999999999999999999999999
Q ss_pred cceeeeecCCC-ccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
|++|+...... ..+.+|||+||+||.+..
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhc
Confidence 99998655432 356789999999998763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=275.24 Aligned_cols=177 Identities=28% Similarity=0.495 Sum_probs=156.4
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 209 (315)
....|.+++.||+|.||+|+.|.. +++.||+|++.+....... ....+.+.+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346889999999999999999987 7899999988765333222 233456779999999999 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a~~~ 288 (315)
.+|+||||+.+|+|.+++.+ ..++.+..+.+++.|++.|++|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999987 3568889999999999999999999999999999999999999 99999999999987
Q ss_pred -ecCCCccCCCCCccccccCccccc
Q 021253 289 -VQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 289 -~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.........|||+.|+|||++.+.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCC
Confidence 455567889999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.25 Aligned_cols=171 Identities=29% Similarity=0.433 Sum_probs=150.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+.+.++|+|+||.||+++. +|+.||||.+.....++ +..+..++|+++|++++|||+|.++.+|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~----~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP----VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH----HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 4577788999999999999987 89999999997655443 34567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~ 291 (315)
+|+||++. ++.+-|.+.. ..++...+.+++.|++.|+.|||++++|||||||+||||+.+|.+||||||+||... ..
T Consensus 78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99999987 6666665543 448999999999999999999999999999999999999999999999999999876 66
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
..++..+.|.+|.|||.+-+
T Consensus 156 d~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred chhhhhhhhhhccChhhhcc
Confidence 67888899999999998864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=271.81 Aligned_cols=173 Identities=32% Similarity=0.581 Sum_probs=147.9
Q ss_pred cccccccccceeecccCceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-E
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-V 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 210 (315)
..++|.-...||+|+||.||+|... ++.||||.+....... .++|.+|+.++.+++|||+|+|+|+|.+.. .
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 3466777789999999999999984 4899999876544321 135999999999999999999999999988 5
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+||+|||++|+|.++|.......++|..+++||.++|.||+|||... ||||||||+|||+|++...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 999999999999999998754337899999999999999999999853 99999999999999999999999999976
Q ss_pred eec-CCCccCC-CCCccccccCcccc
Q 021253 288 EVQ-TEGMTPE-TGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~-~~~~~~~-~gt~~y~APE~~~~ 311 (315)
... ....... .||.+|+|||++..
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred CCccccceeeecCCCCccCChhhhcc
Confidence 544 3322333 89999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=273.69 Aligned_cols=170 Identities=31% Similarity=0.422 Sum_probs=154.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~- 209 (315)
.++|.+.++||.|.||.||+|+. ++..||||.+++....-+.. .=+||+..|++|+ |||||++.+++.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 46899999999999999999986 78899999998766554332 2358999999998 999999999999988
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+|||||+. +|+++++.+ +..+++..++.|+.||+.||+|+|.+|++|||+||+||||.....+||+|||+||-..
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999965 999999987 7889999999999999999999999999999999999999989999999999999887
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
....++..+.|.+|.|||++-
T Consensus 162 SkpPYTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLL 182 (538)
T ss_pred cCCCcchhhhcccccchHHhh
Confidence 777889999999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=250.28 Aligned_cols=179 Identities=26% Similarity=0.406 Sum_probs=159.6
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|.+ ++|++++.||+|.||.||.|+. ++..||+|++.+.... .....+++.+|++|.+.|+||||+++|++|
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~---~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL---KTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH---HhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 44554 7999999999999999999987 6678999999764422 222357899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+...+|+++||...|+|...|+......+++..++.+..|++.||.|||..++|||||||+|+|++..+.+||+|||.+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999999877888999999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCccccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.... .....+.|||..|.|||+....
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv~~~ 197 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMVEGR 197 (281)
T ss_pred eecC-CCCceeeecccccCCHhhcCCC
Confidence 8655 4456778999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=267.28 Aligned_cols=173 Identities=23% Similarity=0.330 Sum_probs=150.9
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (315)
....|+.+++||+|.||.||+|+. +|+.||+|.++......+. ..-..+|+.||++|.||||++|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 346888999999999999999987 8889999999876544332 23567999999999999999999998877
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+|+|||+. +|.-++... .-.+++.++..++.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|++.
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999987 898888753 346899999999999999999999999999999999999999999999999999976
Q ss_pred ecCC--CccCCCCCccccccCcccc
Q 021253 289 VQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
.... .++..+-|..|.|||++-+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcC
Confidence 5433 4788889999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=270.90 Aligned_cols=174 Identities=26% Similarity=0.400 Sum_probs=153.3
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
...+|.+++.||+|+|++|++|+. +++.+|||++.+.....++. .+-+.+|-..|.+| .||.|++||..|+++.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---VKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 457999999999999999999987 78899999997655544433 35677899999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+|+||+++|+|.+++.+. ..+.+..++.++.+|+.||+|||++|||||||||+|||+|.++++||+|||.|+...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999999876 569999999999999999999999999999999999999999999999999998753
Q ss_pred cCCC--------------ccCCCCCccccccCcccc
Q 021253 290 QTEG--------------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~--------------~~~~~gt~~y~APE~~~~ 311 (315)
.... ..+++||..|.+||++..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~ 261 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND 261 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC
Confidence 2111 145789999999999873
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=261.73 Aligned_cols=173 Identities=23% Similarity=0.426 Sum_probs=159.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
..+|++.+.||+|.||+|-+|+. .|+.||||.+++.....++. .-.+.+|++||+.|+||||+++|.+|...+.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 36788899999999999999975 89999999998876665443 34688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
.|||||..+|.|++|+.++ +.+++..+..++.||+.|+.|||.++++|||||.+|||+|.++.+||+|||++-.+.+.
T Consensus 129 vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999999876 45999999999999999999999999999999999999999999999999999988888
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
....++||+|.|.+||++.+
T Consensus 207 kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred cHHHHhcCCcccCCccccCC
Confidence 88899999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=263.71 Aligned_cols=151 Identities=28% Similarity=0.466 Sum_probs=138.5
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
.+..++|++++.||+|+||+||+|+. +|..+|+|++++..+....+ ...+..|-.+|....+|.||+||..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q---v~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ---VEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh---HHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 56778999999999999999999976 89999999998876654322 46788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
..+||||||++||++..+|.+. ..+++..+..++.+++.|++-||+.|+|||||||+|+|||..|++||+|||||.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999999864 569999999999999999999999999999999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.05 Aligned_cols=172 Identities=27% Similarity=0.383 Sum_probs=149.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|...+.||+|.||.||+|++ +++.||||.++....... ......+|+..|+.++|+||+.++++|.....+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG----i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG----INRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC----ccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 3567778999999999999987 789999999987644321 1235679999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
||+|||+. +|...++.. ...++...+..++.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.....
T Consensus 78 lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99999976 999999864 466889999999999999999999999999999999999999999999999999976543
Q ss_pred CCccCCCCCccccccCccccc
Q 021253 292 EGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~ 312 (315)
...+..+-|..|.|||.+-++
T Consensus 156 ~~~~~~V~TRWYRAPELLfGs 176 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGS 176 (318)
T ss_pred cccccceeeeeccChHHhccc
Confidence 344555789999999987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=253.70 Aligned_cols=170 Identities=30% Similarity=0.554 Sum_probs=147.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--E
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--V 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 210 (315)
.++..++.||+|+||.||+++. +++..|||.+....... .+.+.+|+.+|++++|||||+++|...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 4577889999999999999998 47899999987652111 357889999999999999999999754443 6
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeecceeeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEV 289 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~~~ 289 (315)
++|.|||+++|+|.+++.+..+ .+++..+..++.||++||+|||++|||||||||+|||++. ++.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8999999999999999998765 7999999999999999999999999999999999999999 7999999999998654
Q ss_pred c----CCCccCCCCCccccccCcccc
Q 021253 290 Q----TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~----~~~~~~~~gt~~y~APE~~~~ 311 (315)
. ........||+.|||||++..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred cccccccccccccCCccccCchhhcC
Confidence 2 222445789999999999984
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=268.67 Aligned_cols=178 Identities=34% Similarity=0.689 Sum_probs=159.7
Q ss_pred CccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.++|+|+.+++.++..||+|.||+||+|.|-| +||||+++.....+++ .+.|.+|+..+++-+|.||+-+.|+|.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehhhc
Confidence 37899999999999999999999999999977 6899999988877764 479999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
.+.. .||+-||+|.+|+.+++..+ ..+.....++||.||+.||.|||.++|||||||..||++.+++.|||.|||++.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 9887 89999999999999998654 458888999999999999999999999999999999999999999999999998
Q ss_pred eeecC---CCccCCCCCccccccCcccc
Q 021253 287 IEVQT---EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~---~~~~~~~gt~~y~APE~~~~ 311 (315)
..... .......|...|||||++..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhh
Confidence 65433 23445568899999999863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=260.49 Aligned_cols=177 Identities=30% Similarity=0.441 Sum_probs=147.3
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhH--------HHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------AQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
.-+++|++.+.||+|.||+|-+|+. +++.||||++.+....... ...-.++..+|+.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4568999999999999999999987 7889999999765443221 11123688999999999999999999
Q ss_pred EEEEEeC--CEEEEEEeccCCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEE
Q 021253 202 IGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRA-VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 202 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vk 278 (315)
+.+..+. +.+|||+|||..|.+...-. ... +.+.++++++.+++.||+|||.+|||||||||+|+|++.+|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9998664 67999999999888765432 333 89999999999999999999999999999999999999999999
Q ss_pred EeeecceeeeecC------CCccCCCCCccccccCcccc
Q 021253 279 IADFGVARIEVQT------EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 279 l~DFG~a~~~~~~------~~~~~~~gt~~y~APE~~~~ 311 (315)
|+|||.+-..... .......|||.|+|||..++
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 9999999755221 12344689999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=251.45 Aligned_cols=178 Identities=26% Similarity=0.401 Sum_probs=156.9
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..+|-+..++|++...||.|..+.||+|+. .++.||||++.....+ ...+.+.+|+..|+.++||||++++..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-----~~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-----NDLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-----hhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 356778889999999999999999999987 7799999999764333 335789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
|..+..+|+||.||.+|++.++++..-...+++..+..|+.++++||.|||++|.||||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999987666799999999999999999999999999999999999999999999999998
Q ss_pred eeeeecCCC-----ccCCCCCccccccCcc
Q 021253 285 ARIEVQTEG-----MTPETGTYRWMAPSAG 309 (315)
Q Consensus 285 a~~~~~~~~-----~~~~~gt~~y~APE~~ 309 (315)
+-...+... ....+||++|||||++
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHh
Confidence 764332211 1456899999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=266.13 Aligned_cols=172 Identities=27% Similarity=0.483 Sum_probs=155.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
-|++++.||.|+.|.|-.|++ +|+.+|||++.+.....+.. ...+.+|+.||+.+.||||+++|++|.....+|+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~---~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQ---PAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeecccccccccc---ccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 356789999999999999987 99999999997763322221 2467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|.||+++|.|.+++.+. +.+++.++.+++.||+.|+.|||..+|+||||||+|+|+|..+.+||+|||+|.+...+.-
T Consensus 90 vlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999765 4589999999999999999999999999999999999999999999999999999888888
Q ss_pred ccCCCCCccccccCccccc
Q 021253 294 MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~ 312 (315)
..+.||.|.|.|||++++.
T Consensus 168 LeTSCGSPHYA~PEIV~G~ 186 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGR 186 (786)
T ss_pred ccccCCCcccCCchhhcCC
Confidence 8899999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=263.07 Aligned_cols=169 Identities=28% Similarity=0.467 Sum_probs=150.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
...|..-++||+|+.|.||.|+. +++.||||.+....... .+.+.+|+.+|+..+|+|||.+++.+...+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 45677778999999999999976 77899999998765544 25788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+|||||+||+|.+.+... .+++.++..||.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|......
T Consensus 346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999999999764 3899999999999999999999999999999999999999999999999998765433
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
....+.+|||+|||||+.+.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTR 443 (550)
T ss_pred cCccccccCCCCccchhhhhh
Confidence 35677899999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=263.49 Aligned_cols=170 Identities=29% Similarity=0.493 Sum_probs=151.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|.+.+.||+|.||.||+|+. +.+.||+|.+.+....... .+.+.+|++|++.++|||||.++++|+...++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 5688889999999999999976 6789999999775554322 467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+.| +|..++... ..++++.+..++.|++.||.|||+.+|+|||+||.|||++..+++|+||||+||.+....
T Consensus 78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999987 999999764 559999999999999999999999999999999999999999999999999999765543
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
..+...|||.|||||...+
T Consensus 155 ~vltsikGtPlYmAPElv~e 174 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE 174 (808)
T ss_pred eeeeeccCcccccCHHHHcC
Confidence 3466789999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.76 Aligned_cols=177 Identities=25% Similarity=0.382 Sum_probs=153.2
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACR 206 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 206 (315)
-.+...+|.+.++||+|.||+|+++.. +++.+|||++++...-.... .+....|.+|+.... ||.+++++..|+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~---Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE---VESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc---HHHHHHHHHHHHHhccCCeEeecccccc
Confidence 356778999999999999999999988 67799999999876543322 467788888888874 999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
...++|+||||+.||++..+.+ ...+++..+..+++.|+.||.|||++|||+||||.+|||+|.+|.+||+|||+|+
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999999999544443 3559999999999999999999999999999999999999999999999999998
Q ss_pred eee-cCCCccCCCCCccccccCccccc
Q 021253 287 IEV-QTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 287 ~~~-~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
-.- .+...++.||||.|||||++++.
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccC
Confidence 533 44456779999999999999853
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=245.78 Aligned_cols=174 Identities=27% Similarity=0.431 Sum_probs=149.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~- 209 (315)
...|+..++||+|+||.||+|+. +|+.||+|.++....... ......+|+.+++.|+|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 45677788899999999999986 889999999986544210 1134569999999999999 999999998877
Q ss_pred -----EEEEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 210 -----VWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 210 -----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
.+++|+||++. +|..++..... ..++...+..++.||+.||+|||+++|+||||||.||||+++|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 89999999965 99999987543 35777889999999999999999999999999999999999999999999
Q ss_pred cceeeee-cCCCccCCCCCccccccCccccc
Q 021253 283 GVARIEV-QTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 283 G~a~~~~-~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
|+|+... +...+++..+|..|.|||++-++
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs 195 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGS 195 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCC
Confidence 9999655 34457888999999999997554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.49 Aligned_cols=170 Identities=32% Similarity=0.547 Sum_probs=153.7
Q ss_pred CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.-+.|+|+++.+.-++-||+|+.|.||+|++.++.||||.++. .-..++.-|++|+||||+.|.|+|
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceeeEeeee
Confidence 4577999999999999999999999999999999999998743 223678889999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.....+|||||||..|.|.+.|+.. +.+.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999999864 56888999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+...+....-.++||..|||||+|.
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIr 284 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIR 284 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhh
Confidence 8655444455689999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=243.82 Aligned_cols=172 Identities=22% Similarity=0.298 Sum_probs=147.7
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|+..+.||+|+||.||++.. +++.||+|.+........ .....+.+|+.+++.++|++|+++++++.+.+..++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 56678999999999999986 788999999865432211 1234678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
|||+++++|.+++.......+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999999998887655556899999999999999999999999999999999999999999999999999865444344
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....||+.|+|||++..
T Consensus 159 ~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 159 RGRVGTVGYMAPEVINN 175 (285)
T ss_pred cCCCCCCCccCHhhhcC
Confidence 55679999999998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=251.23 Aligned_cols=178 Identities=26% Similarity=0.373 Sum_probs=151.9
Q ss_pred CccccccccccccccceeecccCceEEEEEC---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
...+.+..++|++.+.||+|+||.||+|.+. +..||+|.+....... ....+.+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 3456677889999999999999999999862 2589999986532211 112356889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++.+...+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999999999999999999764 458999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+++.... .....+||+.|+|||++..
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLN 202 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhC
Confidence 9986532 2345679999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=250.74 Aligned_cols=177 Identities=29% Similarity=0.552 Sum_probs=145.5
Q ss_pred cccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (315)
.|+|+.++|++.+.||+|+||.||+|.+ .++.||||+++...... ..+.+.+|+.+++.+ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-----EHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-----HHHHHHHHHHHHHHhccCcceee
Confidence 4889999999999999999999999974 23579999986433221 135788999999999 8999999
Q ss_pred EEEEEEeC-CEEEEEEeccCCCCHHHHHHhhC------------------------------------------------
Q 021253 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (315)
Q Consensus 201 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------ 231 (315)
+++++... ..+++||||+++|+|.+++....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99998764 46899999999999999997532
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccC
Q 021253 232 ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTP 296 (315)
Q Consensus 232 ------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~ 296 (315)
...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 12367788899999999999999999999999999999999999999999999985432221 122
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
..+++.|+|||++.
T Consensus 236 ~~~~~~y~aPE~~~ 249 (338)
T cd05102 236 ARLPLKWMAPESIF 249 (338)
T ss_pred CCCCccccCcHHhh
Confidence 34568899999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=253.80 Aligned_cols=148 Identities=23% Similarity=0.404 Sum_probs=131.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.. +++.||||+++...... ......+.+|+.++..++||+|+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE---KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 3678889999999999999987 67899999997532211 122357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 999999999999999764 4589999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=249.86 Aligned_cols=172 Identities=27% Similarity=0.386 Sum_probs=148.7
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
...+|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK---MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 347899999999999999999988 67899999997532211 1123578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999764 4588999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
. ....+||+.|+|||++..
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred C--cceecCChhhcCHHHHcC
Confidence 2 234579999999998753
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=252.20 Aligned_cols=177 Identities=24% Similarity=0.343 Sum_probs=150.0
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
+..+..++|++.+.||+|+||.||++++ +++.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3445668899999999999999999988 578999999865322211 12346789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
....+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999999999653 47889999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC--ccCCCCCccccccCcccc
Q 021253 287 IEVQTEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~~ 311 (315)
....... ....+||+.|+|||++..
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhc
Confidence 6533221 234679999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=251.62 Aligned_cols=146 Identities=25% Similarity=0.360 Sum_probs=130.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK---KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 677889999999999999987 78899999986532211 1224578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999754 458899999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=239.20 Aligned_cols=173 Identities=26% Similarity=0.315 Sum_probs=147.3
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 209 (315)
.++|+.+..|++|.||.||+|++ +++.||+|.++.......- --.-++|+.+|.+++|||||.+-.+..- -+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF----PItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF----PITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC----cchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 46788899999999999999987 7789999999754422110 0134699999999999999999987743 45
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|||||||+. +|..++.... +++....+..+..|++.|++|||.+.|+||||||+|+|++..|.+||+|||+||-..
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 79999999987 9999998654 678999999999999999999999999999999999999999999999999999654
Q ss_pred c-CCCccCCCCCccccccCccccc
Q 021253 290 Q-TEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 290 ~-~~~~~~~~gt~~y~APE~~~~~ 312 (315)
. ...+++.+-|..|.|||.+-++
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~ 252 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGA 252 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCC
Confidence 3 3457888899999999988654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=246.48 Aligned_cols=169 Identities=27% Similarity=0.369 Sum_probs=146.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|+.++..++||||+++++++......|+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 578889999999999999988 57899999997532211 1123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 79 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence 99999999999999753 4588999999999999999999999999999999999999999999999999985433 2
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
.....||+.|+|||++..
T Consensus 155 ~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred cCCcccCccccChhHhcC
Confidence 345679999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=265.07 Aligned_cols=181 Identities=30% Similarity=0.524 Sum_probs=153.4
Q ss_pred CCccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (315)
.....+|++.++++.+.||+|+||+||+|+.. ...||||.++...... ..++|.+|++++..++||||
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-----~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-----ARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-----HHHHHHHHHHHHHhccCCCe
Confidence 34567889999999999999999999999762 3579999997654432 24789999999999999999
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRA----VPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~----~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 266 (315)
|+|+|+|.+.+.+++|+|||..|+|.+||+... ..+ ++..+.+.||.|||.||+||-++.+|||||.+
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 999999999999999999999999999998542 122 77889999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeecceeeeecCCCccCC---CCCccccccCcccc
Q 021253 267 DNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAPSAGSI 311 (315)
Q Consensus 267 ~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~---~gt~~y~APE~~~~ 311 (315)
+|+||.++..|||+|||++|......-+... .-..+|||||.|..
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY 679 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence 9999999999999999999964433222222 22389999998863
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=250.36 Aligned_cols=148 Identities=24% Similarity=0.366 Sum_probs=131.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|+. +++.||||++....... ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE---KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 3678889999999999999987 67899999997532211 122356789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 78 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred EEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999999999764 3589999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=250.68 Aligned_cols=146 Identities=27% Similarity=0.383 Sum_probs=129.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|++++.||+|+||.||+|++ +++.||||++........ ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR---NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 477889999999999999987 678999999975332211 224578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 99999999999999764 458899999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=244.85 Aligned_cols=166 Identities=26% Similarity=0.372 Sum_probs=141.3
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|+||.||++.. +++.||||+++...... ......+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 67899999997532211 112356779999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccCC
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~~ 297 (315)
++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999999998753 4589999999999999999999999999999999999999999999999999975322 2223446
Q ss_pred CCCccccccCcccc
Q 021253 298 TGTYRWMAPSAGSI 311 (315)
Q Consensus 298 ~gt~~y~APE~~~~ 311 (315)
+||+.|+|||++..
T Consensus 156 ~gt~~y~aPE~~~~ 169 (323)
T cd05571 156 CGTPEYLAPEVLED 169 (323)
T ss_pred ecCccccChhhhcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=247.22 Aligned_cols=170 Identities=28% Similarity=0.474 Sum_probs=152.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (315)
..|++++.||.|.||.||+++. +|+.+|+|++.+....... ..+.+.+|+.+|+++. |||||++++++.....+
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 5788889999999999999987 6889999999876654332 2357889999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC----CcEEEeeecceee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~----~~vkl~DFG~a~~ 287 (315)
++|||++.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||+|..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999876 29999999999999999999999999999999999999643 4799999999998
Q ss_pred eecCCCccCCCCCccccccCccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
..........+||+.|+|||++.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred ccCCceEeeecCCccccCchhhc
Confidence 77655677889999999999987
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.81 Aligned_cols=178 Identities=24% Similarity=0.345 Sum_probs=150.8
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..++.+..++|++.+.||+|+||.||++.. +++.||+|++........ .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR---SDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 345567778999999999999999999987 678999999964322111 123457789999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.+...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999999999999999998653 478889999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCccccccCccc
Q 021253 285 ARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
++...... .....+||+.|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhc
Confidence 98653322 123457999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=249.42 Aligned_cols=179 Identities=23% Similarity=0.342 Sum_probs=151.7
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
...+.+..++|++.+.||+|+||.||++.+ +++.||+|++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345566778999999999999999999988 678999999864322111 123467899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.....+|+||||+++++|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999999998653 478888999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCccccccCcccc
Q 021253 285 ARIEVQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
|+...... .....+||+.|+|||++..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhc
Confidence 98654322 1234579999999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=249.82 Aligned_cols=146 Identities=27% Similarity=0.390 Sum_probs=129.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|++.+.||+|+||.||+|.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 467889999999999999987 6789999998653221 12224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999999754 458899999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.84 Aligned_cols=146 Identities=26% Similarity=0.368 Sum_probs=129.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||+++. +++.||||++...... .....+.+.+|+.+++.++||||+++++.+.+.+.+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 678899999999999999987 6789999998643211 11123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|.
T Consensus 79 v~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 79 VMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999999764 458889999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=243.65 Aligned_cols=169 Identities=23% Similarity=0.340 Sum_probs=145.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL---KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh---HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 577889999999999999987 588999999865322211 123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999999764 45889999999999999999999999999999999999999999999999999864332
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
....+||+.|+|||++..
T Consensus 155 ~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred cccccCChhhcCHHHHcC
Confidence 334579999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=240.34 Aligned_cols=153 Identities=24% Similarity=0.404 Sum_probs=140.6
Q ss_pred cccccccccccceeecccCceEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
.+.++.|++++.||+|.-|.||++...+ ..+|+|++.+...... ....+...|.+||+.+.||.++.||..++.+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r---kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR---KKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh---hHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4567899999999999999999999854 7899999987555432 2356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
...|+|||||+||+|..+++++.++.+++..++.++.+|+.||+|||-.|||+|||||+||||-++|+|.|+||.++.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999873
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=241.09 Aligned_cols=166 Identities=28% Similarity=0.412 Sum_probs=140.3
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (315)
.|...+++|.|+||.||+|.. +++.||||..-....- -.+|+++|+.+.|||||++.-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 455668999999999999987 6789999987543322 238999999999999999999885432
Q ss_pred -EEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeecce
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVA 285 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a 285 (315)
...+|||||+. +|.++++.. .+..++...+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 45689999976 999999852 34568888889999999999999999999999999999999966 89999999999
Q ss_pred eeeecCCCccCCCCCccccccCccccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
+.....+...+...|-.|.|||.+-++
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga 200 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGA 200 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCc
Confidence 998877766667788999999998754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=242.04 Aligned_cols=165 Identities=26% Similarity=0.378 Sum_probs=140.6
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|+||.||++.. +++.||+|+++...... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 3689999999999987 67899999997532211 112356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccCC
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~~ 297 (315)
++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 999999888653 4589999999999999999999999999999999999999999999999999875322 2223446
Q ss_pred CCCccccccCccc
Q 021253 298 TGTYRWMAPSAGS 310 (315)
Q Consensus 298 ~gt~~y~APE~~~ 310 (315)
.||+.|+|||++.
T Consensus 156 ~gt~~y~aPE~~~ 168 (323)
T cd05595 156 CGTPEYLAPEVLE 168 (323)
T ss_pred cCCcCcCCccccc
Confidence 7999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=231.11 Aligned_cols=175 Identities=23% Similarity=0.360 Sum_probs=155.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCC--CCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
..|.-.+.||.|..+.|.++.. ++..+|+|++... ....+....+.+.-.+|+.||+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4556667899999999999876 7889999998643 223334566678888999999998 5999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+++|+|.|+.|.|.++|... -.++++...+|+.|+++|++|||.++|+||||||+|||++++.++||+|||+|....
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999764 468999999999999999999999999999999999999999999999999999888
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.++.....||||+|+|||.+..
T Consensus 175 ~GekLrelCGTPgYLAPEtikC 196 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKC 196 (411)
T ss_pred CchhHHHhcCCCcccChhheee
Confidence 8888888999999999999863
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=241.71 Aligned_cols=165 Identities=25% Similarity=0.374 Sum_probs=141.0
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|+||.||++.. +++.||+|++........ .....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK---DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 678999999975432211 12357789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccCC
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~~ 297 (315)
++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 999999988653 4589999999999999999999999999999999999999999999999999975322 2223446
Q ss_pred CCCccccccCccc
Q 021253 298 TGTYRWMAPSAGS 310 (315)
Q Consensus 298 ~gt~~y~APE~~~ 310 (315)
+||+.|+|||.+.
T Consensus 156 ~gt~~y~aPE~~~ 168 (328)
T cd05593 156 CGTPEYLAPEVLE 168 (328)
T ss_pred cCCcCccChhhhc
Confidence 7999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=245.34 Aligned_cols=181 Identities=30% Similarity=0.496 Sum_probs=150.1
Q ss_pred CCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
...+|.++.++|++++.||+|+||.||+|++ ++..||||+++....... .+.+.+|+.+++.+ +|||
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHIN 100 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 3457899999999999999999999999974 345899999875433221 35788999999999 8999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC----------------------------------------------
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------------------------------------------- 231 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------- 231 (315)
|+++++++......++||||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 9999999999999999999999999999997532
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 232 ---------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 232 ---------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 260 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence 12467888899999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCc---cCCCCCccccccCcccc
Q 021253 285 ARIEVQTEGM---TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~~---~~~~gt~~y~APE~~~~ 311 (315)
++........ ....+++.|+|||.+..
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred ceeccCcccccccCCCCCCcceeChhHhcC
Confidence 9864332211 12234578999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=247.81 Aligned_cols=174 Identities=25% Similarity=0.400 Sum_probs=155.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 210 (315)
.++|..++++|+|+||.++.+++ .++.+++|.+.......... +...+|+.++++++|||||.+++.|.+++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----HHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 35788899999999999987765 67799999998766654432 367799999999999999999999999888
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
++|||+|++||+|.+.+.+.++..++++.+++|+.|++.|+.|||+.+|+|||||+.||++++++.|||.|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999999988878899999999999999999999999999999999999999999999999999998776
Q ss_pred CC-CccCCCCCccccccCcccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~ 311 (315)
.. ...+..|||.||.||+++.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSD 180 (426)
T ss_pred chhhhheecCCCcccCHHHhCC
Confidence 65 4566789999999999873
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=245.45 Aligned_cols=147 Identities=23% Similarity=0.389 Sum_probs=130.3
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. +++.||+|+++..... .......+.+|+.++..++||+|+++++.+.+...+|+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 577889999999999999987 6789999999743221 11224578889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 99999999999999754 4589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=249.94 Aligned_cols=175 Identities=31% Similarity=0.523 Sum_probs=149.8
Q ss_pred cccccccccccceeecccCceEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+++.+.+.++++||+|.||+|.++...+ ..||||.++...... ....|.+|+.+|.+|+||||++++|+|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-----~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-----ARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-----HHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 5678889999999999999999999865 999999997644333 2478999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+++|+|||++|+|.+|+.+.............||.||+.||+||.+.+++||||.++|+|++.++++||+|||++|...
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999987644334555677899999999999999999999999999999999999999999999544
Q ss_pred cCCCccC---CCCCccccccCccc
Q 021253 290 QTEGMTP---ETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~---~~gt~~y~APE~~~ 310 (315)
..+-+.. .+-..+|||||.+-
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHH
Confidence 3332221 23458999999764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=235.49 Aligned_cols=171 Identities=23% Similarity=0.316 Sum_probs=147.1
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|++.+.||+|+||.||++.. +++.||||++........ .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh---hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 66778999999999999987 678999999865332211 1234677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99999999999887655556899999999999999999999999999999999999999999999999999865443333
Q ss_pred cCCCCCccccccCccc
Q 021253 295 TPETGTYRWMAPSAGS 310 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~ 310 (315)
....|++.|+|||.+.
T Consensus 159 ~~~~~~~~y~aPE~~~ 174 (285)
T cd05605 159 RGRVGTVGYMAPEVVK 174 (285)
T ss_pred ccccCCCCccCcHHhc
Confidence 4567899999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=242.20 Aligned_cols=172 Identities=24% Similarity=0.354 Sum_probs=145.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.. +++.||+|++.+.... .....+.+.+|..+++.++|+||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 3678889999999999999987 6789999998642211 1122356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999999753 3458899999999999999999999999999999999999999999999999997543322
Q ss_pred C--ccCCCCCccccccCccc
Q 021253 293 G--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~ 310 (315)
. .....||+.|+|||++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CccccceeccccccCHHHHh
Confidence 2 12246999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=236.99 Aligned_cols=175 Identities=29% Similarity=0.385 Sum_probs=148.0
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|+++ ..|...+.||.|+||.|+.+.. +++.||||.+..+..... .-++..+|+.+|+.++|+||+.+++++..
T Consensus 18 ~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~----~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 18 FEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI----DAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred Eecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH----HHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 4443 3344478999999999999987 789999999875443332 34688899999999999999999999865
Q ss_pred -----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 208 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
-..+|+|+|+|+ .+|.+.++.. +.++...+..+++||+.||+|+|+.+|+||||||+|+|++.+..+||+||
T Consensus 93 ~~~~~f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccccccceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccc
Confidence 346899999994 5999999764 45899999999999999999999999999999999999999999999999
Q ss_pred cceeeeec---CCCccCCCCCccccccCccccc
Q 021253 283 GVARIEVQ---TEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 283 G~a~~~~~---~~~~~~~~gt~~y~APE~~~~~ 312 (315)
|+||.... ...++..+.|..|.|||++..+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence 99997643 4456778899999999998654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=239.67 Aligned_cols=164 Identities=21% Similarity=0.292 Sum_probs=140.1
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|+||.||+|++ +++.||+|+++...... ......+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 68999999999988 57789999987532211 11235678999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETG 299 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~~~g 299 (315)
++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9999999753 4589999999999999999999999999999999999999999999999999985322 222344679
Q ss_pred CccccccCcccc
Q 021253 300 TYRWMAPSAGSI 311 (315)
Q Consensus 300 t~~y~APE~~~~ 311 (315)
|+.|+|||.+..
T Consensus 156 t~~y~aPE~~~~ 167 (312)
T cd05585 156 TPEYLAPELLLG 167 (312)
T ss_pred CcccCCHHHHcC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=245.34 Aligned_cols=171 Identities=28% Similarity=0.423 Sum_probs=147.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||+|+. +++.||||+++...... ......+.+|+.++..++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 578889999999999999998 58899999997532211 1123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999999765 568999999999999999999999999999999999999999999999999997543322
Q ss_pred -----------------------------CccCCCCCccccccCcccc
Q 021253 293 -----------------------------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -----------------------------~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 1234569999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=245.23 Aligned_cols=182 Identities=30% Similarity=0.512 Sum_probs=150.7
Q ss_pred CCCCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CC
Q 021253 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (315)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 195 (315)
+...+.|.++.++|++++.||+|+||.||+|.+ +...||||.++....... .+.+.+|+.+++.+ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h 101 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQH 101 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccC
Confidence 445678999999999999999999999999975 224799999975433221 35688999999999 89
Q ss_pred CCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------------------------------------
Q 021253 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------------------------------------- 231 (315)
Q Consensus 196 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------- 231 (315)
|||+++++++.....+++||||+++|+|.+++....
T Consensus 102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (374)
T cd05106 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY 181 (374)
T ss_pred CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence 999999999999999999999999999999986431
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 232 ------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 232 ------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+++..+++++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence 12467788899999999999999999999999999999999999999999999975
Q ss_pred eecCCCc---cCCCCCccccccCccc
Q 021253 288 EVQTEGM---TPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~~---~~~~gt~~y~APE~~~ 310 (315)
....... ....+++.|+|||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHhc
Confidence 4332211 1223457899999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.33 Aligned_cols=174 Identities=32% Similarity=0.500 Sum_probs=143.1
Q ss_pred ccccccccccceeecccCceEEEEEC------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 193 (315)
++..+|.+.+.||+|+||.||+|.+. +..||+|++...... .....+.+|+.+++++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l 76 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-----NARNDFLKEVKILSRL 76 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-----HHHHHHHHHHHHHhhc
Confidence 34568888999999999999999752 236999998653321 1245788999999999
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 021253 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----------------RAVPLKLAVKQALDVARGMAYVHG 256 (315)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~gL~yLH~ 256 (315)
+||||+++++++.+....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999865321 235778889999999999999999
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
.+|+||||||+|||++.++.+||+|||+++....... .....+++.|+|||++.
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 9999999999999999999999999999975432221 12234578999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=240.42 Aligned_cols=173 Identities=23% Similarity=0.318 Sum_probs=146.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+++. +++.||+|++...... .......+.+|..++..++|++|+++++++.+.+..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3678889999999999999987 6778999998642211 1122356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999999764 2458899999999999999999999999999999999999999999999999997654332
Q ss_pred C--ccCCCCCccccccCcccc
Q 021253 293 G--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~~ 311 (315)
. .....||+.|+|||++..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred ceeeccccCCcccCCHHHHhc
Confidence 2 123579999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=240.24 Aligned_cols=172 Identities=24% Similarity=0.357 Sum_probs=147.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.. +++.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 3678889999999999999987 6789999999753321 1123467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|.+++.+.. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999997642 458999999999999999999999999999999999999999999999999998654332
Q ss_pred C--ccCCCCCccccccCccc
Q 021253 293 G--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~ 310 (315)
. .....||+.|+|||++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred ceeeecccCCccccCHHHhc
Confidence 2 12346899999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=255.06 Aligned_cols=176 Identities=29% Similarity=0.512 Sum_probs=154.1
Q ss_pred ccccccccccccceeecccCceEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
.+||...+++.+.||.|.||+||+|++ .+ ..||||.++....... ..+|+.|+.||.++.||||++|-|+
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq-----rrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ-----RRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH-----HhhhhhhhhhcccCCCCcEEEEEEE
Confidence 367888999999999999999999987 33 4799999976443222 3689999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
.+....+.||+|||++|+|+.||+++.++ ++..++..|+..|+.||+||-+.++|||||.++||||+.+-.+||+|||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 99999999999999999999999987644 88888999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCC--ccccccCcccc
Q 021253 285 ARIEVQTE--GMTPETGT--YRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt--~~y~APE~~~~ 311 (315)
+|+..++. .+++.-|. .+|.|||+|..
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~ 808 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY 808 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhh
Confidence 99876654 23444444 79999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.87 Aligned_cols=166 Identities=26% Similarity=0.368 Sum_probs=140.3
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|+||.||++.. +++.||+|++........ .....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 778999999975332211 12356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
++++|..++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999999988653 458999999999999999999997 7999999999999999999999999999975322 222344
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
..||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (325)
T cd05594 156 FCGTPEYLAPEVLED 170 (325)
T ss_pred ccCCcccCCHHHHcc
Confidence 579999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=234.03 Aligned_cols=172 Identities=25% Similarity=0.381 Sum_probs=144.8
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..++|++.+.||.|+||.||+|.. +++.||+|.++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 346788899999999999999987 678999999865432211 2356789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9999999975 999988754 34578899999999999999999999999999999999999999999999999975432
Q ss_pred C-CCccCCCCCccccccCcccc
Q 021253 291 T-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~-~~~~~~~gt~~y~APE~~~~ 311 (315)
. .......+++.|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred CCccccCceecccccChHHhcC
Confidence 2 12334578999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.03 Aligned_cols=166 Identities=22% Similarity=0.351 Sum_probs=141.0
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||++++ +++.||||++++...... ...+.+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 3689999999999987 678999999976432221 1235678899999988 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cCCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~~~~~~ 296 (315)
+++++|.+++.+. ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999999988653 458999999999999999999999999999999999999999999999999997422 2223345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (329)
T cd05588 156 FCGTPNYIAPEILRG 170 (329)
T ss_pred ccCCccccCHHHHcC
Confidence 679999999998763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=234.65 Aligned_cols=170 Identities=26% Similarity=0.401 Sum_probs=143.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|+. +++.||||+++....... ...+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 5788899999999999999987 678999999875433221 135678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+. ++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9999996 5888888654 345888899999999999999999999999999999999999999999999999754322
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+|+.|+|||++..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLG 177 (303)
T ss_pred ccCCCCcccCCCCChHHHcC
Confidence 22344578999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.55 Aligned_cols=167 Identities=25% Similarity=0.366 Sum_probs=140.1
Q ss_pred cceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
+.||+|+||.||+++. .++.||||+++...... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR--NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh--hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 6799999999999975 56789999997532211 1112346779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-Cc
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GM 294 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~~ 294 (315)
||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999999754 457888889999999999999999999999999999999999999999999997532222 23
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....||+.|+|||++..
T Consensus 158 ~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 158 HTFCGTIEYMAPEILMR 174 (323)
T ss_pred cccCCCccccChhhccC
Confidence 34579999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.50 Aligned_cols=171 Identities=26% Similarity=0.329 Sum_probs=142.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWC 212 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~ 212 (315)
+|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+..|..++..+.|+ +|+++++++...+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 467889999999999999987 56789999997532211 11235678899999999765 5888999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~ 291 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999998754 358899999999999999999999999999999999999999999999999987432 22
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|+|||++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred CceeeecCCccccChhhhcC
Confidence 22344579999999998864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=244.19 Aligned_cols=168 Identities=32% Similarity=0.446 Sum_probs=147.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|...+.||+|.||.||+|.+ +++.||+|++.......+ ++.+++|+.+|.+++++||.++|+.+.....+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 455568999999999999987 778999999976544332 4688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
+||||.||++.+.++.. ..+.+....-++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++.......
T Consensus 89 iMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999999753 334777777889999999999999999999999999999999999999999997655433
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
...+++|||.|||||++.
T Consensus 167 rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred ccccccccccccchhhhc
Confidence 346789999999999998
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.85 Aligned_cols=169 Identities=27% Similarity=0.396 Sum_probs=139.5
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH---HhCCCCCeeeEEEEEEeCCEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML---ATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~ 211 (315)
|++.+.||+|+||.||+|.+ +++.||||+++........ ..+.+.+|+.++ +.++||||+++++++......
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD---EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 45678999999999999987 6789999999754321111 124566666554 567899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~- 290 (315)
|+||||+++++|..++.. ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999999988854 3589999999999999999999999999999999999999999999999999874322
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+||+.|+|||.+..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred CCcccccccCccccCHhHhcC
Confidence 222344679999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=243.95 Aligned_cols=172 Identities=28% Similarity=0.432 Sum_probs=156.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
..|.+.+.||+|.|++|..|++ ++..||||++.+...+.... +.+.+|+.+|+.|+|||||+++.+...+..+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~----~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR----QKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH----HHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 4677889999999999999987 88999999999877776542 45889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+.+|.+.+++.+. ..+.+..+..++.|++.+++|||+++|+|||||++|||++.+..+||+|||++.++....
T Consensus 132 lV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 999999999999999875 346668899999999999999999999999999999999999999999999999887776
Q ss_pred CccCCCCCccccccCccccc
Q 021253 293 GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~ 312 (315)
...+.||++.|.|||++.+.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred cccccCCCCCccChHhhcCc
Confidence 77889999999999998753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=238.35 Aligned_cols=172 Identities=20% Similarity=0.310 Sum_probs=144.2
Q ss_pred ccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
+|++.+.||+|+||.||++.. +++.||+|++.+..... .....+.+.+|+.+++.+ +||+|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 467889999999999999875 56789999997532211 112235678999999999 4999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999999754 458899999999999999999999999999999999999999999999999997543
Q ss_pred cCC--CccCCCCCccccccCcccc
Q 021253 290 QTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
... .....+||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC
Confidence 221 2234579999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=248.86 Aligned_cols=167 Identities=29% Similarity=0.428 Sum_probs=143.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
-|.-++.||.|+||.||-|++ +.+.||||.+.-........ -++++.|+..|.+++|||+|.+-|+|......||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK---WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH---HHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 344567899999999999987 77899999986544333222 3688999999999999999999999998888899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|||||-| +-.+++.-. .+++.+..+..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|.+..+
T Consensus 104 VMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 9999955 888887654 35688889999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
..+++|||+|||||+|-
T Consensus 179 AnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVIL 195 (948)
T ss_pred hhcccCCccccchhHhe
Confidence 35689999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=239.83 Aligned_cols=166 Identities=25% Similarity=0.430 Sum_probs=145.5
Q ss_pred ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+.||+|.||.||-|.+ +|+.||||++.+-.....+ +.++.+|+.||+.+.||.||.+---|+..+.+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq----esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ----ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch----HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 47899999999999976 8999999999876655443 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---CcEEEeeecceeeeecCCCc
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~---~~vkl~DFG~a~~~~~~~~~ 294 (315)
+.| +..+++-.....++++......+.||+.||.|||-++|+|.||||+|||+... -++||||||+||++....-.
T Consensus 645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 966 55555544555679999888999999999999999999999999999999754 38999999999998877777
Q ss_pred cCCCCCccccccCccc
Q 021253 295 TPETGTYRWMAPSAGS 310 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~ 310 (315)
.+.+|||.|+|||++.
T Consensus 724 rsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLR 739 (888)
T ss_pred hhhcCCccccCHHHHh
Confidence 7889999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=241.56 Aligned_cols=178 Identities=31% Similarity=0.515 Sum_probs=148.6
Q ss_pred ccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 199 (315)
..|+++.++|.+++.||+|+||.||+|++. ...||||+++...... ..+.+.+|+.+++++. ||||+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCee
Confidence 679999999999999999999999999862 2469999986543221 1357889999999996 99999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC------------------------------------------------
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------ 231 (315)
++++++.+...+||||||+++|+|.+++.+..
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 99999999999999999999999999986531
Q ss_pred ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 232 ----------------------------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 232 ----------------------------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
...+++..++.++.||+.||+|||+.+++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 1236777888999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+|||++.++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence 9999999999999999999986433221 12234678899999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=235.91 Aligned_cols=171 Identities=26% Similarity=0.319 Sum_probs=142.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 212 (315)
+|++.+.||+|+||.||+|.. +++.||||++.+...... ...+.+..|..++..+ .|++|+++++++...+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 467789999999999999987 567999999975432211 1234566788888777 5899999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-C
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-T 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~ 291 (315)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999998754 4588999999999999999999999999999999999999999999999999975332 2
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|+|||++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CccccCCCChhhcCHHHhcC
Confidence 22345679999999998763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=235.99 Aligned_cols=172 Identities=23% Similarity=0.336 Sum_probs=144.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.+ +++.+|+|++.+.... .....+.+.+|+.++..++|++|+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 3678889999999999999987 5678999998642211 1122345888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999999763 2458899999999999999999999999999999999999999999999999997543222
Q ss_pred C--ccCCCCCccccccCccc
Q 021253 293 G--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~ 310 (315)
. ....+||+.|+|||++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred cceecccccCccccCHHHHh
Confidence 1 22357999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=236.65 Aligned_cols=166 Identities=22% Similarity=0.351 Sum_probs=139.9
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||++.. +++.||+|++++...... ...+.+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 3699999999999987 678999999976432221 1235677888888776 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cCCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~~~~~~ 296 (315)
+++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9999999888653 458999999999999999999999999999999999999999999999999997532 2222344
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (329)
T cd05618 156 FCGTPNYIAPEILRG 170 (329)
T ss_pred ccCCccccCHHHHcC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=231.18 Aligned_cols=171 Identities=26% Similarity=0.435 Sum_probs=140.4
Q ss_pred cccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe-
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~- 207 (315)
++|++.+.||+|+||.||+|.+ .++.||+|.++........ ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc----hHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 3678889999999999999986 3678999998764433221 12445666666655 69999999999852
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...+++||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 599999987655668999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+++............||+.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred ceEeccCCcccccccccccccChHHHh
Confidence 998655443445567899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=227.13 Aligned_cols=175 Identities=33% Similarity=0.530 Sum_probs=151.0
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|.|+.++|++.++||+|+||.||+|.. .+..||+|.+...... .+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 789999999999999999999999987 5678999987653221 35788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999998765567888999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC--ccCCCCCccccccCcccc
Q 021253 289 VQTEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~ 311 (315)
..... .....++..|+|||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINF 178 (261)
T ss_pred CCCceeccCCCccceecCCHHHhcc
Confidence 43221 122345678999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=235.52 Aligned_cols=166 Identities=25% Similarity=0.412 Sum_probs=136.7
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||+||+|.+ +++.||||++........ ...+.+.+|.. +++.++||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 3689999999999988 688999999965322111 11234445544 56889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999999998753 4588999999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (323)
T cd05575 156 FCGTPEYLAPEVLRK 170 (323)
T ss_pred ccCChhhcChhhhcC
Confidence 579999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=235.66 Aligned_cols=165 Identities=24% Similarity=0.370 Sum_probs=140.6
Q ss_pred cceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
+.||+|+||.||++.. +++.||+|++....... .....+.+|+.++++++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV----RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh----hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999864 56899999997533211 11245778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-CCc
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~~~ 294 (315)
||+++++|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999999999653 45899999999999999999999999999999999999999999999999999864333 223
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....||+.|+|||.+..
T Consensus 156 ~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR 172 (318)
T ss_pred ecccCChhhcCHHHHcC
Confidence 44679999999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=235.20 Aligned_cols=165 Identities=35% Similarity=0.563 Sum_probs=142.5
Q ss_pred ccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC--CCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~-- 209 (315)
.+++.+.+.||+|.||+||+|.|.|+.||||++.... +..+.+|.+|++.+ +|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc---------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3788889999999999999999999999999996533 24677888888764 9999999999865442
Q ss_pred --EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CCccCCCCCCCEEEcCCCcEEE
Q 021253 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-----L---GFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 210 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-----~---~iiHrDlkp~NIli~~~~~vkl 279 (315)
.+|||++|.+.|+|.+||.+ ..++....++++..++.||++||- + .|.|||||..||||.+++++.|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 58999999999999999976 458999999999999999999993 2 4999999999999999999999
Q ss_pred eeecceeeeecC-----CCccCCCCCccccccCccc
Q 021253 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~-----~~~~~~~gt~~y~APE~~~ 310 (315)
+|+|+|...... ......+||.+|||||++.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd 393 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD 393 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence 999999765433 2356779999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=242.60 Aligned_cols=179 Identities=26% Similarity=0.556 Sum_probs=156.1
Q ss_pred CccccccccccccccceeecccCceEEEEEC----C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~----~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
...+++.++.+.+.+.||.|.||.||+|.++ | -.||||+.+....... .+.|+.|+.+|+.+.|||||+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhh
Confidence 3467888899999999999999999999872 2 2689999877554433 368999999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
++|+|.+.. .|||||.++-|.|.+||+.++ ..++......++.||+.+|.|||+.+++||||.++|||+....-|||+
T Consensus 456 LIGv~~e~P-~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 456 LIGVCVEQP-MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eeeeeeccc-eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeec
Confidence 999999876 589999999999999998764 458889999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCC--ccccccCccccc
Q 021253 281 DFGVARIEVQTEGMTPETGT--YRWMAPSAGSIC 312 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt--~~y~APE~~~~~ 312 (315)
|||++|...++.-+....|. ..|||||-+..+
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR 567 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR 567 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchh
Confidence 99999988777666555554 799999988753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=235.33 Aligned_cols=165 Identities=27% Similarity=0.333 Sum_probs=138.3
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|++ +++.||||+++...... ....+.+..|..++..+ +||+|+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 3689999999999988 56799999997532211 11234577888888866 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999999998754 4588999999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
.+||+.|+|||++.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (321)
T cd05591 156 FCGTPDYIAPEILQ 169 (321)
T ss_pred cccCccccCHHHHc
Confidence 57999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=244.58 Aligned_cols=172 Identities=20% Similarity=0.276 Sum_probs=144.6
Q ss_pred ccccccccceeecccCceEEEEE--C-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
...|.+.+.||+|+||.||+|.. + ++.||+|.+.... .. ....+.+|+.+++.++||||+++++++...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ER---QAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 34588899999999999999976 3 6788888764322 11 12467789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+||||||+++|+|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999988643 2345888999999999999999999999999999999999999999999999999865
Q ss_pred ecCC---CccCCCCCccccccCcccc
Q 021253 289 VQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
.... .....+||+.|+|||++..
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred CCccccccccccCCCccccCHhHhCC
Confidence 4322 1334579999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=234.23 Aligned_cols=172 Identities=25% Similarity=0.353 Sum_probs=148.3
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||++.+ ++..+|+|++..... ....+++.+|+.+++.++||||+++++++....
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3457889999999999999999988 578899999875321 122467899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999999999999764 3588999999999999999999986 6999999999999999999999999999754
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... ......||+.|+|||.+..
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQG 176 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcC
Confidence 332 2344579999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=228.49 Aligned_cols=172 Identities=23% Similarity=0.305 Sum_probs=146.5
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|+..+.||+|+||.||++.+ +++.||+|.+........ .....+.+|+.+++.++|++++.+++.+...+..++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 45567899999999999988 678999999865432211 1234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999999887655556999999999999999999999999999999999999999999999999999765433334
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....|++.|+|||.+..
T Consensus 159 ~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN 175 (285)
T ss_pred cCCCCCcCccChHHhcC
Confidence 45678999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=235.03 Aligned_cols=166 Identities=24% Similarity=0.409 Sum_probs=137.1
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||+||+|.. +++.||+|++........ .....+.+|.. +++.++||||+++++++...+..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 4689999999999987 688999999975322111 11234445544 57789999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cCCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~~~~~~ 296 (315)
+++++|..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9999999888653 458999999999999999999999999999999999999999999999999997532 2223345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (325)
T cd05604 156 FCGTPEYLAPEVIRK 170 (325)
T ss_pred ccCChhhCCHHHHcC
Confidence 679999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=228.66 Aligned_cols=172 Identities=22% Similarity=0.307 Sum_probs=147.0
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|+..+.||+|+||.||++.+ +++.||||.+........ .....+.+|+.+++.++|++++.+++.+...+.+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 45668899999999999987 678999999875433221 1234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999987655556899999999999999999999999999999999999999999999999999865443334
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....|++.|+|||++..
T Consensus 159 ~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN 175 (285)
T ss_pred cCCCCCccccChHHHcC
Confidence 44579999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=259.67 Aligned_cols=174 Identities=33% Similarity=0.582 Sum_probs=146.6
Q ss_pred ccccccccccceeecccCceEEEEE---CC----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~---~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++...+++.+.||+|+||+||+|++ ++ ..||||.+++.....+ +.+|.+|+.+|+.++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-----~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-----VSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCcceeeEEEe
Confidence 4577888999999999999999987 33 2488898876443322 4689999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
|.+....+|++|||++|+|..||++.+ ...++....+.++.|||.|++||+++++|||||.++|+|++....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999989999999999999999999752 345788899999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCCcc-CC--CCCccccccCccc
Q 021253 280 ADFGVARIEVQTEGMT-PE--TGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~-~~--~gt~~y~APE~~~ 310 (315)
+|||+||.+.+..-+. .. .-..+|||||.+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHh
Confidence 9999999443322111 11 1237999999987
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=234.50 Aligned_cols=166 Identities=23% Similarity=0.347 Sum_probs=140.6
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||++.. +++.||+|++++..... ....+.+.+|+.++.++ +||+|+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 3699999999999987 67899999997643221 12235688999999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cCCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~~~~~~ 296 (315)
+++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999999988653 458999999999999999999999999999999999999999999999999997532 2223345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (327)
T cd05617 156 FCGTPNYIAPEILRG 170 (327)
T ss_pred ccCCcccCCHHHHCC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=234.26 Aligned_cols=166 Identities=26% Similarity=0.333 Sum_probs=136.8
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|++ +++.||||+++....... ...+.+..|..++.. .+||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999987 567899999975322111 112345566666664 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.... ......
T Consensus 78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999999998754 4589999999999999999999999999999999999999999999999999985432 223345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||.+..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05592 156 FCGTPDYIAPEILKG 170 (316)
T ss_pred ccCCccccCHHHHcC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=238.69 Aligned_cols=168 Identities=29% Similarity=0.436 Sum_probs=142.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
....+|+..+.||+|+||.||+|++ +++.||||++...... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-----TVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 3557888899999999999999987 5789999998653321 22357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+++||||+++++|.... ...+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999999999986432 25667788999999999999999999999999999999999999999999998654
Q ss_pred cCC-CccCCCCCccccccCccc
Q 021253 290 QTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~ 310 (315)
... ......||+.|+|||.+.
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERIN 241 (353)
T ss_pred cccccccccccCccccCccccc
Confidence 322 234457999999999874
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=235.41 Aligned_cols=165 Identities=22% Similarity=0.339 Sum_probs=138.4
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|.. +++.||||++++...... ...+.+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc---cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 3689999999999987 578999999875322111 1234667888888776 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-cCCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-~~~~~~~ 296 (315)
+++++|.+++... ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999999988754 458899999999999999999999999999999999999999999999999987532 2223344
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
..||+.|+|||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (320)
T cd05590 156 FCGTPDYIAPEILQ 169 (320)
T ss_pred cccCccccCHHHHc
Confidence 67999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=234.42 Aligned_cols=166 Identities=27% Similarity=0.404 Sum_probs=136.4
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|++ +++.||+|++.+...... .....+.+|. .+++.++||||+++++++......|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK---KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh---hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999988 678999999875322111 1123444554 467889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|...+... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9999999888653 4588888999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||.+..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (321)
T cd05603 156 FCGTPEYLAPEVLRK 170 (321)
T ss_pred ccCCcccCCHHHhcC
Confidence 579999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=227.63 Aligned_cols=166 Identities=20% Similarity=0.350 Sum_probs=140.9
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|+||.||++.. +++.||+|.+........ ...+.+..|+++++.++||||+++++++.....+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 68999999999987 688999999864322211 1124556799999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 300 (315)
++|.+++.......+++..++.++.||+.||+|||+.+++||||||+||+++.++.++|+|||++.............|+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99999887655556889999999999999999999999999999999999999999999999999865443334456789
Q ss_pred ccccccCcccc
Q 021253 301 YRWMAPSAGSI 311 (315)
Q Consensus 301 ~~y~APE~~~~ 311 (315)
+.|+|||++..
T Consensus 158 ~~y~aPE~~~~ 168 (277)
T cd05607 158 NGYMAPEILKE 168 (277)
T ss_pred CCccCHHHHcc
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=234.89 Aligned_cols=166 Identities=25% Similarity=0.389 Sum_probs=135.6
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHH-HHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE-VMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|.+ +++.||+|++......... ....+..| ..+++.++||||+++++++...+..|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh---HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 3689999999999987 5678999999753221111 12233344 4457889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999999999753 4578888899999999999999999999999999999999999999999999975322 222345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (325)
T cd05602 156 FCGTPEYLAPEVLHK 170 (325)
T ss_pred ccCCccccCHHHHcC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=239.74 Aligned_cols=165 Identities=24% Similarity=0.333 Sum_probs=141.8
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+....|++.+.||+|+||.||++.. +++.||+|.... +.+.+|+.++++++||||+++++++....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 3456799999999999999999987 678999996431 34679999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++|+|++. ++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9999999995 6898888654 358899999999999999999999999999999999999999999999999997532
Q ss_pred cC--CCccCCCCCccccccCcccc
Q 021253 290 QT--EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~--~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ......+||+.|+|||++..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLAR 257 (391)
T ss_pred cccccccccccCccCCCChhhhcC
Confidence 21 12334579999999998753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=223.69 Aligned_cols=173 Identities=31% Similarity=0.549 Sum_probs=149.3
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+++.++|++.+.||+|++|.||+|.+ .++.||+|.++..... .+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 778889999999999999999999987 5578999998754332 24688999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999999999998765556899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCccCCC---CCccccccCccc
Q 021253 289 VQTEGMTPET---GTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~~~~~---gt~~y~APE~~~ 310 (315)
.... ..... .+..|+|||++.
T Consensus 154 ~~~~-~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 154 KEDI-YEAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred cCCc-ccccCCCcCceeccCccccc
Confidence 4321 11122 235899999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=227.58 Aligned_cols=175 Identities=16% Similarity=0.269 Sum_probs=146.9
Q ss_pred ccccccccccc--cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMG--TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~--~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+.|+.++++.. ..|++|++|.||+|.++++.||||.++...... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 34555555555 679999999999999999999999997643322 2234678899999999999999999999877
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeee
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
...+++||||+++|+|.+++.+. ..+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence 45789999999999999999764 4588899999999999999999985 9999999999999999999999999
Q ss_pred cceeeeecCCCccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|+++..... .....|++.|+|||++..
T Consensus 168 g~~~~~~~~--~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 168 GLEKILSSP--PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred chHhhhccc--cccccCcccccCHHHhhh
Confidence 999854332 234568999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=227.27 Aligned_cols=166 Identities=24% Similarity=0.310 Sum_probs=139.4
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|+||+||++.+ +++.||+|.+........ ...+.+..|+.+++.++||||+++++++.....+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR---KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh---HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 68999999999987 678999999865332211 1235677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-CccCC
Q 021253 221 GSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPE 297 (315)
Q Consensus 221 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~~~~~ 297 (315)
++|..++... ....+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9999887542 23468999999999999999999999999999999999999999999999999997543322 22335
Q ss_pred CCCccccccCcccc
Q 021253 298 TGTYRWMAPSAGSI 311 (315)
Q Consensus 298 ~gt~~y~APE~~~~ 311 (315)
.||+.|+|||++..
T Consensus 158 ~g~~~y~aPE~~~~ 171 (280)
T cd05608 158 AGTPGFMAPELLQG 171 (280)
T ss_pred CCCcCccCHHHhcC
Confidence 78999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=233.14 Aligned_cols=172 Identities=24% Similarity=0.360 Sum_probs=147.5
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||++.+ ++..+|+|++...... ...+.+.+|+++++.++||||+++++++.+..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 4557899999999999999999988 5778999988653221 12357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999999999764 3588899999999999999999975 7999999999999999999999999999754
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... ......||+.|+|||.+..
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcC
Confidence 322 2334578999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=237.13 Aligned_cols=180 Identities=32% Similarity=0.535 Sum_probs=149.7
Q ss_pred CCccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCC
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN 197 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 197 (315)
...+|+++.++|.+++.||+|+||.||+|++. ++.||+|+++....... .+.+.+|+.++.++. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence 34569999999999999999999999999863 35799999975432221 246889999999997 999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------------------------------
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------------------------------- 232 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------- 232 (315)
|+++++++.....+++||||+++|+|.+++.+...
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999999999999999999999999999975321
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 021253 233 ---------------------------------------------------RAVPLKLAVKQALDVARGMAYVHGLGFIH 261 (315)
Q Consensus 233 ---------------------------------------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 261 (315)
..+++..++.++.||+.||+|||+.+++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 13566778889999999999999999999
Q ss_pred CCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 262 rDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|||||+|||++.++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 99999999999999999999999986432211 12235678999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=226.42 Aligned_cols=173 Identities=26% Similarity=0.439 Sum_probs=145.0
Q ss_pred ccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
|+.++|++.+.||+|+||.||+|++ .+..||+|.++...... ....+.+|+.+++.++||||+++++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 5667899999999999999999976 24689999987543211 1357889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
..+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+|++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999999997643 468899999999999999999999999999999999999999999999999876
Q ss_pred eeecCCCcc--CCCCCccccccCccc
Q 021253 287 IEVQTEGMT--PETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~~--~~~gt~~y~APE~~~ 310 (315)
......... ...++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHh
Confidence 432221111 223567899999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=233.33 Aligned_cols=169 Identities=24% Similarity=0.347 Sum_probs=139.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (315)
+|++.+.||+|+||.||+|.. +++.||||.+......... ..++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh----HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 467889999999999999987 6789999998643222211 24678999999999999999999988543
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 35899999995 6899988753 35899999999999999999999999999999999999999999999999999854
Q ss_pred ecCC----CccCCCCCccccccCcccc
Q 021253 289 VQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......||+.|+|||++..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc
Confidence 2221 1234579999999998753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=229.26 Aligned_cols=170 Identities=28% Similarity=0.378 Sum_probs=142.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++++ +++.||+|+++....... ..+.+.+|+.+++.++||||+++++++......|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 578889999999999999998 577999999976543322 13567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||++++.+..+... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 78 VFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999998766554432 3458899999999999999999999999999999999999999999999999998653322
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLG 175 (287)
T ss_pred ccccccccccccCCcHHHcC
Confidence 2234578999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=233.42 Aligned_cols=170 Identities=25% Similarity=0.318 Sum_probs=141.2
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 213 (315)
|++.+.||+|+||.||+|.. +++.||+|++....... ....+.+..|..++..+. |++|+++++++...+.+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 56778999999999999987 67899999987532211 112356778888888886 5778889999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++... ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999999998754 458999999999999999999999999999999999999999999999999997532221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred cccCccCCccccCHHHHcC
Confidence 2334569999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=234.36 Aligned_cols=169 Identities=26% Similarity=0.351 Sum_probs=141.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
.++|++.+.||+|+||.||++.. +++.||||++........ ....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 36788899999999999999987 678999999975433222 1356779999999999999999999986543
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 210 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999975 67666642 3788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............||+.|+|||.+..
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccC
Confidence 86544434455678999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=231.94 Aligned_cols=166 Identities=25% Similarity=0.348 Sum_probs=137.7
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|++ +++.||+|+++....... ...+.+..|..++..+ +||+|+++++++...+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 4699999999999988 678999999975322111 1124566777777654 899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999999998753 4588999999999999999999999999999999999999999999999999874321 222345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05620 156 FCGTPDYIAPEILQG 170 (316)
T ss_pred cCCCcCccCHHHHcC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=220.97 Aligned_cols=172 Identities=34% Similarity=0.612 Sum_probs=151.3
Q ss_pred ccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
|.++.++|++.+.||.|+||.||+|...++.||+|.+..... ..+++.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 567788999999999999999999999999999999965432 2367889999999999999999999999888
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|||.++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999999999987655568999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.. ......+..|+|||.+.
T Consensus 154 ~~--~~~~~~~~~~~ape~~~ 172 (256)
T cd05039 154 QG--QDSGKLPVKWTAPEALR 172 (256)
T ss_pred cc--cccCCCcccccCchhhc
Confidence 22 22334567899999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=223.82 Aligned_cols=174 Identities=25% Similarity=0.530 Sum_probs=149.2
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|+++..+|.+.+.||+|++|.||+|.+ .++.||+|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 788889999999999999999999987 5789999998643211 2468899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+++||||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+||++++++.+||+|||+++.
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999765555689999999999999999999999999999999999999999999999999976
Q ss_pred eecCCC--ccCCCCCccccccCccc
Q 021253 288 EVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
...... .....+++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLA 178 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhc
Confidence 433211 11123457899999765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=230.64 Aligned_cols=166 Identities=25% Similarity=0.340 Sum_probs=137.2
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|++ +++.||||+++....... ...+.+..|..++.. ++||||+++++++.+...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 3689999999999987 567899999975422111 112345667777775 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999999999753 4588899999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
..||+.|+|||++..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05619 156 FCGTPDYIAPEILLG 170 (316)
T ss_pred ecCCccccCHHHHcC
Confidence 579999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=221.89 Aligned_cols=172 Identities=30% Similarity=0.562 Sum_probs=148.1
Q ss_pred ccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 208 (315)
|-++.++|++.+.||+|+||.||++...+..|++|.++.... .+.+.+|+.+++.++|++++++++++. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 678889999999999999999999999999999999854221 246889999999999999999999764 45
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++|+||+++++|.+++.+.....+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 67899999999999999998765556889999999999999999999999999999999999999999999999999854
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... .....++..|+|||++..
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~~~ 173 (256)
T cd05082 153 SST--QDTGKLPVKWTAPEALRE 173 (256)
T ss_pred ccc--CCCCccceeecCHHHHcc
Confidence 322 223345678999998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=230.28 Aligned_cols=166 Identities=28% Similarity=0.446 Sum_probs=147.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
-|.++.+||+|+||.||+|.+ .|+.+|||.+..... .+++..|+.+|+++..|++|++||.+.....+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 456788999999999999976 889999998754221 4678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
|||||-.|++.++++.+ ++++++..+..++.+.+.||+|||...-||||||+.|||++.+|..||+|||+|....+..
T Consensus 106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999999999865 5789999999999999999999999999999999999999999999999999998655443
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
...+..|||.|||||++.
T Consensus 185 KRNTVIGTPFWMAPEVI~ 202 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIE 202 (502)
T ss_pred hhCccccCcccccHHHHH
Confidence 245678999999999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=232.10 Aligned_cols=164 Identities=21% Similarity=0.295 Sum_probs=135.1
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
||+|+||.||+|.. +++.||||++........ .....+..|..++..+ .||+|+.+++++.....+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 68999999999987 678999999864322111 1123445666676655 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9999999998753 4589999999999999999999999999999999999999999999999999875322 222345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||.+..
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (330)
T cd05586 156 FCGTTEYLAPEVLLD 170 (330)
T ss_pred ccCCccccCHHHHcC
Confidence 679999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=220.91 Aligned_cols=170 Identities=28% Similarity=0.504 Sum_probs=143.8
Q ss_pred cccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+.++|++.+.||+|+||.||++++ .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 567788899999999999999988 4458999988644332 24688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999999987543 35889999999999999999999999999999999999999999999999999754322
Q ss_pred CCc--cCCCCCccccccCccc
Q 021253 292 EGM--TPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~~~--~~~~gt~~y~APE~~~ 310 (315)
... ....++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred ceeccCCCCCchhhCChhhcc
Confidence 211 1223557899999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=239.41 Aligned_cols=168 Identities=27% Similarity=0.443 Sum_probs=138.0
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (315)
..++|++++.||+|+||.||+|.. +++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 346788999999999999999987 67899999885422 1234799999999999999999876432
Q ss_pred ------CEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEE
Q 021253 209 ------MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKI 279 (315)
Q Consensus 209 ------~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl 279 (315)
..+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 246799999975 78777653 2345689999999999999999999999999999999999998665 7999
Q ss_pred eeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+|+............||+.|+|||++.+
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcC
Confidence 99999986544444445678999999998753
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=222.99 Aligned_cols=177 Identities=27% Similarity=0.471 Sum_probs=145.8
Q ss_pred ccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
|.+..++|++.+.||+|+||.||+|.+. +..||+|.+....... ...++.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 7788899999999999999999999763 3579999885432211 134688999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~ 274 (315)
+++.+....++||||+++++|.+++.+... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999998899999999999999999975321 235677889999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 275 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+.+||+|||+++....... .....+++.|+|||.+..
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 195 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence 9999999999875322211 112345788999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=249.84 Aligned_cols=174 Identities=22% Similarity=0.323 Sum_probs=144.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|++.+.||+|+||.||+|.+ +++.||||+++....... ...+++.+|+.+++.++||||+++++++.+.+..|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e---~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP---LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH---HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 4678889999999999999987 678999999975433222 23467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 213 IVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
+||||+++++|.+++.... ....+...++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999986421 1234566788999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC-------------------CccCCCCCccccccCcccc
Q 021253 284 VARIEVQTE-------------------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~-------------------~~~~~~gt~~y~APE~~~~ 311 (315)
+|+...... .....+||+.|+|||.+.+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 998641100 0112469999999998753
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=221.06 Aligned_cols=173 Identities=32% Similarity=0.551 Sum_probs=145.8
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|.++..+|++.+.||+|+||.||+|++ ....||+|.++..... .+++.+|+.+++.++||||+++++.+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-------HHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 778888999999999999999999987 4457999998753332 2468899999999999999999998754
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++.+.....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||.++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 45789999999999999998654556789999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCc--cCCCCCccccccCccc
Q 021253 289 VQTEGM--TPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~--~~~~gt~~y~APE~~~ 310 (315)
...... ....++..|+|||...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred cccccccccCCcccceecCHhHhc
Confidence 433221 1234567899999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=231.64 Aligned_cols=177 Identities=29% Similarity=0.555 Sum_probs=145.4
Q ss_pred cccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (315)
+|.++.++|++.+.||+|+||.||+|.+ +++.||+|+++...... ..+.+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-----EYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-----HHHHHHHHHHHHHhhccCcchhh
Confidence 4899999999999999999999999964 23689999986433221 135677899999999 8999999
Q ss_pred EEEEEEeC-CEEEEEEeccCCCCHHHHHHhhCC-----------------------------------------------
Q 021253 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (315)
Q Consensus 201 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 232 (315)
++++|... ..+++++||+++++|.+++.....
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 99988654 578999999999999999865321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCC
Q 021253 233 ------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPE 297 (315)
Q Consensus 233 ------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~ 297 (315)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 2578889999999999999999999999999999999999999999999999986432221 1223
Q ss_pred CCCccccccCccc
Q 021253 298 TGTYRWMAPSAGS 310 (315)
Q Consensus 298 ~gt~~y~APE~~~ 310 (315)
.++..|+|||++.
T Consensus 236 ~~~~~y~aPE~~~ 248 (337)
T cd05054 236 RLPLKWMAPESIF 248 (337)
T ss_pred CCCccccCcHHhc
Confidence 4567899999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=238.47 Aligned_cols=166 Identities=30% Similarity=0.436 Sum_probs=145.1
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-C-----CCeeeEEEEEEe
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-H-----LNIVRFIGACRK 207 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~ 207 (315)
+|.+.+.||+|.||+|.+|.+ +++.||||+++.... ...+-..|+.+|..|+ | -|+|+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 778899999999999999987 789999999976332 2356678999999997 4 389999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC--CcEEEeeecce
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVA 285 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~--~~vkl~DFG~a 285 (315)
.++.|||+|.++. +|.++++..+...++...++.|+.||+.||.+||+.+|||+||||+|||+..- ..|||+|||.|
T Consensus 260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999955 99999999888889999999999999999999999999999999999999753 37999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
....+. .+ +..-+..|.|||+|-+
T Consensus 339 c~~~q~-vy-tYiQSRfYRAPEVILG 362 (586)
T KOG0667|consen 339 CFESQR-VY-TYIQSRFYRAPEVILG 362 (586)
T ss_pred cccCCc-ce-eeeeccccccchhhcc
Confidence 865443 23 5567789999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=223.29 Aligned_cols=176 Identities=27% Similarity=0.475 Sum_probs=147.9
Q ss_pred ccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
|+++.++|++.+.||+|+||.||+|.+. +..||+|.+....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence 7889999999999999999999999863 2679999986433221 134688999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~ 274 (315)
+++......++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 999999999999999999999999975321 236788899999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 275 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+.+||+|||+++....... .....++..|+|||.+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 9999999999975433221 22345678999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=229.90 Aligned_cols=166 Identities=27% Similarity=0.358 Sum_probs=139.1
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||++.+ +++.||||++++...... .....+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD---DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999988 567999999975322111 1234677888999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-CCCccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-~~~~~~ 296 (315)
+++++|..++.+. ..+++..+..++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999999988754 3589999999999999999999999999999999999999999999999999975322 222334
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 156 ~~g~~~y~aPE~~~~ 170 (318)
T cd05570 156 FCGTPDYIAPEILSY 170 (318)
T ss_pred eecCccccCHHHhcC
Confidence 579999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=233.00 Aligned_cols=169 Identities=25% Similarity=0.343 Sum_probs=141.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (315)
.++|++.+.||+|+||.||++.. .++.||||.+......... .+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH----HHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 47888999999999999999986 6789999998764433221 35677999999999999999999988643
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
...|+||||+++ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999975 67777643 3788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............||+.|+|||++..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcC
Confidence 86544434455679999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=244.57 Aligned_cols=167 Identities=29% Similarity=0.491 Sum_probs=144.3
Q ss_pred cccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------E
Q 021253 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM------V 210 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 210 (315)
..+.||+|+||.||+++. +|+.||||.++....... .+...+|+++|++++|||||+++++-.+.. .
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 347899999999999986 899999999976443222 357789999999999999999999865433 4
Q ss_pred EEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc--CCC--cEEEeeecce
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKIADFGVA 285 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~--~~~--~vkl~DFG~a 285 (315)
..+|||||.+|+|...+.+..+ ..+++...+.++.+++.||.|||++||+||||||.||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 5799999999999999987544 3589999999999999999999999999999999999984 334 4699999999
Q ss_pred eeeecCCCccCCCCCccccccCccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|-..++....+..||+.|++||++.
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYE 196 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHh
Confidence 9888877888899999999999987
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=224.04 Aligned_cols=171 Identities=27% Similarity=0.435 Sum_probs=139.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe---
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK--- 207 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 207 (315)
+|++.+.||+|+||.||+|.. +++.||+|.++........ ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL----PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC----chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 467789999999999999987 6789999998754332211 12345666666655 79999999998864
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 208 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
...+++|+||+.+ +|.+++.......+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 3458999999975 8999987765556899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............||+.|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred ccccCcccCCCccccccccCchHhhC
Confidence 86554434455678999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=219.35 Aligned_cols=173 Identities=34% Similarity=0.571 Sum_probs=147.0
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+++.++|++.+.||+|+||.||+|.+ .+..+|+|.+....... +.+.+|+.++++++||+++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 788889999999999999999999987 55689999987644432 468899999999999999999998864
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||++++++.++|+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45789999999999999998655556899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCc--cCCCCCccccccCccc
Q 021253 289 VQTEGM--TPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~--~~~~gt~~y~APE~~~ 310 (315)
...... ....++..|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred cCcccccccCCCCCccccChHHHh
Confidence 432211 1223456899999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=240.74 Aligned_cols=175 Identities=26% Similarity=0.363 Sum_probs=146.6
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (315)
..++|.+.+.||+|+||.||+|.+ +++.||||++......... ...+.+|+.++..++|+|+++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 447899999999999999999987 7889999999765443322 356789999999999999999988775432
Q ss_pred -------EEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 210 -------VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 210 -------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.+++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999987532 3468899999999999999999999999999999999999999999999
Q ss_pred eecceeeeecC---CCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQT---EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~---~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+++..... ......+||+.|+|||++..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 99999864321 12234679999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=232.50 Aligned_cols=167 Identities=33% Similarity=0.492 Sum_probs=143.1
Q ss_pred cccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC--CCCCeeeEEEEEEeCC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKRM- 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~- 209 (315)
....+++.+.||+|.||.||+|.++++.||||++.... .+.|.+|-.|.+.. +|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH---------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 35677888999999999999999999999999985311 25788888888764 7999999999875544
Q ss_pred ---EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCCccCCCCCCCEEEcCCCcE
Q 021253 210 ---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 210 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---------~~iiHrDlkp~NIli~~~~~v 277 (315)
.++||+||.+.|+|.+||+. ..++|....+|+..++.||+|||+ ..|+|||||.+||||..|+++
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 78999999999999999986 458999999999999999999995 259999999999999999999
Q ss_pred EEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 278 KIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 278 kl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
.|+|||+|....... .....+||.+|||||++.+
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 999999998765332 2334689999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=222.74 Aligned_cols=174 Identities=33% Similarity=0.584 Sum_probs=145.3
Q ss_pred ccccccccccceeecccCceEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++..+|++.+.||+|+||.||+|...+ ..|++|.++..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 456789999999999999999998632 46999988643321 123578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
+......+++|||+++++|.+++..... ..+++..++.++.||+.||+|||+++++|+||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9998889999999999999999975421 45788889999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
+++++.+||+|||+++...... ......+++.|+|||.+.
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence 9999999999999998543221 122345678999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=227.86 Aligned_cols=176 Identities=24% Similarity=0.359 Sum_probs=153.0
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
-.+..++|.++++||+|.||+|.+++- +++.+|+|++++...-... ....-+.|-++|+..+||.+..+--.|+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd---EVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD---EVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH---HhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 345678999999999999999999976 8899999999865443221 12356689999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
++++|+||||+.||.|.-.|.+ ...+++..++.+-..|+.||.|||+++||.||||.+|+|+|++|++||+|||+|+-
T Consensus 240 ~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred CceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999999999888875 35689999999999999999999999999999999999999999999999999984
Q ss_pred -eecCCCccCCCCCccccccCccc
Q 021253 288 -EVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 -~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+.....+.++||||.|+|||++.
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred cccccceeccccCChhhcCchhhc
Confidence 23344577899999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=219.43 Aligned_cols=173 Identities=31% Similarity=0.544 Sum_probs=148.2
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+|..++|++.++||+|+||.||+|.. +++.||+|.+....... +++.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-------EAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-------HHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 788899999999999999999999987 67899999987544432 468899999999999999999998754
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 45799999999999999997765667899999999999999999999999999999999999999999999999999765
Q ss_pred ecCCC--ccCCCCCccccccCccc
Q 021253 289 VQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
..... .....+++.|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CCCCcccccCCcccccccCHHHhc
Confidence 42221 12234567899999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=218.96 Aligned_cols=170 Identities=29% Similarity=0.519 Sum_probs=143.6
Q ss_pred cccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+..+|++.+.||+|+||.||++.+ .+..+|+|++....... ..+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 456788999999999999999988 45589999986544322 3677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++...+.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999997643 36889999999999999999999999999999999999999999999999999865432
Q ss_pred CCcc--CCCCCccccccCccc
Q 021253 292 EGMT--PETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~~~~--~~~gt~~y~APE~~~ 310 (315)
.... ...++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~ 174 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFD 174 (256)
T ss_pred cccccCCCCCCccccCHHHhc
Confidence 2111 112346899999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=225.87 Aligned_cols=170 Identities=25% Similarity=0.376 Sum_probs=143.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|.+.+.||+|+||.||+|+. +++.||+|.++....... ...+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 36788889999999999999987 677899999875433221 13567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++ +|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 999999975 888888654 345788899999999999999999999999999999999999999999999999754322
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......+|+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~ 177 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLL 177 (309)
T ss_pred ccccccccccccccCCHHHh
Confidence 1 233456889999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=218.94 Aligned_cols=174 Identities=32% Similarity=0.562 Sum_probs=149.9
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+++.++|.+.+.||+|+||.||+|.+ .++.||||.+...... .+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-------PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC-------HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 788999999999999999999999987 4568999998754433 24688999999999999999999999988
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++.......+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 88999999999999999998765567899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC--ccCCCCCccccccCccc
Q 021253 289 VQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
..... ......+..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~ 177 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAAN 177 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhc
Confidence 32211 11223457899999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=222.39 Aligned_cols=176 Identities=27% Similarity=0.471 Sum_probs=145.1
Q ss_pred ccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
|+++..+|++.+.||+|+||.||+|... +..||+|.+....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-----ERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 8889999999999999999999999652 3479999876433221 124678999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~ 274 (315)
+++.+....++||||+++|+|.+++..... ...+...++.++.||+.||.|||+++++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999999999999999999999999975321 234567788999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 275 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+.+||+|||+++....... .....++..|+|||.+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence 9999999999985432211 12234567899999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=220.69 Aligned_cols=168 Identities=30% Similarity=0.578 Sum_probs=144.8
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|++++.||+|+||.||++.. +++.||+|++......... .....+|+.++++++||||+++++++......++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence 56789999999999999998 5668999999875433222 22345699999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee-ecCCC
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEG 293 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~-~~~~~ 293 (315)
||++++++|.+++... ..+++..++.++.||+.||++||+.+++|+||||+||+++.++.++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999843 45899999999999999999999999999999999999999999999999999753 23334
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||++.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp BSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccccccc
Confidence 55667899999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=231.80 Aligned_cols=171 Identities=22% Similarity=0.386 Sum_probs=154.1
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
-|.+.+.||+|.|..|-+|++ +|..||||++.+........ ..+.+|++.|+.++|||||+||.+...+..+||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st----~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST----GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh----hHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 355668999999999999986 99999999998877665432 467799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~DFG~a~~~~~~~ 292 (315)
|+|+-++|+|.+|+.+.. ..+.+..+.+++.||+.|+.|||+..+|||||||+|+.+- +-|-|||.|||++-.+.+..
T Consensus 95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999998764 4589999999999999999999999999999999999875 56899999999998888888
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
..++.||...|.|||++-+
T Consensus 174 kL~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLG 192 (864)
T ss_pred hhhcccchhhccCchhhhc
Confidence 8899999999999998754
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=229.70 Aligned_cols=177 Identities=28% Similarity=0.554 Sum_probs=144.1
Q ss_pred cccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (315)
+|.++.++|++.+.||+|+||.||+|.+ +++.||||+++....... ...+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhh
Confidence 4888999999999999999999999974 457899999975432211 35688999999999 6899999
Q ss_pred EEEEEEeC-CEEEEEEeccCCCCHHHHHHhhCC-----------------------------------------------
Q 021253 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (315)
Q Consensus 201 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 232 (315)
+++++... ..+++||||+++|+|.+++.....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 99988654 567999999999999999875321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC-
Q 021253 233 ------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (315)
Q Consensus 233 ------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~- 293 (315)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 2357778889999999999999999999999999999999999999999999975432211
Q ss_pred --ccCCCCCccccccCccc
Q 021253 294 --MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 --~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 236 ~~~~~~~~~~~y~aPE~~~ 254 (343)
T cd05103 236 VRKGDARLPLKWMAPETIF 254 (343)
T ss_pred hhcCCCCCCcceECcHHhc
Confidence 11223567899999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=232.77 Aligned_cols=164 Identities=23% Similarity=0.389 Sum_probs=141.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
...|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++||||+++++++......
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 35688999999999999999998 5568999975321 234789999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+|++. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99999995 5898888754 356899999999999999999999999999999999999999999999999999864433
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||++..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred cccccccccccccCCeecCC
Confidence 33445679999999998753
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=221.51 Aligned_cols=174 Identities=30% Similarity=0.507 Sum_probs=144.2
Q ss_pred ccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+++++|++.+.||+|+||.||+|.+ .+..|++|.+...... . ....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-Q----QWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-H----HHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 4567889999999999999999975 3468999998643221 1 135788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ---------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
......|+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 99999999999999999999986432 234778888999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
++.++.+||+|||+++...... ......++..|+|||++.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence 9999999999999997543221 123344567899999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=219.16 Aligned_cols=170 Identities=30% Similarity=0.525 Sum_probs=144.2
Q ss_pred cccccccccceeecccCceEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+.++|++.+.||+|+||.||++.+.+ ..+|+|.++..... .+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45788899999999999999998844 46999998654332 24688999999999999999999999988889
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||.++.....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999999864332
Q ss_pred CCc--cCCCCCccccccCccc
Q 021253 292 EGM--TPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~~~--~~~~gt~~y~APE~~~ 310 (315)
... ....++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred ceeecCCCccChhhCCHHHHh
Confidence 211 1223557899999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=221.24 Aligned_cols=176 Identities=32% Similarity=0.551 Sum_probs=150.4
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+.+..+|++.+.||.|+||.||+|.+ .++.+++|++....... .+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 556678899999999999999999988 56789999986543211 24688999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++.+.....+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999999998766667899999999999999999999999999999999999999999999999999764
Q ss_pred ecCCC-ccCCCCCccccccCcccc
Q 021253 289 VQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
..... .....+++.|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~ 178 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH 178 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc
Confidence 33211 223345678999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=215.97 Aligned_cols=170 Identities=24% Similarity=0.412 Sum_probs=146.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||.|+||.||++.+ ++..+|+|.++...... ..+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-----AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 467789999999999999987 67899999986543221 13567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
||||+++++|.+++.......+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999999998765556689999999999999999999999999999999999999999999999999986543222
Q ss_pred -ccCCCCCccccccCccc
Q 021253 294 -MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~ 310 (315)
.....|++.|+|||++.
T Consensus 156 ~~~~~~~~~~~~aPE~~~ 173 (255)
T cd08219 156 YACTYVGTPYYVPPEIWE 173 (255)
T ss_pred ccccccCCccccCHHHHc
Confidence 23356889999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-31 Score=221.57 Aligned_cols=170 Identities=25% Similarity=0.390 Sum_probs=146.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++-+.||+|.|+.|+++.. +|+.+|+|++......... .+.+.+|++|-+.|+||||+++.+...+....|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~----~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc----HHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 5677889999999999999976 8899999998765544432 367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~~~ 289 (315)
+|+|+|+|++|..-+-.+ ...++..+-..+.||+++|.|+|.++|||||+||.|+++.. ..-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997766554 34788888999999999999999999999999999999953 3479999999998776
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.......+.|||.|||||++.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvr 185 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLK 185 (355)
T ss_pred CccccccccCCCcccCHHHhh
Confidence 555556688999999999875
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=217.62 Aligned_cols=170 Identities=29% Similarity=0.480 Sum_probs=146.2
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
+.++|++.+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 346789999999999999999987 67899999986543221 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++....
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999999998653 4588999999999999999999999999999999999999999999999999986432
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......|++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccccCccccCccccCHhHcc
Confidence 21 233456889999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=223.64 Aligned_cols=179 Identities=32% Similarity=0.530 Sum_probs=147.7
Q ss_pred CccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (315)
...|++..++|.+++.||+|+||.||++.+. ...+|+|.++...... ..+.+.+|+.+++.+ +||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIGKHK 84 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-----HHHHHHHHHHHHHHhcCCC
Confidence 4568898999999999999999999999762 2469999987532211 135688899999999 799
Q ss_pred CeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 021253 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (315)
Q Consensus 197 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (315)
||+++++++......|+||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999999976431 247888999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 263 Dlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||||+||+++.++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence 9999999999999999999999975432111 11223457899999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=243.86 Aligned_cols=165 Identities=27% Similarity=0.430 Sum_probs=140.5
Q ss_pred cccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
++..||.|+||+||+|.. ++-..|.|++.... ....+.++-|+.||..+.||+||+||+.|.-.+.+||+.|
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetks------eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS------EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccc------hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 456799999999999976 44455778775422 2235788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee-ecCCCcc
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMT 295 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~-~~~~~~~ 295 (315)
||.||.+..++-.. +..+.+..+.-+|+|++.||.|||+++|||||||+.|||++.+|.++|+|||++... .......
T Consensus 110 FC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred ecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99999998887765 467999999999999999999999999999999999999999999999999987532 2223456
Q ss_pred CCCCCccccccCccc
Q 021253 296 PETGTYRWMAPSAGS 310 (315)
Q Consensus 296 ~~~gt~~y~APE~~~ 310 (315)
++.|||+|||||+..
T Consensus 189 sFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVM 203 (1187)
T ss_pred cccCCcccccchhee
Confidence 789999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=226.22 Aligned_cols=171 Identities=23% Similarity=0.460 Sum_probs=140.6
Q ss_pred cccccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
...+|+..+.||+|+||.||+|.+ ++. .||+|.++..... ...+++.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 456788999999999999999986 333 4899998643221 12357889999999999999999999997
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
... .++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CCC-ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 754 679999999999999998643 457888899999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---cCCCCCccccccCccc
Q 021253 287 IEVQTEGM---TPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~APE~~~ 310 (315)
........ ....++..|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhc
Confidence 65433221 1123467899999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=231.02 Aligned_cols=169 Identities=26% Similarity=0.342 Sum_probs=141.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (315)
.++|++.+.||+|+||.||++.. .++.||||++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 46788899999999999999987 6789999998754433222 35677999999999999999999987543
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..+|+||||+++ +|.+++.. .++...+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 77777753 3788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............+|+.|+|||++..
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhC
Confidence 86544434455679999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=215.78 Aligned_cols=171 Identities=24% Similarity=0.404 Sum_probs=147.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|.+.+.||+|++|.||++++ +++.|++|.+........ ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 356778999999999999987 678999999875443322 23578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999999876556789999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCccccccCccc
Q 021253 294 -MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~ 310 (315)
.....|++.|+|||++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 157 FANTIVGTPYYLSPELCE 174 (256)
T ss_pred hhhccccCccccCHHHhc
Confidence 23346889999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=221.97 Aligned_cols=170 Identities=26% Similarity=0.394 Sum_probs=147.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|++|.||++.+ +++.||+|++....... ....+.+.+|+.+++++.||||+++++++......|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 3577889999999999999987 67899999986533221 122467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999999764 45899999999999999999999999999999999999999999999999999865433
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
.....+++.|+|||.+..
T Consensus 155 -~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred -CCCCCCCccccChhhhcC
Confidence 344578999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=231.60 Aligned_cols=169 Identities=27% Similarity=0.400 Sum_probs=141.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (315)
+|++.+.||+|+||.||++.. +++.||||.+........ ..+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 467789999999999999986 788999999865332221 1357889999999999999999999998776
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+|+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999996 588888754 346899999999999999999999999999999999999999999999999999864
Q ss_pred ecCC--CccCCCCCccccccCcccc
Q 021253 289 VQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......+|+.|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcC
Confidence 3222 2334568899999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=217.77 Aligned_cols=173 Identities=24% Similarity=0.400 Sum_probs=146.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|+. +++.||||.+........+ ....+.+|+.+++.++||||+++++++...+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 4678889999999999999987 7889999988654332222 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+|+||+++++|.+++... ....+++..++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999999988643 234578899999999999999999999999999999999999999999999999986543
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......+++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~ 179 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred hhHHHhcCCCCccccChhhhc
Confidence 22 123356889999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=216.78 Aligned_cols=174 Identities=32% Similarity=0.542 Sum_probs=147.1
Q ss_pred ccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
+|++++.||+|+||.||+|.. +++.+|+|.+................+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467789999999999999987 7788999998765443333333346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec----
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ---- 290 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~---- 290 (315)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999999754 3578899999999999999999999999999999999999999999999999874321
Q ss_pred ---CCCccCCCCCccccccCcccc
Q 021253 291 ---TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ---~~~~~~~~gt~~y~APE~~~~ 311 (315)
........|++.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred ccccccccccCCCccccChhhhcC
Confidence 111234568899999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=218.01 Aligned_cols=173 Identities=29% Similarity=0.490 Sum_probs=144.8
Q ss_pred cccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+.++|++.+.||+|+||.||+|.+. ...||||.++...... ....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4567889999999999999999873 3479999886543221 13578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999997643 3688999999999999999999999999999999999999999999999999986
Q ss_pred eecC-CCcc--CCCCCccccccCcccc
Q 021253 288 EVQT-EGMT--PETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~-~~~~--~~~gt~~y~APE~~~~ 311 (315)
.... .... ...+++.|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~ 182 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAY 182 (266)
T ss_pred ccccccceeccCCCCCccccChhhhcc
Confidence 5311 1111 1234578999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=222.61 Aligned_cols=178 Identities=31% Similarity=0.556 Sum_probs=147.5
Q ss_pred ccccccccccccccceeecccCceEEEEE---------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
..|++...+|++.+.||+|+||.||+|++ .+..||+|.+....... ..+.+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH-----HHHHHHHHHHHHHhhccCCC
Confidence 35888899999999999999999999974 23468999886432211 135788999999999 8999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
|+++++++......|+||||+++++|.+++.+.. ...+++..++.++.||+.||.|||++|++|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999999999999999999999999997642 13467888899999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
|||+||+++.++.+||+|||+++...... ......+++.|+|||++.
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc
Confidence 99999999999999999999998653221 112234567899999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=215.26 Aligned_cols=174 Identities=30% Similarity=0.491 Sum_probs=146.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|++|.||++.. +++.||+|.+......... ....+.+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 4577889999999999999986 6789999998754433221 222457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998764 358889999999999999999999999999999999999999999999999997543211
Q ss_pred ----CccCCCCCccccccCcccc
Q 021253 293 ----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ----~~~~~~gt~~y~APE~~~~ 311 (315)
......++..|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred cccccccCCCcCccccCcceecc
Confidence 1134567899999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=220.87 Aligned_cols=178 Identities=33% Similarity=0.552 Sum_probs=148.4
Q ss_pred ccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (315)
..|+++.++|++.+.||+|+||.||++.+. ...+|+|.+....... ....+.+|+.+++.+ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 468899999999999999999999999863 2578999986532211 135688999999999 899999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
++++++.....++++|||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999999753 23457889999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+||+++.++.+||+|||+++....... .....+++.|+|||++.
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 207 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence 9999999999999999999986433211 12223457899999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=231.53 Aligned_cols=178 Identities=21% Similarity=0.299 Sum_probs=156.9
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|-+..+.|..-+.||+|+||+||-++. +|+-+|+|.+.+..... ..-+...++|..+|.+++.+.||.+-.++..
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk---r~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK---RKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH---hhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 345667778888999999999998764 89999999886533322 2224567899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+.+++|+..|.||+|.-.|.+..+..+++..++.++.+|+.||++||+.+||.|||||+|||+|+.|+++|+|+|+|.-
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999999999887777899999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCccCCCCCccccccCccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+.........+||.+|||||++.
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred cCCCCccccccCcccccCHHHHc
Confidence 77777677779999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=221.76 Aligned_cols=169 Identities=28% Similarity=0.558 Sum_probs=138.6
Q ss_pred ccccceeecccCceEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 138 NMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
++.+.||.|.||.||+|++. +..|+||.++.. ...+ ..+.+.+|++++++++||||++++|++......
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccc----cceeeeecccccccccccccccccccccccccc
Confidence 35678999999999999987 578999999542 2221 146889999999999999999999999988889
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+||+++|+|.+++.......+++..++.|+.||+.||.|||+++++|+||+++||+++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999875567999999999999999999999999999999999999999999999999999865221
Q ss_pred CC---ccCCCCCccccccCcccc
Q 021253 292 EG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~---~~~~~gt~~y~APE~~~~ 311 (315)
.. .........|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH
T ss_pred ccccccccccccccccccccccc
Confidence 11 122346689999998753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=217.61 Aligned_cols=170 Identities=33% Similarity=0.599 Sum_probs=146.4
Q ss_pred ccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
|-++.++|++.+.||+|+||.||++..+++.||+|.++.... .+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 566778999999999999999999999999999999854221 246889999999999999999999987654
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 6899999999999999987655568999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.. ......+..|+|||.+.
T Consensus 152 ~~--~~~~~~~~~y~~pe~~~ 170 (254)
T cd05083 152 MG--VDNSKLPVKWTAPEALK 170 (254)
T ss_pred cc--CCCCCCCceecCHHHhc
Confidence 22 22234457899999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=248.27 Aligned_cols=180 Identities=23% Similarity=0.329 Sum_probs=148.6
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++..+....+|++++.||.|+||.||+|.+ .+..||+|++......... ...+..|+.+++.|+||||++++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~----~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE----KSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH----HHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 444556678999999999999999999988 6678999998765443322 3578899999999999999999998
Q ss_pred EEe--CCEEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCCCEEEcC
Q 021253 205 CRK--RMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL-------GFIHRDLKSDNLLISA 273 (315)
Q Consensus 205 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-------~iiHrDlkp~NIli~~ 273 (315)
+.. ...+||||||+++++|.+++.... ...+++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 457899999999999999997532 34689999999999999999999984 4999999999999964
Q ss_pred -----------------CCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 274 -----------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 274 -----------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.+.+||+|||+++............||+.|+|||++.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence 2358999999998654433344567999999999874
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=222.04 Aligned_cols=179 Identities=30% Similarity=0.502 Sum_probs=149.6
Q ss_pred ccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (315)
.+|.+..++|.+.+.||+|+||.||++++ .+..||+|.++...... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 35778889999999999999999999975 23479999886543221 135788999999999 799999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
++++++...+..++||||+.+++|.+++.......+++..++.++.|++.||+|||+++++|+||||+|||++.++.+||
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999999997654445899999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++....... .....+++.|+|||.+..
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 217 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN 217 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhcc
Confidence 99999975432211 112345688999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=216.53 Aligned_cols=173 Identities=33% Similarity=0.547 Sum_probs=145.1
Q ss_pred ccccccccccccceeecccCceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+++..+|.+.+.||+|++|.||++.+. +..+|+|.+...... .+.+.+|+.+++.++|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 6777888999999999999999999884 457999987653322 2467899999999999999999998864
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||||+||++++++.++|+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 45789999999999999998755556889999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC--ccCCCCCccccccCccc
Q 021253 289 VQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
..... .....++..|+|||...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhc
Confidence 33221 11234567899999765
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=213.53 Aligned_cols=172 Identities=22% Similarity=0.344 Sum_probs=148.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|+..+.||.|+||.||.++. +++.+++|.+......... .+++.+|+.++++++|+||+++++++.+...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 367889999999999988876 6789999998755433322 3567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
+|||+++++|.+++.+.....+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.+||+|||+++......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987655668999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG 175 (256)
T ss_pred cccccCCCccccCHhhcCC
Confidence 2344578999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=217.65 Aligned_cols=170 Identities=28% Similarity=0.474 Sum_probs=146.1
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
+.++|++.+.||+|+||.||+|.+ +++.||+|+++...... ...+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence 346788889999999999999987 67899999987543221 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.|+|+||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999999998754 4589999999999999999999999999999999999999999999999999875432
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......|++.|+|||++.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccccccccCcccccChhhhc
Confidence 21 223457899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=242.53 Aligned_cols=180 Identities=27% Similarity=0.434 Sum_probs=147.9
Q ss_pred cccccccccccccceeecccCceEEEEE-CC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEE-
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA- 204 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~- 204 (315)
.+++...++++.+.|.+|+|+.||.|+. .+ ..||+|.+-.... ...+.+.+|+++|+.|+ |+|||.+++.
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de------~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE------EALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH------HHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 3456677888999999999999999998 44 8999998865421 12468899999999997 9999999993
Q ss_pred EEe------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcCCCc
Q 021253 205 CRK------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS 276 (315)
Q Consensus 205 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~~~~ 276 (315)
... .-.++|.||||+||.|.+++..+....+++.++++|+.|+|+|+.+||... |||||||.+||||+.++.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 321 135789999999999999999877777999999999999999999999997 999999999999999999
Q ss_pred EEEeeecceeeeecCCCc----------cCCCCCccccccCccccccC
Q 021253 277 IKIADFGVARIEVQTEGM----------TPETGTYRWMAPSAGSICCG 314 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~~----------~~~~gt~~y~APE~~~~~~g 314 (315)
.||||||.|.-.-..... ...--|+-|.|||++-...|
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 999999998632211100 11136899999999987665
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=255.55 Aligned_cols=180 Identities=22% Similarity=0.318 Sum_probs=154.7
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.+.+....+|.+++.||+|+||+|..++. +++.||+|++.+..+.... ....|..|-.+|..-..+-|++++-+|
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~---~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA---ETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch---hHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 34556778999999999999999999987 6788999999764333211 124688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
++..++|+|||||+||+|..++.+.. .+|+++++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999998764 6999999999999999999999999999999999999999999999999988
Q ss_pred eeee-cCCC-ccCCCCCccccccCccccc
Q 021253 286 RIEV-QTEG-MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 286 ~~~~-~~~~-~~~~~gt~~y~APE~~~~~ 312 (315)
-... ++.. ....+|||.|++||++...
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 5444 3322 2446899999999998743
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=216.42 Aligned_cols=174 Identities=30% Similarity=0.514 Sum_probs=147.9
Q ss_pred ccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
|+++.++|++.+.||+|+||.||++.+ .+..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 788999999999999999999999987 556799998864321 13578899999999999999999999887
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...+++|||+++++|.+++.+.....+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||.++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 67899999999999999998765566788899999999999999999999999999999999999999999999999765
Q ss_pred ecCCC--ccCCCCCccccccCcccc
Q 021253 289 VQTEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~ 311 (315)
..... .....++..|+|||++..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~ 177 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINF 177 (260)
T ss_pred cCCCcccccCCcccccccCHhHhcc
Confidence 33221 122235678999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=217.63 Aligned_cols=165 Identities=25% Similarity=0.414 Sum_probs=141.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||+|.+....... ..+.+.+|+.+++++.||||+++++.+......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence 3577889999999999999986 77899999986542211 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|..+. .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++......
T Consensus 76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999999999996552 3678889999999999999999999999999999999999999999999999754332
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||.+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~ 167 (279)
T cd06619 149 IAKTYVGTNAYMAPERISG 167 (279)
T ss_pred cccCCCCChhhcCceeecC
Confidence 2344679999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=228.70 Aligned_cols=165 Identities=24% Similarity=0.374 Sum_probs=139.9
Q ss_pred cccccccccceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
-..+|++.+.||+|+||.||++.. .++.||+|.+... +...+|+.+++.++||||+++++++...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 345789999999999999999975 3468999987542 1345899999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+|||++. ++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999999995 589888843 356899999999999999999999999999999999999999999999999999754
Q ss_pred ecCCC---ccCCCCCccccccCcccc
Q 021253 289 VQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
..... .....||+.|+|||++..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred CcccccccccccccccCccCHhHhcC
Confidence 32211 223579999999998753
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=221.03 Aligned_cols=168 Identities=26% Similarity=0.364 Sum_probs=144.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.+ ++..+|+|.++.... . ...+++.+|++++++++||||+++++++..++.+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-P----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 578889999999999999987 677899998864321 1 123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
||||+++++|.+++.+. ..+++..+..++.||+.||+|||+ .+++|+||||+|||++.++.+||+|||+++.....
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999999764 458899999999999999999997 59999999999999999999999999998754332
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG 172 (308)
T ss_pred ccccCCCCcCccChhHhcC
Confidence 2344678999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=218.45 Aligned_cols=174 Identities=30% Similarity=0.525 Sum_probs=144.8
Q ss_pred cccccccccceeecccCceEEEEECC------------------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYNG------------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 194 (315)
...+|++.+.||+|+||.||+|++.. ..||+|.+...... ...+.+.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcC
Confidence 45688899999999999999987632 45899998654322 22467889999999999
Q ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 195 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
||||+++++++.....+++++||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999999999999999999999999999999997643 1258899999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
|+||+++.++.++|+|||+++....... .....+++.|+|||.+..
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 9999999999999999999975432211 123346789999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=221.37 Aligned_cols=174 Identities=30% Similarity=0.509 Sum_probs=140.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
+.+++|++.+.||+|+||.||+|.+ ++. .+++|.++..... .....+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 3457888999999999999999986 444 4577766432211 1235788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~ 272 (315)
....+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999997542 13578899999999999999999999999999999999999
Q ss_pred CCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.++.+||+|||+++............+++.|+|||.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 196 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence 99999999999986432211112223467899999765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=216.06 Aligned_cols=165 Identities=25% Similarity=0.429 Sum_probs=135.2
Q ss_pred cceeecccCceEEEEEC----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
+.||+|+||.||+|.+. +..+|+|.++....... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999862 35789998865432211 2468899999999999999999999999888999999
Q ss_pred ccCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 217 YAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|+++++|.+++..... ...++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999999975322 2456677888999999999999999999999999999999999999999999975332211
Q ss_pred ---ccCCCCCccccccCccc
Q 021253 294 ---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ---~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred eecCCCcCCcccccCHhHhc
Confidence 12245778999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=223.66 Aligned_cols=179 Identities=32% Similarity=0.540 Sum_probs=147.5
Q ss_pred ccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
-+|++...+|++++.||+|+||.||+|++. ...||+|.++...... ..+.+.+|+.+++++ +|||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCCC
Confidence 578899999999999999999999999752 2368999886432211 135788999999999 7999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
|+++++++......++++||+++++|.+++.+.. ...+++..++.++.||+.||+|||+++++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999999999999999999999997532 23467888899999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
|||+|||++.++.+||+|||+++....... .....+++.|+|||++..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 999999999999999999999986433211 122234578999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=221.44 Aligned_cols=179 Identities=31% Similarity=0.544 Sum_probs=147.3
Q ss_pred ccccccccccccccceeecccCceEEEEE---------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
.+|.++..+|.+.+.||+|+||.||+++. ....+|+|.++...... ....+.+|+.+++.+ .|||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-----DLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH-----HHHHHHHHHHHHHhccCCCC
Confidence 46888999999999999999999999975 23468999886433221 135688999999999 6999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
|+++++++.....+++||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999999889999999999999999997642 23478888999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
|||+|||++.++.+||+|||+++....... .....+++.|+|||.+..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence 999999999999999999999975432211 112234568999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=218.00 Aligned_cols=171 Identities=25% Similarity=0.356 Sum_probs=142.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|+. ++..||+|.++....... ..+.+.+|+.++++++||||+++++++.++..+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 467788999999999999987 678999999865432221 12467789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
||||++ ++|.+++.... ...+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+|||+++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999997 58988886543 3568999999999999999999999999999999999999999999999999997543221
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred ccccCCcccccccChHHhcC
Confidence 2233467899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=227.57 Aligned_cols=172 Identities=25% Similarity=0.396 Sum_probs=142.7
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|++. ++|++.+.||+|+||.||+|.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 10 VWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred Hhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 35553 6788999999999999999987 67799999986533221 12346779999999999999999999875
Q ss_pred eC------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.. ...|+++|++ +++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEc
Confidence 43 3578999998 7799888753 358999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+++.... ......||+.|+|||++..
T Consensus 161 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 161 DFGLARQADD--EMTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CCccceecCC--CcCCccccccccCchHhcC
Confidence 9999986432 2345678999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=217.27 Aligned_cols=164 Identities=27% Similarity=0.451 Sum_probs=132.8
Q ss_pred ceeecccCceEEEEE-C---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAFGKLYRGTY-N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.||+|+||.||+|.. + ...+++|.+...... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999975 2 346788876543211 1135688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC-
Q 021253 218 AKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~- 293 (315)
+++++|.+++..... ...++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999999976432 2346778889999999999999999999999999999999999999999999874322111
Q ss_pred --ccCCCCCccccccCccc
Q 021253 294 --MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 --~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVE 175 (269)
T ss_pred eccCCCCCcccccCHHHHh
Confidence 12234567899999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=216.16 Aligned_cols=173 Identities=28% Similarity=0.478 Sum_probs=143.6
Q ss_pred cccccccccceeecccCceEEEEE--C---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+..+|++.+.||+|+||.||+|.+ + +..+|+|.++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456788899999999999999986 2 2378999886533221 23578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999997643 4578899999999999999999999999999999999999999999999999986
Q ss_pred eecCCC--c--cCCCCCccccccCcccc
Q 021253 288 EVQTEG--M--TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~--~--~~~~gt~~y~APE~~~~ 311 (315)
...... . ....++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc
Confidence 433211 1 11223568999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=219.72 Aligned_cols=174 Identities=27% Similarity=0.464 Sum_probs=144.1
Q ss_pred ccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++..+|++.+.||+|+||.||+|++. +..||+|+++..... ...+.+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45677889999999999999999862 368999998753321 123578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
+......++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 999999999999999999999985321 234788889999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+++++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM 199 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence 99999999999999875432211 12334578999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=221.45 Aligned_cols=163 Identities=23% Similarity=0.389 Sum_probs=132.8
Q ss_pred ccceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Q 021253 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 213 (315)
+++||+|+||.||+|.. +++.||+|.+...... ..+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 46899999999999985 3568999998654322 246689999999999999999999854 456899
Q ss_pred EEeccCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE----cCCCcEEEeee
Q 021253 214 VTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli----~~~~~vkl~DF 282 (315)
|+||+.+ +|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9999964 8888876321 2358889999999999999999999999999999999999 45679999999
Q ss_pred cceeeeecCC----CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
|+|+...... ......||+.|+|||++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcC
Confidence 9998643221 2344578999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=236.15 Aligned_cols=172 Identities=27% Similarity=0.448 Sum_probs=140.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE--
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV-- 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 210 (315)
+-.++...||+|+|-+||+|.+ +|..||=-.++.... .+.....++|..|+.+|+.|+||||+++|.+|.+...
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~--~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV--TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHh--hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4456778999999999999987 555555211111111 1122234789999999999999999999999987654
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEc-CCCcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~-~~~~vkl~DFG~a~~ 287 (315)
+.+|+|.+..|+|..|+++. +.+..+.+..||.||++||.|||++. |||||||.+||+|+ ..|.|||.|+|+|+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 88999999999999999876 45888999999999999999999985 99999999999997 568999999999997
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..... .....|||.|||||++..
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYEE 218 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYEE 218 (632)
T ss_pred hhccc-cceeccCccccChHHHhh
Confidence 76554 344789999999999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=213.88 Aligned_cols=174 Identities=29% Similarity=0.478 Sum_probs=143.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (315)
.+|++++.||+|+||.||++.. +++.||||.+.......... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH-HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 4678889999999999999987 67899999886433222111 1235788999999999999999999998763 56
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
++++|||+++++|.+++... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 88999999999999998754 3478888999999999999999999999999999999999999999999999875321
Q ss_pred ----CCCccCCCCCccccccCcccc
Q 021253 291 ----TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ----~~~~~~~~gt~~y~APE~~~~ 311 (315)
........++..|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred ccccccccccCCCCccccChhhhcC
Confidence 112334568899999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=216.91 Aligned_cols=175 Identities=30% Similarity=0.511 Sum_probs=145.3
Q ss_pred ccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
+..++|.+.+.||+|+||.||+|++. ++.||||.++...... ..+.+.+|+++++.++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeE
Confidence 34567889999999999999999762 3689999986543321 23678999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~ 272 (315)
+......++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~ 156 (280)
T cd05049 77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156 (280)
T ss_pred EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence 999999999999999999999997542 23478888999999999999999999999999999999999
Q ss_pred CCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 273 ADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
.++.+||+|||+++....... .....+++.|+|||++..
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY 198 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence 999999999999975422211 122345789999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=215.73 Aligned_cols=173 Identities=23% Similarity=0.388 Sum_probs=146.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|++.+.||+|+||.||++.. +++.++||.+........ ...+++.+|+.+++.++||||+++++++.+.+..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH---HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 4678889999999999999986 788999998865433222 12357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
++|||+++++|.+++... ....+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999998742 234588999999999999999999999999999999999999999999999999876533
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......+++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccccccCCcCccCHHHhc
Confidence 22 123457889999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=216.94 Aligned_cols=176 Identities=29% Similarity=0.421 Sum_probs=149.2
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.+|-.+.+.|++.+.||.|+||.||+|.. +++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELEDYMVEIEILATCNHPYIVKLLGAF 78 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence 45556667899999999999999999987 578999999865321 1235788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..+..+++||||+++++|..++.+.. ..+++..++.++.|++.+|+|||+.+++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999988876533 45899999999999999999999999999999999999999999999999998
Q ss_pred eeeecCC-CccCCCCCccccccCccc
Q 021253 286 RIEVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
....... ......+++.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred eeccccccccceecCCccccCceeec
Confidence 7532221 223456889999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=218.97 Aligned_cols=174 Identities=30% Similarity=0.524 Sum_probs=142.5
Q ss_pred ccccccccccceeecccCceEEEEECC----------------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG----------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (315)
++.++|++.+.||+|+||.||+++..+ ..||+|.++.... . ...+.+.+|++++++++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-K----TARNDFLKEIKIMSRLKN 76 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-H----HHHHHHHHHHHHHHhCCC
Confidence 456789999999999999999987522 2589999865322 1 123578899999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 196 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
||++++++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++++|+|||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 9999999999999999999999999999999865321 236788889999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+||+++.++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 9999999999999999999975432211 12234567899999764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=211.21 Aligned_cols=172 Identities=24% Similarity=0.354 Sum_probs=147.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|+..+.||+|++|.||++.. +++.+|+|.+......... .+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH----HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 467789999999999999987 6789999999765443322 3578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a~~~~~~~ 292 (315)
||||+++++|.+++.......+++..++.++.|++.+|+|||+++++|+||+|+||+++.+ +.+||+|||+++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999999987655668999999999999999999999999999999999999855 468999999998654433
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG 175 (256)
T ss_pred cccccccCCcccCchhccC
Confidence 3334568899999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=215.53 Aligned_cols=169 Identities=28% Similarity=0.429 Sum_probs=146.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|.+ +++.|++|++........ ..+.+.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 467889999999999999987 678999999976543222 13578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
|+||+ +++|.+++.... ..+++..++.++.||+.+|+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999987543 568999999999999999999999999999999999999999999999999998654332
Q ss_pred -CccCCCCCccccccCccc
Q 021253 293 -GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 155 RLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CccccccCcccccCceeee
Confidence 134457899999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=213.63 Aligned_cols=169 Identities=27% Similarity=0.490 Sum_probs=143.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC---
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 208 (315)
..|++.+.||+|+||.||+|.+ .++.||+|.+...... ...+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4577788999999999999987 6789999998654322 24677899999998 699999999998753
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999998755567899999999999999999999999999999999999999999999999999
Q ss_pred eeeecC-CCccCCCCCccccccCccc
Q 021253 286 RIEVQT-EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~ 310 (315)
+..... .......|++.|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred eecccccccCCcccccccccCHhHhc
Confidence 864322 2234457899999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=210.21 Aligned_cols=172 Identities=24% Similarity=0.392 Sum_probs=145.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 212 (315)
.|++.+.||.|++|.||++.. +++.||+|.+......... .+.+.+|+.++++++|||++++++.+.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE----RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 367889999999999999987 6778999998654433221 3567899999999999999999998764 44689
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999999987655668999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred CccccccCCcCccChhHhcC
Confidence 2234568899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=232.04 Aligned_cols=163 Identities=22% Similarity=0.305 Sum_probs=139.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
..|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+.++++++|+||+++++++......+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4688889999999999999998 567899995321 24568999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999995 6898888653 2468999999999999999999999999999999999999999999999999998643221
Q ss_pred C---ccCCCCCccccccCcccc
Q 021253 293 G---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~---~~~~~gt~~y~APE~~~~ 311 (315)
. .....||+.|+|||++..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred ccccccccCCCcCCcCHHHHcC
Confidence 1 223569999999998754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=211.11 Aligned_cols=165 Identities=30% Similarity=0.493 Sum_probs=136.6
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|+||.||+|++ +++.||+|.+...... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 3689999999999987 7889999987643211 12357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc---c
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---T 295 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~---~ 295 (315)
++++|.+++... ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++........ .
T Consensus 76 ~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999999999753 345889999999999999999999999999999999999999999999999998753321111 1
Q ss_pred CCCCCccccccCcccc
Q 021253 296 PETGTYRWMAPSAGSI 311 (315)
Q Consensus 296 ~~~gt~~y~APE~~~~ 311 (315)
....+..|+|||.+..
T Consensus 155 ~~~~~~~y~aPE~~~~ 170 (252)
T cd05084 155 MKQIPVKWTAPEALNY 170 (252)
T ss_pred CCCCceeecCchhhcC
Confidence 1123467999998753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=211.98 Aligned_cols=173 Identities=23% Similarity=0.399 Sum_probs=147.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.. +++.||+|.++........ ..+.+.+|+.++++++|++++++++++...+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4678889999999999999988 6889999998754433222 1357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999998753 234578999999999999999999999999999999999999999999999999986433
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......+++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccceecCCccccCHHHhc
Confidence 22 223356889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-28 Score=214.81 Aligned_cols=176 Identities=26% Similarity=0.428 Sum_probs=144.9
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (315)
+.+....++|++.+.||+|+||.||++.. +++.+|+|++...... ...+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 44445667889999999999999999987 6789999987542211 24677899999999 69999999998
Q ss_pred EE-----eCCEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcE
Q 021253 205 CR-----KRMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 205 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~v 277 (315)
+. ....+++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 84 345689999999999999988642 23457888999999999999999999999999999999999999999
Q ss_pred EEeeecceeeeecCC-CccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
||+|||+++...... ......|++.|+|||++.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhc
Confidence 999999998643321 223346899999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=239.09 Aligned_cols=172 Identities=31% Similarity=0.437 Sum_probs=147.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.||||+++....... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK---NMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH---HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 46788899999999999999998 488999999976443322 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 9999999999999999754 35788999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......+|+.|+|||..-
T Consensus 158 ~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 158 ELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred cccccccccCccccCccccc
Confidence 2 234467899999998543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=210.31 Aligned_cols=172 Identities=28% Similarity=0.505 Sum_probs=146.4
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|+..+.||+|++|+||+|.. +++.|++|.+........ .....+.+.+|+.+++.++||||+++++++.....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 56678999999999999987 688999999875443221 112246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
+||+++++|.+++.+. ..+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999999754 35788999999999999999999999999999999999999999999999999865443334
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
....+++.|+|||.+..
T Consensus 159 ~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred cccCCCcceeCHHHhcC
Confidence 45678999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=218.06 Aligned_cols=170 Identities=26% Similarity=0.385 Sum_probs=143.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||.|+||.||+|.+ +++.||+|.++....... ...+.+|+.+++.++||||+++++++.....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 46788899999999999999987 578999999875433221 13567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999997 5999988754 345889999999999999999999999999999999999999999999999999754322
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~ 177 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILL 177 (301)
T ss_pred CCcccccceeecccCcHHHh
Confidence 1 223346789999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=212.90 Aligned_cols=174 Identities=28% Similarity=0.449 Sum_probs=146.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|+.++.||+|++|.||++.. +++.||+|++..............+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 356778999999999999986 788999999976544333333345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~~~~~~ 292 (315)
|+||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||+++......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999754 3588999999999999999999999999999999999998775 69999999987543321
Q ss_pred C-----ccCCCCCccccccCcccc
Q 021253 293 G-----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~-----~~~~~gt~~y~APE~~~~ 311 (315)
. .....++..|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~ 182 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG 182 (268)
T ss_pred ccCCccccccccccceeCHhHhcc
Confidence 1 123467899999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=214.31 Aligned_cols=170 Identities=24% Similarity=0.397 Sum_probs=140.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~ 211 (315)
++|++.+.||+|+||.||++.+ +++.||+|.++........ ..+..|..+ ++.+.||||+++++++......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-----KRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 3577889999999999999987 6889999998764433221 244455554 6777999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
|+||||++ ++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999996 5898888653 234689999999999999999999997 9999999999999999999999999999865
Q ss_pred ecCCCccCCCCCccccccCccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~ 310 (315)
......+...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERIN 176 (283)
T ss_pred ccccccccccCCccccChhhcC
Confidence 4433334457889999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=214.31 Aligned_cols=171 Identities=25% Similarity=0.470 Sum_probs=140.8
Q ss_pred cccccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
..++|++.+.||+|+||.||+|++ +++ .||+|+++...... ..+.+.+|+.+++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 456888899999999999999986 443 48999986533221 2357889999999999999999999997
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
... .++++||+++|+|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~-~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 TST-VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CCC-cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 654 67999999999999999754 2458999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---cCCCCCccccccCccc
Q 021253 287 IEVQTEGM---TPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~APE~~~ 310 (315)
........ ....+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhc
Confidence 65432221 1123467899999875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=210.89 Aligned_cols=171 Identities=31% Similarity=0.502 Sum_probs=147.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.. +++.+++|++...... ..+.+.+|+.+++.++||||+++++++.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 46788889999999999999987 5678999999754322 235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|++|||+++++|.+++... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999999998764 245889999999999999999999999999999999999999999999999998754322
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAV 175 (262)
T ss_pred hhccccccCCccccCchhhcc
Confidence 1 2334568899999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=211.18 Aligned_cols=173 Identities=31% Similarity=0.528 Sum_probs=145.7
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChh---HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE---KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
|.+++.||+|++|.||+|.. +++.+|+|.+........ ......+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999987 678999998876544322 2233456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999764 45888899999999999999999999999999999999999999999999998754321
Q ss_pred C-------CccCCCCCccccccCcccc
Q 021253 292 E-------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-------~~~~~~gt~~y~APE~~~~ 311 (315)
. ......|++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred cccCCccccccccCCCcCccChhHhcc
Confidence 1 1123458899999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=216.69 Aligned_cols=171 Identities=32% Similarity=0.512 Sum_probs=138.4
Q ss_pred cccccccceeecccCceEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
++|++.+.||+|+||.||+|.+ ++. .+++|.++...... ..+.+.+|+.++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----DHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----HHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 5788889999999999999987 332 46888776322111 135688999999999 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~ 275 (315)
.+++|+||+++++|.+++.+.. ...+++..++.++.|++.||+|||+++++||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999997532 12478889999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 276 SIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 276 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.+||+|||++..............+..|+|||.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN 191 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhc
Confidence 99999999986422111112223356799999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=215.43 Aligned_cols=171 Identities=28% Similarity=0.507 Sum_probs=142.3
Q ss_pred ccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
.+.|++.+.||+|+||.||++.+ ++..||+|.++..... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----NHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 45678889999999999999974 4678999998643221 123578899999999999999999999877
Q ss_pred C--CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 208 R--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 208 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
. ...++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence 5 56899999999999999986542 35789999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC----ccCCCCCccccccCccc
Q 021253 286 RIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+....... .....++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhc
Confidence 86433221 12345677899999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=214.62 Aligned_cols=169 Identities=29% Similarity=0.446 Sum_probs=143.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|.+ +++.||+|++........ ..+.+.+|+.+++.++|||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 577889999999999999987 578999999865432221 12467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||++++.|..+.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 78 VFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999998887776542 358999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~aPE~~~ 173 (286)
T cd07847 156 DYTDYVATRWYRAPELLV 173 (286)
T ss_pred cccCcccccccCCHHHHh
Confidence 223446789999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=218.21 Aligned_cols=150 Identities=24% Similarity=0.440 Sum_probs=133.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|++|.||+|.. +++.||+|.+........ ...+.+.+|+.+++.++||||+++++.+......|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH---HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEE
Confidence 3577889999999999999987 578999999976543321 12457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+||||+.+++|.+++.......+++..++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 999999999999999865556789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=216.00 Aligned_cols=174 Identities=29% Similarity=0.481 Sum_probs=144.2
Q ss_pred ccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
|...+|.+.+.||+|+||.||++.. ++..+|+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4567889999999999999999974 235688998864321 123578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~ 273 (315)
+.....+++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++++||||||+||+++.
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999999997532 124899999999999999999999999999999999999999
Q ss_pred CCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 274 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
++.+||+|||+++....... .....+++.|+|||.+..
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 99999999999975432211 122345788999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=214.19 Aligned_cols=165 Identities=23% Similarity=0.327 Sum_probs=141.2
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|+||.||++.. +++.||+|.+........ ...+.+.+|+.++++++||||+++++++...+..|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR---KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh---hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 68999999999976 688999999875332211 1235677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 300 (315)
++|.+++.+.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+++............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999998765556899999999999999999999999999999999999999999999999999765433333445678
Q ss_pred ccccccCccc
Q 021253 301 YRWMAPSAGS 310 (315)
Q Consensus 301 ~~y~APE~~~ 310 (315)
..|+|||.+.
T Consensus 158 ~~y~~PE~~~ 167 (277)
T cd05577 158 PGYMAPEVLQ 167 (277)
T ss_pred CCcCCHHHhc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=215.27 Aligned_cols=171 Identities=26% Similarity=0.398 Sum_probs=142.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|++|.||+|.. +++.||||.+........ ...+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-----PFTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-----chhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 36788889999999999999987 678999999875432221 13466899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999975 9999887543 36889999999999999999999999999999999999999999999999998753221
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......+++.|+|||.+.+
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred CccccccccccccCCcHHhhc
Confidence 1 1222356889999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=215.41 Aligned_cols=170 Identities=28% Similarity=0.402 Sum_probs=145.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||.|+||.||++.+ ++..+|+|++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE------EELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH------HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 45788899999999999999987 578999999864321 1235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999999987643 45899999999999999999999999999999999999999999999999998653222
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......+++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred ccccceeecchhhcCHHHHh
Confidence 1 223346899999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=210.30 Aligned_cols=166 Identities=31% Similarity=0.595 Sum_probs=143.1
Q ss_pred cceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
+.||+|+||.||+|.+. +..|++|.+....... ..+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 46899999999999884 7799999987654332 2367889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 216 EYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||.++..
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998642 356899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC---CccCCCCCccccccCcccc
Q 021253 289 VQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......+++.|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred ccccccccccCCCcCccccCHHHhcc
Confidence 4331 1234467899999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=218.78 Aligned_cols=169 Identities=18% Similarity=0.288 Sum_probs=139.2
Q ss_pred cccceeec--ccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 139 MGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 139 ~~~~iG~G--~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
++++||+| +|+.||++.. +++.||+|.+........ ..+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 45789999 6789999987 788999999865433222 235677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC--
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-- 292 (315)
|||+++++|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976544568999999999999999999999999999999999999999999999998653221110
Q ss_pred ------CccCCCCCccccccCcccc
Q 021253 293 ------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ------~~~~~~gt~~y~APE~~~~ 311 (315)
......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccccccceecccChHHhhc
Confidence 0112346788999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=213.40 Aligned_cols=171 Identities=25% Similarity=0.458 Sum_probs=139.0
Q ss_pred cccccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
...+|++.+.||+|+||.||+|.+ +++ .+++|.+..... .....++..|+.+++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-----RQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-----hHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 456788889999999999999988 444 477777643211 122356788899999999999999999886
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
. ...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 4 45688999999999999997543 458999999999999999999999999999999999999999999999999998
Q ss_pred eeecCC---CccCCCCCccccccCccc
Q 021253 287 IEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
...... ......++..|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~ 184 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESIL 184 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhc
Confidence 643221 122345678899999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=215.17 Aligned_cols=172 Identities=25% Similarity=0.311 Sum_probs=144.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--M 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 209 (315)
.++|++.+.||+|.||.||+|++ +++.+++|.++....... ....+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 35788889999999999999998 578899999975443321 124567899999999999999999998877 8
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..|+|+||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 89999999975 9999887543 358999999999999999999999999999999999999999999999999998654
Q ss_pred cC-CCccCCCCCccccccCcccc
Q 021253 290 QT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
.. .......+++.|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLG 180 (293)
T ss_pred CCccccccccccccccCchhhcC
Confidence 33 22334567899999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=210.46 Aligned_cols=171 Identities=25% Similarity=0.458 Sum_probs=139.0
Q ss_pred cccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-
Q 021253 137 LNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 210 (315)
|++++.||+|+||.||+|.+. +..||+|.++....... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 467789999999999999862 26799999875433322 13578899999999999999999998866543
Q ss_pred -----EEEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 211 -----WCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 211 -----~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
.++++||+++++|..++.... ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999986432 23588999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCc---cCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGM---TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~---~~~~gt~~y~APE~~~~ 311 (315)
||+++........ ....++..|+|||.+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhccc
Confidence 9999864332211 11235678999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=212.62 Aligned_cols=170 Identities=27% Similarity=0.387 Sum_probs=141.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|++.+.||+|+||.||+|.. +++.||+|.+........ ...+.+|+.+++.++|+||+++++++......|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 5788889999999999999986 678999999865432221 135678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+|+||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999996 68877775432 45778888899999999999999999999999999999999999999999999753221
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCCCCccccccccCCceeec
Confidence 12233457899999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=212.52 Aligned_cols=160 Identities=19% Similarity=0.385 Sum_probs=131.6
Q ss_pred ceeecccCceEEEEEC--------------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC
Q 021253 142 AFAQGAFGKLYRGTYN--------------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (315)
.||+|+||.||+|.+. ...|++|++.... ......+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 6899999999999741 1358888875321 1223568899999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC
Q 021253 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (315)
Q Consensus 196 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~ 275 (315)
|||+++++++......++||||+++++|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999999999998753 34588999999999999999999999999999999999997644
Q ss_pred -------cEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 276 -------SIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 276 -------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.+|++|||++..... .....+++.|+|||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPG 194 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCchhhcC
Confidence 489999999864322 223457889999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=215.89 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=144.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|.+ +++.||||.++....... .......+..|+.+++.++|+||+++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 366778999999999999987 578999999976543311 11223567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||+++..... .
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 889999997643 36899999999999999999999999999999999999999999999999999865432 2
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 158 KMTHQVVTRWYRAPELLF 175 (298)
T ss_pred cccccccceeeeCHHHHh
Confidence 233445788999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=212.61 Aligned_cols=173 Identities=27% Similarity=0.480 Sum_probs=142.3
Q ss_pred cccccccccceeecccCceEEEEEC--C---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYN--G---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+..+|++.+.||+|+||.||+|.+. + ..||||.+..... . ...+.|..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-E----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-H----HHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 3466788999999999999999872 3 3699999865321 1 123578999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999999999997643 4588999999999999999999999999999999999999999999999999875
Q ss_pred eecCCC---ccCCC---CCccccccCcccc
Q 021253 288 EVQTEG---MTPET---GTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~---~~~~~---gt~~y~APE~~~~ 311 (315)
...... ..... .+..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhcc
Confidence 433221 11111 2357999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=215.44 Aligned_cols=170 Identities=22% Similarity=0.373 Sum_probs=144.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.+ +++.||+|.++..... . ....+.+|+.++++++||||+++++.+......|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-S----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-H----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 3678889999999999999988 5889999988643211 1 1357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+||||+++++|..++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999999999987532 2368999999999999999999996 5999999999999999999999999999975432
Q ss_pred CCCccCCCCCccccccCccc
Q 021253 291 TEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~ 310 (315)
. ......+++.|+|||.+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIK 174 (286)
T ss_pred C-ccccCCCccCccCcchhc
Confidence 2 233456889999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=212.26 Aligned_cols=172 Identities=24% Similarity=0.481 Sum_probs=141.6
Q ss_pred ccccccccccceeecccCceEEEEE--CC----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+...+|++.+.||+|+||.||+|.+ ++ ..+|+|.+...... .....+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-----KANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3456788999999999999999986 33 26899987654331 1235788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.. ...++|+||+++++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence 87 67899999999999999997643 34899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc---cCCCCCccccccCccc
Q 021253 286 RIEVQTEGM---TPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~~---~~~~gt~~y~APE~~~ 310 (315)
+........ ....+++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESIL 184 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhh
Confidence 865422211 1122357899999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=213.46 Aligned_cols=174 Identities=32% Similarity=0.510 Sum_probs=144.0
Q ss_pred ccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
|..+++.+.++||+|+||.||++.. ++..+++|.+..... ...+.+.+|+++++.++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 4567889999999999999999964 345789998754321 123578999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN-------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli 271 (315)
+......+++|||+++++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 9999999999999999999999975431 247889999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 272 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
++++.+||+|||+++....... .....+++.|+|||.+..
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 9999999999999975432211 112235688999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=216.69 Aligned_cols=163 Identities=23% Similarity=0.387 Sum_probs=132.0
Q ss_pred ccceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Q 021253 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 213 (315)
+.+||+|+||.||+|+. ++..||+|.+...... ..+.+|+.+++.++||||+++++++.. ....++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 36799999999999986 3468999998654322 246789999999999999999998854 567899
Q ss_pred EEeccCCCCHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE----cCCCcEEEeee
Q 021253 214 VTEYAKGGSVRQFLTRR-------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli----~~~~~vkl~DF 282 (315)
|+||+.+ +|.+++... ....+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999965 888877532 12347888999999999999999999999999999999999 45679999999
Q ss_pred cceeeeecCC----CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
|+|+...... ......||+.|+|||.+..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcC
Confidence 9998653321 2234568999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=231.76 Aligned_cols=179 Identities=26% Similarity=0.429 Sum_probs=153.4
Q ss_pred CccccccccccccccceeecccCceEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
-++--|+.+++++.++||+|.||.|++|.|+ | ..||||.++...... ....|++|+.+|.+|+|||+++|
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEE
Confidence 3445578889999999999999999999993 3 379999998766654 24689999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 202 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
||+..+ +.+.+|+|+++.|+|.+.|++.....+....+..++.||+.||.||.++++|||||.++|+|+.....|||+|
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence 999998 5578999999999999999985566788888999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCccCCC----CCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPET----GTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~----gt~~y~APE~~~~ 311 (315)
||+.|-....+.+-... -.+-|+|||.+..
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhcc
Confidence 99999765554433222 3478999998763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=213.29 Aligned_cols=170 Identities=29% Similarity=0.554 Sum_probs=139.3
Q ss_pred cccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 207 (315)
.+|++.+.||+|+||.||++.+ +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 5678889999999999999974 467899999865321 113578899999999999999999998754
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
...+++|+||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 346899999999999999997542 358899999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc----cCCCCCccccccCcccc
Q 021253 287 IEVQTEGM----TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~----~~~~gt~~y~APE~~~~ 311 (315)
........ ....++..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 65432211 11223456999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=214.55 Aligned_cols=169 Identities=26% Similarity=0.423 Sum_probs=145.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
..+|++.+.||+|++|.||+|.. +++.|++|.+....... .+.+.+|+.+++.+.||||+++++.+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 35788889999999999999986 67899999987544322 24678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999999864 34788899999999999999999999999999999999999999999999998754322
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......+++.|+|||.+..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTR 190 (296)
T ss_pred ccccCcccCCccccCHHHHcC
Confidence 2 1234578899999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=214.35 Aligned_cols=170 Identities=28% Similarity=0.529 Sum_probs=139.3
Q ss_pred ccccccceeecccCceEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
+|++.+.||+|+||.||+|.... ..+++|.+....... ..+++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-----ELRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-----HHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 46778999999999999998632 468888886433211 135788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 266 (315)
...++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999986531 13477888999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 267 DNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 267 ~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+|||+++++.+||+|||+++....... .....++..|+|||.+.
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 999999999999999999975432211 12234567899999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=211.89 Aligned_cols=168 Identities=32% Similarity=0.518 Sum_probs=138.3
Q ss_pred cccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
+.|++.+.||+|+||+||++.+ ++..||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3457889999999999988753 46689999986543211 135678999999999999999999988653
Q ss_pred --CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 209 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
..+++||||+++++|.+++... .+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 4689999999999999999753 48999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC----ccCCCCCccccccCccc
Q 021253 287 IEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
....... .....++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 6433221 12234567899999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=214.39 Aligned_cols=168 Identities=27% Similarity=0.430 Sum_probs=145.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++++......+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 6788899999999999999986 68899999987543322 246789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999999864 347888999999999999999999999999999999999999999999999997643322
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR 189 (297)
T ss_pred cCcCcccCCccccCHHHHcC
Confidence 1233568899999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=208.44 Aligned_cols=168 Identities=33% Similarity=0.632 Sum_probs=142.9
Q ss_pred ccccceeecccCceEEEEECC------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 138 NMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
++.+.||.|+||.||++.+.. ..||+|.++...... ..+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 567899999999999998843 789999996543321 235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999998654333899999999999999999999999999999999999999999999999999865443
Q ss_pred CCcc--CCCCCccccccCccc
Q 021253 292 EGMT--PETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~~~~--~~~gt~~y~APE~~~ 310 (315)
.... ...+++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~ 177 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLK 177 (258)
T ss_pred cccccccCCCcccccChHHhc
Confidence 2221 233678999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=212.71 Aligned_cols=168 Identities=29% Similarity=0.431 Sum_probs=142.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|++.+.||+|+||.||++.+ ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 356778999999999999988 567889998854321 123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
|+||+++++|..++.+. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 80 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999999999887653 3468999999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccccccCHhhcc
Confidence 223456899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=210.98 Aligned_cols=164 Identities=25% Similarity=0.475 Sum_probs=132.8
Q ss_pred ceeecccCceEEEEE-CCe---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAFGKLYRGTY-NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.||+|+||.||++.. ++. .+++|.+....... ..+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 589999999999975 332 45666664432211 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC---
Q 021253 218 AKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (315)
Q Consensus 218 ~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~--- 292 (315)
+++++|.+++.+.. ....+...++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999999997642 2345677788999999999999999999999999999999999999999999986422111
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 157 TEDDKCVPLRWLAPELVG 174 (268)
T ss_pred cccCCcCcccccCchhcc
Confidence 123356789999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=213.49 Aligned_cols=170 Identities=22% Similarity=0.336 Sum_probs=147.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||.|+||.||++.+ +++.||+|++........ ...+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 467889999999999999988 588999999975433221 124678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999999764 4688999999999999999999999999999999999999999999999999976544323
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
.....|+..|+|||.+.
T Consensus 156 ~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 156 TTSTSGTPGYMAPEVLC 172 (258)
T ss_pred ccccCCChhhcCHHHHc
Confidence 34456889999999875
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=210.84 Aligned_cols=163 Identities=22% Similarity=0.311 Sum_probs=133.1
Q ss_pred ceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH---HHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
.||+|+||.||++.. +++.+|+|.+.+......... ..+.+|.. ++....||+|+.+++++...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 489999999999987 678999999876543322211 22334443 3444579999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccC
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~ 296 (315)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+|||++.++.++|+|||++...... ....
T Consensus 78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 99999999998754 45899999999999999999999999999999999999999999999999999754332 2233
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
..||+.|+|||.+.
T Consensus 155 ~~~~~~y~aPE~~~ 168 (279)
T cd05633 155 SVGTHGYMAPEVLQ 168 (279)
T ss_pred cCCCcCccCHHHhc
Confidence 57899999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=208.95 Aligned_cols=162 Identities=31% Similarity=0.580 Sum_probs=134.5
Q ss_pred ceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.||+|+||.||+|.+ ++..+|+|+++...... ...+.+.+|+.+++.+.||||+++++++.. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 589999999999975 46789999986544332 224678899999999999999999998864 457899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC----
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---- 293 (315)
+++++|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999999999754 4588999999999999999999999999999999999999999999999999976433221
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 155 KTHGKWPVKWYAPECMN 171 (257)
T ss_pred cCCCCCCccccCHhHhc
Confidence 12223457999999775
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-30 Score=233.25 Aligned_cols=174 Identities=25% Similarity=0.302 Sum_probs=157.3
Q ss_pred ccccccccccceeecccCceEEEEECCee--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+.+.+++.+..||-|+||.|=++..+++. +|+|++++...-..+. .+.+..|-.+|..++.|.||++|..|.+..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ---qeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ---QEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH---HHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 45678888899999999999999886665 7999998765554433 356789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|++||-|-||.|+..++++ ..+...++..++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+...
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999875 458899999999999999999999999999999999999999999999999999988
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.....+++||||.|.|||++-
T Consensus 572 ~g~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred cCCceeeecCCcccccchhhh
Confidence 888889999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=207.87 Aligned_cols=171 Identities=27% Similarity=0.522 Sum_probs=144.1
Q ss_pred cccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+..+|++.+.||+|+||.||++.+ .+..+|+|.+...... ...+.+|+.+++.++||+++++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 456788889999999999999988 4788999988654433 24678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999999987543 45788999999999999999999999999999999999999999999999999754332
Q ss_pred CC--ccCCCCCccccccCcccc
Q 021253 292 EG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~--~~~~~gt~~y~APE~~~~ 311 (315)
.. .....++..|+|||.+..
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~ 175 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSF 175 (256)
T ss_pred cccccCCCccchhhcCHhHhcc
Confidence 11 112234578999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=213.83 Aligned_cols=170 Identities=26% Similarity=0.399 Sum_probs=142.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. .++.|++|.+....... ....+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 577889999999999999987 56799999986543211 1223578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999999764 458899999999999999999999999999999999999999999999999987421000
Q ss_pred ---------------CccCCCCCccccccCccc
Q 021253 293 ---------------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ---------------~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhcc
Confidence 011235788999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=197.88 Aligned_cols=170 Identities=25% Similarity=0.395 Sum_probs=144.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|...++||+|.+|.||+|+. +++.||+|.++.......- .....+|+-+++.++|.|||+++++...++.+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv----pssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC----cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 455668999999999999976 7789999999865543321 2356799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
|+|||.. +|..+.... +..+..+.+..++.|++.||.|+|++++.||||||.|+||+.+|.+|++|||+||-+.-. .
T Consensus 79 vfe~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9999965 888888764 467899999999999999999999999999999999999999999999999999854322 2
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
-++..+-|..|.+|.++-+
T Consensus 157 cysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred eeeceeeeeeccCcceeee
Confidence 3555677899999998753
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=209.02 Aligned_cols=173 Identities=27% Similarity=0.410 Sum_probs=147.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++++.||.|+||.||+|.. ++..+++|++....... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 3678899999999999999987 67799999986544332 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 213 IVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
+|+|++++++|.+++..... ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999999976433 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CC-----ccCCCCCccccccCccccc
Q 021253 292 EG-----MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 292 ~~-----~~~~~gt~~y~APE~~~~~ 312 (315)
.. .....|++.|+|||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccccccCChhhcChHHHccc
Confidence 21 1334688999999987643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=210.41 Aligned_cols=160 Identities=24% Similarity=0.442 Sum_probs=133.6
Q ss_pred cceeecccCceEEEEECCe------------eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 141 TAFAQGAFGKLYRGTYNGE------------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
+.||+|+||.||+|.+... .+++|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 3689999999999988322 4777876543221 3578899999999999999999999987
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-------cEEEee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-------SIKIAD 281 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-------~vkl~D 281 (315)
...++||||+++++|.+++..... .+++..++.++.||+.||+|||+++++||||||+||+++.++ .+||+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 667999999999999999986532 588999999999999999999999999999999999999887 799999
Q ss_pred ecceeeeecCCCccCCCCCccccccCccccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
||+++.... .....++..|+|||++...
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNG 179 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCC
Confidence 999985433 2234567889999997643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=208.71 Aligned_cols=174 Identities=30% Similarity=0.487 Sum_probs=143.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 210 (315)
.+|+..+.||+|+||.||+|.. +++.|++|.+......... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 3577889999999999999986 6789999998755433221 1223578899999999999999999998875 367
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.++++||+++++|.+++... ..+++...+.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999999754 3478888999999999999999999999999999999999999999999999875322
Q ss_pred ----CCCccCCCCCccccccCcccc
Q 021253 291 ----TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ----~~~~~~~~gt~~y~APE~~~~ 311 (315)
........++..|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC
Confidence 112233468899999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=208.84 Aligned_cols=162 Identities=29% Similarity=0.558 Sum_probs=132.7
Q ss_pred ceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.||+|+||.||+|.+ .+..||+|++...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-----SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 489999999999976 3456999998654221 123578899999999999999999998864 467899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC----
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---- 293 (315)
+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999999998753 34689999999999999999999999999999999999999999999999999975432221
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 155 RSAGKWPLKWYAPECIN 171 (257)
T ss_pred cCCCCCCcccCCHHHHc
Confidence 11123357899999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=204.65 Aligned_cols=177 Identities=22% Similarity=0.391 Sum_probs=151.7
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIG 203 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 203 (315)
-+.+..+.++++.+..||.|..|.||+++. ++...|||.+.+.....+ .++++..+.++.... .|.||+.+|
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-----~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-----HHHHHHhhhHHhhccCCCeeeeeee
Confidence 356677889999999999999999999988 668999999987654433 357778888776665 899999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+|..+..++|.||.|.. .+..+++. -.+++|+..+-++...++.||.||-+ ++|||||+||+|||+|+.|.+|||||
T Consensus 159 yFi~n~dV~IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 159 YFITNTDVFICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred EEeeCchHHHHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 99999989999999943 55555554 45679999999999999999999985 58999999999999999999999999
Q ss_pred cceeeeecCCCccCCCCCccccccCccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|.+....+....+...|-+.|||||.+.
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERID 264 (391)
T ss_pred cccceeecccccccccCCccccCccccC
Confidence 9998888887778889999999999875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=214.21 Aligned_cols=173 Identities=32% Similarity=0.519 Sum_probs=142.9
Q ss_pred ccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
+..++|.+.+.||+|+||.||++.+ +...+++|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGV 75 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 3456788889999999999999975 234688888754222 113578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
+......++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++++||||||+||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 155 (291)
T cd05094 76 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155 (291)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence 999999999999999999999997532 134788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
++.++.+||+|||+++....... .....+++.|+|||.+.
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 198 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198 (291)
T ss_pred EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence 99999999999999975432211 12334678999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=199.21 Aligned_cols=175 Identities=24% Similarity=0.376 Sum_probs=149.1
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
++++.+++..+..||+|++|.|=+.++ +|+..|+|.++..-.+.++ ++.++|+.+..+. .+|.+|.+||...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-----~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-----KRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----HHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 667777888889999999998766655 8999999999765554433 4677888876554 7999999999998
Q ss_pred eCCEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
....++|.||.|.. +|..+-++ ..+..+++...-+|+..|..||.|||++ .+||||+||+||||+.+|++|+||||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 88889999999954 88887664 3467799999999999999999999987 89999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.+....++-..+...|-..|||||.+.
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERIN 221 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcC
Confidence 999887776666678889999999886
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=209.70 Aligned_cols=168 Identities=29% Similarity=0.457 Sum_probs=145.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||.|++|.||+|.+ +++.||+|.+....... ....+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 577889999999999999987 67899999986543211 13567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
|+||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++..... .
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999999998753 6899999999999999999999999999999999999999999999999999875433 2
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQ 172 (274)
T ss_pred ccccccCCccccChhhhcc
Confidence 2344578899999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=210.63 Aligned_cols=160 Identities=21% Similarity=0.408 Sum_probs=132.6
Q ss_pred cceeecccCceEEEEEC--------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN--------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
+.||+|+||.||+|++. ...|++|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------DISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------hHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 36899999999999852 22588888754221 12357889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc-------EEE
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKI 279 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~-------vkl 279 (315)
.....++||||+++++|..++... ...+++..++.++.||+.||+|||+++++||||||+|||++.++. +|+
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 988899999999999999888653 345899999999999999999999999999999999999987664 899
Q ss_pred eeecceeeeecCCCccCCCCCccccccCccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+|||++..... .....+++.|+|||.+.
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAPECVE 181 (262)
T ss_pred CCCCCCccccC---cccccccccccChhhhc
Confidence 99999874322 22346788999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=212.42 Aligned_cols=172 Identities=20% Similarity=0.328 Sum_probs=143.6
Q ss_pred ccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
+|++.+.||+|+||.||++.. +++.||+|++....... .....+.+.+|+.+++.+ +|++|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 367788999999999999976 67899999986532211 111235678999999999 5999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..|+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999999764 457888999999999999999999999999999999999999999999999997643
Q ss_pred cCC--CccCCCCCccccccCcccc
Q 021253 290 QTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
... ......|+..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred cccccccccccCCcccCChhhccC
Confidence 321 2234568999999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=207.38 Aligned_cols=171 Identities=29% Similarity=0.490 Sum_probs=146.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. +++.|++|.++..... ....+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 467789999999999999987 6789999999765543 2234688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999753 3478888999999999999999999999999999999999999999999999876533221
Q ss_pred -----ccCCCCCccccccCccccc
Q 021253 294 -----MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 294 -----~~~~~gt~~y~APE~~~~~ 312 (315)
.....+++.|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred cccccccCCcCCcCccChhhccCC
Confidence 1124678999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=209.23 Aligned_cols=174 Identities=28% Similarity=0.488 Sum_probs=142.9
Q ss_pred ccccccccccceeecccCceEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
|...+|+..+.||+|+||.||+|.. ++ ..+++|.++...... ..+.+.+|+.+++.++|||++++++++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 4456788889999999999999987 33 368999886543221 1357889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
.....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999999997543 458899999999999999999999999999999999999999999999999997
Q ss_pred eeecCCC--cc--CCCCCccccccCcccc
Q 021253 287 IEVQTEG--MT--PETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~--~~--~~~gt~~y~APE~~~~ 311 (315)
....... .. ....++.|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhc
Confidence 5432211 11 1123467999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=209.42 Aligned_cols=170 Identities=25% Similarity=0.460 Sum_probs=136.3
Q ss_pred ccccceeecccCceEEEEEC--C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021253 138 NMGTAFAQGAFGKLYRGTYN--G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (315)
.+++.||+|+||.||+|.+. + ..||+|.++........ .+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 46789999999999999873 3 26899988764333222 35788999999999999999999987432
Q ss_pred -CEEEEEEeccCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...++++||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2468999999999999987532 22347899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+++....... .....+++.|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccC
Confidence 9986433221 122345678999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=208.50 Aligned_cols=173 Identities=24% Similarity=0.423 Sum_probs=142.4
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
+++..+......||+|+||.||+|.+ ++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 34455555567899999999999986 5678999988653221 135788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeecce
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVA 285 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a 285 (315)
...++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999999997642 224 77888899999999999999999999999999999986 679999999998
Q ss_pred eeeecC-CCccCCCCCccccccCccc
Q 021253 286 RIEVQT-EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~ 310 (315)
...... .......+++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVID 182 (268)
T ss_pred eecccCCCccccCCCCccccChhhhc
Confidence 754322 2233346889999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=213.13 Aligned_cols=174 Identities=30% Similarity=0.504 Sum_probs=143.4
Q ss_pred ccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++.++|++.+.||+|+||.||+|.+ ++..||+|++...... ...+.+.+|+.+++.+.||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 4567889999999999999999986 3568999988643321 123578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (315)
+......++|+||+++++|.+++..... ..+++..++.++.|++.||+|||+++++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 9999899999999999999999975321 24678888999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 265 kp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||+||+++.++.+||+|||+++....... ......++.|+|||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 99999999999999999999875432211 11223467899999765
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=209.90 Aligned_cols=173 Identities=32% Similarity=0.515 Sum_probs=144.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCCh----hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP----EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+|...+.||+|+||.||+|.. +++.||+|.++...... .......+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678999999999999976 67899999886432221 112233467889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999764 458889999999999999999999999999999999999999999999999997543
Q ss_pred cCC---CccCCCCCccccccCccc
Q 021253 290 QTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~---~~~~~~gt~~y~APE~~~ 310 (315)
... ......++..|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~ 183 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIH 183 (272)
T ss_pred ccccccccccccCCccccCHHHhc
Confidence 211 123346889999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=210.31 Aligned_cols=174 Identities=26% Similarity=0.494 Sum_probs=141.8
Q ss_pred cccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
++..++|.+.+.||+|+||.||+|.+. ...|+||........ ...+.+.+|+.+++.+.||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 456678889999999999999999862 236899987543321 1235788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++
T Consensus 77 ~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TEN-PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cCC-CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 765 4689999999999999997643 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc--cCCCCCccccccCcccc
Q 021253 286 RIEVQTEGM--TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~--~~~~gt~~y~APE~~~~ 311 (315)
+........ +...+++.|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINF 182 (270)
T ss_pred eecccccceecCCCCccccccChhhhcc
Confidence 865433211 12234568999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=211.95 Aligned_cols=169 Identities=27% Similarity=0.437 Sum_probs=145.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||.|.+|.||+|.. +++.|++|.+....... .+.+.+|+.+++.++|||++++++++.....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 35788999999999999999986 78899999986543221 24678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+|+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999999999864 34889999999999999999999999999999999999999999999999998754332
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......+++.|+|||.+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~ 189 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTR 189 (296)
T ss_pred cccCCCcCCCccccCcchhcC
Confidence 2 2234568899999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=226.51 Aligned_cols=153 Identities=26% Similarity=0.356 Sum_probs=134.3
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.-..|..-|..++.||-|+||+|.+++. +...+|+|.+++........ .-....|-.||..-..+-||+||..|+
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQ---vaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQ---VAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhh---hhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3445777888899999999999999976 56689999997654433221 235668889999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+.+.+|+||+|++||++..+|.+. ..+++.+++.++.++.+|+++.|..|+|||||||+|||||.+|++||.|||||.
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999999999864 568999999999999999999999999999999999999999999999999985
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=206.52 Aligned_cols=165 Identities=33% Similarity=0.540 Sum_probs=137.1
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 219 (315)
+.||+|+||.||+|.. ++..+|+|.++..... .....+.+|+.+++.++||||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 3689999999999987 6678999988654321 123468899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC--ccCC
Q 021253 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPE 297 (315)
Q Consensus 220 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~--~~~~ 297 (315)
+++|.+++.... ..+++..++.++.|++.+|.|||+++++|+||||+||+++.++.+||+|||+++....... ....
T Consensus 76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 999999987543 4578999999999999999999999999999999999999999999999999975432211 1122
Q ss_pred CCCccccccCcccc
Q 021253 298 TGTYRWMAPSAGSI 311 (315)
Q Consensus 298 ~gt~~y~APE~~~~ 311 (315)
.+++.|+|||++..
T Consensus 155 ~~~~~y~aPE~~~~ 168 (250)
T cd05085 155 QIPIKWTAPEALNY 168 (250)
T ss_pred CCcccccCHHHhcc
Confidence 34578999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=210.90 Aligned_cols=174 Identities=26% Similarity=0.483 Sum_probs=144.5
Q ss_pred ccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
++.++|+..+.||.|+||.||+|+. ..+.|++|.+...... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 3457888899999999999999986 2357899987543221 123578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN-------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~v 277 (315)
+.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence 9998889999999999999999976542 158999999999999999999999999999999999999999999
Q ss_pred EEeeecceeeeecCC--CccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
+|+|||+++...... ......+++.|+|||.+.
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhc
Confidence 999999987432221 223345678899999764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=207.76 Aligned_cols=174 Identities=27% Similarity=0.478 Sum_probs=143.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (315)
.+|++.+.||+|+||.||+|+. +++.||+|.+........ .......+.+|+.++++++||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 4678889999999999999987 678999998854322211 122346788999999999999999999998764 46
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+++++||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 88999999999999998754 3478889999999999999999999999999999999999999999999999975422
Q ss_pred ----CCCccCCCCCccccccCcccc
Q 021253 291 ----TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ----~~~~~~~~gt~~y~APE~~~~ 311 (315)
........++..|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC
Confidence 112234568899999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=209.62 Aligned_cols=163 Identities=21% Similarity=0.278 Sum_probs=133.5
Q ss_pred ceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHH---HHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE---VMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
.||+|+||.||++.. +++.||+|.+........... ..+..| +.+++...||+|+.+++++...+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 479999999999976 678999999876543322211 122233 344555689999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccC
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~ 296 (315)
|+.+++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence 99999999988653 46899999999999999999999999999999999999999999999999998754322 2334
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
..|++.|+|||.+.
T Consensus 155 ~~~~~~y~aPE~~~ 168 (278)
T cd05606 155 SVGTHGYMAPEVLQ 168 (278)
T ss_pred cCCCcCCcCcHHhc
Confidence 57999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=212.82 Aligned_cols=174 Identities=29% Similarity=0.501 Sum_probs=141.4
Q ss_pred ccccccccccceeecccCceEEEEEC------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 193 (315)
++.++|++.+.||+|+||.||++.+. ...||+|+++..... ...+.+.+|+.+++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~E~~~l~~l 76 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-----NARNDFLKEIKIMSRL 76 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhC
Confidence 35577899999999999999998542 236899988653221 1235788999999999
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 021253 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (315)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (315)
+||||+++++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+++|+||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 999999999999999999999999999999999976421 23667889999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 265 kp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||+|||++.++.++|+|||+++....... .....+++.|+|||...
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 99999999999999999999975432211 11223457899999643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=207.21 Aligned_cols=169 Identities=28% Similarity=0.445 Sum_probs=146.3
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.+++|.+..... .+++.+|+.+++.++||||+++++.+......
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 35788889999999999999988 468999999864221 36788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+++||+++++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999999999753 356899999999999999999999999999999999999999999999999999864433
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......++..|+|||.+..
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQE 173 (256)
T ss_pred ccccccccCCccccCHHHHhc
Confidence 2 2233458899999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=211.98 Aligned_cols=171 Identities=27% Similarity=0.384 Sum_probs=143.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|.+ +++.|++|.++....... ..+.+.+|+++++.++|+||+++++++...+.+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc----chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 577889999999999999987 578999999865433221 23578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||++++.+..+..+ ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 78 VFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999998666655543 2448899999999999999999999999999999999999999999999999998654332
Q ss_pred -CccCCCCCccccccCccccc
Q 021253 293 -GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~ 312 (315)
......++..|+|||++...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred ccccCcccccCCcCCchhcCC
Confidence 23345678999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=211.98 Aligned_cols=170 Identities=23% Similarity=0.388 Sum_probs=146.0
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..++|++.+.||+|+||.||++.+ +++.||+|++...... ...+.+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-----SVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 456888999999999999999987 5889999988653221 123578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
+++||||+++++|.+++.+. ..+++..+..++.+++.+|.|||+ .+++||||+|+||+++.++.++|+|||+++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999999998763 458999999999999999999997 589999999999999999999999999987543
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.. ......|+..|+|||++.
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~ 175 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQ 175 (284)
T ss_pred hh-ccCccccCcccCCHHHHc
Confidence 22 223457899999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=206.80 Aligned_cols=172 Identities=25% Similarity=0.420 Sum_probs=146.1
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. +++.||+|.+......... .+.+.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH----HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 467789999999999999987 6789999998754333221 2578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
|+||+++++|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999999765555688999999999999999999999999999999999999999999999999975433211
Q ss_pred -ccCCCCCccccccCcccc
Q 021253 294 -MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~~ 311 (315)
.....|++.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN 175 (256)
T ss_pred hhhhccCCccccCHHHhCC
Confidence 223458899999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=210.45 Aligned_cols=173 Identities=32% Similarity=0.500 Sum_probs=140.6
Q ss_pred cccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..++|++.+.||+|++|.||+|.+. +..|++|.+....... ....+.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4567888999999999999999873 3678888875432211 135688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cE
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SI 277 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~v 277 (315)
.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+||+++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 988889999999999999999976432 2578899999999999999999999999999999999998654 69
Q ss_pred EEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||+|||+++....... ......++.|+|||++.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence 9999999986422211 11223356899999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=207.53 Aligned_cols=163 Identities=23% Similarity=0.315 Sum_probs=140.8
Q ss_pred eeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||.|++|.||+++.. ++.|++|++........ ...+.+.+|+.+++.++||||+++++.+.+....++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999985 88999999976443221 2246789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 300 (315)
++|.+++.+. ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||+++............++
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9999999764 34889999999999999999999999999999999999999999999999999865443333345788
Q ss_pred ccccccCccc
Q 021253 301 YRWMAPSAGS 310 (315)
Q Consensus 301 ~~y~APE~~~ 310 (315)
+.|+|||.+.
T Consensus 156 ~~~~~PE~~~ 165 (262)
T cd05572 156 PEYVAPEIIL 165 (262)
T ss_pred cCccChhHhc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=208.17 Aligned_cols=167 Identities=32% Similarity=0.539 Sum_probs=142.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMV 210 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 210 (315)
.|+..+.||+|+||.||+|.+ +++.||+|.+........ ..++.+|+.+++.++ |||++++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 466778999999999999987 678999999865432221 246778999999997 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999999998652 588999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CccCCCCCccccccCccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~ 310 (315)
.. ......|++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred CccccccccCCcceeCHHHhc
Confidence 22 233456899999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=206.57 Aligned_cols=165 Identities=30% Similarity=0.486 Sum_probs=139.0
Q ss_pred cceeecccCceEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
+.||+|++|.||+|.+. + ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 36899999999999872 2 36899998764432 234688999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC--
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~-- 293 (315)
||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999999875435689999999999999999999999999999999999999999999999999986533211
Q ss_pred --ccCCCCCccccccCcccc
Q 021253 294 --MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 --~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRT 174 (257)
T ss_pred ecccCCCCCceecCHHHhcc
Confidence 112356789999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=206.25 Aligned_cols=172 Identities=25% Similarity=0.417 Sum_probs=144.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 211 (315)
+|++.+.||.|+||.||++.. +++.||+|.+......... .+++.+|+.+++.++||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 467788999999999999987 6789999998765443322 3578899999999999999999998754 4568
Q ss_pred EEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVH-----GLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH-----~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+++|||+++++|.+++... ....+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999999753 2356899999999999999999999 88999999999999999999999999999
Q ss_pred eeeeecCCC-ccCCCCCccccccCcccc
Q 021253 285 ARIEVQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
+........ .....+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcC
Confidence 986544332 334568999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=213.79 Aligned_cols=170 Identities=25% Similarity=0.406 Sum_probs=141.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|.||.||+|.+ +++.||+|.++....... ....+.+|+.+++.++||||+++++++.+...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 366778999999999999988 688999999875432221 12457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
|+||+++ +|.+++... ...+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... .
T Consensus 77 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 9999974 888887653 345899999999999999999999999999999999999999999999999999754322 1
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+.+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CcCCCccccCCcChHHHhC
Confidence 2234567899999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=210.45 Aligned_cols=159 Identities=25% Similarity=0.371 Sum_probs=138.6
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe----CCEEEE
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK----RMVWCI 213 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~l 213 (315)
++||-|-.|+|..+.. +++++|+|++... ....+|+++--.. .|||||.+++++.. ...+.+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 5799999999999976 7889999998531 2345888876555 69999999998753 468899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceeeeec
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQ 290 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~~~~ 290 (315)
|||.|+||.|.+.++.+....+++.++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|+....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999999999988889999999999999999999999999999999999999964 55899999999997665
Q ss_pred CCCccCCCCCccccccCccc
Q 021253 291 TEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~ 310 (315)
.....+.|-||+|.|||++.
T Consensus 217 ~~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred CccccCCcccccccCHHHhC
Confidence 55677789999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=207.86 Aligned_cols=170 Identities=30% Similarity=0.486 Sum_probs=144.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 209 (315)
.++|++.+.||+|++|.||+|.. +++.+++|++...... .+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 46788999999999999999988 5678999998754321 25788999999999 6999999999997644
Q ss_pred -----EEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 210 -----VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 210 -----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
.+++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987543 456899999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCC-CccCCCCCccccccCccc
Q 021253 283 GVARIEVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
|++....... ......|++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIA 186 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhc
Confidence 9987543221 223456889999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=207.46 Aligned_cols=167 Identities=29% Similarity=0.442 Sum_probs=143.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|+..+.||.|+||.||+|.+ ++..||+|.+...... ...+.+.+|+.+++.+.||||+++++++.+....++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 466778999999999999987 6789999998754322 123678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999999864 347888899999999999999999999999999999999999999999999997643322
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||++.
T Consensus 157 ~~~~~~~~~~y~apE~~~ 174 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQ 174 (277)
T ss_pred ccccccCcccccCHhHhc
Confidence 123346889999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=208.17 Aligned_cols=164 Identities=32% Similarity=0.524 Sum_probs=132.4
Q ss_pred ceeecccCceEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEe
Q 021253 142 AFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 216 (315)
.||+|+||.||+|.+ ++. .+++|.++...... ..+.+.+|+.++.++ +||||+++++++.....+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-----HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 589999999999987 333 56888775322111 135788999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 217 YAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997532 124788999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCCCccCCCCCccccccCccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+++.............++.|+|||++.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLN 184 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHc
Confidence 9986322111112223457799999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=210.64 Aligned_cols=172 Identities=26% Similarity=0.385 Sum_probs=141.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|.+|.||+|.+ +++.||+|.+........ ..+.+.+|+.++++++||||+++++++......|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 4678889999999999999987 678999999865433221 1246778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeecceeeeecC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~~~~~ 291 (315)
+||||++ ++|.+++.......+++..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||+++.....
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999996 58888887655555688888999999999999999999999999999999985 557999999999754322
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred ccccccCceeecccCHHHHhC
Confidence 12234467899999998743
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=210.19 Aligned_cols=169 Identities=29% Similarity=0.416 Sum_probs=145.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||++.+ +++.|++|.+...... ...+++.+|++++++++||||+++++.+.....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 567788999999999999988 4789999998764332 223578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
++||+++++|.+++.... ..+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999997643 568899999999999999999999 999999999999999999999999999987543322
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
. ....++..|+|||.+..
T Consensus 156 ~-~~~~~~~~y~~PE~~~~ 173 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQG 173 (265)
T ss_pred h-hcccCChhccCHHHHcC
Confidence 2 22678899999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=224.94 Aligned_cols=169 Identities=29% Similarity=0.482 Sum_probs=146.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe-----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK----- 207 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 207 (315)
.+++.+.||.|.+|.||+++. +++.+|+|++....... +++..|.++++.+ .|||++.+||++..
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 344568999999999999875 88999999987654433 4567889999888 59999999999864
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
++.+|||||||.+|+..++++...+..+.+.....|+..++.||.+||...+||||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 46799999999999999999988888899999999999999999999999999999999999999999999999999875
Q ss_pred eecC-CCccCCCCCccccccCcccc
Q 021253 288 EVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
.... ....+..|||.|||||++..
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred eecccccccCcCCCcccccceeeec
Confidence 4433 24566789999999999863
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=211.43 Aligned_cols=171 Identities=27% Similarity=0.429 Sum_probs=143.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|+..+.||.|++|.||+|.. +++.||||.+........ ..+.+.+|++++++++||||+++++++.+....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 367788999999999999987 678999998865432221 12468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 999996 589999876655678999999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred ccccccccccccCCeEEec
Confidence 2233457889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=209.11 Aligned_cols=174 Identities=24% Similarity=0.416 Sum_probs=143.6
Q ss_pred ccccccccccceeecccCceEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
++.++|++.+.||+|+||.||+|.+. +..|++|.+...... ...+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-----IQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 56678899999999999999999873 478999988643211 1246788999999999999999999987
Q ss_pred Ee-CCEEEEEEeccCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEE
Q 021253 206 RK-RMVWCIVTEYAKGGSVRQFLTRRQN------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 206 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vk 278 (315)
.. ....++++||+++++|.+++..... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 66 4678999999999999999976432 4588999999999999999999999999999999999999999999
Q ss_pred EeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 279 IADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 279 l~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+|||+++....... .....++..|+|||.+.
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 192 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence 999999985432211 12234567899999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=225.39 Aligned_cols=169 Identities=17% Similarity=0.320 Sum_probs=134.6
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC------CCeeeEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH------LNIVRFI 202 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~ 202 (315)
.+...+|++.+.||+|+||.||+|.+ +++.||||+++..... ...+..|+.+++.++| ++++.++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34457899999999999999999987 6788999999642211 1234556666666654 4588999
Q ss_pred EEEEeC-CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCC-----
Q 021253 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK----- 275 (315)
Q Consensus 203 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~----- 275 (315)
+++... ..+|+|||++ +++|.+++.+. ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 5789999988 77899988754 458999999999999999999998 5999999999999998765
Q ss_pred -----------cEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 276 -----------SIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 276 -----------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.+||+|||.+.... ......+||+.|+|||++.+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhc
Confidence 49999999886422 23455689999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=208.48 Aligned_cols=170 Identities=25% Similarity=0.386 Sum_probs=142.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||.|++|.||+|+. +++.||||.++....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 467789999999999999998 688999999875433221 2456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
||||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+++||||+|+||+++.++.+||+|||+++......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999985 8888886543 3458999999999999999999999999999999999999999999999999997543221
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+.+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred cccccccccccccChHHhcC
Confidence 2234467899999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=211.85 Aligned_cols=169 Identities=25% Similarity=0.390 Sum_probs=143.3
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||+|.+ +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 577889999999999999998 57899999986543332 123567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
|+||++++.|..+.... ..+++..++.++.||+.||+|||+.+++|+||+|+||++++++.++|+|||+++..... .
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 78 VFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999998888776543 34889999999999999999999999999999999999999999999999999864332 2
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||++.
T Consensus 156 ~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 156 VYTDYVATRWYRAPELLV 173 (286)
T ss_pred ccCcccceeeccCcHHhc
Confidence 233456889999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=217.02 Aligned_cols=169 Identities=26% Similarity=0.358 Sum_probs=140.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (315)
.++|+..+.||+|+||.||+|.. +++.||||.+......... ...+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 36788899999999999999987 7889999998654332221 24577899999999999999999998644
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
...|+||||+.+ +|.+.+... ++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999964 888887542 788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............+++.|+|||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhC
Confidence 86544333344568899999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=210.61 Aligned_cols=164 Identities=23% Similarity=0.426 Sum_probs=139.6
Q ss_pred ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q 021253 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 216 (315)
.+.||+|+++.|--+.. ++..+|||++.+..... +.++.+|++++.+++ |+||++++++|.++...|||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 36899999999987754 89999999998764433 357889999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cEEEeeecceeeee----
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEV---- 289 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~vkl~DFG~a~~~~---- 289 (315)
-|.||+|...+.++ .-+++.++.++..+|+.||+|||.+||.||||||+|||..... -+||+||.++.-..
T Consensus 157 Km~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999875 4589999999999999999999999999999999999996544 58999999875321
Q ss_pred ----cCCCccCCCCCccccccCcccc
Q 021253 290 ----QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ----~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..+...+.+|+..|||||+..-
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhh
Confidence 1223445579999999998653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=216.62 Aligned_cols=163 Identities=17% Similarity=0.203 Sum_probs=125.6
Q ss_pred ccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee-EEEEEEeCC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~ 209 (315)
...|.+.+.||+|+||+||+|.+ +++.||||++........ .....+.+.+|+++|+.++|+|++. ++++ .
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-KPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-cHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 46788999999999999999986 467789998753211000 1122457899999999999999985 5442 3
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCCEEEcCCCcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..|+||||++|++|... .. .. ...++.|++.+|+|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 47999999999999632 11 11 1467889999999999999999999 999999999999999999999865
Q ss_pred ecCC---------CccCCCCCccccccCccc
Q 021253 289 VQTE---------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~---------~~~~~~gt~~y~APE~~~ 310 (315)
.... ..+...+++.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3322 123456888999999886
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=207.39 Aligned_cols=171 Identities=32% Similarity=0.596 Sum_probs=143.0
Q ss_pred ccccccccceeecccCceEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
.++|++.+.||+|+||.||++++. ++.+|||.+...... ...+.+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 467788899999999999999863 578999999754432 224678999999999999999999999877
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 208 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 557899999999999999997643 35889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc----cCCCCCccccccCccc
Q 021253 286 RIEVQTEGM----TPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~~----~~~~gt~~y~APE~~~ 310 (315)
+........ ....++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHc
Confidence 865422111 1224456799999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=227.29 Aligned_cols=177 Identities=21% Similarity=0.268 Sum_probs=134.0
Q ss_pred ccccccccceeecccCceEEEEEC---CeeEEEEEeeCCCCCh-----------hHHHHHHHHHHHHHHHHHhCCCCCee
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNP-----------EKAQVMEQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~niv 199 (315)
..+|++.+.||+|+||+||++.+. +..+++|.+....... .........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998752 2222222111000000 00111245688999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~ 276 (315)
++++++...+..|+|+|++. ++|.+++.... ........+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 57888775432 112345667889999999999999999999999999999999999
Q ss_pred EEEeeecceeeeecCCC--ccCCCCCccccccCcccc
Q 021253 277 IKIADFGVARIEVQTEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~--~~~~~gt~~y~APE~~~~ 311 (315)
+||+|||+++....... .....||+.|+|||++..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 99999999986543221 223579999999999764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=203.89 Aligned_cols=169 Identities=28% Similarity=0.432 Sum_probs=146.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||+|+. +++.|++|.+...... ...+.+.+|+..+.+++|||++++++++......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 577889999999999999987 5889999998764432 224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999999764 558999999999999999999999 999999999999999999999999999998654332
Q ss_pred Cc-cCCCCCccccccCcccc
Q 021253 293 GM-TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~-~~~~gt~~y~APE~~~~ 311 (315)
.. ....++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~ 174 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQG 174 (264)
T ss_pred CcccceeecccccCHhhhCC
Confidence 22 24468899999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=210.24 Aligned_cols=178 Identities=24% Similarity=0.398 Sum_probs=146.8
Q ss_pred ccccccccccccccceeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (315)
..|.++.++|++.+.||+|++|.||+|.+. ++.||||.++....... ...+.+|+.++..+ .||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 457788899999999999999999999984 88999999975433221 23556677666666 49999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
+.+....|+||||+. ++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999999999985 47877776543 468899999999999999999997 599999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
++.............+++.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred cchhccCCCcccCCCCCccccCHhhcCCC
Confidence 99765443334445678999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=206.13 Aligned_cols=168 Identities=29% Similarity=0.442 Sum_probs=143.1
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
-|+..+.||.|+||.||+|.+ +++.||+|.+...... ...+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 356778999999999999986 6789999988643322 123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+++......
T Consensus 80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999999864 358899999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......++..|+|||.+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hhccccCCccccChhhhcc
Confidence 2234568899999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=244.40 Aligned_cols=172 Identities=28% Similarity=0.435 Sum_probs=146.3
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+++-+..||.|.||+||-|.. +|...|+|.++...... .....+.+|..++..++|||+|++||+-...+.++|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~----k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH----KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc----ccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345667899999999999976 88899999887544431 224578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
.||||++|+|.+.+... ...++.....+..|++.|+.|||++|||||||||+||+++.+|.+|+.|||.|+......
T Consensus 1312 FMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999999864 336677777888999999999999999999999999999999999999999998654332
Q ss_pred ----CccCCCCCccccccCcccccc
Q 021253 293 ----GMTPETGTYRWMAPSAGSICC 313 (315)
Q Consensus 293 ----~~~~~~gt~~y~APE~~~~~~ 313 (315)
......||+-|||||+|++--
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccc
Confidence 233457999999999998654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=208.23 Aligned_cols=170 Identities=28% Similarity=0.481 Sum_probs=142.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK--- 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 207 (315)
...|++.+.||.|+||.||+|.+ .++.+|+|++..... ....+..|+.+++++ .||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 35677889999999999999988 678999999865321 124677899999998 69999999999853
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 208 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
....|++|||+.+++|.+++.......+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999999876656688888999999999999999999999999999999999999999999999
Q ss_pred eeeeecC-CCccCCCCCccccccCccc
Q 021253 285 ARIEVQT-EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~-~~~~~~~gt~~y~APE~~~ 310 (315)
++..... .......|++.|+|||.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcC
Confidence 8754321 1233456899999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=210.35 Aligned_cols=168 Identities=31% Similarity=0.466 Sum_probs=143.0
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|+..+.||+|+||.||+|.+ +++.||+|.+....... ..+.+.+|+.++++++||||+++++++......|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 456678899999999999987 67899999986443221 23578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999999998864 358889999999999999999999999999999999999999999999999997643322
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......++..|+|||.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hhhcccCcccccCHHHhCc
Confidence 1233468899999998753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=210.50 Aligned_cols=172 Identities=28% Similarity=0.389 Sum_probs=142.1
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (315)
+.++|++.+.||+|+||.||+|.+ +++.||+|.++........ ...+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 456788999999999999999987 6889999998754322211 12456899999999999999999998755
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 568999999975 8988887543 56899999999999999999999999999999999999999999999999999865
Q ss_pred ecC-CCccCCCCCccccccCccc
Q 021253 289 VQT-EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~-~~~~~~~gt~~y~APE~~~ 310 (315)
... .......+++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLL 181 (309)
T ss_pred CCccCCCCcccccccccChhhhc
Confidence 432 2233345678899999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=203.13 Aligned_cols=163 Identities=31% Similarity=0.544 Sum_probs=134.5
Q ss_pred cceeecccCceEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
+.||+|+||.||+|.+ .+ ..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEE
Confidence 4689999999999976 22 57999998765443 224678899999999999999999998764 4579999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc-
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM- 294 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~- 294 (315)
||+++++|.+++.... .+++..++.++.|++.+|+|||+.+++|+||||+||+++.++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999997643 5899999999999999999999999999999999999999999999999999865332211
Q ss_pred ---cCCCCCccccccCcccc
Q 021253 295 ---TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ---~~~~gt~~y~APE~~~~ 311 (315)
....++..|+|||.+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05060 153 RATTAGRWPLKWYAPECINY 172 (257)
T ss_pred ccccCccccccccCHHHhcC
Confidence 11123468999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=208.83 Aligned_cols=171 Identities=26% Similarity=0.383 Sum_probs=139.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE--
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV-- 210 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-- 210 (315)
+|++.+.||+|+||.||+|.+ +++.||+|.++....... ....+.+|+.+++.++ ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 577889999999999999987 678999998865432211 1246778999999995 6999999999977665
Q ss_pred ---EEEEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeec
Q 021253 211 ---WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFG 283 (315)
Q Consensus 211 ---~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG 283 (315)
+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+.+++||||+|+||+++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 8988886542 245799999999999999999999999999999999999998 8899999999
Q ss_pred ceeeeecC-CCccCCCCCccccccCcccc
Q 021253 284 VARIEVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
+++..... .......+++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhC
Confidence 99754322 22233467889999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=210.03 Aligned_cols=172 Identities=23% Similarity=0.339 Sum_probs=140.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (315)
.++|+..+.||+|+||.||++.+ +++.||+|.+....... ....+.+|+.++.++. ||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 35667778999999999999987 67899999987543321 2357889999999996 9999999999998888
Q ss_pred EEEEEeccCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 211 WCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
.+++|||+.. +|.++.. ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 9999999864 6655432 23345689999999999999999999974 99999999999999999999999999997
Q ss_pred eeecCCCccCCCCCccccccCcccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
............|++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDP 181 (288)
T ss_pred HhccCCccccccCccCccCHHHhcc
Confidence 5443333344578999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=210.18 Aligned_cols=172 Identities=28% Similarity=0.534 Sum_probs=139.5
Q ss_pred cccccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
...+|+..+.||+|+||.||+|.+ ++. .||+|.+....... ....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 446778889999999999999987 443 57888876433211 1246889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
... .++++||+++|+|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPT-IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CCC-ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 654 57899999999999998754 2357889999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC---ccCCCCCccccccCcccc
Q 021253 287 IEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
....... .....++..|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhcc
Confidence 6432221 122345678999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=206.26 Aligned_cols=170 Identities=27% Similarity=0.453 Sum_probs=141.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 208 (315)
..+|++.+.||+|.||.||++.. +++.+|+|++...... ...+.+|+.++.++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 46788889999999999999987 6789999998643221 24577899999998 799999999998754
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 3589999999999999988642 23568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC-CccCCCCCccccccCccc
Q 021253 284 VARIEVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
+++...... ......|++.|+|||.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred cchhcccccccccCccCCccccChhhhc
Confidence 987543222 123346889999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=207.19 Aligned_cols=161 Identities=21% Similarity=0.413 Sum_probs=133.5
Q ss_pred cceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+.||.|+||.||+|... ...+++|.+.... ....+.+.+|+.+++.+.||||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 36899999999999762 2347888764321 12245788999999999999999999999998889
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc--------EEEeeec
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFG 283 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~--------vkl~DFG 283 (315)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++. ++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999999997643 35788999999999999999999999999999999999987764 6999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
++..... .....+++.|+|||.+..
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPPECIEN 178 (258)
T ss_pred cccccCC---chhccccCCccCchhccC
Confidence 9864322 233568899999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=212.22 Aligned_cols=171 Identities=23% Similarity=0.394 Sum_probs=139.5
Q ss_pred cccccceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (315)
|++.+.||+|+||.||+|.+ .++.||+|.+........ ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc---CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 66778999999999999987 468999999976432111 1124677899999999999999999999988 88
Q ss_pred EEEEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC----CCcEEEeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----DKSIKIADFG 283 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~----~~~vkl~DFG 283 (315)
+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+.+++||||||+||+++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 7777765332 236889999999999999999999999999999999999999 8999999999
Q ss_pred ceeeeecCCC----ccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEG----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~ 311 (315)
+++....... .....+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC
Confidence 9985432211 223467899999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=212.28 Aligned_cols=167 Identities=23% Similarity=0.406 Sum_probs=141.3
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|.....||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.+.||||+++++.+......++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 344456899999999999987 68899999986533221 2467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
|+||+++++|..++.. ..+++..++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++......
T Consensus 96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999999999998754 347899999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......|++.|+|||++..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~ 191 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISR 191 (297)
T ss_pred cccceecCccccCHHHHcc
Confidence 2234568999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=200.23 Aligned_cols=169 Identities=36% Similarity=0.568 Sum_probs=146.2
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|.+|.||+++. .++.|++|.+....... ...+.+.+|++++++++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE----EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 366789999999999999987 56799999997654331 124678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
++||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCccccccCccc
Q 021253 294 -MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~ 310 (315)
.....++..|+|||...
T Consensus 155 ~~~~~~~~~~y~~pe~~~ 172 (254)
T cd06627 155 DDASVVGTPYWMAPEVIE 172 (254)
T ss_pred cccccccchhhcCHhhhc
Confidence 23456889999999764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=204.28 Aligned_cols=175 Identities=20% Similarity=0.327 Sum_probs=144.3
Q ss_pred cccccceeecccCceEEEEEC---CeeEEEEEeeCCCCChh----HHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeC
Q 021253 137 LNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKR 208 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~~---~~~vavK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 208 (315)
|++.+.||+|+||.||++.+. ++.+|+|.+........ .......++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 667889999999999999983 57899998864332211 112234567788888865 7999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
...++||||+++++|.+++... ....+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999988542 34568899999999999999999996 68999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.............|+..|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred eecccccccccccCcccCcChhhhcC
Confidence 87554434455678999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=208.11 Aligned_cols=168 Identities=32% Similarity=0.426 Sum_probs=143.4
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 213 (315)
|++.+.||+|++|.||+|.. +++.|+||.+........ .....+|+..+++++ |||++++++++......++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 45678999999999999998 578899999865433221 123457899999999 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
||||+ +++|.+++.......+++..++.++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 77999998875545689999999999999999999999999999999999999999999999999986554444
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
.....++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 155 YTDYVSTRWYRAPEILL 171 (283)
T ss_pred cCCCCCcccccCceeee
Confidence 44567889999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=201.68 Aligned_cols=171 Identities=23% Similarity=0.477 Sum_probs=146.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||.|+||.||++.+ ++..|++|.+......... .+.+.+|+++++.++|||++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH----HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 466778999999999999998 4889999999765443222 3568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||+++++|.+++.... ...+++..++.++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999998653 466899999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......|++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~ 176 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQ 176 (258)
T ss_pred cceecceeeeecccChhHhc
Confidence 2 223346889999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=206.82 Aligned_cols=168 Identities=27% Similarity=0.420 Sum_probs=142.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|+||.||+|+. +++.||+|.+......... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH---HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4577889999999999999987 6789999998654332221 2356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+++....
T Consensus 92 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999997 57877776432 4589999999999999999999999999999999999999999999999999975432
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 168 -~~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 168 -ANSFVGTPYWMAPEVIL 184 (307)
T ss_pred -CCCccCCccccCceeee
Confidence 23456889999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=210.75 Aligned_cols=174 Identities=23% Similarity=0.374 Sum_probs=141.8
Q ss_pred cccccccccceeecccCceEEEEE----C--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY----N--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~----~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
++..|+....||+|.||.||+|.. . ...+|||.++.......- -....+|+.+++.++||||+.+..++.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 456788889999999999999954 2 237899998765221111 124559999999999999999999987
Q ss_pred e-CCEEEEEEeccCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC----CcEE
Q 021253 207 K-RMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIK 278 (315)
Q Consensus 207 ~-~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~----~~vk 278 (315)
. +..+++++||.+. +|.++++-. ..+.++...+..++.||+.|+.|||++=|+||||||+||||..+ |.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 7889999999987 999988732 23468999999999999999999999999999999999999877 8999
Q ss_pred EeeecceeeeecCC----CccCCCCCccccccCcccc
Q 021253 279 IADFGVARIEVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 279 l~DFG~a~~~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
|+|||+||.+.+.- .....+-|..|.|||.+-+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 99999999754321 2234567899999998765
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=199.37 Aligned_cols=169 Identities=32% Similarity=0.535 Sum_probs=147.0
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 212 (315)
|+..+.||+|++|.||+|.. +++.|++|++....... ...+.+.+|+.++++++||||+++++.+... ...+
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 56678999999999999988 48899999987654431 2246788999999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+++++|.+++.... .+++..++.++.|++.+|+|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999999998653 68999999999999999999999999999999999999999999999999998755443
Q ss_pred C---ccCCCCCccccccCcccc
Q 021253 293 G---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~---~~~~~gt~~y~APE~~~~ 311 (315)
. .....++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred ccccccCCCCCccccCHhhhcC
Confidence 2 344578899999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=204.13 Aligned_cols=172 Identities=25% Similarity=0.434 Sum_probs=144.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|+||.||++.. ++..+|+|.+......... .+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE----KEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh----hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 366788999999999999987 6789999998664332211 3567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceeeeecCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~~~~~~ 292 (315)
|+||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999875555689999999999999999999999999999999999999876 56999999987654322
Q ss_pred C-ccCCCCCccccccCcccc
Q 021253 293 G-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~-~~~~~gt~~y~APE~~~~ 311 (315)
. .....|++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred ccccccCCCccccCHHHHcC
Confidence 1 223458899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=204.94 Aligned_cols=165 Identities=25% Similarity=0.355 Sum_probs=137.5
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR--MVW 211 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~ 211 (315)
|++.+.||+|.||.||+|.. +++.||+|.++........ ....+|+.++.++. |||++++++++.+. ..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 45678899999999999987 6789999998754332221 23447888888885 99999999999887 889
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+++||||+|+||+++. +.+||+|||+++.....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99999997 48888887543 46899999999999999999999999999999999999999 99999999999865444
Q ss_pred CCccCCCCCccccccCcc
Q 021253 292 EGMTPETGTYRWMAPSAG 309 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~ 309 (315)
.......+++.|+|||.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 153 PPYTEYISTRWYRAPECL 170 (282)
T ss_pred CCcCCCCCCcccCChhHh
Confidence 334445688999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=212.44 Aligned_cols=167 Identities=27% Similarity=0.426 Sum_probs=140.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|.....||+|+||.||++.. ++..||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 344456799999999999987 678999998854221 123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999999998854 347889999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......|++.|+|||.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~ 192 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISR 192 (292)
T ss_pred cCceeecCccccCHHHHcc
Confidence 2233468899999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=207.81 Aligned_cols=169 Identities=27% Similarity=0.433 Sum_probs=143.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
..+|++.+.||+|+||.||++.. ++..|++|.+....... .+.+.+|+.+++.++||||+++++.+......
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 36778889999999999999976 67889999985432211 25688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999999998753 4788889999999999999999999999999999999999999999999998754322
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......+++.|+|||.+..
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTR 189 (293)
T ss_pred ccccccccCChhhcCchhhcc
Confidence 2 2233468899999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=204.85 Aligned_cols=170 Identities=28% Similarity=0.380 Sum_probs=141.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVW 211 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 211 (315)
+|+..+.||.|++|.||++.. +++.+|+|.+...... ....++.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 466778999999999999988 6789999998754332 1235788999999999999999999998653 478
Q ss_pred EEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999999987642 23557889999999999999999999999999999999999999999999999987543
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ......++..|+|||.+..
T Consensus 157 ~~-~~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 157 NS-LAGTFTGTSFYMAPERIQG 177 (287)
T ss_pred cc-ccccccCCccccCHHHhcC
Confidence 22 1234467889999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=208.44 Aligned_cols=173 Identities=26% Similarity=0.395 Sum_probs=140.5
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (315)
+.++|++.+.||+|+||.||+|.. +++.||||.+......... ...+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc----hhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 446788899999999999999987 6789999998654322111 134568999999999999999999986643
Q ss_pred -------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 210 -------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 210 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
..++||||+.+ +|.+++... ...+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999965 888887653 345899999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCC-----CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE-----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~-----~~~~~~gt~~y~APE~~~~ 311 (315)
|++....... ......++..|+|||.+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcC
Confidence 9997543221 1123457889999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=216.99 Aligned_cols=176 Identities=27% Similarity=0.354 Sum_probs=147.7
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 207 (315)
.|...+|.++.+||+|+||+|.+|.. +.+.+|||++++...-.... .+--..|.++|... +-|.+++++.+++.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence 56778999999999999999999987 45689999998754322211 13345677777776 57889999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
-+++|+||||+.||+|.-.+++. ..+.+..+..+|..|+-||-+||++|||.||||.+|||++.+|++||+|||+++-
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999999888765 4488889999999999999999999999999999999999999999999999984
Q ss_pred ee-cCCCccCCCCCccccccCcccc
Q 021253 288 EV-QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~-~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.- ......+.||||.|+|||++..
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~Y 524 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAY 524 (683)
T ss_pred cccCCcceeeecCCCcccccceEEe
Confidence 22 2333566899999999999874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=202.01 Aligned_cols=164 Identities=29% Similarity=0.478 Sum_probs=131.4
Q ss_pred cceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KRMVWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv 214 (315)
+.||+|+||.||+|.+. ...||+|.+...... ...+.+.+|+.+++.++||||+++++++. .+...++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 36899999999999862 357999987542211 11357889999999999999999999875 45567899
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC--
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-- 292 (315)
+||+.+++|.+++.+.. ...++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999999997543 345677788999999999999999999999999999999999999999999997543211
Q ss_pred ---CccCCCCCccccccCccc
Q 021253 293 ---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ---~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred eecccccCcCCccccChhHhc
Confidence 112234567899999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=205.78 Aligned_cols=170 Identities=26% Similarity=0.390 Sum_probs=142.3
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|++.+.||.|.+|.||+|.+ +++.||+|++........ ....+.+|+.+++.++|||++++++++.+....|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 45678999999999999987 688999999875432211 124577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-CC
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~~ 293 (315)
+||++ ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||+++..... ..
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99995 69999987655456899999999999999999999999999999999999999999999999999754221 12
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
.....+++.|+|||++..
T Consensus 156 ~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 156 YTHEVVTLWYRAPEILLG 173 (283)
T ss_pred cCccccccCCCCCceeec
Confidence 233456899999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=220.64 Aligned_cols=174 Identities=23% Similarity=0.325 Sum_probs=146.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHHhCC---CCCeeeEEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLK---HLNIVRFIGAC 205 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~---h~niv~l~~~~ 205 (315)
+.+|...+.+|+|+||+|+.|.+ +...|+||.+.+...... .++. .-.+.-|++||..++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~D-tWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVD-TWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhh-hhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 35678999999999999999998 556899998865432211 1111 122457999999997 99999999999
Q ss_pred EeCCEEEEEEecc-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 206 RKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 206 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
++++.+||+||-- ++.+|.+++... ..+.+.++..|+.||+.|+++||++||||||||-+|+.++.+|-+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999976 566899999764 4589999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCccccccCcccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|...... ....++||..|.|||++.+
T Consensus 717 aa~~ksg-pfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 717 AAYTKSG-PFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred hhhhcCC-CcceeeeeccccchhhhCC
Confidence 9876655 4677899999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=204.36 Aligned_cols=168 Identities=25% Similarity=0.386 Sum_probs=141.4
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 212 (315)
|++.+.||+|++|.||+|.+ +++.+|+|.+........ ..+.+.+|+.+++.++|||++++++++... ...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 45678999999999999988 568999999986542211 124678999999999999999999999888 8899
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+++ +|.+++.... ..+++..++.++.||+.||+|||+.+++|+||+|+||++++++.+||+|||+++......
T Consensus 77 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99999975 8988886542 468999999999999999999999999999999999999999999999999998654332
Q ss_pred --CccCCCCCccccccCccc
Q 021253 293 --GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 --~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 155 SADYTNRVITLWYRPPELLL 174 (287)
T ss_pred cccccccccccccCCceeeE
Confidence 233446788999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=200.21 Aligned_cols=165 Identities=32% Similarity=0.544 Sum_probs=137.8
Q ss_pred cceeecccCceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q 021253 141 TAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 219 (315)
++||+|+||.||++.+. ++.|++|.+...... .....+.+|+.+++.+.||||+++++++......++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 46899999999999874 889999988764432 123578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc---cC
Q 021253 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TP 296 (315)
Q Consensus 220 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~---~~ 296 (315)
+++|.+++.... ..++...++.++.+++.+|+|||+++++||||+|+||+++.++.+||+|||+++........ ..
T Consensus 76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999999997543 35788899999999999999999999999999999999999999999999999754321110 11
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
...+..|+|||.+..
T Consensus 155 ~~~~~~y~~PE~~~~ 169 (251)
T cd05041 155 KQIPIKWTAPEALNY 169 (251)
T ss_pred CcceeccCChHhhcc
Confidence 233567999998753
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=235.58 Aligned_cols=173 Identities=28% Similarity=0.444 Sum_probs=139.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
.+|+.++.||+|+||.||+++. +|+.||||.+.... .. ..-..+.+|+.++++|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~----~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SD----KLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HH----HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 5677788999999999999986 99999999997644 22 223578899999999999999999865410
Q ss_pred --------------------------------------------------------------------------------
Q 021253 208 -------------------------------------------------------------------------------- 207 (315)
Q Consensus 208 -------------------------------------------------------------------------------- 207 (315)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021253 208 --------------------------R--------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (315)
Q Consensus 208 --------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (315)
. ..+||-||||+...|.+++...... -....+|+++.+|++||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHH
Confidence 0 1368999999997777777654221 1467789999999999999
Q ss_pred HHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee-------------------cCCCccCCCCCccccccCcccccc
Q 021253 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------------------QTEGMTPETGTYRWMAPSAGSICC 313 (315)
Q Consensus 254 LH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~APE~~~~~~ 313 (315)
+|+.|+|||||||.||++++++.|||.|||+|+... .....+..+||.-|+|||++....
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999999999999999999999999999999997511 111346678999999999998654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=212.19 Aligned_cols=167 Identities=27% Similarity=0.393 Sum_probs=138.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
++|++.+.||+|+||.||+|.+ +++.||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 5788899999999999999987 6789999998642221 1134677899999999999999999987654
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
..+|+|+||+.+ +|.+++.. ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 357999999965 88887753 4589999999999999999999999999999999999999999999999999976
Q ss_pred eecCCC----ccCCCCCccccccCccc
Q 021253 288 EVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
...... .....||+.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhh
Confidence 432211 12346889999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.07 Aligned_cols=179 Identities=34% Similarity=0.587 Sum_probs=152.7
Q ss_pred ccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
+.|+++.+++++.+.||+|.||+|++|... ...||||.++......+ .+.+..|+.+|+.+ +|||
T Consensus 289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPN 363 (609)
T ss_pred CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 389999999999999999999999999742 35799999876555432 36899999999999 5999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------N--RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
|+.++|+|.....+++|+||++.|+|.++|+..+ . ..++....+.++.||+.||+||++..+||||
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 9999999999999999999999999999998765 0 1378889999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCCCccC--CCC--CccccccCcccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTP--ETG--TYRWMAPSAGSI 311 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~--~~g--t~~y~APE~~~~ 311 (315)
|.++|||+.++..+||+|||+||.......+.. ..| ..+|||||.+..
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 999999999999999999999996544443322 222 357999998864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=208.58 Aligned_cols=170 Identities=20% Similarity=0.295 Sum_probs=140.5
Q ss_pred ccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+++.+|.|+++.|+++..+++.||||++.......+ ..+.+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE----DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh----HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 3455566666767777777899999999976533322 246789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC----
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---- 293 (315)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999999876556689999999999999999999999999999999999999999999999998864322111
Q ss_pred ----ccCCCCCccccccCcccc
Q 021253 294 ----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ----~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred cccccccccccccccCHHHhcC
Confidence 123457789999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=207.24 Aligned_cols=172 Identities=24% Similarity=0.367 Sum_probs=141.5
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (315)
...+|++.+.||+|+||.||+|.+ +++.||+|.++........ ...+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~----~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF----PITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc----hHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 346788889999999999999998 5789999998754322111 245678999999999999999999987654
Q ss_pred ---------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 210 ---------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 210 ---------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.+++|+||+++ +|..++... ...+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 777777653 3468999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCC--CccCCCCCccccccCccc
Q 021253 281 DFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 281 DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|||+++...... ......+++.|+|||.+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhc
Confidence 999998654322 122335678899999774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=197.68 Aligned_cols=169 Identities=28% Similarity=0.539 Sum_probs=146.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|...+.||+|++|.||++.. +++.+++|++..... ...+.+.+|+.+++.++||+++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 366778999999999999998 478999999976443 123578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~ 293 (315)
++||+++++|.+++.... ..+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999999987643 4689999999999999999999999999999999999999999999999999986544322
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||.+..
T Consensus 154 ~~~~~~~~~~~~PE~~~~ 171 (253)
T cd05122 154 RNTMVGTPYWMAPEVING 171 (253)
T ss_pred ccceecCCcccCHHHHcC
Confidence 344578899999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=200.34 Aligned_cols=163 Identities=25% Similarity=0.417 Sum_probs=134.3
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.||+|+||.||+|.. +++.||+|++......... ....+..|..+ .....|||++++++++...+.+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHH---HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 5789999999999987 6789999998654322111 12234445444 4556899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~ 297 (315)
+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||+++.... ....
T Consensus 79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9999999999754 3588999999999999999999999999999999999999999999999999985432 2334
Q ss_pred CCCccccccCcccc
Q 021253 298 TGTYRWMAPSAGSI 311 (315)
Q Consensus 298 ~gt~~y~APE~~~~ 311 (315)
.+++.|+|||.+..
T Consensus 154 ~~~~~y~~pe~~~~ 167 (260)
T cd05611 154 VGTPDYLAPETILG 167 (260)
T ss_pred CCCcCccChhhhcC
Confidence 68899999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=208.73 Aligned_cols=174 Identities=24% Similarity=0.334 Sum_probs=141.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHH--------HHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ--------VMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
+...+.+.||.|+||.||+|.+ .++.||||.++.......... .....+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 3344667899999999999986 678999999876443321100 001257799999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+......++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999997 5999998653 4588999999999999999999999999999999999999999999999999
Q ss_pred eeeeec---------------CCCccCCCCCccccccCcccc
Q 021253 285 ARIEVQ---------------TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~---------------~~~~~~~~gt~~y~APE~~~~ 311 (315)
++.... ........+++.|+|||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 975431 111223456889999998753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=204.19 Aligned_cols=168 Identities=28% Similarity=0.426 Sum_probs=141.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|+||.||++.+ ++..||+|.+........ ...+.+.+|+.+++.++|||++++++++.+....+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 4466778999999999999987 678999999875433222 22357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 99999975 888877643 34588999999999999999999999999999999999999999999999999875332
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 178 -~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 -ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred -cccccCCccccChhhhh
Confidence 23457889999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=208.56 Aligned_cols=167 Identities=20% Similarity=0.318 Sum_probs=136.9
Q ss_pred cceeec--ccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 141 TAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G--~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
..||.| +||.||++.+ +++.||+|++........ ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 356666 8899999987 789999999876543332 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~--- 293 (315)
|+.+++|.+++.......+++..+..++.||+.||+|||+++++||||||+||+++.++.+|++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999999876555689999999999999999999999999999999999999999999999986532211100
Q ss_pred -----ccCCCCCccccccCcccc
Q 021253 294 -----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 -----~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred ccccccccccCccCccChhhhcC
Confidence 011234577999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=220.74 Aligned_cols=164 Identities=26% Similarity=0.454 Sum_probs=139.1
Q ss_pred ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
--+||+|.||.||-|++ +...+|||-+...... ..+-+.+|+.+-++|+|.|||+++|.+.++..+-|.||-
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccch------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 34799999999999987 5668899987543322 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEeeecceeeeec-CCC
Q 021253 218 AKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQ-TEG 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~DFG~a~~~~~-~~~ 293 (315)
++||+|.++|+..= .++ .+.+.-.+..||++||+|||++.|||||||-+|+||+ -.|.+||+|||-++.... .+.
T Consensus 654 VPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999999998642 234 6677778899999999999999999999999999997 578999999998875432 334
Q ss_pred ccCCCCCccccccCccc
Q 021253 294 MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~ 310 (315)
..++.||..|||||+|-
T Consensus 733 TETFTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVID 749 (1226)
T ss_pred ccccccchhhhChHhhc
Confidence 56788999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=201.95 Aligned_cols=169 Identities=27% Similarity=0.445 Sum_probs=139.7
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCE-
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMV- 210 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~- 210 (315)
|++.+.||+|+||.||+|.+ +++.||+|.++........ ...+.+|+.+++++ .|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 45678999999999999998 4789999999754432211 23455777777666 59999999999988776
Q ss_pred ----EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 211 ----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 211 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
++++|||+.+ +|.+++.......+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999975 89998876544568999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCccccccCccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
............+++.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLL 179 (287)
T ss_pred eccCCcccccccccccccChHHhc
Confidence 654443334456789999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=203.66 Aligned_cols=164 Identities=32% Similarity=0.548 Sum_probs=134.4
Q ss_pred ceeecccCceEEEEECC--------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 142 AFAQGAFGKLYRGTYNG--------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.||+|+||.||+|++.. ..+|+|.+....... ....+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-----EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchh-----hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 68999999999998632 578999886432211 13578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-----cEEEeeec
Q 021253 214 VTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-----SIKIADFG 283 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-----~vkl~DFG 283 (315)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999999997532 23478888999999999999999999999999999999999877 89999999
Q ss_pred ceeeeecCCC---ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+++....... .....++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHc
Confidence 9975432211 11234568899999765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=202.31 Aligned_cols=163 Identities=24% Similarity=0.428 Sum_probs=138.8
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||.|+||.||++.+ +++.+++|.+....... ....+.+.+|+.++++++||||+++++.+......|+++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 58899999999998 48899999986543321 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC--------
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------- 292 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-------- 292 (315)
++|.+++.+.. .+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999997643 58999999999999999999999999999999999999999999999999987533221
Q ss_pred -CccCCCCCccccccCccc
Q 021253 293 -GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~ 310 (315)
......++..|+|||...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred ccccCcccCccccCHHHhc
Confidence 123346788999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=210.33 Aligned_cols=171 Identities=26% Similarity=0.428 Sum_probs=141.6
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|.+ .++|++.+.||+|+||.||++.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 11 WEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 444 35688899999999999999986 67899999986533221 123467899999999999999999999875
Q ss_pred CC------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 208 RM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 208 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
.. .+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence 43 458999999 7799888764 3589999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+++.... ......+++.|+|||.+..
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 162 FGLARQTDS--EMTGYVVTRWYRAPEVILN 189 (343)
T ss_pred ccccccccc--CccccccCCcccCHHHHhC
Confidence 999975432 2334567899999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=200.67 Aligned_cols=170 Identities=23% Similarity=0.459 Sum_probs=136.3
Q ss_pred cccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 45678999999999999975 3578999999654433322 357889999999999999999999886532
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 210 ----VWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 210 ----~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
..++++||+++++|.+++.... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 3578999999999998875321 12478889999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||+++....... .....+++.|++||.+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLA 188 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHh
Confidence 999985432211 12234567899999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=210.95 Aligned_cols=175 Identities=24% Similarity=0.391 Sum_probs=149.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCC-CCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERP-ENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KRM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 209 (315)
-++|-++.+||+|+|++||+|.+ ..+.||||+-... .+..++...+.+...+|..|-+.|.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788899999999999999976 6778999987654 3445566677788889999999999999999999985 456
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCCCEEEc---CCCcEEEeeecc
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLIS---ADKSIKIADFGV 284 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NIli~---~~~~vkl~DFG~ 284 (315)
.+|-|+|||+|.+|.-||+.. +.++++.++.|+.||+.||.||.+. -|||-||||.|||+- ..|.+||.|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 789999999999999999764 5689999999999999999999977 499999999999995 357899999999
Q ss_pred eeeeecCCC--------ccCCCCCccccccCccc
Q 021253 285 ARIEVQTEG--------MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~--------~~~~~gt~~y~APE~~~ 310 (315)
++++.++.. .+...||++|++||.|.
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceee
Confidence 998754321 24457999999999875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=199.99 Aligned_cols=171 Identities=25% Similarity=0.443 Sum_probs=145.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|++.+.||+|++|.||++.. +++.+++|.+......... ...+.+|+.+++.++||||+++++++......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE----REDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH----HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 366778999999999999987 6789999998754433221 3567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||+++++|.+++.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||+++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999999987632 345888999999999999999999999999999999999999999999999999865443
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred -CcccccCCccccCHHHHCC
Confidence 3334568899999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=206.54 Aligned_cols=179 Identities=21% Similarity=0.326 Sum_probs=153.5
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (315)
..|.+.+.+|.++++||+|+|.+|..+++ +.+.+|+|++++.-.+.... ++-.+.|..+..+. +||.+|-+..+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded---idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED---IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc---chhHHhhHHHHHhccCCCeEEehhhh
Confidence 46888899999999999999999999987 67889999998765443322 34556777777665 69999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
|+....+++|.||++||+|.-.+++. ..+|++.++.+...|+.||.|||++|||.||||.+|+|+|..|++||.|+|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999999998777654 4599999999999999999999999999999999999999999999999999
Q ss_pred eeee-ecCCCccCCCCCccccccCcccc
Q 021253 285 ARIE-VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~-~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
++-. .+....+++||||.|+|||++.+
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRG 425 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcc
Confidence 9853 23334677899999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=202.57 Aligned_cols=167 Identities=26% Similarity=0.421 Sum_probs=140.8
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|...+.||+|++|.||++.. +++.+++|.+...... ..+.+.+|+.+++.+.||||+++++++...+..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 344457899999999999986 6788999988643221 13467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
|+||+++++|.+++.. ..+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||+++......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999999999999876 348889999999999999999999999999999999999999999999999887543221
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......|++.|+|||.+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~ 189 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISR 189 (285)
T ss_pred ccccccCCccccCHHHhcC
Confidence 2233468999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=204.67 Aligned_cols=172 Identities=26% Similarity=0.420 Sum_probs=145.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (315)
++|++.+.||+|++|.||++.. ++..|++|++......... ..+.+.+|+.+++++. ||||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchH---HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 3678889999999999999987 6889999998764332221 2357889999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|||++++++|.+++.+. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999999764 35899999999999999999999999999999999999999999999999998754322
Q ss_pred C---------------------CccCCCCCccccccCcccc
Q 021253 292 E---------------------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~---------------------~~~~~~gt~~y~APE~~~~ 311 (315)
. ......++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 1 1123457899999997653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=201.14 Aligned_cols=168 Identities=30% Similarity=0.467 Sum_probs=145.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|.+|.||++.+ .+..|++|++..... ..+.+.+|+++++.++|+|++++++.+......|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 5677888999999999999988 478999999975433 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998753 368999999999999999999999999999999999999999999999999886433221
Q ss_pred -CccCCCCCccccccCccc
Q 021253 293 -GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~ 310 (315)
......+++.|+|||.+.
T Consensus 171 ~~~~~~~~~~~y~~PE~~~ 189 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIK 189 (286)
T ss_pred hhhccccCCcccCCHhHhc
Confidence 223345789999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=203.08 Aligned_cols=172 Identities=20% Similarity=0.328 Sum_probs=142.5
Q ss_pred ccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
+|++.+.||+|++|.||+++. +++.||||+++..... ......+.+.+|+.++.++ .||+|+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 366788999999999999875 4578999998753221 1122345788999999999 5999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999998753 458888999999999999999999999999999999999999999999999987643
Q ss_pred cCCC--ccCCCCCccccccCcccc
Q 021253 290 QTEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~--~~~~~gt~~y~APE~~~~ 311 (315)
.... .....|++.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred cccccccccccCCccccCHHHhcC
Confidence 3221 123468899999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=203.76 Aligned_cols=163 Identities=25% Similarity=0.395 Sum_probs=138.9
Q ss_pred cccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
....||+|+||.||++.. +++.||||.+..... .....+.+|+.+++.++|||++++++.+...+..++|||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 346899999999999987 678999998753221 123568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-Ccc
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMT 295 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~~~ 295 (315)
|+++++|.+++.. ..+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 98 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999999998754 347889999999999999999999999999999999999999999999999987543221 223
Q ss_pred CCCCCccccccCccc
Q 021253 296 PETGTYRWMAPSAGS 310 (315)
Q Consensus 296 ~~~gt~~y~APE~~~ 310 (315)
...|++.|+|||.+.
T Consensus 175 ~~~~~~~y~~pE~~~ 189 (292)
T cd06657 175 SLVGTPYWMAPELIS 189 (292)
T ss_pred ccccCccccCHHHhc
Confidence 356889999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=208.14 Aligned_cols=168 Identities=27% Similarity=0.389 Sum_probs=138.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--C
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--M 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~ 209 (315)
.+|++.+.||+|+||.||+|.+ +++.+|+|.+......... ...+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 5788889999999999999987 5789999988653322221 24567899999999 999999999998654 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+. ++|.+++... .+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999997 4999888653 57888889999999999999999999999999999999999999999999997543
Q ss_pred cCC------CccCCCCCccccccCccc
Q 021253 290 QTE------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~------~~~~~~gt~~y~APE~~~ 310 (315)
... ......|++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred cccccccCcchhcccccccccCceeee
Confidence 221 122346889999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=209.71 Aligned_cols=169 Identities=25% Similarity=0.365 Sum_probs=140.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----C
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 208 (315)
++|++.+.||+|++|.||+|.. +++.||+|++........ ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 5777889999999999999987 688999999875432221 13567789999999999999999998753 3
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 56899999996 5898888643 44899999999999999999999999999999999999999999999999999764
Q ss_pred ecCCC-----ccCCCCCccccccCccc
Q 021253 289 VQTEG-----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~-----~~~~~gt~~y~APE~~~ 310 (315)
..... .....++..|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLL 184 (334)
T ss_pred cccCcCCCcccccccccccccChHHhc
Confidence 32211 12346889999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=209.55 Aligned_cols=169 Identities=26% Similarity=0.345 Sum_probs=140.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
++|.+.+.||+|+||.||++.. +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4688889999999999999987 6789999998754322211 24567899999999999999999987654
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 34799999996 6898888653 4589999999999999999999999999999999999999999999999999986
Q ss_pred eecC-CCccCCCCCccccccCccc
Q 021253 288 EVQT-EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~ 310 (315)
.... .......++..|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred cCCCcccccccccccCccChHHHh
Confidence 4332 1233456889999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=211.69 Aligned_cols=176 Identities=19% Similarity=0.271 Sum_probs=145.9
Q ss_pred ccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 205 (315)
.-..+.-+.|+++++||+|+.++||++.. +.+.+|+|.+.....+. ....-|.+|+.+|.+|+ |.+||+||+|-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~----qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN----QTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH----HHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 34566778999999999999999999987 45677877665433332 23568999999999995 89999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..++.+|+|||+=+ .+|..+|++.... .+.-.+..+..|++.++.++|++||||.||||+|+|+- .|.+||+|||.|
T Consensus 430 v~d~~lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 430 VTDGYLYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred ccCceEEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence 99999999999885 4999999876433 34347788899999999999999999999999999996 789999999999
Q ss_pred eeeecCCC---ccCCCCCccccccCccc
Q 021253 286 RIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
.....+.. ..+.+||+.||+||++.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~ 534 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALT 534 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHh
Confidence 86554332 34578999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=208.53 Aligned_cols=170 Identities=25% Similarity=0.366 Sum_probs=143.4
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (315)
+|++.+.||.|++|.||+|.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 467889999999999999987 57899999987643222 12357889999999999999999999988775
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 78999999974 898888653 36899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC----CccCCCCCccccccCccccc
Q 021253 289 VQTE----GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~~ 312 (315)
.... ......+++.|+|||.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred cccccccccccccccccCcCCceeeecc
Confidence 4432 23445688999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-28 Score=210.05 Aligned_cols=169 Identities=25% Similarity=0.381 Sum_probs=140.7
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (315)
+++-.+.||-|+||.||.+++ +++.||+|.+..... ....-+++.+|+.+|..++|.|++..++..+...
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq----~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ----NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH----HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 345568999999999999998 789999998753222 2222367889999999999999999998876543
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+|+++|.|.. +|..++-. .+.++.+.+.-+++||++||+|||+.+|.||||||.|+|++.+..+||||||+||..
T Consensus 130 qEiYV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 46889999955 88888754 356888888999999999999999999999999999999999999999999999976
Q ss_pred ecCC--CccCCCCCccccccCcccc
Q 021253 289 VQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
..+. .++..+-|.+|.|||++.+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhc
Confidence 5433 4666778999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=195.49 Aligned_cols=180 Identities=18% Similarity=0.208 Sum_probs=148.5
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
...|+-++|.+.+.||+|+|.-||.++. +++.+|+|.+.-.... .++..++|++..++++||||++++++..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~------~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE------DIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH------HHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 3457788999999999999999999985 8889999988654321 1467889999999999999999999874
Q ss_pred eCC-----EEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcCCCcE
Q 021253 207 KRM-----VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 207 ~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~~~~v 277 (315)
.+. ..||+++|...|+|.+.+... ++..+++...+.|+.+|++||++||+.. ++||||||+|||+.+++.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 433 489999999999999998754 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeeecceeeeec-----CC-----CccCCCCCccccccCccccccC
Q 021253 278 KIADFGVARIEVQ-----TE-----GMTPETGTYRWMAPSAGSICCG 314 (315)
Q Consensus 278 kl~DFG~a~~~~~-----~~-----~~~~~~gt~~y~APE~~~~~~g 314 (315)
+|.|||.++...- .. .......|..|.|||.+....|
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~ 215 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH 215 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence 9999998863210 00 0122346899999999986544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=200.25 Aligned_cols=166 Identities=29% Similarity=0.427 Sum_probs=139.6
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|...+.||+|+||.||+|+. +++.|++|.+......... ..+.+.+|+.+++.++|||++++++++.+....|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 44557799999999999987 6789999998754332221 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~ 294 (315)
|||+. ++|.+++... ...+++..++.++.||+.+|.|||++|++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 99996 5888887653 3458899999999999999999999999999999999999999999999999986422 23
Q ss_pred cCCCCCccccccCccc
Q 021253 295 TPETGTYRWMAPSAGS 310 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~ 310 (315)
....|+..|+|||.+.
T Consensus 175 ~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 175 NSFVGTPYWMAPEVIL 190 (313)
T ss_pred CCccccccccChhhcc
Confidence 3457899999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=197.51 Aligned_cols=160 Identities=19% Similarity=0.275 Sum_probs=130.9
Q ss_pred ccccccce--eecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q 021253 136 KLNMGTAF--AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (315)
Q Consensus 136 ~~~~~~~i--G~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (315)
+|++.+.+ |+|+||.||++.. ++..+|+|.+....... .|+.....+ +||||+++++.+...+.
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 44444554 9999999999986 67889999986533221 122222222 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceeeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEV 289 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~~~ 289 (315)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999764 3689999999999999999999999999999999999999988 99999999997643
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ....+++.|+|||++..
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKG 180 (267)
T ss_pred CC---ccCCCCCcccChhhhcC
Confidence 22 23468899999998864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=203.31 Aligned_cols=167 Identities=31% Similarity=0.450 Sum_probs=139.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 211 (315)
++|++.+.||.|+||.||++.. +++.||||.+........ ..+.+.+|+.+++.++||||+++++++.. ....
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 5688899999999999999986 678999998865433221 12567799999999999999999999865 4578
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 9999999 5689888864 3478888889999999999999999999999999999999999999999999975322
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
......+++.|+|||.+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred -CcCCCcccccccCceeeec
Confidence 2334567889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=206.29 Aligned_cols=171 Identities=26% Similarity=0.388 Sum_probs=140.4
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|.+. ++|++.+.||+|+||.||++.. +++.||+|++........ ..+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 4443 6788999999999999999986 688999999875432221 23567789999999999999999998854
Q ss_pred C------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 208 R------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 208 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
. ...|++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence 3 3468888887 7799888764 3488999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+++.... ......+++.|+|||.+..
T Consensus 164 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 164 FGLARHTDD--EMTGYVATRWYRAPEIMLN 191 (345)
T ss_pred ccccccccc--cccccccCCCccCHHHHhC
Confidence 999975422 2344578899999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=199.54 Aligned_cols=177 Identities=18% Similarity=0.254 Sum_probs=128.5
Q ss_pred ccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHH-----HHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
+..++|++.+.||+|+||.||+|.+. +..+++|+............ ........+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 34468889999999999999999873 34667776433222111100 001123344455667789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcE
Q 021253 202 IGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 202 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~v 277 (315)
++++.... ..++++|++.. ++.+++... ...++..+..++.|++.||+|||+.+++||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99775543 34778888743 777776543 235788889999999999999999999999999999999999999
Q ss_pred EEeeecceeeeecCC--------CccCCCCCccccccCcccc
Q 021253 278 KIADFGVARIEVQTE--------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 278 kl~DFG~a~~~~~~~--------~~~~~~gt~~y~APE~~~~ 311 (315)
+|+|||+|+...... ......||+.|+|||++..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 999999998643211 1123469999999998753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=199.95 Aligned_cols=169 Identities=28% Similarity=0.422 Sum_probs=143.2
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|++.+.||+|++|.||++.. +++.+++|.+........ ....+.+|+.++++++||+|+++++++......++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 45668899999999999987 678999999876543321 235778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-C
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~ 293 (315)
+||+++ +|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||.+....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999975 8888887643 568999999999999999999999999999999999999999999999999997654332 2
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG 172 (283)
T ss_pred ccCccCcccccCcHHHhc
Confidence 334567889999998754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=201.22 Aligned_cols=178 Identities=22% Similarity=0.305 Sum_probs=146.7
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-HhCCCCCeeeEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIG 203 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~ 203 (315)
...|++...+++-+..||.|+||.|++..+ .|+..|||.++......++ ++++.|.... +.-+.||||++||
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----KRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----HHHHHHHHHHHhhcCCcHHHHHhh
Confidence 345677777888888999999999999987 7889999999865553332 5677777654 5557999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEE
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl 279 (315)
.+..+...||.||.|+- +|..+.+ ..+...+++..+-.|....+.||+||-.. .|||||+||+|||++..|.+||
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEee
Confidence 98888888999999954 7766543 34456789999999999999999999854 8999999999999999999999
Q ss_pred eeecceeeeecCCCccCCCCCccccccCccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
||||.+....++-..+.-.|-..|||||.+.
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccC
Confidence 9999998766665566678889999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=203.73 Aligned_cols=169 Identities=24% Similarity=0.303 Sum_probs=136.1
Q ss_pred ccccccceeecccCceEEEEEC----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 208 (315)
+|++.+.||+|+||.||++... +..||+|.+........ ..+.+.+|+.+++++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI----LAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 3667789999999999999983 66899999864322211 235678899999999 599999999975432
Q ss_pred --CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 209 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
..+|+++||+. ++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 45789999986 5899988643 458999999999999999999999999999999999999999999999999997
Q ss_pred eeecCC-----CccCCCCCccccccCcccc
Q 021253 287 IEVQTE-----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~-----~~~~~~gt~~y~APE~~~~ 311 (315)
...... ......||+.|+|||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhC
Confidence 543211 1233468999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=199.24 Aligned_cols=169 Identities=28% Similarity=0.431 Sum_probs=141.8
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|+..+.||+|.+|.||+|+. +++.||+|++........ ..+.+.+|+.+++.++|||++++++++.+...+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 34567899999999999988 578999999976542211 124677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-C
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~ 293 (315)
+||++ ++|.+++.+.. ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99997 49999998643 458999999999999999999999999999999999999999999999999998643322 2
Q ss_pred ccCCCCCccccccCcccc
Q 021253 294 MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ~~~~~gt~~y~APE~~~~ 311 (315)
.....++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 155 YTHEVVTLWYRAPEILLG 172 (282)
T ss_pred cCccccCcCcCChHHhcC
Confidence 334456788999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=193.84 Aligned_cols=164 Identities=28% Similarity=0.391 Sum_probs=140.5
Q ss_pred eeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|+||.||++.+ +++.+++|.+........ .....+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 68999999999988 478999999876443221 1245788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-CCccCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETG 299 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~~~~~~~g 299 (315)
++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 9999999764 35889999999999999999999999999999999999999999999999999865432 22344568
Q ss_pred CccccccCcccc
Q 021253 300 TYRWMAPSAGSI 311 (315)
Q Consensus 300 t~~y~APE~~~~ 311 (315)
+..|+|||.+..
T Consensus 156 ~~~~~~Pe~~~~ 167 (250)
T cd05123 156 TPEYLAPEVLLG 167 (250)
T ss_pred CccccChHHhCC
Confidence 899999998753
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=212.52 Aligned_cols=180 Identities=19% Similarity=0.299 Sum_probs=133.7
Q ss_pred cccccccccccceeecccCceEEEEE------------------CCeeEEEEEeeCCCCChhHH--------HHHHHHHH
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY------------------NGEDVAIKILERPENNPEKA--------QVMEQQFQ 184 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~--------~~~~~~~~ 184 (315)
.+..++|++.++||+|+||.||+|.+ .++.||||.+.......... ....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 45678999999999999999999964 34579999986432211100 00112344
Q ss_pred HHHHHHHhCCCCCe-----eeEEEEEEe--------CCEEEEEEeccCCCCHHHHHHhhCC-------------------
Q 021253 185 QEVMMLATLKHLNI-----VRFIGACRK--------RMVWCIVTEYAKGGSVRQFLTRRQN------------------- 232 (315)
Q Consensus 185 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~------------------- 232 (315)
.|+.++.+++|.++ ++++++|.. ....++||||+++++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 667777643 3457999999999999999864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCC--CCCccccccC
Q 021253 233 ---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAPS 307 (315)
Q Consensus 233 ---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~--~gt~~y~APE 307 (315)
..+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++........... .+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356778899999999999999999999999999999999999999999999754333222222 3479999999
Q ss_pred ccc
Q 021253 308 AGS 310 (315)
Q Consensus 308 ~~~ 310 (315)
.+.
T Consensus 381 ~l~ 383 (507)
T PLN03224 381 ELV 383 (507)
T ss_pred hhc
Confidence 875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=205.66 Aligned_cols=171 Identities=26% Similarity=0.419 Sum_probs=140.0
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|++. .+|...+.||+|+||.||+|.+ +++.||||.+........ ....+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheec
Confidence 46663 4788889999999999999986 688999999875432211 1246789999999999999999999986
Q ss_pred eC------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.. ..+++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~ 159 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 54 346999999964 7766652 348899999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+++.... ......+++.|+|||.+..
T Consensus 160 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 160 DFGLARHADA--EMTGYVVTRWYRAPEVILN 188 (342)
T ss_pred eCCCCcCCCC--CCCCceeeecccChhhhcC
Confidence 9999975322 2334567899999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.61 Aligned_cols=171 Identities=26% Similarity=0.354 Sum_probs=138.3
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (315)
.++|++.+.||+|+||.||+|.+ +++.+|||.+......... ...+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 46888999999999999999987 6789999998654332211 13466899999999999999999987543
Q ss_pred -----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 209 -----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 209 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
..+++|+||+.+ +|...+... ...+++..+..++.||+.||+|||+++++|+||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999965 777777643 3468999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC------------ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG------------MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~------------~~~~~gt~~y~APE~~~ 310 (315)
+++....... .+...+++.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 9975432211 12235678899999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=198.90 Aligned_cols=168 Identities=29% Similarity=0.431 Sum_probs=140.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|+||.||+|.. ++..+++|.+........ ...+++.+|+.+++.++|+|++++++++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 4566778999999999999987 677899999865322221 12356789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+||+. ++|.+++... ...+++..++.++.|++.||.|||+++++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 5888877643 34588899999999999999999999999999999999999999999999999875432
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
.....+++.|+|||.+.
T Consensus 168 -~~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 168 -ANXFVGTPYWMAPEVIL 184 (308)
T ss_pred -cccccCCccccCHHHHh
Confidence 23456889999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=218.76 Aligned_cols=178 Identities=26% Similarity=0.492 Sum_probs=147.0
Q ss_pred Ccccccccc-ccccccceeecccCceEEEEE--CC----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee
Q 021253 127 YDEWTIDLR-KLNMGTAFAQGAFGKLYRGTY--NG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 127 ~~~~~i~~~-~~~~~~~iG~G~~G~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 199 (315)
.-...|..+ +.+..++||+|+||.||+|.| .+ -+||||++........ -+++++|+.+|.++.|||++
T Consensus 687 ~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-----s~e~LdeAl~masldHpnl~ 761 (1177)
T KOG1025|consen 687 LALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-----SIELLDEALRMASLDHPNLL 761 (1177)
T ss_pred hhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-----hHHHHHHHHHHhcCCCchHH
Confidence 334445443 556778999999999999988 33 3899999976554432 25789999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
+++++|.... +-||++||+.|.|.++++..+ ..+-.+..+.|+.||++||.|||+++++||||.++||||..-..+||
T Consensus 762 RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 762 RLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEE
Confidence 9999998876 679999999999999998754 45778888999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCC-CccCCCC--CccccccCcccc
Q 021253 280 ADFGVARIEVQTE-GMTPETG--TYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~-~~~~~~g--t~~y~APE~~~~ 311 (315)
.|||+|+....+. .+....| .+.|||=|.+..
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~ 874 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI 874 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhc
Confidence 9999999765433 3443333 389999888764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=195.21 Aligned_cols=173 Identities=27% Similarity=0.421 Sum_probs=138.4
Q ss_pred ccccccceeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
+|.+.+.||+|+||.||++.+. +..+++|+++......... ....++.+|+.+++.++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 3677899999999999999873 4456677665433211111 112356689999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++. +.+||+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999988742 3356899999999999999999999999999999999999974 67999999999865332
Q ss_pred C-CccCCCCCccccccCccc
Q 021253 292 E-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~ 310 (315)
. ......|++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred cccccCCCCCcCccCHHHHc
Confidence 2 223456889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-27 Score=200.32 Aligned_cols=171 Identities=28% Similarity=0.443 Sum_probs=139.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeC---CCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
+.-..|+-..+||+|.||+||+|+. +++.||+|++-- ...-+ ....+|+.+|..|+|+|++.++..|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-------italreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-------ITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-------HHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 3445677778999999999999976 677888886532 11111 24569999999999999999998874
Q ss_pred e--------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEE
Q 021253 207 K--------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 207 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vk 278 (315)
. ...+|+|+.+|+. +|.-+|... ...++...+.+++.+++.||.|+|+..|+|||+||+|+||+.+|.+|
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence 3 3358999999987 999998754 35689999999999999999999999999999999999999999999
Q ss_pred EeeecceeeeecC-----CCccCCCCCccccccCcccc
Q 021253 279 IADFGVARIEVQT-----EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 279 l~DFG~a~~~~~~-----~~~~~~~gt~~y~APE~~~~ 311 (315)
|+|||+||.+... +.++..+-|..|.+||.+-+
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 9999999865432 33566677999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-27 Score=218.80 Aligned_cols=170 Identities=28% Similarity=0.465 Sum_probs=148.0
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
+..+|++...+|+|.+|.||++++ +++..|+|+++......- +-+++|+-+++.++|||||.+++.+...+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 456888899999999999999987 788999999987555442 457799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
++|+||||.+|+|.++-+-. .++++.+...++...+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 87 lwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999999987643 4588888889999999999999999999999999999999999999999998754322
Q ss_pred -CCCccCCCCCccccccCccc
Q 021253 291 -TEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 -~~~~~~~~gt~~y~APE~~~ 310 (315)
-.....+.||++|||||+..
T Consensus 165 ti~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhhhcccCCccccchhHHH
Confidence 22356678999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=203.55 Aligned_cols=172 Identities=26% Similarity=0.410 Sum_probs=142.6
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|++. ++|++.+.||+|++|.||+|.+ +++.||||++........ ..+.+.+|+.+++.++|||++++++++.
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 34443 5688999999999999999988 578999998865432221 2356778999999999999999998876
Q ss_pred eCCE------EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.... .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence 6544 89999999 6699998864 358999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||++..... ......+++.|+|||.+..
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 161 DFGLARHTDD--EMTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccccccccc--cccCCcccccccCHHHHhC
Confidence 9999975432 2344568899999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=189.19 Aligned_cols=150 Identities=17% Similarity=0.241 Sum_probs=126.9
Q ss_pred cccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCH
Q 021253 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSV 223 (315)
Q Consensus 146 G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 223 (315)
|.+|.||++.+ +++.||+|.+.... .+.+|...+....||||+++++++......++||||+++++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 89999999987 78899999986532 223455555666799999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccc
Q 021253 224 RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303 (315)
Q Consensus 224 ~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y 303 (315)
.+++.+. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 9998764 34899999999999999999999999999999999999999999999999987654322 2334567789
Q ss_pred cccCccc
Q 021253 304 MAPSAGS 310 (315)
Q Consensus 304 ~APE~~~ 310 (315)
+|||.+.
T Consensus 149 ~aPE~~~ 155 (237)
T cd05576 149 CAPEVGG 155 (237)
T ss_pred cCCcccC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=201.09 Aligned_cols=166 Identities=23% Similarity=0.316 Sum_probs=135.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
.+|.+.+.||.|+||.||+|.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 5788899999999999999987 67899999986544321 25678999999999999999999776543
Q ss_pred ----------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcE
Q 021253 209 ----------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSI 277 (315)
Q Consensus 209 ----------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~v 277 (315)
...|+|+||++ ++|.+++.. ..+++..++.++.||+.||+|||+.|++||||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35799999997 488888754 35889999999999999999999999999999999999974 5678
Q ss_pred EEeeecceeeeecCC----CccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQTE----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~~----~~~~~~gt~~y~APE~~~ 310 (315)
||+|||+++...... ......++..|+|||.+.
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHh
Confidence 999999997543211 112235788999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=186.35 Aligned_cols=164 Identities=18% Similarity=0.395 Sum_probs=142.5
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR- 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 208 (315)
..++|++.+++|+|.+++||.|.. +.++++||++++.. .+.+.+|+.||..|+ ||||++++++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 457899999999999999999985 78899999997522 357889999999997 99999999998764
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeeccee
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVAR 286 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a~ 286 (315)
....+|+||+++.+...+... ++...+..++.+++.||.|||+.||+|||+||.|++||.. -.++|+|+|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 467899999999887777643 6777788999999999999999999999999999999964 479999999999
Q ss_pred eeecCCCccCCCCCccccccCccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+.-....+...+.+.+|--||.+.
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLV 205 (338)
T ss_pred hcCCCceeeeeeehhhcCCchhee
Confidence 877777777778888999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=209.27 Aligned_cols=177 Identities=26% Similarity=0.372 Sum_probs=138.0
Q ss_pred CCcccccc------ccccccccceeecccC-ceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 126 NYDEWTID------LRKLNMGTAFAQGAFG-KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 126 ~~~~~~i~------~~~~~~~~~iG~G~~G-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
..+.|... ..-+.-.+.+|.|+-| .||+|.+.++.||||.+-... .....+|+..|+.- .|||
T Consensus 494 ~~~~~~~~~~~v~~k~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---------~~~A~rEi~lL~eSD~H~N 564 (903)
T KOG1027|consen 494 SLDGPEAGGKVVVGKLFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---------FDFAQREIQLLQESDEHPN 564 (903)
T ss_pred cccccccccceeeeeeeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---------HHHHHHHHHHHHhccCCCc
Confidence 34556554 2334445678999998 589999999999999874322 24567999999887 6999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhh-CCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC--
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-QNR-AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-- 273 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~-~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-- 273 (315)
||++|+.-++++..||+.|.|.. +|.+++... ... .......+..+.|++.||++||+.+||||||||.||||+.
T Consensus 565 viRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 565 VIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred eEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 99999999999999999999965 999999863 111 1111345778899999999999999999999999999976
Q ss_pred -C--CcEEEeeecceeeeecCC----CccCCCCCccccccCccccc
Q 021253 274 -D--KSIKIADFGVARIEVQTE----GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 274 -~--~~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~APE~~~~~ 312 (315)
+ .+++|+|||+++....+. ......||.+|+|||++..-
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc
Confidence 3 478999999998654322 13445799999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=211.99 Aligned_cols=172 Identities=17% Similarity=0.222 Sum_probs=121.5
Q ss_pred cccccccccccccceeecccCceEEEEE--C----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--N----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
.+.+..++|++.+.||+|+||.||+|++ + +..||||.+...... +.+..| .+....+.++..++
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--------e~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--------EIWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--------HHHHHH--HHHhhchhhHHHHH
Confidence 4556778999999999999999999987 4 679999987542211 011111 11111122222211
Q ss_pred EE------EEeCCEEEEEEeccCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 021253 203 GA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNR------------------AVPLKLAVKQALDVARGMAYVHGLG 258 (315)
Q Consensus 203 ~~------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (315)
.. +......++|+||+.+++|.+++...... ......+..++.||+.||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24556789999999999999998753210 0122345678999999999999999
Q ss_pred CccCCCCCCCEEEcC-CCcEEEeeecceeeeecCC--CccCCCCCccccccCccc
Q 021253 259 FIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 259 iiHrDlkp~NIli~~-~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|+||||||+|||++. ++.+||+|||+|+...... ......+|+.|+|||.+.
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 999999999999985 5799999999998543221 234567899999999653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=180.28 Aligned_cols=143 Identities=21% Similarity=0.189 Sum_probs=109.9
Q ss_pred ccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHHhCCCCCe
Q 021253 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~ni 198 (315)
...||+|+||.||+|.. +|+.||||+++........ .........+|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 7899999999865322111 01112344569999999988776
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCCEEEcCCCcE
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NIli~~~~~v 277 (315)
.....+.... .+|||||++++++...... ...++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 4443332222 2799999998777655322 24588899999999999999999 799999999999999998 5789
Q ss_pred EEeeecceee
Q 021253 278 KIADFGVARI 287 (315)
Q Consensus 278 kl~DFG~a~~ 287 (315)
+|+|||+|..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=221.12 Aligned_cols=158 Identities=20% Similarity=0.370 Sum_probs=131.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
..+...+.||+|+||.||+|.+ ++..||||.++..... ...|++.+++++|||||+++++|.+....|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 3455667899999999999986 6889999988643321 124688899999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH---GLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
+||||+++|+|.++++. +++..+.+++.||+.||+||| +.+|+||||||+||+++.++..++. |+.+....
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999953 788899999999999999999 6699999999999999998888875 66665322
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+|+.|+|||++..
T Consensus 834 ~---~~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 834 T---DTKCFISSAYVAPETRET 852 (968)
T ss_pred c---CCCccccccccCcccccC
Confidence 1 223468899999998763
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=176.11 Aligned_cols=144 Identities=19% Similarity=0.159 Sum_probs=112.5
Q ss_pred ccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHHhCCCCCe
Q 021253 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~ni 198 (315)
.+.||+|++|.||+|.. +|+.||||+++........ .......+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 6999999999875322111 01112345689999999999987
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCc
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS 276 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~ 276 (315)
.....+.... .++||||++++++... +.. ..++...+..++.|++.+|.+||+ .||+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 5544444333 3899999998755443 332 347788889999999999999999 9999999999999999 899
Q ss_pred EEEeeecceeeee
Q 021253 277 IKIADFGVARIEV 289 (315)
Q Consensus 277 vkl~DFG~a~~~~ 289 (315)
++|+|||+|+...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=177.27 Aligned_cols=167 Identities=32% Similarity=0.563 Sum_probs=143.4
Q ss_pred cccccceeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
|.+.+.||+|++|.||++... ++.+++|.+...... ...+.+.+|+..++.++|+|++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 356688999999999999883 689999999764433 1246888999999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC--
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-- 292 (315)
+|++++++|.+++..... .+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999976432 17888999999999999999999999999999999999999999999999998754432
Q ss_pred CccCCCCCccccccCcc
Q 021253 293 GMTPETGTYRWMAPSAG 309 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~ 309 (315)
......++..|++||.+
T Consensus 155 ~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 155 LLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccceeccCCcCCHhHh
Confidence 23445788999999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=189.19 Aligned_cols=169 Identities=24% Similarity=0.337 Sum_probs=143.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--C----CeeeEEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--L----NIVRFIGAC 205 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~ 205 (315)
..+|.+...+|+|.||+|.++.+ .+..||||+++.. ..+.+...-|+++|+++.+ | .++++.+++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 47888999999999999999977 5679999998642 2334567789999999943 2 378889999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-----------
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----------- 274 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~----------- 274 (315)
.-.++++||+|.+ |-++.+++..+...+++...+..|+.|++++++|||+.+++|-||||+|||+.+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 6699999998888889999999999999999999999999999999999998432
Q ss_pred ---------CcEEEeeecceeeeecCCCccCCCCCccccccCccccc
Q 021253 275 ---------KSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 275 ---------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
-.|||+|||.|+..... .+..+.|..|.|||+|-+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheecc
Confidence 25899999999875433 3667889999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=169.99 Aligned_cols=163 Identities=29% Similarity=0.577 Sum_probs=140.2
Q ss_pred eeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Q 021253 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 143 iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
||+|.+|.||++... ++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999985 8999999997654432 235788999999999999999999999998999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeecceeeeecCC-CccCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE-GMTPET 298 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~~~~~~-~~~~~~ 298 (315)
++|.+++.... ..++...++.++.+++.+|++||+.+++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999997642 35788999999999999999999999999999999999998 8999999999998654332 133356
Q ss_pred CCccccccCcccc
Q 021253 299 GTYRWMAPSAGSI 311 (315)
Q Consensus 299 gt~~y~APE~~~~ 311 (315)
+...|++||.+..
T Consensus 155 ~~~~~~~pe~~~~ 167 (215)
T cd00180 155 GTPAYMAPEVLLG 167 (215)
T ss_pred CCCCccChhHhcc
Confidence 7899999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=176.09 Aligned_cols=157 Identities=33% Similarity=0.517 Sum_probs=136.8
Q ss_pred ccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHH
Q 021253 147 AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224 (315)
Q Consensus 147 ~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 224 (315)
+||.||+|.+ +++.+++|++........ .+.+.+|++.+++++|++++++++.+......++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999998 468999999976544321 357889999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCcccc
Q 021253 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304 (315)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~ 304 (315)
+++..... ++...++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.............+++.|+
T Consensus 76 ~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 99876432 7889999999999999999999999999999999999999999999999998765543455667899999
Q ss_pred ccCccc
Q 021253 305 APSAGS 310 (315)
Q Consensus 305 APE~~~ 310 (315)
|||.+.
T Consensus 154 ~pE~~~ 159 (244)
T smart00220 154 APEVLL 159 (244)
T ss_pred CHHHHc
Confidence 999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=183.52 Aligned_cols=168 Identities=26% Similarity=0.319 Sum_probs=139.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
..+|.-++.++.|+- .|.-+-+ .+++||+|.+..+..+... -++..+|..++..+.|+|+++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 355666788888888 6666654 7899999988766433221 246789999999999999999999996543
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 210 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..|+|||+|.. +|.+.+.. .+.-.....+..|++.|++|||+.||+||||||+||++..++.+||.|||+|
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 57999999955 88888763 2666778899999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+....+-.++..+.|-+|.|||++-+
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred cccCcccccCchhheeeccCchheec
Confidence 97655546788889999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=190.57 Aligned_cols=162 Identities=20% Similarity=0.321 Sum_probs=135.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (315)
..+|.+...+|.|+|+.|-++.. +++..++|++.+.... ..+|+.++... .||||+++.+++.+...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----------cccccchhhhhcCCCcceeecceecCCce
Confidence 45777788899999999999976 7788999999776322 23667565555 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE-cCCCcEEEeeecceeeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEV 289 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli-~~~~~vkl~DFG~a~~~~ 289 (315)
.|+|||.+.|+-|.+.+.... .....+..|+++|+.++.|||++|+|||||||+|||+ +..++++|+|||.++...
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999999999888886543 2236777899999999999999999999999999999 689999999999998654
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
.. ....+-|..|.|||++.
T Consensus 468 ~~--~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLA 486 (612)
T ss_pred hh--hcccchhhcccChhhhc
Confidence 43 33446789999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=172.44 Aligned_cols=165 Identities=27% Similarity=0.382 Sum_probs=136.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (315)
-.|+++++||+|.||+++.|+. ++++||||.-......+ ++..|.+..+.|. .+.|...|-+.++..+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc--------hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3678999999999999999975 99999999764433332 5678888888884 78999999999999888
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-----CcEEEeeeccee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADFGVAR 286 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-----~~vkl~DFG~a~ 286 (315)
.||+|++ |-+|.++.. ..+..++.+++..+|.|++.-++|+|++.+|.|||||+|+||..- ..+.|+|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999999 778988875 456779999999999999999999999999999999999999754 369999999998
Q ss_pred eeecCC--------CccCCCCCccccccCcc
Q 021253 287 IEVQTE--------GMTPETGTYRWMAPSAG 309 (315)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~APE~~ 309 (315)
...+.. ...+..||.+||+-...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTH 208 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTH 208 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeecc
Confidence 643321 13455799999985443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=164.87 Aligned_cols=140 Identities=19% Similarity=0.346 Sum_probs=117.4
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
+.||+|++|.||+|.+.+..|++|+......... .......++.+|+.++..+.|++++....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999999999998764433221 11222356889999999999999887777777777789999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+|++|.+++.... . ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986431 2 6788999999999999999999999999999999 78999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=163.88 Aligned_cols=136 Identities=16% Similarity=0.286 Sum_probs=104.7
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCC---E-
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-----KHLNIVRFIGACRKRM---V- 210 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~- 210 (315)
.+.||+|+||.||.-..+... +||++....... .+.+.+|+.+++.+ .||||+++|+++.++. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 368999999999962224334 689886533221 25689999999999 5799999999998873 3
Q ss_pred EEEEEec--cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCCEEEcCC----CcEEEee-e
Q 021253 211 WCIVTEY--AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM-AYVHGLGFIHRDLKSDNLLISAD----KSIKIAD-F 282 (315)
Q Consensus 211 ~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL-~yLH~~~iiHrDlkp~NIli~~~----~~vkl~D-F 282 (315)
+.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+| |
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 5579999999653 25554 35677888777 99999999999999999999743 3899999 6
Q ss_pred cceee
Q 021253 283 GVARI 287 (315)
Q Consensus 283 G~a~~ 287 (315)
|.+..
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 65544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=175.34 Aligned_cols=170 Identities=21% Similarity=0.341 Sum_probs=135.3
Q ss_pred ccccccceeecccCceEEEEECC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC----CCeeeEEEEE-Ee
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYNG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----LNIVRFIGAC-RK 207 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~ 207 (315)
+|++.++||+|+||.||.+.... ..+|+|+......... ..+..|..++..+.. +++..+++.. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 78889999999999999999743 4689888765432221 145678888888762 6889999998 47
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-----CcEEEeee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADF 282 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-----~~vkl~DF 282 (315)
...-|+||+.+ |.+|.++......+.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77789999988 7899998876666789999999999999999999999999999999999999865 46999999
Q ss_pred ccee--eeecCC------C---ccCCCCCccccccCccccc
Q 021253 283 GVAR--IEVQTE------G---MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 283 G~a~--~~~~~~------~---~~~~~gt~~y~APE~~~~~ 312 (315)
|+|+ ...... . .....||.+|+++.+..++
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~ 212 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI 212 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC
Confidence 9998 321111 0 1234599999999876644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=161.68 Aligned_cols=167 Identities=27% Similarity=0.384 Sum_probs=135.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 208 (315)
|-..+|+++++||+|+||.+|.|.. .|+.||||+-......+ ++..|..+...|++ ..|..+..+..+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 4557899999999999999999987 89999999876544433 57789999999974 6788888888888
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---CcEEEeeecce
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVA 285 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~---~~vkl~DFG~a 285 (315)
..-.+||+.+ |-+|.+++.- ....++.++++..+-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 8889999999 6688888753 34568999999999999999999999999999999999999743 47899999999
Q ss_pred eeeecCC--------CccCCCCCccccccCc
Q 021253 286 RIEVQTE--------GMTPETGTYRWMAPSA 308 (315)
Q Consensus 286 ~~~~~~~--------~~~~~~gt~~y~APE~ 308 (315)
+...+.. .....+||.+|.+--+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinA 192 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINA 192 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhh
Confidence 8543321 1233468888876443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=163.88 Aligned_cols=144 Identities=10% Similarity=0.153 Sum_probs=116.6
Q ss_pred ccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (315)
..+|+..+.+|.|+||.||++..++..+|||++++.....+..... ...+.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3678899999999999999987778899999997655443322111 12368999999999999999998886543
Q ss_pred ------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 209 ------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 209 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
...+|||||++|.+|.++.. +++ ....+++.+|..||+.|++|||++|+||+++.++ ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35799999999999988742 222 2356899999999999999999999999999988 999999
Q ss_pred cceeee
Q 021253 283 GVARIE 288 (315)
Q Consensus 283 G~a~~~ 288 (315)
|..+..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=161.66 Aligned_cols=137 Identities=19% Similarity=0.317 Sum_probs=111.0
Q ss_pred ceeecccCceEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Q 021253 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 219 (315)
.||+|+||.||+|.+.+..|++|.......... .......++.+|+.++..++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 379999999999999999999999765432211 122224678899999999998876655555555666789999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 220 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
|++|.+++.... . .++.+++.+|.+||+.+++|+|++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999875421 0 7789999999999999999999999999999 889999999999764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-22 Score=168.41 Aligned_cols=165 Identities=21% Similarity=0.346 Sum_probs=131.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE-EEeCCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA-CRKRMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~ 210 (315)
+.|.+.+.||+|.||.+-++.+ ..+.+++|.+.++... ..+|.+|...--.| .|.||+.-|++ |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4677889999999999999998 5678999988654332 36788998776666 58999988875 567788
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc--CCCcEEEeeecceeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIE 288 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~--~~~~vkl~DFG~a~~~ 288 (315)
+.+++||++.|+|.+-+.. ..+.+.-..+++.|++.|++|+|+.++||||||.+||||- +..++||||||+.+..
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 8999999999999887754 3477888899999999999999999999999999999994 3458999999998743
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... .....-+..|.|||...+
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDT 194 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhh
Confidence 221 112234567888887543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=179.83 Aligned_cols=170 Identities=23% Similarity=0.349 Sum_probs=141.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC------CCeeeEEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH------LNIVRFIGAC 205 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 205 (315)
...|.+....|+|-|+.|.+|.+ .+..||||+++.... +-+.=+.|++||++|.. -++++|+..|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-------M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-------MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-------HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 35777778899999999999987 677999999976433 23455689999999963 3799999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeec
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFG 283 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG 283 (315)
...+++|||+|-+. -+|.+.|++.. +-.+....+..++.|++.||..|-.+||+|.||||+||||++. ..+||||||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 99999999999995 59999999764 3357889999999999999999999999999999999999865 478999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.|...... ..++..-+-.|.|||++-+.
T Consensus 583 SA~~~~en-eitPYLVSRFYRaPEIiLG~ 610 (752)
T KOG0670|consen 583 SASFASEN-EITPYLVSRFYRAPEIILGL 610 (752)
T ss_pred cccccccc-cccHHHHHHhccCcceeecC
Confidence 99765444 35555566789999998753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=183.14 Aligned_cols=149 Identities=19% Similarity=0.294 Sum_probs=119.1
Q ss_pred ccccccc---ccccccceeecccCceEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLR---KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~---~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
.|..+.. .|...+.||+|+||.||++.+.+..+++|+......... ......+++.+|+++++.++|++++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 4555443 234578999999999999999877777776433221111 12223467889999999999999988887
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++......++||||+++++|.+++. ....++.+++.+|.+||+.+++||||||+|||+ .++.++|+|||
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 7777667789999999999999885 246788999999999999999999999999999 57899999999
Q ss_pred ceeee
Q 021253 284 VARIE 288 (315)
Q Consensus 284 ~a~~~ 288 (315)
+|+..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-21 Score=173.32 Aligned_cols=139 Identities=24% Similarity=0.381 Sum_probs=123.5
Q ss_pred cccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 208 (315)
+.|....+||+|.|+.||++++ ..+.||+|.+...... .++.+|+++|..+. +.||+.+.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 5677889999999999999975 3568999998764443 46889999999995 89999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeeccee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVAR 286 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~ 286 (315)
+.+.+|+||++.....++... ++...+..++..++.||+++|.+|||||||||.|+|.+. .+.-.|+|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999999999999865 667888999999999999999999999999999999984 5688999999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=164.20 Aligned_cols=146 Identities=18% Similarity=0.213 Sum_probs=111.9
Q ss_pred ccccccceeecccCceEEEE-E--CCeeEEEEEeeCCCCChh------------------HHHHHHHHHHHHHHHHHhCC
Q 021253 136 KLNMGTAFAQGAFGKLYRGT-Y--NGEDVAIKILERPENNPE------------------KAQVMEQQFQQEVMMLATLK 194 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~-~--~~~~vavK~~~~~~~~~~------------------~~~~~~~~~~~E~~~l~~l~ 194 (315)
-|.+.+.||+|++|.||+|. . +++.||||+++....... ........+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999998 3 789999999976432110 01112345678999999997
Q ss_pred CC--CeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCCEEE
Q 021253 195 HL--NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLI 271 (315)
Q Consensus 195 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NIli 271 (315)
+. .++++++. . ..++||||+++.+|...... ........+..++.||+.+|.+||+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455543 2 24899999999888765432 223555667889999999999999999 9999999999999
Q ss_pred cCCCcEEEeeecceeee
Q 021253 272 SADKSIKIADFGVARIE 288 (315)
Q Consensus 272 ~~~~~vkl~DFG~a~~~ 288 (315)
+ ++.++|+|||.|...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999999753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-20 Score=153.77 Aligned_cols=135 Identities=19% Similarity=0.167 Sum_probs=107.4
Q ss_pred cccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEec
Q 021253 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+...|++|.||+||.+...+.+++.+.+.....-... .....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~--~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG--VAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh--HHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4468999999999988888899988877654432111 11236889999999995 5889999886 335899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCCEEEcCCCcEEEeeecceeee
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
++|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||.|||++.++.++|+|||+|...
T Consensus 80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 999998654321 1 1346789999999999999999999 799999999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-19 Score=160.83 Aligned_cols=171 Identities=27% Similarity=0.450 Sum_probs=144.0
Q ss_pred cccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCEEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 215 (315)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 556788999999999999988 8889999876554432 1246789999999999988 7999999998887789999
Q ss_pred eccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceeeeecCC-
Q 021253 216 EYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE- 292 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~~~~~~- 292 (315)
+++.++++.+++..... ..++......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765321 2588899999999999999999999999999999999999888 79999999998543322
Q ss_pred ------CccCCCCCccccccCcccc
Q 021253 293 ------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ------~~~~~~gt~~y~APE~~~~ 311 (315)
......||..|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred cccccccccccccccccCCHHHhcC
Confidence 2356689999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=165.82 Aligned_cols=132 Identities=23% Similarity=0.420 Sum_probs=116.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----C---CCeeeEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----H---LNIVRFIGA 204 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~ 204 (315)
.+|.+.++||-|.|++||++.+ ..+.||+|+.+. ++++.+..+.|+.+|++++ | ..||+|++.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 6888999999999999999987 667999999874 4455677889999999985 2 369999999
Q ss_pred EEe----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCC
Q 021253 205 CRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISAD 274 (315)
Q Consensus 205 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~ 274 (315)
|.. ..++++|+|++ |.+|..++....-+.++...+.+|+.||+.||.|||. +||||-||||+|||+..+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 965 45899999999 7899999998877889999999999999999999996 599999999999999754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=155.07 Aligned_cols=139 Identities=20% Similarity=0.212 Sum_probs=107.6
Q ss_pred cccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHH----------------HHHHHHHHHHHHHHHhCCCC--C
Q 021253 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------QVMEQQFQQEVMMLATLKHL--N 197 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~--n 197 (315)
|.+.+.||+|+||.||++.. +++.||||+++......... ......+.+|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55678999999999999988 78999999987543211100 01123467889999999877 4
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcE
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~v 277 (315)
++..++. ...++||||+++++|..+... .....++.+++.++.++|+.+++||||||+||+++.++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4555542 334899999999998765421 2345788899999999999999999999999999999999
Q ss_pred EEeeecceee
Q 021253 278 KIADFGVARI 287 (315)
Q Consensus 278 kl~DFG~a~~ 287 (315)
+|+|||+|..
T Consensus 165 ~liDfg~~~~ 174 (198)
T cd05144 165 YIIDWPQMVS 174 (198)
T ss_pred EEEECCcccc
Confidence 9999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-18 Score=147.69 Aligned_cols=142 Identities=19% Similarity=0.199 Sum_probs=109.1
Q ss_pred cccee-ecccCceEEEEECCeeEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHHhCCCCCe--eeEEEEEEeCC
Q 021253 140 GTAFA-QGAFGKLYRGTYNGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNI--VRFIGACRKRM 209 (315)
Q Consensus 140 ~~~iG-~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 209 (315)
+..|| .|+.|.||.+...+..++||.+.....-.. .......++.+|+.++..|.|+++ +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35677 899999999999999999999865322000 001123568899999999998875 67777654322
Q ss_pred ----EEEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 210 ----VWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 210 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
..++|||++++ .+|.+++... .++.. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 6898888642 34443 356899999999999999999999999999989999999999
Q ss_pred eeee
Q 021253 285 ARIE 288 (315)
Q Consensus 285 a~~~ 288 (315)
++..
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 9764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=143.72 Aligned_cols=140 Identities=21% Similarity=0.220 Sum_probs=99.5
Q ss_pred ccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHH------------------HHHHHHHHHHHHhCCCCC--e
Q 021253 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVM------------------EQQFQQEVMMLATLKHLN--I 198 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~n--i 198 (315)
++.||+|+||.||+|.. +++.||||+++............ ......|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999988 48999999987644332211110 011245666666665432 4
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCc
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS 276 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~ 276 (315)
.++++.. ..++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+++|+||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4555432 2489999999854322 121110 11 5578899999999999999 9999999999999999 899
Q ss_pred EEEeeecceeee
Q 021253 277 IKIADFGVARIE 288 (315)
Q Consensus 277 vkl~DFG~a~~~ 288 (315)
++|+|||.|+..
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.5e-19 Score=175.68 Aligned_cols=178 Identities=22% Similarity=0.306 Sum_probs=138.3
Q ss_pred CCCCccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCee
Q 021253 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIV 199 (315)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv 199 (315)
+....+.++....|.+.+.||+|+||.||+|+. +++.||+|+-+++..- +|.--.+++.+|+ -+-|.
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---------EfYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---------EFYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---------eeeehHHHHHhhchhhhcchH
Confidence 344556777778999999999999999999987 7899999997765432 2334445566666 12333
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC------
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------ 273 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~------ 273 (315)
.+..+..-.+.-+||+||.+.|+|.+++. ..+.+++..++.++.|++..++.||..+|||+||||+|+||..
T Consensus 758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 758 HISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCC
Confidence 44444444555689999999999999997 4567999999999999999999999999999999999999953
Q ss_pred -CCcEEEeeecceeee---ecCCCccCCCCCccccccCccccc
Q 021253 274 -DKSIKIADFGVARIE---VQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 274 -~~~vkl~DFG~a~~~---~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
...++|+|||.+-.+ .+.......++|-.+-.+|+..+|
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence 346999999998643 333345666788888888888765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=137.49 Aligned_cols=131 Identities=21% Similarity=0.266 Sum_probs=111.5
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+.||+|.++.||++...+..+++|....... ...+.+|+.+++.++| ..+++++.+....+..++++||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46799999999999999888999999865432 2467899999999976 5889999988887888999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+++..+..+ +......++.+++.+|++||.. +++|+|++|+||++++.+.++++|||.++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777554 3455567789999999999985 699999999999999989999999999975
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-18 Score=153.17 Aligned_cols=176 Identities=23% Similarity=0.372 Sum_probs=138.3
Q ss_pred cccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
+..+...+++....+-+|.||+||+|.|. .+.|.+|.++... .+.....++.|..++..+.|||+..+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-----S~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-----SQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-----cHHHHHHHHHHHHHHhcCcCCCccce
Confidence 34455667788888999999999999662 3467777775422 22235688999999999999999999
Q ss_pred EEEEEeC-CEEEEEEeccCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC
Q 021253 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (315)
Q Consensus 202 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~ 274 (315)
.+++.+. ...++++.++.-|+|..||..- ..+.++..+...++.|++.||+|||++++||.||.++|++||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 9998654 5678899999999999999822 12356777788999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeeecCCCccC----CCCCccccccCccc
Q 021253 275 KSIKIADFGVARIEVQTEGMTP----ETGTYRWMAPSAGS 310 (315)
Q Consensus 275 ~~vkl~DFG~a~~~~~~~~~~~----~~gt~~y~APE~~~ 310 (315)
-++||+|=.++|..-+. .+.. .-...+||+||.+.
T Consensus 433 LqVkltDsaLSRDLFP~-DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPG-DYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred eeEEeccchhccccCcc-cccccCCCCCCcccccCHHHHh
Confidence 99999999999853221 1111 12347999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-18 Score=172.14 Aligned_cols=118 Identities=16% Similarity=0.195 Sum_probs=87.3
Q ss_pred hCCC-CCeeeEEEEE-------EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 192 TLKH-LNIVRFIGAC-------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 192 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
.++| +||.++++++ .....+++++|++ +++|.+++... ...+++..++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 5777777776 3334677889988 55999999753 35589999999999999999999999999999
Q ss_pred CCCCCEEEcC-------------------CCcEEEeeecceeeeecCC-----------------CccCCCCCccccccC
Q 021253 264 LKSDNLLISA-------------------DKSIKIADFGVARIEVQTE-----------------GMTPETGTYRWMAPS 307 (315)
Q Consensus 264 lkp~NIli~~-------------------~~~vkl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~APE 307 (315)
|||+||||+. ++.+||+|||+++...... ......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999954 3456666777665321100 001135889999999
Q ss_pred cccc
Q 021253 308 AGSI 311 (315)
Q Consensus 308 ~~~~ 311 (315)
++..
T Consensus 186 ~~~~ 189 (793)
T PLN00181 186 EDNG 189 (793)
T ss_pred hhcc
Confidence 8753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-17 Score=159.74 Aligned_cols=171 Identities=21% Similarity=0.268 Sum_probs=129.3
Q ss_pred ccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
.....+|.|++|.|+.... .....+.|..+......+........+..|..+-.+++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997776654 33334444333110011222222333778888899999999988887777766666669
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC---
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~--- 292 (315)
||+++ +|..++... ..+....+..++.|++.|++|||+.||.|||+|++|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999999764 347788888999999999999999999999999999999999999999999998654222
Q ss_pred --CccCCCCCccccccCcccc
Q 021253 293 --GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 --~~~~~~gt~~y~APE~~~~ 311 (315)
.....+|+..|+|||.+..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred hhhhcCcccCCcCcCcccccc
Confidence 2344679999999998763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-17 Score=142.73 Aligned_cols=173 Identities=32% Similarity=0.524 Sum_probs=142.4
Q ss_pred cccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
-|+..++.+..+|.+...|+.|+|+|.|..+++|+++......... +.|..|.-.|+-+.||||+.+++.|..+..
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ris----rdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARIS----RDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhc----chhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3677888889999999999999999999999999998766655432 578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccC-CCCCCCEEEcCCCcEEEeeecceeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHR-DLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHr-Dlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+.++..||+.|+|+..|....+-.+...++.+++.+|+.||+|||+.. ++-| -|....++||++-+.+|+ ++-+++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee
Confidence 999999999999999999877666788899999999999999999874 4433 688899999999887764 3333332
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
-+..+ ..-.|.||+||.++.
T Consensus 341 fqe~g---r~y~pawmspealqr 360 (448)
T KOG0195|consen 341 FQEVG---RAYSPAWMSPEALQR 360 (448)
T ss_pred eeccc---cccCcccCCHHHHhc
Confidence 22211 234589999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-17 Score=157.57 Aligned_cols=159 Identities=23% Similarity=0.357 Sum_probs=133.1
Q ss_pred eeecccCceEEEE-----ECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q 021253 143 FAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 143 iG~G~~G~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 216 (315)
+|+|.||.|+.+. +.+..+|+|++++........ .....|..++..++ ||.++++...++.+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 6899999998763 366788999987765443322 14456778888887 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccC
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~ 296 (315)
|..+|.|...+.+. ..+.+.....+...++.+++++|+.+++|||+|++||+++.+|++|+.|||+++.....+..
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99999998888654 34667777788889999999999999999999999999999999999999999865444322
Q ss_pred CCCCccccccCccc
Q 021253 297 ETGTYRWMAPSAGS 310 (315)
Q Consensus 297 ~~gt~~y~APE~~~ 310 (315)
|||+.|||||++.
T Consensus 154 -cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN 166 (612)
T ss_pred -ccchhhhhhHhhh
Confidence 9999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=143.25 Aligned_cols=144 Identities=19% Similarity=0.266 Sum_probs=99.4
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHH----------------------------HH------HHHHHHH
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QV------MEQQFQQ 185 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~----------------------------~~------~~~~~~~ 185 (315)
+.||.|++|+||+|++ +|+.||||+.++.....-.. .. .+-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6899999999999998 89999999986542111000 00 0113566
Q ss_pred HHHHHHhCC-----CCCeeeEEEEE-EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 021253 186 EVMMLATLK-----HLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR-GMAYVHGLG 258 (315)
Q Consensus 186 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~-gL~yLH~~~ 258 (315)
|+..+.+++ ++++ .+-.++ .-....+|||||++|++|.++....... .. ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCC
Confidence 776666653 3333 222222 1123358999999999999887542211 22 2345555555 478899999
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
++|+|++|.||+++.++.++|+|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=136.66 Aligned_cols=181 Identities=23% Similarity=0.352 Sum_probs=123.6
Q ss_pred cccccccccccccceeecccCceEEEEECC-------------------------------------eeEEEEEeeCCCC
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------------------------------------EDVAIKILERPEN 171 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~-------------------------------------~~vavK~~~~~~~ 171 (315)
.-.+.+++|++++.||+|....||.++... -+.|||.+-.-..
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 344566899999999999999999886410 1345665433222
Q ss_pred ChhHHHHHHHHHHHHHH-------H----------HH----h-CCCCCeeeEEEEEEe----------------------
Q 021253 172 NPEKAQVMEQQFQQEVM-------M----------LA----T-LKHLNIVRFIGACRK---------------------- 207 (315)
Q Consensus 172 ~~~~~~~~~~~~~~E~~-------~----------l~----~-l~h~niv~l~~~~~~---------------------- 207 (315)
.. ......+...+|.. . +. . -+|||||++.++|.+
T Consensus 231 ~s-~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 231 DS-GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred CC-chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 21 12222233333320 0 11 1 369999999887742
Q ss_pred -----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc--CCC--cEE
Q 021253 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIK 278 (315)
Q Consensus 208 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~--~~~--~vk 278 (315)
...+|+||...+. +|.+++-.+. .+.....-++.|+++|+.|||++||.|||+|.+|||+. +++ .+.
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence 3367999998865 9999997642 56667788899999999999999999999999999984 343 678
Q ss_pred Eeeecceeeeec-------CCCccCCCCCccccccCccccccC
Q 021253 279 IADFGVARIEVQ-------TEGMTPETGTYRWMAPSAGSICCG 314 (315)
Q Consensus 279 l~DFG~a~~~~~-------~~~~~~~~gt~~y~APE~~~~~~g 314 (315)
|+|||+|--... .......-|.-.-||||+....-|
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999998742111 001223357788999999886654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=119.09 Aligned_cols=127 Identities=16% Similarity=0.172 Sum_probs=96.3
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEEEEeccC
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAK 219 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 219 (315)
+.|+.|.++.||+++..+..|++|+....... ...+.+|+.+++.+.+.++ ++++.+... ..++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 57889999999999999999999997543321 1235688888888865444 455554432 2479999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-----IHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 220 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i-----iHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
|.++.+.. .. ....+.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98875430 11 12346789999999999885 9999999999999 67899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.2e-15 Score=142.26 Aligned_cols=151 Identities=19% Similarity=0.250 Sum_probs=94.6
Q ss_pred ccccccccceeecccCceEEEEE-C-CeeEEEEEeeCCCCCh----------------------------hHHHHHH---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY-N-GEDVAIKILERPENNP----------------------------EKAQVME--- 180 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~-~-~~~vavK~~~~~~~~~----------------------------~~~~~~~--- 180 (315)
+.+|+. +.||+|++|+||+|++ + |+.||||++++..... +-.....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455666 7999999999999998 4 8999999998642110 0001111
Q ss_pred ---HHHHHHHHHHHhCC----CCCeeeEEEEEEe-CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 021253 181 ---QQFQQEVMMLATLK----HLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252 (315)
Q Consensus 181 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~ 252 (315)
-++.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+++.++..-... ........... +..-+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d~~~la~~~--v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTDMKLLAERG--VEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCCHHHHHHHH--HHHHHH
Confidence 23455555555553 3333333333322 2334799999999999875321111 12222111111 112234
Q ss_pred HHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 021253 253 YVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (315)
Q Consensus 253 yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~~ 288 (315)
.+...|++|+|++|.||+++.++ .++++|||++...
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 45579999999999999999888 9999999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-13 Score=111.14 Aligned_cols=139 Identities=22% Similarity=0.287 Sum_probs=107.1
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeC-CCCChhH-HHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILER-PENNPEK-AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~-~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 218 (315)
..+++|+-+.+|.+.+-+.++++|.-.+ ....++- .....++..+|+.++.+++-..|...+=+..+.+...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999999888877775432 2333332 2233567889999999998666665555666666668999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 219 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
+|..|.+++... ...++..|-.-+.-||..||+|+||.++||++..++ +.++|||++.+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999898753 144567777888999999999999999999998554 9999999998643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-13 Score=113.68 Aligned_cols=140 Identities=14% Similarity=0.143 Sum_probs=99.8
Q ss_pred cceeecccCceEEEEEC--------CeeEEEEEeeCCCCChh--------------------HHHHHHHHHHHHHHHHHh
Q 021253 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPE--------------------KAQVMEQQFQQEVMMLAT 192 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~--------~~~vavK~~~~~~~~~~--------------------~~~~~~~~~~~E~~~l~~ 192 (315)
..||.|--+.||.|... +..+|||+++.....-. ..........+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999753 37999999874322111 011112233489999999
Q ss_pred CCC--CCeeeEEEEEEeCCEEEEEEeccCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCC
Q 021253 193 LKH--LNIVRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDN 268 (315)
Q Consensus 193 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~N 268 (315)
+.. -++++++++ ..-+|||||+.+..+.. .++. ..++......+..+++.+|..| |+.|++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 466677765 23479999997654422 2322 2345556677789999999998 89999999999999
Q ss_pred EEEcCCCcEEEeeecceeee
Q 021253 269 LLISADKSIKIADFGVARIE 288 (315)
Q Consensus 269 Ili~~~~~vkl~DFG~a~~~ 288 (315)
||+. ++.++|+|||.|...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 578999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.7e-15 Score=146.62 Aligned_cols=171 Identities=19% Similarity=0.226 Sum_probs=129.3
Q ss_pred ccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 215 (315)
++...+.||++.|=+|.+|++..-.|+||++-+......- ... .+..+|++ ....++||++.+.-+-..+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL-~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL-RPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc-hHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6777899999999999999986556999998765433221 111 22334455 66779999999988877777789999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee---cCC
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV---QTE 292 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~---~~~ 292 (315)
+|+.. +|.+.+..+. -+...+..-|+.|++.||..+|..||.|+|||.+||||+.-+-+.|+||..-+... +.+
T Consensus 101 qyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99965 9999997653 35666677789999999999999999999999999999999999999998665321 111
Q ss_pred -Cc----cCCCCCccccccCccccc
Q 021253 293 -GM----TPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 293 -~~----~~~~gt~~y~APE~~~~~ 312 (315)
.+ .+...-..|+|||.|-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhcc
Confidence 11 112233689999998653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=121.62 Aligned_cols=170 Identities=19% Similarity=0.330 Sum_probs=105.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC----------CCeeeEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----------LNIVRFI 202 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~ 202 (315)
+.+..++.||.|+++.||++++ +++++|+|+.......... ..+++.+|.-....+.+ -.++..+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~---~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASAN---EYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTT---HHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchH---HHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 4667788999999999999999 6799999998766633222 23556666655444332 1222222
Q ss_pred EEEEe---------C---C-----EEEEEEeccCCCCHHHHHH---hhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 021253 203 GACRK---------R---M-----VWCIVTEYAKGGSVRQFLT---RRQNR--AVPLKLAVKQALDVARGMAYVHGLGFI 260 (315)
Q Consensus 203 ~~~~~---------~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~--~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (315)
+.... . . ..+++|+-+. ++|.+++. ..... .+.......+..|++..+++||+.|++
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 32211 1 1 2367888884 48888754 22222 122233345568999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+||+|+|++++.+|.++|.||+........ ......+..|.+||...
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELES 215 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce--eeccCCCcccCChhhhh
Confidence 9999999999999999999999987643322 12133457788898653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.8e-13 Score=107.53 Aligned_cols=149 Identities=22% Similarity=0.291 Sum_probs=111.8
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCC-CCChh-HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERP-ENNPE-KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~-~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
...|-+|+-+.|+++.+.|+...||.-... ...+. ..+...++..+|++++.+++--.|.-..-++.+...-.|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 467889999999999999999888854222 22222 2334467888999999998755554444444444444789999
Q ss_pred cCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cEEEeeecceeee
Q 021253 218 AKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIE 288 (315)
Q Consensus 218 ~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~vkl~DFG~a~~~ 288 (315)
++| -++.+++................+.+|-+.+.-||..+|||+||..+||++..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 977 4788888766544444444578899999999999999999999999999997655 4589999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-12 Score=106.44 Aligned_cols=78 Identities=22% Similarity=0.217 Sum_probs=67.2
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCC
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 300 (315)
|+|.+++... ...+++..++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999764 346999999999999999999999998 999999999999999 9999865432 23689
Q ss_pred ccccccCcccc
Q 021253 301 YRWMAPSAGSI 311 (315)
Q Consensus 301 ~~y~APE~~~~ 311 (315)
+.|||||++..
T Consensus 68 ~~y~aPE~~~~ 78 (176)
T smart00750 68 PYFMAPEVIQG 78 (176)
T ss_pred ccccChHHhcC
Confidence 99999998854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-11 Score=106.69 Aligned_cols=142 Identities=16% Similarity=0.108 Sum_probs=100.4
Q ss_pred cccCceEEEEECCeeEEEEEeeCCCCCh-hHH----HHHHHHHHHHHHHHHhCCCCCe--eeEEEEEEe-----CCEEEE
Q 021253 146 GAFGKLYRGTYNGEDVAIKILERPENNP-EKA----QVMEQQFQQEVMMLATLKHLNI--VRFIGACRK-----RMVWCI 213 (315)
Q Consensus 146 G~~G~Vy~~~~~~~~vavK~~~~~~~~~-~~~----~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~l 213 (315)
-....|++..+.|+.+.||......... -+. ..-...+.+|...+..|...+| +.++++... ...-+|
T Consensus 33 ~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 33 LEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344577888899999999774322110 000 0001146788888888854333 344444432 234689
Q ss_pred EEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-------CCcEEEeeecce
Q 021253 214 VTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------DKSIKIADFGVA 285 (315)
Q Consensus 214 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-------~~~vkl~DFG~a 285 (315)
|||++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. +..+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999886 8999986433344566677889999999999999999999999999999975 468999999988
Q ss_pred ee
Q 021253 286 RI 287 (315)
Q Consensus 286 ~~ 287 (315)
+.
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 64
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-11 Score=106.77 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=102.7
Q ss_pred cceeecccCceEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCC---EEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM---VWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv 214 (315)
+.|+.|..+.||+++..+ +.+++|+........ ....+.+|+.+++.+++ ..+.+++.+..... ..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 568899999999998855 899999976543311 12367899999999976 34577777776542 56899
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (315)
|||++|.++.+.+.. ..++......++.+++..|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999887665421 224555556666667777766663
Q ss_pred ------------------CCCccCCCCCCCEEEcC--CCcEEEeeecceee
Q 021253 257 ------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARI 287 (315)
Q Consensus 257 ------------------~~iiHrDlkp~NIli~~--~~~vkl~DFG~a~~ 287 (315)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.2e-13 Score=133.37 Aligned_cols=174 Identities=21% Similarity=0.327 Sum_probs=137.7
Q ss_pred ccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 209 (315)
...|.+.+.||+|+|+.|-.... ....+|+|.+....... ...+....|..+-+.+. |+|++.+++......
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~----~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE----DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc----chhhhcCccccccccccccccccccCCccCCCc
Confidence 35667778899999999887755 44567777765544211 11245667888888887 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCEEEcCCC-cEEEeeecceee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~ 287 (315)
..++++++..++++.+.+........+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999998884222224566677888999999999999 99999999999999999999 999999999986
Q ss_pred eec-CC---CccCCCC-CccccccCcccc
Q 021253 288 EVQ-TE---GMTPETG-TYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~-~~---~~~~~~g-t~~y~APE~~~~ 311 (315)
... .. .....+| ++.|+|||....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc
Confidence 544 21 1234578 999999998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-12 Score=129.87 Aligned_cols=132 Identities=27% Similarity=0.434 Sum_probs=93.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|+.++.|..|++|.||..++ +.+++|+|+-+. . .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhhc--cccccCCccee-------------
Confidence 5788889999999999999977 477889854321 1 11111 33333444433
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec--
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-- 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~-- 290 (315)
|+....++.. ..++-. ++.+++|||+.+|+|||+||+|.+|..-|++|+.|||+++....
T Consensus 136 --------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 5666666543 223322 26799999999999999999999999999999999999874210
Q ss_pred --------------CCCccCCCCCccccccCcccc
Q 021253 291 --------------TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 --------------~~~~~~~~gt~~y~APE~~~~ 311 (315)
.-.....||||.|.|||++-.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 001244589999999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-11 Score=101.01 Aligned_cols=128 Identities=22% Similarity=0.290 Sum_probs=83.1
Q ss_pred eEEEEE-CCeeEEEEEeeCCCCCh--------------------hHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEEe
Q 021253 151 LYRGTY-NGEDVAIKILERPENNP--------------------EKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRK 207 (315)
Q Consensus 151 Vy~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~ 207 (315)
||.|.. ++..+|||+.+.....- ...........+|.+.|.++... ++++++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 899987 78899999987432211 11122346688999999999866 566776552
Q ss_pred CCEEEEEEeccC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 208 RMVWCIVTEYAK--GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY-VHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 208 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y-LH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
.. .|||||++ |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ~~--~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 RN--VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp TT--EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred CC--EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 33 69999998 65565444321 1123345566777775555 579999999999999999876 999999999
Q ss_pred eee
Q 021253 285 ARI 287 (315)
Q Consensus 285 a~~ 287 (315)
|..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 974
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.3e-12 Score=118.12 Aligned_cols=122 Identities=28% Similarity=0.437 Sum_probs=102.1
Q ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCCC
Q 021253 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-IHRDLKSDN 268 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i-iHrDlkp~N 268 (315)
|+.+.|.|+.+++|.+.+....++|++|+..|+|.+.+... ...+.+.-...++.+|+.||.|||...| .|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35788999999999999999999999999999999999863 4557777788889999999999998765 999999999
Q ss_pred EEEcCCCcEEEeeecceeeeecC---CCccCCCCCccccccCccccc
Q 021253 269 LLISADKSIKIADFGVARIEVQT---EGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 269 Ili~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~APE~~~~~ 312 (315)
++++....+||+|||+..+.... .......-...|.|||.+...
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 99999999999999998765421 112222344789999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.4e-12 Score=117.49 Aligned_cols=99 Identities=29% Similarity=0.476 Sum_probs=85.6
Q ss_pred EEEEEEeccCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+||.|++|+..+|.+++..+ .....+......++.|++.+++| ++.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 579999999999999999743 33456777889999999999999 99999999999999999999999999998765
Q ss_pred ecCC-------CccCCCCCccccccCcccc
Q 021253 289 VQTE-------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~-------~~~~~~gt~~y~APE~~~~ 311 (315)
.... ..+...||..||+||.+.+
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 5444 4567789999999998874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=93.63 Aligned_cols=106 Identities=21% Similarity=0.296 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHhCCCCC--eeeEEEEEEeC----CEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021253 181 QQFQQEVMMLATLKHLN--IVRFIGACRKR----MVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (315)
Q Consensus 181 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (315)
.+..+|...+..|.... +++.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 46778888887775433 34555655442 2458999999884 79999876332 5566678889999999999
Q ss_pred HHhCCCccCCCCCCCEEEcCCC---cEEEeeecceeee
Q 021253 254 VHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIE 288 (315)
Q Consensus 254 LH~~~iiHrDlkp~NIli~~~~---~vkl~DFG~a~~~ 288 (315)
||++||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=94.18 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=100.9
Q ss_pred ccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhH----------------HHHHHHHHHHHHHHHHhCCCC--Ce
Q 021253 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK----------------AQVMEQQFQQEVMMLATLKHL--NI 198 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~--ni 198 (315)
.++..||.|--+.||.|.. .+.++|||.-+....+-.+ .........+|.++|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678899999999999988 6999999976533211110 012234577899999999654 67
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEE
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vk 278 (315)
++.+++- .-.+|||+++|-.|...-- .....-.++..|++-+.-+-..|+||+|+++=||+++++|.+.
T Consensus 174 P~P~~~n----RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 174 PKPIAWN----RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCccccc----cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 7777653 3479999999966654421 1222344555666666666689999999999999999999999
Q ss_pred Eeeecceee
Q 021253 279 IADFGVARI 287 (315)
Q Consensus 279 l~DFG~a~~ 287 (315)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-10 Score=106.60 Aligned_cols=174 Identities=19% Similarity=0.238 Sum_probs=134.1
Q ss_pred cccccccceee--cccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q 021253 135 RKLNMGTAFAQ--GAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (315)
Q Consensus 135 ~~~~~~~~iG~--G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 207 (315)
..+...+.+|. |.+|.||.+.. .+..+|+|.-+.....+... ..=.+|+..-+.+ .|++.++.+..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~----~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS----KRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc----ccccchhhcccccCccccccccCccccc
Confidence 44566678999 99999998865 56788988754333321111 1223666666666 49999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADF 282 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~----gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DF 282 (315)
.+..|+-+|++. .+|.++.... ...++...++....+... ||.++|+.+++|-|+||+||++..+ ..+++.||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 999999999994 6888887654 344788889999999999 9999999999999999999999998 89999999
Q ss_pred cceeeeecCCC-c-----cCCCCCccccccCccccccC
Q 021253 283 GVARIEVQTEG-M-----TPETGTYRWMAPSAGSICCG 314 (315)
Q Consensus 283 G~a~~~~~~~~-~-----~~~~gt~~y~APE~~~~~~g 314 (315)
|+...+.+..- . ....|...|++||.....++
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~ 305 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT 305 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccc
Confidence 99886554331 1 11257789999999887665
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.1e-09 Score=101.98 Aligned_cols=118 Identities=15% Similarity=0.317 Sum_probs=100.2
Q ss_pred CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCC
Q 021253 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236 (315)
Q Consensus 157 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 236 (315)
.+.+|.|..++.... +. .+...+.+..|+.++||+|+++++.+...+..|||+|.+. .|..++.+..
T Consensus 36 ~~~~vsVF~~~~~~~--~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----- 102 (690)
T ss_pred cCCceEEEEEeCCCc--hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence 677899998876554 11 2456788899999999999999999999999999999984 7888887642
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 237 LKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 237 ~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+.--+.||+.||.||| +.+++|++|.-+.|+|+..|..||.+|.++..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence 4555667889999999998 66899999999999999999999999998854
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.6e-09 Score=87.40 Aligned_cols=143 Identities=12% Similarity=0.098 Sum_probs=101.9
Q ss_pred eecccCceEEEEECCeeEEEEEeeC-CCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEEe----CCEEEEEEe
Q 021253 144 AQGAFGKLYRGTYNGEDVAIKILER-PENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRK----RMVWCIVTE 216 (315)
Q Consensus 144 G~G~~G~Vy~~~~~~~~vavK~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----~~~~~lv~e 216 (315)
+.|+-+-|++....|..+-+|.-.. -...-. ...-+..|.+|...+..|...+ +++....... .-.-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r-~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR-YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCccccccc-CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 4577888999988888888886541 000000 0001246889999999886433 4444422111 124689999
Q ss_pred ccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc--EEEeeecceee
Q 021253 217 YAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (315)
Q Consensus 217 ~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~--vkl~DFG~a~~ 287 (315)
-+.+ -+|.+++....-.+.+......++.+|+..+.-||+.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8864 48988886644345677777899999999999999999999999999999986676 99999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-08 Score=98.14 Aligned_cols=144 Identities=18% Similarity=0.245 Sum_probs=94.2
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHH----------------------------HH------HHHHHHH
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QV------MEQQFQQ 185 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~----------------------------~~------~~~~~~~ 185 (315)
+.|+.++-|+||+|++ +|+.||||+.++.-...-.. .. .+-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999 59999999987543221110 00 1123556
Q ss_pred HHHHHHhCC-----CCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 021253 186 EVMMLATLK-----HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG-MAYVHGLGF 259 (315)
Q Consensus 186 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~g-L~yLH~~~i 259 (315)
|+.-+.+++ .|++.-.-=++.-...-.|+|||++|-.+.++..... ...+.+. ++..++.+ +..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence 666666553 2333211112221223379999999999999854332 2344333 23333322 445556899
Q ss_pred ccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 260 IHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 260 iHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+|.|..|.||+++.+|.+.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.2e-08 Score=82.17 Aligned_cols=142 Identities=16% Similarity=0.234 Sum_probs=92.1
Q ss_pred cccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHHhCCC---CCeeeEEEEEEe-
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKH---LNIVRFIGACRK- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h---~niv~l~~~~~~- 207 (315)
.+|+..+.+-......|.+-..++..+++|..+......++.-.. -....+++..+.+++. .....++.+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 456666677777777788888899999999876544332221110 0112344444444432 223333333322
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
....+++|||++|..|.++.. +++. ++..|...+.-||+.|+.|+|..|.|++++.+ .++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 234568999999988877642 2222 34566778999999999999999999999854 59999998
Q ss_pred ceee
Q 021253 284 VARI 287 (315)
Q Consensus 284 ~a~~ 287 (315)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.84 E-value=6e-08 Score=84.16 Aligned_cols=136 Identities=13% Similarity=0.136 Sum_probs=85.0
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEEeCCEEEEEEecc
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 218 (315)
.+||+|..+.||+. .+..+++|...... .. ....+|.++++.+..-. +.+.+++........+|||++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~-------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK-------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH-------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 57899999999984 35567888875422 11 24578999998886433 467788888888889999999
Q ss_pred CCCC-HHHHH--------------Hh----hC---CCCCCHHHHHH-HHH----------HHHH-HHHHHHh----CCCc
Q 021253 219 KGGS-VRQFL--------------TR----RQ---NRAVPLKLAVK-QAL----------DVAR-GMAYVHG----LGFI 260 (315)
Q Consensus 219 ~~g~-L~~~l--------------~~----~~---~~~~~~~~~~~-i~~----------qi~~-gL~yLH~----~~ii 260 (315)
+|.. +...+ .+ -. ....+...... +-. .+.. ..++|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9863 21111 11 00 01111111110 000 1111 1222321 2478
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
|+|+.|.||+++.++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.7e-08 Score=83.74 Aligned_cols=139 Identities=20% Similarity=0.198 Sum_probs=94.7
Q ss_pred ceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHH------------------HHHHHHHHHHHHHHhCC--CCCeee
Q 021253 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQ------------------VMEQQFQQEVMMLATLK--HLNIVR 200 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~--h~niv~ 200 (315)
.|.+|--+.||+|.. ++..+|||+++.....-.+.. ....-...|..-|+++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 566777778999875 789999999976544332211 11123446777777774 334455
Q ss_pred EEEEEEeCCEEEEEEeccCCCC-HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEE
Q 021253 201 FIGACRKRMVWCIVTEYAKGGS-VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vk 278 (315)
.+.+.. -.|||||+.... -.-.|+ .-.++...+..+..+++..+.-|-. .++||+||+.=|||+. ++.+.
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 555433 268999995531 111111 2223333577778888899988876 8999999999999999 88999
Q ss_pred Eeeecceeee
Q 021253 279 IADFGVARIE 288 (315)
Q Consensus 279 l~DFG~a~~~ 288 (315)
|+||+.|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-07 Score=89.44 Aligned_cols=137 Identities=17% Similarity=0.259 Sum_probs=107.2
Q ss_pred CceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEEEEeccCC-C
Q 021253 149 GKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKG-G 221 (315)
Q Consensus 149 G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g 221 (315)
...|+++. +|..|++|.++-...... .....-++.++++.|+|+|++.+++.. +..+++|++|.++ .
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 46788876 889999999843322211 122355778999999999999998863 4578999999976 4
Q ss_pred CHHHHHHhh-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 222 SVRQFLTRR-------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 222 ~L~~~l~~~-------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+|.++.... .+...++..+|.++.|+..||.++|+.|+..+-|.|.+||++.+.+++|+..|...+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 777765432 1234678999999999999999999999999999999999998889999988887765
Q ss_pred ecC
Q 021253 289 VQT 291 (315)
Q Consensus 289 ~~~ 291 (315)
..+
T Consensus 444 ~~d 446 (655)
T KOG3741|consen 444 QED 446 (655)
T ss_pred cCC
Confidence 444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.2e-08 Score=88.85 Aligned_cols=121 Identities=26% Similarity=0.399 Sum_probs=91.6
Q ss_pred HHhCCCCCeeeEEEEEEeC-----CEEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q 021253 190 LATLKHLNIVRFIGACRKR-----MVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG--FI 260 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~--ii 260 (315)
+-.+-|.|||+++.++.+. ....+++|||+.|+|.++|++.+ ...+......+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4456789999999998654 45788999999999999998643 346788888999999999999999985 99
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeee-----cCCCccCCCCCccccccCccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEV-----QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~-----~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+++..+-|++..+|-+|+.--....... .........+.++|.|||...
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence 99999999999999999984322221110 111122334668899998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.3e-08 Score=96.48 Aligned_cols=147 Identities=22% Similarity=0.236 Sum_probs=116.3
Q ss_pred ccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
.-++..+..||.|.|+.|+.... ++..+++|-+.......... ..-..|+.+...+ .|.+++.++..|....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 35788889999999999998765 56688888776544333221 1223555555555 5889999999888888
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeeccee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVAR 286 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a~ 286 (315)
..||-.||++++++.....- ...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.||+.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 88999999999988776632 2346777789999999999999999999999999999999876 788999999886
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-07 Score=76.48 Aligned_cols=135 Identities=21% Similarity=0.306 Sum_probs=96.5
Q ss_pred ccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee-eEEEEEEeCCEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVWC 212 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~ 212 (315)
....+..+.|++|.+|.||.+.|.+..+|+|+-+.+.. ...+..|+++|..+.-.++- ++|.+..+ +
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--------r~~l~kEakiLeil~g~~~~p~vy~yg~~----~ 88 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--------RRNLEKEAKILEILAGEGVTPEVYFYGED----F 88 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc--------hhhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence 34556778899999999999999999999998765433 24678999999999876653 55555443 4
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCCEEEcCCCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK-SDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk-p~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
+.|||+.|-+|.+..... ..+. ...+++.---|-..||-|..|. |...++..++.+.|+||.-|++..
T Consensus 89 i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 569999998888776431 2222 3345555444566789998885 444444456699999999998543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.3e-07 Score=86.59 Aligned_cols=142 Identities=19% Similarity=0.311 Sum_probs=91.6
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHH-------------------------HHH------HHHHHHHHH
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA-------------------------QVM------EQQFQQEVM 188 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~-------------------------~~~------~~~~~~E~~ 188 (315)
+.||.-+.|+||+|+. +|+.||||+.++.-...... .+. +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999998 88999999987543222100 001 123555554
Q ss_pred HHHhC----CCCC------eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 021253 189 MLATL----KHLN------IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG-MAYVHGL 257 (315)
Q Consensus 189 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~g-L~yLH~~ 257 (315)
-..++ +|-+ |+++|..+... -.|+||||+|..+.+.-.-.. ..++... ++..+.++ ++.|=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~-~gi~~~~---i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDK-RGISPHD---ILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcc--eEEEEEecCCccCCCHHHHHH-cCCCHHH---HHHHHHHHHHHHHHhc
Confidence 44433 3444 44444444333 379999999988877643222 2244443 33333333 2334467
Q ss_pred CCccCCCCCCCEEEcC----CCcEEEeeecceeee
Q 021253 258 GFIHRDLKSDNLLISA----DKSIKIADFGVARIE 288 (315)
Q Consensus 258 ~iiHrDlkp~NIli~~----~~~vkl~DFG~a~~~ 288 (315)
|++|.|-.|.||++.. ++.+.+.|||+.+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 8999999999999984 668999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.8e-07 Score=77.61 Aligned_cols=137 Identities=16% Similarity=0.134 Sum_probs=85.4
Q ss_pred ceeeccc-CceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEeccC
Q 021253 142 AFAQGAF-GKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAK 219 (315)
Q Consensus 142 ~iG~G~~-G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 219 (315)
.|..|.. ..||+....+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 4555666 6799998877788889875432 124557888887774 3446677887776666789999999
Q ss_pred CCCHHHHHH----------------hh---CC--CCCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 021253 220 GGSVRQFLT----------------RR---QN--RAVPLK--LAVKQAL--------------------DVARGMAYVH- 255 (315)
Q Consensus 220 ~g~L~~~l~----------------~~---~~--~~~~~~--~~~~i~~--------------------qi~~gL~yLH- 255 (315)
|.+|..... +. .. ...... ....... .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 987764321 00 00 011100 0000000 0111122221
Q ss_pred ------hCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 256 ------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 256 ------~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...++|+|+.|.|||++.++.+.|+||+.|.+
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22489999999999999887889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-06 Score=73.73 Aligned_cols=131 Identities=19% Similarity=0.331 Sum_probs=95.0
Q ss_pred cccccccceeeccc-CceEEEEECCeeEEEEEeeCC---CC--C----h------hHHHHHHHHHHHHHHHHHhCC---C
Q 021253 135 RKLNMGTAFAQGAF-GKLYRGTYNGEDVAIKILERP---EN--N----P------EKAQVMEQQFQQEVMMLATLK---H 195 (315)
Q Consensus 135 ~~~~~~~~iG~G~~-G~Vy~~~~~~~~vavK~~~~~---~~--~----~------~~~~~~~~~~~~E~~~l~~l~---h 195 (315)
.++++++.||.|.- |.||+++..|+.+|+|+.+.- .. . . ........-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78899999999999 999999999999999993311 00 0 0 001123456888998888775 4
Q ss_pred CCe--eeEEEEEEeC------------------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021253 196 LNI--VRFIGACRKR------------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255 (315)
Q Consensus 196 ~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (315)
..+ |+.+|+..-. ..+.||.||++... .+. .+-+.+|.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence 455 8999987221 24678888886633 122 333567778899999
Q ss_pred hCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 256 GLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 256 ~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3488999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.6e-06 Score=73.33 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=83.9
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEEe---CCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRK---RMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~ 215 (315)
+.|+.|..+.||+.+..+..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 57899999999999997789999997542 1124677888888887533 35667765433 34579999
Q ss_pred eccCCCCHHH----------------HHHh---h--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 021253 216 EYAKGGSVRQ----------------FLTR---R--QNRAVPLKL---------AVKQ------------ALDVAR-GMA 252 (315)
Q Consensus 216 e~~~~g~L~~----------------~l~~---~--~~~~~~~~~---------~~~i------------~~qi~~-gL~ 252 (315)
+++++..+.. .+.. . ......... .... ...+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 1111 1 011111100 0000 011222 333
Q ss_pred HHHh-------CCCccCCCCCCCEEEc-CCCcEEEeeecceeee
Q 021253 253 YVHG-------LGFIHRDLKSDNLLIS-ADKSIKIADFGVARIE 288 (315)
Q Consensus 253 yLH~-------~~iiHrDlkp~NIli~-~~~~vkl~DFG~a~~~ 288 (315)
.+++ ..++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3332 3599999999999999 6677789999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.3e-06 Score=85.86 Aligned_cols=77 Identities=13% Similarity=0.198 Sum_probs=55.4
Q ss_pred cceeecccCceEEEEECC----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCe--eeEEEEEEeC---CE
Q 021253 141 TAFAQGAFGKLYRGTYNG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI--VRFIGACRKR---MV 210 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~ 210 (315)
+.++.|.+..+|+.+..+ ..+++|+......... ...+.+|..+++.+. |+++ ++++.+|.+. ..
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 678899999999988743 4677776543222111 135779999999995 6654 7888888764 35
Q ss_pred EEEEEeccCCCC
Q 021253 211 WCIVTEYAKGGS 222 (315)
Q Consensus 211 ~~lv~e~~~~g~ 222 (315)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.4e-06 Score=70.97 Aligned_cols=100 Identities=22% Similarity=0.310 Sum_probs=79.6
Q ss_pred HHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 021253 184 QQEVMMLATLKH-LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHG---LG 258 (315)
Q Consensus 184 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~ 258 (315)
..|.-+++.+++ +++++++|+|.. ++|+||...+++...... .+-...+|..+.++|.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 699999999954 679999987766432000 001236899999999999999999997 34
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+.-.|++|+|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77889999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.1e-05 Score=64.92 Aligned_cols=139 Identities=17% Similarity=0.277 Sum_probs=94.4
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhH----------HHHHHHHHHHHHHHHHhCC------CCCeeeEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK----------AQVMEQQFQQEVMMLATLK------HLNIVRFIGA 204 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~~~E~~~l~~l~------h~niv~l~~~ 204 (315)
..||+|+.-.||.--.+ ....||+.......... .....++..+|+.....+. +.+|.++||+
T Consensus 7 ~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 57999999988864333 34578888765500000 0011245667776666665 7889999999
Q ss_pred EEeCCEEEEEEeccCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---
Q 021253 205 CRKRMVWCIVTEYAKG------GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--- 275 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~--- 275 (315)
.+.+.-..+|+|.+.+ -+|.+++++. .++. . ....+-+-.+||-+.+|+.+|++|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999888999998753 3577888542 2444 2 233334556788999999999999999996432
Q ss_pred -cEEEee-ecceee
Q 021253 276 -SIKIAD-FGVARI 287 (315)
Q Consensus 276 -~vkl~D-FG~a~~ 287 (315)
.+.|+| ||....
T Consensus 159 ~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 159 FRLVLIDGLGEKEL 172 (199)
T ss_pred eEEEEEeCCCCccc
Confidence 588888 776554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=69.71 Aligned_cols=30 Identities=30% Similarity=0.555 Sum_probs=26.1
Q ss_pred CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 258 ~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.++|+|+.+.||+++.++..-|+||+.|..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998766667999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.3e-05 Score=71.30 Aligned_cols=163 Identities=18% Similarity=0.225 Sum_probs=108.6
Q ss_pred ccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE-------EeCC
Q 021253 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC-------RKRM 209 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-------~~~~ 209 (315)
..++.||+|+-+.+|-.-.-+-.| -|+++.+...... +-+..|... .||-+-.-+.+- ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchhhchh-heeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 356889999999999654433344 4888776554322 112222222 455332211111 1223
Q ss_pred EEEEEEeccCCC-CHHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 210 VWCIVTEYAKGG-SVRQFLTR----RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 210 ~~~lv~e~~~~g-~L~~~l~~----~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
.+-+.|..+.+- .+..++.. +.-....|..+++.+..++.+.+-||..|.+-+|+.++|+|+++++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 467888888764 33333321 1122357788899999999999999999999999999999999999999998665
Q ss_pred eeeeecCCCccCCCCCccccccCccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
-.+...+......+|...|++||.-.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhc
Confidence 55544555566678999999999754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.4e-05 Score=68.01 Aligned_cols=76 Identities=16% Similarity=0.120 Sum_probs=56.5
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEEe---CCEEEE
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRK---RMVWCI 213 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~l 213 (315)
.+.||.|..+.||+....+..+.+|..+... .. ..+..|+..|+.+.. -.++++++++.. .+..+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS-TP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc-cc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 4679999999999998755567788854311 11 367899999988853 367888888754 356799
Q ss_pred EEeccCCCCH
Q 021253 214 VTEYAKGGSV 223 (315)
Q Consensus 214 v~e~~~~g~L 223 (315)
|||++++.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.4e-05 Score=69.54 Aligned_cols=139 Identities=19% Similarity=0.200 Sum_probs=84.1
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEE------EEeCCEE
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGA------CRKRMVW 211 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~ 211 (315)
.+.|..|....+|+....+..+++|+... ... ..+..|+.++..+.+.. +++++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 35677788889999887777899998754 111 24556777777774322 4444432 2334566
Q ss_pred EEEEeccCCCCHHH-----------HHH---hh-CC---C-----CCCHHHHH----------HHHHHHHHHHHHHHh--
Q 021253 212 CIVTEYAKGGSVRQ-----------FLT---RR-QN---R-----AVPLKLAV----------KQALDVARGMAYVHG-- 256 (315)
Q Consensus 212 ~lv~e~~~~g~L~~-----------~l~---~~-~~---~-----~~~~~~~~----------~i~~qi~~gL~yLH~-- 256 (315)
++|++|++|..+.. .+. .. .. . ...+.... .....+...+.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 111 00 00 0 00110000 011122334455543
Q ss_pred -----CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 -----LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 -----~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3699999999999999887789999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.5e-06 Score=83.55 Aligned_cols=168 Identities=20% Similarity=0.216 Sum_probs=114.3
Q ss_pred CCCCCCCCccccccccccccccceeecccCceEEEEECCe-eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-
Q 021253 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN- 197 (315)
Q Consensus 120 ~~~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n- 197 (315)
..+.+....+|.-.+. .+++++++++++.+...+ ....+.+... ....-++++|.+++|||
T Consensus 233 qpp~lkDk~kws~~fh------~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~ 295 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFH------NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNP 295 (829)
T ss_pred CCCcccCCccchHHHH------HHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCC
Confidence 3444556666765444 457899999999876433 3334544321 12346788999999999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~ 276 (315)
.+..++-+..++..+++++++.++ +...... ...-.+........+..-++++++||+.--+|+| ||+.. ++.
T Consensus 296 ~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~ 369 (829)
T KOG0576|consen 296 VVRYLEDYDGEDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEE 369 (829)
T ss_pred cccccccCCcccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccc
Confidence 778888888888899999999876 2111110 0111123333444556667889999998778998 77765 478
Q ss_pred EEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 277 IKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.|..||+.+..........+..+|+.|+|||+..
T Consensus 370 ~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~ 403 (829)
T KOG0576|consen 370 VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQ 403 (829)
T ss_pred cccccccCCcccCcccccccCCCCCCCCCchhhc
Confidence 9999999987655544456678999999999654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.5e-07 Score=90.12 Aligned_cols=151 Identities=19% Similarity=0.241 Sum_probs=108.3
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+......+.+.+.+-+|.++.++.+.- .+...++|+......-.... .+....+-.++...++|-++...-.+..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~---~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND---YESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc---ccccCCccCccccCCCCceecccCCCCC
Confidence 556677888888999999999998765 34444555443322111100 1223344444445566777766665556
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
....+++++|+.+++|...++... .....-+......+..+++|||...+.|+|++|.|+++..++..++.||+..
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence 667899999999999999987643 2444455666778889999999999999999999999999999999999843
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.2e-05 Score=67.51 Aligned_cols=135 Identities=18% Similarity=0.198 Sum_probs=77.9
Q ss_pred ceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEEEEeccCC
Q 021253 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 220 (315)
.+..|-...+|+.+.++..+++|.......... -...+|..+++.+....+ .+++.... + ++|+||++|
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~--~--~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE--H--WLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC--C--EEEEEeccC
Confidence 345688889999988888899997543221110 023578888888754323 34444432 2 689999998
Q ss_pred CCHHH--------------HHHhhC-----CCCCCHH-HHHHHHHH---------HHHHHHHHHh--------CCCccCC
Q 021253 221 GSVRQ--------------FLTRRQ-----NRAVPLK-LAVKQALD---------VARGMAYVHG--------LGFIHRD 263 (315)
Q Consensus 221 g~L~~--------------~l~~~~-----~~~~~~~-~~~~i~~q---------i~~gL~yLH~--------~~iiHrD 263 (315)
..+.. .+.+-. ...+... ....+..+ +...++.+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66531 111111 1111111 11111111 1111222221 2489999
Q ss_pred CCCCCEEEcCCCcEEEeeecceee
Q 021253 264 LKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+.|.||+++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0002 Score=64.96 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=81.9
Q ss_pred cccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEE------EeCCE
Q 021253 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGAC------RKRMV 210 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~ 210 (315)
..+.++.|....+|+...++..+++|+.+.... . ..+..|..++..|... .+++++... ...+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCCC-H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 346677888889999877666788898754221 1 2334566666666322 234444321 22456
Q ss_pred EEEEEeccCCCCHH-----------HHH---Hhh-CC--CC----CCHH---HHH------------HHHHHHHHHHHHH
Q 021253 211 WCIVTEYAKGGSVR-----------QFL---TRR-QN--RA----VPLK---LAV------------KQALDVARGMAYV 254 (315)
Q Consensus 211 ~~lv~e~~~~g~L~-----------~~l---~~~-~~--~~----~~~~---~~~------------~i~~qi~~gL~yL 254 (315)
.++++||++|..+. ..+ +.. .. .. .... ... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 111 110 00 00 0000 000 0011233445555
Q ss_pred Hh-------CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 255 HG-------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 255 H~-------~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888779999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=2e-05 Score=70.77 Aligned_cols=137 Identities=18% Similarity=0.251 Sum_probs=95.5
Q ss_pred ccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChh--------------HHHHH--HHHHHHHHHHHHhCCC--CCe
Q 021253 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE--------------KAQVM--EQQFQQEVMMLATLKH--LNI 198 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~--------------~~~~~--~~~~~~E~~~l~~l~h--~ni 198 (315)
.++..||-|.-+.||.+-+ .|++.++|+-+....+-. ..+.. +-...+|...|+.|.- --+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4678999999999999987 689999996542211110 01112 1235678888888842 234
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEE
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vk 278 (315)
++.+++. .-++|||++.+.+|.+.-.-. . .-.+...+..-+--|-.+|+||+|..-=||+|++++.++
T Consensus 175 PkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 175 PKPIDHN----RHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCccccc----ceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 5555543 348999999998876654221 1 123344555556678899999999999999999999999
Q ss_pred Eeeeccee
Q 021253 279 IADFGVAR 286 (315)
Q Consensus 279 l~DFG~a~ 286 (315)
++||..+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99999764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00018 Score=62.52 Aligned_cols=72 Identities=13% Similarity=0.220 Sum_probs=46.2
Q ss_pred cceeecccCceEEEEEC---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCCEEEEEEe
Q 021253 141 TAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 216 (315)
+.|..|-...+|+.... +..|++|+........ -...+|..+++.+.... .+++++.+. . .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 45677888899999875 5788999775432111 12236888888875333 344444332 2 47999
Q ss_pred ccCCCCH
Q 021253 217 YAKGGSV 223 (315)
Q Consensus 217 ~~~~g~L 223 (315)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.001 Score=60.63 Aligned_cols=138 Identities=17% Similarity=0.210 Sum_probs=75.8
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEE------EEEeCCEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIG------ACRKRMVWC 212 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~ 212 (315)
+.|..|....+|+.+.++..+++|++.. ... +.+..|..++..|... .+.+.+. +....+..+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~--~~~-------~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFER--LTA-------EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEecc--CCh-------HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 5677788889999987666889998752 111 1233444555444211 1333332 122345678
Q ss_pred EEEeccCCCCHH-----------HHHHh---h-CC------C--CCCH-HHHHH------------HH-HHHHHHHHHHH
Q 021253 213 IVTEYAKGGSVR-----------QFLTR---R-QN------R--AVPL-KLAVK------------QA-LDVARGMAYVH 255 (315)
Q Consensus 213 lv~e~~~~g~L~-----------~~l~~---~-~~------~--~~~~-~~~~~------------i~-~qi~~gL~yLH 255 (315)
+++||++|..+. +.+.+ . .. . .+.+ ..... .+ ..+...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 11111 0 00 0 0001 11000 01 11111223332
Q ss_pred -------hCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 256 -------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 256 -------~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23799999999999999766668999998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00033 Score=65.68 Aligned_cols=80 Identities=11% Similarity=-0.012 Sum_probs=51.9
Q ss_pred cceeecccCceEEEEECC--eeEEEEEeeCCCCCh-hHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNG--EDVAIKILERPENNP-EKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~--~~vavK~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 214 (315)
+.||.|.+..||++...+ +.|+||.-.+..... +.-....+++..|.+.|+.+. ...++++|.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 578999999999999843 489999854211100 000011245667788877763 346777888754 335799
Q ss_pred EeccCCCC
Q 021253 215 TEYAKGGS 222 (315)
Q Consensus 215 ~e~~~~g~ 222 (315)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00047 Score=62.32 Aligned_cols=73 Identities=12% Similarity=0.258 Sum_probs=46.0
Q ss_pred cceeecccCceEEEEEC--------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEE
Q 021253 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVW 211 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~ 211 (315)
+.+..|-...+|+.+.. ++.+++|+........ ....+|..+++.+....+ .++++++..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL-------IDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce-------echHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 34556777789998764 4789999976533221 134577777777753333 455555532
Q ss_pred EEEEeccCCCCHH
Q 021253 212 CIVTEYAKGGSVR 224 (315)
Q Consensus 212 ~lv~e~~~~g~L~ 224 (315)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3689999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=60.77 Aligned_cols=141 Identities=19% Similarity=0.166 Sum_probs=92.8
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChh--------------------HHHHHHHHHHHHHHHHHhCCCCCee
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE--------------------KAQVMEQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~h~niv 199 (315)
..|..|--+-||.|+- +|..+|||+++.....-. ...+..--...|++-|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4466677778999987 888999999874322110 0112223345678888888765543
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCEEEcCCCcEE
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIli~~~~~vk 278 (315)
..--..... -.|||+|+-. +=+-... .+...++...+...-.|++.-|.-|- .+++||.||.-=|+|+- +|.+.
T Consensus 230 ~PePIlLk~--hVLVM~FlGr-dgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 230 CPEPILLKN--HVLVMEFLGR-DGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCceeeec--ceEeeeeccC-CCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 322222222 2689999953 2211111 12345676777777788888888775 56999999999999985 78999
Q ss_pred Eeeeccee
Q 021253 279 IADFGVAR 286 (315)
Q Consensus 279 l~DFG~a~ 286 (315)
|+|.+.+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00091 Score=60.71 Aligned_cols=143 Identities=17% Similarity=0.249 Sum_probs=81.9
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCC--EEEEEEe
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM--VWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e 216 (315)
+.+..|..-.+|....++++++++ ........+. .....+|..+++.+.- .-+...++.|.+.. ..|.||+
T Consensus 31 ~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 31 EEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeccCCcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 344445555677777778888888 3211121111 2455678888877743 23445667776665 6799999
Q ss_pred ccCCCCH------------------HHHHHhhC------CCC------CCHHHHHHHHH--------------HHHHHHH
Q 021253 217 YAKGGSV------------------RQFLTRRQ------NRA------VPLKLAVKQAL--------------DVARGMA 252 (315)
Q Consensus 217 ~~~~g~L------------------~~~l~~~~------~~~------~~~~~~~~i~~--------------qi~~gL~ 252 (315)
|++|..+ .++|.... ... ........+.. ....-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9998322 12221110 000 00000011111 1122244
Q ss_pred HHHhC--------CCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 253 YVHGL--------GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 253 yLH~~--------~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+|+.+ .++|+|+.+.||+++.++-+-|+||+++.+-
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 45432 4899999999999999888999999999753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.012 Score=53.22 Aligned_cols=30 Identities=30% Similarity=0.590 Sum_probs=26.1
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.007 Score=56.83 Aligned_cols=79 Identities=11% Similarity=-0.011 Sum_probs=51.1
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEEE
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 215 (315)
.+.||.|..-.||+....+..++||.-.......... .....+-..|+..|+.+. ...++++|.++.+.. +++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--LIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--EEEE
Confidence 3678999999999998877789999765221110000 000123334566665553 357888999988554 6889
Q ss_pred eccCC
Q 021253 216 EYAKG 220 (315)
Q Consensus 216 e~~~~ 220 (315)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0063 Score=56.24 Aligned_cols=136 Identities=15% Similarity=0.242 Sum_probs=77.7
Q ss_pred cceeecccCceEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCI 213 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 213 (315)
+.|-.|-.-.+|+..+. ++.|++|+........ .+ -.+|..+++.+...++ .++++.+.. . .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~------id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF------FD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee------ec-hHHHHHHHHHHHHcCCCCceEEEECC-c---e
Confidence 34555778899999762 2578999875532111 11 2478888888754444 355565532 2 5
Q ss_pred EEeccCCCCHHHH--------------HH---hhC--CC--CCCHHHHHHHHHH-----------------HHHHHHHH-
Q 021253 214 VTEYAKGGSVRQF--------------LT---RRQ--NR--AVPLKLAVKQALD-----------------VARGMAYV- 254 (315)
Q Consensus 214 v~e~~~~g~L~~~--------------l~---~~~--~~--~~~~~~~~~i~~q-----------------i~~gL~yL- 254 (315)
|.||+++.+|... +. ... .. .........+..+ +...++.|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7899987665321 11 000 00 1111222222211 11112222
Q ss_pred ---H----hCCCccCCCCCCCEEEcC-CCcEEEeeecceee
Q 021253 255 ---H----GLGFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (315)
Q Consensus 255 ---H----~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~ 287 (315)
. ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46899999999975
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0035 Score=57.84 Aligned_cols=77 Identities=10% Similarity=-0.055 Sum_probs=45.4
Q ss_pred ceeecccCceEEEEECC--eeEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEEeCCEEEEEE
Q 021253 142 AFAQGAFGKLYRGTYNG--EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 142 ~iG~G~~G~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 215 (315)
.||.|...-||++...+ +.|+||.-.+.... .+.-....++...|...|+... -| .++++|.+-.+. ..+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~--~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEM--AVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcccc--ceehH
Confidence 47889999999998754 58999975321110 0000011234556777776653 23 455666554433 36899
Q ss_pred eccCC
Q 021253 216 EYAKG 220 (315)
Q Consensus 216 e~~~~ 220 (315)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.00054 Score=66.91 Aligned_cols=68 Identities=19% Similarity=0.320 Sum_probs=51.3
Q ss_pred HHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-----CccC-----CCCCccccccCcccc
Q 021253 244 ALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTP-----ETGTYRWMAPSAGSI 311 (315)
Q Consensus 244 ~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-----~~~~-----~~gt~~y~APE~~~~ 311 (315)
+.+++.||.|+|.. ++||+.|.|++|.++..+..||+.|+++....... .+.. ..-...|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34555899999965 89999999999999999999999999886433211 1111 123478999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0036 Score=56.02 Aligned_cols=30 Identities=27% Similarity=0.523 Sum_probs=25.7
Q ss_pred CCccCCCCCCCEEEcCCCc-EEEeeecceee
Q 021253 258 GFIHRDLKSDNLLISADKS-IKIADFGVARI 287 (315)
Q Consensus 258 ~iiHrDlkp~NIli~~~~~-vkl~DFG~a~~ 287 (315)
.++|+|+.|.|||++.++. .-|+||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0088 Score=54.92 Aligned_cols=136 Identities=14% Similarity=0.205 Sum_probs=76.3
Q ss_pred cceeecccCceEEEEECC-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 214 (315)
+.|..|-.-.+|+....+ ..|++|+........ . .-.+|..+++.+...++ +++++++. .. +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~------I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV------I-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE------e-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence 344447777899987643 378899876532211 0 12478888888865444 35565553 22 58
Q ss_pred EeccCCCCHHH--------------HHHhhCCCC------C-CHHHHHHHHHH----------------------HHHHH
Q 021253 215 TEYAKGGSVRQ--------------FLTRRQNRA------V-PLKLAVKQALD----------------------VARGM 251 (315)
Q Consensus 215 ~e~~~~g~L~~--------------~l~~~~~~~------~-~~~~~~~i~~q----------------------i~~gL 251 (315)
.+|+++..|.. .+++-.... . .+....++..+ +..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99998765421 111110100 1 11222222211 11112
Q ss_pred HH----HHhC----CCccCCCCCCCEEEcC-CCcEEEeeecceee
Q 021253 252 AY----VHGL----GFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (315)
Q Consensus 252 ~y----LH~~----~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~ 287 (315)
.. +... -+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 2122 2799999999999975 57899999999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0046 Score=57.79 Aligned_cols=78 Identities=12% Similarity=0.064 Sum_probs=48.3
Q ss_pred cceeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEEeCCEEEEEE
Q 021253 141 TAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 215 (315)
+.||.|.-.-||++... ++.|+||.-.+.-...+.-....++...|...|+... -| .++++|.+-.+. ..+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~--~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM--NCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH--hhHHH
Confidence 67899999999999974 6789999643211111110111345667777777653 33 466666654443 36789
Q ss_pred eccCC
Q 021253 216 EYAKG 220 (315)
Q Consensus 216 e~~~~ 220 (315)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0059 Score=54.88 Aligned_cols=74 Identities=16% Similarity=0.190 Sum_probs=48.3
Q ss_pred cccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEEE
Q 021253 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 139 ~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 215 (315)
-.+.++.|....+|+.+.+++.+.||+-..... ..|..|+.-|+.|. .-.+++.+++....+..+|||
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 346788899999999998889999998763221 35778888888883 345778899887776679999
Q ss_pred eccCCC
Q 021253 216 EYAKGG 221 (315)
Q Consensus 216 e~~~~g 221 (315)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.034 Score=50.96 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=78.9
Q ss_pred eeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC------eeeEEE----EEEeCCEEE
Q 021253 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIG----ACRKRMVWC 212 (315)
Q Consensus 143 iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~ 212 (315)
|.+ .-..+|+.+..+..+++|+.+.. ... .++.-|...+..|.-.. +..+=| ........+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~-------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WTR-------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CCH-------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 444 45578999886666699999775 332 24556666666663211 222222 111213678
Q ss_pred EEEeccCCCCHHH------------HH---Hhh-CCC---------CCCHH----H---------HHHHHHHHHHHHHHH
Q 021253 213 IVTEYAKGGSVRQ------------FL---TRR-QNR---------AVPLK----L---------AVKQALDVARGMAYV 254 (315)
Q Consensus 213 lv~e~~~~g~L~~------------~l---~~~-~~~---------~~~~~----~---------~~~i~~qi~~gL~yL 254 (315)
-+.+|++|..+.. ++ ... ++. ...+. . ......++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999877762 11 000 000 11111 0 011223444445555
Q ss_pred Hh--------CC--CccCCCCCCCEEEcCCC-cEEEeeecceee
Q 021253 255 HG--------LG--FIHRDLKSDNLLISADK-SIKIADFGVARI 287 (315)
Q Consensus 255 H~--------~~--iiHrDlkp~NIli~~~~-~vkl~DFG~a~~ 287 (315)
.+ .+ +||+|+.|.||+++.+. .+.++||+.|..
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 43 23 99999999999999877 499999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.09 Score=47.71 Aligned_cols=30 Identities=17% Similarity=0.262 Sum_probs=27.9
Q ss_pred CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 258 ~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+++|+|+.+.|+|++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.012 Score=54.07 Aligned_cols=72 Identities=18% Similarity=0.260 Sum_probs=54.5
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...|++|++- |++|.-.- ...++++..|+.+.+..+.-+... ..=|||+.-.||||+ +|.|.|+||-++|.
T Consensus 299 ~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4567777765 55553321 134667788888877777777755 689999999999999 99999999999995
Q ss_pred e
Q 021253 288 E 288 (315)
Q Consensus 288 ~ 288 (315)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.022 Score=49.18 Aligned_cols=75 Identities=19% Similarity=0.214 Sum_probs=55.3
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.+.-|.--+.|+..+...++.||+-.. .....|..|+.-|..+. .-.+.+.+.+..+....|+|+||
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~~---------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQR---------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecch---------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 4455566666777777778999997532 22356778887776664 45678899999999999999999
Q ss_pred cCCCCHH
Q 021253 218 AKGGSVR 224 (315)
Q Consensus 218 ~~~g~L~ 224 (315)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9986664
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.012 Score=54.78 Aligned_cols=60 Identities=28% Similarity=0.348 Sum_probs=44.6
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCCEEEcC
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDNLLISA 273 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NIli~~ 273 (315)
..++=+|+.|.++..+++... .+++...+++.--+.++--+ --.+++|.|+.|.||++-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 356778999999999987543 55666677776666665543 3568999999999999953
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.084 Score=49.50 Aligned_cols=30 Identities=33% Similarity=0.409 Sum_probs=25.2
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....|.|+-+.||+.+ ++.++++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 3579999999999976 45699999998864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.14 Score=54.10 Aligned_cols=31 Identities=39% Similarity=0.554 Sum_probs=26.1
Q ss_pred CCCccCCCCCCCEEEcCCC--cEE-Eeeecceee
Q 021253 257 LGFIHRDLKSDNLLISADK--SIK-IADFGVARI 287 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~--~vk-l~DFG~a~~ 287 (315)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999775 454 999998853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.27 Score=45.02 Aligned_cols=28 Identities=29% Similarity=0.368 Sum_probs=24.4
Q ss_pred CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 258 ~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 689999999999995 4 588999998864
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.036 Score=49.80 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=25.7
Q ss_pred CccCCCCCCCEEEcCC--C---cEEEeeecceeee
Q 021253 259 FIHRDLKSDNLLISAD--K---SIKIADFGVARIE 288 (315)
Q Consensus 259 iiHrDlkp~NIli~~~--~---~vkl~DFG~a~~~ 288 (315)
++|+|+++.|||+..+ | .++++||-+++..
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g 251 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG 251 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccCC
Confidence 8999999999999654 3 6999999998753
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.033 Score=58.02 Aligned_cols=127 Identities=18% Similarity=0.211 Sum_probs=91.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE----EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 021253 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWC----IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256 (315)
Q Consensus 181 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~ 256 (315)
.....|...+..+.|+|++.++.+..+..... +..|++..-++...+... ...+....+.+..++.+||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 44556777788889999999999986654332 345788888888888764 457888899999999999999999
Q ss_pred CCCccCCCCCC---CEEEcCCCcEEEe--eecceeeeecCCCccCCCCCccccccCcc
Q 021253 257 LGFIHRDLKSD---NLLISADKSIKIA--DFGVARIEVQTEGMTPETGTYRWMAPSAG 309 (315)
Q Consensus 257 ~~iiHrDlkp~---NIli~~~~~vkl~--DFG~a~~~~~~~~~~~~~gt~~y~APE~~ 309 (315)
....|.-|..+ +..++.++.+.+. ||+..+...+........-+..|.|||..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~ 362 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDL 362 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccc
Confidence 97777666555 4555666777777 89888765444333333344556666654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.19 Score=48.02 Aligned_cols=77 Identities=12% Similarity=0.177 Sum_probs=46.1
Q ss_pred cccccccceeecccCceEEEEEC----------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee-eEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIG 203 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~ 203 (315)
+++ -.+.|..|-.-.+|+++.. ++.|.+|+.-.....- . .-.+|..+++.+...+|- ++++
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l------I-dR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL------Y-NPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce------e-CHHHHHHHHHHHHHCCCCCceEE
Confidence 344 3356667777889998753 4578888875433211 1 123577777777544442 4555
Q ss_pred EEEeCCEEEEEEeccCCCCH
Q 021253 204 ACRKRMVWCIVTEYAKGGSV 223 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L 223 (315)
.+. + +.|.||++|..|
T Consensus 178 ~f~--g--g~I~efi~g~~l 193 (442)
T PTZ00296 178 TFS--G--GRIEEWLYGDPL 193 (442)
T ss_pred EeC--C--CEEEEeeCCccC
Confidence 443 2 467899988643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.088 Score=45.35 Aligned_cols=100 Identities=12% Similarity=0.120 Sum_probs=62.5
Q ss_pred eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHH
Q 021253 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239 (315)
Q Consensus 160 ~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 239 (315)
+..+|.+........ ...|.++.+++.++. .|+++..- ..-.+.++.|+|-.- +..+
T Consensus 87 ~L~lKKi~slp~~~~-----~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------~i~~--- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCIN-----DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------KINF--- 143 (308)
T ss_pred hhhhhhccCCCcccc-----hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------ccch---
Confidence 455666654333311 135677888888775 46666632 333567889988331 1111
Q ss_pred HHHHHHHHHHHHHHHHhC--CCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 240 AVKQALDVARGMAYVHGL--GFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 240 ~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
..++.-=+..|.-.|+. +.+|+|..|+||+-|..|.+||.|=+
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 11111113456677843 69999999999999999999999966
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.1 Score=45.93 Aligned_cols=77 Identities=16% Similarity=0.132 Sum_probs=53.5
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc-
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA- 218 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~- 218 (315)
..+..|..+.|+.++. +|.++++|+..+...... +. .....|+...-...|++++.-.+.. .+++|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-------E~-~g~~~L~~w~G~GaVrll~~d~~~~--AlLLErl~ 77 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-------EA-RGEAALRWWNGRGAVRLLAADPERG--ALLLERLD 77 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-------hh-hHHhHhheeCCCCceeeeccccccc--hhhhhhcc
Confidence 4456788899999976 889999999865433211 01 1225577778888899999875554 6788999
Q ss_pred CCCCHHHHH
Q 021253 219 KGGSVRQFL 227 (315)
Q Consensus 219 ~~g~L~~~l 227 (315)
.+.+|.++.
T Consensus 78 ~g~~L~~~~ 86 (253)
T PF04655_consen 78 PGRSLASLP 86 (253)
T ss_pred CCCchhhcc
Confidence 445776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 315 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-04 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 3e-84
Identities = 65/190 (34%), Positives = 102/190 (53%), Gaps = 8/190 (4%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME 180
+G + D+ I LN+ G+FG ++R ++G DVA+KIL + + E
Sbjct: 23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RV 78
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKL 239
+F +EV ++ L+H NIV F+GA + IVTEY GS+ + L + R + +
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTP 296
+ A DVA+GM Y+H +HR+LKS NLL+ ++K+ DFG++R++ T
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 297 ETGTYRWMAP 306
GT WMAP
Sbjct: 199 AAGTPEWMAP 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 4e-81
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 107 DDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL 166
+ +L A R ++ EW I +L +G +G FG++Y G ++G +VAI+++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLI 63
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
+ +N + + F++EVM +H N+V F+GAC I+T KG ++
Sbjct: 64 DIERDNED----QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ R + + + A ++ +GM Y+H G +H+DLKS N+ + + I DFG+
Sbjct: 120 V-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 287 IE------VQTEGMTPETGTYRWMAP 306
I + + + + G +AP
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 6e-80
Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ- 62
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
Q F+ EV +L +H+NI+ F+G + IVT++ +G S+ L
Sbjct: 63 ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKF 117
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293
+K + A ARGM Y+H IHRDLKS+N+ + D ++KI DFG+A + + G
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 294 -MTPETGTYRWMAP 306
+G+ WMAP
Sbjct: 178 QFEQLSGSILWMAP 191
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-78
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
ID ++LN T + G+L++G + G D+ +K+L+ + + + F +E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR----KSRDFNEEC 58
Query: 188 MMLATLKHLNIVRFIGACRKRMVW--CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
L H N++ +GAC+ ++T + GS+ L N V AVK AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 246 DVARGMAYVHGLGF--IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+ARGMA++H L L S +++I D + +I+ V M W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAW 174
Query: 304 MAP 306
+AP
Sbjct: 175 VAP 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-77
Identities = 69/188 (36%), Positives = 102/188 (54%), Gaps = 17/188 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKL 59
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A LKH NI+ G C K C+V E+A+GG + + L + +P + V A+ +AR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116
Query: 250 GMAYVHGLG---FIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPET 298
GM Y+H IHRDLKS N+LI ++K +KI DFG+AR +T M+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AA 175
Query: 299 GTYRWMAP 306
G Y WMAP
Sbjct: 176 GAYAWMAP 183
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 5e-76
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 113 ALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE 170
A+ +P T+ ++ +G FG +++G + VAIK L +
Sbjct: 2 AMGGSEFPK-----SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 171 NNPEKAQVME-QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ E + + Q+FQ+EV +++ L H NIV+ G +V E+ G + L
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-L 113
Query: 230 RQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-----ADKSIKIADF 282
+ + + ++ LD+A G+ Y+ +HRDL+S N+ + A K+ADF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G+++ V + ++ G ++WMAP
Sbjct: 174 GLSQQSVHS--VSGLLGNFQWMAP 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-74
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ 184
L G +G FG+ + T+ GE + +K L R + ++ F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+EV ++ L+H N+++FIG K +TEY KGG++R + + + P V A
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFA 114
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------------ 292
D+A GMAY+H + IHRDL S N L+ +K++ +ADFG+AR+ V +
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 293 ---GMTPETGTYRWMAP 306
G WMAP
Sbjct: 175 DRKKRYTVVGNPYWMAP 191
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-72
Identities = 60/183 (32%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
ID +++ + +GAFG + + + +DVAIK +E + F E+
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELR 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDV 247
L+ + H NIV+ GAC + C+V EYA+GGS+ L A+ L
Sbjct: 54 QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 248 ARGMAYVHGL---GFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRW 303
++G+AY+H + IHRDLK NLL+ A +KI DFG A MT G+ W
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169
Query: 304 MAP 306
MAP
Sbjct: 170 MAP 172
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 3e-69
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+++ M +G +G+++ G + GE VA+K+ E + E+
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFRETEIY 83
Query: 189 MLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
++H NI+ FI A K ++T+Y + GS+ +L ++ + K +K A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 245 LDVARGMAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293
G+ ++H F HRDLKS N+L+ + + IAD G+A +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 294 --MTPETGTYRWMAP 306
GT R+M P
Sbjct: 201 IPPNTRVGTKRYMPP 215
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-67
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 27/189 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
R + + +G +G+++RG++ GE+VA+KI + + E+ L+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLR 60
Query: 195 HLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
H NI+ FI + ++T Y + GS+ +L Q + ++ L +A G
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 251 MAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTPE 297
+A++H F HRDLKS N+L+ + IAD G+A + Q+ G P
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 298 TGTYRWMAP 306
GT R+MAP
Sbjct: 178 VGTKRYMAP 186
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 9e-67
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
E ++DL L + +G +G +Y+G+ + VA+K+ Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53
Query: 185 QE--VMMLATLKHLNIVRFIGACRK-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
E + + ++H NI RFI + RM + +V EY GS+ ++L+
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110
Query: 238 KLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288
+ + A V RG+AY+H HRDL S N+L+ D + I+DFG++
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 289 VQTE---------GMTPETGTYRWMAP 306
E GT R+MAP
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAP 197
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-66
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 117 HRYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + G++ + L + A+G FG +++ E VA+KI +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ--- 61
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQ 231
Q + EV L +KH NI++FIGA ++ + ++T + + GS+ FL
Sbjct: 62 ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 232 NRAVPLKLAVKQALDVARGMAYVHG----------LGFIHRDLKSDNLLISADKSIKIAD 281
V A +ARG+AY+H HRD+KS N+L+ + + IAD
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 282 FGVARI---EVQTEGMTPETGTYRWMAP 306
FG+A + GT R+MAP
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAP 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-65
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
GL + TI R + + + +G FG+++RG + GE+VA+KI E
Sbjct: 28 SGSGLPLLVQRTI-ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER------- 79
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
+ E+ L+H NI+ FI A K +V++Y + GS+ +L R V
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136
Query: 236 PLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++ +K AL A G+A++H HRDLKS N+L+ + + IAD G+A
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 288 EVQTE-----GMTPETGTYRWMAP 306
GT R+MAP
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAP 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
+ W +++++L + +G FG + G Y G VA+K + K
Sbjct: 7 AQDEFY-RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDAT 57
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ L+H N+V+ +G ++ IVTEY GS+ +L R +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTP 296
+K +LDV M Y+ G F+HRDL + N+L+S D K++DFG+ + Q G P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 297 ETGTYRWMAPSA 308
+W AP A
Sbjct: 178 ----VKWTAPEA 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 103 HALNDDALAQALMD-----HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN 157
+ + D L L+ + W +++++L + +G FG + G Y
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTE 216
G VA+K + K Q F E ++ L+H N+V+ +G ++ IVTE
Sbjct: 216 GNKVAVKCI--------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
Y GS+ +L R + +K +LDV M Y+ G F+HRDL + N+L+S D
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 277 IKIADFGVAR--IEVQTEGMTPETGTYRWMAPSA 308
K++DFG+ + Q G P +W AP A
Sbjct: 328 AKVSDFGLTKEASSTQDTGKLP----VKWTAPEA 357
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 15/192 (7%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--DVAIKILERPENNPEKAQVME 180
G NYD+W ++ + M G +G++Y G + VA+K L K ME
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME 52
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L + V +
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 171
Query: 300 T---YRWMAPSA 308
+W AP +
Sbjct: 172 AKFPIKWTAPES 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 59/186 (31%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQ 185
DEW + L + G FG+++ G YNG VA+K L K M F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLA 57
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ ++ T G +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIK 175
Query: 303 WMAPSA 308
W AP A
Sbjct: 176 WTAPEA 181
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-45
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 22/213 (10%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--D 160
L + D+W ++ L +G +G FG+++ G +
Sbjct: 85 LLSTQQPLTKKS---GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VA+K + + F QE +L H NIVR IG C ++ IV E
Sbjct: 142 VAVKSC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+GG FL R + + +K ++ D A GM Y+ IHRDL + N L++ +
Sbjct: 194 VQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 278 KIADFGVARIEVQTEGMTPETGT----YRWMAP 306
KI+DFG++R E G +W AP
Sbjct: 253 KISDFGMSREEADGV-YAASGGLRQVPVKWTAP 284
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 103 HALNDDALAQAL------MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY 156
H+ D L L + NYD+W ++ + M G +G++Y G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 157 NGE--DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213
VA+K L K ME + F +E ++ +KH N+V+ +G C + + I
Sbjct: 242 KKYSLTVAVKTL--------KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+TE+ G++ +L + V + + A ++ M Y+ FIHR+L + N L+
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPSA 308
+ +K+ADFG++R+ + + T G +W AP +
Sbjct: 354 NHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPES 390
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM 179
T GL Y W ID + L G FG + G + G+ DVAIK++ K M
Sbjct: 11 TAGLG-YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--------KEGSM 61
Query: 180 EQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F +E ++ L H +V+ G C K+ I+TEY G + +L R +
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQ 120
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
++ DV M Y+ F+HRDL + N L++ +K++DFG++R V + T
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSV 179
Query: 299 GT---YRWMAPSA 308
G+ RW P
Sbjct: 180 GSKFPVRWSPPEV 192
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-44
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENN 172
R E ++ ID L +G +G FG + G ED VA+K + + +N+
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNS 75
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC-----IVTEYAKGGSVRQFL 227
++ ++F E + H N++R +G C + ++ + K G + +L
Sbjct: 76 SQREI---EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ P + ++ +D+A GM Y+ F+HRDL + N ++ D ++ +ADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 284 VARI-------EVQTEGMTPETGTYRWMAP 306
+++ P +W+A
Sbjct: 193 LSKKIYSGDYYRQGRIAKMP----VKWIAI 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-44
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 54 GSVSMSVDNSSVGSNDSLTH----ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDA 109
GS S+SV + D++ H L + G + ++ + V + +D
Sbjct: 106 GSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDH-----YKKGNDG 160
Query: 110 LAQALMD--HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKIL 166
L Q L + D W I L + G FG+++ TYN VA+K +
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 167 ERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
K M + F E ++ TL+H +V+ K ++ I+TE+ GS+
Sbjct: 221 --------KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLD 271
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
FL + PL + + +A GMA++ +IHRDL++ N+L+SA KIADFG+A
Sbjct: 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
Query: 286 RIEVQTEGMTPETGT---YRWMAPSA 308
R+ ++ T G +W AP A
Sbjct: 332 RV-IEDNEYTAREGAKFPIKWTAPEA 356
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 38/209 (18%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
I R + + +GAFGK++ VA+K L +
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLA 59
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ FQ+E +L L+H +IV+F G C +V EY K G + +FL
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
Q R +L + Q A +A GM Y+ F+HRDL + N L+ A+ +KI DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
+R V M P RWM P
Sbjct: 180 SRDVYSTDYYRVGGHTMLP----IRWMPP 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 115 MDHRYPTEGL--ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKIL 166
M H + D + R L + +G FG + Y+ VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVR 224
+ + P++ ++ FQ+E+ +L L IV++ G R +V EY G +R
Sbjct: 61 Q--HSGPDQ----QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
FL +R + + + + +GM Y+ +HRDL + N+L+ ++ +KIADFG+
Sbjct: 115 DFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 285 ARI--------EVQTEGMTPETGTYRWMAP 306
A++ V+ G +P W AP
Sbjct: 174 AKLLPLDKDYYVVREPGQSP----IFWYAP 199
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---- 158
H + + L + G D R L +G FGK+ Y+
Sbjct: 7 HHHHHHGALEVL----FQGPG----DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDG 58
Query: 159 --EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV--WCIV 214
E VA+K L + + P+ ++QE+ +L TL H +I+++ G C +V
Sbjct: 59 TGEMVAVKAL-KADAGPQ----HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GS+R +L ++ L + A + GMAY+H +IHRDL + N+L+ D
Sbjct: 114 MEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 275 KSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
+ +KI DFG+A+ V+ +G +P W AP
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWYAP 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-43
Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQE 186
+W ID +L G FG ++ G + + VAIK + + M ++ F +E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEE 53
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L H +V+ G C ++ C+VTE+ + G + +L ++ L + LD
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLD 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
V GMAY+ IHRDL + N L+ ++ IK++DFG+ R V + T TGT +W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKW 171
Query: 304 MAPSA 308
+P
Sbjct: 172 ASPEV 176
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 209 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 259
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAPSA 308
K+ADFG+AR ++ T G +W AP A
Sbjct: 320 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 352
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 112 QALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKI 165
+ L E+ D + R L +G FG + Y+ VA+K
Sbjct: 18 ENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 166 LERPENNPEKAQVMEQQ--FQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGG 221
L + E F++E+ +L +L+H NIV++ G C R ++ EY G
Sbjct: 78 L--------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
S+R +L + + R +KL ++ + +GM Y+ +IHRDL + N+L+ + +KI D
Sbjct: 130 SLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
Query: 282 FGVARI--------EVQTEGMTPETGTYRWMAP 306
FG+ ++ +V+ G +P W AP
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESP----IFWYAP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-43
Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 30/201 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
++ I ++ +G +G FG + ED VA+K+L + + + E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEE-- 71
Query: 183 FQQEVMMLATLKHLNIVRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
F +E + H ++ + +G + + ++ + K G + FL + P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
L ++ +D+A GM Y+ FIHRDL + N +++ D ++ +ADFG++R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 288 --EVQTEGMTPETGTYRWMAP 306
P +W+A
Sbjct: 192 YYRQGCASKLP----VKWLAL 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-43
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 291
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 292 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 342
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAPSA 308
K+ADFG+AR ++ T G +W AP A
Sbjct: 403 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 435
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-43
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 18/193 (9%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FGK+ Y GE VA+K L +PE+
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN----HIA 68
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
++E+ +L L H NIV++ G C + ++ E+ GS++++L + +N+ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
+K A+ + +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ + IE E T +
Sbjct: 129 -LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 299 GT---YRWMAPSA 308
W AP
Sbjct: 188 DRDSPVFWYAPEC 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-43
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 31/197 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FG + Y+ E VA+K L + E
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEH 54
Query: 182 Q--FQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
F++E+ +L +L+H NIV++ G C R ++ EY GS+R +L + + R +
Sbjct: 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EV 289
KL ++ + +GM Y+ +IHRDL + N+L+ + +KI DFG+ ++ +V
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 290 QTEGMTPETGTYRWMAP 306
+ G +P W AP
Sbjct: 174 KEPGESP----IFWYAP 186
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-43
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQEV 187
+ ++ + G FG + G + G+ DVA+K++ K M + F QE
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI--------KEGSMSEDEFFQEA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+ L H +V+F G C K IVTEY G + +L R + + ++ DV
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
GMA++ FIHRDL + N L+ D +K++DFG+ R V + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWS 172
Query: 305 APSA 308
AP
Sbjct: 173 APEV 176
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 41/208 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
I R + + +GAFGK++ + VA+K L E ++
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESAR 87
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
Q FQ+E +L L+H +IVRF G C + +V EY + G + +FL R +
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLA 145
Query: 234 ----AVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
P L + Q A VA GM Y+ GL F+HRDL + N L+ +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 286 R-------IEVQTEGMTPETGTYRWMAP 306
R V M P RWM P
Sbjct: 206 RDIYSTDYYRVGGRTMLP----IRWMPP 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G G VAIK + N +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 72
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVP 236
+F E ++ ++VR +G + ++ E G ++ +L N V
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
++ + A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 288 --EVQTEGMTPETGTYRWMAP 306
+G+ P RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 35/257 (13%)
Query: 77 HPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--DEWTIDL 134
+ + Y S + + + + + Y G + D +
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ-FQQE 186
+ + + GAFG++Y G +G VA+K L PE ++ F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQDELDFLME 124
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQ-- 243
++++ H NIVR IG + + I+ E GG ++ FL R + P LA+
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 244 --ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVAR-------IEVQT 291
A D+A G Y+ FIHRD+ + N L++ + KI DFG+AR
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 292 EGMTPETGTYRWMAPSA 308
M P +WM P A
Sbjct: 245 CAMLP----VKWMPPEA 257
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 119 YPTEGLENY--DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERP 169
Y G + D + + + + GAFG++Y G +G VA+K L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--- 68
Query: 170 ENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL- 227
PE ++ F E ++++ H NIVR IG + + I+ E GG ++ FL
Sbjct: 69 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIA 280
R + P LA+ A D+A G Y+ FIHRD+ + N L++ + KI
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 281 DFGVAR-------IEVQTEGMTPETGTYRWMAPSA 308
DFG+AR M P +WM P A
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLP----VKWMPPEA 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-42
Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 37/207 (17%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ 182
I L + + FGK+Y+G G VAIK L + + ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLR---EE 58
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----------QN 232
F+ E M+ A L+H N+V +G K ++ Y G + +FL R +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 233 RAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI- 287
R V L +A GM Y+ +H+DL + N+L+ ++KI+D G+ R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 288 ------EVQTEGMTPETGTYRWMAPSA 308
++ + P RWMAP A
Sbjct: 179 YAADYYKLLGNSLLP----IRWMAPEA 201
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 61/246 (24%), Positives = 91/246 (36%), Gaps = 53/246 (21%)
Query: 103 HALNDDALAQAL----MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG 158
L + L L M R P + +GAFG++++ G
Sbjct: 11 TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 159 ED-------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211
VA+K+L E Q FQ+E ++A + NIV+ +G C
Sbjct: 71 LLPYEPFTMVAVKML--KEEASADMQ---ADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125
Query: 212 CIVTEYAKGGSVRQFLTRRQNR--------------------AVPLKLAVKQ----ALDV 247
C++ EY G + +FL R P L+ + A V
Sbjct: 126 CLLFEYMAYGDLNEFL--RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGT 300
A GMAY+ F+HRDL + N L+ + +KIADFG++R + P
Sbjct: 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP---- 239
Query: 301 YRWMAP 306
RWM P
Sbjct: 240 IRWMPP 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 16/190 (8%)
Query: 128 DEWTIDLRKLNM-GTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
E +D + L + G FG + +G Y + VA+KIL + E N + +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPAL---KDE 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++ L + IVR IG C +V E A+ G + ++L +QNR V K ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + +T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 301 --YRWMAPSA 308
+W AP
Sbjct: 182 WPVKWYAPEC 191
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 44/190 (23%), Positives = 90/190 (47%), Gaps = 16/190 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I + + +G FG++Y G Y VA+K + ++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 58
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F E +++ L H +IV+ IG + W I+ E G + +L R ++ + V
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLV 116
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
+L + + MAY+ + +HRD+ N+L+++ + +K+ DFG++R ++ E + T
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTR 175
Query: 301 --YRWMAPSA 308
+WM+P +
Sbjct: 176 LPIKWMSPES 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-41
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 21/193 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQ 182
I+ ++++ G G++ G VAIK L KA E+Q
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQ 93
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G + + IVTEY + GS+ FL + ++L
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V V GM Y+ LG++HRDL + N+L+ ++ K++DFG++R +E + T
Sbjct: 154 -VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 299 GT---YRWMAPSA 308
G RW AP A
Sbjct: 213 GGKIPIRWTAPEA 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-41
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 22/194 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQ 181
I + G FG++Y+G VAIK L KA E+
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEK 88
Query: 182 Q---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ H NI+R G K I+TEY + G++ +FL + L+
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPE 297
L V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +E E
Sbjct: 149 L-VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 298 TGT---YRWMAPSA 308
+G RW AP A
Sbjct: 208 SGGKIPIRWTAPEA 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-41
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 117 HRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED----VAIKILERPEN 171
H + + + +D + +G FG++ + + AIK +
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----- 60
Query: 172 NPEKAQVMEQQ---FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL 227
K + F E+ +L L H NI+ +GAC R + EYA G++ FL
Sbjct: 61 ---KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 228 TRRQNRAVPL------------KLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
R++R + L+ +Q A DVARGM Y+ FIHRDL + N+L+
Sbjct: 118 --RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 272 SADKSIKIADFGVARIE----VQTEGMTPETGTYRWMAP 306
+ KIADFG++R + +T G P RWMA
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTMGRLP----VRWMAI 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L+ G GAFGK+ T G VA+K+L A + E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------KPSAHLTE 69
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--- 235
++ E+ +L+ L H+NIV +GAC ++TEY G + FL R+++ +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 236 ---------PLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L L ++ + VA+GMA++ IHRDL + N+L++ + KI DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR V+ P +WMAP
Sbjct: 190 GLARDIKNDSNYVVKGNARLP----VKWMAP 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 27/202 (13%)
Query: 124 LENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
++ I ++ +G FG +Y GT D A+K L
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 69
Query: 177 QVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
QF E +++ H N++ +G C R +V Y K G +R F+ R +
Sbjct: 70 V---SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNP 125
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--------- 286
+K + L VA+GM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 287 IEVQTEGMTPETGTYRWMAPSA 308
+ +T P +WMA +
Sbjct: 186 VHNKTGAKLP----VKWMALES 203
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
+D +++ G FG++ G VAIK L K E+Q
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--------KVGYTEKQ 89
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G K IVTEY + GS+ FL + + ++L
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V +A GM Y+ +G++HRDL + N+LI+++ K++DFG+ R +E E
Sbjct: 150 -VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 299 GT---YRWMAPSA 308
G RW +P A
Sbjct: 209 GGKIPIRWTSPEA 221
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 14/190 (7%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
I + L + G+FG + RG ++ VA+K L+ + +A
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DD 67
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
F +EV + +L H N++R G + +VTE A GS+ L R+ L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL-RKHQGHFLLGTLSR 125
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
A+ VA GM Y+ FIHRDL + NLL++ +KI DFG+ R + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 301 --YRWMAPSA 308
+ W AP +
Sbjct: 186 VPFAWCAPES 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-40
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 51/218 (23%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W + L +G +G FGK+ + T VA+K+L E A E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML------KENASPSE 69
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ E +L + H ++++ GAC + ++ EYAK GS+R FL R++R V
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGY 127
Query: 240 AVKQ------------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
A +++GM Y+ + +HRDL + N+L++ +
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 276 SIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+KI+DFG++R +++G P +WMA
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIP----VKWMAI 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F +Y+G T +VA L+ + Q+F++E ML L+H NIVRF
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 203 GA----CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--G 256
+ + + +VTE G+++ +L R + + +K+ + +G+ ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 257 LGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK DN+ I+ S+KI D G+A ++ + GT +MAP
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAP 199
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 29/203 (14%)
Query: 124 LENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
L + I + + +G FG +Y G Y + AIK L
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------SRIT 61
Query: 177 QVME-QQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
++ + + F +E +++ L H N++ IG + ++ Y G + QF+ R R
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRN 120
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------- 286
+K + L VARGM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 287 -IEVQTEGMTPETGTYRWMAPSA 308
++ P +W A +
Sbjct: 181 SVQQHRHARLP----VKWTALES 199
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 66/267 (24%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 74 ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTID 133
+ + Y +G + L M L W +
Sbjct: 8 HHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELP 67
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVMEQQ-F 183
+L +G +GAFG++ G D VA+K+L A +
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDL 121
Query: 184 QQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L + R L+ +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYN 179
Query: 243 Q----------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
A VARGM Y+ IHRDL + N+L++ D +KIADFG+AR
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
+ T G P +WMAP
Sbjct: 240 DIHHIDYYKKTTNGRLP----VKWMAP 262
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-40
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +GAFG++ G D VA+K+L + A
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 81
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 202 GLARDINNIDYYKKTTNGRLP----VKWMAP 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 38/207 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
++W L G GAFGK+ T G VA+K+L A E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML------KSTAHADE 92
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
++ E+ +++ L +H NIV +GAC ++TEY G + FL R+
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 231 QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + + VA+GMA++ IHRD+ + N+L++ KI DFG+AR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
V+ P +WMAP
Sbjct: 213 DIMNDSNYIVKGNARLP----VKWMAP 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +G FG++ G D VA+K+L + A
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 127
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 248 GLARDINNIDYYKKTTNGRLP----VKWMAP 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 39/209 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L +G +GAFG++ G D VA+K+L
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEH 74
Query: 181 QQFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ E+ +L + HLN+V +GAC + ++ E+ K G++ +L +
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
L ++ + VA+GM ++ IHRDL + N+L+S +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
AR + + P +WMAP
Sbjct: 195 ARDIYKDPDYVRKGDARLP----LKWMAP 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ--- 182
+ + GAFG +Y+G + E VAIK L + +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++A++ + ++ R +G C V ++T+ G + ++ R + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 301 -YRWMAPSA 308
+WMA +
Sbjct: 182 PIKWMALES 190
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 128 DEWTIDLRKLNMG-TAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
+ + L + G FG + +G Y DVAIK+L + ++
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 56
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E ++ L + IVR IG C+ + +V E A GG + +FL + +P+ +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEIPVSNVAE 114
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + T +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 301 --YRWMAPSA 308
+W AP
Sbjct: 175 WPLKWYAPEC 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 16/190 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I ++ +G +G FG +++G Y + VAIK + + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVRE 61
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F QE + + H +IV+ IG + VW I+ E G +R FL R+ L +
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASL-I 119
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++ +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178
Query: 301 --YRWMAPSA 308
+WMAP +
Sbjct: 179 LPIKWMAPES 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-39
Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ- 182
+L G FG +++G + E V IK++E +K+ Q
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE------DKSGRQSFQA 61
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H +IVR +G C + +VT+Y GS+ + R+ A+ +L +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLN 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ G +HR+L + N+L+ + +++ADFGVA + + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 301 -YRWMAPSA 308
+WMA +
Sbjct: 180 PIKWMALES 188
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 119 YPTEGLENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPEN 171
E ++ I ++ +G FG +Y GT D A+K L
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI 128
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR 230
QF E +++ H N++ +G C R +V Y K G +R F+ R
Sbjct: 129 TDIGE---VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RN 184
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ +K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 287 -----IEVQTEGMTPETGTYRWMAPSA 308
+ +T P +WMA +
Sbjct: 245 KEFDSVHNKTGAKLP----VKWMALES 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 53/254 (20%), Positives = 104/254 (40%), Gaps = 27/254 (10%)
Query: 71 LTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--- 127
+ ++P + + + D+ + + Y
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380
Query: 128 --DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME 180
++ I ++ +G +G FG +++G Y + VAIK + +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVR 435
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
++F QE + + H +IV+ IG + VW I+ E G +R FL R+ L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASL- 493
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------EVQTEGM 294
+ A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++G
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 295 TPETGTYRWMAPSA 308
P +WMAP +
Sbjct: 554 LP----IKWMAPES 563
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKA 176
E +W L G GAFGK+ T G VA+K+L EKA
Sbjct: 34 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKA 87
Query: 177 QVMEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
E++ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 235 VPLKLAVKQ---------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
++ + A VA+GM ++ +HRDL + N+L++
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 274 DKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
K +KI DFG+AR V+ P +WMAP
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLP----VKWMAP 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 42/186 (22%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQ 185
+ + GAFG +Y+G + E VAIK L + ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILD 66
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++A++ + ++ R +G C V ++T+ G + ++ R + + + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 303 WMAPSA 308
WMA +
Sbjct: 185 WMALES 190
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG++++ +G+ IK ++ ++EV LA L H+NIV
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVH 68
Query: 201 FIGA----------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ G K I E+ G++ Q++ +R+ + LA++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304
+ +G+ Y+H I+RDLK N+ + K +KI DFG+ T GT R+M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 305 AP 306
+P
Sbjct: 189 SP 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 36/197 (18%), Positives = 77/197 (39%), Gaps = 29/197 (14%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
I L + QG F K+++G V +K+L + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL------DKAHRNYS 56
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ F + M++ L H ++V G C +V E+ K GS+ +L ++ + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWK 115
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFGVAR-IEVQT 291
++ A +A M ++ IH ++ + N+L+ ++ IK++D G++ + +
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 292 EGMTPETGTYRWMAPSA 308
W+ P
Sbjct: 176 ILQER----IPWVPPEC 188
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 23/261 (8%)
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
S SN S + P + + A M
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 124 LENYDEWTIDLRKLNM--------GTAFAQGAFGKLYRGTYNGE----DVAIKILERPEN 171
D + +KL + G FG + +G Y DVAIK+L +
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGT 375
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
++ +E ++ L + IVR IG C+ + +V E A GG + +FL +
Sbjct: 376 EKA----DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGK 429
Query: 232 NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQ 290
+P+ + V+ GM Y+ F+HR+L + N+L+ KI+DFG+++ +
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 291 TEGMTPETGT---YRWMAPSA 308
T + +W AP
Sbjct: 490 DSYYTARSAGKWPLKWYAPEC 510
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 42/166 (25%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK L + T +G IK + K + ++ ++EV +LA +KH NIV++
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKER---EESRREVAVLANMKHPNIVQYR 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + IV +Y +GG + + + ++ + + + + +VH +HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
D+KS N+ ++ D ++++ DFG+AR+ T + GT +++P
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSP 194
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 27/218 (12%)
Query: 110 LAQALMDHRYPTEGLENYDE---WTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIK 164
+ + H + + Y + ID + +G F + G ++G A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKG 220
+ E ++ Q+E M H NI+R + C + ++ + K
Sbjct: 61 RILCHEQQ------DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 221 GSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278
G++ + R +++ L + L + RG+ +H G+ HRDLK N+L+ +
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174
Query: 279 IADFGVARIE----------VQTEGMTPETGTYRWMAP 306
+ D G + + + T + AP
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y G N +AIK + E+ Q +E+ + LKH NIV+++
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-------VKQALDVARGMAYVH 255
G+ + I E GGS+ L +++ PLK KQ L G+ Y+H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EGLKYLH 139
Query: 256 GLGFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
+HRD+K DN+LI + +KI+DFG + R+ TGT ++MAP
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 46/196 (23%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGAFG++ + + AIK + + EVM+LA+L H +VR+
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 203 GA-------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A +K+ I EY + G++ + L + + R
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFR 123
Query: 250 ----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------- 298
++Y+H G IHRDLK N+ I +++KI DFG+A+ ++ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 299 --------GTYRWMAP 306
GT ++A
Sbjct: 184 SDNLTSAIGTAMYVAT 199
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F ++YR +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKYY 98
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + + + + K + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA + E VAIK + N EK Q + +E+ ++ H NIV +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL------DVARGMAYVH 255
+ K +W +V + GGSV + + + ++ +V G+ Y+H
Sbjct: 80 TSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G IHRD+K+ N+L+ D S++IADFGV+ +T GT WMAP
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G++G++++ +G A+K P P+ + EV + +H VR
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A + + + TE G S++Q ++P D +A++H G +H
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+ + K+ DFG+ + G R+MAP
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+++R G A+K + +E +E++ A L IV
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---VKQALDVARGMAYVHGLGF 259
GA R+ I E +GGS+ Q + +Q +P A + QAL G+ Y+H
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQAL---EGLEYLHTRRI 171
Query: 260 IHRDLKSDNLLISAD-KSIKIADFGVA-RIEVQTEGMTPET-----GTYRWMAP 306
+H D+K+DN+L+S+D + DFG A ++ G + T GT MAP
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 39/190 (20%), Positives = 74/190 (38%), Gaps = 33/190 (17%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG + + + AIK + P + ++ +EV LA L+H IVR+
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-----EKVMREVKALAKLEHPGIVRYF 69
Query: 203 GAC------------RKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVAR 249
A ++ I + + +++ ++ R + + L +A
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------------EVQTEGMTP 296
+ ++H G +HRDLK N+ + D +K+ DFG+ T
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 297 ETGTYRWMAP 306
+ GT +M+P
Sbjct: 190 QVGTKLYMSP 199
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKL-NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPEN 171
M H GL D +L +G+FG++++G N + VAIKI+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----- 55
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRR 230
+ E+A+ + QQE+ +L+ + ++ G+ K +W I+ EY GGS L
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG 114
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ +++ L +G+ Y+H IHRD+K+ N+L+S +K+ADFGVA Q
Sbjct: 115 PLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168
Query: 291 -TEGMTPET---GTYRWMAP 306
T+ GT WMAP
Sbjct: 169 LTDTQIKRNTFVGTPFWMAP 188
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ G A K++E ++ E + + E+ +LAT H IV+ +
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIE-TKSEEEL-----EDYIVEIEILATCDHPYIVKLL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGFI 260
GA I+ E+ GG+V + ++ V +Q L + ++H I
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRII 139
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
HRDLK+ N+L++ + I++ADFGV+ ++T + GT WMAP
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAP 186
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G FG +++ +G AIK ++P EQ +EV A L +H ++VR+
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRY 76
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGF 259
A + I EY GGS+ ++ K L V RG+ Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 260 IHRDLKSDNLLISADKSI-------------------KIADFGVARIEVQTEGMTPETGT 300
+H D+K N+ IS KI D G + E G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEEGD 193
Query: 301 YRWMAP 306
R++A
Sbjct: 194 SRFLAN 199
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 33/168 (19%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 121
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ G +M P
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 34/168 (20%), Positives = 68/168 (40%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 74
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 34/168 (20%), Positives = 69/168 (41%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRF 201
G K+++ + AIK + E + + ++ E+ L L+ + I+R
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 24/172 (13%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +Y+ + G+ VAIK + E++ ++ +E+ ++ ++V++
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQE-------IIKEISIMQQCDSPHVVKY 89
Query: 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLG 258
G+ K +W IV EY GSV + R ++A + L +G+ Y+H +
Sbjct: 90 YGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGVA Q T+ M GT WMAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAP 194
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-31
Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 30/174 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRM-VWCIVTEYAKGGSVRQFLTRR-----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ +W +V EY GGS+ +T Q AV ++ L + + ++H
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECL---QALEFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+KSDN+L+ D S+K+ DFG Q T + + GT WMAP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAP 185
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 26/177 (14%)
Query: 146 GAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ Y GE V ++ LE N M Q E+ + H NIV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPY 91
Query: 202 IGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGMAYVHGL 257
+W +VT + GS + + + L +A + L + + Y+H +
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA--------RIEVQTEGMTPETGTYRWMAP 306
G++HR +K+ ++LIS D + ++ R V + W++P
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 86 NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQ 145
+ F+ G VTH AL + ++D P L++Y + +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAAL-RMVVDQGDPRLLLDSYVK-------------IGE 55
Query: 146 GAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G+ G + G VA+K+++ + + EV+++ +H N+V
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMD-LRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 204 ACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +W ++ E+ +GG++ +++ + + + L + +AY+H G IHR
Sbjct: 110 SYLVGEELW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIHR 165
Query: 263 DLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
D+KSD++L++ D +K++DFG A+I GT WMAP
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y E VAIK + + Q +EV L L+H N +++
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNTIQYR 120
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G + W +V EY GS L + +++A AL +G+AY+H
Sbjct: 121 GCYLREHTAW-LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM 175
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 219
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG +Y+G N VA+K L + + ++QQF QE+ ++A +H N+V +G
Sbjct: 41 EGGFGVVYKGYVNNTTVAVKKLA-AMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHR 262
C+V Y GS+ L+ PL + K A A G+ ++H IHR
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
D+KS N+L+ + KI+DFG+AR + T T GT +MAP
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAYMAP 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 25/176 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATY 86
Query: 202 IGACRKRMV-------WCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGM 251
GA K+ W +V E+ GSV + + + +A ++ L RG+
Sbjct: 87 YGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
+++H IHRD+K N+L++ + +K+ DFGV+ +T G GT WMAP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEK 175
R P+ + W + +L G FG + R GE VAIK + E
Sbjct: 4 RSPSLPTQTCGPWEMK-ERLG------TGGFGYVLRWIHQDTGEQVAIKQCRQ-----EL 51
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFI------GACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ +++ E+ ++ L H N+V + + EY +GG +R++L +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 230 RQNRAVPLKLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282
+N L D++ + Y+H IHRDLK +N+++ KI D
Sbjct: 112 FENCC---GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G A+ Q E T GT +++AP
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAP 192
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ R +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 71
Query: 203 GA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLG 258
R IV EY +GG + +T+ L + ++ + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 259 F-----IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + +++K+ DFG+ARI +T GT +M+P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSP 185
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQ 182
+W ++ +G +G FG +Y R + +A+K+L KAQ+ +E Q
Sbjct: 5 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQ 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++EV + + L+H NI+R G ++ EYA G+V + L ++ ++ +
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSK-FDEQRTAT 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
++A ++Y H IHRD+K +NLL+ + +KIADFG + V GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGT 170
Query: 301 YRWMAP 306
++ P
Sbjct: 171 LDYLPP 176
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ +L + A+G F +Y + +G + A+K L E + QEV
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRAIIQEVC 77
Query: 189 MLATLK-HLNIVRFIGAC--------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ L H NIV+F A + + ++TE KG V +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARI 287
+K R + ++H IHRDLK +NLL+S +IK+ DFG A
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 59/172 (34%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FGK+Y+G +G VA+K L+ E+ Q E QFQ EV M++ H N++R G
Sbjct: 40 RGGFGKVYKGRLADGTLVAVKRLKE-----ERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVH---GLG 258
C +V Y GSV L R PL + AL ARG+AY+H
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K+ N+L+ + + DFG+A++ T T GT +AP
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FGK+Y+G +G VA+K PE +Q ++F+ E+ L+ +H ++V IG
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRR-----TPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIH 261
C +R ++ +Y + G++++ L + + + ++ + ARG+ Y+H IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 262 RDLKSDNLLISADKSIKIADFGVARIE-------VQTEGMTPETGTYRWMAP 306
RD+KS N+L+ + KI DFG+++ + T GT ++ P
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDP 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 36/188 (19%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILER-----------PENNPEKAQVMEQQFQQEVMMLATL 193
QG F K+ + + A+K E+ N+ + F+ E+ ++ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 194 KHLNIVRFIGACRKRMVW------CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAV 241
K+ + G + I+ EY + S+ L + +P+++
Sbjct: 101 KNEYCLTCEG------IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 242 KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-- 298
V +Y+H HRD+K N+L+ + +K++DFG + +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMVDKKIKGSR 211
Query: 299 GTYRWMAP 306
GTY +M P
Sbjct: 212 GTYEFMPP 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++GK+ A+KIL++ + E ++E+ +L L+H N+++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 201 --FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYV 254
+++M +V EY G + + V QA G+ Y+
Sbjct: 73 DVLYNEEKQKM--YMVMEYCVCGMQEML-----DSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
H G +H+D+K NLL++ ++KI+ GVA
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 96
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 70
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 145 QGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFI 202
GA G +YRG ++ DVA+K + PE ++ EV +L +H N++R+
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADR----EVQLLRESDEHPNVIRYF 84
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVHGLGFI 260
+ R I E ++++++ ++ + L+ ++Q G+A++H L +
Sbjct: 85 CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS---GLAHLHSLNIV 140
Query: 261 HRDLKSDNLLISADKS-----IKIADFGVARIEVQTEG----MTPETGTYRWMAP 306
HRDLK N+LIS + I+DFG+ + + GT W+AP
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
++TID ++G +G FG +Y R N +A+K+L + + E +E Q ++E
Sbjct: 10 KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG---VEHQLRRE 64
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+ + + L+H NI+R R ++ E+A G + + L + + + +
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 122
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWM 304
+A + Y H IHRD+K +NLL+ +KIADFG + V + T GT ++
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGTLDYL 179
Query: 305 AP 306
P
Sbjct: 180 PP 181
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAI+I+ + + + E+ +L L H I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV E +GG + L + Q L + Y+
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 255
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 199 VRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
++ + +V + K G + + L+ ++ R + ++ L+V +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEV---IC 138
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H L +HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+F +YR + G +VAIK+++ K + M Q+ Q EV + LKH +I
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 199 VRFIG--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E G + ++L + + + A + GM Y+H
Sbjct: 74 LELYNYFEDSNYVY--LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA 285
G +HRDL NLL++ + +IKIADFG+A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 42/169 (24%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R N ++ +++ ++ + + T+ V F
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQE----QKRLLMDLDISMRTVDCPFTVTF 71
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHG-L 257
GA R+ VW I E S+ +F + ++ + + K A+ + + + ++H L
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+LI+A +K+ DFG++ V + G +MAP
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ G +A K++ E P Q +E+ +L IV F
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAI----RNQIIRELQVLHECNSPYIVGFY 97
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIH 261
GA I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ +H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAIKI+ + + + E+ +L L H I++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ IV E +GG + L + Q L + Y+
Sbjct: 80 IKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 130
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 36/173 (20%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199
+G + R + G + A+KI+E +PE+ + + + ++E +L + H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 200 RFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
I + +V + + G + + L+ ++ R++ ++ L+ +++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA---VSF 215
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +HRDLK +N+L+ + I+++DFG + E + GT ++AP
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ + D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++ +G + IK + + +++QV +Q + E+ +L +L H NI++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINK-----DRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
IV E +GG + + + Q R L +KQ ++ +AY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ 143
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H+DLK +N+L S IKI DFG+A + E T GT +MAP
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 39/169 (23%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R + ++ ++Q ++ +++ + IV+F
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQF 86
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVR--QFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
GA R+ W I E + +++ + +P ++ K L + + ++ L
Sbjct: 87 YGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+L+ +IK+ DFG++ V + T + G +MAP
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +Y T VAIK + E ++F++EV + L H NIV
Sbjct: 20 GGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEE----TLKRFEREVHNSSQLSHQNIV 74
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
I + + +V EY +G ++ +++ + + + A+ + G+ + H +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
+HRD+K N+LI ++K++KI DFG+A+ + +T +T
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLT-QTNH 171
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F K+ G +VAIKI+++ + NP Q+ +EV ++ L H NIV+
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLF 80
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
++ EYA GG V +L ++ K+A R + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK++NLL+ AD +IKIADFG + T G + G + AP
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAP 182
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 35/187 (18%)
Query: 145 QGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFI 202
G+ G + ++G++ G VA+K + E+ ++ + H N++R+
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLID---------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA-----LDVARGMAYVHGL 257
+ I E +++ + + LKL + +A G+A++H L
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 258 GFIHRDLKSDNLLISADKS-------------IKIADFGVARIEVQTEG-----MTPETG 299
IHRDLK N+L+S I I+DFG+ + + + +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 300 TYRWMAP 306
T W AP
Sbjct: 195 TSGWRAP 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+G HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 23/172 (13%)
Query: 144 AQGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
A G G +Y NG V +K L + E + E LA + H +IV+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAE----AQAMAMAERQFLAEVVHPSIVQ 143
Query: 201 ------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + IV EY G S+++ ++ +P+ A+ L++ ++Y+
Sbjct: 144 IFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H +G ++ DLK +N++++ ++ +K+ D G G GT + AP
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF-GYL--YGTPGFQAP 246
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 43/238 (18%), Positives = 80/238 (33%), Gaps = 44/238 (18%)
Query: 107 DDALAQALMDH-RYPTEGLENYDEWTIDLRKLNMGTAFA-------------QGAFGKLY 152
DD L L+ P N EW L + T F +GAF ++Y
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 153 RGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
T N + +K+ + NP + + Q + L ++F A
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQ----LMERLKPSMQHMFMKFYSAH 136
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V E G++ + +N + +P L + A+ + + VH IH
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 263 DLKSDNLLIS-----------ADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
D+K DN ++ + + D G + +++ +G T +
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILER-------PENNPEKAQVMEQQFQQEVMMLATLKH 195
GA+G++ + AIK++++ ++ + + ++ E+ +L +L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVAR 249
NI++ + + +VTE+ +GG + R + +KQ L
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG-- 158
Query: 250 GMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ Y+H +HRD+K +N+L+ ++ +IKI DFG++ + + GT ++AP
Sbjct: 159 -ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 30/188 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILER--------------------PENNPEKAQVMEQQ 182
+G++G L + A+K+L + + + +Q
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 183 FQQEVMMLATLKHLNIVRF---IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
QE+ +L L H N+V+ + + +V E G V +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKP-LSEDQ 138
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
A D+ +G+ Y+H IHRD+K NLL+ D IKIADFGV+ ++ + T
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 199 GTPAFMAP 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+G HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 6e-24
Identities = 28/204 (13%), Positives = 48/204 (23%), Gaps = 38/204 (18%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
RKL + G ++ ED A+K+ N ++ + A
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAAR 118
Query: 193 LKHLNIVRFIGACRKRMVW--------------------------CIVTEYAKG--GSVR 224
L + R + ++ A +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 225 QFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L + L + R A + G +H DNL I D + + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
P + AP
Sbjct: 239 SALWKVGTR---GPASSVPVTYAP 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-24
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +++ + DVA+K+L R + +P +F++E A L H IV
Sbjct: 21 GFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPS----FYLRFRREAQNAAALNHPAIV 75
Query: 200 RF--IGACRKRMVWC--IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
G IV EY G ++R + + K A++ D + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
G IHRD+K N++ISA ++K+ DFG+AR + +T
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ G++ A+K++ + K + ++ +EV +L L H NI++
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E GG + R+ + + ++Q L + Y+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ S D +I+I DFG++ ++ M + GT ++AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 8e-24
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF +++ G+ A+K +++ + + E+ +L +KH NIV
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK------SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + GG R T + V ++Q L + Y+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHE 124
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + I I DFG++++E Q M+ GT ++AP
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAP 176
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-24
Identities = 37/166 (22%), Positives = 73/166 (43%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G G++++ + G +A+K + R N E+ ++ ++ ++L + IV+
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEE----NKRILMDLDVVLKSHDCPYIVQC 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFI 260
G I E + + L +R +P ++ K + + + + Y+ G I
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ IK+ DFG++ V + G +MAP
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ + AIKI+ + + + +EV +L L H NI++
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLY 102
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E KGG + R + +KQ L + Y+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHK 154
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ D IKI DFG++ + + M GT ++AP
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 27/174 (15%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G++G++ A K + K V +F+QE+ ++ +L H NI+R
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP-------KYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 202 IGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+V E GG ++ + +K L +AY H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---VAYCH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L HRDLK +N L S D +K+ DFG+A + M + GT +++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---VVGKIKREIQNLKLFRHPHIIKLY 77
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+ +V EY GG + ++ + ++ +A + + + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM 160
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 71
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 123
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G++ A K +++ + + V ++ ++EV +L ++H NI+
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ LD G+ Y+H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYLHS 126
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ + IK+ DFG+A GT ++AP
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG + R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG R E VA+K +E + +++ Q+E++ +L+H NIVRF
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------GMAYV 254
I+ EYA GG + + + + + D AR G++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG------RFSE----DEARFFFQQLLSGVSYC 132
Query: 255 HGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
H + HRDLK +N L+ + +KI DFG ++ P++ GT ++AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAP 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H NI+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA +YR + A+K+L++ + ++ + E+ +L L H NI++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V E GG + + + + R VKQ L+ +AY+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLHE 166
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + D +KIADFG+++I M GT + AP
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 35/222 (15%), Positives = 77/222 (34%), Gaps = 15/222 (6%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLN-MGTAFAQGAFGKLYRGTYNG 158
+ + ++D A + E L KL G A+ + +
Sbjct: 24 EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218
E I + + + P + ++ + N V + ++ I +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 219 KGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ +++ ++ RR + + + + +A + ++H G +HRDLK N+ + D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 278 KIADFGVARI-------------EVQTEGMTPETGTYRWMAP 306
K+ DFG+ T + GT +M+P
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R + G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 94
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 146
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ L+ G+ Y+H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYLHS 132
Query: 257 LGFIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L H DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 48/209 (22%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG++G + AIKI+ + + + +E+ + EV ++ L H NI R
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLY 94
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--------------------- 241
C+V E GG + L + +
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 242 -------------KQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKS--IKIADF 282
K ++ R + Y+H G HRD+K +N L S +KS IK+ DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 283 GVARI-----EVQTEGMTPETGTYRWMAP 306
G+++ + GMT + GT ++AP
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G G +Y T VA+K++ ++P + Q+E L+ ++V
Sbjct: 43 GRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPV----FRTRMQREARTAGRLQEPHVV 97
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
G ++ + G + L R+ + AV + + H
Sbjct: 98 PIHDFGE-IDGQLY-VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
G HRD+K +N+L+SAD + DFG+A E +T + GT +MAP
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLT-QLGNTVGTLYYMAP 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G + + G VAIK LE ++ K M +E+ +L L+H N+V
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQLRHENLVNL 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ C+K+ W +V E+ ++ L N ++ + Q + G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHNI 145
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+L+S +K+ DFG AR + E E T YR AP
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--AP 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 29/171 (16%), Positives = 63/171 (36%), Gaps = 22/171 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG ++R + + K ++ + ++E+ +L +H NI+
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
+ ++ E+ G + + + V V Q + + ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCE---ALQFLHSH 121
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H D++ +N++ +S IKI +FG AR + + AP
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-22
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +++ G+ VAIK LE ++ K + +E+ ML LKH N+V
Sbjct: 13 EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQLKHPNLVNL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ R++ +V EY +V L R Q +K Q L + + + H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHNC 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+LI+ IK+ DFG AR + ++ E T YR +P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SP 171
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-22
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 201 FIGACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ E + + F+T R + +LA V + + H G
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGV 170
Query: 260 IHRDLKSDNLLISADK-SIKIADFG 283
+HRD+K +N+LI ++ +K+ DFG
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFG 195
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 7/146 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKIL--ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GAFG ++ ++V +K + E+ + + E+ +L+ ++H NI++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 201 FIGACRKRMVWCIVTE-YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V E + G + F+ R + LA + + Y+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA 285
IHRD+K +N++I+ D +IK+ DFG A
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-22
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ T + VA+K + R M + ++E+ L L+H +I++
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSD---MHMRVEREISYLKLLRHPHIIKLY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EYA GG + ++ ++ ++ + + + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+HRDLK +NLL+ + ++KIADFG++ I
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---VVGKIRREIQNLKLFRHPHIIKLY 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EY GG + ++ + +L K++ + + G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHM 136
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G++ A I+ + + Q+ ++E + LKH NIVR
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLH 76
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + ++ + GG R++ + ++Q L+ + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQ 128
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+G +HR+LK +NLL+ ++K+ADFG+A +E + + GT +++P
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 34/173 (19%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + + ++ ++E+ ++ L+H +V
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV------MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A ++ E+ GG ++ + ++Q G+ ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMH 272
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H DLK +N++ + +K+ DFG+ + + TGT + AP
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 30/205 (14%), Positives = 64/205 (31%), Gaps = 39/205 (19%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
R L GT Q T GE + + E P A +Q ++EV+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI---KQMKEEVLRLRL 134
Query: 193 L----------------------KHLNIVRFIGACRKRMVWCIVTEY-------AKGGSV 223
L K + I +++ + + +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 224 RQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ L ++++ ++ L V R +A +H G +H L+ ++++ + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
F + ++P + P
Sbjct: 255 FEHLVRD-GASAVSPIGRGF--APP 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R G K + + + + E+ ++ L H ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
A + ++ E+ GG + + + + ++QA + G+ ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE---GLKHMHEH 168
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H D+K +N++ K+ +KI DFG+A E + T T + AP
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 35/259 (13%), Positives = 77/259 (29%), Gaps = 36/259 (13%)
Query: 78 PGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKL 137
PG + ++ +V + + D ++ +L + P E R L
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP---RTL 75
Query: 138 NMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQ------------------ 177
GT Q T GE + + E P A
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 178 ----VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY----AKGGSVRQFLTR 229
+ +F ++ + ++R R V Y + + + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++++ ++ L V R +A +H G +H L+ ++++ + + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253
Query: 288 EVQTEGMTPETGTYRWMAP 306
V+ + + + P
Sbjct: 254 -VRDGARVVSSVSRGFEPP 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG++++ G +A KI+ + +++ + E+ ++ L H N+++
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A + +V EY GG LT +KQ + G+ ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE---GIRHMH 204
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ +H DLK +N+L K IKI DFG+AR E + GT ++AP
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 15/173 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F + R G+ A+KI++ + + ++E + LKH +IV +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
+ +V E+ G + + +R + ++Q L+ + Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN 149
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
IHRD+K +L+ +K+ FGVA + GT +MAP
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRF 201
+G F + + G++ A K L++ + + E+ +L K ++
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINL 94
Query: 202 IGACRKRMVWCIVTEYAKGG--------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
++ EYA GG + + ++ + +KQ L+ G+ Y
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYY 146
Query: 254 VHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +H DLK N+L+ IKI DFG++R + GT ++AP
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 36/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG +Y+ +GE VAIK +L+ +++F+ E+ ++ L H NIVR
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ------------DKRFKNRELQIMRKLDHCNIVR 111
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F + K+ + V +Y +V + L KL + Q R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---R 167
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
+AY+H G HRD+K NLL+ D +K+ DFG A+ V+ E + YR AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-20
Identities = 20/145 (13%), Positives = 46/145 (31%), Gaps = 9/145 (6%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ ++ T VA+ ++ P+ Q+ + L+ + + R
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGVARV 96
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ R +V E+ +GGS+++ A++ +A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
+ +S D + +A
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 34/182 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA ++ ++ A+KI+E+ + + + +EV ML + H N++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
I + + +V E +GGS+ R+ + V V+ VA + ++H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD---VASALDFLH 128
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI--------EVQTEGMTPETGTYRWM 304
G HRDLK +N+L + +KI DF + + T + G+ +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 305 AP 306
AP
Sbjct: 189 AP 190
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 10/147 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNI 198
+G FG ++ G + VAIK++ R EV +L + H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 199 VRFIGACRKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+R + + + +V E + ++T + + + V + + H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR 158
Query: 258 GFIHRDLKSDNLLISADK-SIKIADFG 283
G +HRD+K +N+LI + K+ DFG
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ G+ VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 27 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 82
Query: 203 GACRKRMVWC--------IVTEYA----KG--GSVRQFLTRRQNRAVPLKLAVKQALDVA 248
CR + +V ++ G +V T + +K ++ L
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IKRVMQMLL--- 134
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-----IEVQTEGMTPETGT--Y 301
G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 302 RWMAP 306
R P
Sbjct: 195 R--PP 197
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 40/172 (23%), Positives = 67/172 (38%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ G+ A+K+L +QEV +IV
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCI 87
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + I+ E +GG + + R ++A + A + D+ + ++H
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL D +K+ DFG A+ Q TP T ++AP
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-19
Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 37/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G+FG +++ + E VAIK + ++ N +E+ ++ +KH N+V
Sbjct: 50 NGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVD 96
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F K+ + V EY +V + + KL + Q L R
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
+AY+H +G HRD+K NLL+ +K+ DFG A+I + E + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 39/175 (22%), Positives = 77/175 (44%), Gaps = 30/175 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+G+F + + + A+KI+ + ME Q+E+ L + H NIV+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKR---------MEANTQKEITALKLCEGHPNIVKL 71
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++ +V E GG + ++ + + + +++ + ++++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
+G +HRDLK +NLL + + IKI DFG AR+ + + T + AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL + +K+ DFG A+ +T T ++AP
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 88 SVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGA 147
++ Q + V++ ++++ +D+++ + + +T+ ++ GA
Sbjct: 17 KIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV-GDSTFTVL-KRYQNLKPIGSGA 74
Query: 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----F 201
G + +VAIK L RP N A+ + +E++++ + H NI+ F
Sbjct: 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVF 130
Query: 202 IGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
V+ +V E ++ L + + + Q L G+ ++H
Sbjct: 131 TPQKTLEEFQDVY-LVMELMDANLCQVIQMELDHERMSYL-----LYQML---CGIKHLH 181
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G IHRDLK N+++ +D ++KI DFG+AR + MTP T R+
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RY 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 63/194 (32%), Positives = 85/194 (43%), Gaps = 36/194 (18%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK--ILERPENNPEKAQVM 179
+E Y + L KL +G + +Y+G VA+K LE E P A
Sbjct: 1 METYIK----LDKLG------EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-- 48
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--L 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 49 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNV 102
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGM 294
KL + Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR I +T
Sbjct: 103 KLFLFQLL---RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y 157
Query: 295 TPETGT--YRWMAP 306
E T YR P
Sbjct: 158 DNEVVTLWYR--PP 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-I-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G + +Y+G G VA+K + L+ E P A +E+ ++ LKH NIVR
Sbjct: 15 NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-------REISLMKELKHENIVR 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-------LKLAVKQALDVARGMAY 253
+V E+ +++++ R P +K Q L +G+A+
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
H +HRDLK NLLI+ +K+ DFG+AR I V T + E T YR AP
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYR--AP 177
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 8e-18
Identities = 46/214 (21%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-F------AQGAFGK--LYRG 154
++ + A L +Y + L+ + + L+++ + F +GAF + + +
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214
G+ A+KI+ + ++ +V F++E +L I + A + +V
Sbjct: 83 KQTGQVYAMKIM-NKWDMLKRGEV--SCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GG + L + +P ++A ++ + VH LG++HRD+K DN+L+
Sbjct: 140 MEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198
Query: 275 KSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I++ADFG + GT +++P
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G++ R + A+KI+++ + +P +E+ ++L +H NI+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----------TEEIEILLRYGQHPNIITL 81
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+VTE KGG + ++F + R+ AV + + + + Y+H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITKTVEYLH 133
Query: 256 GLGFIHRDLKSDNLLISADK----SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+L + SI+I DFG A+ + + + T ++AP
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-17
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VA+K + R + E +E+ +L L H NIV+ +
Sbjct: 13 EGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPS---TAIREISLLKELNHPNIVKLL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGF 259
+V E+ +++F+ +PL K + Q L +G+A+ H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---QGLAFCHSHRV 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +IK+ADFG+AR + V+T T E T YR AP
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYR--AP 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 22/163 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRF 201
G GK+ + E A+K+L+ ++EV + +IVR
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPK-----------ARREVELHWRASQCPHIVRI 76
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPE 297
HRD+K +NLL + +K+ DFG A+ E E
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGEKYDKS 178
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+T+ R N+ GA G + +VAIK L RP N A+ + +E
Sbjct: 20 TFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVP 236
++++ + H NI+ F V+ IV E ++ L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHER----- 128
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + Q L G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP
Sbjct: 129 MSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 297 ETGTYRW 303
T R+
Sbjct: 186 YVVT-RY 191
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
L D+ L + E LE +T ++++ + F +GAFG+ + +
Sbjct: 36 CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+KIL K +++++ F++E +L I A +
Sbjct: 96 KNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V +Y GG + L + +P ++A ++ + VH L ++HRD+K DN+L
Sbjct: 149 LYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ + I++ADFG ++ + GT +++P
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + +GE VAIK L RP + A+ + +E+++L ++H N++
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RAYRELLLLKHMQHENVIGLL 89
Query: 201 --FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
F A R + +V + + + + + ++ V Q L +G+
Sbjct: 90 DVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFSEEK-----IQYLVYQML---KGLK 140
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
Y+H G +HRDLK NL ++ D +KI DFG+AR MT T RW
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVT-RW 188
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ N GE A+K + R E E +E+ +L LKH NIV
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTI-------REISILKELKHSNIV 63
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
+ + +V E+ +++ L + K + Q L G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +KIADFG+AR I V+ T E T YR AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR--AP 169
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLNI 198
G++G + G + G VAIK + ++ ++ F E+ +L H NI
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 199 VR----FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDV 247
+ F+ M ++ +VTE + Q + ++ + + + + L
Sbjct: 92 LGLRDIFVHFEEPAMHKLY-LVTELM-RTDLAQVIHDQR---IVISPQHIQYFMYHIL-- 144
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G+ +H G +HRDL N+L++ + I I DF +AR + T RW
Sbjct: 145 -LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-RW 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + R +++ E +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPS---SALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFI 260
+V E+ ++++ P +K + Q L +G+ + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRNVL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
HRDLK NLLI+ + +K+A+FG+AR I V+ + E T YR P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR--PP 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G +G +Y+ G VA+K + R + E +E+ +L L H NIV I
Sbjct: 31 EGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPS---TAIREISLLKELHHPNIVSLID 86
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFIH 261
+V E+ + +++ L + +K+ + Q L RG+A+ H +H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHRILH 142
Query: 262 RDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
RDLK NLLI++D ++K+ADFG+AR I V++ T E T YR AP
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR--AP 188
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIV 199
GA+G +Y+ ++G VA+K + R N + +EV +L L+ H N+V
Sbjct: 19 VGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 200 RFIGACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
R + C +V E+ +R +L + +P K ++Q L RG+
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL---RGL 133
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
++H +HRDLK +N+L+++ ++K+ADFG+ARI +TP T YR AP
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR--AP 188
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 20 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QALDVARGMAYVHGL 257
A + +V ++ + + + ++ ++ L + +K L +G+ Y+H
Sbjct: 79 DAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTL---QGLEYLHQH 131
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK +NLL+ + +K+ADFG+A+ + T + T YR AP
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYR--AP 181
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 36/180 (20%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G+F L R + AIKILE K ++++ V +++ L H
Sbjct: 40 EGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------G 250
V+ + YAK G + +++ + R
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSA 142
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
+ Y+HG G IHRDLK +N+L++ D I+I DFG A+ + E GT ++++P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-17
Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ G D VA+K+L+ + E
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 69
Query: 179 MEQQFQQEV-MMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVP 236
+ E+ +++ HLN+V +GAC K ++ E+ K G++ +L ++N VP
Sbjct: 70 --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
K + +G Y +G I DLK I++ +S + F + E
Sbjct: 128 YKT---KGARFRQGKDY---VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
Query: 297 ETGTYRWMAPSAGSICCG 314
Y+ IC
Sbjct: 182 PEDLYKDFLTLEHLICYS 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTP 296
+ VA+GM ++ IHRDL + N+L+S +KI DFG+AR + + P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 297 ETGTYRWMAP 306
+WMAP
Sbjct: 259 ----LKWMAP 264
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + + VA+K++ N +Q +E+ +L L+
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKR----FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 197 NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
N++ + R + C+ E ++ + + + + + L L K A + + + +
Sbjct: 160 NVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 255 HGLGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
H IH DLK +N LL +S IK+ DFG + E Q
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 42/186 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQ----QEVMMLATLKHLN 197
QG FG + G G VAIK +++ P +F+ Q + LA L H N
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPN 80
Query: 198 IVR----FIGACRKRMV---WCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QAL 245
IV+ F + +V EY ++ + R V +K Q +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 246 DVARGMAYVH--GLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGT-- 300
R + +H + HRD+K N+L+ AD ++K+ DFG A+ +E +
Sbjct: 140 ---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 301 YRWMAP 306
YR AP
Sbjct: 197 YR--AP 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
AL D AL ++ L Y + +R L M + +GAFG+ L R
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+K+L K +++++ F +E ++A +V+ A +
Sbjct: 91 KSTRKVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + N VP K A +V + +H +GFIHRD+K DN+L
Sbjct: 144 LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ +K+ADFG + + +T GT +++P
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 30/162 (18%)
Query: 145 QGAFGKLYRG----TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G +G +Y+ + +D A+K +E A +E+ +L LKH N++
Sbjct: 31 RGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSAC-------REIALLRELKHPNVIS 82
Query: 201 FIGACRKRMVWCI--VTEYA----KGGSVRQFLTRRQNRAVPLKLA-VK----QALDVAR 249
+ + +YA ++ + V L VK Q L
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 37/208 (17%), Positives = 78/208 (37%), Gaps = 60/208 (28%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG + +G+ A+K +L+ + +++ E+ ++ L H+NI++
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQ------------DPRYKNRELDIMKVLDHVNIIK 64
Query: 201 ----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---------------- 240
F + + + +++V + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 241 ---------VKQALDVA----------RGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIA 280
+++ + R + ++H LG HRD+K NLL+ S D ++K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 281 DFGVARIEVQTEGMTPETGT--YRWMAP 306
DFG A+ + +E + YR AP
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--AP 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 41/183 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNI 198
+G +G++Y+ T E VAIK + R E+ E A +EV +L L+H NI
Sbjct: 44 EGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-------REVSLLKELQHRNI 95
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAY 253
+ ++ EY L + ++ + K + Q + G+ +
Sbjct: 96 IELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLI---NGVNF 147
Query: 254 VHGLGFIHRDLKSDNLLISADKS-----IKIADFGVAR---IEVQTEGMTPETGT--YRW 303
H +HRDLK NLL+S + +KI DFG+AR I ++ T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYR- 204
Query: 304 MAP 306
P
Sbjct: 205 -PP 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 53/264 (20%), Positives = 101/264 (38%), Gaps = 32/264 (12%)
Query: 60 VDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
N + L + + + +F+ L + L+ A
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQE---LTRLTHEYLSVAPFADYL 162
Query: 120 PTEGLENYDEWT-IDLRKLNMGTAFA------QGAFGKLY----RGTYNGEDVAIKILER 168
+ + +W ++ + + T F +G FG++ R T G+ A K LE
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRAT--GKMYACKKLE- 218
Query: 169 PENNPEKAQVMEQQFQQEVM----MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
K ++ +++ + + +L + +V A + C+V GG ++
Sbjct: 219 ------KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
+ P AV A ++ G+ +H ++RDLK +N+L+ I+I+D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 285 ARIEVQTEGMTPET--GTYRWMAP 306
A V EG T + GT +MAP
Sbjct: 333 AV-HV-PEGQTIKGRVGTVGYMAP 354
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 22/184 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
W + ++ GA+G + G VAIK L RP + A+ + +E
Sbjct: 20 AWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ +L ++H N++ F + +V + G + + + + ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-GTDLGKLMKHEKLGEDRIQF 132
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
V Q L +G+ Y+H G IHRDLK NL ++ D +KI DFG+AR MT
Sbjct: 133 LVYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVV 187
Query: 300 TYRW 303
T RW
Sbjct: 188 T-RW 190
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 31/167 (18%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR- 200
+G + +++ N E V +KIL +P V +++ ++E+ +L L+ NI+
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKIL-KP--------VKKKKIKREIKILENLRGGPNIITL 96
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ +V E+ +Q + + + + + L + + Y H +
Sbjct: 97 ADIVKDPVSRTPA--LVFEHVNNTDFKQLYQTLTDYDI--RFYMYEIL---KALDYCHSM 149
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G +HRD+K N++I + +++ D+G+A + + R+
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RY 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 94
Query: 201 --FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
F A V+ +VT G + + ++ ++ + Q L RG+ Y+H
Sbjct: 95 DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQIL---RGLKYIH 149
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
IHRDLK NL ++ D +KI DFG+AR + MT T RW
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVAT-RW 194
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNI 198
+G+FGK + + + A+K + K + +E+ +E+ ++ L+H +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V + + M +V + GG +R L +QN + ++ + Y+
Sbjct: 78 VNLWYSFQDEEDM--FMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQN 133
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K DN+L+ + I DF +A + + +T GT +MAP
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNIV 199
G+FG+ L + +G A+KIL+ K +V++ + + E +L + +V
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V EY GG + F R+ A A + Y+H L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +NLLI I++ DFG A R++ +T + TPE +AP
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---A--LAP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G FG+ + G+ A K L K ++ +++ Q M +LA + I
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLN-------KKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG 256
V A + C+V GG +R + N A+ + G+ ++H
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +N+L+ D +++I+D G+A E++ + GT +MAP
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAP 358
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLN 197
G+FG+ L R +NG A+K+L+ K V+ + Q E +ML+ + H
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLK-QVEHTNDERLMLSIVTHPF 67
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G + ++ +Y +GG + L R+ R P +A A +V + Y+H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQR-FPNPVAKFYAAEVCLALEYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +N+L+ + IKI DFG A + T + TP+ Y +AP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD---Y--IAP 172
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 41/182 (22%), Positives = 71/182 (39%), Gaps = 32/182 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
G++G + VAIK + R + + + +E+ +L L H ++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LREIAILNRLNHDHVVKVL 118
Query: 201 --FIGACRKRM--VWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
I ++ ++ +V E A + +LT +K + L
Sbjct: 119 DIVIPKDVEKFDELY-VVLEIADSDFKKLFRTP---VYLTELH-----IKTLLYNLL--- 166
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSA 308
G+ YVH G +HRDLK N L++ D S+K+ DFG+AR E +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 309 GS 310
Sbjct: 227 LV 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT---YNGEDVAIKILERPEN 171
M+ + Y+ + ++ +GA+GK+++ G VA+K + R +
Sbjct: 1 MEKDGLCRADQQYEC----VAEIG------EGAYGKVFKARDLKNGGRFVALKRV-RVQT 49
Query: 172 N----PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWC-----IVTEYAK 219
P +EV +L L+ H N+VR C +V E+
Sbjct: 50 GEEGMPLSTI-------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102
Query: 220 GGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +L + VP K + Q L RG+ ++H +HRDLK N+L+++
Sbjct: 103 Q-DLTTYLDKVPEPGVPTETIKDMMFQLL---RGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 277 IKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
IK+ADFG+ARI +T T YR AP
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYR--AP 188
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 5e-14
Identities = 40/231 (17%), Positives = 71/231 (30%), Gaps = 59/231 (25%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENN 172
H PTE L+ K+ +G FG++++ + VAIKI +E P+
Sbjct: 13 FSHCLPTEKLQR-------CEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 173 PEKAQVMEQQFQQEVMMLATLKHL---------NIVRFIGAC------------------ 205
Q ++ E+++ L L +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 206 ------------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K IV E+ GG + + + + K + Q + +A
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ---LTASLAV 176
Query: 254 VH-GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYR 302
L F HRDL N+L+ K+ + + + G+ Y
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 28/175 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G FGK L R G A+KIL K ++ + + + L +H
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILR-------KEVIIAKD-EVAHTVTESRVLQNTRHPF 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ A + C V EYA GG + F + R + A ++ + Y+H
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RD+K +NL++ D IKI DFG+ + EG++ GT ++AP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 174
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 24/178 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
G+FG +Y GT GE+VAIK+ E + Q E + ++ + I
Sbjct: 19 SGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V E G S+ L +R LK + A + + Y+H FIH
Sbjct: 71 RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 262 RDLKSDNLLISADK---SIKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPSA 308
RD+K DN L+ K + I DFG+A+ + +T P TGT R+ + +
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 26/179 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++G +Y ++VAIK + R + + + +E+ +L LK I+R
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RILREITILNRLKSDYIIRLY 91
Query: 201 --FIGACRKRM--VWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
I + ++ IV E A K FLT +K + L G
Sbjct: 92 DLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEH-----IKTILYNLL---LGE 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310
++H G IHRDLK N L++ D S+K+ DFG+AR + P +
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + E VAIKI++ N Q Q EV +L +
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIK---NKKA----FLNQAQIEVRLLELMNKHDTEMKY 116
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV R C+V E ++ L R V L L K A + + ++
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 257 --LGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
L IH DLK +N LL + +S IKI DFG + Q
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + N VAIK + E+ Q Q+ +E+ +L +H NI+
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGIN 91
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
++M V+ IV + + + L + L + Q L RG+
Sbjct: 92 DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLL-----KTQHLSNDHICYFLYQIL---RGL 141
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H +HRDLK NLL++ +KI DFG+AR+ T +T T RW
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-RW 196
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 511
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 49/182 (26%), Positives = 71/182 (39%), Gaps = 26/182 (14%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIV 199
G FG+L G Y E VAIK+ E + Q E L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +V E G S+ L +R LK + A+ + M YVH
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 260 IHRDLKSDNLLI-----SADKSIKIADFGVAR--IEVQTEGMTPE------TGTYRWMAP 306
I+RD+K +N LI + I I DF +A+ I+ +T+ P TGT R+M+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 307 SA 308
+
Sbjct: 187 NT 188
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 20/188 (10%), Positives = 61/188 (32%), Gaps = 32/188 (17%)
Query: 145 QGAFGKLYRGT----------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+ G LY + ++K+ + ++ + Q + + + K
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-D-AKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAK--------GGSVRQFLTRRQNRAVPLKLAVKQALD 246
L + + V + G S++ L + + ++ A
Sbjct: 110 KLYSTPLLAIPT--CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTP 296
+ + ++H ++H ++ ++N+ + + + +A +G A + +P
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 297 ETGTYRWM 304
G ++
Sbjct: 228 HEGDLEFI 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN- 197
+G FG++Y R G+ A+K L+ K ++ +Q + + ML+ + +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 198 --IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV A + + GG + L Q+ A ++ G+ ++H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKHLNI 198
+G FGK L + G A+KIL+ K ++ + + L +H +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
+ + C V EYA GG + F + R A ++ + Y+H
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + EG+ GT ++AP
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 318
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM------LATLKHL 196
+G+FGK L R G+ A+K+L+ K +++ E M H
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDD-DVECTMTEKRILSLARNHP 84
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V E+ GG + +++R A A ++ + ++H
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+L+ + K+ADFG+ + EG+ GT ++AP
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 35/167 (20%), Positives = 66/167 (39%), Gaps = 36/167 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
G F ++ N VA+KI+ +V + + E+ +L +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 197 -----NIVR------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
+I++ G + +V E G ++ + + ++R +PL + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--VMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 246 DVARGMAYVH-GLGFIHRDLKSDNLLIS------ADKSIKIADFGVA 285
+ G+ Y+H G IH D+K +N+L+ IKIAD G A
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+K+++ K V + + V H
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 72 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 179
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 40/169 (23%)
Query: 145 QGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+GAFGK+ G VA+KI++ N + + E+ +L L
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVK---NVDR----YCEAARSEIQVLEHLNTTDPNST 76
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V+ + + CIV E G S F+ L K A + + + +
Sbjct: 77 FRCVQMLEWFEHHGHI--CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 254 VHGLGFIHRDLKSDNLLIS-------------------ADKSIKIADFG 283
+H H DLK +N+L + IK+ DFG
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+++++ K V + + V H
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 115 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 31/177 (17%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L + AIK L+ K V+ + M+ +H
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 198 IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+ ++ + V EY GG + + L A A ++ G+ ++H
Sbjct: 80 LTHMFCTFQTKENL--FFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + E M + GT ++AP
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAP 187
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 40/183 (21%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + T+ GE VAIK + P + P A + +E+ +L KH NI+
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFAL----RTLREIKILKHFKHENIITIF 75
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
+ V+ I+ E + + + L + + Q L R +
Sbjct: 76 NIQRPDSFENFNEVY-IIQELM-QTDLHRVI-----STQMLSDDHIQYFIYQTL---RAV 125
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----------EVQTEGMTPETGT 300
+HG IHRDLK NLLI+++ +K+ DFG+ARI Q GM T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 301 YRW 303
RW
Sbjct: 186 -RW 187
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
+G+FG ++ GT N + VAIK E + Q + E L I
Sbjct: 20 EGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G S+ L R +K A + + +H ++
Sbjct: 72 YYFGQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 262 RDLKSDNLLISADKS-----IKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPSA 308
RD+K DN LI S I + DFG+ + + T+ P +GT R+M+ +
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 189
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
GA+GK++ G G+ A+K+L+ KA ++++ E L ++
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIR 116
Query: 195 HLN-IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+V A ++ ++ +Y GG + F Q ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKL--HLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ V E GT +MAP
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 24/178 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
G+FG++Y GT E+VAIK+ E + Q E + L+ I
Sbjct: 17 SGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V + G S+ L +R + LK + A + + +VH F+H
Sbjct: 69 RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPSA 308
RD+K DN L+ + + I DFG+A+ + T P TGT R+ + +
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 37/171 (21%), Positives = 59/171 (34%), Gaps = 40/171 (23%)
Query: 145 QGAFGKLYR---GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+G FGK+ VA+KI+ N + + + E+ +L +K
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIR---NVGK----YREAARLEINVLKKIKEKDKENK 81
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V M CI E G + +FL + PL A + + +
Sbjct: 82 FLCVLMSDWFNFHGHM--CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 254 VHGLGFIHRDLKSDNLLISADK-------------------SIKIADFGVA 285
+H H DLK +N+L + SI++ADFG A
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 7e-12
Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
+G +GK++ G G+ A+K+L+ KA ++ L +K
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 195 HLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
H IV I A ++ ++ EY GG + F+ + A +++ +
Sbjct: 80 HPFIVDLIYAFQTGGKL--YLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++H G I+RDLK +N++++ +K+ DFG+ + + +T T GT +MAP
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAP 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L R A+K+L+ K +++++ ++ +M L +KH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A ++A + Y+H L
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +N+L+ + I + DFG+ + E + + GT ++AP
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAP 208
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 40/184 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
G G ++ + VAIK K + + Q + E+ ++ L H NI
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK----------KIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 199 VR---FIGACRKRMVWC-----------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
V+ +G ++ IV EY + L + +L + Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARI----EVQTEGMTPETG 299
L RG+ Y+H +HRDLK NL I + D +KI DFG+ARI ++
Sbjct: 130 L---RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 300 TYRW 303
T +W
Sbjct: 187 T-KW 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKH 195
QG+FGK++ G+ + A+K+L+ KA + + + M L + H
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRD-RVRTKMERDILVEVNH 85
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV+ A + ++ ++ +GG + F + + ++A + ++H
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E + GT +MAP
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAP 195
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 32/173 (18%), Positives = 66/173 (38%), Gaps = 44/173 (25%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-----N 197
G FG++ N + A+K++ N + + + E +L +++ N
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVR---NIKK----YTRSAKIEADILKKIQNDDINNNN 97
Query: 198 IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G M C++ E G S+ + +TR ++ +++ + + Y+
Sbjct: 98 IVKYHGKFMYYDHM--CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 256 GLGFIHRDLKSDNLLI-------------------------SADKSIKIADFG 283
+ H DLK +N+L+ + IK+ DFG
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA+G +++ GE VA+K + N AQ + +E+M+L L H NIV
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RTFREIMILTELSGHENIVNL 74
Query: 202 IGACR---KRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+ R R V+ +V +Y + L + V Q + +
Sbjct: 75 LNVLRADNDRDVY-LVFDYMETDLHAVIRA----NILEPVH-----KQYVVYQLI---KV 121
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPS 307
+ Y+H G +HRD+K N+L++A+ +K+ADFG++R V +T
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 35/186 (18%), Positives = 64/186 (34%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVM---MLATLKHLN 197
G FG +Y E A + +E EN P E +F Q V +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERK 103
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGS---VRQFL------TRRQNRAVPLKLAVKQALDVA 248
+ ++G +TE+ V + L QN ++ + +
Sbjct: 104 QLDYLGIPL--FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTPET 298
+ Y+H ++H D+K+ NLL+ + +AD+G++ + Q
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 299 GTYRWM 304
GT +
Sbjct: 222 GTIEFT 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 37/213 (17%), Positives = 82/213 (38%), Gaps = 29/213 (13%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
+ + + ++ +RKL G + L + VA+K+++ E+ E
Sbjct: 24 GGYHLVKIGDLFNGRYHVIRKLGWGHF----STVWLSWDIQGKKFVAMKVVKSAEHYTET 79
Query: 176 AQVMEQQFQQEVMMLATLKHLN--------IVRFI------GACRKRMVWCIVTEYAKGG 221
A E+ +L ++++ + +V+ + G + C+V E G
Sbjct: 80 AL-------DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI--CMVFEVL-GH 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIA 280
+ +++ + + +PL K V +G+ Y+H IH D+K +N+L+S ++
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSICC 313
A ++ P +AG+
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 222
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 32/190 (16%), Positives = 63/190 (33%), Gaps = 36/190 (18%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQ--VMEQQFQQEV---MMLATLKHLNI 198
QG FG +Y + E V + P E +F Q +
Sbjct: 45 QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 199 VRFIGACRKRMVWCIVTEYAKG----------GSVRQFLTRRQNRAVPLK----LAVKQA 244
++++G + + + GS Q + + K L++ +
Sbjct: 105 LKYLGVPK--YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-RI 161
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--IEVQTEGMTPE--- 297
LD+ + Y+H ++H D+K+ NLL++ + + D+G+A
Sbjct: 162 LDI---LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 298 ---TGTYRWM 304
GT +
Sbjct: 219 RCHDGTIEFT 228
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 37/184 (20%), Positives = 69/184 (37%), Gaps = 23/184 (12%)
Query: 118 RYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE- 174
Y T+ +E N+ + ++ +GA + R +Y DV IK +++ +
Sbjct: 318 NYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL 377
Query: 175 KAQVMEQQFQQEVMMLATLKHLNI----VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+ + + +E LA +K I + + KR I+ Y G + +
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR----IMMSYINGKLAKDVIEDN 433
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ A + + +H IH DL + N + DK + I DFG+ +I
Sbjct: 434 LDIAY----------KIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481
Query: 291 TEGM 294
E
Sbjct: 482 DEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.98 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.98 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.14 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.44 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.61 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 96.27 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 96.26 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 95.89 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 95.52 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 95.41 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 95.17 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 94.99 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 94.66 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 94.65 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 94.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.28 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 94.26 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 94.23 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 93.86 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 93.79 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 93.66 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 93.37 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 93.32 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 93.17 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 93.14 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 93.06 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 92.85 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 92.77 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 92.24 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 91.59 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 91.54 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 91.5 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 91.25 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 91.13 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 91.06 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 90.35 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 90.25 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 90.19 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 89.76 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 89.64 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 89.24 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 89.23 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 88.82 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 88.58 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 88.0 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 88.21 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 88.18 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.73 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 87.61 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 87.57 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 87.26 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 86.73 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 86.59 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 86.56 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 86.28 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 86.27 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 86.17 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 85.51 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 84.84 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 84.52 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 84.11 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.1 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 81.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 81.14 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 80.54 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=323.24 Aligned_cols=179 Identities=33% Similarity=0.615 Sum_probs=151.5
Q ss_pred CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..+.|+|+.+++++++.||+|+||+||+|++.+ .||||+++......+. .+.|.+|+.++++++|||||++++++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 346799999999999999999999999999865 5999999765544332 46899999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.++ .+|||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||+++++.+||+|||+|
T Consensus 102 ~~~-~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 102 TKD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CSS-SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred ECC-eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 654 579999999999999999764 346999999999999999999999999999999999999999999999999999
Q ss_pred eeeecC---CCccCCCCCccccccCcccc
Q 021253 286 RIEVQT---EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~---~~~~~~~gt~~y~APE~~~~ 311 (315)
+..... ......+||+.|||||++..
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHC
T ss_pred eecccCCcceeecccccCCCccCHHHhhc
Confidence 865432 22345689999999999853
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=327.61 Aligned_cols=175 Identities=23% Similarity=0.376 Sum_probs=150.2
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..++|++++.||+|+||+||+|++ +++.||||+++........ .+.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999998 6899999999876554432 4678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+|||||||+||+|.+++...+...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999877666789999999999999999999999999999999999999999999999999987543
Q ss_pred CC-CccCCCCCccccccCcccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~ 311 (315)
.. .....+||+.|||||++.+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT
T ss_pred CcccccccCCCccccCHHHHCC
Confidence 32 2344679999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.79 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=151.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46799999999999999999998 78899999997532111 11236789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
||||||++||+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999999875 45999999999999999999999999999999999999999999999999999976432
Q ss_pred C---CccCCCCCccccccCcccc
Q 021253 292 E---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~---~~~~~~gt~~y~APE~~~~ 311 (315)
. ...+.+||+.|||||++..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcC
Confidence 2 2456789999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=319.14 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=150.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.+.|++.+.||+|+||+||+|++ +++.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35688899999999999999998 68999999997644332 24678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|||||||++|+|.+++.+ ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 147 ~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999999975 34899999999999999999999999999999999999999999999999999875443
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|||||++..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISR 244 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTT
T ss_pred CCcccccccCcCcCCHHHHCC
Confidence 34567899999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=315.83 Aligned_cols=178 Identities=28% Similarity=0.468 Sum_probs=152.4
Q ss_pred cccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
-++|+..++++.+.||+|+||+||+|++ +++.||||+++....... .++|.+|+.++++++|||||++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCc
Confidence 3567888999999999999999999987 357899999975433222 3579999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 021253 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (315)
Q Consensus 202 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (315)
+|+|.+.+.++||||||++|+|.++|.... ...+++..++.|+.||+.||+|||+++||||||||+
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999999999997542 235899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 268 NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 268 NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
||||++++.+||+|||+|+...... .....+||+.|||||++..
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 9999999999999999998643322 2345679999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.63 Aligned_cols=172 Identities=25% Similarity=0.433 Sum_probs=136.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|++.+.||+|+||+||+|++ +++.||||++++....... ..+++.+|+.++++++|||||++++++.+.+.+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5788999999999999999987 6899999999865443222 2357899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
|||||+ +|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999999 67999999764 459999999999999999999999999999999999999999999999999998766555
Q ss_pred CccCCCCCccccccCccccc
Q 021253 293 GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~ 312 (315)
...+.+||+.|||||++.+.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~ 186 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGK 186 (275)
T ss_dssp --------CTTSCHHHHSSS
T ss_pred ccCCeeECcccCChhhhcCC
Confidence 56678999999999998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=315.48 Aligned_cols=176 Identities=28% Similarity=0.465 Sum_probs=149.8
Q ss_pred ccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
+.|+.++|.+.+.||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||+++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D----NARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 457889999999999999999999986 36789999997532 1 1246799999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli 271 (315)
++|.+.+.+|||||||++|+|.++|.... ...+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 99999999999999999999999997632 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 272 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+.++.+||+|||+|+....... .....||+.|||||++..
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 9999999999999986433222 123468999999998863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=321.39 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=151.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.+.|++.+.||+|+||.||+|++ +++.||||++........ +.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG------GGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 46789999999999999999998 689999999986544332 4688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|||||||+||+|.+++... .+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999999999753 4899999999999999999999999999999999999999999999999999875433
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|||||++..
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISR 321 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTT
T ss_pred CccccccccCcCcCCHHHHCC
Confidence 34566789999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.00 Aligned_cols=178 Identities=32% Similarity=0.497 Sum_probs=146.8
Q ss_pred ccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
..+.|+.+++.+.++||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E----SARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H----HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H----HHHHHHHHHHHHHHhCCCCCCCc
Confidence 34567888999999999999999999986 36789999996532 1 12468999999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (315)
++++|.+...+|||||||++|+|.+++.+.. ...+++..++.|+.||+.||+|||+++||||||||+
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 9999999999999999999999999997642 235899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 268 NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 268 NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
|||++.++.+||+|||+|+...... .....+||+.|||||++..
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 9999999999999999998653322 1234579999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=306.05 Aligned_cols=170 Identities=29% Similarity=0.472 Sum_probs=146.9
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CC
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RM 209 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 209 (315)
.|++.+.||+|+||.||+|.+ +++.||+|++......... .++|.+|+.++++++|||||++++++.. ..
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 356778899999999999998 6789999999765544332 4679999999999999999999999865 35
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEc-CCCcEEEeeeccee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVAR 286 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~-~~~~vkl~DFG~a~ 286 (315)
.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 689999999999999999865 45899999999999999999999998 99999999999998 47899999999998
Q ss_pred eeecCCCccCCCCCccccccCccccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
..... ...+.+||+.|||||++...
T Consensus 181 ~~~~~-~~~~~~GTp~YmAPE~~~~~ 205 (290)
T 3fpq_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTC
T ss_pred eCCCC-ccCCcccCccccCHHHcCCC
Confidence 64333 34567899999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=314.28 Aligned_cols=175 Identities=22% Similarity=0.350 Sum_probs=146.1
Q ss_pred cccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.++.++|++++.||+|+||+||+|+. +++.||||++++....... ..++.+|+.+|++++|||||++++++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 35668899999999999999999986 4678999999764432221 13577899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+++.+||||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999999999875 45999999999999999999999999999999999999999999999999999
Q ss_pred eeeecC-CCccCCCCCccccccCcccc
Q 021253 286 RIEVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
+..... ......+||+.|||||++..
T Consensus 174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 174 KESIDHEKKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp EC-----CCCCSCCCCGGGCCHHHHHT
T ss_pred eeccCCCccccccccCcccCCHHHhcc
Confidence 864332 33456789999999998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=312.58 Aligned_cols=168 Identities=26% Similarity=0.295 Sum_probs=145.7
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
....+.|++.++||+|+||+||+|++ +++.||||+++.... ..+|+.+++.++|||||++++++.+.
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34556788899999999999999998 689999999976432 23799999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~ 287 (315)
+.+|||||||+||+|.+++++. ..+++..++.++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+.
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 9999999999999999999875 4599999999999999999999999999999999999999887 699999999987
Q ss_pred eecCCC------ccCCCCCccccccCcccc
Q 021253 288 EVQTEG------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~------~~~~~gt~~y~APE~~~~ 311 (315)
...... ....+||+.|||||++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTT
T ss_pred ccCCCcccceecCCccccCccccCHHHHCC
Confidence 543221 123579999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.24 Aligned_cols=172 Identities=24% Similarity=0.429 Sum_probs=137.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (315)
.+|++.+.||+|+||+||+|++ +++.||||+++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 5688999999999999999998 6889999999754321 22367899999999999999999999987544
Q ss_pred ---------EEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 210 ---------VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 210 ---------~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
.+||||||+++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999986432 23456778899999999999999999999999999999999999999
Q ss_pred eeecceeeeecCC-------------CccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTE-------------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~-------------~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+|+...... ..+..+||+.|||||++.+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 9999998654321 1234579999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=315.51 Aligned_cols=180 Identities=28% Similarity=0.531 Sum_probs=153.1
Q ss_pred CccccccccccccccceeecccCceEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCe
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI 198 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 198 (315)
.++|+|+.++|++++.||+|+||+||+|++.+ +.||||.++......+ .+.|.+|+.+|++++| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----HHHHHHHHHHHHHcCCCCcE
Confidence 46799999999999999999999999998732 5799999976443221 3679999999999965 899
Q ss_pred eeEEEEEEeC-CEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 199 VRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 199 v~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
|+++++|.+. ..+|||||||++|+|.++|+... ...+++..++.++.||+.||+|||+++|||||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999999764 56899999999999999997642 23488999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
|||+|||+++++.+||+|||+|+....... ....+||+.|||||++..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 999999999999999999999986543322 234578999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=300.26 Aligned_cols=167 Identities=34% Similarity=0.517 Sum_probs=139.2
Q ss_pred cccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----E
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 210 (315)
++|.+.+.||+|+||+||+|+++|+.||||+++... .. ...+..|+..+.+++|||||+++++|.+.+ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 567888999999999999999999999999986421 11 123345666677899999999999998653 6
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCCEEEcCCCcEEEeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+|||||||++|+|.++++.. .+++..+++++.|++.||+|||++ +||||||||+|||++.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 89999999999999999763 489999999999999999999987 8999999999999999999999999
Q ss_pred cceeeeecCCC-----ccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEG-----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~-----~~~~~gt~~y~APE~~~~ 311 (315)
|+|+....... ....+||+.|||||++.+
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcc
Confidence 99987654322 223579999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.50 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=202.2
Q ss_pred HHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCch
Q 021253 33 YQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDD 108 (315)
Q Consensus 33 ~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~ 108 (315)
.+....|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +.+++. ....|. ...+.| ....+
T Consensus 121 l~~~~~G~fLvR~s~~---~~~~~~lsv~~~---------~~v~h~~I~~~~~g~~~~~-~~~~F~sl~eLv~~~~~~~~ 187 (495)
T 1opk_A 121 LSSGINGSFLVRESES---SPGQRSISLRYE---------GRVYHYRINTASDGKLYVS-SESRFNTLAELVHHHSTVAD 187 (495)
T ss_dssp GGGCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTTSCEESS-TTSCBSSHHHHHHHHTTCCT
T ss_pred hhCCCCceEEEEeCCC---CCCceEEEEeeC---------CeEEEEEEEecCCCceEec-cCccchhHHHHhhhhccccc
Confidence 3333479999998876 578999999952 267999998765 556554 333332 222332 33445
Q ss_pred HHHHHHhcCCCCC------CCCCCCccccccccccccccceeecccCceEEEEEC--CeeEEEEEeeCCCCChhHHHHHH
Q 021253 109 ALAQALMDHRYPT------EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVME 180 (315)
Q Consensus 109 ~l~~~l~~~~~~~------~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~ 180 (315)
+++..+..++... .....++.|++...+|++.+.||+|+||.||+|.+. +..||||+++..... .
T Consensus 188 g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~ 260 (495)
T 1opk_A 188 GLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------V 260 (495)
T ss_dssp TSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------H
T ss_pred ccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------h
Confidence 5544443333211 111246889999999999999999999999999984 789999999765433 2
Q ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 021253 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260 (315)
Q Consensus 181 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (315)
+.|.+|+.++++++||||+++++++.....+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+
T Consensus 261 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 340 (495)
T 1opk_A 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340 (495)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 57889999999999999999999999999999999999999999999876666789999999999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeeecCC--CccCCCCCccccccCccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
||||||+|||++.++.+||+|||+++...... ......+++.|+|||++.
T Consensus 341 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred cCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence 99999999999999999999999998654322 122334678999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=312.31 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=201.1
Q ss_pred cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCchHHHH
Q 021253 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (315)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~ 112 (315)
-.|+|+++.|+. ..|.|++|++..+... ...++|+.|.... +.|++. ....|. ...+.+ ....++++.
T Consensus 92 ~~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~H~~I~~~~~g~~~i~-~~~~F~sl~eLv~~y~~~~~~l~~ 163 (454)
T 1qcf_A 92 MLGSFMIRDSET---TKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQ 163 (454)
T ss_dssp CTTCEEEEECSS---STTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSS
T ss_pred CCceEEEEECcC---CCCeEEEEEEecccCC----CCceEEEEEEEcCCCcEEEe-CccccCCHHHHHHHHHhccCCccc
Confidence 369999998875 5789999998754332 2367899998765 667665 333342 122222 334455555
Q ss_pred HHhcCCCCCCC--CCCCccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021253 113 ALMDHRYPTEG--LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (315)
Q Consensus 113 ~l~~~~~~~~~--~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (315)
.+..++..... ....+.|+++.++|++.+.||+|+||.||+|.+ .+..||||+++..... .+.|.+|+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~ 236 (454)
T 1qcf_A 164 KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANV 236 (454)
T ss_dssp CCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHH
T ss_pred cccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHH
Confidence 55555543222 224678999999999999999999999999999 5788999999764432 2578999999
Q ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCE
Q 021253 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (315)
++.++||||+++++++. ...+++||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 99999999999999987 55679999999999999999865444688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeeecCC--CccCCCCCccccccCccc
Q 021253 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 270 li~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|++.++.+||+|||+|+...... ......+|+.|+|||++.
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc
Confidence 99999999999999998643221 123345678999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.49 Aligned_cols=177 Identities=19% Similarity=0.262 Sum_probs=150.4
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+.+++|++++.||+|+||+||+|+. +++.||||++.+................+++.+++.++|||||++++++.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4567899999999999999999998 78999999997532221111112223334567778889999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+||||||++||+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999999875 459999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ...+.+||+.|||||++..
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHST
T ss_pred CC-CCCCccCCcCccCHHHHhC
Confidence 43 3456799999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.06 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=194.6
Q ss_pred cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceeeeeceeeec--CCceee-ccCchHHHHH
Q 021253 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (315)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (315)
..|+|++++|++ ..|.+++++... ..++|+.|....+.+++. ....|. ...+.+ ....++++..
T Consensus 100 ~~G~FlvR~S~~---~~g~~~Lsv~~~---------~~v~H~~I~~~~~~~~i~-~~~~F~sl~eLv~~y~~~~~~~~~~ 166 (450)
T 1k9a_A 100 ETGLFLVRESTN---YPGDYTLCVSCE---------GKVEHYRIMYHASKLSID-EEVYFENLMQLVEHYTTDADGLCTR 166 (450)
T ss_dssp CTTEEEEEECSS---STTSEEEEEECS---------SSEEEEEEEEETTEEESS-SSSCBSSHHHHHHHHHHCCTTSSSC
T ss_pred CCceEEEEecCC---CCCceEEEEEeC---------CeeeEEEEEecCCceEec-cccccccHHHHHhhhcccccchhhh
Confidence 569999998875 578899999741 146888886555667765 223332 112222 2233444433
Q ss_pred HhcCCCCCCCCC-----CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH
Q 021253 114 LMDHRYPTEGLE-----NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (315)
Q Consensus 114 l~~~~~~~~~~~-----~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (315)
+..++....... ..+.|+++.++|++.+.||+|+||.||+|.++++.||||+++.... .+.|.+|+.
T Consensus 167 l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~ 238 (450)
T 1k9a_A 167 LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEAS 238 (450)
T ss_dssp CCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHH
T ss_pred ccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHH
Confidence 333332221110 1467999999999999999999999999999999999999976431 247889999
Q ss_pred HHHhCCCCCeeeEEEEEEeCC-EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 021253 189 MLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (315)
Q Consensus 189 ~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (315)
++++++||||+++++++.... .+|+||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 999999999999999987765 7899999999999999999876556799999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 268 NLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 268 NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||++.++.+||+|||+++..... .....+++.|+|||++..
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE 360 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHS
T ss_pred hEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC
Confidence 999999999999999999854322 223467899999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.51 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=197.0
Q ss_pred CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCchHHHHH
Q 021253 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (315)
.|+|+++.|++ ..|.|++||+..+... ...++|+.|+... +.|++. ....|. +..+.+ ....++++..
T Consensus 88 ~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~~~-~~~~F~Sl~~Li~~y~~~~~~l~~~ 159 (452)
T 1fmk_A 88 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 159 (452)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-TTSEESSHHHHHHHHTTCCTTSSSC
T ss_pred CceEEEEeCCC---CCCceEEEEEeeccCC----CCcEEEEEEEEcCCCCEEEe-cCcccCCHHHHHHHhhhccccchhh
Confidence 39999998876 5789999998654321 1367999998765 667765 333442 233332 3455566655
Q ss_pred HhcCCCCC---CCCCCCccccccccccccccceeecccCceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021253 114 LMDHRYPT---EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (315)
Q Consensus 114 l~~~~~~~---~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (315)
+..++... ......+.|+++.++|++.+.||+|+||.||+|.+. +..||||+++...... +.|.+|+.+
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 232 (452)
T 1fmk_A 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 232 (452)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHH
T ss_pred ccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH-------HHHHHHHHH
Confidence 55554321 111236789999999999999999999999999995 4689999997654332 468899999
Q ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCE
Q 021253 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (315)
+++++||||+++++++.+ ...++||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999999999876 5679999999999999999865445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeeecCCC--ccCCCCCccccccCccc
Q 021253 270 LISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 270 li~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
|++.++.+||+|||+++....... .....+++.|+|||++.
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 354 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354 (452)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred EECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh
Confidence 999999999999999986543221 22335678999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.51 Aligned_cols=171 Identities=25% Similarity=0.342 Sum_probs=147.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
++|++++.||+|+||+||+|++ +++.||||+++........ .+.+.+|+.+|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 5799999999999999999998 6899999999765444332 3578899999999999999999999864
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
...+|||||||+ |+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 357899999996 6899999753 569999999999999999999999999999999999999999999999999998
Q ss_pred eeec-----CCCccCCCCCccccccCccccc
Q 021253 287 IEVQ-----TEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 287 ~~~~-----~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.... .......+||+.|||||++.+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCC
Confidence 6432 2234567899999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=313.22 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=201.1
Q ss_pred CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCchHHHHH
Q 021253 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (315)
.|+|+++.|+. ..|.|++||+...... ...++|+.|+... +.|++. ....|. ...+.+ ..+.++++..
T Consensus 171 ~G~FLvR~S~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~i~-~~~~F~SL~eLv~~y~~~~~~~~~~ 242 (535)
T 2h8h_A 171 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 242 (535)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEBC-CCSCEEEE-TTEEESSHHHHHHHHHHCCTTSSSC
T ss_pred CCeEEEEecCC---CCCcEEEEEEeeccCC----CCceEEEEEEEcCCCcEEee-ccccccChHHhheeeccccCccccc
Confidence 49999998876 5789999998644221 1367999998865 667776 334443 233332 4455666655
Q ss_pred HhcCCCCC---CCCCCCccccccccccccccceeecccCceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021253 114 LMDHRYPT---EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (315)
Q Consensus 114 l~~~~~~~---~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (315)
+..+|... ......+.|+++.++|++.+.||+|+||.||+|++. +..||||+++...... +.|.+|+.+
T Consensus 243 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 315 (535)
T 2h8h_A 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 315 (535)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHH
T ss_pred cccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH-------HHHHHHHHH
Confidence 55554321 111236789999999999999999999999999995 4689999998654332 468899999
Q ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCE
Q 021253 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (315)
|++++||||+++++++.+ ..+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 999999999999999876 5679999999999999999865445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeeecCC--CccCCCCCccccccCccc
Q 021253 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 270 li~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|++.++.+||+|||+++...... ......+++.|+|||++.
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 437 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc
Confidence 99999999999999998643221 122345678999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=287.48 Aligned_cols=165 Identities=23% Similarity=0.374 Sum_probs=141.3
Q ss_pred cccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (315)
+.|++.+.||+|+||.||+|+. +++.||||.+..... ..++.+|+.+|+.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 5689999999999999999976 367899999865332 13577999999998 699999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG~a~~ 287 (315)
+.+||||||+++|+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999984 38999999999999999999999999999999999999876 7999999999985
Q ss_pred eecC-----------------------------CCccCCCCCccccccCccccc
Q 021253 288 EVQT-----------------------------EGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 288 ~~~~-----------------------------~~~~~~~gt~~y~APE~~~~~ 312 (315)
..+. ...++.+||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 4321 113445899999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.45 Aligned_cols=171 Identities=22% Similarity=0.411 Sum_probs=152.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+++|++++.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 46899999999999999999998 7889999999764321 135788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC--CcEEEeeecceeeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~--~~vkl~DFG~a~~~~ 289 (315)
|||||||+||+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999653 3468999999999999999999999999999999999999854 899999999999876
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|||||++.+
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTT
T ss_pred CCCceeeeEECccccCHHHhCC
Confidence 6555666799999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.00 Aligned_cols=268 Identities=25% Similarity=0.386 Sum_probs=189.7
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -..+....+ -.|+|++++|.+ .+ .|++|+... ..++|+.|+..++.|
T Consensus 13 ~~wyhg~i~---------r~~a~~lL~--~~G~flvR~s~~---~~-~~~lsv~~~---------~~~~h~~i~~~~~~~ 68 (377)
T 3cbl_A 13 QLWYHGAIP---------RAEVAELLV--HSGDFLVRESQG---KQ-EYVLSVLWD---------GLPRHFIIQSLDNLY 68 (377)
T ss_dssp CTTBCTTCC---------HHHHHHHCC--STTEEEEEECC-----C-CEEEEC--------------CCEEEC----CCC
T ss_pred CCccCCCCC---------HHHHHHHHh--cCCCEEEEEeCC---CC-cEEEEEEEC---------CCccchhhccccceE
Confidence 378888775 223323332 469999999875 33 899999842 256899998766555
Q ss_pred eeeeceeeec--CCceeecc-CchHHHHHHhcCCCCCCCCCCCccccccccccccccceeecccCceEEEEE--CCeeEE
Q 021253 88 SVSVGQSVFR--PGKVTHAL-NDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVA 162 (315)
Q Consensus 88 ~i~~~~~~~~--~~~v~~~~-~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~va 162 (315)
.+. ...|. +..+.|.. +.+.+... ...........+.|.++.++|++.+.||+|+||.||+|++ +++.||
T Consensus 69 ~~~--~~~F~sl~~LI~~y~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va 143 (377)
T 3cbl_A 69 RLE--GEGFPSIPLLIDHLLSTQQPLTKK---SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143 (377)
T ss_dssp CC------CCSHHHHHHHHHHHTCCC--------CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEE
T ss_pred Eec--ceeccchHHHHHHHhhccCCcccc---cCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEE
Confidence 443 12231 22222211 11111000 0011111123578999999999999999999999999998 588999
Q ss_pred EEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHH
Q 021253 163 IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242 (315)
Q Consensus 163 vK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 242 (315)
||+++.... . ...+.+.+|+.+++.++||||+++++++.....+|+||||+++++|.+++.... ..+++..++.
T Consensus 144 vK~~~~~~~-~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~ 217 (377)
T 3cbl_A 144 VKSCRETLP-P----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQ 217 (377)
T ss_dssp EEECCTTSC-H----HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHH
T ss_pred EEEccccCC-H----HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHH
Confidence 999875321 1 123578899999999999999999999999889999999999999999998642 4589999999
Q ss_pred HHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCc---cCCCCCccccccCccc
Q 021253 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPSAGS 310 (315)
Q Consensus 243 i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~APE~~~ 310 (315)
++.||+.||+|||+++++||||||+|||++.++.+||+|||+++........ ....+++.|+|||++.
T Consensus 218 ~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 288 (377)
T 3cbl_A 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288 (377)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc
Confidence 9999999999999999999999999999999999999999999864322111 1123567899999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.47 Aligned_cols=272 Identities=22% Similarity=0.371 Sum_probs=193.4
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -..+....++.| .|+|++++| + ..|.|++|++.. ..++|+.|.... +
T Consensus 162 ~wyhg~i~---------r~~ae~~L~~~~~~~G~FLvR~s-~---~~~~~~lsv~~~---------~~v~h~~I~~~~~g 219 (613)
T 2ozo_A 162 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPR-K---EQGTYALSLIYG---------KTVYHYLISQDKAG 219 (613)
T ss_dssp TTBCTTCC---------HHHHHHHHSSSCCCTTCEEEEEC-S---STTEEEEEEEET---------TEEEEEEEEECTTC
T ss_pred CccccCCC---------HHHHHHHHhhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CeEEEEEEEECCCC
Confidence 68887774 334444454434 799999987 2 468999999852 267899998654 6
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCCC-----------------------------------------
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPT----------------------------------------- 121 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~----------------------------------------- 121 (315)
.|++. ....|. +++|.| ..+.++++..|..+|...
T Consensus 220 ~~~~~-~~~~F~sl~~Lv~~y~~~~~~l~~~L~~pC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (613)
T 2ozo_A 220 KYCIP-EGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298 (613)
T ss_dssp CEECT-TSCEESSHHHHHHHHHHCCTTCSSCCCSBCCC------------------------------------------
T ss_pred CEEEC-CCCCcCCHHHHHHHHhhCCCCceeccccccccccccccccccCcccCCCCccccccccccccccccCCCCCccc
Confidence 67765 334442 233322 223333322222222110
Q ss_pred --------------C-------CCC--CCcccccccccccccc-ceeecccCceEEEEE----CCeeEEEEEeeCCCCCh
Q 021253 122 --------------E-------GLE--NYDEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNP 173 (315)
Q Consensus 122 --------------~-------~~~--~~~~~~i~~~~~~~~~-~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~ 173 (315)
. ... ....|.+...++.+.+ .||+|+||.||+|.+ ++..||||+++......
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~ 378 (613)
T 2ozo_A 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 378 (613)
T ss_dssp -----------CCCCSCSSSSSCSCSSCCCCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST
T ss_pred cCCCCCCCCCCCccccccCCcCChhHhcccceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH
Confidence 0 000 0124556666666666 799999999999987 34579999997653322
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021253 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (315)
Q Consensus 174 ~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (315)
. .+.+.+|+.+|+.++||||+++++++.. +.+++||||+++|+|.+++... ...+++..++.++.||+.||+|
T Consensus 379 ~-----~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~ 451 (613)
T 2ozo_A 379 D-----TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKY 451 (613)
T ss_dssp T-----HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHH
T ss_pred H-----HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHH
Confidence 2 3578899999999999999999999976 4589999999999999999754 4568999999999999999999
Q ss_pred HHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC----ccCCCCCccccccCccc
Q 021253 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 254 LH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
||+++|+||||||+|||++.++.+||+|||+|+....... .....+|+.|+|||++.
T Consensus 452 LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred HHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence 9999999999999999999999999999999986432221 12234568999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.59 Aligned_cols=176 Identities=30% Similarity=0.532 Sum_probs=141.8
Q ss_pred cccccccccccc-cceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLRKLNMG-TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~~~~~~-~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
+|.++.+.+.+. +.||+|+||.||+|.+ .++.||||+++........ .+.+.+|+.++++++||||+++++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL----KDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGG----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 455666666554 4799999999999976 4578999999764333221 357899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++... .+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 438 ~~~~~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEecC-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 99754 578999999999999999754 458999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC----CccCCCCCccccccCcccc
Q 021253 284 VARIEVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
+|+...... ......+|+.|+|||++..
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHH
T ss_pred CccccccCccccccccCCCCceeeeChhhhcC
Confidence 998643322 1233456789999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=268.00 Aligned_cols=173 Identities=29% Similarity=0.443 Sum_probs=154.6
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
...+|++.+.||+|+||.||+|++ +++.||||++......... .+++.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 457899999999999999999997 7889999999765544322 3578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999999765 3589999999999999999999999999999999999999999999999999986655
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+||+.|+|||++.+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHT
T ss_pred CCccccccCCcceeCcccccC
Confidence 555667789999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=272.94 Aligned_cols=179 Identities=20% Similarity=0.304 Sum_probs=157.0
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.+.+..++|++.+.||+|+||.||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4567789999999999999999999998 67889999986422111 111357889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+...+|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999999999763 459999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccCCCCCccccccCccccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
...........+||+.|+|||++...
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~ 189 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSR 189 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCC
T ss_pred eccCCCceeccCCCccccCCeeeccC
Confidence 76665556778999999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=266.74 Aligned_cols=175 Identities=25% Similarity=0.366 Sum_probs=151.0
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|+. +++.||||++++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 4567899999999999999999998 6889999999642110 0111356889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999999999865 358999999999999999999999999999999999999999999999999998532
Q ss_pred -cCCCccCCCCCccccccCcccc
Q 021253 290 -QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 -~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSS
T ss_pred cCCCcccccccChhhCChhhhcC
Confidence 2333456789999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=271.48 Aligned_cols=177 Identities=21% Similarity=0.347 Sum_probs=151.5
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
..+..++|++++.||+|+||.||+|++ +++.||||++++....... ..+.+.+|..++.++ +||||+++++++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~---~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---HHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 346678999999999999999999998 6789999999865433221 124577899999877 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+...+|+||||+++|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999999999865 358999999999999999999999999999999999999999999999999998
Q ss_pred ee-ecCCCccCCCCCccccccCcccc
Q 021253 287 IE-VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~-~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. .........+||+.|+|||++..
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred ecccCCCccccccCCcccCCchhhcC
Confidence 53 23334566789999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=262.86 Aligned_cols=182 Identities=35% Similarity=0.583 Sum_probs=147.6
Q ss_pred CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..+.|+++..+|++.+.||+|+||.||+|+++++.||||++......... .+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34678889999999999999999999999999999999999766544332 35788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcCCCcEEEeee
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
.....+++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999999975421 23889999999999999999999999 999999999999999999999999
Q ss_pred cceeeeecCC-CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
|+++...... ......||+.|+|||++..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp C-----------------CCTTSCHHHHTT
T ss_pred CCCccccccccccccCCCCccccChhhhcC
Confidence 9998643332 2344679999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=262.80 Aligned_cols=175 Identities=22% Similarity=0.362 Sum_probs=152.4
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (315)
+..++|++.+.||+|+||.||+|++ +++.||||++++....... ..+.+.+|..+++.+ +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH---HHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 4567899999999999999999998 5889999999865443322 235688999999988 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999999999865 35899999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCccccccCcccc
Q 021253 289 V-QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. ........+||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cCCCCcccccCCCccccCccccCC
Confidence 2 2233456789999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=257.73 Aligned_cols=176 Identities=34% Similarity=0.539 Sum_probs=151.5
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.+.+..++|.+++.||+|+||.||+|++ +++.||+|.+.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--E----ETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--H----HHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 3456778999999999999999999998 58899999885422 1 12467899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 999999999999999999999864 3568999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---------------cCCCCCccccccCcccc
Q 021253 287 IEVQTEGM---------------TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~---------------~~~~gt~~y~APE~~~~ 311 (315)
........ ....||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTT
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcC
Confidence 64332211 14579999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=266.81 Aligned_cols=175 Identities=22% Similarity=0.376 Sum_probs=152.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++++.||+|+||.||+|+. +++.||+|+++.............+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5688999999999999999998 68899999998755432211111357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~~ 288 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999653 4689999999999999999999999999999999999998777 7999999999876
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.........+||+.|+|||++..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT
T ss_pred CCCCccccCCCCccEECchHHcC
Confidence 65555666789999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=265.34 Aligned_cols=174 Identities=21% Similarity=0.325 Sum_probs=143.9
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (315)
+..++|++.+.||+|+||.||+|++ +++.||||++++.... .....+.+.+|..+++.+ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 4567899999999999999999998 6789999999752111 111235678999999988 699999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999875 45899999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCccccccCccc
Q 021253 289 V-QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~ 310 (315)
. ........+||+.|+|||++.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp CC---------CCGGGCCHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcC
Confidence 2 222345568999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=273.59 Aligned_cols=179 Identities=23% Similarity=0.339 Sum_probs=152.4
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.++.+..++|++.+.||+|+||.||+|++ +++.||+|++++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAF 138 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT---CCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566778999999999999999999998 678999999964211000 0013477999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+...+|+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999999999753 4899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCccccccCccccc
Q 021253 286 RIEVQTE--GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~APE~~~~~ 312 (315)
+...... .....+||+.|+|||++...
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 244 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTT
T ss_pred EeeccCCcccccCCcCCccccCHHHhhcc
Confidence 8654332 23457899999999988643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=274.43 Aligned_cols=178 Identities=22% Similarity=0.321 Sum_probs=151.7
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
++.+..++|++.+.||+|+||+||+|++ +++.||+|++++...... ...+.+.+|..++..++||||+++++++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR---AETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT---TTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4456678999999999999999999998 578999999964211000 01124789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+...+|+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999999999763 3468999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC--ccCCCCCccccccCccc
Q 021253 287 IEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
....... ....+||+.|+|||++.
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hcccCCCcccccccCCcCeeChHHHh
Confidence 6543322 23468999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=269.11 Aligned_cols=179 Identities=22% Similarity=0.316 Sum_probs=153.4
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.++.+..++|++.+.||+|+||+||+++. +++.||||++++.... .....+.+.+|..++..++||||+++++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34556778999999999999999999998 6889999999642111 111124578999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+...+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999998653 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC--ccCCCCCccccccCccc
Q 021253 286 RIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
+....... ....+||+.|+|||++.
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHh
Confidence 86544332 23468999999999886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=260.34 Aligned_cols=173 Identities=26% Similarity=0.406 Sum_probs=150.1
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|+. +++.||+|++++..... ....+.+.+|..+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 3467899999999999999999998 68899999996421110 011356789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999998643
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+||+.|+|||++..
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT
T ss_pred C--ccccccCCccccCHhHhcC
Confidence 3 2345689999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=263.43 Aligned_cols=180 Identities=31% Similarity=0.524 Sum_probs=152.8
Q ss_pred CccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (315)
...|.++.++|++++.||+|+||.||+|++. +..||||+++.... ....+.+.+|+.+++.+ +||
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp 147 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIGKHK 147 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-----HHHHHHHHHHHHHHHHSCCCT
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-----HHHHHHHHHHHHHHHHhcCCC
Confidence 3468888999999999999999999999862 34799999975422 12246789999999999 899
Q ss_pred CeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 021253 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (315)
Q Consensus 197 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (315)
||+++++++.....+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 99999999999999999999999999999998653 2357899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 263 DLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 263 Dlkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
||||+|||++.++.+||+|||+|+...... ......+|+.|+|||++..
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 999999999999999999999998644322 1233467889999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=253.98 Aligned_cols=170 Identities=26% Similarity=0.419 Sum_probs=149.6
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 346889999999999999999986 78899999997544332 2468899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+++||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999999999764 489999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CccCCCCCccccccCcccc
Q 021253 291 TE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~ 311 (315)
.. ......||+.|+|||++..
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHC
T ss_pred cccccCCccCCcCccChhhhcC
Confidence 32 3445689999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=250.77 Aligned_cols=175 Identities=28% Similarity=0.535 Sum_probs=152.8
Q ss_pred ccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
..|.++.++|++.+.||+|+||.||+|.+ +++.||+|++....... +++.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46899999999999999999999999998 77899999997654432 46889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999999999754 3468999999999999999999999999999999999999999999999999997
Q ss_pred eeecCC--CccCCCCCccccccCccc
Q 021253 287 IEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
...... ......+|+.|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFS 180 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred cccccccccccCcccccccCCHHHhc
Confidence 543221 223445778999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=259.30 Aligned_cols=175 Identities=22% Similarity=0.374 Sum_probs=151.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++.+.||+|+||.||+|.. +++.||+|++..............+.+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5788999999999999999998 58899999998654432211111357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~~ 288 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999653 4689999999999999999999999999999999999999877 8999999999876
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..........||+.|+|||++..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTT
T ss_pred CCCCccccccCCcCcCCceeecC
Confidence 55555566789999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=261.69 Aligned_cols=176 Identities=23% Similarity=0.346 Sum_probs=148.7
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 207 (315)
.+..++|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh---hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 35668899999999999999999998 68899999997532100 01124677899999876 99999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999865 3589999999999999999999999999999999999999999999999999985
Q ss_pred eec-CCCccCCCCCccccccCcccc
Q 021253 288 EVQ-TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~-~~~~~~~~gt~~y~APE~~~~ 311 (315)
... .......+||+.|+|||++..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccCCCcccCCCCCcccCChhhhcC
Confidence 332 223456789999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=260.22 Aligned_cols=171 Identities=25% Similarity=0.384 Sum_probs=151.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5788999999999999999998 6889999999876554332 357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---CcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~---~~vkl~DFG~a~~~~ 289 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999999753 458999999999999999999999999999999999999865 459999999998765
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTT
T ss_pred CCcccccCCCCccccCHHHHcc
Confidence 5545566789999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=261.91 Aligned_cols=178 Identities=18% Similarity=0.254 Sum_probs=153.2
Q ss_pred CCCccccccccccccccceeecccCceEEEE-------ECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--- 194 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 194 (315)
....++++..++|.+.+.||+|+||.||+|. .+++.||||+++... ...+.+|+.+++.++
T Consensus 55 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------PWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp CSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---------HHHHHHHHHHHHHSCGGG
T ss_pred ccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---------hhHHHHHHHHHHHhhhhh
Confidence 3456778888999999999999999999993 267899999996532 135778888888887
Q ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE
Q 021253 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (315)
Q Consensus 195 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli 271 (315)
|+||+++++++...+..|+||||+++|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 999999999999999999999999999999999753 34569999999999999999999999999999999999999
Q ss_pred cC-----------CCcEEEeeecceeeee---cCCCccCCCCCccccccCcccc
Q 021253 272 SA-----------DKSIKIADFGVARIEV---QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 272 ~~-----------~~~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+. ++.+||+|||+|+... ........+||+.|+|||++.+
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 98 8999999999997543 2223456689999999998864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.93 Aligned_cols=171 Identities=27% Similarity=0.363 Sum_probs=141.2
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
.+.++|++.+.||+|+||.||+++. +++.||||++....... +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 3557899999999999999999998 68899999997654432 35779999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc--EEEeeecceee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~--vkl~DFG~a~~ 287 (315)
.+++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999999999997653 5899999999999999999999999999999999999987765 99999999985
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........||+.|+|||++..
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp -------------CTTSCHHHHHC
T ss_pred ccccCCCCCCcCCCCcCChhhhcC
Confidence 444444455689999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.44 Aligned_cols=172 Identities=24% Similarity=0.423 Sum_probs=143.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (315)
++|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 6788999999999999999998 688999999976543222 357899999999999999999999986543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCCHHHHHHhhCC-CC
Q 021253 210 ------------------------------------------------------VWCIVTEYAKGGSVRQFLTRRQN-RA 234 (315)
Q Consensus 210 ------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~ 234 (315)
..++||||+++++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999986432 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-------------CccCCCCCc
Q 021253 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------------GMTPETGTY 301 (315)
Q Consensus 235 ~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~gt~ 301 (315)
.++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... .....+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 4666789999999999999999999999999999999999999999999998654331 223457999
Q ss_pred cccccCcccc
Q 021253 302 RWMAPSAGSI 311 (315)
Q Consensus 302 ~y~APE~~~~ 311 (315)
.|+|||++..
T Consensus 241 ~y~aPE~~~~ 250 (332)
T 3qd2_B 241 LYMSPEQIHG 250 (332)
T ss_dssp GGSCHHHHHC
T ss_pred CccChHHhcC
Confidence 9999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=251.73 Aligned_cols=176 Identities=20% Similarity=0.252 Sum_probs=145.0
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEe
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRK 207 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 207 (315)
.+-.++|++.+.||+|+||.||+|.+ +++.||||++......... ...+..|+..+.. .+||||+++++++.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 34447899999999999999999998 6889999998765444332 2334455555544 499999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 99999999999 669999987653 4699999999999999999999999999999999999999999999999999987
Q ss_pred eecCCCccCCCCCccccccCccccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
...........||+.|+|||++.+.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~ 231 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGS 231 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTC
T ss_pred cccCCCCcccCCCccccCHhHhcCC
Confidence 6555445566799999999988753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=257.22 Aligned_cols=175 Identities=31% Similarity=0.426 Sum_probs=151.1
Q ss_pred CccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
-.+|.++.++|++.+.||+|+||.||+|++.++.||||++.... . ....+.+|+.++++++||||+++++++.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~----~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---K----QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---H----HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---h----HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 35678899999999999999999999999999999999995421 1 1234567999999999999999999998
Q ss_pred eCC----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCCCEEEc
Q 021253 207 KRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL----------GFIHRDLKSDNLLIS 272 (315)
Q Consensus 207 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----------~iiHrDlkp~NIli~ 272 (315)
... .+++||||+++|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 743 479999999999999999763 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 273 ADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
.++.+||+|||+|+....... .....||+.|+|||++..
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence 999999999999986543322 333579999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=276.96 Aligned_cols=177 Identities=22% Similarity=0.319 Sum_probs=155.1
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|+. +++.||||++....... ......+.+|+.+++.++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 5668899999999999999999998 68899999996422111 111356789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987655569999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTT
T ss_pred cCccccccCCCccccCHHHHcC
Confidence 5544566789999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.60 Aligned_cols=173 Identities=24% Similarity=0.424 Sum_probs=146.3
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 46789999999999999999987 678999999976544332 2246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999999875 35899999999999999999999999999999999999999999999999999754332
Q ss_pred C--CccCCCCCccccccCcccc
Q 021253 292 E--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~--~~~~~~gt~~y~APE~~~~ 311 (315)
. ......||+.|+|||.+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp ----------CCSSCCHHHHHT
T ss_pred cccccCccccCccccCHhHhcC
Confidence 2 2234579999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=259.64 Aligned_cols=172 Identities=24% Similarity=0.415 Sum_probs=150.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
..+|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+.+|+.+++.++||||+++++++.....+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc---chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46889999999999999999998 7889999998642111 011124688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 67999998765 35899999999999999999999999999999999999999999999999999876555
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|+|||++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCC
T ss_pred cccccccCCcCcCCHHHHcC
Confidence 55667789999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.22 Aligned_cols=178 Identities=22% Similarity=0.320 Sum_probs=142.4
Q ss_pred ccccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..+..++|++.+.||+|+||.||+++. +++.||+|+++....... ......+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 346678999999999999999999986 578999999976533211 1123467899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.....+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999999999865 3588999999999999999999999999999999999999999999999999
Q ss_pred eeeeecC-CCccCCCCCccccccCcccc
Q 021253 285 ARIEVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
++..... ......+||+.|+|||++..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTT
T ss_pred ccccccCCccccccCCCcCccCHhhCcC
Confidence 9753322 23345689999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=261.83 Aligned_cols=175 Identities=25% Similarity=0.325 Sum_probs=148.6
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (315)
+...+|++.+.||+|+||.||+|+. +++.||||++++..... ....+.+.+|..++..+ +||+|+++++++...
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc---chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4567899999999999999999998 46789999997532110 11135678999999988 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999999865 34899999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCccccccCcccc
Q 021253 289 V-QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. ........+||+.|+|||++..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred ccCCcccccccCCccccChhhhcC
Confidence 2 2223456789999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=260.79 Aligned_cols=182 Identities=32% Similarity=0.513 Sum_probs=155.5
Q ss_pred CCCccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-C
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-K 194 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 194 (315)
.....|++..++|++++.||+|+||.||+|++. +..||||+++..... ...+++.+|+.+++.+ +
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~ 133 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIGK 133 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHCC
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----HHHHHHHHHHHHHHHhcC
Confidence 345678999999999999999999999999862 257999999754322 1236788999999999 8
Q ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 021253 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFI 260 (315)
Q Consensus 195 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (315)
||||+++++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++|+
T Consensus 134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 213 (382)
T 3tt0_A 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213 (382)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 99999999999999999999999999999999987542 3589999999999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
||||||+|||++.++.+||+|||+|+...... ......+|+.|+|||++..
T Consensus 214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 99999999999999999999999998654321 2334567899999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=260.88 Aligned_cols=173 Identities=24% Similarity=0.305 Sum_probs=150.3
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
...++|++.+.||+|+||.||+|++ +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3457899999999999999999998 68899999996422111 111357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999999999875 348999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+||+.|+|||++..
T Consensus 193 ~--~~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 193 G--RTWTLCGTPEALAPEIILS 212 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTT
T ss_pred C--CcccccCCccccCHHHhcC
Confidence 3 2345689999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.00 Aligned_cols=177 Identities=27% Similarity=0.521 Sum_probs=151.5
Q ss_pred CCccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
....|+++.++|++.+.||+|+||.||++.+ ++..||||+++...... +++.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4678999999999999999999999999998 56689999997654432 468899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.+....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999997632 4589999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCccccccCccc
Q 021253 285 ARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
++...... ......+|+.|+|||.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHH
T ss_pred cccccccccccccCCccCcccCCHHHhc
Confidence 97543221 223345778999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.34 Aligned_cols=169 Identities=17% Similarity=0.257 Sum_probs=149.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||+|++.... . ....+.+|+.+++.++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---T----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---H----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---c----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 6788999999999999999998 67899999986432 1 1246889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC--CCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~--~~~vkl~DFG~a~~~~~ 290 (315)
+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999999653 346899999999999999999999999999999999999987 78999999999987655
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
........||+.|+|||++..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT
T ss_pred CCccccccCChhhcCcHHhcC
Confidence 544555679999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=262.81 Aligned_cols=175 Identities=23% Similarity=0.352 Sum_probs=142.9
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~ 208 (315)
+..++|++.+.||+|+||.||+|++ +++.||||++++....... ..+.+.+|..+ ++.++||||+++++++...
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 4567899999999999999999998 5778999999765433221 12456677776 5778999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999999999865 35889999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCccccccCcccc
Q 021253 289 V-QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~ 311 (315)
. ........+||+.|+|||++..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred ccCCCccccccCCccccCHHHhCC
Confidence 2 2233456789999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.09 Aligned_cols=179 Identities=26% Similarity=0.549 Sum_probs=157.3
Q ss_pred CCCccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
..++.|++..++|++.+.||+|+||.||+|.+ ++..||+|++...... .+.+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 35789999999999999999999999999998 4789999999753321 35788999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+++......++||||+++++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999998766677999999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCCC--ccCCCCCccccccCccc
Q 021253 283 GVARIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
|+++....... .....+|+.|+|||.+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred ccceeccCCccccccCCccccCcCChhhhc
Confidence 99986443221 22334678999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=258.41 Aligned_cols=178 Identities=17% Similarity=0.268 Sum_probs=154.6
Q ss_pred ccccccccccccceeec--ccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 130 WTIDLRKLNMGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G--~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+.....+|++.+.||+| +||.||+|++ +++.||||+++....... ..+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 44566899999999999 9999999998 588999999986544332 346788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.....+|+||||+++++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999999999998765567999999999999999999999999999999999999999999999999998
Q ss_pred eeeecC--------CCccCCCCCccccccCcccc
Q 021253 286 RIEVQT--------EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~--------~~~~~~~gt~~y~APE~~~~ 311 (315)
...... .......||+.|+|||++..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred eeeccccccccccccccccccccccccCHHHHhc
Confidence 653221 11223478999999998865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=246.01 Aligned_cols=174 Identities=27% Similarity=0.498 Sum_probs=152.1
Q ss_pred cccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+|++..++|++.+.||+|+||.||+|.+ ++..||+|+++...... +.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 5778889999999999999999999998 55689999997654432 468899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred CCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 99999999999999999999765 34589999999999999999999999999999999999999999999999999986
Q ss_pred eecCCC--ccCCCCCccccccCccc
Q 021253 288 EVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
...... .....+|+.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFH 178 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHH
T ss_pred cchhhhhcccCCCcCcccCCHHHHh
Confidence 543321 22345678899999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=253.93 Aligned_cols=173 Identities=24% Similarity=0.334 Sum_probs=149.6
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (315)
..++|++.+.||+|+||.||+|.+ +++.||||++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 346889999999999999999998 488999999965332211 256789999999999999999999998765
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE----cCCCcEEEeeec
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli----~~~~~vkl~DFG 283 (315)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999986432 338999999999999999999999999999999999999 778889999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+|+............||+.|+|||++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhh
Confidence 999766655556678999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=247.98 Aligned_cols=171 Identities=23% Similarity=0.379 Sum_probs=147.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.++++++||||+++++++.+...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 5788999999999999999998 6789999999865543322 356789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999976 676666543 356999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||++..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT
T ss_pred ccccCCccccCCcChHHHcC
Confidence 23455678999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=262.85 Aligned_cols=171 Identities=22% Similarity=0.332 Sum_probs=148.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.. +++.||+|++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 6788999999999999999987 7899999999875543322 357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc---CCCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~---~~~~vkl~DFG~a~~~~ 289 (315)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999864 4589999999999999999999999999999999999998 46789999999998654
Q ss_pred cCC-CccCCCCCccccccCcccc
Q 021253 290 QTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
... .....+||+.|+|||++..
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTT
T ss_pred CCCceeecccCCcccCCHHHhcC
Confidence 332 2345689999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=254.39 Aligned_cols=176 Identities=28% Similarity=0.476 Sum_probs=148.0
Q ss_pred cccccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
.+++...+|++.+.||+|+||.||+|.+ .+..||||+++...... ..+.+.+|+.+++.++||||+++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3567788999999999999999999998 23469999997543221 2367899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++.+....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999999999999754 3468999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC----ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+++....... .....+|+.|+|||++.
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhc
Confidence 9986543221 22234678999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=246.69 Aligned_cols=175 Identities=29% Similarity=0.427 Sum_probs=154.8
Q ss_pred cccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
.+.++.++|++.+.||+|+||.||+|+++++.||||+++........ .+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 46678899999999999999999999999999999999876544432 35789999999999999999999999877
Q ss_pred --CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 209 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
...++||||+++++|.+++.......+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 77899999999999999998765556899999999999999999999999 99999999999999999999999998
Q ss_pred eeeeecCCCccCCCCCccccccCcccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+... ......||+.|+|||.+..
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 160 KFSF----QSPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp CCTT----SCTTCBSCGGGSCHHHHHS
T ss_pred eeee----cccCccCCccccChhhhcc
Confidence 7542 2334578999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=256.36 Aligned_cols=178 Identities=28% Similarity=0.487 Sum_probs=151.6
Q ss_pred ccccccccccccccceeecccCceEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
..|.++.++|++.+.||+|+||.||+|++.+ +.||||+++..... ...+.+.+|+.+++.++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEEE
Confidence 4567888999999999999999999999843 78999999754321 22467899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (315)
+++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986431 46899999999999999999999999
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
|+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 249 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence 9999999999999999999999999997543221 223456889999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=267.53 Aligned_cols=175 Identities=26% Similarity=0.436 Sum_probs=153.4
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+...+|.+++.||+|+||.||+|++ +++.||||++...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH---HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4457899999999999999999998 6899999999642111 1112357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999999753 458999999999999999999999999999999999999999999999999999766
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTT
T ss_pred ccccccccCCCcCeEChhhccC
Confidence 5555566789999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=250.89 Aligned_cols=181 Identities=30% Similarity=0.506 Sum_probs=154.9
Q ss_pred CCCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (315)
....+|+++.++|++.+.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +||
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHM 87 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccCC
Confidence 34577999999999999999999999999985 45789999997543221 236789999999999 999
Q ss_pred CeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 021253 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----------------AVPLKLAVKQALDVARGMAYVHGLGFI 260 (315)
Q Consensus 197 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (315)
||+++++++......++||||+++++|.+++...... .+++..++.++.||+.||+|||+++++
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999865422 489999999999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||||||+||+++.++.+||+|||+++....... .....+|+.|+|||.+.
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence 999999999999999999999999986543322 22345678999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=250.62 Aligned_cols=180 Identities=27% Similarity=0.527 Sum_probs=153.9
Q ss_pred CCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (315)
....|+++.++|++.+.||+|+||.||+|++ +++.||||+++.... . ...+.+.+|+.+++.++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-P----SELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-H----HHHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-H----HHHHHHHHHHHHHhhCCCCce
Confidence 3467889999999999999999999999986 237899999975432 1 123678899999999999999
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHG 256 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gL~yLH~ 256 (315)
+++++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986532 347899999999999999999999
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
++|+||||||+||+++.++.+||+|||+++....... .....+|+.|+|||.+.
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 9999999999999999999999999999986543221 23345788999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=268.44 Aligned_cols=178 Identities=24% Similarity=0.354 Sum_probs=142.7
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.+.+..++|++.+.||+|+||.||+|.. +++.||||+++...... ......+.+|+.+++.++||||+++++++.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 4566778999999999999999999997 68899999997431111 112356789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999999999999765 358999999999999999999998 99999999999999999999999999999
Q ss_pred eeee-cCCCccCCCCCccccccCcccc
Q 021253 286 RIEV-QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+... ........+||+.|+|||++..
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHT
T ss_pred eeccCCCcccccccCCccccCHhhcCC
Confidence 8532 2233456789999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=255.50 Aligned_cols=170 Identities=26% Similarity=0.457 Sum_probs=146.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 6788999999999999999988 68899999997543322 1256889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999999998653 45899999999999999999999999999999999999999999999999999864322
Q ss_pred --CCccCCCCCccccccCcccc
Q 021253 292 --EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|+|||++..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHC
T ss_pred cccccCCCccCcCccCcHHhcc
Confidence 12345689999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=267.33 Aligned_cols=174 Identities=20% Similarity=0.223 Sum_probs=142.7
Q ss_pred ccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCC---------CCCeee
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLK---------HLNIVR 200 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~---------h~niv~ 200 (315)
+..++|++.+.||+|+||.||+|+++++.||||++........ ......+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4568899999999999999999999999999999986543200 00011246778888888875 888888
Q ss_pred EEEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q 021253 201 FIGACR------------------------------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250 (315)
Q Consensus 201 l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~g 250 (315)
+++++. ....+||||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 888753 26789999999999977776643 458999999999999999
Q ss_pred HHHHH-hCCCccCCCCCCCEEEcCCC--------------------cEEEeeecceeeeecCCCccCCCCCccccccCcc
Q 021253 251 MAYVH-GLGFIHRDLKSDNLLISADK--------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAPSAG 309 (315)
Q Consensus 251 L~yLH-~~~iiHrDlkp~NIli~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~ 309 (315)
|+||| +++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999887 9999999999875432 34799999999998
Q ss_pred ccc
Q 021253 310 SIC 312 (315)
Q Consensus 310 ~~~ 312 (315)
.+.
T Consensus 250 ~g~ 252 (336)
T 2vuw_A 250 TGD 252 (336)
T ss_dssp CCC
T ss_pred cCC
Confidence 753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=250.02 Aligned_cols=177 Identities=27% Similarity=0.376 Sum_probs=144.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHH
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMM 189 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~ 189 (315)
+..++|++.+.||+|+||.||+|+. +++.||||++......... .....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4567899999999999999999987 6889999999765432110 01123568899999
Q ss_pred HHhCCCCCeeeEEEEEEe--CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 021253 190 LATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (315)
Q Consensus 190 l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (315)
+++++||||+++++++.. ...+|+||||+++++|.+++. ...+++..++.++.||+.||+|||+++|+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999987 568999999999999987653 346899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeeecCC-CccCCCCCccccccCcccc
Q 021253 268 NLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 268 NIli~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
|||++.++.+||+|||+++...... ......||+.|+|||.+..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCT
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhcc
Confidence 9999999999999999998654332 2345679999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=269.85 Aligned_cols=177 Identities=23% Similarity=0.272 Sum_probs=152.1
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|++ +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 4557889999999999999999998 68899999996422111 111356889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999997643 34689999999999999999999999999999999999999999999999999987
Q ss_pred eecCCC-ccCCCCCccccccCcccc
Q 021253 288 EVQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
...... ....+||+.|+|||++..
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred ccCCCcccccccCCccccChhhhcC
Confidence 544332 334589999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=250.30 Aligned_cols=172 Identities=26% Similarity=0.377 Sum_probs=144.8
Q ss_pred ccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.++|++.+.||+|+||.||+|++ +++.||+|++........ ..+.+.+|+.++++++||||+++++++.+...++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C----HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch----hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 47889999999999999999998 788999999975433221 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999975 888888754 345899999999999999999999999999999999999999999999999999865322
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||++..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp C---CCCCCCTTCCHHHHTT
T ss_pred ccccCCcccCCcCCHHHhcC
Confidence 23445678999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=258.58 Aligned_cols=180 Identities=28% Similarity=0.529 Sum_probs=151.1
Q ss_pred CCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
....|+++.++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +|||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-----HHHHHHHHHHHHHhhcCCcc
Confidence 3467999999999999999999999999985 34789999997543221 135789999999999 7899
Q ss_pred eeeEEEEEEeCC-EEEEEEeccCCCCHHHHHHhhCC--------------------------------------------
Q 021253 198 IVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN-------------------------------------------- 232 (315)
Q Consensus 198 iv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------- 232 (315)
|+++++++.+.. .+++||||+++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998754 48999999999999999986532
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 233 --------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 233 --------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128899999999999999999999999999999999999999999999999998543222
Q ss_pred ---CccCCCCCccccccCccc
Q 021253 293 ---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ---~~~~~~gt~~y~APE~~~ 310 (315)
......||+.|+|||++.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHH
T ss_pred cchhccccCCCceeEChhhhc
Confidence 123356889999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=255.88 Aligned_cols=178 Identities=28% Similarity=0.486 Sum_probs=150.0
Q ss_pred ccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (315)
.+|+++.++|++.+.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +||||+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 47999999999999999999999999986 34589999997543221 135788999999999 899999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (315)
++++++.....+++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986532 23788999999999999999999999
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 99999999999999999999999999986543322 12345678999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=252.06 Aligned_cols=176 Identities=21% Similarity=0.367 Sum_probs=152.3
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|++ +++.||||++..............+.+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 36788999999999999999998 6889999999865443221111135788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARI 287 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~ 287 (315)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999753 4589999999999999999999999999999999999999887 799999999987
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........||+.|+|||.+..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTT
T ss_pred cCccccccccCCCCCccCcccccC
Confidence 665545566789999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=246.17 Aligned_cols=175 Identities=31% Similarity=0.547 Sum_probs=151.1
Q ss_pred ccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
++|+++.++|++.+.||+|+||.||+|.+ .+..||||.++..... .+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-------HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 67999999999999999999999999998 4568999999765433 246889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
.. ..++||||+++++|.+++.......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 54 47899999999999999976433468999999999999999999999999999999999999999999999999998
Q ss_pred eeecCC--CccCCCCCccccccCccc
Q 021253 287 IEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
...... ......+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred cccCcccccccCCCCccCccChhhhc
Confidence 654332 123345678999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=256.59 Aligned_cols=176 Identities=20% Similarity=0.328 Sum_probs=146.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++.+.||+|+||.||+|.+ +++.||||++......... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5788999999999999999988 6889999998632110000 001357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc---EEEeeecceee
Q 021253 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~---vkl~DFG~a~~ 287 (315)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999887653 2345899999999999999999999999999999999999986654 99999999987
Q ss_pred eecCCC-ccCCCCCccccccCcccc
Q 021253 288 EVQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
...... ....+||+.|+|||++..
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred ecCCCeeecCCcCCcCccCHHHHcC
Confidence 554332 345689999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=242.21 Aligned_cols=170 Identities=25% Similarity=0.362 Sum_probs=150.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ ++..||+|++....... .+.+.+|+.+++.++||||+++++++......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 5788999999999999999998 56689999987643332 257889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~~~ 289 (315)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+++++||||||+||++ +.++.+||+|||+++...
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999999999765 348999999999999999999999999999999999999 788899999999998766
Q ss_pred cCCCccCCCCCccccccCccccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.........||+.|+|||.+...
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC
T ss_pred CccchhccCCCCCccChHHhccc
Confidence 55555667899999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=263.55 Aligned_cols=174 Identities=24% Similarity=0.362 Sum_probs=134.9
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|.+. ++|++++.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+|+.++||||+++++++.
T Consensus 48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID----CKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH----HHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 34443 6799999999999999999987 6789999999765433322 367889999999999999999999994
Q ss_pred eC-----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 207 KR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 207 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
.. ..+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 43 5689999998 46999999753 5699999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCC----------------------------CccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTE----------------------------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~----------------------------~~~~~~gt~~y~APE~~~ 310 (315)
||+|+...... ..+..+||+.|+|||++.
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 99998643211 234457899999999763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=244.88 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=144.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|.+.+.||+|+||.||++.. ++..||+|++........ .+.+.+|+.+++.++||||+++++++......+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 6788999999999999999998 678999999976543222 257889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceee
Q 021253 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~ 287 (315)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+||++ +.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 23568999999999999999999999999999999999999 4567899999999987
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........||+.|+|||++..
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ----------CTTGGGCCHHHHTT
T ss_pred cCCcccCcCcccccCcCChHHhcc
Confidence 655545566789999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.73 Aligned_cols=172 Identities=25% Similarity=0.403 Sum_probs=134.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.||+|+++....... .+.+.+|+.+++.++||||+++++++...+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 36788999999999999999987 688999999976543221 14677999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
++||||++ ++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999998 59999987542 23588999999999999999999999999999999999999999999999999986
Q ss_pred eecC-CCccCCCCCccccccCcccc
Q 021253 288 EVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
.... .......||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred cCCCcccCCCCcccccccCchHhhC
Confidence 5322 23345679999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.68 Aligned_cols=168 Identities=27% Similarity=0.322 Sum_probs=146.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (315)
.++|++.+.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++.+ +||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 36788999999999999999996 7899999999764332 2577999999999 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc-----EEEeeecce
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFGVA 285 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~-----vkl~DFG~a 285 (315)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999999 89999999864 356999999999999999999999999999999999999998887 999999999
Q ss_pred eeeecCCC--------ccCCCCCccccccCcccc
Q 021253 286 RIEVQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
+....... .....||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence 86543221 245679999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=257.63 Aligned_cols=178 Identities=28% Similarity=0.442 Sum_probs=149.0
Q ss_pred ccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
+.+++..++|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+|+.+++.++||||++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCe
Confidence 34567789999999999999999999985 35689999986432221 1357889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~ 275 (315)
+++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 139 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred EEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence 99999999889999999999999999987532 3588999999999999999999999999999999999999555
Q ss_pred ---cEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 276 ---SIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 276 ---~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
.+||+|||+|+...... ......||+.|+|||++.
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 259 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence 59999999997542221 223346789999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=242.83 Aligned_cols=174 Identities=29% Similarity=0.547 Sum_probs=152.4
Q ss_pred cccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+|.++.++|++.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 6899999999999999999999999998 77899999997654432 468899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999999999764 34589999999999999999999999999999999999999999999999999975
Q ss_pred eecCC--CccCCCCCccccccCccc
Q 021253 288 EVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
..... ......+++.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFS 178 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred cccccccccccccccccccChhhhc
Confidence 43221 223346788999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.85 Aligned_cols=171 Identities=19% Similarity=0.316 Sum_probs=149.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh------hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 36789999999999999999998 6789999999754311 124788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC--CCcEEEeeecceeeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~--~~~vkl~DFG~a~~~~ 289 (315)
++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+...
T Consensus 124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999998753 346899999999999999999999999999999999999974 4689999999998765
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTT
T ss_pred CCcceeeeccCCCccCchhccC
Confidence 5444455689999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=241.74 Aligned_cols=171 Identities=25% Similarity=0.382 Sum_probs=150.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 6788999999999999999988 5789999999765544332 357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc---EEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~---vkl~DFG~a~~~~ 289 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++++||||||+||+++.++. +||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999998765 35899999999999999999999999999999999999986654 9999999998766
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.........||+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT
T ss_pred cCccccCCCCCcCCcCchhhcC
Confidence 5555566789999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=244.16 Aligned_cols=179 Identities=27% Similarity=0.496 Sum_probs=149.8
Q ss_pred CCccccccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 199 (315)
..+...+..+.|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.+++.++||||+
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBC
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCee
Confidence 3455567778899999999999999999984 678999999975432211 35788999999999999999
Q ss_pred eEEEEEEeC--CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcE
Q 021253 200 RFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (315)
Q Consensus 200 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~v 277 (315)
++++++... ..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence 999999876 66899999999999999997653 458999999999999999999999999999999999999999999
Q ss_pred EEeeecceeeeecCC----CccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQTE----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~~----~~~~~~gt~~y~APE~~~ 310 (315)
||+|||+++...... ......||+.|+|||.+.
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence 999999998654332 123456888999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=257.31 Aligned_cols=166 Identities=23% Similarity=0.360 Sum_probs=133.6
Q ss_pred cccccc-cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEEe---
Q 021253 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (315)
Q Consensus 135 ~~~~~~-~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--- 207 (315)
.+|.+. +.||+|+||.||++.+ +++.||||+++.. ..+.+|+.++ +..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 455555 6899999999999998 6789999999631 2456788887 45589999999999875
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeec
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG 283 (315)
...+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999998765567999999999999999999999999999999999999997 7899999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+++...........+||+.|+|||++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCC
T ss_pred cccccCCCCccccCCCCCCccCHhhcCC
Confidence 9987654444566789999999999853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=263.10 Aligned_cols=172 Identities=26% Similarity=0.381 Sum_probs=146.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++++.||+|+||.||+|++ ++..||||++......... ...+.+|+.+++.++||||+++++++.....+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5788999999999999999998 6789999999865433222 246889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~~~ 289 (315)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999999998765 34899999999999999999999999999999999999976 4569999999998776
Q ss_pred cCCCccCCCCCccccccCccccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
........+||+.|+|||++...
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~ 213 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKK 213 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTC
T ss_pred CCccccccCCCcCeeCHHHHccc
Confidence 65556677899999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=249.92 Aligned_cols=181 Identities=31% Similarity=0.522 Sum_probs=153.5
Q ss_pred CCCccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-C
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-K 194 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 194 (315)
.....|+++.++|++++.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.+++++ +
T Consensus 25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~ 99 (334)
T 2pvf_A 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGK 99 (334)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----HHHHHHHHHHHHHHHHCC
T ss_pred CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----HHHHHHHHHHHHHHHhhc
Confidence 345678999999999999999999999999863 467999998754321 1246788999999999 8
Q ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 021253 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFI 260 (315)
Q Consensus 195 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (315)
||||+++++++.....+++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++|+
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 179 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999999999999999999999999986432 2488999999999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 261 HrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
||||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 999999999999999999999999986543221 23345788999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=253.41 Aligned_cols=168 Identities=26% Similarity=0.387 Sum_probs=132.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.+.|++.+.||+|+||.||+|++ +++.||||+++.... .+.+.+|+.++++++||||+++++++......
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 35788999999999999999998 567899999975321 24678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~~ 288 (315)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999999753 45899999999999999999999999999999999999975 889999999999876
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.........+||+.|+|||++..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp -----------CGGGSCHHHHTT
T ss_pred CcccccccccCCCCccCHHHhcC
Confidence 55444556789999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=256.59 Aligned_cols=175 Identities=28% Similarity=0.487 Sum_probs=139.6
Q ss_pred ccccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
.+++..+|++.+.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-----KQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3567789999999999999999999863 568999999754321 123679999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.+....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999999999754 34689999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCC----ccCCCCCccccccCccc
Q 021253 285 ARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
++....... .....+|+.|+|||++.
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223 (373)
T ss_dssp --------------------CTTSCHHHHH
T ss_pred ccccccCCccceeccCCCcCCCccChhhhc
Confidence 986543221 11223568899999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.49 Aligned_cols=177 Identities=26% Similarity=0.499 Sum_probs=139.1
Q ss_pred CccccccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
..+|++..++|++.+.||+|+||.||+|.+. +..||+|+++.... ....+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-----HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCccceE
Confidence 3568889999999999999999999999872 35699998865322 1224678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 202 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
++++.+ +..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 82 IGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEEECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEcc-CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence 999854 5578999999999999999764 34689999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCC--ccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
||+++....... .....+|+.|+|||.+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp -------------------CCGGGCCHHHHH
T ss_pred cccccccCcccccccccCCCcccccChhhcc
Confidence 999986543322 22345678999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.13 Aligned_cols=174 Identities=22% Similarity=0.399 Sum_probs=146.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|++ +++.||+|+++.............+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5788999999999999999998 58899999998654432211112357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~~ 288 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++++||||||+||+++.++ .+||+|||+++..
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999764 3589999999999999999999999999999999999998877 8999999999876
Q ss_pred ecCCCccCCCCCccccccCccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~ 310 (315)
..........||+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~ 184 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVN 184 (283)
T ss_dssp C--------CCCGGGCCHHHHT
T ss_pred cCCCcccccCCCcCccCcceec
Confidence 5544455567999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=250.55 Aligned_cols=174 Identities=22% Similarity=0.384 Sum_probs=154.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCC--ChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN--NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (315)
.+|++.+.||+|+||.||+|.+ +++.||||+++.... .........+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5788999999999999999998 588999999986542 2233344457889999999999 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999864 358999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCccccccCccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~ 310 (315)
........+||+.|+|||++.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILK 272 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHH
T ss_pred CCcccccCCCCCCccChhhcc
Confidence 555556678999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=246.75 Aligned_cols=167 Identities=24% Similarity=0.418 Sum_probs=146.5
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
.|+..+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.+++.++||||+++++++......++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 456667899999999999998 68999999997654332 2468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999999999864 358999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISR 215 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred ccccccCCccccCHhhhcC
Confidence 3345689999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=251.14 Aligned_cols=173 Identities=25% Similarity=0.407 Sum_probs=141.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
.++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 36788999999999999999997 788999999976543332 23467889999999999999999999987653
Q ss_pred --EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 210 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 359999999999999999865 3589999999999999999999999999999999999999999999999999986
Q ss_pred eecCC----CccCCCCCccccccCcccc
Q 021253 288 EVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
..... ......||+.|+|||++..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp ----------------CCTTCCHHHHHT
T ss_pred ccccccccccccccCcCcccCCHHHhcC
Confidence 43321 1233568999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=258.78 Aligned_cols=175 Identities=23% Similarity=0.306 Sum_probs=146.1
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|.+ .++|++.+.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+++.++||||+++++++
T Consensus 20 ~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 20 KNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp GGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred Cccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 34444 36899999999999999999988 678999999976543332 236788999999999999999999999
Q ss_pred EeC-----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 206 RKR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 206 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
... ..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp CCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEc
Confidence 776 57899999996 5999999753 458999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCC-----------------------CccCCCCCccccccCccc
Q 021253 281 DFGVARIEVQTE-----------------------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 281 DFG~a~~~~~~~-----------------------~~~~~~gt~~y~APE~~~ 310 (315)
|||+|+...... ..+..+||+.|+|||++.
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 999998654321 235678999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=244.75 Aligned_cols=168 Identities=30% Similarity=0.526 Sum_probs=142.3
Q ss_pred cccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEe---
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRK--- 207 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--- 207 (315)
-.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 34788999999999999999999999999999985421 1345567777766 799999999998754
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCCEEEcCCCcEE
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NIli~~~~~vk 278 (315)
...+++||||+++++|.++++. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 2468999999999999999954 45899999999999999999999 99999999999999999999999
Q ss_pred EeeecceeeeecCCC-----ccCCCCCccccccCccccc
Q 021253 279 IADFGVARIEVQTEG-----MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 279 l~DFG~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~ 312 (315)
|+|||+|+....... .....||+.|+|||++...
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 999999986544322 2334799999999988643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-32 Score=241.27 Aligned_cols=175 Identities=23% Similarity=0.349 Sum_probs=154.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCC---ChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN---NPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 207 (315)
.++|++.+.||+|+||.||+|.+ +++.||||++..... .........+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46788999999999999999998 678999999976542 22333445678899999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999865 4589999999999999999999999999999999999999999999999999987
Q ss_pred eecCCCccCCCCCccccccCccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
...........||+.|+|||++.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHH
T ss_pred cCCCcccccccCCccccCHHHhc
Confidence 65554556678999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=263.06 Aligned_cols=173 Identities=25% Similarity=0.430 Sum_probs=147.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.++++++||||+++++++.....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH----HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 36788999999999999999998 6889999998643211111 25788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc---CCCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~---~~~~vkl~DFG~a~~~ 288 (315)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999998765 3589999999999999999999999999999999999995 4568999999999866
Q ss_pred ecCCCccCCCCCccccccCccccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
.........+||+.|+|||++.+.
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGSC
T ss_pred CCCCccCCCcCCCCCCCHHHhCCC
Confidence 555555667899999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=243.15 Aligned_cols=167 Identities=27% Similarity=0.482 Sum_probs=147.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
.+|++.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 5788999999999999999998 58899999997543 245689999999999999999998864
Q ss_pred -----------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc
Q 021253 208 -----------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (315)
Q Consensus 208 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~ 276 (315)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||+++|+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 445899999999999999998765567999999999999999999999999999999999999999999
Q ss_pred EEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 277 IKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+||+|||+++............||+.|+|||.+..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC
T ss_pred EEECcchhheeccccccccccCCcccccChhhhcc
Confidence 99999999987655544556679999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=252.40 Aligned_cols=175 Identities=22% Similarity=0.342 Sum_probs=150.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhH--HHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
++|++.+.||+|+||.||+|.+ +++.||||+++........ .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6789999999999999999987 7889999999875432210 00011356789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 211 WCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 211 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
+++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999999754 458999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|+|||++..
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTT
T ss_pred CCCceeccCCCccccChhhhcC
Confidence 5555556789999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.81 Aligned_cols=178 Identities=34% Similarity=0.637 Sum_probs=141.6
Q ss_pred CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..+.|+|+..+|++.+.||+|+||.||+|++.+ .||||+++........ .+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 457789999999999999999999999998765 5999999765544332 36789999999999999999999965
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
. ....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 T-APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred c-CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 4 45578999999999999999654 356899999999999999999999999999999999999999999999999999
Q ss_pred eeeec---CCCccCCCCCccccccCccc
Q 021253 286 RIEVQ---TEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~---~~~~~~~~gt~~y~APE~~~ 310 (315)
+.... ........||+.|+|||.+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ----------------CCCTTCCHHHHC
T ss_pred cccccccccccccccCCCccccCchhhc
Confidence 75432 12234457999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=249.17 Aligned_cols=180 Identities=27% Similarity=0.467 Sum_probs=153.0
Q ss_pred CCccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (315)
..++|++..++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTB
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCCE
Confidence 45789999999999999999999999999763 5789999987543221 23578899999999999999
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
+++++++......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 999999999999999999999999999997532 135688999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
++.++.+||+|||+++....... .....+|+.|+|||.+.
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence 99999999999999975433221 22345688999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=247.02 Aligned_cols=171 Identities=27% Similarity=0.371 Sum_probs=142.9
Q ss_pred cccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
++|++.+.||+|+||.||+|++ +++.||+|++......... .+.+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 5788999999999999999998 5889999999754322211 2467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-C
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~ 292 (315)
||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999976 999998754 345899999999999999999999999999999999999999999999999999754322 2
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp ------CCCTTCCHHHHTT
T ss_pred ccccccccccccCchheeC
Confidence 2344578999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=247.87 Aligned_cols=174 Identities=28% Similarity=0.521 Sum_probs=143.9
Q ss_pred ccccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
.++..++|++.+.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--E----EHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 346678999999999999999999985 57899999986432 1 12357889999999999999999999
Q ss_pred EEEeC--CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 204 ACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 204 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
++... ..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence 98653 45899999999999999997643 3589999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCC----ccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
||+++....... .....+++.|+|||.+.
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 999986543321 23345778899999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=254.17 Aligned_cols=168 Identities=23% Similarity=0.379 Sum_probs=140.9
Q ss_pred cccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 214 (315)
+...+.||+|+||.||+|.. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.....+++|
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 33467899999999999987 6889999999764321 135788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE--cCCCcEEEeeecceeeeecCC
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI--SADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli--~~~~~vkl~DFG~a~~~~~~~ 292 (315)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999998753 2458999999999999999999999999999999999999 567899999999999766555
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
.....+||+.|+|||++..
T Consensus 244 ~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTT
T ss_pred ccccccCCCcEeChhhccC
Confidence 5556689999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=253.70 Aligned_cols=170 Identities=26% Similarity=0.398 Sum_probs=135.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~- 209 (315)
.++|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.+. ||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 46889999999999999999987 6889999999755433322 357789999999997 999999999997654
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 7899999997 589999876 35889999999999999999999999999999999999999999999999999864
Q ss_pred ec----------------------CCCccCCCCCccccccCcccc
Q 021253 289 VQ----------------------TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~----------------------~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ....+..+||+.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 22 112344589999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-33 Score=245.62 Aligned_cols=174 Identities=30% Similarity=0.564 Sum_probs=144.1
Q ss_pred CccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
...|.++.++|++.+.||+|+||.||+++++++.||||+++.... .+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 456889999999999999999999999999999999999875331 257889999999999999999999976
Q ss_pred eC-CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 207 KR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 207 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
+. ...++||||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 54 46899999999999999998654444788999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+..... .....+++.|+|||.+.
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~ 187 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAPEALR 187 (278)
T ss_dssp -------------CCTTTSCHHHHH
T ss_pred cccccc--ccCCCccccccCHHHhC
Confidence 854332 23346789999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=261.47 Aligned_cols=175 Identities=22% Similarity=0.408 Sum_probs=148.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
++|++++.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 6788999999999999999998 678999999976543211 0011246788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cEEEeee
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADF 282 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~vkl~DF 282 (315)
.+...+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999765 3589999999999999999999999999999999999998776 6999999
Q ss_pred cceeeeecCCCccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|+|+...........+||+.|+|||++..
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc
Confidence 99997766555667789999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=245.04 Aligned_cols=171 Identities=26% Similarity=0.415 Sum_probs=143.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.++++++||||+++++++......+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 5788999999999999999998 588999999876543322 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999999888653 458999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
......||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp ---------GGGCCHHHHHT
T ss_pred cccCCCcCCccccChHHHhc
Confidence 2345679999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=261.40 Aligned_cols=169 Identities=25% Similarity=0.339 Sum_probs=139.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (315)
.++|++++.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh----HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 47899999999999999999987 68899999997643222 2246788999999999999999999999654
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 209 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 467999999976 57777643 3889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+........+..+||+.|+|||++..
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTT
T ss_pred eecCCCcccCCCcccccccCHHHHcC
Confidence 87665555667789999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=257.44 Aligned_cols=172 Identities=24% Similarity=0.335 Sum_probs=148.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
.++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 46889999999999999999998 488999999965322111 256789999999999999999999998765
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE----cCCCcEEEeeecc
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFGV 284 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli----~~~~~vkl~DFG~ 284 (315)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999999976432 338999999999999999999999999999999999999 7778899999999
Q ss_pred eeeeecCCCccCCCCCccccccCccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+............||+.|+|||++.
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred ceEccCCCccccccCCccccCHHHhh
Confidence 98766555556678999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=273.50 Aligned_cols=177 Identities=25% Similarity=0.313 Sum_probs=148.9
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 205 (315)
...+...+|++++.||+|+||.||+|++ +++.||||++++..... ....+.+.+|..++..+ +||+|+++++++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH---TTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc---HHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 3456678999999999999999999998 67789999997421100 11135677899999987 799999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+...+||||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999999999875 35899999999999999999999999999999999999999999999999999
Q ss_pred eeee-cCCCccCCCCCccccccCccc
Q 021253 286 RIEV-QTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~APE~~~ 310 (315)
+... ........+||+.|+|||++.
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred eccccCCcccccccCCCcccCHhhhc
Confidence 8633 233455678999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=263.30 Aligned_cols=174 Identities=25% Similarity=0.404 Sum_probs=151.6
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
-.++|++.+.||+|+||.||+|.. +++.||||++.......... .+.+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH---HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346889999999999999999998 68899999997654332211 2578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~ 287 (315)
+|+||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999754 458999999999999999999999999999999999999 5678999999999986
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..........+||+.|+|||++.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT
T ss_pred cccccccccCCCCccccCceeecC
Confidence 655544555689999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=250.81 Aligned_cols=179 Identities=31% Similarity=0.481 Sum_probs=151.8
Q ss_pred CccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..++.+..++|++.+.||+|+||.||+|.+ +++.||||++........ ...+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEEEE
Confidence 345666778999999999999999999987 688999999875433221 13588999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCCEEEcCCCcEEEe
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998653 23489999999999999999999999 99999999999999999999999
Q ss_pred eecceeeeecCC--CccCCCCCccccccCccc
Q 021253 281 DFGVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 281 DFG~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|||+++...... ......||+.|+|||++.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred cCccccccCcccccccccccCCcCccCHHHhc
Confidence 999998654322 233456999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=247.00 Aligned_cols=175 Identities=26% Similarity=0.440 Sum_probs=143.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKR 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 208 (315)
.++|++.+.||+|+||.||+|++ +++.||||+++......... .....+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46889999999999999999996 78899999987433211100 0012455677776666 499999999999875
Q ss_pred C-----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 209 M-----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 209 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
. .+++||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 5899999997 599999987666669999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+|+............||+.|+|||++.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLL 192 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHH
T ss_pred cccccCCCcccCCccccccccCchHHc
Confidence 998665444556678999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=250.13 Aligned_cols=180 Identities=29% Similarity=0.506 Sum_probs=152.9
Q ss_pred CCccccccccccccccceeecccCceEEEEEC--C-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
..+.|+++.++|++.+.||+|+||.||+|.+. + ..||+|.+....... ..+.+.+|+.+++.+ +|||
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCC
Confidence 34679999999999999999999999999973 2 379999997543221 236788999999999 8999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (315)
|+++++++.....+++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++|+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 9999999999999999999999999999997542 3457899999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 266 p~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|+|||++.++.+||+|||+++....... .....+|+.|+|||.+.
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 239 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence 9999999999999999999986433322 12345678999999765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.92 Aligned_cols=172 Identities=26% Similarity=0.471 Sum_probs=148.2
Q ss_pred cccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
..++|++.+.||+|+||.||+|++ +++.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 457889999999999999999998 57899999987643322 35788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999986543 2358999999999999999999999999999999999999999999999999998643
Q ss_pred cCC---CccCCCCCccccccCccc
Q 021253 290 QTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 290 ~~~---~~~~~~gt~~y~APE~~~ 310 (315)
... ......||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHH
T ss_pred cccccccccccCCCccccCHHHhc
Confidence 221 123345899999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=242.88 Aligned_cols=176 Identities=23% Similarity=0.338 Sum_probs=138.6
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|++..++|++.+.||+|+||.||+|.+ +++.||||+++....... ..+.+.++...++.++||||+++++++.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH----HHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 567789999999999999999999998 789999999975433222 23445566666888999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
....++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++ |++||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 9999999999975 88888764 2345799999999999999999999998 999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCccccccCccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
++............||+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp -------------CCCCCCSCHHHHS
T ss_pred cccccccccccccCCCccccChhhcC
Confidence 98765544445567999999999963
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=241.39 Aligned_cols=174 Identities=37% Similarity=0.664 Sum_probs=138.0
Q ss_pred cccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
+++..+|++.+.||+|+||.||+|.+.++.||||+++...... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED--ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc--HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4567899999999999999999999999999999987543322 11223578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCCEEEcC--------CCcEEE
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISA--------DKSIKI 279 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlkp~NIli~~--------~~~vkl 279 (315)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999999853 45899999999999999999999999 899999999999986 678999
Q ss_pred eeecceeeeecCCCccCCCCCccccccCccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+|||+++...... .....||+.|+|||.+.
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIR 187 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHH
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhc
Confidence 9999998654332 33457999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-32 Score=239.40 Aligned_cols=170 Identities=26% Similarity=0.377 Sum_probs=146.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 211 (315)
.+|++.+.||+|+||.||+|.+ +++.||||+++........ ...+.+|+..+..+ +||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 6788999999999999999998 6889999999865444332 35778999999999 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---------------
Q 021253 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--------------- 274 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~--------------- 274 (315)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999997642 2558999999999999999999999999999999999999844
Q ss_pred ----CcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 275 ----KSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 275 ----~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..+||+|||+++..... ....||+.|+|||.+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE 204 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcC
Confidence 47999999999865332 33469999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=241.51 Aligned_cols=174 Identities=26% Similarity=0.408 Sum_probs=146.2
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|.+ +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 4558899999999999999999988 5678999998642211 1112457889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999999999865 348999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.. ......||+.|+|||.+..
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp --------CCCCTTCCHHHHTT
T ss_pred cc-cccccCCCCCccCHhHhcc
Confidence 32 2345679999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=239.98 Aligned_cols=175 Identities=26% Similarity=0.438 Sum_probs=142.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4567899999999999999999998 588999999864211 11112357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999999865 348999999999999999999999999999999999999999999999999998655
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.........||+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp C-------------CCTGGGTT
T ss_pred CCcceecccCCccccCHHHHcC
Confidence 4444455679999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=246.59 Aligned_cols=168 Identities=29% Similarity=0.431 Sum_probs=146.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|+||.||+|+. +++.||||++........ ...+.+.+|+.++++++||||+++++++......+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 5688889999999999999997 788999999976544332 22467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+. |+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9999997 58888886543 5689999999999999999999999999999999999999999999999999986432
Q ss_pred CccCCCCCccccccCccc
Q 021253 293 GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~ 310 (315)
.....||+.|+|||++.
T Consensus 207 -~~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVIL 223 (348)
T ss_dssp -BCCCCSCGGGCCHHHHH
T ss_pred -CCcccCCcceeCHhhhc
Confidence 33468999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=246.92 Aligned_cols=174 Identities=20% Similarity=0.305 Sum_probs=150.3
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----CCCeee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 200 (315)
.+..+-.++|++.+.||+|+||.||+|++ +++.||||+++... ...+.+..|+.+++.++ ||||++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 33445567899999999999999999998 78899999996411 12356778999999997 999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-------
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------- 273 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~------- 273 (315)
+++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 889999998876667999999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 274 ------------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 274 ------------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
++.+||+|||+|+.... ......||+.|+|||++..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN 233 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC
Confidence 78999999999986433 2345689999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=239.48 Aligned_cols=173 Identities=27% Similarity=0.330 Sum_probs=150.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|.+.+.||+|+||.||++.+ +++.||+|++......... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH---HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 46889999999999999999998 5789999999765433222 246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999998765 35899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||.+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTT
T ss_pred ccccccccCCCCcCCcchhcc
Confidence 23344679999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=247.32 Aligned_cols=182 Identities=22% Similarity=0.422 Sum_probs=136.5
Q ss_pred CCccccccccccccccceeecccCceEEEEEC--C---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
...++.++.++|++.+.||+|+||.||+|++. + ..||||+++........ .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD----IEEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH----HHHHHHHHHHHTTCCCTTBCC
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH----HHHHHHHHHHHHHCCCCceeh
Confidence 45667788899999999999999999999873 2 27999999764433222 467899999999999999999
Q ss_pred EEEEEEeCCEE------EEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEE
Q 021253 201 FIGACRKRMVW------CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (315)
Q Consensus 201 l~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIl 270 (315)
+++++...... ++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEE
Confidence 99999877654 99999999999999997542 125899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 271 i~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
++.++.+||+|||+|+....... .....+++.|+|||.+..
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 99999999999999986533221 223456789999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=244.99 Aligned_cols=173 Identities=27% Similarity=0.325 Sum_probs=150.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|.+.+.||+|+||.||++.+ +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 46889999999999999999998 577999999976443322 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999999998765 35899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||.+..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHT
T ss_pred cccccccCCCccccCHHHhcc
Confidence 23345679999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=244.47 Aligned_cols=176 Identities=23% Similarity=0.417 Sum_probs=146.9
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
+....++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 344568899999999999999999998 588999999976554332 23568899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999999999998888886543 4589999999999999999999999999999999999999999999999999976
Q ss_pred eecC-CCccCCCCCccccccCcccc
Q 021253 288 EVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
.... .......||+.|+|||++..
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVG 198 (331)
T ss_dssp ----------CCCCCTTCCHHHHTT
T ss_pred ecCCccccCCCcCCccccCcccccC
Confidence 4332 23345679999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=257.82 Aligned_cols=174 Identities=25% Similarity=0.337 Sum_probs=137.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
.++|.+.+.||+|+||.||+|.+ +++.||||++........ ........+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46789999999999999999988 678999999975432211 111112357899999999999999999999754 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cEEEeeeccee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVAR 286 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~vkl~DFG~a~ 286 (315)
..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 579999999999999988653 4689999999999999999999999999999999999997544 59999999998
Q ss_pred eeecCCCccCCCCCccccccCccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
...........+||+.|+|||++.
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp SCC-----------CTTCCTTTTC
T ss_pred ecCCCccccccCCCCCccCceeee
Confidence 765554556678999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-32 Score=240.14 Aligned_cols=176 Identities=24% Similarity=0.385 Sum_probs=150.7
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
..+..++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc---hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 345668899999999999999999998 5789999998642111 11113578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
....++||||+++++|.+++.... .+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999999999998753 589999999999999999999999999999999999999999999999999976
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......||+.|+|||.+..
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 164 APSL-RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CSSS-CBCCCCSCGGGCCHHHHTT
T ss_pred Cccc-ccccccCCCCcCCHHHhcc
Confidence 4432 2345679999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=250.98 Aligned_cols=171 Identities=23% Similarity=0.433 Sum_probs=142.8
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|+...++|++++.||+|+||.||+|++ +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeee
Confidence 345567899999999999999999988 7889999998754322 2379999999999999999999844
Q ss_pred --------------------------------------CCEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHH
Q 021253 208 --------------------------------------RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDV 247 (315)
Q Consensus 208 --------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi 247 (315)
...+++||||++ ++|.+.+.. .....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 334899999998 488887764 345679999999999999
Q ss_pred HHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 248 ARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 248 ~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+.||+|||++||+||||||+|||++ .++.+||+|||+|+............||+.|+|||.+.+
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG 215 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC
Confidence 9999999999999999999999998 688999999999997665555666789999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=244.87 Aligned_cols=174 Identities=30% Similarity=0.507 Sum_probs=144.6
Q ss_pred ccccccccccceeecccCceEEEEE--CCee--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
++.++|++.+.||+|+||.||+|++ ++.. +|+|.++...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 4568899999999999999999986 5664 4999987533221 135688999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~ 272 (315)
.....++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997643 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.++.+||+|||+++............+++.|+|||.+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 214 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhc
Confidence 99999999999998543333334456789999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=244.55 Aligned_cols=161 Identities=24% Similarity=0.394 Sum_probs=124.5
Q ss_pred ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Q 021253 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 216 (315)
.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 47899999999999998 57899999996421 246779999999997 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC---cEEEeeecceeeeecC-C
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQT-E 292 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~---~vkl~DFG~a~~~~~~-~ 292 (315)
|+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..... .
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999999999864 4589999999999999999999999999999999999998766 8999999999865432 2
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
.....+||+.|+|||++..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp -------------------
T ss_pred cccccCCCcCccCHHHhcC
Confidence 3345678999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=246.71 Aligned_cols=173 Identities=20% Similarity=0.290 Sum_probs=145.1
Q ss_pred cccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEe
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRK 207 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~ 207 (315)
.+..++|++.+.||+|+||.||++.. +++.||||++......... .+.+.+|+.+++.++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH----HHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 45567899999999999999999987 6788999999865544322 3678899999999986 999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+|+|||+ .+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999999995 578999999864 4589999999999999999999999999999999999997 68899999999986
Q ss_pred eecCCC---ccCCCCCccccccCcccc
Q 021253 288 EVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
...... ....+||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp C------------CCCCSSCCHHHHHH
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhh
Confidence 543221 234579999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=238.99 Aligned_cols=174 Identities=28% Similarity=0.460 Sum_probs=134.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 46788999999999999999997 7889999998642111 111235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999754 356899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||.+..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp ---------------------
T ss_pred CCcceeccCCCCcCCcchhcC
Confidence 22334579999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=245.93 Aligned_cols=164 Identities=23% Similarity=0.378 Sum_probs=141.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 211 (315)
++|++.+.||+|+||.||+|.+ +++.||||++...... ..+|++++.++ +||||+++++++.+...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 6788999999999999999998 6889999999765432 23678888777 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC----CcEEEeeecceee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~----~~vkl~DFG~a~~ 287 (315)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999999999754 458999999999999999999999999999999999998543 3599999999986
Q ss_pred eecCC-CccCCCCCccccccCccc
Q 021253 288 EVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
..... .....+||+.|+|||++.
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHH
T ss_pred CcCCCCceeccCCCccccCHHHhc
Confidence 54332 345568999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=244.21 Aligned_cols=171 Identities=22% Similarity=0.417 Sum_probs=146.0
Q ss_pred cccccccccccceeecccCceEEEEEC--C-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN--G-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
++..++|++.+.||+|+||.||+|.+. + ..||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 466789999999999999999999873 3 57999998643221 13578899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc-----
Q 021253 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS----- 276 (315)
Q Consensus 202 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~----- 276 (315)
++++......++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999999999864 334899999999999999999999999999999999999998887
Q ss_pred ---EEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 277 ---IKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 277 ---vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+||+|||+++.... .....||+.|+|||.+..
T Consensus 157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP---KDILQERIPWVPPECIEN 191 (289)
T ss_dssp CCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHC
T ss_pred cceeeeccCcccccccC---ccccCCcCcccCHHHhCC
Confidence 99999999964322 123457899999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=253.23 Aligned_cols=176 Identities=20% Similarity=0.338 Sum_probs=148.3
Q ss_pred ccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 205 (315)
+..++|++.+.||+|+||.||+++. +++.||||+++........ ...+.+.+|+.+++.+ .||||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4567899999999999999999987 6789999998643211000 0013566899999999 699999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.....+++||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999865 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCccccccCcccc
Q 021253 286 RIEVQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
+...... .....+||+.|+|||++..
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred eecccCCCCcccCcccCcCccChhhhcC
Confidence 8653322 2334579999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=238.31 Aligned_cols=176 Identities=23% Similarity=0.389 Sum_probs=139.8
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
...+|++.+.||+|+||.||+|.. +++.||||+++........ ..+.+.+|+.+++.++||||+++++++.....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 456899999999999999999997 6889999999764433222 24678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999998752 3456899999999999999999999999999999999999999999999999999864
Q ss_pred ecCC-CccCCCCCccccccCcccc
Q 021253 289 VQTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......||+.|+|||.+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp ------------CCSSCCHHHHTT
T ss_pred cCCCccccccCCCeeEeChHHhCC
Confidence 4322 2334578999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=239.91 Aligned_cols=173 Identities=31% Similarity=0.459 Sum_probs=146.9
Q ss_pred cccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
+..++.||+|+||.||+|.++++.||||++........ ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999999999999999975432211 1124678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC--
Q 021253 217 YAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~-- 293 (315)
|+++++|.+++.... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999997532 34689999999999999999999999999999999999999999999999999986543221
Q ss_pred -ccCCCCCccccccCcccc
Q 021253 294 -MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~~ 311 (315)
.....||+.|+|||.+..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT
T ss_pred cccccCCCcCcCChHHhcC
Confidence 234579999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=241.01 Aligned_cols=182 Identities=23% Similarity=0.452 Sum_probs=143.5
Q ss_pred CCccccccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
....+.++.++|.+++.||+|+||.||+|.+ +++.||+|+++........ .+.+.+|+.++++++||||++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCeee
Confidence 4577888999999999999999999999986 2348999999765444322 357889999999999999999
Q ss_pred EEEEEEeCC-----EEEEEEeccCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE
Q 021253 201 FIGACRKRM-----VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (315)
Q Consensus 201 l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli 271 (315)
+++++.+.. ..++||||+++++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||++
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 999997754 359999999999999998542 23568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 272 SADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 272 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
+.++.+||+|||+++...... ......+++.|+|||.+..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence 999999999999998653322 1223457889999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=238.22 Aligned_cols=175 Identities=27% Similarity=0.506 Sum_probs=148.4
Q ss_pred ccccccccccccc-ceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~~~~~~~-~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
+|.++.++|.+.+ .||+|+||.||+|.+ ++..||||+++..... ...+.+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 5778888888887 999999999999985 5678999999764321 12467889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++ ..+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 455689999999999999999753 3568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC----ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+++....... .....+|+.|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred ceeeeccCcceeeccccccccccccCHHHhc
Confidence 9986543221 23345689999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=236.50 Aligned_cols=174 Identities=29% Similarity=0.465 Sum_probs=148.3
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-- 207 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 207 (315)
.+.+.|++.+.||+|+||.||+|.+ ++..||+|++......... .+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3446688889999999999999998 6678999999765544332 4678899999999999999999999875
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEc-CCCcEEEeee
Q 021253 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADF 282 (315)
Q Consensus 208 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~-~~~~vkl~DF 282 (315)
...+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++ .++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 45689999999999999999865 45899999999999999999999999 99999999999997 7899999999
Q ss_pred cceeeeecCCCccCCCCCccccccCccccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
|+++..... ......||+.|+|||++...
T Consensus 177 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 177 GLATLKRAS-FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp TGGGGCCTT-SBEESCSSCCCCCGGGGGTC
T ss_pred CCccccccc-ccccccCCcCcCCHHHHhcc
Confidence 999754332 33446799999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=246.58 Aligned_cols=172 Identities=24% Similarity=0.400 Sum_probs=138.3
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..++|++.+.||+|+||.||+|.+ +++.||||+++....... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----cchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 346889999999999999999987 788999999975443221 23567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-----CCCcEEEeeecce
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVA 285 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-----~~~~vkl~DFG~a 285 (315)
+++||||+++ +|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+|
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999999975 999999764 3589999999999999999999999999999999999994 4556999999999
Q ss_pred eeeecC-CCccCCCCCccccccCcccc
Q 021253 286 RIEVQT-EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~~ 311 (315)
+..... .......||+.|+|||++..
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcC
Confidence 754322 23445678999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=243.61 Aligned_cols=171 Identities=32% Similarity=0.523 Sum_probs=139.7
Q ss_pred cccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH--HHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM--LATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~ 206 (315)
++.++.++|++.+.||+|+||.||+|+++++.||||++.... .+.+..|.++ +..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 456778999999999999999999999999999999996421 1233344444 45689999999998664
Q ss_pred e-----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCCEEEc
Q 021253 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------GFIHRDLKSDNLLIS 272 (315)
Q Consensus 207 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---------~iiHrDlkp~NIli~ 272 (315)
. ...+++||||+++++|.+++... ..++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 3 23678999999999999999764 358889999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecceeeeecC---------CCccCCCCCccccccCcccc
Q 021253 273 ADKSIKIADFGVARIEVQT---------EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~---------~~~~~~~gt~~y~APE~~~~ 311 (315)
.++.+||+|||+|+..... .......||+.|+|||++.+
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9999999999999864322 11234579999999998864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=240.77 Aligned_cols=172 Identities=31% Similarity=0.514 Sum_probs=145.7
Q ss_pred ccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
++.+.|++++.||+|+||.||++.+ +++.||||+++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-----QHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-----HHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 4556669999999999999999875 6789999999754321 1246789999999999999999999999
Q ss_pred Ee--CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 206 RK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 206 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
.+ ...+++||||+++++|.+++... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence 88 46889999999999999999764 38999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC----ccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEG----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~ 311 (315)
+++....... .....+|+.|+|||.+..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcC
Confidence 9987543321 233468889999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=240.19 Aligned_cols=173 Identities=21% Similarity=0.320 Sum_probs=142.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.+++.++||||+++++++.....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 46888999999999999999997 68899999986533221 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999999865 35899999999999999999999999999999999999999999999999999765432
Q ss_pred C--CccCCCCCccccccCcccc
Q 021253 292 E--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~--~~~~~~gt~~y~APE~~~~ 311 (315)
. ......||+.|+|||.+..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp ---------CCGGGCCGGGTCC
T ss_pred ccccccccCCCcCccCHHHHcC
Confidence 2 2234579999999998853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.75 Aligned_cols=168 Identities=29% Similarity=0.474 Sum_probs=141.1
Q ss_pred cccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC--CCCCeeeEEEEEEeC--
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKR-- 208 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 208 (315)
-.++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34789999999999999999999999999999985421 12344556665554 899999999999887
Q ss_pred --CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCCEEEcCCCcEE
Q 021253 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 209 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NIli~~~~~vk 278 (315)
..+++||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999753 489999999999999999999998 999999999999999999999
Q ss_pred EeeecceeeeecCCC-----ccCCCCCccccccCccccc
Q 021253 279 IADFGVARIEVQTEG-----MTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 279 l~DFG~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~ 312 (315)
|+|||+|+....... .....||+.|+|||++...
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 221 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc
Confidence 999999976433221 1245799999999988643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=244.80 Aligned_cols=172 Identities=25% Similarity=0.374 Sum_probs=145.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 207 (315)
..+|++.+.||+|+||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 47899999999999999999998 6889999998665433221 2467799999999999999999999977
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...+++||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999975 8888876543 458999999999999999999999999999999999999999999999999
Q ss_pred ceeeeec-----CCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQ-----TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~-----~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+.... ........||+.|+|||++..
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred hcccccccccccccccCCcccccCccCchhhcC
Confidence 9986532 122345678999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.71 Aligned_cols=169 Identities=26% Similarity=0.337 Sum_probs=135.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (315)
.++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 46789999999999999999987 688999999986543322 2357889999999999999999999997654
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 210 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+|+||||+++ +|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 78888853 3889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+............||+.|+|||++..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp ---------------CTTCCHHHHTT
T ss_pred cccccccccCCceecCCccCHHHhcC
Confidence 87654444556789999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=249.01 Aligned_cols=173 Identities=20% Similarity=0.280 Sum_probs=145.8
Q ss_pred cccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEe
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRK 207 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 207 (315)
.+..++|++.+.||+|+||.||+|.. .++.||||++........ ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 34556799999999999999999987 578899999987554432 2467899999999996 5999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+|+||| +.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|+.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred CCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 999999999 5678999999864 3588889999999999999999999999999999999996 68999999999986
Q ss_pred eecCC---CccCCCCCccccccCcccc
Q 021253 288 EVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
..... .....+||+.|+|||++..
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHC
T ss_pred ccCCCccccCCCCCcCCCccChHHhhh
Confidence 54322 1345679999999998854
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=238.80 Aligned_cols=176 Identities=30% Similarity=0.539 Sum_probs=145.0
Q ss_pred cccccccccccccc-ceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 128 DEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 128 ~~~~i~~~~~~~~~-~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
.++.++.++|++.+ .||+|+||.||+|.+ .++.||||+++....... ..+.+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH----HHHHHHHHHHHHHhCCCCCEEEEE
Confidence 46678889999988 999999999999965 357899999976433222 246789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+++ .....++||||+++++|.+++... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 999 556689999999999999999864 45899999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCCC----ccCCCCCccccccCccc
Q 021253 283 GVARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
|+++....... .....+|+.|+|||.+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhc
Confidence 99986543322 12235678999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=244.02 Aligned_cols=175 Identities=27% Similarity=0.466 Sum_probs=143.5
Q ss_pred ccccccccccccceeecccCceEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
++++.++|++.+.||+|+||.||+|.+. +..||||+++..... .....+.+|+.+++.++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-----KQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4677889999999999999999999872 235999999754321 12357889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++......++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999999999764 3568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC----ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+++....... .....+|+.|+|||.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp C-----------------CCCGGGSCHHHHH
T ss_pred cchhhccccccccccCCCCccccccCchhcc
Confidence 9986543221 12234678999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=247.48 Aligned_cols=173 Identities=24% Similarity=0.359 Sum_probs=149.0
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
++..++|++.+.||+|+||.||+|.+ +++.||+|++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 34567899999999999999999998 5889999999764321 2246789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998753 489999999999999999999996 999999999999999999999999999975
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......||+.|+|||++..
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHHTT
T ss_pred cccc-cccCCCCCCCeECHHHHcC
Confidence 4332 2345689999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=239.92 Aligned_cols=168 Identities=24% Similarity=0.378 Sum_probs=139.4
Q ss_pred ccccc-ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE
Q 021253 135 RKLNM-GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (315)
Q Consensus 135 ~~~~~-~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (315)
+.|++ .+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 35666 37899999999999987 68899999997654322 24688999999885 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc---EEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~---vkl~DFG~a~~ 287 (315)
+|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999999999875 35899999999999999999999999999999999999988775 99999999875
Q ss_pred eecC--------CCccCCCCCccccccCccc
Q 021253 288 EVQT--------EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~--------~~~~~~~gt~~y~APE~~~ 310 (315)
.... ......+||+.|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp ------------------CCSGGGCCHHHHH
T ss_pred cccCCccccccccccccccCCcCccChHHhh
Confidence 4321 1123346999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=236.18 Aligned_cols=170 Identities=26% Similarity=0.457 Sum_probs=148.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 6788999999999999999998 58899999997543322 1357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999999998643 45899999999999999999999999999999999999999999999999999864322
Q ss_pred --CCccCCCCCccccccCcccc
Q 021253 292 --EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTC
T ss_pred chhcccCCccccCccChHHHhc
Confidence 12345679999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=241.09 Aligned_cols=164 Identities=17% Similarity=0.345 Sum_probs=145.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe--C
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK--R 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~ 208 (315)
.++|++.+.||+|+||.||+|.. +++.||||+++... .+.+.+|+.+++.++ ||||+++++++.. .
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 47899999999999999999987 78899999996422 246889999999997 9999999999988 6
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~ 287 (315)
...++||||+++++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 678999999999999999853 88899999999999999999999999999999999999777 899999999987
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........||+.|+|||++..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred cCCCCccccccccccccChhhhcC
Confidence 665555666789999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=236.30 Aligned_cols=174 Identities=27% Similarity=0.496 Sum_probs=146.9
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
+..++|++.+.||+|+||.||+|++ +++.||+|++.......... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4457889999999999999999998 68899999987654433221 11125788999999999999999999999777
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcCCCc-----EEEee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS-----IKIAD 281 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~~~~-----vkl~D 281 (315)
. ++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6 6999999999999998754 356899999999999999999999999 999999999999988776 99999
Q ss_pred ecceeeeecCCCccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
||+++.... ......||+.|+|||.+.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSS
T ss_pred CCccccccc--cccccCCCccccCchhhc
Confidence 999975332 345568999999999983
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=248.35 Aligned_cols=178 Identities=17% Similarity=0.282 Sum_probs=142.5
Q ss_pred ccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHH-----HHHHHHHHHHHHhCCCCCee
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVM-----EQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv 199 (315)
+..++|++.+.||+|+||.||+|.+. ++.||||++............. ...+.+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34568999999999999999999882 4789999987643211111111 12345677788889999999
Q ss_pred eEEEEEEeC----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc--C
Q 021253 200 RFIGACRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--A 273 (315)
Q Consensus 200 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~--~ 273 (315)
++++++... ...|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 4589999999 99999999864 35699999999999999999999999999999999999999 8
Q ss_pred CCcEEEeeecceeeeecCCC--------ccCCCCCccccccCcccc
Q 021253 274 DKSIKIADFGVARIEVQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 274 ~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
++.+||+|||+|+....... ....+||+.|+|||++..
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence 89999999999986543221 133459999999998764
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=239.34 Aligned_cols=173 Identities=27% Similarity=0.434 Sum_probs=146.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+++|++.+.||+|+||.||+|+. +++.||||+++....... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchh----hHHHHHHHHHHHHHcCCCCeeeEEEEEecCCce
Confidence 46788999999999999999998 688999999865432211 125678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||++ ++|.+++.......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 156 (299)
T 2r3i_A 78 YLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156 (299)
T ss_dssp EEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EEEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence 99999997 59999998766567899999999999999999999999999999999999999999999999999754322
Q ss_pred -CCccCCCCCccccccCcccc
Q 021253 292 -EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~ 311 (315)
.......+|+.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 157 VRTYTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp SBCTTSCBCCCTTCCHHHHTT
T ss_pred ccccCcccccccccCcHHhhc
Confidence 22344578999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=244.22 Aligned_cols=179 Identities=25% Similarity=0.374 Sum_probs=132.7
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-----TSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 45788889999999999999999999986 7889999988643221 1235788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
...+..++||||+++++|.+++... ....+++..++.++.||+.||+|||+++++||||||+||+++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999998742 2345899999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCC------CccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTE------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~------~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++...... ......||+.|+|||.+..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 9999987543221 1234579999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=248.84 Aligned_cols=177 Identities=27% Similarity=0.404 Sum_probs=142.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... ......+.+.+|+.++++++||||+++++++.+....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 36789999999999999999988 67799999986431100 0011246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 021253 212 CIVTEYAKGGSVRQFLTRRQ--------------------------------------NRAVPLKLAVKQALDVARGMAY 253 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~gL~y 253 (315)
++||||+++++|.+++.... ...+++..++.++.||+.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999985210 1123567788999999999999
Q ss_pred HHhCCCccCCCCCCCEEEcCCC--cEEEeeecceeeeecCC-----CccCCCCCccccccCcccc
Q 021253 254 VHGLGFIHRDLKSDNLLISADK--SIKIADFGVARIEVQTE-----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 254 LH~~~iiHrDlkp~NIli~~~~--~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~APE~~~~ 311 (315)
||+++|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++..
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999999999999998776 89999999998643321 1345679999999998864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=236.68 Aligned_cols=170 Identities=29% Similarity=0.447 Sum_probs=149.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.+.|++.+.||+|+||.||+|.. +++.||||++........ .+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 35688999999999999999987 678999999976543322 35788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999999864 45899999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCccccccCcccc
Q 021253 292 E-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~ 311 (315)
. ......||+.|+|||.+..
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTT
T ss_pred ccccCccCCCcCccCHHHHhc
Confidence 2 2345679999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=235.43 Aligned_cols=170 Identities=24% Similarity=0.327 Sum_probs=146.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (315)
+..++|++.+.||+|+||.||+|.. +++.||||++...... +.+.+|+.+++.+ +|++++++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 3456789999999999999999996 7899999998754332 2567899999999 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc-----EEEeeec
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFG 283 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~-----vkl~DFG 283 (315)
...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999999 99999999864 345899999999999999999999999999999999999987765 9999999
Q ss_pred ceeeeecCCC--------ccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
+++....... .....||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcC
Confidence 9986543321 244579999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=241.92 Aligned_cols=172 Identities=29% Similarity=0.501 Sum_probs=147.3
Q ss_pred ccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
++.++|++.+.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--P----DQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--H----HHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4668999999999999999999985 57899999997532 1 1235788999999999999999999998
Q ss_pred E--eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 206 R--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 206 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
. ....+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 7 4567899999999999999998643 358999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC----CccCCCCCccccccCccc
Q 021253 284 VARIEVQTE----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~----~~~~~~gt~~y~APE~~~ 310 (315)
+++...... ......||+.|+|||.+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhc
Confidence 998654332 123456889999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=247.85 Aligned_cols=171 Identities=25% Similarity=0.407 Sum_probs=141.3
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|++ .++|++.+.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++..
T Consensus 21 ~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 21 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----HHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred eee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----HHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 444 36789999999999999999998 68899999996654332 224678899999999999999999999976
Q ss_pred CC------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 208 RM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 208 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
.. .+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEe
Confidence 53 469999999 7899999976 3489999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+|+.... ..+...+|+.|+|||++..
T Consensus 172 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 172 FGLARQADS--EMTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHT
T ss_pred eeccccccc--ccCcCcCCCCcCCHHHHhC
Confidence 999986432 3456689999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=240.97 Aligned_cols=174 Identities=26% Similarity=0.448 Sum_probs=145.3
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
+.....+|++.+.||+|+||.||+|++ +++.||||++....... +.+.+|+.+++++ +||||+++++++.
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334567899999999999999999998 78899999997644332 4678999999999 7999999999997
Q ss_pred e------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 K------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
. ...+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 4678999999999999999987655678999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCC-CccCCCCCccccccCccc
Q 021253 281 DFGVARIEVQTE-GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 281 DFG~a~~~~~~~-~~~~~~gt~~y~APE~~~ 310 (315)
|||+++...... ......||+.|+|||++.
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC
T ss_pred eCcCceecCcCccccccccCCccccChhhhc
Confidence 999997643321 234457999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=234.51 Aligned_cols=179 Identities=26% Similarity=0.398 Sum_probs=150.1
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..+|.+...++.....||+|+||.||+|.+ +++.||||.+....... .+.+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~ 87 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGS 87 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeE
Confidence 345566667777778999999999999998 67899999997643221 3578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeee
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADF 282 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DF 282 (315)
+......++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++++|+||||+||+++. ++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999999999999998653 234678889999999999999999999999999999999987 899999999
Q ss_pred cceeeeecCC-CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
|+++...... ......||+.|+|||++..
T Consensus 168 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp TTCEESCC-----CCCCCCGGGCCHHHHHH
T ss_pred ccccccCCCCCcccccCCCccccChhhhcC
Confidence 9998654322 2345679999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=245.00 Aligned_cols=173 Identities=21% Similarity=0.329 Sum_probs=143.9
Q ss_pred cccccc-cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Q 021253 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (315)
Q Consensus 135 ~~~~~~-~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (315)
..|.+. +.||+|+||.||+|.. +++.||+|++......... ...+.+|+.+++.+. ||||+++++++.....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345555 8899999999999998 5889999999765433322 257889999999995 6999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~ 287 (315)
+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999987655567999999999999999999999999999999999999987 78999999999987
Q ss_pred eecCCCccCCCCCccccccCcccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........||+.|+|||++..
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNY 207 (327)
T ss_dssp C---------CCCGGGCCHHHHTT
T ss_pred cCCccccccccCCcCccCCeeecC
Confidence 655544556789999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=244.12 Aligned_cols=179 Identities=28% Similarity=0.530 Sum_probs=150.4
Q ss_pred CccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (315)
..+|++..++|++.+.||+|+||.||+|.+ +++.||||+++...... ..+.+.+|+.+++++ +||||
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-----HHHHHHHHHHHHHhcccCCCe
Confidence 457889999999999999999999999985 34789999997543221 235788999999999 79999
Q ss_pred eeEEEEEEeCC-EEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 199 VRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 199 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
+++++++...+ .+++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++|+|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 99999987754 58999999999999999986532 1278999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|||+||+++.++.+||+|||+++....... .....||+.|+|||++.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence 999999999999999999999985433221 22345788999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=236.87 Aligned_cols=176 Identities=23% Similarity=0.481 Sum_probs=145.8
Q ss_pred ccccccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
..|.+..++|++.+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-----DNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-----HHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-----hHHHHHHHHHHHHHhCCCCCcceEE
Confidence 356778899999999999999999999862 235999998754321 1236789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+++.+.. .++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 80 GIIEEEP-TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEcCCC-CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 9987654 589999999999999997653 45899999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCC--CccCCCCCccccccCccc
Q 021253 283 GVARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 283 G~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|+++...... ......+|+.|+|||.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHH
T ss_pred CCCcccccccccccccCCCCcceeCchhhc
Confidence 9997644322 123345788999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=240.15 Aligned_cols=179 Identities=22% Similarity=0.355 Sum_probs=133.6
Q ss_pred CCccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFI 202 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~ 202 (315)
....|.+..++|++.+.||+|+||.||+|.+ +++.||||+++....... ..++..|+. +++.++||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeee
Confidence 3467889999999999999999999999998 589999999976432221 234445555 77888999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEE
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIK 278 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vk 278 (315)
+++...+..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 999999999999999985 88887763 2345689999999999999999999999 999999999999999999999
Q ss_pred EeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 279 IADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 279 l~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+|||+++............||+.|+|||++.
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198 (327)
T ss_dssp ECCCSSSCC-----------------------
T ss_pred EccCCCceecccccccccCCCCccccCceeec
Confidence 99999998655444444557999999999983
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=241.57 Aligned_cols=166 Identities=34% Similarity=0.546 Sum_probs=145.6
Q ss_pred ccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEeCC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM-- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-- 209 (315)
.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4688999999999999999999999999999985321 2467788888887 78999999999998875
Q ss_pred --EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCCEEEcCCCcEEE
Q 021253 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 210 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
..++||||+++++|.+++.+. .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999763 4899999999999999999999 899999999999999999999999
Q ss_pred eeecceeeeecCC-----CccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTE-----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~-----~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++...... ......||+.|+|||++..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 9999998765433 2344579999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=238.04 Aligned_cols=169 Identities=25% Similarity=0.401 Sum_probs=145.5
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|.+.+.||+|+||.||+++. +++.||+|+++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 36788999999999999999998 68899999998643221 24688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~~ 288 (315)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||++ +.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999999999765 358999999999999999999999999999999999999 77889999999999754
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... ......||+.|+|||.+..
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 160 QNG-IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp CCB-TTHHHHSCCCBCCTTTBSS
T ss_pred CCC-ccccccCCCCccChHHhcc
Confidence 332 2334568999999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=242.33 Aligned_cols=169 Identities=36% Similarity=0.582 Sum_probs=138.8
Q ss_pred cccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
.++.++|++.+.||+|+||.||+|++.++.||||.+.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 73 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELRQLSRVNHPNIVKLYGACLNP-- 73 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence 3577899999999999999999999999999999986421 135788999999999999999999988744
Q ss_pred EEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCCEEEcCCCc-EEEeeecce
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHG---LGFIHRDLKSDNLLISADKS-IKIADFGVA 285 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlkp~NIli~~~~~-vkl~DFG~a 285 (315)
.++||||+++++|.+++..... ..++...++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 6899999999999999986432 246888999999999999999999 89999999999999998886 799999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+..... .....||+.|+|||.+..
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 154 CDIQTH--MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp -------------CCTTSSCHHHHTC
T ss_pred cccccc--cccCCCCCceEChhhhCC
Confidence 754322 334579999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=241.88 Aligned_cols=178 Identities=21% Similarity=0.282 Sum_probs=147.5
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+.+.++.++|++.+.||+|+||.||++.. +++.||||++.... . ...+.+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--Q----QDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--H----HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--H----HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34667788999999999999999999997 78899999986522 1 1236788999999999999999999998
Q ss_pred Ee----CCEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 206 RK----RMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 206 ~~----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
.. ....++||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 63 34789999999999999999763 3456899999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCC----------ccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTEG----------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~~----------~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++....... .....||+.|+|||.+..
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhcc
Confidence 99999875321110 122357999999998763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=243.75 Aligned_cols=173 Identities=23% Similarity=0.460 Sum_probs=139.1
Q ss_pred ccccccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+..++|++.+.||+|+||.||+|++ +++ +||+|.++..... ...+.+.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3457899999999999999999987 444 4688877543221 1235788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.... .++|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8866 678999999999999998643 46899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC---ccCCCCCccccccCcccc
Q 021253 286 RIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+....... .....+|+.|+|||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHH
T ss_pred eEccCCcccccccCCCccccccChHHhcc
Confidence 86433222 223456889999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=246.22 Aligned_cols=170 Identities=26% Similarity=0.371 Sum_probs=138.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 5788999999999999999998 678999999965332211 124558999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||++ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9999997 4999998764 346899999999999999999999999999999999999999999999999999864322
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||++..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp --------CGGGCCHHHHTT
T ss_pred cccccccCcccccChhhhcC
Confidence 22344578999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=244.46 Aligned_cols=173 Identities=25% Similarity=0.353 Sum_probs=141.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
++|++.+.||+|+||.||+|.+ +++.||||++........ ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5788999999999999999998 678999999976432211 11112346889999999999999999999997766
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc---EEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~---vkl~DFG~a~~ 287 (315)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 79999999999999998653 46899999999999999999999999999999999999987654 99999999987
Q ss_pred eecCCCccCCCCCccccccCccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
...........||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHH
T ss_pred cccccccccccCCcCccCchhhc
Confidence 54433233456899999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=244.79 Aligned_cols=172 Identities=26% Similarity=0.499 Sum_probs=140.0
Q ss_pred ccccccccccceeecccCceEEEEE--CCee----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+........ .+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4557899999999999999999987 4443 78888754332221 13567899999999999999999998
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.. ...++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 85 ~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 PG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp CB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 64 4578999999999999999754 245888899999999999999999999999999999999999999999999999
Q ss_pred eeeecCC---CccCCCCCccccccCccc
Q 021253 286 RIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
+...... ......||+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIH 190 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHH
T ss_pred cccCcccccccccCCCCcccccChHHhc
Confidence 8653322 123456788999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=246.19 Aligned_cols=180 Identities=21% Similarity=0.340 Sum_probs=153.1
Q ss_pred ccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHH-----------HHHHHHHHHHHHHHHhCCCCCeee
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-----------QVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
+..++|++.+.||+|+||.||+|.++++.||||++.......... ....+.+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 446799999999999999999999999999999986432111000 001157889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcC
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQF------LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISA 273 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~ 273 (315)
+++++.+.+..++||||+++++|.++ +.......+++..++.++.||+.||+|||+ +|++||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 655445679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecceeeeecCCCccCCCCCccccccCccccc
Q 021253 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 274 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
++.+||+|||+++..... ......||+.|+|||.+...
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSC
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCC
Confidence 999999999999865443 34556899999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=253.09 Aligned_cols=177 Identities=15% Similarity=0.187 Sum_probs=141.5
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHH---HHHHhCCCCCeeeEE-
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFI- 202 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~- 202 (315)
+|....++|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+ .+++.++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 4555668899999999999999999986 6899999999754333222 135788999 555666899999998
Q ss_pred ------EEEEeCC-----------------EEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 021253 203 ------GACRKRM-----------------VWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYV 254 (315)
Q Consensus 203 ------~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yL 254 (315)
+++...+ ..|+||||+ +|+|.+++..... ..+++..++.++.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 6666553 279999999 6799999986421 1223477888999999999999
Q ss_pred HhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCccccc
Q 021253 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 255 H~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
|++||+||||||+|||++.++.+||+|||+|+... ......+| +.|+|||++...
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhccc
Confidence 99999999999999999999999999999998532 23455678 999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=246.15 Aligned_cols=175 Identities=21% Similarity=0.320 Sum_probs=141.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|++ +++.||||++........ .....+.+.+|+.+++.++||||+++++++......
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 46788999999999999999988 588999999875432211 111224678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~- 290 (315)
++||||+++ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999986 898888753 34578888999999999999999999999999999999999999999999999986432
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
........||+.|+|||++..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTT
T ss_pred cccCCcccccccccCchHhhC
Confidence 223455689999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=241.05 Aligned_cols=176 Identities=27% Similarity=0.393 Sum_probs=134.6
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 204 (315)
..+++...+|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++++. ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 45667778999999999999999999998 788999999854321 12357889999999996 9999999999
Q ss_pred EE--------eCCEEEEEEeccCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEcC
Q 021253 205 CR--------KRMVWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISA 273 (315)
Q Consensus 205 ~~--------~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~~ 273 (315)
+. ....+++||||+. |+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 94 3456899999996 6999988752 3456999999999999999999999999 999999999999999
Q ss_pred CCcEEEeeecceeeeecCCC-------------ccCCCCCccccccCccc
Q 021253 274 DKSIKIADFGVARIEVQTEG-------------MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 274 ~~~vkl~DFG~a~~~~~~~~-------------~~~~~gt~~y~APE~~~ 310 (315)
++.+||+|||+++....... .....||+.|+|||++.
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 99999999999986543221 11346899999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=243.42 Aligned_cols=177 Identities=16% Similarity=0.247 Sum_probs=140.7
Q ss_pred ccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHH-----HHHHHHHHHHHHHhCCCCCeeeE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQV-----MEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l 201 (315)
+..++|++.+.||+|+||.||+|.+ ++..||||++............ ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999998 4578999999765432211111 12347789999999999999999
Q ss_pred EEEEEe----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC--
Q 021253 202 IGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (315)
Q Consensus 202 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-- 275 (315)
++++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999988 77899999999 999999997643 689999999999999999999999999999999999999887
Q ss_pred cEEEeeecceeeeecCCC--------ccCCCCCccccccCcccc
Q 021253 276 SIKIADFGVARIEVQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 276 ~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
.+||+|||+|+....... .....||+.|+|||++..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 999999999986533211 144579999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=234.96 Aligned_cols=171 Identities=27% Similarity=0.425 Sum_probs=143.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
...++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 3457889999999999999999998 4889999999764322 46789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999999999743 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCC-CccCCCCCccccccCcccc
Q 021253 290 QTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
... ......||+.|+|||.+..
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSS
T ss_pred hhccccCccCCCCCccChhhcCC
Confidence 332 2344579999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=248.12 Aligned_cols=166 Identities=27% Similarity=0.395 Sum_probs=139.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
.+|++.+.||+|+||.||+|++ +++.||||++..... .+.+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 4688899999999999999998 688999999875432 233799999999999999999998542
Q ss_pred --CEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-CcEEEeeec
Q 021253 209 --MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFG 283 (315)
Q Consensus 209 --~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-~~vkl~DFG 283 (315)
..+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 246799999976 77776653 234669999999999999999999999999999999999999965 678999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+............||+.|+|||++..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTT
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcC
Confidence 9997655545556789999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=238.69 Aligned_cols=176 Identities=28% Similarity=0.533 Sum_probs=146.8
Q ss_pred ccccccccccccccceeecccCceEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
+...+..++|++.+.||+|+||.||+|++ +++.||||++..... . ..+.+.+|+.+++.++||||+++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~----~~~~~~~E~~~l~~l~h~~iv~~ 107 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--E----HLRDFEREIEILKSLQHDNIVKY 107 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--H----HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--H----HHHHHHHHHHHHHhCCCCCeeeE
Confidence 33445678899999999999999999985 578999999976322 1 13578899999999999999999
Q ss_pred EEEEEeCC--EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 202 IGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 202 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
++++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp EEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred EEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence 99986643 6799999999999999998643 45899999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCC----ccCCCCCccccccCccc
Q 021253 280 ADFGVARIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 280 ~DFG~a~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+|||+++....... .....++..|+|||.+.
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhc
Confidence 99999987543322 23345778899999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=235.76 Aligned_cols=169 Identities=26% Similarity=0.425 Sum_probs=139.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
++|++.+.||+|+||.||+|+. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 5788899999999999999997 6889999998641 1224678899999999999999999999865
Q ss_pred --------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 208 --------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 208 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
....|+||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 35789999999999999999863 345788899999999999999999999999999999999999999999
Q ss_pred eeecceeeeecC---------------CCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQT---------------EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~---------------~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++..... .......||+.|+|||++..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 999999754211 12334568999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=236.37 Aligned_cols=171 Identities=27% Similarity=0.449 Sum_probs=142.1
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
..+.|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 446889999999999999999998 47899999986543221 3578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999999987643 4589999999999999999999999999999999999999999999999999754221
Q ss_pred -CCCccCCCCCccccccCccc
Q 021253 291 -TEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 291 -~~~~~~~~gt~~y~APE~~~ 310 (315)
........||+.|+|||.+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHHC-----CCGGGCCHHHHH
T ss_pred cccccccccCChhhcCCeeec
Confidence 11233457999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=237.52 Aligned_cols=174 Identities=23% Similarity=0.395 Sum_probs=144.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 210 (315)
++|++++.||+|+||.||++.+ +++.||+|+++...... .....+.+.+|+.+++.++||||+++++++. +...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 6788999999999999999998 67899999986422110 0112467899999999999999999999984 4557
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
.++||||++++ |.+++.......+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999875 88888776667799999999999999999999999999999999999999999999999999986532
Q ss_pred C---CCccCCCCCccccccCcccc
Q 021253 291 T---EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~---~~~~~~~gt~~y~APE~~~~ 311 (315)
. .......||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTC
T ss_pred cccccccccCCCCCCCcChhhccC
Confidence 2 12234579999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=246.29 Aligned_cols=172 Identities=26% Similarity=0.386 Sum_probs=129.7
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|++. ++|++.+.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 35554 6799999999999999999987 788999999976543322 2357889999999999999999999986
Q ss_pred eC------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.. ..+|+|+|++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 54 5679999999 6799998865 458999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+|+.... ......||+.|+|||++..
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp C-----------------CCCTTCCHHHHTT
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcC
Confidence 9999986433 2455689999999998764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=238.91 Aligned_cols=173 Identities=26% Similarity=0.427 Sum_probs=144.8
Q ss_pred ccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEE-
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACR- 206 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~- 206 (315)
.++|++.+.||+|+||.||+|.+ +++.||+|+++........ ...+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC----CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 46899999999999999999987 4689999998754322111 12345677666665 8999999999987
Q ss_pred ----eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 207 ----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 207 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
....+++||||++ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 59999998766666999999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCCCccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|+++............||+.|+|||++..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred cccccccCCCCccccccccceeCHHHHhc
Confidence 99987654444556789999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=242.76 Aligned_cols=177 Identities=20% Similarity=0.289 Sum_probs=139.1
Q ss_pred cccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChh-----HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE-----KAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
..++|++.+.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 347889999999999999999987 788999999865433211 12233468999999999999999999999985
Q ss_pred e-----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 207 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
. ...+|+||||++ ++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 346899999997 5888888753 34689999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+++............||+.|+|||++..
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TTC---------------CGGGCCHHHHTT
T ss_pred cCcccccccccccceecccceecCcHHhcC
Confidence 999986555545556789999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=239.14 Aligned_cols=176 Identities=28% Similarity=0.455 Sum_probs=144.0
Q ss_pred ccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (315)
+++..++|++.+.||+|+||.||+|++ +++.||||++....... ...++.+|+.++++++||||++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-----hHHHHHHHHHHHhhCCCCCCCeEE
Confidence 456778999999999999999999983 45689999996433211 235788999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---C
Q 021253 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D 274 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~ 274 (315)
+++......|+||||+++++|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999999889999999999999999987532 34889999999999999999999999999999999999984 4
Q ss_pred CcEEEeeecceeeeecCC---CccCCCCCccccccCccc
Q 021253 275 KSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 275 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~ 310 (315)
..+||+|||+++...... ......||+.|+|||.+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 218 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence 469999999997432221 122346789999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=241.29 Aligned_cols=167 Identities=25% Similarity=0.355 Sum_probs=143.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
.+|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 5789999999999999999987 6889999999753221 2236788999999999999999999999765
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...|+||||+++ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 368999999974 999998753 489999999999999999999999999999999999999999999999999986
Q ss_pred eecCCC----ccCCCCCccccccCccc
Q 021253 288 EVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
...... ....+||+.|+|||++.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhc
Confidence 543322 24458999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=259.57 Aligned_cols=164 Identities=18% Similarity=0.170 Sum_probs=128.1
Q ss_pred eeecccCceEEEE--ECCeeEEEEEeeCCCC----ChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEE
Q 021253 143 FAQGAFGKLYRGT--YNGEDVAIKILERPEN----NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVT 215 (315)
Q Consensus 143 iG~G~~G~Vy~~~--~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 215 (315)
.+.|.+|.+..++ +.|+.++||++..... ..++.+...++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555543 3788999999976532 3334445567899999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-CCc
Q 021253 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (315)
Q Consensus 216 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~-~~~ 294 (315)
||++|++|.+++.+. ..++.. +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999764 346553 57899999999999999999999999999999999999999999865432 234
Q ss_pred cCCCCCccccccCcccc
Q 021253 295 TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 295 ~~~~gt~~y~APE~~~~ 311 (315)
...+||+.|||||++.+
T Consensus 397 ~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE 413 (569)
T ss_dssp HHHHHHHHHHHHHHC--
T ss_pred cCceechhhccHHHhCC
Confidence 45679999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=234.29 Aligned_cols=172 Identities=25% Similarity=0.426 Sum_probs=148.1
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++.+.||+|+||.||+|+. +++.||||++......... .+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 36888999999999999999998 6889999999754332221 25788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC---CcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~---~~vkl~DFG~a~~~ 288 (315)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++++||||||+||+++.+ +.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999987653 58999999999999999999999999999999999999754 47999999999865
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..........||+.|+|||.+..
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTT
T ss_pred cCCCccccccCcccccChHHhcC
Confidence 54444444568999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=243.88 Aligned_cols=179 Identities=28% Similarity=0.564 Sum_probs=149.8
Q ss_pred CCccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
....|+++.++|++.+.||+|+||.||+|.+.+ .||+|+++........ .+.+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 467899999999999999999999999999865 5999998765433221 13567899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.....+++||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+||+++ ++.+||+|||++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999999999754 34688999999999999999999999999999999999998 789999999998
Q ss_pred eeeec------CCCccCCCCCccccccCcccc
Q 021253 286 RIEVQ------TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~------~~~~~~~~gt~~y~APE~~~~ 311 (315)
+.... ........||+.|+|||++..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccccccCCCcccccChHHhhh
Confidence 75321 112334568999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=234.28 Aligned_cols=174 Identities=24% Similarity=0.390 Sum_probs=146.4
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 209 (315)
.++|++.+.||+|+||.||++.+ +++.||+|.+......... .+.+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 46888999999999999999998 6889999999876544332 4678999999999999999999998854 56
Q ss_pred EEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCCEEEcCCCcEEEeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
..++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999999753 2345899999999999999999999999 999999999999999999999999
Q ss_pred cceeeeecCCC-ccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEG-MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~-~~~~~gt~~y~APE~~~~ 311 (315)
|+++....... .....||+.|+|||.+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred chheeeccccccccccCCCccccChHHhcc
Confidence 99975433211 223468999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=244.97 Aligned_cols=168 Identities=21% Similarity=0.322 Sum_probs=144.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC------CCCCeeeEEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL------KHLNIVRFIGAC 205 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~ 205 (315)
..+|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 35789999999999999999988 57899999996421 1234677888888777 577999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc--EEEeeec
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFG 283 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~--vkl~DFG 283 (315)
.....+++||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 59999998876667999999999999999999999999999999999999999887 9999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+.... .....+||+.|+|||++..
T Consensus 248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 248 SSCYEHQ--RVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHHHT
T ss_pred cceecCC--cccccCCCCCccChHHHhC
Confidence 9975432 3445689999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=243.74 Aligned_cols=167 Identities=23% Similarity=0.362 Sum_probs=139.1
Q ss_pred ccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (315)
..+|++.+.||+|+||.||+|++ .+..||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 35789999999999999999998 5566999988653322 237999999999999999999996543
Q ss_pred ---EEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEeeec
Q 021253 210 ---VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (315)
Q Consensus 210 ---~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~DFG 283 (315)
.+++||||+++ ++...+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 38899999987 44444332 2345689999999999999999999999999999999999999 79999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+............||+.|+|||++.+
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred CcccccCCCCCcccccCcCccCHHHHcC
Confidence 9997655555566789999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=245.04 Aligned_cols=170 Identities=29% Similarity=0.496 Sum_probs=133.2
Q ss_pred cccccccceeecccCceEEEEE---CC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-C
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY---NG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-R 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 208 (315)
..|++.+.||+|+||.||+|++ ++ ..||||.++....... .+++.+|+.++++++||||+++++++.. .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 3567889999999999999986 22 3689999865433222 3678999999999999999999998754 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 5789999999999999999754 345788999999999999999999999999999999999999999999999999854
Q ss_pred ecCC-----CccCCCCCccccccCccc
Q 021253 289 VQTE-----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~-----~~~~~~gt~~y~APE~~~ 310 (315)
.... ......+|+.|+|||.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 269 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQ 269 (373)
T ss_dssp ---------------CCGGGSCHHHHH
T ss_pred cccccccccccCCCCCcccccChHHhc
Confidence 3221 123345778999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=235.16 Aligned_cols=177 Identities=21% Similarity=0.389 Sum_probs=134.1
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.++..+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 45777889999999999999999999998 688999999976543221 124455666678889999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
.....+++||||+ ++.+..+.... ...+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 55555555433 45689999999999999999999995 999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCccccccCccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
++............||+.|+|||.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERID 197 (318)
T ss_dssp C--------------CCTTCCHHHHC
T ss_pred chhccCCccccccCCCccccChhhcc
Confidence 98655444445567999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=234.69 Aligned_cols=170 Identities=28% Similarity=0.457 Sum_probs=140.5
Q ss_pred cccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 208 (315)
.+|++.+.||+|+||.||+|++. ...||+|.+...... ...+.+.+|+.++++++||||+++++++. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 56888999999999999999862 235899988653322 12367889999999999999999999864 45
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++||||+++++|.+++... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 6789999999999999999753 355889999999999999999999999999999999999999999999999999854
Q ss_pred ecCC-----CccCCCCCccccccCccc
Q 021253 289 VQTE-----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~-----~~~~~~gt~~y~APE~~~ 310 (315)
.... ......+|+.|+|||.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQ 205 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHH
T ss_pred cccchhccccccCCCCCccccChHHhc
Confidence 3221 123345788999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=241.43 Aligned_cols=182 Identities=23% Similarity=0.317 Sum_probs=148.8
Q ss_pred CccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFI 202 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~ 202 (315)
...++.-.++|++.+.||+|+||.||+|.+ +++.||||++..............+.+.+|+.+++.++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344455567899999999999999999987 78899999997653322100000134668999999996 59999999
Q ss_pred EEEEeCCEEEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEe
Q 021253 203 GACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIA 280 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~ 280 (315)
+++......++|+|++.+ ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999999986 8999999865 4589999999999999999999999999999999999999 78899999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+++..... ......||+.|+|||++..
T Consensus 193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 222 (320)
T 3a99_A 193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRY 222 (320)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHH
T ss_pred eCccccccccc-cccCCCCCccCCChHHhcc
Confidence 99999875543 3455679999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=241.03 Aligned_cols=169 Identities=20% Similarity=0.324 Sum_probs=143.8
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--------CCCeeeEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--------HLNIVRFI 202 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~ 202 (315)
-..+|++.+.||+|+||.||+|++ +++.||||+++.. ....+.+.+|+.+++.++ ||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 347899999999999999999987 6889999999642 122357889999999986 78899999
Q ss_pred EEEE----eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEcCCC--
Q 021253 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADK-- 275 (315)
Q Consensus 203 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~~~~-- 275 (315)
+++. ....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 456899999999 66887877765556799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------------cEEEeeecceeeeecCCCccCCCCCccccccCc
Q 021253 276 -----------------------------------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAPSA 308 (315)
Q Consensus 276 -----------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~ 308 (315)
.+||+|||+|+.... ......||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChh
Confidence 799999999986543 3455689999999998
Q ss_pred ccc
Q 021253 309 GSI 311 (315)
Q Consensus 309 ~~~ 311 (315)
+..
T Consensus 265 ~~~ 267 (397)
T 1wak_A 265 LIG 267 (397)
T ss_dssp HHT
T ss_pred hcC
Confidence 764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=243.29 Aligned_cols=177 Identities=14% Similarity=0.114 Sum_probs=130.9
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC--CCCCeeeEE-
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFI- 202 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~- 202 (315)
..|....++|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.+++.+ +||||++++
T Consensus 55 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~~hp~iv~~~~ 131 (371)
T 3q60_A 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLGESPEEARDRR 131 (371)
T ss_dssp ETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC----------
T ss_pred ecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcccChhhhhhce
Confidence 34555567899999999999999999997 6889999999876543322 245677885555444 699988755
Q ss_pred ------EEEEeC-----------------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHH
Q 021253 203 ------GACRKR-----------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA------VKQALDVARGMAY 253 (315)
Q Consensus 203 ------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~qi~~gL~y 253 (315)
+++... ..+|+||||++ ++|.+++.... ..++...+ +.++.||+.||+|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 555433 34899999998 79999998642 22344444 6777999999999
Q ss_pred HHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 254 LH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+++|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++..
T Consensus 210 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp HHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTC
T ss_pred HHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccC
Confidence 99999999999999999999999999999999864322 224467799999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=234.25 Aligned_cols=168 Identities=24% Similarity=0.361 Sum_probs=145.0
Q ss_pred ccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC------eeeEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIGA 204 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~ 204 (315)
.++|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.++|++ +++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 46889999999999999999987 57899999996421 12356788999998887654 9999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-----------
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----------- 273 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~----------- 273 (315)
+...+.+++||||+ +++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 889999998776567899999999999999999999999999999999999987
Q ss_pred --------CCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 274 --------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 274 --------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
++.+||+|||+++.... ......||+.|+|||++..
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT
T ss_pred ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC
Confidence 66899999999986432 3445689999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=237.43 Aligned_cols=172 Identities=23% Similarity=0.473 Sum_probs=137.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCee----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+........ .+.+.+|+.+++.++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3457899999999999999999997 4443 57777754332222 25788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.... .++|+||+.+++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8766 689999999999999998643 45899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC---ccCCCCCccccccCccc
Q 021253 286 RIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
+....... .....+|+.|+|||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp ---------------CCCGGGSCHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHHc
Confidence 86533221 22345678999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=231.62 Aligned_cols=178 Identities=26% Similarity=0.413 Sum_probs=145.4
Q ss_pred cccccccc--ccccccceeecccCceEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 128 DEWTIDLR--KLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~--~~~~~~~iG~G~~G~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
.++.++.. .|+..+.||+|+||.||+|.+ ++ ..||+|++...... ...+.+.+|+.+++.++||||++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-----QQVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-----HHHHHHHHHHHHHHhCCCCCeee
Confidence 44555554 445679999999999999986 22 37999998653321 12467889999999999999999
Q ss_pred EEEEEEeCCEE-EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 201 FIGACRKRMVW-CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 201 l~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
+++++.+.... ++||||+.+++|.+++... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence 99999876554 8999999999999999763 356889999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecC-----CCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~-----~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++..... .......+|+.|+|||.+..
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhcc
Confidence 999999753221 12234567899999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=241.94 Aligned_cols=172 Identities=25% Similarity=0.418 Sum_probs=143.4
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|++. ++|.+.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh----HHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 446654 6899999999999999999987 689999999976544322 246788999999999999999999999
Q ss_pred EeCCEE------EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 206 RKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 206 ~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
...... |+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 877654 99999997 58888773 34899999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+++.... ......||+.|+|||++..
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCHHHHSC
T ss_pred EecCccccccc--CcCCcccCccccCHHHhcC
Confidence 99999986433 2455689999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=246.22 Aligned_cols=167 Identities=23% Similarity=0.388 Sum_probs=127.4
Q ss_pred cccc-ccceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--C
Q 021253 136 KLNM-GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--R 208 (315)
Q Consensus 136 ~~~~-~~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 208 (315)
.|++ +++||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++||||+++++++.. .
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3444 56899999999999996 3678999999754433 357799999999999999999999955 6
Q ss_pred CEEEEEEeccCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE----cCCCcE
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSI 277 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli----~~~~~v 277 (315)
..+|+||||+++ +|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999965 8888876321 2248999999999999999999999999999999999999 677899
Q ss_pred EEeeecceeeeecC----CCccCCCCCccccccCcccc
Q 021253 278 KIADFGVARIEVQT----EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 278 kl~DFG~a~~~~~~----~~~~~~~gt~~y~APE~~~~ 311 (315)
||+|||+|+..... ......+||+.|+|||++..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 99999999865432 22345679999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=242.06 Aligned_cols=166 Identities=13% Similarity=0.230 Sum_probs=141.8
Q ss_pred ccccccccceeecccCceEEEEEC----------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee---
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR--- 200 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 200 (315)
.++|++.+.||+|+||.||+|++. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 478999999999999999999873 679999999753 25779999999999999887
Q ss_pred ------------EEEEEEe-CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 021253 201 ------------FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (315)
Q Consensus 201 ------------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (315)
+++++.. ....|+||||+ +++|.+++.......+++..++.++.||+.||+|||+++|+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 6777776 67899999999 999999998754467999999999999999999999999999999999
Q ss_pred CEEEcCCC--cEEEeeecceeeeecCC--------CccCCCCCccccccCcccc
Q 021253 268 NLLISADK--SIKIADFGVARIEVQTE--------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 268 NIli~~~~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~APE~~~~ 311 (315)
|||++.++ .+||+|||+++...... ......||+.|+|||++..
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 99999988 99999999997643321 1234579999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=237.25 Aligned_cols=167 Identities=27% Similarity=0.406 Sum_probs=141.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (315)
++|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 6788999999999999999998 5889999999643221 1235788999999999999999999998764
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 599999876 3589999999999999999999999999999999999999999999999999986
Q ss_pred eecCC-----------CccCCCCCccccccCccc
Q 021253 288 EVQTE-----------GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 288 ~~~~~-----------~~~~~~gt~~y~APE~~~ 310 (315)
..... ......||+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeec
Confidence 43211 123357899999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=231.74 Aligned_cols=175 Identities=31% Similarity=0.467 Sum_probs=136.6
Q ss_pred cccccccccccceeecccCceEEEEE---CC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY---NG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
.+..++|++.+.||+|+||.||+|++ ++ ..||||+++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 45678999999999999999999986 22 2689999875433221 1246789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.... .++|+||+++++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8766 789999999999999998653 45899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC----ccCCCCCccccccCccc
Q 021253 286 RIEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
+....... .....+|+.|+|||.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred ccccccccchhhhccCCCCceeeCchhhc
Confidence 86543221 22345788999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=237.03 Aligned_cols=172 Identities=24% Similarity=0.317 Sum_probs=133.5
Q ss_pred cccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
....++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|+..++.++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34567899999999999999999998 58899999986644332 2456788888999999999999999664
Q ss_pred C-------EEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCCEEEcC-CCc
Q 021253 209 M-------VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKS 276 (315)
Q Consensus 209 ~-------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NIli~~-~~~ 276 (315)
. .+++||||+++ +|...+.. .....+++..++.++.||+.||.||| +++|+||||||+|||++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 3 27899999986 66555443 23456889999999999999999999 999999999999999996 899
Q ss_pred EEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 277 IKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+||+|||+++............||+.|+|||++.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHc
Confidence 9999999998766555556678999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=227.45 Aligned_cols=167 Identities=27% Similarity=0.384 Sum_probs=141.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~ 211 (315)
++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 6789999999999999999996 7899999998765433 2577999999999988866655554 667888
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~~ 288 (315)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999 88999999753 3468999999999999999999999999999999999999 47889999999999865
Q ss_pred ecCCC--------ccCCCCCccccccCcccc
Q 021253 289 VQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
..... .....||+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccccccccccccCChhhhcC
Confidence 44322 244579999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=237.07 Aligned_cols=176 Identities=21% Similarity=0.276 Sum_probs=140.5
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC----CCCCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~l~~~~ 205 (315)
.-.++|++.+.||+|+||.||+|.+ +++.||||++................+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999987 6789999999765443322212234566899999998 899999999999
Q ss_pred EeCCEEEEEEec-cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcEEEeeec
Q 021253 206 RKRMVWCIVTEY-AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (315)
Q Consensus 206 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~vkl~DFG 283 (315)
...+..++|+|+ +.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||+++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 998899999999 7899999999875 3589999999999999999999999999999999999999 88999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+++..... ......||+.|+|||++.
T Consensus 186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 186 SGALLHDE-PYTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp SCEECCSS-CBCCCCSCTTTSCHHHHH
T ss_pred hhhhcccC-cccccCCcccccCceeee
Confidence 99875543 345567999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-30 Score=227.58 Aligned_cols=167 Identities=27% Similarity=0.384 Sum_probs=138.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~ 211 (315)
++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 5788999999999999999996 7889999987654332 2477899999999988877666655 677888
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~~ 288 (315)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 89999999754 3458999999999999999999999999999999999999 78899999999999865
Q ss_pred ecCCC--------ccCCCCCccccccCcccc
Q 021253 289 VQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
..... .....||+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcC
Confidence 43321 234579999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=254.64 Aligned_cols=177 Identities=26% Similarity=0.498 Sum_probs=146.9
Q ss_pred CccccccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (315)
...|++..++|++++.||+|+||.||+|.+. +..||||.++.... ....+.+.+|+.+++.++||||+++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-----HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-----HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4578888899999999999999999999872 35799998865322 1224678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 202 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
++++.+ +..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 457 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 457 IGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEec-CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEe
Confidence 999854 4579999999999999999864 34589999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCCC--ccCCCCCccccccCccc
Q 021253 282 FGVARIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 282 FG~a~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
||+++....... .....+|+.|+|||.+.
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHH
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhc
Confidence 999986543322 22345678999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=257.93 Aligned_cols=166 Identities=23% Similarity=0.345 Sum_probs=140.3
Q ss_pred cccccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
-..+|++.+.||+|+||.||+|.+ +++.||||++..... . ...+.+.+|+.+++.++||||+++++++....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-A----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-H----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-H----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 347899999999999999999987 578999999865322 1 12357889999999999999999999998765
Q ss_pred E-----EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 210 V-----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 210 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
. .||||||+++++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 4 7999999999999988753 58999999999999999999999999999999999999875 899999999
Q ss_pred eeeeecCCCccCCCCCccccccCcccc
Q 021253 285 ARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
++..... ....||+.|+|||++..
T Consensus 228 a~~~~~~---~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 228 VSRINSF---GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp CEETTCC---SCCCCCTTTSCTTHHHH
T ss_pred chhcccC---CccCCCccccCHHHHcC
Confidence 9864332 45679999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=230.18 Aligned_cols=177 Identities=20% Similarity=0.293 Sum_probs=146.1
Q ss_pred CccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~ 203 (315)
+....+..++|++.+.||+|+||.||++.+ +++.||||++......... .+.+.+|+.++++++ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc----hHHHHHHHHHHHhccccCCceEEEEE
Confidence 445567778899999999999999999987 6788999999765544322 467889999999997 599999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++......++||| +.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999999 5578999999864 4589999999999999999999999999999999999996 5899999999
Q ss_pred ceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
+++....... .....||+.|+|||.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTT
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 9986433221 234579999999999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=242.31 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=138.6
Q ss_pred CccccccccccccccceeecccCce-EEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~V-y~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (315)
...+.+...+|...+.||+|+||.| |++..+++.||||++...... .+.+|+.+++.+ +||||++++++
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEE
Confidence 4456777788999999999999985 555668999999999653321 345899999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---C--CcEEE
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKI 279 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~--~~vkl 279 (315)
+.+....|+||||+. ++|.+++.... ....+..++.++.||+.||+|||+++|+||||||+|||++. + ..+||
T Consensus 87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 87 EKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 999999999999996 59999998653 23444456789999999999999999999999999999953 2 36889
Q ss_pred eeecceeeeecC----CCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQT----EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~----~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+|+..... ......+||+.|+|||++..
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSC
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 999999865432 12344679999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=231.74 Aligned_cols=166 Identities=22% Similarity=0.333 Sum_probs=121.5
Q ss_pred ccccccc-cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---
Q 021253 134 LRKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (315)
Q Consensus 134 ~~~~~~~-~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 207 (315)
.++|.+. +.||+|+||.||+|.+ +++.||||++.... ....+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 3567774 4699999999999998 58899999996521 112223344667799999999999876
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeec
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG 283 (315)
...+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998766667999999999999999999999999999999999999976 4569999999
Q ss_pred ceeeeecCCCccCCCCCccccccCccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
+++..... ......||+.|+|||++.
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp TCEEC----------------------
T ss_pred cceecccc-ccccCCCCcCccChhhhC
Confidence 99865433 344567899999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=240.96 Aligned_cols=168 Identities=26% Similarity=0.361 Sum_probs=142.7
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMV 210 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 210 (315)
.++|++++.||+|+||.||+|++ +++.||||++...... .++.+|+.+++.++| +++..+..++.....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 36789999999999999999997 6889999998765433 246789999999987 566667777788889
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE---cCCCcEEEeeecceee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli---~~~~~vkl~DFG~a~~ 287 (315)
.+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+|+.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999999 89999999754 3469999999999999999999999999999999999999 5889999999999987
Q ss_pred eecCCC--------ccCCCCCccccccCcccc
Q 021253 288 EVQTEG--------MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~~--------~~~~~gt~~y~APE~~~~ 311 (315)
...... .....||+.|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC
Confidence 544322 125679999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=229.95 Aligned_cols=166 Identities=25% Similarity=0.334 Sum_probs=134.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE------
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR------ 206 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------ 206 (315)
.+|++.+.||+|+||.||+|.+ +++.||||++.... . ...+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--P----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--h----HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 6788999999999999999998 48899999987532 1 12467889999999999999999999873
Q ss_pred --------eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc-CCCcE
Q 021253 207 --------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSI 277 (315)
Q Consensus 207 --------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~-~~~~v 277 (315)
+....++||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999864 4589999999999999999999999999999999999997 56799
Q ss_pred EEeeecceeeeecC----CCccCCCCCccccccCccc
Q 021253 278 KIADFGVARIEVQT----EGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 278 kl~DFG~a~~~~~~----~~~~~~~gt~~y~APE~~~ 310 (315)
||+|||+++..... .......+|+.|+|||.+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhc
Confidence 99999999864321 1223346789999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=231.31 Aligned_cols=168 Identities=23% Similarity=0.350 Sum_probs=143.6
Q ss_pred ccccccccceeecccCceEEEEE--CC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC------eeeEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIGA 204 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~ 204 (315)
.++|++.+.||+|+||.||+|.+ ++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 46889999999999999999987 33 789999996421 12357788999999997765 9999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEE-------------
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI------------- 271 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli------------- 271 (315)
+......++||||+ +++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 6688888877655679999999999999999999999999999999999999
Q ss_pred ------cCCCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 272 ------SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 272 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+.++.+||+|||+++.... ......||+.|+|||++..
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE 213 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeec
Confidence 5678999999999986432 3455689999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=235.99 Aligned_cols=171 Identities=25% Similarity=0.427 Sum_probs=141.2
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
.|++. ++|.+.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 34443 6788999999999999999987 689999999976543322 2467889999999999999999999998
Q ss_pred eCCE------EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 207 ~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
.... +|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 7653 499999997 58877763 348999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+++.... ......||+.|+|||++..
T Consensus 169 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 169 DFGLARHADA--EMTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSC
T ss_pred ecccccCCCC--CccccccCcCcCCHHHHhC
Confidence 9999975432 2345678999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=234.35 Aligned_cols=170 Identities=22% Similarity=0.327 Sum_probs=144.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----------CCCe
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLNI 198 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni 198 (315)
+...+|++.+.||+|+||.||+|++ +++.||||++.... ...+.+.+|+.++++++ ||||
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 4557899999999999999999997 78899999996421 12356788999998886 8999
Q ss_pred eeEEEEEEeCC----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCEEEc-
Q 021253 199 VRFIGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLIS- 272 (315)
Q Consensus 199 v~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NIli~- 272 (315)
+++++++.... .+++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999987654 789999999 88999999876666799999999999999999999998 999999999999995
Q ss_pred -----CCCcEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 273 -----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 273 -----~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..+.+||+|||+++.... ......||+.|+|||++..
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT
T ss_pred cCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhC
Confidence 344899999999986543 3445689999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=232.01 Aligned_cols=168 Identities=26% Similarity=0.346 Sum_probs=142.9
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CC-----CeeeEEEEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HL-----NIVRFIGAC 205 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~ 205 (315)
.++|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.++ |+ +|+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 46889999999999999999988 67899999996421 12356778888888885 54 499999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCCEEEc--CCCcEEEee
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLIS--ADKSIKIAD 281 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NIli~--~~~~vkl~D 281 (315)
......++||||+.+ +|.+++.......+++..++.++.||+.||.||| +.+|+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999999964 9999998766566999999999999999999999 46999999999999995 477899999
Q ss_pred ecceeeeecCCCccCCCCCccccccCcccc
Q 021253 282 FGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 282 FG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
||+|+.... ......||+.|+|||++..
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTT
T ss_pred ccCceeccc--ccccccCCccccChHHHcC
Confidence 999986532 3455689999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=249.20 Aligned_cols=172 Identities=26% Similarity=0.365 Sum_probs=145.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
.+|++.+.||+|+||.||+|.+ +++.||||+++.... . ...+.+.+|+.+++.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-P----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-H----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-H----HHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 6788999999999999999987 688999999865422 2 123678899999999999999999999755
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCc---EEEeee
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~---vkl~DF 282 (315)
....++||||+++++|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999998643 235888899999999999999999999999999999999997664 999999
Q ss_pred cceeeeecCCCccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|+++............||+.|+|||++..
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCC
T ss_pred ccccccccccccccccCCcccCChHHhcc
Confidence 99987655544556789999999999863
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=249.23 Aligned_cols=160 Identities=19% Similarity=0.191 Sum_probs=126.5
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+.||+|+||.||+|++.++.+++|.......... ......+++.+|+.++++++||||+++..++......||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 56899999999999988999999998765433322 2223356789999999999999999555555566667999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC----
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---- 293 (315)
+++++|.+++.. ++.++.||+.||+|||+++|+||||||+|||++. .+||+|||+|+.......
T Consensus 421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 999999999865 4688999999999999999999999999999998 999999999997543221
Q ss_pred ----ccCCCCCccccccCcccc
Q 021253 294 ----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 294 ----~~~~~gt~~y~APE~~~~ 311 (315)
....+||+.|||||++..
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHH
T ss_pred hhhhhhhhcCCCCcCCHHHHHH
Confidence 134579999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=235.02 Aligned_cols=165 Identities=22% Similarity=0.320 Sum_probs=127.1
Q ss_pred cccccceeecccCceEEE-EECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEE
Q 021253 137 LNMGTAFAQGAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 214 (315)
|...+.||+|+||.||.+ ..+++.||||++.... .+.+.+|+.+++.+ +||||+++++++.....+|+|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 345688999999999755 4489999999986421 23567899999876 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC-------------Cc
Q 021253 215 TEYAKGGSVRQFLTRRQNRAV-----PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-------------KS 276 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~-------------~~ 276 (315)
|||+. ++|.+++........ ++..++.++.||+.||+|||+++|+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 599999976432111 223457899999999999999999999999999999754 48
Q ss_pred EEEeeecceeeeecCCC-----ccCCCCCccccccCcccc
Q 021253 277 IKIADFGVARIEVQTEG-----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 277 vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~APE~~~~ 311 (315)
+||+|||+|+....... ....+||+.|+|||++..
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 99999999986543221 234579999999998854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=213.61 Aligned_cols=144 Identities=13% Similarity=0.152 Sum_probs=127.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
.+|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD---VLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH---HHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 5788999999999999999998 4899999999865543322 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
+||||+++++|.+++... .....+..++.||+.||+|||++||+||||||+|||++.++.+||++++..
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999999542 355568899999999999999999999999999999999999999987754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=213.28 Aligned_cols=143 Identities=24% Similarity=0.397 Sum_probs=126.7
Q ss_pred cccccc-cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEEe---
Q 021253 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (315)
Q Consensus 135 ~~~~~~-~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--- 207 (315)
.+|.+. +.||+|+||.||+|.. +++.||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 455555 7899999999999988 6889999999641 2466888887 66699999999999987
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeec
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG 283 (315)
...+++||||+++++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678899999999999999999866667999999999999999999999999999999999999998 7899999999
Q ss_pred ceeee
Q 021253 284 VARIE 288 (315)
Q Consensus 284 ~a~~~ 288 (315)
+++..
T Consensus 166 ~a~~~ 170 (299)
T 3m2w_A 166 FAKET 170 (299)
T ss_dssp TCEEC
T ss_pred ccccc
Confidence 99754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=228.30 Aligned_cols=175 Identities=17% Similarity=0.222 Sum_probs=131.1
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CC--------
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LN-------- 197 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~n-------- 197 (315)
++....++|..++.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.+++.++| ++
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 3445567788999999999999999998 589999999874433322 113578899999999987 21
Q ss_pred -eee------------EEEEEEe-----CCEEEEEEeccCCCCHHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHH
Q 021253 198 -IVR------------FIGACRK-----RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAVKQALDVARGMAYV 254 (315)
Q Consensus 198 -iv~------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~gL~yL 254 (315)
++. +..++.. ...++++|+++ +++|.+++.. .....+++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 111 1111111 22457777766 6799999852 2234477788899999999999999
Q ss_pred HhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 255 H~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
|+++|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.
T Consensus 228 H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 228 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHH
T ss_pred HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhh
Confidence 9999999999999999999999999999999864333 455678 9999999983
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=206.11 Aligned_cols=161 Identities=14% Similarity=0.099 Sum_probs=120.9
Q ss_pred CCCCcccccccccc---------------ccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChh----HH-------
Q 021253 124 LENYDEWTIDLRKL---------------NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE----KA------- 176 (315)
Q Consensus 124 ~~~~~~~~i~~~~~---------------~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~----~~------- 176 (315)
...++.|++....+ .+++.||+|+||.||+|.+ +++.||||+++....... ..
T Consensus 64 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w 143 (282)
T 1zar_A 64 QKDYEGSTFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143 (282)
T ss_dssp CSSSCEEEECHHHHHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CH
T ss_pred CCCccceeeecCCccHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhh
Confidence 34567777764433 3559999999999999999 688999999965332111 00
Q ss_pred -HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021253 177 -QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255 (315)
Q Consensus 177 -~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (315)
......+.+|+.+++.++| +++++++.. +..|+||||+++++|.+ +.. .....++.||+.||.|||
T Consensus 144 ~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH 210 (282)
T 1zar_A 144 SVLAIRSARNEFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY 210 (282)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH
Confidence 0234678999999999994 555554443 34599999999999988 421 124568999999999999
Q ss_pred hCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 256 ~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
++||+||||||+|||++ ++.+||+|||+|+. +..++|||++.
T Consensus 211 ~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 211 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999999999999999 99999999999973 23457777664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-23 Score=179.59 Aligned_cols=141 Identities=15% Similarity=0.139 Sum_probs=107.2
Q ss_pred cccccceeecccCceEEEEE--CCee--EEEEEeeCCCCChhH------------------HHHHHHHHHHHHHHHHhCC
Q 021253 137 LNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEK------------------AQVMEQQFQQEVMMLATLK 194 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~--~~~~--vavK~~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l~ 194 (315)
|.+.+.||+|+||.||+|.+ +|+. ||||+++........ .......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999988 8888 999998654221110 1122346889999999998
Q ss_pred CCCe--eeEEEEEEeCCEEEEEEeccCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCC
Q 021253 195 HLNI--VRFIGACRKRMVWCIVTEYAKG-G----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKS 266 (315)
Q Consensus 195 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp 266 (315)
|+++ +.+++. . ..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~--~--~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY--M--KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE--E--TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc--C--CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8754 444443 2 34899999942 3 67766432 224456789999999999999 99999999999
Q ss_pred CCEEEcCCCcEEEeeecceeee
Q 021253 267 DNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 267 ~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999997 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=166.38 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=100.9
Q ss_pred cccccceeecccCceEEEEE-CCeeEEEEEeeCCCCCh--------------hHHH--HHHHHHHHHHHHHHhCCCCCee
Q 021253 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNP--------------EKAQ--VMEQQFQQEVMMLATLKHLNIV 199 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~--------------~~~~--~~~~~~~~E~~~l~~l~h~niv 199 (315)
|.++..||+|++|.||+|.. +|+.||||+++...... .... ...-...+|...|.++.++.+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 67889999999999999987 78999999986431110 0001 1112234677888888655443
Q ss_pred --eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC--
Q 021253 200 --RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (315)
Q Consensus 200 --~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-- 275 (315)
..++. ... +|||||++|.+|..+.. .+ ....++.||+.+|.+||++|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~--~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRH--TIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETT--EEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCc--eEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 33332 222 79999999988754421 11 2356789999999999999999999999999998776
Q ss_pred --------cEEEeeecceee
Q 021253 276 --------SIKIADFGVARI 287 (315)
Q Consensus 276 --------~vkl~DFG~a~~ 287 (315)
.+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 489999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.5e-14 Score=124.28 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=109.8
Q ss_pred ccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 214 (315)
.|++...++.|+.+.||++...+..+++|+......... ..+.+|+.+++.+. +..++++++++......|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 455667788888899999988888999999864211111 24778999999884 67788999999988899999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (315)
|||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999998876321 11234678899999999998
Q ss_pred ---------------------CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 ---------------------~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998766677999998875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.4e-12 Score=117.86 Aligned_cols=139 Identities=13% Similarity=0.247 Sum_probs=105.6
Q ss_pred ccceeecccCceEEEEECCeeEEEEEee--CCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeC---CEEE
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILE--RPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKR---MVWC 212 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~ 212 (315)
.+.|+.|.++.||+.+..+..+++|+.. ....... ...+.+|..+++.+. +..+++++.++.+. ...|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~-----~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPS-----AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCc-----HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3678899999999999877889999775 3221111 246778999999997 45578899988776 3478
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------ 256 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~------------------------------------ 256 (315)
+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999997774311 1236677788899999999999997
Q ss_pred ----------------------CCCccCCCCCCCEEEcCCC--cEEEeeecceee
Q 021253 257 ----------------------LGFIHRDLKSDNLLISADK--SIKIADFGVARI 287 (315)
Q Consensus 257 ----------------------~~iiHrDlkp~NIli~~~~--~vkl~DFG~a~~ 287 (315)
..++|+|++|.|||++.++ .+.|+||+.|..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3589999999999999765 369999999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=112.01 Aligned_cols=126 Identities=13% Similarity=0.089 Sum_probs=94.4
Q ss_pred eecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEEeCCEEEEEEeccCC
Q 021253 144 AQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 144 G~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~ 220 (315)
+.|..+.||++.. ++..+++|+...... ..+.+|+.+++.+.+.+ +.+++++....+..++||||++|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3556689999976 467899999765311 24668899998886444 56789988887788999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG------------------------------------------ 258 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~------------------------------------------ 258 (315)
.+|. ... ... ..++.+++..|..||+..
T Consensus 100 ~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8883 211 111 245667777777777643
Q ss_pred ----------------CccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 259 ----------------FIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 259 ----------------iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
++|+|++|.||+++.++.++|+||+.|...
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766779999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=5.3e-09 Score=93.32 Aligned_cols=133 Identities=23% Similarity=0.243 Sum_probs=97.2
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCC--eeeEEEEEEeCC---EEEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN--IVRFIGACRKRM---VWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv 214 (315)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 468899999999864 57889986431 11357889999998883 332 445555544333 34889
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (315)
||+++|.+|.+.... .++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999888654332 26677777788888888888885
Q ss_pred --------------------CCCccCCCCCCCEEEcC--CCcEEEeeecceeee
Q 021253 257 --------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARIE 288 (315)
Q Consensus 257 --------------------~~iiHrDlkp~NIli~~--~~~vkl~DFG~a~~~ 288 (315)
..++|+|++|.||+++. ...+.|+||+.+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 557899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-07 Score=84.81 Aligned_cols=133 Identities=19% Similarity=0.197 Sum_probs=91.5
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC---CeeeEEEEEE-eCCEEEEEEe
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVRFIGACR-KRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e 216 (315)
+.++.|....||+. +..+++|+-.. . .....+.+|..+|+.+.+. .+.+.+.++. .....++|||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 46788888899988 67889998522 1 1135788999999999752 3567777764 3455689999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------------------------------------- 257 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------------------------------------- 257 (315)
+++|.+|.+.... .++......++.+++..|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763211 133344444444444444444431
Q ss_pred ---------------------CCccCCCCCCCEEEcC---CCc-EEEeeecceeee
Q 021253 258 ---------------------GFIHRDLKSDNLLISA---DKS-IKIADFGVARIE 288 (315)
Q Consensus 258 ---------------------~iiHrDlkp~NIli~~---~~~-vkl~DFG~a~~~ 288 (315)
.++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 355 589999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.8e-07 Score=81.53 Aligned_cols=132 Identities=20% Similarity=0.168 Sum_probs=94.6
Q ss_pred ceeecccC-ceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAFG-KLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~G-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+..|..+ .||+... .+..+++|+-... . ...+.+|...|+.+. +--+.++++++.+.+..++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 45557666 5898765 4568899986531 1 246778999998884 33467889999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG----------------------------------------- 256 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~----------------------------------------- 256 (315)
++|.++.+...... .....++.+++..|..||+
T Consensus 102 l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 102 IPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp CCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred eCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99988877654311 1123344555555555553
Q ss_pred ----------C-------CCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 257 ----------L-------GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 257 ----------~-------~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
. .++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 2789999999999998777789999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=9.1e-08 Score=87.06 Aligned_cols=77 Identities=9% Similarity=0.078 Sum_probs=52.9
Q ss_pred cce-eecccCceEEEEEC--------CeeEEEEEeeCCC---CChhHHHHHHHHHHHHHHHHHhCC-C--CCeeeEEEEE
Q 021253 141 TAF-AQGAFGKLYRGTYN--------GEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLK-H--LNIVRFIGAC 205 (315)
Q Consensus 141 ~~i-G~G~~G~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~ 205 (315)
+.| +.|....+|+.+.. +..+++|+..... .... ..+.+|+.+++.+. + -.+.+++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 567 78888999998765 6789999865422 1000 24567888887774 2 3567788887
Q ss_pred EeC---CEEEEEEeccCCCCH
Q 021253 206 RKR---MVWCIVTEYAKGGSV 223 (315)
Q Consensus 206 ~~~---~~~~lv~e~~~~g~L 223 (315)
.+. ...++||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 655 346899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.43 E-value=2e-06 Score=77.18 Aligned_cols=137 Identities=12% Similarity=0.134 Sum_probs=78.1
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----CCCeeeEE-E--EEEeCCEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVRFI-G--ACRKRMVWC 212 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~ 212 (315)
+.|+.|..+.||+....+..+++|+.... . ..+..|..+++.|. .|.++... + +....+..+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 45666778899999887777999998651 1 12233444444442 34443310 0 123456789
Q ss_pred EEEeccCCCCHH-----------HH---HHh-hCCC--C---------CCHHH---------------------------
Q 021253 213 IVTEYAKGGSVR-----------QF---LTR-RQNR--A---------VPLKL--------------------------- 239 (315)
Q Consensus 213 lv~e~~~~g~L~-----------~~---l~~-~~~~--~---------~~~~~--------------------------- 239 (315)
+||||++|..+. .. ++. .... + ..+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986531 11 111 1100 0 01111
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 240 ----AVKQALDVARGMAYVH-------------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 240 ----~~~i~~qi~~gL~yLH-------------~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
...+..++..++++|+ ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0011122334566665 25799999999999998888999999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=6e-07 Score=82.94 Aligned_cols=79 Identities=11% Similarity=-0.032 Sum_probs=48.0
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCC-ChhHHHHHHHHHHHHHHHHHhCCC--C-CeeeEEEEEEeCCEEEEE
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPEN-NPEKAQVMEQQFQQEVMMLATLKH--L-NIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lv 214 (315)
+.||.|..+.||+++. .++.++||....... ..+......+++..|..+++.+.. | .+++++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 5789999999999964 568899998753221 000000011356678888887742 3 345666553 3334799
Q ss_pred EeccCCC
Q 021253 215 TEYAKGG 221 (315)
Q Consensus 215 ~e~~~~g 221 (315)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-07 Score=89.41 Aligned_cols=135 Identities=11% Similarity=0.070 Sum_probs=59.2
Q ss_pred cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceeeeeceeeec--CCceeeccCchHHHHHH
Q 021253 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (315)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~~~~~~~~--~~~v~~~~~~~~l~~~l 114 (315)
..|+|++++|++ .+|.|++|++.. ..++|+.|.. ++.|++. ...|. ++.+. |+++..+
T Consensus 70 ~~G~FLvR~S~~---~~g~~~Lsv~~~---------~~v~H~~I~~-~g~~~~~--~~~F~sl~~Lv~-----dGl~~~~ 129 (463)
T 3cxl_A 70 AEGSYLIRESQR---QPGTYTLALRFG---------SQTRNFRLYY-DGKHFVG--EKRFESIHDLVT-----DGLITLY 129 (463)
T ss_dssp STTEEEEEECSS---STTCEEEEEECS---------SSEEEEECEE-SSSEESS--SCCBSCHHHHHH-----HHHHHHH
T ss_pred CCCeEEEeccCC---CCCCEEEEEEEC---------CEEEEEEEec-CCeEEEC--CCccCCHHHHHH-----HHHHhhh
Confidence 379999999876 678899999962 2568999987 6667653 23332 22222 5555555
Q ss_pred hcCCCCCCCCCCCccccccccccccccceeecccCceEEEEECC--eeEEE------EEeeCCCCChhHHHHHHHHHHHH
Q 021253 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAI------KILERPENNPEKAQVMEQQFQQE 186 (315)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~E 186 (315)
..+... .+.....--.+.+.|| ||.||+|.+.+ .+||| |..+......++ ...+.+|
T Consensus 130 ~~~~~~--------~~~l~~~i~~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~----~~~~~re 194 (463)
T 3cxl_A 130 IETKAA--------EYIAKMTINPIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR----LTSLVRR 194 (463)
T ss_dssp HHHHTH--------HHHHHTTSSCSTTTSS---BCCC---------CCBGGGC---------------------------
T ss_pred ccCCCc--------chhhccccccccccCC---chhhhcccccccCCchhhhhccCccccccccccccc----ccccccc
Confidence 433210 0000000014556776 99999999854 58888 665543322221 3467889
Q ss_pred HHHHHhCCCCCeeeEEEEEE
Q 021253 187 VMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 187 ~~~l~~l~h~niv~l~~~~~ 206 (315)
..+++.++|||+++.+++..
T Consensus 195 a~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 195 ATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp ------------CBCCCEEE
T ss_pred ccccccccccccCCCcceEE
Confidence 99999999999999988764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.9e-05 Score=70.59 Aligned_cols=74 Identities=19% Similarity=0.181 Sum_probs=59.9
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
+.|+.|....+|+.+..+..+++|+..... ...+..|...|+.|. ...+++++.++......++||||
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 578899999999998888899999875321 246788988888884 35688899988888889999999
Q ss_pred cCCCCH
Q 021253 218 AKGGSV 223 (315)
Q Consensus 218 ~~~g~L 223 (315)
+++..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.4e-05 Score=71.80 Aligned_cols=32 Identities=19% Similarity=0.374 Sum_probs=28.2
Q ss_pred hCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 256 ~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
...++|+|++|.|||++.++ ++|+||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999998776 999999999753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=3.5e-05 Score=68.24 Aligned_cols=71 Identities=11% Similarity=0.125 Sum_probs=43.2
Q ss_pred ccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEEEEecc
Q 021253 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYA 218 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~ 218 (315)
.+.|+.|....+|+. ..+++|+......... ...+|+.+++.+....+ .++++++.+.. ++|+||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~-------~r~~E~~~l~~l~~~g~~P~~~~~~~~~~--~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI-------NRANEAVAAREAAKAGVSPEVLHVDPATG--VMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC-------CHHHHHHHHHHHHHTTSSCCEEEECTTTC--CEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee-------CHHHHHHHHHHHHHcCCCCceEEEECCCC--EEEEeec
Confidence 577888999999998 6788998864321110 12356666666642222 45565543333 6899999
Q ss_pred -CCCCH
Q 021253 219 -KGGSV 223 (315)
Q Consensus 219 -~~g~L 223 (315)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=8.8e-05 Score=65.18 Aligned_cols=77 Identities=16% Similarity=0.148 Sum_probs=53.6
Q ss_pred cccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEEeCCEEE
Q 021253 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKRMVWC 212 (315)
Q Consensus 137 ~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~ 212 (315)
+.-.+.+|.|..+.||+.+. +|+.|.+|+......... ..|..|+..|+.|.. --+++.+++. .. +
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~--~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD------GLFRAEALGLDWLGRSFGSPVPQVAGWD--DR--T 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT------THHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--E
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh------hHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--e
Confidence 33457889999999999998 789999998654332211 357789999888842 2345555543 33 7
Q ss_pred EEEeccCCCCH
Q 021253 213 IVTEYAKGGSV 223 (315)
Q Consensus 213 lv~e~~~~g~L 223 (315)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00018 Score=64.39 Aligned_cols=137 Identities=16% Similarity=0.192 Sum_probs=73.3
Q ss_pred cceeecccCc-eEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEEEEe
Q 021253 141 TAFAQGAFGK-LYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e 216 (315)
+.|+.|.... +|+.+.. +..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.. +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 4565565554 7788764 77788876543221 123355666665532 23556777654444 68999
Q ss_pred ccCCCCHHHHHHhhC---------------------C---CCCCHHHHH-------HH-------------HHHHHHHHH
Q 021253 217 YAKGGSVRQFLTRRQ---------------------N---RAVPLKLAV-------KQ-------------ALDVARGMA 252 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~---------------------~---~~~~~~~~~-------~i-------------~~qi~~gL~ 252 (315)
++.+..+.+.+.... . ..+...... .+ ...+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 998766655443110 0 011111100 00 011112233
Q ss_pred HH------HhCCCccCCCCCCCEEEcCC----CcEEEeeecceeee
Q 021253 253 YV------HGLGFIHRDLKSDNLLISAD----KSIKIADFGVARIE 288 (315)
Q Consensus 253 yL------H~~~iiHrDlkp~NIli~~~----~~vkl~DFG~a~~~ 288 (315)
.+ +...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 33 12469999999999999874 68999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.76 E-value=7.6e-05 Score=66.47 Aligned_cols=139 Identities=14% Similarity=0.150 Sum_probs=78.4
Q ss_pred cceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEE------EEeCCEEE
Q 021253 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGA------CRKRMVWC 212 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~ 212 (315)
+.|+.|....+|+....+..+++|+....... +.+..|..++..+.... +.+++.. ....+..+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCCCCH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 56777888899999886668899998652111 23456666666653211 2333321 12345678
Q ss_pred EEEeccCCCCHH-----------HH---HHhh-CC--CC----CC---HHHHHHH------------HHHHHHHHHHHHh
Q 021253 213 IVTEYAKGGSVR-----------QF---LTRR-QN--RA----VP---LKLAVKQ------------ALDVARGMAYVHG 256 (315)
Q Consensus 213 lv~e~~~~g~L~-----------~~---l~~~-~~--~~----~~---~~~~~~i------------~~qi~~gL~yLH~ 256 (315)
++++|++|..+. .. ++.. .. .. .. +...+.. ...+...++.+++
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999986531 11 1111 00 00 11 1110000 0123445556652
Q ss_pred -------CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 -------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 -------~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999998776668999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00059 Score=60.77 Aligned_cols=137 Identities=16% Similarity=0.139 Sum_probs=77.4
Q ss_pred cceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEE-----EEeCCEEE
Q 021253 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGA-----CRKRMVWC 212 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~ 212 (315)
+.++ |....||+... +|+.+++|+........ ..+..|..+++.+... .+++++.. ....+..+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 3455 77888999876 46689999986443322 2455677777666421 23344432 22345668
Q ss_pred EEEeccCCCCHH-----H------HH---Hhh-CC------CCCCHHHH----HHH---------------HHHHHHHHH
Q 021253 213 IVTEYAKGGSVR-----Q------FL---TRR-QN------RAVPLKLA----VKQ---------------ALDVARGMA 252 (315)
Q Consensus 213 lv~e~~~~g~L~-----~------~l---~~~-~~------~~~~~~~~----~~i---------------~~qi~~gL~ 252 (315)
+++||++|..+. . .+ +.. .. ........ ..+ ...+-..++
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 899999875421 1 11 110 00 01111111 000 001111223
Q ss_pred HHH-------hCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 253 YVH-------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 253 yLH-------~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.+. ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 332 23589999999999998 4 899999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00014 Score=67.97 Aligned_cols=70 Identities=13% Similarity=0.241 Sum_probs=46.8
Q ss_pred cceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCE
Q 021253 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMV 210 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~ 210 (315)
+.|+.|....+|++... +..+++|+.... ... ..+.+|..+++.+...++ +++++.+. +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~-------~~li~E~~~l~~L~~~g~~P~l~~~~~--~- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-------SHLVAESVIFTLLSERHLGPKLYGIFS--G- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-------HHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcH-------HHHHHHHHHHHHHHhCCCCCcEEEEeC--C-
Confidence 56778888899999874 468999988432 110 234478888887753333 56676553 2
Q ss_pred EEEEEeccCCCC
Q 021253 211 WCIVTEYAKGGS 222 (315)
Q Consensus 211 ~~lv~e~~~~g~ 222 (315)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999998633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00061 Score=62.47 Aligned_cols=141 Identities=14% Similarity=0.240 Sum_probs=80.8
Q ss_pred cccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 204 (315)
..+++ +.|..|....+|+.+.. ++.+++|+.-..... ...+.+|..+++.|. +.-..++++.
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~-------~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG-------VDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC-------HHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch-------HHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 34443 56777888899999873 368899986321111 134558888888774 2223566666
Q ss_pred EEeCCEEEEEEeccCCCCHH--------------HHHHhh---C---CCCCC--HHHHHHHHHHHH--------------
Q 021253 205 CRKRMVWCIVTEYAKGGSVR--------------QFLTRR---Q---NRAVP--LKLAVKQALDVA-------------- 248 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~--------------~~l~~~---~---~~~~~--~~~~~~i~~qi~-------------- 248 (315)
+.. .+|+||++|..|. +.|.+. . ..... +..+.++..++.
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 543 2899999985542 111111 0 11111 233444443332
Q ss_pred -----HHHHHHH----hC----CCccCCCCCCCEEEcCC----CcEEEeeecceee
Q 021253 249 -----RGMAYVH----GL----GFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (315)
Q Consensus 249 -----~gL~yLH----~~----~iiHrDlkp~NIli~~~----~~vkl~DFG~a~~ 287 (315)
..++.|. .. .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1233333 22 48999999999999876 7899999999975
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0036 Score=58.77 Aligned_cols=72 Identities=13% Similarity=0.083 Sum_probs=47.2
Q ss_pred cceeecccCceEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEEEEEEec
Q 021253 141 TAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 217 (315)
+.|+.|....+|+....+ ..+++|+......... ...+|..+++.|...++ +++++.+. + .+|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 567788888999999866 8899998854321110 11478888888865444 56777662 3 359999
Q ss_pred cCCCCH
Q 021253 218 AKGGSV 223 (315)
Q Consensus 218 ~~~g~L 223 (315)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00028 Score=64.24 Aligned_cols=71 Identities=11% Similarity=0.166 Sum_probs=42.1
Q ss_pred cceeecccCceEEEEECC----------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC
Q 021253 141 TAFAQGAFGKLYRGTYNG----------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM 209 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~ 209 (315)
+.|+.|..-.+|+....+ ..+++|+........ .....|..+++.+...+ +.++++.. .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence 567788888999998754 688899875421110 01246777777764333 34666544 33
Q ss_pred EEEEEEeccCCCC
Q 021253 210 VWCIVTEYAKGGS 222 (315)
Q Consensus 210 ~~~lv~e~~~~g~ 222 (315)
++|+||++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 68999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0061 Score=54.75 Aligned_cols=32 Identities=25% Similarity=0.466 Sum_probs=28.3
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35899999999999998888999999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0038 Score=58.02 Aligned_cols=71 Identities=11% Similarity=0.084 Sum_probs=45.5
Q ss_pred cceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Q 021253 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (315)
+.+..|....+|+.... +..+++|+......... ...+|..+++.+. +.-..++++.+ .+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-------dR~~E~~~l~~L~~~gi~P~l~~~~--~~- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-------DSKVELDVFRYLSNINIAPNIIADF--PE- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-------CHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-------CHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence 45667888899999875 67899998654321110 1236777777774 22234556533 33
Q ss_pred EEEEEeccCCCC
Q 021253 211 WCIVTEYAKGGS 222 (315)
Q Consensus 211 ~~lv~e~~~~g~ 222 (315)
++|+||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999865
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00017 Score=54.92 Aligned_cols=73 Identities=8% Similarity=0.093 Sum_probs=51.5
Q ss_pred cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceeeeec-eeeec--CCceee-ccCchHHHH
Q 021253 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVG-QSVFR--PGKVTH-ALNDDALAQ 112 (315)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~~~-~~~~~--~~~v~~-~~~~~~l~~ 112 (315)
..|+|++++|++ . ++|++||++... ...++||+|+...++|+|+.. ...|. +++|.| ..+.++++.
T Consensus 36 ~~GaFLVR~Se~---~-~~ySLSVR~~~~------~~~VKHYkI~~~~G~y~I~~~~~~~F~SL~eLV~yY~~~adGl~~ 105 (125)
T 3maz_A 36 SLGNMILRPGSD---S-RNYSITIRQEID------IPRIKHYKVMSVGQNYTIELEKPVTLPNLFSVIDYFVKETRGNLR 105 (125)
T ss_dssp GGCSEEEEECTT---S-SSEEEEEEECSS------SCEEEEEEEEEETTEEEECSSSCEEESSHHHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEeCCC---C-CCEEEEEEecCC------CCCEeeeEEEEeCCEEEEecCCCcCcCCHHHHHHHHHhCCCcCcc
Confidence 379999999864 2 389999998532 237899999988888998742 34563 456655 667788888
Q ss_pred HHhcCCC
Q 021253 113 ALMDHRY 119 (315)
Q Consensus 113 ~l~~~~~ 119 (315)
.|..+|.
T Consensus 106 ~L~~~c~ 112 (125)
T 3maz_A 106 PFIASTD 112 (125)
T ss_dssp BCCC---
T ss_pred ccccccc
Confidence 7777774
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.00065 Score=50.38 Aligned_cols=72 Identities=17% Similarity=0.242 Sum_probs=48.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~- 84 (315)
-+||++.+. -.-+....+..| .|+|+++.|.+ .+|.|++|++...... ...++|+.|....
T Consensus 5 ~~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~ 68 (106)
T 1aot_F 5 EEWYFGKLG---------RKDAERQLLSFGNPRGTFLIRESET---TKGAYSLSIRDWDDMK----GDHVKHYKIRKLDN 68 (106)
T ss_dssp SSSCCBSCC---------HHHHHHHHHTTTCCTTEECCBCBSS---SSSBBCCEEECCBTTT----BCCEEECCBEEETT
T ss_pred CccCCCCCC---------HHHHHHHHhhCCCCCcEEEEEeCCC---CCCCEEEEEEecccCC----CCcEEEEEEEEeCC
Confidence 378888774 233444555444 79999999876 5789999998644221 1367999998764
Q ss_pred Cceeeeeceeee
Q 021253 85 HNYSVSVGQSVF 96 (315)
Q Consensus 85 ~~~~i~~~~~~~ 96 (315)
+.|++. +...|
T Consensus 69 g~~~l~-~~~~F 79 (106)
T 1aot_F 69 GGYYIT-TRAQF 79 (106)
T ss_dssp TEEEEE-TTEEE
T ss_pred CCEEEC-CCCcc
Confidence 678875 34444
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0021 Score=48.57 Aligned_cols=98 Identities=22% Similarity=0.232 Sum_probs=59.6
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCc--c-c
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLK--P-V 83 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~--~-~ 83 (315)
-+||++.+. -.-+....+..+ .|+|++++| + ..|.|++|++....... ...++|+.|+ . .
T Consensus 9 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~~ 72 (118)
T 3s9k_A 9 YEWYNKSIS---------RDKAEKLLLDTGKEGAFMVRDS-R---TPGTYTVSVFTKAIISE---NPCIKHYHIKETNDS 72 (118)
T ss_dssp STTBCTTCC---------HHHHHHHHHHHCCTTCEEEEEC-S---STTCEEEEEEECCSCSS---SCEEEEEEEEECSCS
T ss_pred CceecCCCC---------HHHHHHHHHhcCCCCeEEEEee-C---CCCCEEEEEEecccccC---CCceEEEEEeEEECC
Confidence 378888774 334455665555 899999988 4 57899999997643221 1368999993 3 3
Q ss_pred CCceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCCCC
Q 021253 84 RHNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTE 122 (315)
Q Consensus 84 ~~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~ 122 (315)
.+.|++. +...|. +++|.+ ..+.+++...|..|+.+.+
T Consensus 73 ~g~~~~~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~Pv~~~~ 113 (118)
T 3s9k_A 73 PKRYYVA-EKYVFDSIPLLIQYHQYNGGGLVTRLRYPVCGSP 113 (118)
T ss_dssp SCCEEEE-CSCCCSCHHHHHHHHHHCCTTSSSCCCCCCCCST
T ss_pred CCCEEEC-CCcccCCHHHHHHHheeCCCCCccCCCCcCCCCC
Confidence 4667775 333442 334433 3444555555555554443
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0012 Score=53.63 Aligned_cols=83 Identities=19% Similarity=0.248 Sum_probs=52.1
Q ss_pred cHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee
Q 021253 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH 103 (315)
Q Consensus 29 ~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~ 103 (315)
+....+..| .|+|++++|.+ ..|.|++|++......+ ..++|+.|.... +.|++. +...|. +++|.|
T Consensus 86 ae~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~~~----~~v~H~~I~~~~~g~~~~~-~~~~F~sl~~LV~~ 157 (175)
T 4d8k_A 86 AERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQG----EVVKHYKIRNLDNGGFYIS-PRITFPGLHELVRH 157 (175)
T ss_dssp HHHHHHSTTCCTTCEEEEECSS---STTCEEEEEEEECTTSC----EEEEEEEEEECSSSCEESS-TTSEESSHHHHHHH
T ss_pred HHHHHhcCCCCCCEEEEEECCC---CCCeEEEEEEeCcccCC----CceEEEEEEECCCCCEEEC-CCCccCCHHHHHHH
Confidence 344555444 89999998865 67899999986543222 367999998754 667765 334442 344443
Q ss_pred -ccCchHHHHHHhcCCC
Q 021253 104 -ALNDDALAQALMDHRY 119 (315)
Q Consensus 104 -~~~~~~l~~~l~~~~~ 119 (315)
..+.++++..|..||.
T Consensus 158 y~~~~~gl~~~L~~Pc~ 174 (175)
T 4d8k_A 158 YTNASDGLCTRLSRPCQ 174 (175)
T ss_dssp HHHCCTTSSSCCCSBCC
T ss_pred HhhCCCCCcccCCCcCC
Confidence 4455666555555553
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=95.41 E-value=0.0024 Score=47.91 Aligned_cols=94 Identities=19% Similarity=0.198 Sum_probs=56.3
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHh--cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
.-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++..... ...++|+.|....
T Consensus 11 ~~~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~ 73 (114)
T 1blj_A 11 VEKWFFRTIS---------RKDAERQLLAPMNKAGSFLIRESES---NKGAFSLSVKDITTQ-----GEVVKHYKIRSLD 73 (114)
T ss_dssp CSSSBCCSCC---------HHHHHHHHSSTTCCTTCEEBCBCTT---CSSCEEEEECBCCTT-----TCBCCCEEEEEET
T ss_pred cCCccCCCCC---------HHHHHHHHhhCCCCCceEEEEeCCC---CCCCEEEEEEEecCC-----CCcEEEEEEEEcC
Confidence 3478887774 23344444432 369999999875 578999999965422 1367999998764
Q ss_pred -Cceeeeeceeeec--CCceee-ccCchHHHHHHhcCC
Q 021253 85 -HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHR 118 (315)
Q Consensus 85 -~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~ 118 (315)
+.|++. +...|. +++|.+ ..+.+++...|..|+
T Consensus 74 ~g~~~l~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~p~ 110 (114)
T 1blj_A 74 NGGYYIS-PRITFPTLQALVQHYSKKGDGLCQKLTLPC 110 (114)
T ss_dssp TTEEEEE-TTEEESSHHHHHHHHHHCCSSSSSCCCCCS
T ss_pred CCCEEEC-CCcccCCHHHHHHHhhhCCCCCceecCccC
Confidence 678875 344442 334433 333344433333333
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.00089 Score=48.85 Aligned_cols=62 Identities=16% Similarity=0.109 Sum_probs=43.8
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -..+....+....|+|++++|.+ .+|.|++|++.. ..++|+.|....+.|
T Consensus 5 ~~Wyhg~is---------r~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 63 (98)
T 3us4_A 5 MPWFHGKIS---------GQEAVQQLQPPEDGLFLVRESAR---HPGDYVLCVSFG---------RDVIHYRVLHRDGHL 63 (98)
T ss_dssp CTTBCCSCC---------HHHHHHHTCSCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEEETTEE
T ss_pred CcccCCCCC---------HHHHHHHccCCCCcEEEEEeCCC---CCCcEEEEEEEC---------CceEEEEEEEeCCEE
Confidence 378888774 22333344333579999998765 678999999962 267899998866777
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 64 ~~~ 66 (98)
T 3us4_A 64 TID 66 (98)
T ss_dssp ESS
T ss_pred EEC
Confidence 765
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=94.99 E-value=0.0024 Score=46.74 Aligned_cols=66 Identities=18% Similarity=0.158 Sum_probs=45.1
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc-CC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RH 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~-~~ 85 (315)
+||++.+. -.-+....+..| .|+|+++.|.+ .+|.|++|++.. ..++|+.|... ++
T Consensus 3 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 61 (100)
T 1rja_A 3 PWFFGCIS---------RSEAVRRLQAEGNATGAFLIRVSEK---PSADYVLSVRDT---------QAVRHYKIWRRAGG 61 (100)
T ss_dssp CCBCTTCC---------HHHHHHHHSSTTCSSCCEEEEECSS---SSSCEEEEECTT---------SSCEEEEEEECSSS
T ss_pred CcccCCCC---------HHHHHHHHhccCCCCCEEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 57777664 334445555544 79999999875 568899999852 25789999875 46
Q ss_pred ceeeeeceeee
Q 021253 86 NYSVSVGQSVF 96 (315)
Q Consensus 86 ~~~i~~~~~~~ 96 (315)
.|++. +...|
T Consensus 62 ~~~l~-~~~~F 71 (100)
T 1rja_A 62 RLHLN-EAVSF 71 (100)
T ss_dssp CEEEE-TTEEE
T ss_pred cEEEC-CCCcc
Confidence 68775 33444
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=94.66 E-value=0.0013 Score=48.68 Aligned_cols=93 Identities=17% Similarity=0.206 Sum_probs=55.9
Q ss_pred cccCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
+-.-+||++.+. -..+....+..-.|+|++++|.+ .+|.|++|++.. ..++|+.|....
T Consensus 5 L~~~~Wyhg~is---------r~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~ 63 (106)
T 3eaz_A 5 LSLMPWFHGKIT---------REQAERLLYPPETGLFLVRESTN---YPGDYTLCVSSD---------GKVEHYRIMYHA 63 (106)
T ss_dssp GGGCTTBCCSCC---------HHHHHHHTCSCCTTEEEEEECTT---STTCEEEEEEET---------TEEEEEECEEET
T ss_pred cccCCCcCCCCC---------HHHHHHHhCCCCCCEEEEEECCC---CCCcEEEEEEeC---------CceEEEEEEecC
Confidence 344588988875 22333333333579999998865 578999999862 267899998766
Q ss_pred Cceeeeeceeeec--CCceee-ccCchHHHHHHhcCCC
Q 021253 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (315)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (315)
+.|++. +...|. ++.+.+ ..+.+++...|..|+.
T Consensus 64 g~~~l~-~~~~F~sl~~Lv~~y~~~~~gl~~~L~~P~~ 100 (106)
T 3eaz_A 64 SKLSID-EEVYFENLMQLVEHYTSDADGLCTRLIKPKV 100 (106)
T ss_dssp TEEESS-SSSCBSSHHHHHHHHHHCCTTSSSCCCEECC
T ss_pred CEEEEC-CCCccCCHHHHHHHHhhCCCCCCeecCCcCC
Confidence 777765 223332 233332 3344444444444443
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.0015 Score=48.19 Aligned_cols=66 Identities=17% Similarity=0.208 Sum_probs=44.1
Q ss_pred CCccccccCccCCCCccccccHHHHHHh--cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++...... ...++|+.|.... +
T Consensus 5 ~Wyhg~is---------R~~Ae~lL~~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g 68 (105)
T 1lkk_A 5 PWFFKNLS---------RKDAERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNG 68 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHTSTTCCTTCEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEEECTTS
T ss_pred ceecCCCC---------HHHHHHHHHhcCCCCceEEEEECCC---CCCcEEEEEEEcccCC----CCcEEEEEEEECCCC
Confidence 68887774 23343344432 369999998875 5789999998643221 1367999998764 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 69 ~~~l~ 73 (105)
T 1lkk_A 69 GFYIS 73 (105)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 67764
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=94.48 E-value=0.003 Score=47.61 Aligned_cols=61 Identities=18% Similarity=0.175 Sum_probs=43.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc--C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--R 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~--~ 84 (315)
+||++.+. -..+....+..| .|+|++++|.+ .+|.|++|++.. ..++|+.|... .
T Consensus 15 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~ 73 (117)
T 3pqz_A 15 LWFHGRIS---------REESQRLIGQQGLVDGLFLVRESQR---NPQGFVLSLCHL---------QKVKHYLILPSEEE 73 (117)
T ss_dssp TTBCCSCC---------HHHHHHHHHHTTCCTTEEEEEECCC----CCCEEEEEEET---------TEEEEEEEEEECCT
T ss_pred ccccCCCC---------HHHHHHHHhcCCCCCCEEEEEecCC---CCCcEEEEEEeC---------CeeEEEEEEEecCC
Confidence 68888774 345556666655 79999998875 568999999962 26789999874 3
Q ss_pred Cceeee
Q 021253 85 HNYSVS 90 (315)
Q Consensus 85 ~~~~i~ 90 (315)
+.+++.
T Consensus 74 g~~~~~ 79 (117)
T 3pqz_A 74 GRLYFS 79 (117)
T ss_dssp TCCEEE
T ss_pred CCEEEE
Confidence 444444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.28 E-value=0.12 Score=47.24 Aligned_cols=29 Identities=28% Similarity=0.556 Sum_probs=25.6
Q ss_pred CccCCCCCCCEEE------cCCCcEEEeeecceee
Q 021253 259 FIHRDLKSDNLLI------SADKSIKIADFGVARI 287 (315)
Q Consensus 259 iiHrDlkp~NIli------~~~~~vkl~DFG~a~~ 287 (315)
++|+|+.+.|||+ +++..++|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999999975
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.0075 Score=45.72 Aligned_cols=90 Identities=19% Similarity=0.199 Sum_probs=55.8
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-R 84 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~-~ 84 (315)
-+||++.+. -.-+.....+.| .|+|+++.|.+ ..|.|++|++.. ..++|+.|... .
T Consensus 16 ~~WyhG~is---------R~eAe~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~ 74 (121)
T 2dly_A 16 EPWFFGAIK---------RADAEKQLLYSENQTGAFLIRESES---QKGDFSLSVLDE---------GVVKHYRIRRLDE 74 (121)
T ss_dssp CSSBCSSCC---------HHHHHHHHTSSSCCTTCEEEEECSS---SSSCEEEEEESS---------SCEEEEEEEECSS
T ss_pred CCccccCCC---------HHHHHHHHhcCCCCCCEEEEEcCCC---CCCceEEEEEEC---------CeEEEEEEEEcCC
Confidence 478887774 233334444333 59999999875 578899999852 26799999874 4
Q ss_pred Cceeeeeceeeec--CCceee-ccCchHHHHHHhcCCC
Q 021253 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (315)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (315)
+.|++. +...|. +++|.+ ..+.+++...|..|+.
T Consensus 75 g~~~l~-~~~~F~sl~eLV~~y~~~~~~l~~~L~~P~~ 111 (121)
T 2dly_A 75 GGFFLT-RRKVFSTLNEFVNYYTTTSDGLCVKLEKPCL 111 (121)
T ss_dssp SCEEEE-TTEEESSHHHHHHHHTTCCSSSSSCCCSBCC
T ss_pred CCEEEC-CCCccCCHHHHHHHHhhCCCCCceeCCeecC
Confidence 778875 444553 344443 3344444444544443
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.007 Score=45.76 Aligned_cols=90 Identities=18% Similarity=0.179 Sum_probs=55.7
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cc
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~ 86 (315)
-+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.
T Consensus 16 ~~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 74 (119)
T 2ecd_A 16 HSWYHGPVS---------RSAAEYLLSSLINGSFLVRESES---SPGQLSISLRYE---------GRVYHYRINTTADGK 74 (119)
T ss_dssp SSSEEEECC---------HHHHHHHHHTSCTTBEEEEEESS---STTEEEEEEECS---------SCEEEECCCCCSSSC
T ss_pred CccccCCCC---------HHHHHHHhcCCCCCeEEEEeCCC---CCCCEEEEEEEC---------CeEEEEEEEEcCCCC
Confidence 378888774 33444555544579999999875 568999999952 257999998754 56
Q ss_pred eeeeeceeeec--CCceee-ccCchHHHHHHhcCCC
Q 021253 87 YSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (315)
Q Consensus 87 ~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (315)
|++. ....|. +++|.+ ....+++...|..|+.
T Consensus 75 ~~l~-~~~~F~sl~~LV~~y~~~~~gl~~~L~~P~~ 109 (119)
T 2ecd_A 75 VYVT-AESRFSTLAELVHHHSTVADGLVTTLHYPAP 109 (119)
T ss_dssp CCCC-SSCCCSSHHHHHHHHHHCCTTSSSCCCBCCS
T ss_pred EEEc-CCCcCCCHHHHHHHHhhCCCCCceECCCccC
Confidence 6664 333442 334433 3334444444444443
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=93.86 E-value=0.0038 Score=46.09 Aligned_cols=54 Identities=15% Similarity=0.214 Sum_probs=40.2
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~ 83 (315)
+||++.+. -.-+....+..| .|+|+++.|.+ .+|.|++|++.. ..++|+.|...
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~ 61 (105)
T 1nrv_A 6 HWFHGRIS---------REESHRIIKQQGLVDGLFLLRDSQS---NPKAFVLTLCHH---------QKIKNFQILPC 61 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEET---------TEEEEEEEEEC
T ss_pred cccCCCCC---------HHHHHHHHHhcCCCCceEEEEeCCC---CCCCEEEEEEeC---------CEEEEEEEEEE
Confidence 68887774 344556666655 79999999876 578999999863 26789999864
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=93.79 E-value=0.0024 Score=47.76 Aligned_cols=91 Identities=18% Similarity=0.143 Sum_probs=56.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cc
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~ 86 (315)
-+||++.+. -..+....+....|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.
T Consensus 5 ~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 63 (112)
T 3k2m_A 5 HSWYHGPVS---------RNAAEYLLSSGINGSFLVRESES---SPGQRSISLRYE---------GRVYHYRINTASDGK 63 (112)
T ss_dssp STTEEESCC---------HHHHHHHTTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTSC
T ss_pred CcceeeCCC---------HHHHHHHhccCCCceEEEEeCCC---CCCCEEEEEEeC---------CcEEEEEEEECCCCc
Confidence 378887774 22333444433479999998875 578999999962 267899998754 55
Q ss_pred eeeeeceeeec--CCceee-ccCchHHHHHHhcCCCC
Q 021253 87 YSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (315)
Q Consensus 87 ~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (315)
|++. +...|. ++.|.+ ..+.+++...|..|+.+
T Consensus 64 ~~~~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~P~~~ 99 (112)
T 3k2m_A 64 LYVS-SESRFNTLAELVHHHSTVADGLITTLHYPAPK 99 (112)
T ss_dssp EESS-TTCCBSSHHHHHHHHHHCCTTSSSCCCEECCC
T ss_pred EEEC-CCCeECCHHHHHHHHhhCCCCCccCCCCCCCC
Confidence 6654 333442 334433 44555565555555543
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=93.66 E-value=0.0044 Score=47.77 Aligned_cols=69 Identities=9% Similarity=0.095 Sum_probs=45.2
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCC----CCc--ccccccCCCCcc
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGS----NDS--LTHILSHPGLKP 82 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s----~~~--~~~~~~~~~i~~ 82 (315)
+||++.+. -..+....+....|+|++++|.+ .+|.|++|++....+. ..+ ....++|+.|..
T Consensus 21 ~Wyhg~is---------R~eAe~lL~~~~~G~FLVR~S~s---~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~ 88 (131)
T 2kno_A 21 FWYKPHLS---------RDQAIALLKDKDPGAFLIRDSHS---FQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIET 88 (131)
T ss_dssp HHBCTTCC---------HHHHHHHHTTSCTTBEEEEECSS---STTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEEC
T ss_pred CceecCCC---------HHHHHHHhcCCCCCeEEEecCCC---CCCCEEEEEEeCCCCcccccccccccCCceEEEEEEE
Confidence 56666553 23444455545689999999875 6789999999754211 000 013689999988
Q ss_pred cCCceee
Q 021253 83 VRHNYSV 89 (315)
Q Consensus 83 ~~~~~~i 89 (315)
...+|++
T Consensus 89 ~~~g~~l 95 (131)
T 2kno_A 89 GPKGVKI 95 (131)
T ss_dssp CSSCCCE
T ss_pred CCCCCEE
Confidence 7766877
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=93.37 E-value=0.032 Score=40.25 Aligned_cols=61 Identities=21% Similarity=0.163 Sum_probs=44.7
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cc
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~ 86 (315)
+||++.+. -.-+....+..+ .|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +.
T Consensus 4 ~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~ 62 (96)
T 1jyr_A 4 AWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFG---------NDVQHFKVLRDGAGK 62 (96)
T ss_dssp TTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTTSC
T ss_pred ceeccCCC---------HHHHHHHHhcCCCCcEEEEEecCC---CCCCEEEEEEeC---------CeEEEEEEEEcCCCC
Confidence 67877764 344555666666 89999999875 578899999962 267899998754 66
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 63 ~~l~ 66 (96)
T 1jyr_A 63 YFLW 66 (96)
T ss_dssp EESS
T ss_pred EEEC
Confidence 7764
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.32 E-value=0.055 Score=40.67 Aligned_cols=66 Identities=18% Similarity=0.166 Sum_probs=45.9
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
-+||++.+. -..+.....+. -.|+|++++|.+ .+|.|++|++....+ ...++|+.|....+.
T Consensus 21 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~g~ 83 (118)
T 2el8_A 21 TPSCFLKVS---------RLEAQLLLERYPECGNLLLRPSGD---GADGVSVTTRQMHNG-----THVVRHYKVKREGPK 83 (118)
T ss_dssp SCTTCCCCC---------HHHHHHHHHHSSTTCSBEEEECCS---SSSSEEEEECCCBTT-----BCCCEEECBCCBTTB
T ss_pred CCceecCCC---------HHHHHHHHhhCCCCcEEEEeeCCC---CCCceEEEEEEecCC-----CCcEEEEEEEEcCCE
Confidence 367777664 33455555443 369999999876 578999999864421 236799999885577
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 84 ~~i~ 87 (118)
T 2el8_A 84 YVID 87 (118)
T ss_dssp CCBS
T ss_pred EEEe
Confidence 8775
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.17 E-value=0.0064 Score=46.53 Aligned_cols=61 Identities=21% Similarity=0.258 Sum_probs=43.3
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc--C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--R 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~--~ 84 (315)
+||++.+. -.-+....+..| .|+|+++.|.+ .+|.|++|++.. ..++|+.|... .
T Consensus 27 ~WyhG~is---------R~eAe~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~ 85 (126)
T 2aug_A 27 PWFHHKIS---------RDEAQRLIIQQGLVDGVFLVRDSQS---NPKTFVLSMSHG---------QKIKHFQIIPVEDD 85 (126)
T ss_dssp TTEETTCC---------HHHHHHHHHTTTCCTTEEEEEECSS---SSCCEEEEEEET---------TEEEEEEEEEEEET
T ss_pred CcccCCCC---------HHHHHHHHhccCCCCCEEEEeecCC---CCCCEEEEEEcC---------CeEEEEEEEEECCC
Confidence 78877764 344555666555 69999999875 578999999962 26799999875 3
Q ss_pred Cceeee
Q 021253 85 HNYSVS 90 (315)
Q Consensus 85 ~~~~i~ 90 (315)
+.|++.
T Consensus 86 G~~~~~ 91 (126)
T 2aug_A 86 GEMFHT 91 (126)
T ss_dssp TEEEEE
T ss_pred CeEEEE
Confidence 556553
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.14 E-value=0.0062 Score=45.31 Aligned_cols=67 Identities=16% Similarity=0.166 Sum_probs=45.7
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|+++.|+ .+|.|++|++....+.. ...++|+.|.... +
T Consensus 11 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 74 (110)
T 2ekx_A 11 YDWFAGNIS---------RSQSEQLLRQKGKEGAFMVRNSS----QVGMYTVSLFSKAVNDK---KGTVKHYHVHTNAEN 74 (110)
T ss_dssp SSSBCCSCC---------HHHHHHHHHHTCCTTEEEEEECS----STTCEEEEECCCCSSCS---SCCCEEEECEECTTC
T ss_pred CCeecCCCC---------HHHHHHHHhccCCCceEEEEecC----CCCCEEEEEEeccccCC---CCcEEEEEEEECCCC
Confidence 478888774 33444555554 46999999983 47899999996543211 1367999998765 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 75 ~~~l~ 79 (110)
T 2ekx_A 75 KLYLA 79 (110)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 57764
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=93.06 E-value=0.015 Score=49.98 Aligned_cols=92 Identities=16% Similarity=0.194 Sum_probs=60.9
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc-CC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RH 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~-~~ 85 (315)
+||++.+. -..+....+..| .|+|+++.|.+ ..|.|++|++.. ..++|+.|... .+
T Consensus 7 ~Wyhg~is---------R~~Ae~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 65 (254)
T 2oq1_A 7 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHD---------VRFHHFPIERQLNG 65 (254)
T ss_dssp TTBCBSCC---------HHHHHHHHHHTTCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHhccCCCCcEEEEEeCCC---CCCCEEEEEEEC---------CeEEEEEEEEeCCC
Confidence 78888775 344555554434 79999998876 578999999952 26799999984 47
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCCCC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTE 122 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~ 122 (315)
.|++. +...|. ++.|.+ ..+.+++...|..|+.+..
T Consensus 66 ~~~l~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~p~~~~~ 104 (254)
T 2oq1_A 66 TYAIA-GGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPS 104 (254)
T ss_dssp CEEET-TSCCBSSHHHHHHHHHHCCTTSSSCCCSBCCCCT
T ss_pred CEEeC-CCCccCCHHHHHHHHHhCCCCcccccccccCCCC
Confidence 78875 334452 344544 4455666666666665433
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.85 E-value=0.019 Score=43.67 Aligned_cols=67 Identities=19% Similarity=0.129 Sum_probs=45.3
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|+++.|+ ..|.|++|++....+.. ...++|+.|.... +
T Consensus 16 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 79 (125)
T 2dm0_A 16 YEWYHRNIT---------RNQAEHLLRQESKEGAFIVRDSR----HLGSYTISVFMGARRST---EAAIKHYQIKKNDSG 79 (125)
T ss_dssp SSSBCCSCC---------HHHHHHHHHHHCSTTCBCEEEET----TEEEEEEEEECCCSSSS---SCCEEEEEEEECTTC
T ss_pred CCcccCCCC---------HHHHHHHHhhcCCCCEEEEEecC----CCCCEEEEEEeccccCC---CCcEEEEEEEEcCCC
Confidence 378887774 33444555544 57999999983 46899999996542211 2367999998765 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 80 ~~~l~ 84 (125)
T 2dm0_A 80 QWYVA 84 (125)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 57764
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.0093 Score=45.49 Aligned_cols=67 Identities=16% Similarity=0.188 Sum_probs=46.2
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|+++.| + .+|.|++|++..+.+.. ...++|+.|.... +
T Consensus 11 ~~WyhG~is---------R~eAe~lL~~~g~~G~FLVR~S-s---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 74 (125)
T 2ge9_A 11 YEWYSKHMT---------RSQAEQLLKQEGKEGGFIVRDS-S---KAGKYTVSVFAKSTGDP---QGVIRHYVVCSTPQS 74 (125)
T ss_dssp SSSEETTCC---------HHHHHHHHHHHTCTTEEEEEEC-S---SSCCEEEEEEESSSSST---TCEEEEEECEEETTT
T ss_pred CCccccCCC---------HHHHHHHHhhcCCCceEEEEec-C---CCCCEEEEEEeccccCC---CCeEEEEEEEEcCCC
Confidence 478887774 33455556555 4799999998 3 47899999997653221 1367999998765 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 75 ~~~l~ 79 (125)
T 2ge9_A 75 QYYLA 79 (125)
T ss_dssp EEESS
T ss_pred CEEEC
Confidence 57765
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=92.24 E-value=0.019 Score=49.37 Aligned_cols=90 Identities=18% Similarity=0.210 Sum_probs=58.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc-CC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RH 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~-~~ 85 (315)
+||++.+. -..+....+..| .|+|++++|.+ .+|.|++|++.. ..++|+.|... .+
T Consensus 6 ~Wy~g~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 64 (254)
T 1a81_A 6 PFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHG---------RKAHHYTIERELNG 64 (254)
T ss_dssp TTBCSSCC---------HHHHHHHHHHTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred ccccCCCC---------HHHHHHHHhcCCCCCcEEEEEecCC---CCCCEEEEEEEC---------CeeEEEEEEEcCCC
Confidence 68887774 344555565444 79999998876 578999999952 26799999874 46
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (315)
.|++. +...|. ++++.+ ..+.++++..|..|+.+
T Consensus 65 ~~~l~-~~~~F~sl~eLv~~y~~~~~~l~~~L~~p~~~ 101 (254)
T 1a81_A 65 TYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFNR 101 (254)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTTCCTTSSSCCCEECCC
T ss_pred CEEeC-CCCCcCCHHHHHHHHHhCCCCceECCccccCC
Confidence 78875 344442 344443 34455565556555543
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=91.59 E-value=0.039 Score=42.17 Aligned_cols=62 Identities=13% Similarity=0.109 Sum_probs=44.3
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|++++|.+ ..|.|++|++.. ..++|+.|.... +
T Consensus 4 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 62 (128)
T 1ka6_A 4 VAVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYH---------GYIYTYRVSQTETG 62 (128)
T ss_dssp CSSBCCSCC---------HHHHHHHHHHHCCTTCEEEEECSS---STTCEEEEEESS---------SCEEEEEEEECTTS
T ss_pred CcccCCCCC---------HHHHHHHHhcCCCCCEEEEeecCC---CCCCEEEEEEeC---------CEEEEEEEEECCCC
Confidence 378888774 33455555443 469999999875 568999999952 267899998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|.+.
T Consensus 63 ~~~l~ 67 (128)
T 1ka6_A 63 SWSAE 67 (128)
T ss_dssp CEEEE
T ss_pred eEEEe
Confidence 67776
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.021 Score=41.93 Aligned_cols=62 Identities=13% Similarity=0.109 Sum_probs=43.9
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|++++|.+ .+|.|++|++.. ..++|+.|.... +
T Consensus 4 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 62 (104)
T 1d4t_A 4 VAVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYH---------GYIYTYRVSQTETG 62 (104)
T ss_dssp CTTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CceEccCCC---------HHHHHHHHHhcCCCCEEEEeeCCC---CCCCEEEEEEEC---------CeEEEEEEEECCCC
Confidence 378887774 33444555544 479999998875 578999999962 267899998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|.+.
T Consensus 63 ~~~l~ 67 (104)
T 1d4t_A 63 SWSAE 67 (104)
T ss_dssp CEEEC
T ss_pred eEEEe
Confidence 67765
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=91.50 E-value=0.026 Score=48.33 Aligned_cols=54 Identities=17% Similarity=0.238 Sum_probs=37.1
Q ss_pred cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCC----ceeeeeceeeec--CCceee
Q 021253 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRH----NYSVSVGQSVFR--PGKVTH 103 (315)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~----~~~i~~~~~~~~--~~~v~~ 103 (315)
..|+|++++|.+ .+|.|+||+.... .++|+.|..... .|++. ....|. +++|.|
T Consensus 35 ~dG~FLVR~S~s---~~G~y~LSv~~~~---------~v~H~~I~~~~~~g~~~~~~~-~~~~F~sl~~LV~~ 94 (246)
T 4fbn_A 35 PDGSFLVRESET---FVGDYTLSFWRNG---------KVQHCRIHSRQDAGTPKFFLT-DNLVFDSLYDLITH 94 (246)
T ss_dssp CTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEEEEECGGGCCEEEEE-TTEEESSHHHHHHH
T ss_pred CCCEEEEEcCCC---CCCCEEEEEEECC---------EEEEEEEEEECCCCceeEEec-CCcccCCHHHHHHh
Confidence 369999999876 7899999998532 578999976552 36665 444453 344443
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=91.25 E-value=0.016 Score=42.46 Aligned_cols=62 Identities=15% Similarity=0.174 Sum_probs=42.8
Q ss_pred CCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|+... ..++|+.|.... +
T Consensus 3 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 61 (103)
T 1i3z_A 3 LPYYHGCLT---------KRECEALLLKGGVDGNFLIRDSES---VPGALCLCVSFK---------KLVYSYRIFREKHG 61 (103)
T ss_dssp CTTEESSCC---------HHHHHHHHHTTCSTTEEEEEECSS---STTCEEEEEECS---------SSEEEEEEEECTTS
T ss_pred CccccCCCC---------HHHHHHHHhhcCCCceEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEECCCC
Confidence 468887774 33444445432 369999999875 568999999852 267899998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 62 ~~~l~ 66 (103)
T 1i3z_A 62 YYRIE 66 (103)
T ss_dssp CEEEC
T ss_pred eEEEe
Confidence 67765
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=91.13 E-value=0.071 Score=40.32 Aligned_cols=63 Identities=13% Similarity=0.159 Sum_probs=45.5
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
.-+||++.+. -.-+....+....|+|+++.|.+ .+|.|++|++.. ..++|+.|....+.
T Consensus 21 ~~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~ 79 (122)
T 2lnw_A 21 AYPWFAGNME---------RQQTDNLLKSHASGTYLIRERPA---EAERFAISIKFN---------DEVKHIKVVEKDNW 79 (122)
T ss_dssp TSTTBCCSCC---------HHHHHHHHHHSCTTBEEEEECCC---SSEEEEEEEECS---------SCEEEEEEEEETTE
T ss_pred cCcCCCcCCC---------HHHHHHHhcCCCCCeEEEEeCCC---CCCcEEEEEEeC---------CcEEEEEEEEcCCE
Confidence 3478887774 33445555555689999998865 579999999962 25789999876677
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 80 ~~l~ 83 (122)
T 2lnw_A 80 IHIT 83 (122)
T ss_dssp EESS
T ss_pred EEEC
Confidence 7764
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=91.06 E-value=0.087 Score=38.24 Aligned_cols=63 Identities=16% Similarity=0.052 Sum_probs=44.7
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
.-+||++.+. -.-+....+....|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +
T Consensus 8 ~~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 66 (100)
T 1r1p_A 8 FPEWFHEGLS---------RHQAENLLMGKDIGFFIIRASQS---SPGDFSISVRHE---------DDVQHFKVMRDTKG 66 (100)
T ss_dssp TTTTSCTTCC---------HHHHHHHHHTSCTTBEEEEECSS---STTCEEEEEECS---------SSEEEEECEECTTC
T ss_pred cCCccccCCC---------HHHHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 3478887774 33444555555689999998875 568899999952 257899998754 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 67 ~~~l~ 71 (100)
T 1r1p_A 67 NYFLW 71 (100)
T ss_dssp CEESS
T ss_pred CEEEe
Confidence 67754
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=90.35 E-value=0.12 Score=38.14 Aligned_cols=64 Identities=16% Similarity=0.162 Sum_probs=43.3
Q ss_pred cccCCCccccccCccCCCCccccccHHHHHHh-cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc
Q 021253 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (315)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~ 83 (315)
|.+-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++.. ..++|+.|...
T Consensus 4 l~~~~Wyhg~is---------r~~Ae~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~ 62 (109)
T 3tkz_A 4 MTSRRWFHPNIT---------GVEAENLLLTRGVDGSFLARPSKS---NPGDFTLSVRRN---------GAVTHIKIQNT 62 (109)
T ss_dssp ---CCSBCTTCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEEC
T ss_pred cccCCceecCCC---------HHHHHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEeC
Confidence 344589988874 33444555554 379999998875 578999999962 26789998875
Q ss_pred CCceee
Q 021253 84 RHNYSV 89 (315)
Q Consensus 84 ~~~~~i 89 (315)
.+.|.+
T Consensus 63 ~~~~~~ 68 (109)
T 3tkz_A 63 GDYYDL 68 (109)
T ss_dssp SSCEES
T ss_pred CCEEEe
Confidence 555554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=90.25 E-value=0.041 Score=53.74 Aligned_cols=91 Identities=18% Similarity=0.180 Sum_probs=64.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~- 84 (315)
-+||++.+. -.-+.......| .|+|++++|++ .+|.|++|++... .++|+.|....
T Consensus 13 ~~Wy~g~is---------r~~Ae~~L~~~~~~~G~FLvR~S~~---~~g~y~lsv~~~~---------~v~h~~i~~~~~ 71 (635)
T 4fl3_A 13 LPFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHGR---------KAHHYTIERELN 71 (635)
T ss_dssp CTTBCBSCC---------HHHHHHHHHHTTCCTTEEEEEECTT---SSSCEEEEEEETT---------EEEEEEEEECTT
T ss_pred CCccCCCCC---------HHHHHHHHhcCCCCCceEEEeeccc---CCCCEEEEEEeCC---------EEEeEEEEEcCC
Confidence 378888775 334455666655 89999999875 6789999999632 67999998774
Q ss_pred Cceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCC
Q 021253 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (315)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (315)
+.|++. +...|. ++.+.| ..+.++++..|..|+..
T Consensus 72 g~~~~~-~~~~f~sl~~Lv~~y~~~~~~l~~~L~~p~~~ 109 (635)
T 4fl3_A 72 GTYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFNR 109 (635)
T ss_dssp SCEEST-TCCCBSSHHHHHHHHTTCCTTSSSCCCEECCC
T ss_pred CCEEeC-CCCccCCHHHHHHHHhhCCCCCeeccCCcCCC
Confidence 777775 444553 445544 55677887778777764
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=90.19 E-value=0.12 Score=41.23 Aligned_cols=62 Identities=11% Similarity=0.003 Sum_probs=45.9
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -..+....+..-.|+|++++|++ ..|.|++|++.. ..++|+.|....+.|
T Consensus 23 ~~WyhG~Is---------R~eAe~lL~~~~~GtFLVR~S~s---~~g~y~LSvr~~---------~~v~H~rI~~~~g~f 81 (164)
T 2bbu_A 23 SGFYWSAVT---------GGEANLLLSAEPAGTFLIRDSSD---QRHFFTLSVKTQ---------SGTKNLRIQCEGGSF 81 (164)
T ss_dssp TSCCCTTSC---------HHHHHHHHHHSSTTCCEEEECST---TSCCEEEEECCT---------TCCEEEECEEETTEE
T ss_pred CCccCCCCC---------HHHHHHHhcCCCCCCEEEEECCC---CCCCEEEEEEEC---------CceEEEEEEeCCCeE
Confidence 478888775 34455566555689999999876 578999999852 256899998766777
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 82 ~l~ 84 (164)
T 2bbu_A 82 SLQ 84 (164)
T ss_dssp ESS
T ss_pred EEe
Confidence 765
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=89.76 E-value=0.16 Score=38.00 Aligned_cols=64 Identities=22% Similarity=0.174 Sum_probs=45.2
Q ss_pred ccCCCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 6 VEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
-.-+||++.+. -..+....+..+ .|+|++++|.+ .+|.|++|++.. ..++|+.|....
T Consensus 4 ~~~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~ 62 (117)
T 3ov1_A 4 KPHPWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFG---------NDVQHFKVLRDG 62 (117)
T ss_dssp CCCTTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEET---------TEEEEEECEECT
T ss_pred ccCCcccCCCC---------HHHHHHHHhCCCCCCcEEEEeCCC---CCCCEEEEEecC---------CceEEEEEEECC
Confidence 34478888774 344555565533 59999998875 578999999862 267899997644
Q ss_pred -Cceeee
Q 021253 85 -HNYSVS 90 (315)
Q Consensus 85 -~~~~i~ 90 (315)
+.|++.
T Consensus 63 ~g~~~l~ 69 (117)
T 3ov1_A 63 AGKYFLW 69 (117)
T ss_dssp TSCEESS
T ss_pred CCeEEEC
Confidence 667764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.64 E-value=0.043 Score=53.38 Aligned_cols=90 Identities=17% Similarity=0.187 Sum_probs=61.7
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++-+. -.-+.......| .|+|++++|++ ..|.|++|++.. ..++|+.|.... +
T Consensus 9 ~W~~g~i~---------r~~ae~~L~~~~~~~G~fLvR~s~~---~~g~~~ls~~~~---------~~~~h~~i~~~~~g 67 (613)
T 2ozo_A 9 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHD---------VRFHHFPIERQLNG 67 (613)
T ss_dssp TTBCBSCC---------HHHHHHHHHTTTCCTTEEEEEECTT---BTTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CCcCccCC---------HHHHHHHHhccCCCCCeEEEEecCC---CCCCEEEEEEEC---------CeEEEEEEEECCCC
Confidence 68888775 223344443334 59999999876 679999999962 267899998764 6
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (315)
.|++. +...|. +++|.| ..+.++++..|..||..
T Consensus 68 ~~~~~-~~~~f~sl~~Lv~~y~~~~~~l~~~L~~p~~~ 104 (613)
T 2ozo_A 68 TYAIA-GGKAHCGPAELCEFYSRDPDGLPCNLRKPCNR 104 (613)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTSCCTTSSSCCCSBCCC
T ss_pred cEEEC-CCCCcCCHHHHHHHHhhCCCCCCccCCccCCC
Confidence 77775 444453 445554 55667787778887764
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.24 E-value=0.12 Score=38.70 Aligned_cols=63 Identities=13% Similarity=0.159 Sum_probs=45.6
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
.-+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|++|++.. ..++|+.|...++.
T Consensus 15 ~~~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~g~ 73 (118)
T 2dlz_A 15 AYPWFAGNME---------RQQTDNLLKSHASGTYLIRERPA---EAERFAISIKFN---------DEVKHIKVVEKDNW 73 (118)
T ss_dssp GSTTEEESCC---------HHHHHHHHHHSCTTBEEEECCSC---SSCCEEEEEECS---------SSEEEEEEEEETTE
T ss_pred cCCceecCCC---------HHHHHHHhcCCCCCEEEEEeCCC---CCCCEEEEEEEC---------CcEEEEEEEEcCCE
Confidence 3478887774 33445556555689999999875 578999999952 25789999876677
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 74 ~~l~ 77 (118)
T 2dlz_A 74 IHIT 77 (118)
T ss_dssp EEST
T ss_pred EEEe
Confidence 7764
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=89.23 E-value=0.12 Score=41.39 Aligned_cols=63 Identities=14% Similarity=0.115 Sum_probs=46.0
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
+-+||++.+. -.-+....+....|+|++++|++ ..|.+++|++... .++|+.|....+.
T Consensus 16 ~~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~~---------~v~H~rI~~~~g~ 74 (169)
T 2c9w_A 16 QTGWYWGSMT---------VNEAKEKLKEAPEGTFLIRDSSH---SDYLLTISVKTSA---------GPTNLRIEYQDGK 74 (169)
T ss_dssp HTSCBCTTCC---------HHHHHHHHTTSCTTCEEEEECCS---TTCSEEEEEEETT---------EEEEEEEEEETTE
T ss_pred cCCccccCCC---------HHHHHHHcCCCCCcEEEEecCCC---CCCeEEEEEEECC---------eeEEEEEEEeCCE
Confidence 3478888875 33444555544579999999876 5789999998632 5689999886677
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 75 ~~l~ 78 (169)
T 2c9w_A 75 FRLD 78 (169)
T ss_dssp EEEC
T ss_pred EEEc
Confidence 8875
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.82 E-value=0.11 Score=40.22 Aligned_cols=61 Identities=16% Similarity=0.106 Sum_probs=44.2
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCcee
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~ 88 (315)
+||++.+. -..+....+..-.|+|++++|++ ..|.|++|++.. ..++|+.|....+.|+
T Consensus 25 ~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~---------~~v~H~~I~~~~g~~~ 83 (141)
T 2vif_A 25 GWYWGPIT---------RWEAEGKLANVPDGSFLVRDSSD---DRYLLSLSFRSH---------GKTLHTRIEHSNGRFS 83 (141)
T ss_dssp TCBCCSCC---------HHHHHHHTTTSCTTCEEEEECSS---TTCSEEEEEEET---------TEEEEEEEEEETTEEE
T ss_pred CCcccCCC---------HHHHHHHhcCCCCceEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEEECCEEE
Confidence 68887774 23344444444579999999876 578999999862 2578999988777788
Q ss_pred ee
Q 021253 89 VS 90 (315)
Q Consensus 89 i~ 90 (315)
+.
T Consensus 84 l~ 85 (141)
T 2vif_A 84 FY 85 (141)
T ss_dssp ET
T ss_pred Ee
Confidence 75
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=88.58 E-value=0.14 Score=40.34 Aligned_cols=62 Identities=11% Similarity=0.025 Sum_probs=45.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -.-+....+..-.|+|++++|++ ..|.|++|++.. ..++|+.|....+.|
T Consensus 34 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~rI~~~~g~f 92 (152)
T 2hmh_A 34 SGFYWSAVT---------GGEANLLLSAEPAGTFLIRDSSD---QRHFFTLSVKTQ---------SGTKNLRIQXEGGSF 92 (152)
T ss_dssp TSSEETTCC---------HHHHHHHHHTSCTTEEEEEECCS---TTCSEEEEEEET---------TEEEEEEEECGGGCB
T ss_pred CCCcCCCCC---------HHHHHHHhcCCCCCcEEEEeCCC---CCCcEEEEEEcC---------CceEEEEEEecCCEE
Confidence 378887774 33444555545689999999876 578999999863 267899998855778
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
.+.
T Consensus 93 ~l~ 95 (152)
T 2hmh_A 93 SLQ 95 (152)
T ss_dssp EEC
T ss_pred EEe
Confidence 875
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=88.00 E-value=0.092 Score=46.31 Aligned_cols=88 Identities=16% Similarity=0.158 Sum_probs=56.4
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~ 87 (315)
+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|+||++.. ..++|+.|.... +.|
T Consensus 13 ~Wyhg~is---------R~~Ae~lL~~~~~G~FLvR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~ 71 (303)
T 2lqn_A 13 AWYMGPVS---------RQEAQTRLQGQRHGMFLVRDSST---CPGDYVLSVSEN---------SRVSHYIINSLPNRRF 71 (303)
Confidence 78888775 22343444444679999999875 578899999852 257999999855 556
Q ss_pred eeeeceeee--cCCceeeccCchHHHHHHhcCCC
Q 021253 88 SVSVGQSVF--RPGKVTHALNDDALAQALMDHRY 119 (315)
Q Consensus 88 ~i~~~~~~~--~~~~v~~~~~~~~l~~~l~~~~~ 119 (315)
.+. ...| .+.+|.|......++..|..++.
T Consensus 72 ~~~--~~~F~sl~~Lv~~y~~~~~~~~~L~~P~~ 103 (303)
T 2lqn_A 72 KIG--DQEFDHLPALLEFYKIHYLDTTTLIEPAP 103 (303)
Confidence 664 3455 36677664333334455555544
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=88.21 E-value=0.19 Score=37.10 Aligned_cols=63 Identities=14% Similarity=0.088 Sum_probs=44.3
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHh---cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKL---GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~ 83 (315)
.-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++.. ..++|+.|...
T Consensus 8 ~~~WyhG~is---------R~~Ae~lL~~~g~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~ 66 (111)
T 2hdv_A 8 GYPWFHGMLS---------RLKAAQLVLEGGTGSHGVFLVRQSET---RRGECVLTFNFQ---------GKAKHLRLSLN 66 (111)
T ss_dssp GSTTEEEECC---------HHHHHHHHHTTGGGGTTEEEEEECSS---CTTEEEEEEEET---------TEEEEEEEEEC
T ss_pred cCCCcCCCCC---------HHHHHHHHHHcCCCCCCeEEEEecCC---CCCCEEEEEEeC---------CeEEEEEEEEc
Confidence 3478888774 33444555544 479999999875 678999999962 26789999865
Q ss_pred C-Cceeee
Q 021253 84 R-HNYSVS 90 (315)
Q Consensus 84 ~-~~~~i~ 90 (315)
. +.|.+.
T Consensus 67 ~~g~~~l~ 74 (111)
T 2hdv_A 67 AAGQCRVQ 74 (111)
T ss_dssp TTCCEEET
T ss_pred CCCCEEeC
Confidence 4 556653
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=88.18 E-value=0.17 Score=36.81 Aligned_cols=61 Identities=18% Similarity=0.135 Sum_probs=42.4
Q ss_pred CCccccccCccCCCCccccccHHHHH-HhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQ-KLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
+||++.+. -.-+....+ ..-.|+|+++.|.+ .+|.|++|++.. ..++|+.|....+.|
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~g~~ 64 (102)
T 2cia_A 6 EWYYGNVT---------RHQAECALNERGVEGDFLIRDSES---SPSDFSVSLKAS---------GKNKHFKVQLVDNVY 64 (102)
T ss_dssp TTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEECCS---------SSCEEEEEEEETTEE
T ss_pred ccccCCCC---------HHHHHHHHhhCCCCcEEEEEECCC---CCCCEEEEEEeC---------CeeEEEEEEecCCEE
Confidence 67777664 233444553 23479999998875 568999999852 256899998555777
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
.+.
T Consensus 65 ~l~ 67 (102)
T 2cia_A 65 CIG 67 (102)
T ss_dssp EET
T ss_pred EEC
Confidence 764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.73 E-value=1.3 Score=36.86 Aligned_cols=84 Identities=10% Similarity=-0.032 Sum_probs=58.0
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCccCCCCCCCEEEc
Q 021253 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA-YVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~-yLH~~~iiHrDlkp~NIli~ 272 (315)
.||.+ -...-.+.+.+.+.++.-+++.=...++. ++....++.+.+|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57777 44444667777777776544333334432 677888888887665554 33 3456778999999999
Q ss_pred CCCcEEEeeeccee
Q 021253 273 ADKSIKIADFGVAR 286 (315)
Q Consensus 273 ~~~~vkl~DFG~a~ 286 (315)
.++.++|.-.|+-.
T Consensus 119 ~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 119 RALEPFFLHVGVKE 132 (219)
T ss_dssp TTCCEEESCCEETT
T ss_pred CCCcEEEEEcCCcc
Confidence 99999999888644
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.61 E-value=0.38 Score=36.00 Aligned_cols=62 Identities=13% Similarity=0.132 Sum_probs=44.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+..| .|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +
T Consensus 16 ~~WyhG~is---------R~~Ae~lL~~~g~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 74 (119)
T 2gsb_A 16 KIWFHGKIS---------KQEAYNLLMTVGQVCSFLVRPSDN---TPGDYSLYFRTN---------ENIQRFKICPTPNN 74 (119)
T ss_dssp CSSBCCSSC---------HHHHHHHHHHTCCSSEEEEEECSS---STTCEEEEEECS---------SCBCCCCEEEETTT
T ss_pred CCcccCCCC---------HHHHHHHHhhcCCCCeEEEEeCCC---CCCceEEEEEEC---------CEEEEEEEEEcCCC
Confidence 478887774 334555666544 69999999875 578999999853 267999998754 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|.+.
T Consensus 75 ~~~l~ 79 (119)
T 2gsb_A 75 QFMMG 79 (119)
T ss_dssp EEEES
T ss_pred CEEEC
Confidence 67664
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.57 E-value=0.21 Score=37.36 Aligned_cols=62 Identities=11% Similarity=0.064 Sum_probs=44.4
Q ss_pred CCCccccccCccCCCCccccccHHHHHH-hcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQK-LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
-+||++.+. -.-+....+. .-.|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +
T Consensus 10 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 68 (119)
T 2ysx_A 10 PCWNHGNIT---------RSKAEELLSRTGKDGSFLVRASES---ISRAYALCVLYR---------NCVYTYRILPNEDD 68 (119)
T ss_dssp CSSEEESCC---------HHHHHHHHHHHCCTTEEEEEECSS---CTTSEEEEEECS---------SCEEEEEEEECTTS
T ss_pred CccccCCCC---------HHHHHHHHhhcCCCCEEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 378888774 3344455554 3469999999875 578999999952 267899998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 69 ~~~l~ 73 (119)
T 2ysx_A 69 KFTVQ 73 (119)
T ss_dssp CEEEC
T ss_pred CEEEe
Confidence 67775
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=87.26 E-value=0.11 Score=39.02 Aligned_cols=64 Identities=13% Similarity=0.107 Sum_probs=44.6
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
.-+||++.+. -.-+....+..-.|+|+++.|.+. .+|.|++|++... .++|+.|....+.
T Consensus 10 ~~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~~--~~g~y~LSv~~~~---------~v~H~~I~~~~g~ 69 (120)
T 2iug_A 10 NAEWYWGDIS---------REEVNEKLRDTADGTFLVRDASTK--MHGDYTLTLRKGG---------NNKLIKIFHRDGK 69 (120)
T ss_dssp TCTTBCCSCC---------HHHHHHHHTTCCTTEEEEEECSSG--GGCSEEEEEEETT---------EEEEEEEEEETTE
T ss_pred cCCccccCCC---------HHHHHHHhcCCCCcEEEEECCCCC--CCCcEEEEEEECC---------EEEEEEEEEcCCE
Confidence 3478888774 233444554445799999998752 1689999998621 5689999877777
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 70 ~~l~ 73 (120)
T 2iug_A 70 YGFS 73 (120)
T ss_dssp EESS
T ss_pred EEEC
Confidence 7764
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=86.73 E-value=0.14 Score=37.96 Aligned_cols=61 Identities=16% Similarity=0.139 Sum_probs=42.1
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
.-+||++.+. -.-+....+..-.|+|+++.| + .+|.|++|++.. ..++|+.|.....+
T Consensus 9 ~~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S-~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 66 (112)
T 1h9o_A 9 EKTWNVGSSN---------RNKAENLLRGKRDGTFLVRES-S---KQGCYACSVVVD---------GEVKHCVINKTATG 66 (112)
T ss_dssp GGGTBCCSCC---------HHHHHHHHTTCCTTEEEEEEC-S---STTCEEEEEEET---------TEEEEEEEEEETTE
T ss_pred CCCcccCCCC---------HHHHHHHhcCCCCceEEEeec-C---CCCCEEEEEEEC---------CEEEEEEEEEcCCc
Confidence 4478887774 233444444345799999988 4 568899999962 26789999877666
Q ss_pred eee
Q 021253 87 YSV 89 (315)
Q Consensus 87 ~~i 89 (315)
|++
T Consensus 67 ~~~ 69 (112)
T 1h9o_A 67 YGF 69 (112)
T ss_dssp EES
T ss_pred eEE
Confidence 654
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=86.59 E-value=0.056 Score=46.41 Aligned_cols=60 Identities=10% Similarity=0.129 Sum_probs=42.2
Q ss_pred CCccccccCccCCCCccccccHHHHHHh--cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+....+.. -.|+|+++.| + .+|.|++|++.. ..++|+.|.... +
T Consensus 160 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S-~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 217 (254)
T 2oq1_A 160 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPR-K---EQGTYALSLIYG---------KTVYHYLISQDKAG 217 (254)
T ss_dssp TTBCSSCC---------HHHHHHHHHSSCCCTTEEEEEEC-S---STTEEEEEEEET---------TEEEEEEEEECTTS
T ss_pred cccccCCC---------HHHHHHHHHhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CeEEEEEEEEcCCC
Confidence 68887664 33444555544 3799999988 3 578999999962 267999998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 218 ~~~~~ 222 (254)
T 2oq1_A 218 KYCIP 222 (254)
T ss_dssp CEEST
T ss_pred CEEEC
Confidence 67764
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=86.56 E-value=0.26 Score=36.95 Aligned_cols=60 Identities=15% Similarity=0.133 Sum_probs=42.4
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~ 87 (315)
+||++.+. -.-+....+..-.|+|+++.|.+ .+| |++|++.. ..++|+.|.... +.|
T Consensus 17 ~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~~-y~LSv~~~---------~~v~H~~I~~~~~g~~ 74 (119)
T 2cs0_A 17 EWFHGAIS---------REDAENLLESQPLGSFLIRVSHS---HVG-YTLSYKAQ---------SSCCHFMVKLLDDGTF 74 (119)
T ss_dssp SSBCSSCC---------HHHHHHHHHTSCTTCEEEEECSS---SSS-EEEEECCS---------SSCEEEEEEECTTSCE
T ss_pred CccccCCC---------HHHHHHHhcCCCCCEEEEEecCC---CCC-EEEEEEEC---------CEEEEEEEEEcCCCcE
Confidence 68887774 33455566544579999999875 456 99999853 257899998765 567
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 75 ~l~ 77 (119)
T 2cs0_A 75 MIP 77 (119)
T ss_dssp ECT
T ss_pred EEe
Confidence 764
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=86.28 E-value=0.066 Score=45.98 Aligned_cols=60 Identities=15% Similarity=0.168 Sum_probs=42.3
Q ss_pred CCccccccCccCCCCccccccHHHHHHh--cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+....+.. -.|+|+++.| + .+|.|++|+... ..++|+.|.... +
T Consensus 159 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S-~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 216 (254)
T 1a81_A 159 PWFHGKIS---------REESEQIVLIGSKTNGKFLIRAR-D---NNGSYALCLLHE---------GKVLHYRIDKDKTG 216 (254)
T ss_dssp TTEEEECC---------HHHHHHHHHSSCCCTTCEEEEEC-S---SSSCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CccccCCC---------HHHHHHHHHhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 78887774 33444555544 3799999988 3 568999999952 267899998654 6
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 217 ~~~l~ 221 (254)
T 1a81_A 217 KLSIP 221 (254)
T ss_dssp CEECT
T ss_pred CEEec
Confidence 67764
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=86.27 E-value=0.26 Score=36.24 Aligned_cols=55 Identities=18% Similarity=0.166 Sum_probs=37.1
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
+||++.+. -.-+....+..-.|+|++++|++ .+|.|++|++.. ..++|+.|....
T Consensus 1 ~Wyhg~is---------r~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~ 55 (109)
T 1ju5_A 1 SWYWGRLS---------RQEAVALLQGQRHGVFLVRDSST---SPGDYVLSVSEN---------SRVSHYIINSSG 55 (109)
T ss_dssp CCEETTCC---------HHHHHHHHTTCCTTEEEEEECSS---STTEEEEEEECS---------SCEEEEEEECCS
T ss_pred CccccCCC---------HHHHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CeEEEEEEEECC
Confidence 36666553 23344455444479999999875 578999999852 256888887654
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.17 E-value=0.28 Score=37.20 Aligned_cols=41 Identities=7% Similarity=0.041 Sum_probs=32.3
Q ss_pred CCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceeee
Q 021253 39 GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (315)
Q Consensus 39 g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~ 90 (315)
|+|++++|+ .+|.|++||+... ...++|+.|+...+.|++.
T Consensus 45 G~FLVR~S~----~~g~y~LSv~~~~-------~~~vkH~rI~~~~~~~~i~ 85 (126)
T 2cr4_A 45 GLYCIRNSS----TKSGKVLVVWDET-------SNKVRNYRIFEKDSKFYLE 85 (126)
T ss_dssp TCEEEEECS----STTCEEEEEEETT-------TTEECCEECEEETTEEESS
T ss_pred CeEEEEecC----CCCCEEEEEEeCC-------CCCEEEEEEEECCCeEEEc
Confidence 999999887 4689999999742 1268999998777777764
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.51 E-value=0.16 Score=37.51 Aligned_cols=50 Identities=20% Similarity=0.239 Sum_probs=35.4
Q ss_pred cHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCccc-CCceeee
Q 021253 29 TQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVS 90 (315)
Q Consensus 29 ~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~-~~~~~i~ 90 (315)
+....+..-.|+|++++|.+ .+|.|++|++.. ..++|+.|... ++.|.+.
T Consensus 31 Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 81 (111)
T 2eo3_A 31 AQTRLQGQRHGMFLVRDSST---CPGDYVLSVSEN---------SRVSHYIINSLPNRRFKIG 81 (111)
T ss_dssp HHHHHSSCCTTCEEEEECSS---SSSCEEEEEEET---------TEEEEEEEEEETTTEEEET
T ss_pred HHHHhcCCCCceEEEEeecC---CCCCEEEEEEeC---------CeEEEEEEEEcCCCCEEEC
Confidence 33444433579999999875 568999999852 26789999874 4667763
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=84.84 E-value=0.22 Score=40.59 Aligned_cols=62 Identities=24% Similarity=0.254 Sum_probs=44.0
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -.-+....+....|+|++++|++ ..+.+++|++... .++|+.|....+.|
T Consensus 34 ~~WYhG~is---------R~eAE~lL~~~~dGtFLVR~S~~---~~~~lsLSvr~~~---------~v~H~rI~~~~g~f 92 (187)
T 2izv_A 34 NPCYWGVMD---------KYAAEALLEGKPEGTFLLRDSAQ---EDYLFSVSFRRYS---------RSLHARIEQWNHNF 92 (187)
T ss_dssp CTTEEEECC---------HHHHHHHHTTCCTTEEEEEECSS---TTCSEEEEEEETT---------EEEEEECEEETTEE
T ss_pred CCccccCCC---------HHHHHHHhcCCCCCcEEEEECCC---CCceEEEEEeeCC---------eEEEEEEEECCCEE
Confidence 468887775 22333444444579999999984 6678999998522 67899998877777
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 93 ~l~ 95 (187)
T 2izv_A 93 SFD 95 (187)
T ss_dssp ESC
T ss_pred EEe
Confidence 765
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=84.52 E-value=0.2 Score=38.67 Aligned_cols=48 Identities=10% Similarity=0.221 Sum_probs=34.6
Q ss_pred HHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceeee
Q 021253 31 GFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (315)
Q Consensus 31 ~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i~ 90 (315)
...+..-.|+|+++.|.+ .+|.|++|++.. ..++|+.|+...+.|++.
T Consensus 40 ~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~g~~~l~ 87 (138)
T 2crh_A 40 SILANRSDGTFLVRQRVK---DAAEFAISIKYN---------VEVKHIKIMTAEGLYRIT 87 (138)
T ss_dssp HHTTTSCTTEEEEECCSS---TTCCCEEEEEET---------TEEEEEECEEETTEEESS
T ss_pred HHhcCCCCCEEEEEECCC---CCCCEEEEEEEC---------CeEEEEEEEeCCCEEEEC
Confidence 344334479999999875 568999999962 267899997545667765
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=84.11 E-value=0.38 Score=36.30 Aligned_cols=60 Identities=7% Similarity=0.140 Sum_probs=42.3
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
+||++.+. -.-+....+..+ .|+|++++|. ..|.|++|++.. ..++|+.|....+.|
T Consensus 20 ~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 77 (124)
T 2eob_A 20 PWYYDRLS---------RGEAEDMLMRIPRDGAFLIRKRE----GTDSYAITFRAR---------GKVKHCRINRDGRHF 77 (124)
T ss_dssp TTEESSCC---------HHHHHHHHHHCCSSSEEEEECCT----TSSCEEEEEEET---------TEEEEEEEEESSSCE
T ss_pred CCeecCCC---------HHHHHHHHhcCCCCCEEEEEecC----CCCCEEEEEEeC---------CeEEEEEEEECCCEE
Confidence 77777764 334455566555 6999999887 368999999862 267899998655556
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
.+.
T Consensus 78 ~~~ 80 (124)
T 2eob_A 78 VLG 80 (124)
T ss_dssp ESS
T ss_pred EEC
Confidence 553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.10 E-value=1 Score=37.44 Aligned_cols=84 Identities=10% Similarity=0.028 Sum_probs=58.7
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc
Q 021253 194 KHLNIVRFIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~ 272 (315)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. ++ ..+....++++.+|+....+++ .-+|--|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence 57888766 5556666666666654322 2222 32 2678888889988887775443 336777899999999
Q ss_pred CCCcEEEeeeccee
Q 021253 273 ADKSIKIADFGVAR 286 (315)
Q Consensus 273 ~~~~vkl~DFG~a~ 286 (315)
.++.+++.--|+-.
T Consensus 114 ~~~~p~i~~RGik~ 127 (215)
T 4ann_A 114 RDGLPIAKTRGLQN 127 (215)
T ss_dssp TTSCEEESCCEETT
T ss_pred CCCCEEEEEccCcc
Confidence 99999999888643
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=81.88 E-value=0.43 Score=41.93 Aligned_cols=60 Identities=15% Similarity=0.127 Sum_probs=40.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCcee
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~ 88 (315)
+||++.+. -.-+....+..-.|+|+++.| + .+|.|++|++.. ..++|+.|.....+|+
T Consensus 195 ~WyhG~Is---------R~eAE~lL~~~~~GtFLVR~S-s---~~g~y~LSv~~~---------~~V~H~rI~~~~~g~~ 252 (302)
T 2y3a_B 195 TWYVGKIN---------RTQAEEMLSGKRDGTFLIRES-S---QRGCYACSVVVD---------GDTKHCVIYRTATGFG 252 (302)
T ss_dssp TTBCCSCC---------HHHHHHHHTTSCTTBEEBCCC-S---STTCEEEEEECS---------SSEEEEEEEEETTEEE
T ss_pred CccCCCCC---------HHHHHHHhcCCCCCcEEEEec-c---CCCceEEEEEeC---------CeeEEEEEEECCCceE
Confidence 56666553 223333443345799999988 4 568999999852 2579999988776666
Q ss_pred ee
Q 021253 89 VS 90 (315)
Q Consensus 89 i~ 90 (315)
+.
T Consensus 253 ~~ 254 (302)
T 2y3a_B 253 FA 254 (302)
T ss_dssp SB
T ss_pred Ee
Confidence 54
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=81.14 E-value=4.4 Score=33.79 Aligned_cols=60 Identities=13% Similarity=0.083 Sum_probs=46.2
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCEEEcCCCcEEEee
Q 021253 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIAD 281 (315)
Q Consensus 221 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NIli~~~~~vkl~D 281 (315)
-+|.++|... +.+++++++|.++.|.+..|.-+- ++.-..+=+.|..|++..+|.|.+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 3799999876 578999999999999999988762 22222334457899999999998763
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=80.54 E-value=0.32 Score=38.92 Aligned_cols=55 Identities=16% Similarity=0.166 Sum_probs=37.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcc
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKP 82 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~ 82 (315)
+||++.+. -.-+....+..| .|+|++++| + ..|.|++|++....+ ..++|+.|+.
T Consensus 13 ~Wyhg~is---------R~~Ae~lL~~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~------~~v~H~~I~~ 69 (174)
T 3qwx_X 13 SFYFPGMS---------REEAHKLLGEPQVSIGTFLMRDS-S---RPGEYSLTVREADEG------NAVCHYLIER 69 (174)
T ss_dssp GGEETTCC---------HHHHHHHHHSTTCCTTEEEEEEC-S---STTCEEEEEECCSSS------SCEEEEEEEE
T ss_pred CCccCCCC---------HHHHHHHHhccCCCCCeEEEEec-C---CCCCEEEEEEECCCC------CceEEEEEEe
Confidence 67777664 233444555423 599999988 3 678999999963321 2579999976
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 315 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-49
Identities = 59/182 (32%), Positives = 99/182 (54%), Gaps = 10/182 (5%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+ Q F+ EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEV 55
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L +H+NI+ F+G + IVT++ +G S+ L + + + + A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWM 304
A+GM Y+H IHRDLKS+N+ + D ++KI DFG+A ++ + G +G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 305 AP 306
AP
Sbjct: 174 AP 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-45
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K ++ Q F E +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--------TAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
M Y+ G F+HRDL + N+L+S D K++DFG+ + + +W AP
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-43
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQE 186
DEW + L + G FG+++ G YN VA+K L+ + + F E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-------QGSMSPDAFLAE 58
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWM 304
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ + + +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 305 AP 306
AP
Sbjct: 178 AP 179
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-42
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV 178
T+GL D W I L + QG FG+++ GT+ VAIK L+ +
Sbjct: 3 QTQGL-AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTM 54
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F QE ++ L+H +V+ + ++ IVTEY GS+ FL + + L
Sbjct: 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTP 296
V A +A GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ + +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 297 ETGTYRWMAP 306
+W AP
Sbjct: 174 AKFPIKWTAP 183
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 4e-42
Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENN 172
MD P NYD+W ++ + M G +G++Y G + VA+K L+
Sbjct: 2 MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----- 51
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
+ + ++F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L
Sbjct: 52 --EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQ 290
+ V + + A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 291 TEGMTPETGTYRWMAP 306
+W AP
Sbjct: 170 YTAHAGAKFPIKWTAP 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+W ++ +G +G FG +Y + +A+K+L + + +E Q ++E
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---VEHQLRRE 56
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + + L+H NI+R G ++ EYA G+V + L ++ + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 114
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+A ++Y H IHRD+K +NLL+ + +KIADFG + + T GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-41
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ +G +A K++ + E + Q +E+ +L IV F
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLI-----HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIH 261
GA I E+ GGS+ Q L + +P ++ K ++ V +G+ Y+ +H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSP 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 6e-41
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 10/164 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y N E VAIK + + Q +EV L L+H N +++
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G + +V EY G + L + + +G+AY+H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-40
Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 19/184 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQ 185
++W + ++ L +GA+G++ E VA+KI+ + ++A + ++
Sbjct: 5 EDWDL-VQTL------GEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKK 52
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E+ + L H N+V+F G R+ + + EY GG + + + +P A +
Sbjct: 53 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFH 110
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYR 302
+ G+ Y+HG+G HRD+K +NLL+ ++KI+DFG+A + + + GT
Sbjct: 111 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 303 WMAP 306
++AP
Sbjct: 171 YVAP 174
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-40
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ A K+++ K++ + + E+ +LA+ H NIV+ +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A I+ E+ GG+V + + R + + Y+H IHR
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
DLK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (344), Expect = 3e-38
Identities = 38/184 (20%), Positives = 74/184 (40%), Gaps = 18/184 (9%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQ 184
YD + I L +L GAFG ++R G K + P + + +
Sbjct: 28 YDYYDI-LEEL------GSGAFGVVHRCVEKATGRVFVAKFINTPY------PLDKYTVK 74
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
E+ ++ L H ++ A + ++ E+ GG + + ++ + +
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 133
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H +H D+K +N++ K+ +KI DFG+A E + T T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193
Query: 303 WMAP 306
+ AP
Sbjct: 194 FAAP 197
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-38
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ I+TEY G + +L ++R + ++ DV
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 306
M Y+ F+HRDL + N L++ +K++DFG++R + + RW P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-38
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 145 QGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG + +G Y DVAIK+L + ++ +E ++ L + IVR
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
IG C+ +V E A GG + +FL + +P+ + V+ GM Y+ F+
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
HRDL + N+L+ KI+DFG+++ + + +W AP
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 116 DHRY--PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKIL 166
++ Y PT+ L +W +L+ G GAFGK+ T VA+K+L
Sbjct: 3 NYVYIDPTQ-LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
P + E+ +L+ L H+NIV +GAC ++TEY G +
Sbjct: 62 -----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 226 FLTRRQNR----------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
FL R+++ A+ L+ + + VA+GMA++ IHRDL + N+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 270 LISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
L++ + KI DFG+AR + +WMAP
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (339), Expect = 1e-37
Identities = 39/166 (23%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + P + ++ ++E+ ++ L+H +V
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLH 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A ++ E+ GG + + + N+ + AV+ V +G+ ++H ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 263 DLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N++ + +S +K+ DFG+ + + TGT + AP
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQ 181
+ T++ ++L G FG + +G Y + VA+KIL+ N+P ++
Sbjct: 4 DRKLLTLEDKEL------GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKD 53
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+ E ++ L + IVR IG C W +V E A+ G + ++L + NR V K +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNII 110
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPE 297
+ V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ E + T
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 298 TGTYRWMAP 306
+W AP
Sbjct: 171 KWPVKWYAP 179
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-37
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++RG + GE+VA+KI + + E+ L+H NI+ FI A
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 205 CRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH----- 255
K +V++Y + GS+ +L R V ++ +K AL A G+A++H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 256 ---GLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
HRDLKS N+L+ + + IAD G+A + GT R+MAP
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 126 NYDE-WTIDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQ 177
YD W L G GAFGK+ T VA+K+L +
Sbjct: 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADS 81
Query: 178 VMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR--- 233
+ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 234 ------------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
+ + + A VA+GM ++ +HRDL + N+L++ K
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201
Query: 276 SIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
+KI DFG+AR + +WMAP
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-37
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID +L G FG ++ G + N + VAIK + + + E+ F +E ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-------EGAMSEEDFIEEAEVM 54
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ C+V E+ + G + + R Q + + LDV G
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 306
MAY+ IHRDL + N L+ ++ IK++DFG+ R + Q T +W +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-37
Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ D R L +G+F +Y+G +VA L+ + + Q+F++E
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAE 60
Query: 189 MLATLKHLNIVRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
ML L+H NIVRF + + + +VTE G+++ +L ++ + + +K+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 118
Query: 245 LDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTEGMTPETGTY 301
+ +G+ ++H IHRDLK DN+ I+ S+KI D G+A + + GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTP 177
Query: 302 RWMAP 306
+MAP
Sbjct: 178 EFMAP 182
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 131 bits (330), Expect = 5e-37
Identities = 39/168 (23%), Positives = 76/168 (45%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
++ + +V + K G + +L + + K K + + +H L
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-37
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQM-NLQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + + + ++H IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG I + + GT WMAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-36
Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ + +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 69
Query: 203 GAC--RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--- 255
R IV EY +GG + +T+ ++ + + + ++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 256 --GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+ + +++K+ DFG+AR + T GT +M+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 47/184 (25%), Positives = 89/184 (48%), Gaps = 14/184 (7%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQF 183
++ I ++ +G +G FG +++G Y VAIK + + + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-----CTSDSVREKF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QE + + H +IV+ IG + VW I+ E G +R FL R+ + L +
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILY 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTY 301
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 302 RWMA 305
+WMA
Sbjct: 174 KWMA 177
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 3e-35
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 18/198 (9%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
P E + + + ID+ + + G FG++ G VAIK L
Sbjct: 12 PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSG 65
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
+ + F E ++ H N++ G K I+TE+ + GS+ F R+ +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQ 124
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------E 288
+ V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 289 VQTEGMTPETGTYRWMAP 306
RW AP
Sbjct: 185 PTYTSALGGKIPIRWTAP 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-34
Identities = 33/186 (17%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQ 182
E Y+++ I L +G FG ++R T + + K ++ + +
Sbjct: 2 ELYEKYMI-AEDL------GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVL 47
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++E+ +L +H NI+ + ++ E+ G + + + + + V
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGT 300
V + ++H H D++ +N++ +S IKI +FG AR +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 301 YRWMAP 306
+ AP
Sbjct: 167 PEYYAP 172
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 7e-34
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
+D + +G FG++ + + D AIK + ++ + F E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGEL 61
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------N 232
+L L H NI+ +GAC R + EYA G++ FL + +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+ + + A DVARGM Y+ FIHRDL + N+L+ + KIADFG++R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 293 GMTPETGTYRWMAP 306
T RWMA
Sbjct: 182 KKTMGRLPVRWMAI 195
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQE 186
I + L + G+FG + RG ++ VA+K L+ + +A F +E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DDFIRE 61
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + +L H N++R G + +VTE A GS+ L + Q L + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQ 119
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYR 302
VA GM Y+ FIHRDL + NLL++ +KI DFG+ R Q + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 303 WMAP 306
W AP
Sbjct: 180 WCAP 183
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 1e-33
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF ++ + VAIK + + + E + E+ +L +KH NIV
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
++ + GG + + + + A + V + Y+H LG +HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 263 DLKSDNLLIS---ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +NLL D I I+DFG++++E ++ GT ++AP
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G VAIK + N +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
+F E ++ ++VR +G + ++ E G ++ +L +
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 234 -AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EV 289
L ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 290 QTEGMTPETGTYRWMAP 306
RWM+P
Sbjct: 188 YYRKGGKGLLPVRWMSP 204
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (308), Expect = 1e-33
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 37/212 (17%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVM 179
+ +GAFG++++ VA+K+L E + M
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADM 59
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV---- 235
+ FQ+E ++A + NIV+ +G C C++ EY G + +FL V
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 236 ------------------PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ A VA GMAY+ F+HRDL + N L+ + +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 278 KIADFGVARIEVQTEGMTPET---GTYRWMAP 306
KIADFG++R + + RWM P
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (309), Expect = 4e-33
Identities = 33/163 (20%), Positives = 70/163 (42%), Gaps = 5/163 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y G+ A+K L++ ++ + + + + +++T IV
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + + GG + L Q+ A ++ G+ ++H ++R
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
DLK N+L+ ++I+D G+A + + GT+ +MA
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMA 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-33
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F + + AIKILE+ E +E +++ L H V+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLY 74
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ YAK G + +++ + + ++ + Y+HG G IHR
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L++ D I+I DFG A++ GT ++++P
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-33
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK++ + + AIK L++ + +E ++ ++ +H +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + + + L A A ++ G+ ++H G ++R
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK DN+L+ D IKIADFG+ + + GT ++AP
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G FG++Y+G VAIK L + F E ++ H NI
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHHNI 71
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+R G K I+TEY + G++ +F R ++ + V +A GM Y+ +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
++HRDL + N+L++++ K++DFG++R+ T + RW AP
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-32
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ VA+K+L+ + E
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 60
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ +++ HLN+V +GAC + ++ E+ K G++ +L ++N VP
Sbjct: 61 -RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 238 KL--------------AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
K+ + + VA+GM ++ IHRDL + N+L+S +KI DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 284 VARIEVQTEGMTPET---GTYRWMAP 306
+AR + + +WMAP
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAP 205
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-32
Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 258 GFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL ++ + +K+ DFG A+ +T T ++AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-32
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E GG + FL +++ + + A + + G+ Y+H L H
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 263 DLKSDNLLISAD----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-31
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 7/167 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + ++ E + + + +LA V + + H G +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 261 HRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +N+LI ++ +K+ DFG + ++ T GT + P
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPP 178
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 3e-31
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 130 WTID----LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
+++ LR L G+FG+++ +NG A+K+L++ K +
Sbjct: 1 YSLQDFQILRTL------GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHT 51
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E +ML+ + H I+R G + ++ +Y +GG + L + Q P +A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFY 109
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A +V + Y+H I+RDLK +N+L+ + IKI DFG A+ + GT +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDY 167
Query: 304 MAP 306
+AP
Sbjct: 168 IAP 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-31
Identities = 38/165 (23%), Positives = 75/165 (45%), Gaps = 6/165 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V ++ + + + + + + L +G+ Y+H +HR
Sbjct: 67 DAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +NLL+ + +K+ADFG+A+ T + T + AP
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G + N VAIK + +P + Q Q+ +E+ +L +H NI+
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R ++M + + G + + L + + + + RG+ Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
+HRDLK NLL++ +KI DFG+AR+ T +T T + AP
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 7e-31
Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 122 EGLENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
E ++ I ++ +G FG +Y GT A+K L N
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRI 66
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
QF E +++ H N++ +G C R +V Y K G +R F+ +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR E
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 294 MTPET-----GTYRWMAP 306
+ +WMA
Sbjct: 186 DSVHNKTGAKLPVKWMAL 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 8e-31
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
GAFG +Y+G + E VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHV 73
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R +G C V I + G + ++ ++ + + + + +A+GM Y+
Sbjct: 74 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
+HRDL + N+L+ + +KI DFG+A++ E + +WMA
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
W + +L +G +GAFG++ G D VA+K+L + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEK 60
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------ 231
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 232 --------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 284 VARIEVQTEGMT---PETGTYRWMAP 306
+AR + +WMAP
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAP 206
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 9e-30
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQ 182
+E Y L K+ +G +G +Y+ N GE A+K + + + +
Sbjct: 1 MEKYHG----LEKI------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPST 46
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E+ +L LKH NIV+ + +V E+ + + A
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS 104
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
L + G+AY H +HRDLK NLLI+ + +KIADFG+AR
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 303 WMAP 306
W
Sbjct: 165 WYRA 168
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-29
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQ 181
+EN+ + + K+ +G +G +Y+ GE VA+K + +
Sbjct: 1 MENFQK----VEKI------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPS 46
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+E+ +L L H NIV+ + +V E+ +++F+ +PL L
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT 300
+ +G+A+ H +HRDLK NLLI+ + +IK+ADFG+AR V T E T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 301 YRWMAP 306
+ AP
Sbjct: 166 LWYRAP 171
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (278), Expect = 2e-29
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G +++ DVA+K+L + + +F++E A L H IV
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+ IV EY G ++R + + K A++ D + + + H G
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K N++ISA ++K+ DFG+AR + +T GT ++++P
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 8/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + +++ + +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V E+ + N + ++ + +G+ + H +HR
Sbjct: 68 DVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPS 307
DLK NLLI+ + +K+A+FG+AR W P
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 145 QGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 202 IGAC-----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK N+L+++ IK+ADFG+ARI +T T + AP
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-28
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 8/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK+ G A+KIL R E K +V E +L +H +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEV--AHTVTESRVLQNTRHPFLTALK 71
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C V EYA GG + L+R + + A ++ + Y+H ++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D+K +NL++ D IKI DFG+ + + GT ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-27
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ +GE VAIK + + + + +E+ ++ L H NIVR
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 203 GAC------RKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVH 255
+ + +V +Y R R + +P+ + R +AY+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 256 GLGFIHRDLKSDNLLISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G HRD+K NLL+ D + +K+ DFG A+ V+ E + + AP
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 1e-26
Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 108 DALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKI 165
A L P++ D++ ++ L G+FG++ + +G A+KI
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDR-IKTL------GTGSFGRVMLVKHKESGNHYAMKI 73
Query: 166 LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
L++ + K + E +L + +V+ + + +V EY GG +
Sbjct: 74 LDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
L R A A + Y+H L I+RDLK +NLLI I++ DFG A
Sbjct: 131 HLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 286 RIEVQTEGMTPETGTYRWMAP 306
+ GT +AP
Sbjct: 189 K--RVKGRTWTLCGTPEALAP 207
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (260), Expect = 2e-26
Identities = 30/190 (15%), Positives = 78/190 (41%), Gaps = 23/190 (12%)
Query: 126 NYDEWTIDLRKLN---MGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVME 180
+Y+ ++ + + +G + +++ N E V +KIL+ V +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------VKK 73
Query: 181 QQFQQEVMMLATLK-HLNIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
++ ++E+ +L L+ NI+ + + +V E+ +Q + +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTP 296
++ + + Y H +G +HRD+K N++I + + +++ D+G+A +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 297 ETGTYRWMAP 306
+ + P
Sbjct: 189 RVASRYFKGP 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA G + +VAIK L RP N ++ +E++++ + H NI+ +
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLL 82
Query: 203 GACRKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V E + + + G+ ++H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-26
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ + G+ VA+K + EN E +E+ +L LKH N+V I
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEG---FPITALREIKILQLLKHENVVNLI 75
Query: 203 GACRKRMV--------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
CR + +V ++ + L + + G+ Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYYI 133
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T + P
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 5e-26
Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 24/176 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y GT GE+VAIK+ + Q E + ++ + I
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLE--------CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 203 GAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
C + +V E + L +R LK + A + + Y+H FIH
Sbjct: 69 RWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVARIEVQTEG--------MTPETGTYRWMAP 306
RD+K DN L+ K + I DFG+A+ TGT R+ +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 9e-25
Identities = 43/191 (22%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQ 177
G+EN++ L+ L GA+GK++ G+ A+K+L + +KA+
Sbjct: 22 GIENFEL----LKVL------GTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAK 70
Query: 178 VMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
E + E +L ++ +V A + ++ +Y GG + L++R+
Sbjct: 71 TTEH-TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FT 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGM 294
++ + ++H LG I+RD+K +N+L+ ++ + + DFG+++ + +TE
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 295 TPETGTYRWMA 305
GT +MA
Sbjct: 188 YDFCGTIEYMA 198
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 9e-25
Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 18/170 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + G VAIK L RP + ++ +E+ +L ++H N++ +
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLL 83
Query: 203 GACRKR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + G + + + ++ + + +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK NL ++ D +KI DFG+AR MT T + AP
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAP 187
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 98.0 bits (243), Expect = 3e-24
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRF 201
+G+FG ++ GT N + VAIK R + P Q + E L I
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--------QLRDEYRTYKLLAGCTGIPNV 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G + L R +K A + + +H ++
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 262 RDLKSDNLLISA-----DKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
RD+K DN LI I + DFG+ + + +GT R+M+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 2e-22
Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 14/178 (7%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++ +
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 83
Query: 203 GACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G + + ++ ++ + Q + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---ILRGLKYIHSA 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSICCGE 315
IHRDLK NL ++ D +KI DFG+AR T YR + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 8e-18
Identities = 21/143 (14%), Positives = 52/143 (36%), Gaps = 3/143 (2%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G ++ + +K + + +K + +LA N R +
Sbjct: 10 EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ V + + + + + ++ V ++ + + +A + G +H D
Sbjct: 70 KLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGD 128
Query: 264 LKSDNLLISADKSIKIADFGVAR 286
L N+L+S ++ I I DF +
Sbjct: 129 LSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.8 bits (190), Expect = 9e-17
Identities = 33/185 (17%), Positives = 69/185 (37%), Gaps = 32/185 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F ++ N VA+KI+ +V + + E+ +L + + +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 203 GACRKRMV--------------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ ++ G ++ + + ++R +PL + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 249 RGMAYVH-GLGFIHRDLKSDNLLISADK------SIKIADFGVARIEVQTEGMTPETGTY 301
G+ Y+H G IH D+K +N+L+ IKIAD G A + + T
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTR 193
Query: 302 RWMAP 306
+ +P
Sbjct: 194 EYRSP 198
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.52 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 95.44 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 95.4 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 95.17 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 95.03 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 94.67 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 94.45 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 94.36 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 94.33 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 94.19 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 93.46 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 93.23 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 92.64 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 92.54 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 92.14 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 92.13 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 91.81 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 90.28 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 89.57 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 89.37 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 88.88 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 88.59 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 88.57 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 87.98 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 87.08 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 86.46 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 86.26 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 83.46 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 81.58 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 80.52 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-43 Score=313.32 Aligned_cols=178 Identities=26% Similarity=0.553 Sum_probs=159.2
Q ss_pred CCccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
.+++|+|+.++|++.+.||+|+||.||+|++ +++.||||+++..... .++|.+|+.+|++++|||||++++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-------HHHHHHHHHHHHhCCCCCEecCCc
Confidence 6789999999999999999999999999998 5889999998764433 246889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
+|.+.+.+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999999987767789999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCC--ccCCCCCccccccCccc
Q 021253 284 VARIEVQTEG--MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~~--~~~~~gt~~y~APE~~~ 310 (315)
+|+....... .....||+.|+|||++.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~ 189 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLA 189 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred ceeecCCCCceeeccccccccccChHHHc
Confidence 9986543322 22335789999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=308.12 Aligned_cols=177 Identities=33% Similarity=0.626 Sum_probs=150.8
Q ss_pred ccccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|+|+|+.++|++++.||+|+||.||+|++++ .||||+++........ .+.|.+|+.++++++|||||++++++.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 6899999999999999999999999998765 5999999765544432 3678999999999999999999998765
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 208 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
+ .++|||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus 76 ~-~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 P-QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp S-SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred c-EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 4 579999999999999999754 34689999999999999999999999999999999999999999999999999986
Q ss_pred eecCC---CccCCCCCccccccCcccc
Q 021253 288 EVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
..... ......||+.|||||++..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp ------------CCCCGGGCCHHHHTT
T ss_pred ccccCCcccccccccCcccCCHHHHhc
Confidence 54322 2345689999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=303.62 Aligned_cols=178 Identities=31% Similarity=0.539 Sum_probs=155.4
Q ss_pred CCccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..++|+|+.++|++++.||+|+||.||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH-------HHHHHHHHHHHhCCCCCEeEEEee
Confidence 3578999999999999999999999999999 56789999997644332 468999999999999999999998
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.++ .+|+||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 8654 568999999999999988765555689999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCccccccCcccc
Q 021253 285 ARIEVQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
|+...... ......||+.|||||++..
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHH
T ss_pred eEEccCCccccccccCCcccccChHHHhC
Confidence 99764432 2344578999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=301.83 Aligned_cols=170 Identities=26% Similarity=0.462 Sum_probs=147.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++++.||+|+||+||+|++ +++.||||+++...... ..+.+.+|+.++++++|||||++++++.+.+.+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 5788999999999999999998 68899999997643221 1356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
|||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999999864 346999999999999999999999999999999999999999999999999999875432
Q ss_pred --CCccCCCCCccccccCcccc
Q 021253 292 --EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~ 311 (315)
......+||+.|||||++..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHC
T ss_pred ccccccceeeCcCccCHhHhcC
Confidence 22455689999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=297.64 Aligned_cols=175 Identities=26% Similarity=0.440 Sum_probs=152.5
Q ss_pred cccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
+|.+ ++|++++.||+|+||+||+|++ +++.||+|++.+..... ....+.+.+|+.++++++|||||++++++.
T Consensus 2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---hHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 4654 6899999999999999999998 67899999986422111 112457889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
+++.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 999999999999999999999865 358999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCccccccCcccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..... .....+||+.|||||++.+
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHHTT
T ss_pred ecCCC-cccccCCCCcccCHHHHcC
Confidence 65443 3455689999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=296.97 Aligned_cols=168 Identities=26% Similarity=0.430 Sum_probs=149.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||+||+|++ +++.||||+++...... .+.+.+|+.++++++|||||++++++.+.+.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 5788999999999999999987 68999999997644332 257889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
|||||+++|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999999988653 48999999999999999999999999999999999999999999999999998754332
Q ss_pred -CccCCCCCccccccCcccc
Q 021253 293 -GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~ 311 (315)
.....+||+.|+|||++..
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTR 190 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSS
T ss_pred ccccccccCCCccChhhhcC
Confidence 3455689999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=293.28 Aligned_cols=172 Identities=28% Similarity=0.508 Sum_probs=142.4
Q ss_pred ccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
|+.++|++++.||+|+||.||+|.+ +++.||||+++...... ++|.+|+.++++++||||++++++|...+.
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 5678899999999999999999998 67789999997644332 468999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 99999999999999998764 35688999999999999999999999999999999999999999999999999986544
Q ss_pred CCC--ccCCCCCccccccCcccc
Q 021253 291 TEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~--~~~~~gt~~y~APE~~~~ 311 (315)
... .....||+.|+|||++..
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp -----------CTTSCCHHHHTT
T ss_pred CCceeecceecCcccCChHHhcC
Confidence 322 233568999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-41 Score=302.68 Aligned_cols=172 Identities=24% Similarity=0.352 Sum_probs=150.4
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
+..++|++.+.||+|+||.||+|++ +++.||+|+++....... .+++.+|+.+|+.++|||||++++++.+..
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4567899999999999999999998 689999999976533221 357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999999865 358999999999999999999997 59999999999999999999999999999865
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... .....+||+.|+|||++.+
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHC
T ss_pred CCC-ccccccCCccccCchHHcC
Confidence 443 3455789999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=296.10 Aligned_cols=177 Identities=33% Similarity=0.571 Sum_probs=150.2
Q ss_pred CCccccccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
..++|+|+.++|++++.||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEE
Confidence 5789999999999999999999999999998 55689999997554332 468999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.++ ..++||||+++|+|..++.......+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+
T Consensus 81 ~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 8654 468999999999999998866556699999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCccccccCccc
Q 021253 285 ARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
|+...... ......||+.|+|||++.
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 187 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAAL 187 (285)
T ss_dssp TC--------------CCGGGSCHHHHH
T ss_pred hhhccCCCceeeccccccccccChHHHh
Confidence 98654332 233457899999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=294.50 Aligned_cols=169 Identities=28% Similarity=0.427 Sum_probs=148.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++++.||+|+||.||+|++ +++.||||+++...... .+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 4578899999999999999998 67899999997643322 246889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999999998764 3469999999999999999999999999999999999999999999999999998644321
Q ss_pred -CccCCCCCccccccCccc
Q 021253 293 -GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~ 310 (315)
.....+||+.|+|||++.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHT
T ss_pred ccccccccccccCCHHHHh
Confidence 234578999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-40 Score=294.95 Aligned_cols=169 Identities=27% Similarity=0.417 Sum_probs=148.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|+..+.||+|+||.||+|++ +++.||||+++........ ..+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 4588899999999999999997 6889999999875544332 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999987776543 4689999999999999999999999999999999999999999999999999986433
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
....+||+.|||||++.+
T Consensus 168 -~~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILA 185 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTT
T ss_pred -CCccccCccccCHHHHhc
Confidence 345689999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=299.64 Aligned_cols=175 Identities=25% Similarity=0.361 Sum_probs=153.2
Q ss_pred ccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (315)
|.+++|++++.||+|+||.||+|+. +++.||||++++..... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 5678999999999999999999997 78999999997432111 112357889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeee
Q 021253 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (315)
Q Consensus 210 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~ 289 (315)
.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999999999875 358999999999999999999999999999999999999999999999999998643
Q ss_pred c-CCCccCCCCCccccccCcccc
Q 021253 290 Q-TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~-~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .......+||+.|+|||++..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSS
T ss_pred cCCcccccceeCHHHhhhhhccC
Confidence 3 334456789999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=287.67 Aligned_cols=171 Identities=29% Similarity=0.478 Sum_probs=146.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----C
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 208 (315)
+.|++.+.||+|+||+||+|++ +++.||+|.+......... .+.+.+|+++|++++|||||++++++.. .
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 4456778899999999999998 5779999999765544322 3578999999999999999999999865 3
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCEEEc-CCCcEEEeeecce
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVA 285 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NIli~-~~~~vkl~DFG~a 285 (315)
..+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 5689999999999999999865 45899999999999999999999998 99999999999996 5789999999999
Q ss_pred eeeecCCCccCCCCCccccccCccccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
+..... .....+||+.|||||++...
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGGTC
T ss_pred eeccCC-ccCCcccCccccCHHHhCCC
Confidence 864433 34556899999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=294.97 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=147.8
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC---HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 36799999999999999999998 68899999996422111 11235789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999999998865 45999999999999999999999999999999999999999999999999999875432
Q ss_pred C---CccCCCCCccccccCcccc
Q 021253 292 E---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~---~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+||+.|+|||++..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp --------CCCCGGGCCHHHHHT
T ss_pred CcccccccccCCccccCceeecc
Confidence 2 2345689999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=295.41 Aligned_cols=170 Identities=25% Similarity=0.391 Sum_probs=132.8
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++.+.||+|+||+||+|++ +++.||||++........ .+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4589999999999999999998 688999999976543322 246889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc---CCCcEEEeeecceeeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~---~~~~vkl~DFG~a~~~~ 289 (315)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+. .++.+||+|||+|+...
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999999753 5699999999999999999999999999999999999995 57899999999998766
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|||||++..
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp -----------CTTSCHHHHTT
T ss_pred CCCeeeeeeeCccccCcHHHcC
Confidence 5555566789999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-40 Score=292.35 Aligned_cols=175 Identities=22% Similarity=0.374 Sum_probs=153.6
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
+.|++++.||+|+||+||+|++ +++.||||++++............+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4689999999999999999998 68899999997654433222222467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~----~vkl~DFG~a~~~ 288 (315)
|||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999875 3599999999999999999999999999999999999998776 5999999999877
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
..........||+.|+|||++..
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTT
T ss_pred CCCccccccCCCCcccCHHHHcC
Confidence 65555666789999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=291.93 Aligned_cols=173 Identities=24% Similarity=0.384 Sum_probs=139.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 210 (315)
++|++.+.||+|+||+||+|++ +++.||||+++........ .+.+.+|+.++++++|||||++++++.+ ...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 6788999999999999999988 6889999999876554332 3678899999999999999999999865 456
Q ss_pred EEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCCEEEcCCCcEEEeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
+||||||+++|+|.+++.+. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 89999999999999998753 3456999999999999999999999876 9999999999999999999999999
Q ss_pred ceeeeecCC-CccCCCCCccccccCcccc
Q 021253 284 VARIEVQTE-GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~-~~~~~~gt~~y~APE~~~~ 311 (315)
+|+...... .....+||+.|||||++..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTT
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcC
Confidence 998654432 2345789999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=299.16 Aligned_cols=179 Identities=28% Similarity=0.490 Sum_probs=150.6
Q ss_pred ccccccccccccccceeecccCceEEEEEC--C-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~--~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (315)
.+|+|+.++|++++.||+|+||+||+|++. + ..||+|.+........ .+.+.+|+.++.++ +|||||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----REALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-----HHHHHHHHHHHHHhcCCCcEe
Confidence 469999999999999999999999999872 2 3699999865432221 35788999999998 899999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021253 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (315)
Q Consensus 200 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (315)
++++++.+.+.+|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 24788999999999999999999999
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
||||||||+|||++.++.+||+|||+|+....... .....||+.|||||++..
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 99999999999999999999999999986544332 223467999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-40 Score=294.97 Aligned_cols=171 Identities=26% Similarity=0.418 Sum_probs=150.0
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+++|++++.||+|+||+||+|++ +++.||||++++..... ....+.+.+|+.++++++|||||++++++.+...+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 47899999999999999999997 68899999996422111 11236788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
|+||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999999998764 45788899999999999999999999999999999999999999999999999875433
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
....+||+.|||||++.+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTT
T ss_pred --cccccCcccccCHHHHcC
Confidence 455789999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-39 Score=297.01 Aligned_cols=171 Identities=22% Similarity=0.411 Sum_probs=151.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+++|++++.||+|+||.||+|++ +++.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999998 6899999999653321 135788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC--CCcEEEeeecceeeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~--~~~vkl~DFG~a~~~~ 289 (315)
||||||+++|+|.+++.+. ...+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999653 345999999999999999999999999999999999999964 5789999999999766
Q ss_pred cCCCccCCCCCccccccCcccc
Q 021253 290 QTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+||+.|||||++.+
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHT
T ss_pred cccccceecCcccccCHHHHcC
Confidence 5555566789999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=282.74 Aligned_cols=172 Identities=27% Similarity=0.483 Sum_probs=151.1
Q ss_pred ccccccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
++.++|+++++||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++||||++++++|.++..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 3568899999999999999999999 56799999998755442 468899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+++||||+++|+|.+++.... ..+++..+++++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999999999999987543 4588999999999999999999999999999999999999999999999999986543
Q ss_pred CCC--ccCCCCCccccccCcccc
Q 021253 291 TEG--MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~--~~~~~gt~~y~APE~~~~ 311 (315)
... .....||+.|+|||.+..
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHH
T ss_pred CCceeecccCCCCCcCCcHHhcC
Confidence 332 233568999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-39 Score=290.89 Aligned_cols=175 Identities=26% Similarity=0.464 Sum_probs=139.0
Q ss_pred cccccccccccceeecccCceEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+++.++|++.+.||+|+||+||+|++ ++ ..||||.+....... ..+.|.+|+.+|++++|||||++++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 46778899999999999999999987 23 258888876533221 235799999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
...+.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999999999998754 346899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc------cCCCCCccccccCcccc
Q 021253 286 RIEVQTEGM------TPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~------~~~~gt~~y~APE~~~~ 311 (315)
+........ ....||+.|||||.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp --------------------CGGGSCHHHHHS
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhc
Confidence 865433221 12357899999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-39 Score=282.68 Aligned_cols=174 Identities=23% Similarity=0.350 Sum_probs=156.1
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCCh---hHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP---EKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 208 (315)
++|++.+.||+|+||+||+|+. +++.||||++++..... +..+...+++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999998 78999999998765432 333445678999999999997 99999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+.+||||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999865 35899999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCccCCCCCccccccCccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~ 310 (315)
......+..+||+.|+|||.+.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIE 182 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHH
T ss_pred cCCCceeeeeccCCCCCHHHhh
Confidence 6655556678999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=286.23 Aligned_cols=175 Identities=27% Similarity=0.510 Sum_probs=147.8
Q ss_pred cccccccccccccc-eeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLRKLNMGTA-FAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~~~~~~~~-iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
+|.+..+++.+.+. ||+|+||.||+|.+ ++..||||+++...... ..++|.+|+.+|++++|||||++++
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEee
Confidence 46677788888884 99999999999976 34579999997543221 2467899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++..+ .+||||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 77 VCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred eeccC-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 98754 578999999999999998653 3468999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC----CccCCCCCccccccCccc
Q 021253 284 VARIEVQTE----GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~----~~~~~~gt~~y~APE~~~ 310 (315)
+|+...... .....+||+.|+|||++.
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred hhhcccccccccccccccccCccccChHHHh
Confidence 998754322 123456899999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-39 Score=294.39 Aligned_cols=170 Identities=19% Similarity=0.316 Sum_probs=150.4
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|++ +++.||||+++..... ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688999999999999999998 6899999999764321 1357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc--CCCcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~--~~~~vkl~DFG~a~~~~~ 290 (315)
|||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999987653 34699999999999999999999999999999999999998 578999999999998766
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
........||+.|+|||++..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTT
T ss_pred CCceeeccCcccccCHHHHcC
Confidence 555566789999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-39 Score=295.49 Aligned_cols=176 Identities=19% Similarity=0.258 Sum_probs=148.4
Q ss_pred cccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (315)
.+++|++.+.||+|+||.||+|++ +++.||||++.+................+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 357899999999999999999998 688999999864322211111112233455778888899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~ 290 (315)
+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999875 4588999999999999999999999999999999999999999999999999986554
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
. .....+||+.|+|||++..
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHST
T ss_pred C-cccccccccccchhHHhhc
Confidence 3 3455689999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=284.55 Aligned_cols=175 Identities=27% Similarity=0.473 Sum_probs=143.3
Q ss_pred cccccccccccceeecccCceEEEEECC------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 131 ~i~~~~~~~~~~iG~G~~G~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
+|+.++|+..+.||+|+||.||+|.+.+ ..||||+++...... ...+|.+|+.++++++|||||+++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 4667888999999999999999998732 479999996533221 23578999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
+.+...+++||||+.+++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999999988754 35689999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCC----ccCCCCCccccccCcccc
Q 021253 285 ARIEVQTEG----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~ 311 (315)
|+....... .....||+.|||||++..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp -----------------CCCGGGSCHHHHHS
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHcc
Confidence 986543221 223468999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=284.72 Aligned_cols=171 Identities=31% Similarity=0.582 Sum_probs=144.7
Q ss_pred ccccccccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-C
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-R 208 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 208 (315)
|+|+.++|++++.||+|+||.||+|+++++.||||+++.... .+.|.+|+.++++++||||+++++++.+ .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 999999999999999999999999999999999999965322 2568899999999999999999999865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
+.+|+||||+++|+|.+++.+.....+++..+++++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 56899999999999999998765456899999999999999999999999999999999999999999999999999864
Q ss_pred ecCCCccCCCCCccccccCccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~ 310 (315)
... .....+|+.|+|||++.
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~ 173 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALR 173 (262)
T ss_dssp ----------CCTTTSCHHHHH
T ss_pred CCC--CccccccccCCChHHHh
Confidence 432 33457899999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-39 Score=282.34 Aligned_cols=175 Identities=26% Similarity=0.517 Sum_probs=139.7
Q ss_pred cccccccccccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021253 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (315)
Q Consensus 129 ~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (315)
+|+|+.++|++++.||+|+||.||+|++. +..||||.++..... ...+.+.+|+.++++++||||+++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 59999999999999999999999999872 246888887543321 22467999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 204 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
++.+ +.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 76 VITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEec-CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 9964 5679999999999999988754 3568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCC--CccCCCCCccccccCccc
Q 021253 284 VARIEVQTE--GMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 284 ~a~~~~~~~--~~~~~~gt~~y~APE~~~ 310 (315)
+|+...... ......||+.|+|||.+.
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp -----------------CCGGGCCHHHHH
T ss_pred hheeccCCcceeccceecCcccchhhHhc
Confidence 998654332 233456899999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=281.28 Aligned_cols=163 Identities=31% Similarity=0.562 Sum_probs=135.4
Q ss_pred cceeecccCceEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Q 021253 141 TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 216 (315)
++||+|+||.||+|.+ .++.||||+++....... ..++|.+|+.+|++++|||||+++++|..+ .++||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 4799999999999986 236899999975443322 246799999999999999999999999654 5689999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCCC---
Q 021253 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (315)
Q Consensus 217 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~~--- 293 (315)
|+++|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999986543221
Q ss_pred -ccCCCCCccccccCccc
Q 021253 294 -MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 294 -~~~~~gt~~y~APE~~~ 310 (315)
.....||+.|||||.+.
T Consensus 166 ~~~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECIN 183 (277)
T ss_dssp C----CCCGGGCCHHHHH
T ss_pred cccccCCCceecCchhhc
Confidence 23356899999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-38 Score=291.37 Aligned_cols=171 Identities=25% Similarity=0.308 Sum_probs=150.2
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (315)
+++|++++.||+|+||.||+|++ +++.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.....+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 46889999999999999999998 68999999986422111 11235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999999998753 589999999999999999999999999999999999999999999999999987543
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.....+||+.|||||++.+
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILS 212 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTT
T ss_pred -ccccccCccccCCHHHHcC
Confidence 2445789999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=284.32 Aligned_cols=181 Identities=27% Similarity=0.514 Sum_probs=142.7
Q ss_pred CCccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 126 ~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
..++|+|+.++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|..++.++ +|+|
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-----HHHHHHHHHHHHHhhcCCCe
Confidence 4578999999999999999999999999986 23689999986533322 135677888877776 6899
Q ss_pred eeeEEEEEEeC-CEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 021253 198 IVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (315)
Q Consensus 198 iv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (315)
|+.+++++.+. ..+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 99999998765 46899999999999999997542 2347899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 263 DLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 263 Dlkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
||||+|||++.++.+||+|||+|+...... ......||+.|+|||++..
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence 999999999999999999999998654332 2334579999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-38 Score=284.07 Aligned_cols=166 Identities=23% Similarity=0.352 Sum_probs=144.5
Q ss_pred cccccc-cceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEe---
Q 021253 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRK--- 207 (315)
Q Consensus 135 ~~~~~~-~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~--- 207 (315)
++|++. +.||+|+||.||+|++ +++.||||+++.. +.+.+|+.++.+ ++|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 567766 4699999999999997 6889999999641 356789988655 589999999999875
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeec
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG 283 (315)
...+|||||||+||+|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467899999999999999998765667999999999999999999999999999999999999985 5679999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+...........+||+.|||||++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCG
T ss_pred eeeeccCCCccccccCCcccCCcHHHcC
Confidence 9997766656677789999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-38 Score=282.06 Aligned_cols=169 Identities=17% Similarity=0.267 Sum_probs=148.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++++.||+|+||+||+|.+ +++.||||+++.... . ...+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--D-----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--H-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--c-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 5788999999999999999998 688999999975321 1 246789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCC--CcEEEeeecceeeeec
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEVQ 290 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~--~~vkl~DFG~a~~~~~ 290 (315)
|||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999999754 3468999999999999999999999999999999999999854 4899999999987655
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
........+|+.|+|||.+..
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT
T ss_pred CCcccccccccccccchhccC
Confidence 444555679999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-38 Score=280.76 Aligned_cols=179 Identities=27% Similarity=0.461 Sum_probs=152.0
Q ss_pred ccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (315)
..|+++.++|++.+.||+|+||.||+|++. ++.||||+++..... ...++|.+|+.++++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-----HHHHHHHHHHHHHHhcCCCCccc
Confidence 458899999999999999999999999874 368999998653322 12467999999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021253 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (315)
Q Consensus 201 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (315)
+++++......++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999997532 124788899999999999999999999
Q ss_pred CccCCCCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 259 iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
+|||||||+|||++.++.+||+|||+|+...... ......||+.|+|||.+..
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 9999999999999999999999999998643322 2234578899999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-38 Score=281.68 Aligned_cols=181 Identities=27% Similarity=0.460 Sum_probs=154.5
Q ss_pred CCCccccccccccccccceeecccCceEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC
Q 021253 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197 (315)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 197 (315)
...++|+|+.++|++++.||+|+||.||+|++. ++.||||+++...... ....|.+|+.++++++|||
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTT
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCCCC
Confidence 345789999999999999999999999999873 4689999997543221 1357899999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCE
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (315)
|+++++++......++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 85 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164 (308)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred EeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCce
Confidence 9999999999999999999999999999987432 13468889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCccc
Q 021253 270 LISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 270 li~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
|++.++++||+|||+|+....... .....||+.|+|||.+.
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~ 208 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred eecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc
Confidence 999999999999999986543322 23346899999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=279.48 Aligned_cols=172 Identities=24% Similarity=0.350 Sum_probs=146.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~ 211 (315)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..++. .++|||||++++++.+...+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh---HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 5788999999999999999998 789999999964221110 11234556666654 78999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeec-
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~- 290 (315)
||||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 79 yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999999865 3489999999999999999999999999999999999999999999999999986443
Q ss_pred CCCccCCCCCccccccCcccc
Q 021253 291 TEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~ 311 (315)
....+..+||+.|+|||++..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT
T ss_pred cccccccCCCCCcCCHHHHcC
Confidence 233455789999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=278.64 Aligned_cols=180 Identities=31% Similarity=0.514 Sum_probs=155.0
Q ss_pred CccccccccccccccceeecccCceEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021253 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (315)
Q Consensus 127 ~~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (315)
-.+|+|+.++|++++.||+|+||.||+|++ +++.||||+++....... ...+.+|+.+++.+ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 357999999999999999999999999986 346899999976443222 35788999999999 69999
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 021253 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (315)
Q Consensus 199 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (315)
|++++++.+....++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999999999986432 258899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeeecCCC---ccCCCCCccccccCcccc
Q 021253 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 263 Dlkp~NIli~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~APE~~~~ 311 (315)
||||+|||++.++.+||+|||+++....... ....+||+.|+|||.+..
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence 9999999999999999999999986543322 234578999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-37 Score=272.47 Aligned_cols=172 Identities=25% Similarity=0.404 Sum_probs=141.5
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (315)
++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4588899999999999999997 689999999986544332 23467999999999999999999999987653
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 210 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
.+||||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 489999999999999998765 35899999999999999999999999999999999999999999999999998754
Q ss_pred ecCC----CccCCCCCccccccCcccc
Q 021253 289 VQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
.... .....+||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp C----------------TTCCHHHHTT
T ss_pred ccccccccccccccCcccccCHHHHcC
Confidence 3222 2344679999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=276.21 Aligned_cols=179 Identities=32% Similarity=0.542 Sum_probs=148.5
Q ss_pred ccccccccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (315)
.+|+|+.++|++++.||+|+||.||+|+.. +..||||+++....... ..++.+|...+.++ +|||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCCe
Confidence 459999999999999999999999999862 24799999975443221 35788899988888 8999
Q ss_pred eeeEEEEEEeCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 021253 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (315)
Q Consensus 198 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (315)
||+++++|.++..+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 9999999999999999999999999999997553 24589999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeeecCC---CccCCCCCccccccCcccc
Q 021253 264 LKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 264 lkp~NIli~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~APE~~~~ 311 (315)
|||+|||++.++.+||+|||+++...... ......||+.|+|||.+..
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 211 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence 99999999999999999999998654432 2334578999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=277.81 Aligned_cols=174 Identities=31% Similarity=0.525 Sum_probs=146.7
Q ss_pred ccccccccccceeecccCceEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (315)
|+.++|++.+.||+|+||.||+|++ ++. .||||.++....... .+.|.+|+.+|+++ +|||||++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 6778999999999999999999987 444 577888764332221 35789999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEc
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~ 272 (315)
+.+.+++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999999753 235689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeecceeeeecCCCccCCCCCccccccCccc
Q 021253 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGS 310 (315)
Q Consensus 273 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~ 310 (315)
.++.+||+|||+|+............||+.|+|||.+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~ 199 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhc
Confidence 99999999999998765544445567999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=275.28 Aligned_cols=172 Identities=27% Similarity=0.426 Sum_probs=145.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++.+.||+|+||.||+|.+ +++.||||+++...... ...+++.+|+.++++++|||||++++++.+...+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 5788999999999999999998 68899999996543221 12357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC-
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~- 291 (315)
+||||+.+ .+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999965 6666666555667999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCccccccCcccc
Q 021253 292 EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~ 311 (315)
.......||+.|+|||.+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTT
T ss_pred ccceeecccceeeehhhhcc
Confidence 23445689999999997653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=275.19 Aligned_cols=174 Identities=24% Similarity=0.354 Sum_probs=145.9
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMV 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 210 (315)
++|++++.||+|+||.||+|++ +++.||||++++.............++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688999999999999999998 68899999997543322110000124668999999996 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-CCcEEEeeecceeee
Q 021253 211 WCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIE 288 (315)
Q Consensus 211 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-~~~vkl~DFG~a~~~ 288 (315)
+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 5788888765 45899999999999999999999999999999999999985 479999999999865
Q ss_pred ecCCCccCCCCCccccccCcccc
Q 021253 289 VQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
... ..+..+||+.|+|||++..
T Consensus 162 ~~~-~~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHH
T ss_pred ccc-cccccccCCCcCCHHHHcC
Confidence 433 4566789999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-37 Score=270.10 Aligned_cols=174 Identities=31% Similarity=0.482 Sum_probs=136.5
Q ss_pred ccccccccccceeecccCceEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (315)
|+.++|++.+.||+|+||.||+|++. + ..||||++++....... ..+.|.+|+.++++++||||+++++++.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH---HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHH---HHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 66789999999999999999999862 2 37899998765443322 2467999999999999999999999997
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 207 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
++ ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 82 TP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ec-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 64 5689999999999999887653 458999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCC----ccCCCCCccccccCccc
Q 021253 287 IEVQTEG----MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~APE~~~ 310 (315)
....... .....|++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 187 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLK 187 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred hcccCCCcceecCccccCcccCCHHHHh
Confidence 7543322 23345789999999775
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=271.62 Aligned_cols=167 Identities=33% Similarity=0.509 Sum_probs=138.4
Q ss_pred cccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----E
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 210 (315)
++|.+.+.||+|+||.||+|+++++.||||+++... .. ......|+..++.++||||+++++++.+.. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 567788999999999999999999999999985321 11 112334556667889999999999997653 6
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 211 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--------~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
+|+||||+++|+|.+++++. .+++..++.++.|++.||+|||+ .+|+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999763 48999999999999999999996 58999999999999999999999999
Q ss_pred cceeeeecCC-----CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE-----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~-----~~~~~~gt~~y~APE~~~~ 311 (315)
|+++...... ......||+.|+|||++..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccc
Confidence 9998764432 2234679999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=273.76 Aligned_cols=169 Identities=24% Similarity=0.475 Sum_probs=138.5
Q ss_pred cccccccceeecccCceEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (315)
.+|++++.||+|+||.||+|.+ +++ +||+|.++...... ..++|.+|+.++++++|||||+++++|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----THHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 5789999999999999999987 333 68999886533221 135789999999999999999999999876
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
. .++++|++.+++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 5 57889999999999988764 456899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC---ccCCCCCccccccCccc
Q 021253 289 VQTEG---MTPETGTYRWMAPSAGS 310 (315)
Q Consensus 289 ~~~~~---~~~~~gt~~y~APE~~~ 310 (315)
..... .....||+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~ 186 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESIL 186 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHH
T ss_pred ccccccccccccccCccccChHHHh
Confidence 43222 22346899999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=275.98 Aligned_cols=169 Identities=22% Similarity=0.298 Sum_probs=137.7
Q ss_pred ccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Q 021253 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 140 ~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 217 (315)
++.||+|+||+||+|++ +++.||||+++....... .....+.+.+|+.++++++|||||++++++...+.+|+||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 47899999999999987 688999999976443221 112235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-CccC
Q 021253 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTP 296 (315)
Q Consensus 218 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~-~~~~ 296 (315)
+.++.+..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 98876665543 24568889999999999999999999999999999999999999999999999998644332 3345
Q ss_pred CCCCccccccCcccc
Q 021253 297 ETGTYRWMAPSAGSI 311 (315)
Q Consensus 297 ~~gt~~y~APE~~~~ 311 (315)
.+||+.|+|||++..
T Consensus 160 ~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFG 174 (299)
T ss_dssp SCCCCTTCCHHHHTT
T ss_pred eecChhhccHHHHcc
Confidence 679999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-35 Score=267.02 Aligned_cols=165 Identities=17% Similarity=0.346 Sum_probs=143.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR-- 208 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-- 208 (315)
.++|++++.||+|+||+||+|++ +++.||||+++... .+++.+|+.+|+.++ ||||+++++++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 46799999999999999999998 68999999996532 246789999999995 99999999999754
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecceee
Q 021253 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (315)
Q Consensus 209 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a~~ 287 (315)
..+++||||+.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 5689999999999987653 3489999999999999999999999999999999999998655 699999999997
Q ss_pred eecCCCccCCCCCccccccCccccc
Q 021253 288 EVQTEGMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~ 312 (315)
..........++|+.|+|||.+...
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred ccCCCcccccccCccccCcccccCC
Confidence 7665556677899999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-36 Score=265.00 Aligned_cols=171 Identities=27% Similarity=0.346 Sum_probs=142.8
Q ss_pred cccccccceeecccCceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 213 (315)
++|++.+.||+|+||.||+|++ +++.||||+++....... ..+++.+|+.+|++++||||+++++++...+..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 5788999999999999999998 678999999976533221 13578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC-
Q 021253 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (315)
Q Consensus 214 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~- 292 (315)
++|++.++.+..+... ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|.......
T Consensus 78 ~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999987666555543 3569999999999999999999999999999999999999999999999999997644322
Q ss_pred CccCCCCCccccccCcccc
Q 021253 293 GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~ 311 (315)
......|++.|+|||.+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMG 174 (286)
T ss_dssp ------CCCTTCCHHHHTT
T ss_pred ccceecccchhhhHHHHhC
Confidence 2344568999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=268.73 Aligned_cols=173 Identities=25% Similarity=0.394 Sum_probs=142.9
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
..|++ .++|++++.||+|+||.||+|++ +++.||||+++....... ..+.+.+|+.+|+.++|||||+++++|
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 34666 46899999999999999999998 689999999976544332 246788999999999999999999999
Q ss_pred EeCC------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEE
Q 021253 206 RKRM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (315)
Q Consensus 206 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl 279 (315)
...+ .+|+||||+ +.+|..+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 7654 579999999 5678777754 35999999999999999999999999999999999999999999999
Q ss_pred eeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 280 ADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 280 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+|||+|+.... ..+...||+.|+|||.+..
T Consensus 163 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 163 LDFGLARQADS--EMTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CCCTTCEECCS--SCCSSCSCGGGCCTHHHHT
T ss_pred ccccceeccCC--ccccccccccccCHHHHcC
Confidence 99999986533 3566789999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-35 Score=266.19 Aligned_cols=172 Identities=24% Similarity=0.336 Sum_probs=140.0
Q ss_pred ccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021253 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (315)
Q Consensus 130 ~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (315)
|+|. .+|++++.||+|+||.||+|+. +++.||||+++..... ...+++.+|+.+|++++||||+++++++..
T Consensus 4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 3443 3589999999999999999987 6899999999753321 224678899999999999999999999976
Q ss_pred CC-----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeee
Q 021253 208 RM-----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (315)
Q Consensus 208 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DF 282 (315)
.. .+|+ ++++.+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~l-~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 78 PTIEQMKDVYL-VTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp SSTTTCCCEEE-EEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ccccccceEEE-EEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEccc
Confidence 43 3445 4566689999999753 4899999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCC----CccCCCCCccccccCcccc
Q 021253 283 GVARIEVQTE----GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 283 G~a~~~~~~~----~~~~~~gt~~y~APE~~~~ 311 (315)
|+|+...... .....+||+.|+|||++..
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred CceeeccCCCccceeeccccccceechHHHhhc
Confidence 9998653322 2344679999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-35 Score=266.77 Aligned_cols=166 Identities=27% Similarity=0.381 Sum_probs=139.6
Q ss_pred ccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021253 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (315)
+|+..++||+|+||+||+|++ +++.||||+++..... +.+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 678889999999999999998 6889999999764432 33799999999999999999998543
Q ss_pred -CEEEEEEeccCCCCHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCC-cEEEeeecce
Q 021253 209 -MVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVA 285 (315)
Q Consensus 209 -~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~-~vkl~DFG~a 285 (315)
..+||||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 35799999997654333332 23455799999999999999999999999999999999999999775 8999999999
Q ss_pred eeeecCCCccCCCCCccccccCcccc
Q 021253 286 RIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+...........+||+.|+|||.+..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFG 196 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTT
T ss_pred hhccCCcccccccccccccChHHhhc
Confidence 97766655667789999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=263.67 Aligned_cols=172 Identities=26% Similarity=0.405 Sum_probs=140.5
Q ss_pred cccccccceeecccCceEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe-
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~- 207 (315)
++|++++.||+|+||.||+|++ +++.||||+++......... ..+.+|+.+++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 6899999999999999999997 35679999987543322111 2345677666655 89999999999853
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...++++|||++++.+... .......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 3478999999987655444 34445678999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCCCccCCCCCccccccCcccc
Q 021253 284 VARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
+++............||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcC
Confidence 9987665555677889999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-35 Score=260.90 Aligned_cols=168 Identities=28% Similarity=0.460 Sum_probs=139.6
Q ss_pred ccccceeecccCceEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEE
Q 021253 138 NMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVW 211 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 211 (315)
++.++||+|+||+||+|++. ...||||.++.... .. ..++|.+|+.+|++++||||+++++++.. +...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IG----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HH----HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HH----HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 34678999999999999872 23689999864322 21 24679999999999999999999999876 4588
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecC
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~ 291 (315)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999999999998754 345778889999999999999999999999999999999999999999999999864332
Q ss_pred CC-----ccCCCCCccccccCcccc
Q 021253 292 EG-----MTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 292 ~~-----~~~~~gt~~y~APE~~~~ 311 (315)
.. .....||+.|+|||.+..
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred ccccceecccccccccccChHHHhc
Confidence 21 223468999999998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-34 Score=254.06 Aligned_cols=167 Identities=23% Similarity=0.336 Sum_probs=142.7
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~ 211 (315)
++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|++.++.++| +|++.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 5788999999999999999997 6889999998654332 246688999999975 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC-----CCcEEEeeeccee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-----DKSIKIADFGVAR 286 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~-----~~~vkl~DFG~a~ 286 (315)
++||||+ +++|.+++... ...++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 67999998754 456899999999999999999999999999999999999974 5789999999998
Q ss_pred eeecCC--------CccCCCCCccccccCcccc
Q 021253 287 IEVQTE--------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~APE~~~~ 311 (315)
...... .....+||+.|||||++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC
Confidence 754321 1234579999999998864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-34 Score=253.01 Aligned_cols=172 Identities=23% Similarity=0.357 Sum_probs=149.0
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (315)
++|++++.||+|+||+||+|++ +++.||||+++....... ..+++.+|+.+++.++||||+++++++......+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 5789999999999999999998 678999999976544322 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecceeeeecCC
Q 021253 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (315)
Q Consensus 213 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~~~~~ 292 (315)
+|+|++.+++|..++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+......
T Consensus 78 iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999999888887764 3568999999999999999999999999999999999999999999999999998754433
Q ss_pred -CccCCCCCccccccCccccc
Q 021253 293 -GMTPETGTYRWMAPSAGSIC 312 (315)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~ 312 (315)
......+++.|+|||.+...
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~ 176 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTC
T ss_pred ccceeeccccchhhhhHhccC
Confidence 23344677999999987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=258.80 Aligned_cols=172 Identities=24% Similarity=0.349 Sum_probs=139.6
Q ss_pred ccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----
Q 021253 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (315)
Q Consensus 134 ~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 207 (315)
.++|++++.||+|+||+||+|++ +++.||||++......... .+++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 57899999999999999999998 6889999998655433221 2567899999999999999999999855
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeec
Q 021253 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (315)
Q Consensus 208 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG 283 (315)
...+|+||||++++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 345899999998766554433 24568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecC-----CCccCCCCCccccccCcccc
Q 021253 284 VARIEVQT-----EGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 284 ~a~~~~~~-----~~~~~~~gt~~y~APE~~~~ 311 (315)
+|+..... ......+||+.|+|||++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcC
Confidence 99764321 12334579999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-34 Score=259.64 Aligned_cols=168 Identities=25% Similarity=0.327 Sum_probs=133.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (315)
++|+++++||+|+||+||+|.+ +++.||||++......... .+++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 6799999999999999999998 6899999999876554332 3578899999999999999999999964
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeeccee
Q 021253 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (315)
Q Consensus 208 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a~ 286 (315)
...+|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 3688999999976 5555553 348999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCccccccCcccc
Q 021253 287 IEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
...........++|+.|+|||++..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp -------------CCTTCCHHHHTT
T ss_pred ccccccccccccccccccChhhhcC
Confidence 7665555666789999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-33 Score=249.33 Aligned_cols=167 Identities=26% Similarity=0.344 Sum_probs=137.2
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCEE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVW 211 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~ 211 (315)
++|++++.||+|+||.||+|++ +++.||||++...... +++.+|+++++.++|+++ +.+.+++.+.+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3688999999999999999998 5889999998765433 246789999999987765 5555666788889
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcC---CCcEEEeeecceeee
Q 021253 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (315)
Q Consensus 212 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~---~~~vkl~DFG~a~~~ 288 (315)
++||||+ +++|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999999 55777776543 456999999999999999999999999999999999999864 457999999999975
Q ss_pred ecCC--------CccCCCCCccccccCcccc
Q 021253 289 VQTE--------GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 289 ~~~~--------~~~~~~gt~~y~APE~~~~ 311 (315)
.... ......||+.|||||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC
Confidence 4322 1234579999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=260.11 Aligned_cols=174 Identities=24% Similarity=0.361 Sum_probs=143.9
Q ss_pred ccccccccccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021253 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (315)
Q Consensus 128 ~~~~i~~~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (315)
+.|+++ ++|++.+.||+|+||.||+|++ +++.||||+++........ .+++.+|+.+|++++|||||++++++
T Consensus 12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 457774 6799999999999999999987 6899999999865544332 35788999999999999999999998
Q ss_pred EeC-----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEe
Q 021253 206 RKR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (315)
Q Consensus 206 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~ 280 (315)
... ...+++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence 643 234566777889999999864 359999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCCCccCCCCCccccccCcccc
Q 021253 281 DFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 281 DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
|||+|..... ......||+.|+|||.+..
T Consensus 164 dfg~a~~~~~--~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 164 DFGLARHTDD--EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp CC----CCTG--GGSSSCHHHHTSCHHHHTT
T ss_pred ccchhcccCc--ccccccccccccCchhhcC
Confidence 9999975432 3455689999999998654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=258.72 Aligned_cols=176 Identities=20% Similarity=0.346 Sum_probs=148.4
Q ss_pred ccccccccccceeecccCceEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEE
Q 021253 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGAC 205 (315)
Q Consensus 132 i~~~~~~~~~~iG~G~~G~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~ 205 (315)
+.+++|++++.||+|+||+||+|.. +++.||||++++....... ...+.+.+|+.++++++| |||+++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 4568899999999999999999986 4689999998653221110 012467899999999976 8999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecce
Q 021253 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (315)
Q Consensus 206 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~a 285 (315)
.+...+++||||+.+++|.+++.... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999999998764 4788899999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCccccccCcccc
Q 021253 286 RIEVQTE--GMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~APE~~~~ 311 (315)
+...... ......|++.|+|||.+..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred hhhcccccccccccccccccchhHHhhc
Confidence 8653322 2344579999999998753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=1.7e-27 Score=217.15 Aligned_cols=168 Identities=21% Similarity=0.335 Sum_probs=133.3
Q ss_pred cccccccceeecccCceEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----------CCCeeeE
Q 021253 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLNIVRF 201 (315)
Q Consensus 135 ~~~~~~~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l 201 (315)
.+|+++++||+|+||.||+|+. +++.||||+++... ...+.+.+|+.+++.+. |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 3589999999999999999987 78999999997532 11346778888888775 5789999
Q ss_pred EEEEEe--CCEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCEEEcCCC--
Q 021253 202 IGACRK--RMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK-- 275 (315)
Q Consensus 202 ~~~~~~--~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NIli~~~~-- 275 (315)
++++.. ....+++++++..+ .............+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 998754 34566666666554 34444445556678999999999999999999998 8999999999999998665
Q ss_pred ----cEEEeeecceeeeecCCCccCCCCCccccccCcccc
Q 021253 276 ----SIKIADFGVARIEVQTEGMTPETGTYRWMAPSAGSI 311 (315)
Q Consensus 276 ----~vkl~DFG~a~~~~~~~~~~~~~gt~~y~APE~~~~ 311 (315)
.+|++|||.|+.... .....+||+.|+|||++..
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccc
Confidence 499999999986433 3455689999999998763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.2e-25 Score=185.43 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=106.2
Q ss_pred ccccceeecccCceEEEEE-CCeeEEEEEeeCCCCCh------------hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021253 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNP------------EKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (315)
Q Consensus 138 ~~~~~iG~G~~G~Vy~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (315)
.++++||+|+||.||+|++ +++.||||+++...... ...........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3678999999999999987 78999999986432210 0111223456678999999999999998876
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCEEEcCCCcEEEeeecc
Q 021253 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (315)
Q Consensus 205 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIli~~~~~vkl~DFG~ 284 (315)
.. . +++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus 83 ~~--~--~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 83 EG--N--AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ET--T--EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred cC--C--EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 32 2 79999998865432 3344467789999999999999999999999999999865 589999999
Q ss_pred eeee
Q 021253 285 ARIE 288 (315)
Q Consensus 285 a~~~ 288 (315)
|+..
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 9754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.1e-08 Score=86.92 Aligned_cols=140 Identities=17% Similarity=0.145 Sum_probs=91.7
Q ss_pred ccccccceeecccCceEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEE
Q 021253 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 136 ~~~~~~~iG~G~~G~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 214 (315)
.+++.+..+-++...||+....+..+.+|+......... ..+.+|...+..+. +--+.+++.+....+..++|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 334444433344568999988888889998764332211 23567888877764 33367788888888889999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021253 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (315)
Q Consensus 215 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (315)
|++++|.++.+..... .. ...++.+++..+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998775543211 11 11123333333444442
Q ss_pred ---------------------CCCccCCCCCCCEEEcCCCcEEEeeecceeee
Q 021253 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (315)
Q Consensus 257 ---------------------~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~~ 288 (315)
..++|+|+.|.|||+++++.+.|+||+.+...
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 12789999999999997766779999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=9e-07 Score=74.22 Aligned_cols=137 Identities=14% Similarity=0.084 Sum_probs=82.6
Q ss_pred ceeeccc-CceEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEEEEec
Q 021253 142 AFAQGAF-GKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEY 217 (315)
Q Consensus 142 ~iG~G~~-G~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~ 217 (315)
.+..|.. ..||+.+.. +..+.+|........ .+..|...++.+.. -.+.+++.+..+.+..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 4455554 578999874 456788876543322 35577777776643 3367788888888888999999
Q ss_pred cCCCCHHH--------------HHHhhCC-----CC--CCHHHHHHHHH--------------------HHHHHHHHHHh
Q 021253 218 AKGGSVRQ--------------FLTRRQN-----RA--VPLKLAVKQAL--------------------DVARGMAYVHG 256 (315)
Q Consensus 218 ~~~g~L~~--------------~l~~~~~-----~~--~~~~~~~~i~~--------------------qi~~gL~yLH~ 256 (315)
++|.++.+ .+.+... .. ........... .....+..+.+
T Consensus 88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 98865421 1111100 00 01110000000 11222333332
Q ss_pred C-------CCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 L-------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 ~-------~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
. .++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2 379999999999999877778999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=3.9e-06 Score=75.35 Aligned_cols=80 Identities=13% Similarity=-0.007 Sum_probs=46.5
Q ss_pred cceeecccCceEEEEE--CCeeEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHHhCC-C--CCeeeEEEEEEeCCEEEEE
Q 021253 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK-H--LNIVRFIGACRKRMVWCIV 214 (315)
Q Consensus 141 ~~iG~G~~G~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 214 (315)
+.||.|....||+.+. .++.++||.-.+.... .+......++...|...|+.+. + ..+++++.+..+. .++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~--~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM--AVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT--TEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCC--CEEE
Confidence 4689999999999975 4678999965321000 0000000123446777776652 2 3466777665443 3789
Q ss_pred EeccCCCC
Q 021253 215 TEYAKGGS 222 (315)
Q Consensus 215 ~e~~~~g~ 222 (315)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.52 E-value=0.00014 Score=63.00 Aligned_cols=66 Identities=11% Similarity=0.109 Sum_probs=42.6
Q ss_pred CceEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe--eeEEE-----EEEeCCEEEEEEeccCC
Q 021253 149 GKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI--VRFIG-----ACRKRMVWCIVTEYAKG 220 (315)
Q Consensus 149 G~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~ 220 (315)
-.||+++. +|..+++|+.++...+. +++..|...+..|....+ +..+. ........+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999987 78899999997655443 356677777776642222 11111 22345667889999876
Q ss_pred C
Q 021253 221 G 221 (315)
Q Consensus 221 g 221 (315)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=3.7e-06 Score=63.35 Aligned_cols=117 Identities=16% Similarity=0.212 Sum_probs=73.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++-+. -.-+....+..| .|+|++++|.+ ..|.|++|++... .+.|+.|.... +
T Consensus 7 pWy~g~i~---------R~~Ae~~L~~~g~~~G~FLVR~S~~---~~g~yvLSv~~~~---------~v~H~~I~~~~~g 65 (130)
T d2oq1a1 7 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHDV---------RFHHFPIERQLNG 65 (130)
T ss_dssp TTBCBSCC---------HHHHHHHHHHTTCCTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEEEECTTS
T ss_pred CCccCCCC---------HHHHHHHHHhcCCCCceEEEEecCC---CCccEEEEEeeCC---------ceEEEEEEEcCCC
Confidence 67877664 334445555555 49999998865 6789999999521 57899997665 6
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCCCCCCCCC-CccccccccccccccceeecccCceEE
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTEGLEN-YDEWTIDLRKLNMGTAFAQGAFGKLYR 153 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~~~~~-~~~~~i~~~~~~~~~~iG~G~~G~Vy~ 153 (315)
.|++. +...|. ..++.+ ..+.++|...|..|+........ ...|+. +.+.+++|.||+||+
T Consensus 66 ~~~l~-~~~~F~sl~~Lv~~Y~~~~~gL~~~L~~P~~r~~~~~~~~~~~~~------~~~~~~~~~~~~~w~ 130 (130)
T d2oq1a1 66 TYAIA-GGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDC------LRDAMVRDYVRQTWK 130 (130)
T ss_dssp CEEET-TSCCBSSHHHHHHHHHHCCTTSSSCCCSBCCCCTTCCCBCCHHHH------HHHHHHHHHHHHHHC
T ss_pred ceecc-CCCCcCCHHHHHHHHhhCCCCCCccCCccCCCCCCCCCCcchHHH------HHHHHHHhhccCccC
Confidence 67775 334452 334443 55667777777777654332221 111221 336789999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.00087 Score=57.30 Aligned_cols=31 Identities=35% Similarity=0.434 Sum_probs=27.9
Q ss_pred CCCccCCCCCCCEEEcCCCcEEEeeecceee
Q 021253 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (315)
Q Consensus 257 ~~iiHrDlkp~NIli~~~~~vkl~DFG~a~~ 287 (315)
.|+||+|+.++||+++.+...-|+||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999888789999999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0009 Score=59.34 Aligned_cols=78 Identities=13% Similarity=0.216 Sum_probs=48.8
Q ss_pred cccccccccceeecccCceEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEE
Q 021253 133 DLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFI 202 (315)
Q Consensus 133 ~~~~~~~~~~iG~G~~G~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~ 202 (315)
+.+++++ +.|+.|-.=.+|++... .+.|.+++.-. .... ....+|..+++.+.-.+ ..+++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 3344444 46777777899999863 24577777642 2111 13347888888775333 35777
Q ss_pred EEEEeCCEEEEEEeccCCCCH
Q 021253 203 GACRKRMVWCIVTEYAKGGSV 223 (315)
Q Consensus 203 ~~~~~~~~~~lv~e~~~~g~L 223 (315)
+++.. .+|+||++|..|
T Consensus 112 ~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT----EEEECCCCEEEC
T ss_pred EEcCC----ceEEEEeccccC
Confidence 77643 689999987543
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.44 E-value=0.00081 Score=49.93 Aligned_cols=89 Identities=18% Similarity=0.207 Sum_probs=58.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+.....+-| .|+|++++|.+ ..|.|++|++.. ..++|+.|.... +
T Consensus 6 PWyhg~is---------R~~Ae~lL~~~g~~dG~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 64 (129)
T d1a81a1 6 PFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHG---------RKAHHYTIERELNG 64 (129)
T ss_dssp TTBCSSCC---------HHHHHHHHHHTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CcccCCCC---------HHHHHHHHHhcCCCCccEEEEccCC---CCcceEEEeeec---------ccceEEEEEEcCCC
Confidence 67877664 334555665555 49999998775 678999999842 267899997665 5
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCCC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (315)
.|++. ....|. .++|.+ ..+.+++...|..|+.
T Consensus 65 ~~~i~-~~~~F~sl~eLV~~Y~~~~~gl~~~L~~P~~ 100 (129)
T d1a81a1 65 TYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFN 100 (129)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTTCCTTSSSCCCEECC
T ss_pred Ceeec-CCcccCCHHHHHHHHhhCCCCCcccCCCCCC
Confidence 67765 334452 344443 4556677666766654
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.40 E-value=0.00096 Score=48.37 Aligned_cols=96 Identities=20% Similarity=0.199 Sum_probs=59.5
Q ss_pred ccC-CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcc
Q 021253 6 VEG-PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKP 82 (315)
Q Consensus 6 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~ 82 (315)
+|. +||++-+. -..+.....+.+ .|+|+++.|.. .+|.|++|++..... ...+.|+.+..
T Consensus 9 l~~e~Wy~g~is---------R~eAe~~L~~~~~~~G~FLVR~S~~---~~g~~~Lsv~~~~~~-----~~~v~H~~i~~ 71 (114)
T d1blja_ 9 LEVEKWFFRTIS---------RKDAERQLLAPMNKAGSFLIRESES---NKGAFSLSVKDITTQ-----GEVVKHYKIRS 71 (114)
T ss_dssp SCCSSSBCCSCC---------HHHHHHHHSSTTCCTTCEEBCBCTT---CSSCEEEEECBCCTT-----TCBCCCEEEEE
T ss_pred cccCCCcCCCCC---------HHHHHHHHHhcCCCCceEEEeccCC---CCCCeEEEEEeeccC-----CCEEEEEEEEE
Confidence 443 78887764 333433332222 59999998865 679999999854321 13678999987
Q ss_pred cC-Cceeeeeceeeec--CCceee-ccCchHHHHHHhcCCC
Q 021253 83 VR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (315)
Q Consensus 83 ~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (315)
.. +.|++. ....|. ...|.+ ..+.+++...|..||.
T Consensus 72 ~~~g~~~l~-~~~~F~sl~eLV~~y~~~~~gL~~~L~~PC~ 111 (114)
T d1blja_ 72 LDNGGYYIS-PRITFPTLQALVQHYSKKGDGLCQKLTLPCV 111 (114)
T ss_dssp ETTTEEEEE-TTEEESSHHHHHHHHHHCCSSSSSCCCCCSC
T ss_pred cCCCCEEec-CCceECCHHHHHHHHhhCCCCCCccCCccCc
Confidence 75 678875 444453 344433 4455566666666554
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.17 E-value=0.00091 Score=47.31 Aligned_cols=66 Identities=18% Similarity=0.160 Sum_probs=43.3
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++-+. -.-+....++.| .|+|++++|.+ ..|.|++||+.. ..+.|+.|.... +
T Consensus 3 pWy~g~is---------R~~Ae~~L~~~~~~~G~FLvR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 61 (100)
T d1rjaa_ 3 PWFFGCIS---------RSEAVRRLQAEGNATGAFLIRVSEK---PSADYVLSVRDT---------QAVRHYKIWRRAGG 61 (100)
T ss_dssp CCBCTTCC---------HHHHHHHHSSTTCSSCCEEEEECSS---SSSCEEEEECTT---------SSCEEEEEEECSSS
T ss_pred CCcCCCCC---------HHHHHHHHhccCCCCCeEEeecCCC---CCCCEEEEEEcC---------CCceEEEEEECCCC
Confidence 67776664 233334444334 49999998865 678999999842 146899997665 5
Q ss_pred ceeeeeceeee
Q 021253 86 NYSVSVGQSVF 96 (315)
Q Consensus 86 ~~~i~~~~~~~ 96 (315)
.|++. +...|
T Consensus 62 ~~~l~-~~~~F 71 (100)
T d1rjaa_ 62 RLHLN-EAVSF 71 (100)
T ss_dssp CEEEE-TTEEE
T ss_pred CEEec-CCCcc
Confidence 68775 33344
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.03 E-value=0.00035 Score=49.29 Aligned_cols=61 Identities=16% Similarity=0.129 Sum_probs=42.6
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCcee
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~ 88 (315)
+||++.+. -.-+....+....|+|+++.|.+ ..|.|++||... ..+.|+.|...++.|+
T Consensus 5 PWy~g~is---------R~eAe~~L~~~~~G~FLVR~S~~---~~g~~vLSv~~~---------~~v~H~~I~~~~~~~~ 63 (97)
T d1jwoa_ 5 PWFHGKIS---------GQEAVQQLQPPEDGLFLVRESAR---HPGDYVLCVSFG---------RDVIHYRVLHRDGHLT 63 (97)
T ss_dssp TTEEESCC---------HHHHHHHTCSCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEESSSEES
T ss_pred CccCCCCC---------HHHHHHHhcCCCCCeEEEEecCC---CCccEEEEEEec---------CceEEEEEEEcCCcEE
Confidence 67777664 22333444445679999998765 678999999852 1468999987777777
Q ss_pred ee
Q 021253 89 VS 90 (315)
Q Consensus 89 i~ 90 (315)
+.
T Consensus 64 ~~ 65 (97)
T d1jwoa_ 64 ID 65 (97)
T ss_dssp ST
T ss_pred ec
Confidence 64
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.67 E-value=0.00042 Score=49.22 Aligned_cols=61 Identities=16% Similarity=0.175 Sum_probs=42.0
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCcee
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~ 88 (315)
+||++.+. -.-+....+....|+|++++|.+ ..|.|++|++.. ..++|+.|....+.|+
T Consensus 5 PWy~g~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~ 63 (101)
T d1k9aa2 5 PWFHGKIT---------REQAERLLYPPETGLFLVRESTN---YPGDYTLCVSCE---------GKVEHYRIMYHASKLS 63 (101)
T ss_dssp TTBCTTCC---------HHHHHHHTCSCCTTEEEEEECSS---STTSEEEEEECS---------SSEEEEEEEEETTEEE
T ss_pred CccCCCCC---------HHHHHHHHcCCCCCCEEEeccCC---CCCCEEEEEEeC---------CccEEEEEEEcCCCce
Confidence 57776664 22233334444579999998754 678899999842 2578999988777787
Q ss_pred ee
Q 021253 89 VS 90 (315)
Q Consensus 89 i~ 90 (315)
+.
T Consensus 64 ~~ 65 (101)
T d1k9aa2 64 ID 65 (101)
T ss_dssp SS
T ss_pred ec
Confidence 64
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.45 E-value=0.00084 Score=48.03 Aligned_cols=92 Identities=15% Similarity=0.201 Sum_probs=53.4
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+....++.| .|+|++++|.+ ..|.|++|++....... ..+.|+.+.... +
T Consensus 6 ~Wy~g~i~---------R~eAe~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~~~----~~i~h~~i~~~~~g 69 (106)
T d1o48a_ 6 EWYFGKIT---------RRESERLLLNAENPRGTFLVRESET---TKGAYCLSVSDFDNAKG----LNVKHYKIRKLDSG 69 (106)
T ss_dssp TTEEESCC---------HHHHHHHHCCTTCCTTCEEEEECSS---STTCEEEEEEEEETTTE----EEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCCcEEEEcccC---CCCCEEEEEEecccCcc----cceEEEEEEEecCC
Confidence 78887775 344445554444 59999998865 67899999985443322 245677776654 5
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDH 117 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~ 117 (315)
.|.+. +...|. .+.|.+ ..+.+++...|..|
T Consensus 70 ~~~~~-~~~~F~sl~eLV~~y~~~~~gL~~~L~~p 103 (106)
T d1o48a_ 70 GFYIT-SRTQFNSLQQLVAYYSKHADGLCHRLTTV 103 (106)
T ss_dssp CEESS-TTSEESSHHHHHHHHTTCCTTSSSCCCSB
T ss_pred CEEEc-CCeeECCHHHHHHHHhhCCCCCCccCCCc
Confidence 66664 333442 233332 33344444444433
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.36 E-value=0.0011 Score=47.19 Aligned_cols=55 Identities=15% Similarity=0.173 Sum_probs=38.9
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcC--CCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE--GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
+||++.+. -..+.......|. |+|++++|.+ .+|.|.+|+.... .+.|+.|....
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~g~~dG~FLVR~S~~---~~g~y~LSv~~~~---------~v~H~~I~~~~ 62 (105)
T d1nrva_ 6 HWFHGRIS---------REESHRIIKQQGLVDGLFLLRDSQS---NPKAFVLTLCHHQ---------KIKNFQILPCE 62 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEETT---------EEEEEEEEEC-
T ss_pred cccCCCCC---------HHHHHHHHhhcCCCCceEEEEeCCC---CCCCEEEEEEECC---------ceeEEEEEEec
Confidence 68887764 4455566666564 9999998765 6788999998522 56888886653
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.33 E-value=0.0019 Score=45.92 Aligned_cols=66 Identities=18% Similarity=0.262 Sum_probs=44.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+.....+.| .|+|+++.|.+ ..|.|++|+.......+. .+.|+.|.... +
T Consensus 7 ~Wy~g~i~---------R~eAe~~L~~~g~~~G~FLVR~S~~---~~g~~~Lsv~~~~~~~~~----~v~h~~i~~~~~g 70 (104)
T d1g83a2 7 EWYFGKLG---------RKDAERQLLSFGNPRGTFLIRESET---TKGAYSLSIRDWDDMKGD----HVKHYKIRKLDNG 70 (104)
T ss_dssp SSBCTTCC---------HHHHHHHHHSTTCCTTCEEEEECSS---STTCEEEEEEEECSSSCE----EEEEEEEEECTTS
T ss_pred CCcCCCCC---------HHHHHHHHHhcCCCCCcEEEeccCC---CCCCeEEEEEEeecCcCC----eEEEEEEEEcCCC
Confidence 78887664 233334454444 59999998865 678999999876654332 57888887665 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 71 ~~~~~ 75 (104)
T d1g83a2 71 GYYIT 75 (104)
T ss_dssp CEEET
T ss_pred CEEec
Confidence 56654
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.19 E-value=0.00099 Score=47.53 Aligned_cols=93 Identities=18% Similarity=0.208 Sum_probs=53.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHh--cCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+.....+. -.|+|+++.|.+ ..|.+++|+.......+ ..+.|+.+.... +
T Consensus 5 pWy~g~is---------R~eAe~~L~~~~~~~GtFLVR~S~~---~~g~~~lsv~~~~~~~~----~~v~h~~i~~~~~~ 68 (105)
T d1lkka_ 5 PWFFKNLS---------RKDAERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQG----EVVKHYKIRNLDNG 68 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHTSTTCCTTCEEEEECSS---STTCEEEEEEEEETTTE----EEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCCcEEEEccCC---CCCCEEEEEEEcccCCC----ccEEEEEEEEcCCC
Confidence 68887664 22333344332 359999998775 67899999986554332 257888887765 6
Q ss_pred ceeeeeceeeec--CCceee-ccCchHHHHHHhcCC
Q 021253 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHR 118 (315)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~ 118 (315)
.|++. +...|. +..|.+ ..+.+++...|..||
T Consensus 69 ~~~~~-~~~~F~sl~~LV~~y~~~~~gL~~~L~~Pc 103 (105)
T d1lkka_ 69 GFYIS-PRITFPGLHELVRHYTNASDGLCTRLSRPC 103 (105)
T ss_dssp CEESS-TTSCBSSHHHHHHHHHHCCTTSSSCCCSBC
T ss_pred CEEec-CCcccCCHHHHHHHHhhCCCCCCccCCCcC
Confidence 67664 333342 233332 334444444444443
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.46 E-value=0.0023 Score=47.00 Aligned_cols=60 Identities=10% Similarity=0.109 Sum_probs=41.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcC--CCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE--GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+....++.|. |+|+++.|. ..|.|.+||.... .++|+.|...+ +
T Consensus 30 pWyhg~is---------R~eAe~lL~~~~~~dGtFLVR~S~----~~g~yvLSv~~~~---------~v~H~~I~~~~~g 87 (124)
T d2oq1a2 30 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPRK----EQGTYALSLIYGK---------TVYHYLISQDKAG 87 (124)
T ss_dssp TTBCSSCC---------HHHHHHHHHSSCCCTTEEEEEECS----STTEEEEEEEETT---------EEEEEEEEECTTS
T ss_pred CCccCCCC---------HHHHHHHHhhcCCCCceEEeEecC----CCCCEEEEeecCC---------ceEEEEEEECCCC
Confidence 68887775 3344455554454 999999884 3588999998521 57899998765 5
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|++.
T Consensus 88 ~~~l~ 92 (124)
T d2oq1a2 88 KYCIP 92 (124)
T ss_dssp CEEST
T ss_pred CEEeC
Confidence 57664
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.23 E-value=0.0027 Score=44.82 Aligned_cols=62 Identities=15% Similarity=0.128 Sum_probs=43.2
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cc
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~ 86 (315)
-+||++.+. -.-+....+....|+|+++.|.+ .+|.|++|++... .+.|+.|.... +.
T Consensus 5 ~~Wy~g~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~g~ 63 (101)
T d1opka2 5 HSWYHGPVS---------RNAAEYLLSSGINGSFLVRESES---SPGQRSISLRYEG---------RVYHYRINTASDGK 63 (101)
T ss_dssp STTEEEECC---------HHHHHHHGGGCCTTEEEEEECSS---STTCEEEEEEETT---------EEEEEECEECTTSC
T ss_pred CcccCCCCC---------HHHHHHHhcCCCCCeEEEEecCC---CCCCEEEEEEcCc---------ceEEEEeEECCCCC
Confidence 378888775 23344455556689999998765 6788999998532 56899998776 44
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|.+.
T Consensus 64 ~~~~ 67 (101)
T d1opka2 64 LYVS 67 (101)
T ss_dssp EESS
T ss_pred EEeC
Confidence 5543
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.64 E-value=0.012 Score=41.67 Aligned_cols=59 Identities=7% Similarity=0.080 Sum_probs=41.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
+||++.+. -.-+.......+ .|+|+++.|. ..|.|++|+.... .+.|+.|......|
T Consensus 10 ~Wy~g~i~---------R~eAe~lL~~~~~~G~FLVR~S~----~~~~yvLSv~~~~---------~v~H~~I~~~~~~~ 67 (105)
T d2fcia1 10 EWYHASLT---------RAQAEHMLMRVPRDGAFLVRKRN----EPNSYAISFRAEG---------KIKHCRVQQEGQTV 67 (105)
T ss_dssp CCCCSSSC---------SHHHHHHHHHSSSSCCEEEEECS----STTCEEEEEEETT---------EECCCEEBCCSSCE
T ss_pred CCccCCCC---------HHHHHHHHHhCCCCCeEEEEecC----CCCCEEEEEEecc---------ccEEEEEEecCCeE
Confidence 79988875 344555666666 5999999874 3578999998521 56899987655555
Q ss_pred ee
Q 021253 88 SV 89 (315)
Q Consensus 88 ~i 89 (315)
.+
T Consensus 68 ~~ 69 (105)
T d2fcia1 68 ML 69 (105)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.54 E-value=0.003 Score=44.64 Aligned_cols=73 Identities=26% Similarity=0.295 Sum_probs=43.6
Q ss_pred CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cceeeeeceeeec--CCceee-ccCchHHHHH
Q 021253 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (315)
.|+|++++|.+ ..|.+++||.......+ ..+.|+.+.... +.|++. +...|. ++.|.+ ..+.+++...
T Consensus 24 ~G~FLVR~S~~---~~g~~~Lsv~~~~~~~~----~~v~H~~i~~~~~g~~~~~-~~~~F~sl~~LV~~y~~~~~gL~~~ 95 (103)
T d1qcfa2 24 LGSFMIRDSET---TKGSYSLSVRDYDPRQG----DTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQK 95 (103)
T ss_dssp TTCEEEEECSS---STTSEEEEEEEEETTTE----EEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSSC
T ss_pred CCcEEEEccCC---CCCCeEEEEEecCCCcC----ceEEEEEEEEcCCCceeec-CCcccCCHHHHHHHHhhCCCCCCcc
Confidence 59999998875 67899999985433222 367888888775 556654 222332 233332 3334444444
Q ss_pred HhcCC
Q 021253 114 LMDHR 118 (315)
Q Consensus 114 l~~~~ 118 (315)
|..||
T Consensus 96 L~~PC 100 (103)
T d1qcfa2 96 LSVPC 100 (103)
T ss_dssp CCSBC
T ss_pred CCccC
Confidence 44444
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.14 E-value=0.036 Score=39.25 Aligned_cols=61 Identities=16% Similarity=0.214 Sum_probs=44.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
.||++.+. -.-+.......+ .|+|++++|.+ ..|.|++|++... .+.|+.|....+.|
T Consensus 4 ~Wy~g~is---------R~~Ae~lL~~~~~~G~FLvR~S~~---~~g~y~LSv~~~~---------~v~H~~I~~~~~~~ 62 (109)
T d2shpa2 4 RWFHPNIT---------GVEAENLLLTRGVDGSFLARPSKS---NPGDLTLSVRRNG---------AVTHIKIQNTGDYY 62 (109)
T ss_dssp TTBCSSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEETT---------EEEEEEEECSSSCE
T ss_pred ccccCCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEEeCC---------cEEEEEEEEcCCeE
Confidence 57777664 334445666666 59999998865 6788999998422 56899998877888
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 63 ~~~ 65 (109)
T d2shpa2 63 DLY 65 (109)
T ss_dssp EET
T ss_pred EEc
Confidence 875
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.13 E-value=0.004 Score=44.86 Aligned_cols=55 Identities=18% Similarity=0.192 Sum_probs=39.7
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
+||++.+. -.-+.......| .|+|+++.|.+ .+|.|++|+.... .+.|+.|...+
T Consensus 11 ~Wy~g~is---------R~~Ae~lL~~~g~~dG~FLvR~S~~---~~g~y~LSv~~~~---------~v~H~~I~~~~ 67 (113)
T d2qmsa1 11 LWFHGRIS---------REESQRLIGQQGLVDGLFLVRESQR---NPQGFVLSLCHLQ---------KVKHYLILPSE 67 (113)
T ss_dssp TTEEEEBC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEETT---------EEEEEEEEEEE
T ss_pred CccCCCCC---------HHHHHHHHhccCCCCccEEEEeccC---CCCCEEEEEEeCC---------eEEEEEEEEeC
Confidence 78888875 344555665555 49999998875 6688999998532 57888886543
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.81 E-value=0.04 Score=38.45 Aligned_cols=60 Identities=15% Similarity=0.201 Sum_probs=42.8
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-Cc
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~~ 86 (315)
+||++.+. -.-+....++.+ .|+|+++.|.+ ..|.+++|+.... .+.|+.|.... +.
T Consensus 5 pwyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~~~Lsv~~~~---------~v~H~~I~~~~~~~ 63 (104)
T d1d4ta_ 5 AVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYHG---------YIYTYRVSQTETGS 63 (104)
T ss_dssp TTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEETT---------EEEEEEEEECTTSC
T ss_pred CccccCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEecCC---------CceEEEEEEcCCCc
Confidence 78888775 344556666556 59999998875 6689999998532 56889887766 44
Q ss_pred eee
Q 021253 87 YSV 89 (315)
Q Consensus 87 ~~i 89 (315)
|.+
T Consensus 64 ~~~ 66 (104)
T d1d4ta_ 64 WSA 66 (104)
T ss_dssp EEE
T ss_pred EEE
Confidence 443
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.28 E-value=0.026 Score=39.68 Aligned_cols=63 Identities=17% Similarity=0.141 Sum_probs=41.5
Q ss_pred ccccC-CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcc
Q 021253 4 KMVEG-PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKP 82 (315)
Q Consensus 4 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~ 82 (315)
+=+++ +||++.+.- .-+....+ -.|+|+++.|.+ ..|.+++|+.... .+.|+.|..
T Consensus 2 ~~l~~~pWyhG~i~R---------~~Ae~lL~--~~G~FLVR~S~~---~~g~~vLSv~~~~---------~v~H~~I~~ 58 (104)
T d1mila_ 2 SQLRGEPWFHGKLSR---------REAEALLQ--LNGDFLVRESTT---TPGQYVLTGLQSG---------QPKHLLLVD 58 (104)
T ss_dssp CSTTTCTTBCSSCCH---------HHHHTTCC--STTEEEEEECCS---SCSSEEEEEEETT---------EEEEEEEBC
T ss_pred cccccCCCcCCCCCH---------HHHHHHHh--cCCcEEEEecCC---CCCCEEEEEEEcc---------ccceEEEEe
Confidence 33444 899988863 11111222 159999998765 6789999998532 568898877
Q ss_pred cCCceee
Q 021253 83 VRHNYSV 89 (315)
Q Consensus 83 ~~~~~~i 89 (315)
..+.|.+
T Consensus 59 ~~~~~~~ 65 (104)
T d1mila_ 59 PEGVVRT 65 (104)
T ss_dssp TTSSEEC
T ss_pred CCCEEEe
Confidence 6666654
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.57 E-value=0.054 Score=37.74 Aligned_cols=63 Identities=14% Similarity=0.115 Sum_probs=44.4
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
+-+||++.+. -+-+....+....|+|+++.|.+ ..|.++||+.... .+.|+.|....+.
T Consensus 14 ~~~Wy~g~i~---------R~~Ae~~L~~~~~GtFLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~~ 72 (103)
T d2c9wa2 14 QTGWYWGSMT---------VNEAKEKLKEAPEGTFLIRDSSH---SDYLLTISVKTSA---------GPTNLRIEYQDGK 72 (103)
T ss_dssp HTSCBCTTCC---------HHHHHHHHTTSCTTCEEEEECCS---TTCSEEEEEEETT---------EEEEEEEEEETTE
T ss_pred hCCCcCCCCC---------HHHHHHHhcCCCCCceEEeccCC---CCCCEEEEEEECC---------EEEEEEEEEcCCe
Confidence 3478887664 33455566666789999998865 6788999998532 4578888776666
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|.+.
T Consensus 73 ~~~~ 76 (103)
T d2c9wa2 73 FRLD 76 (103)
T ss_dssp EEEC
T ss_pred EeeC
Confidence 6654
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.37 E-value=0.014 Score=42.67 Aligned_cols=60 Identities=15% Similarity=0.159 Sum_probs=39.2
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc--CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-C
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~-~ 85 (315)
+||++.+. -.-+.......| .|+|++++|. ..|.|++|+.... .+.|+.|.... +
T Consensus 30 pWyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~----~~~~yvLSv~~~~---------~v~H~~I~~~~~g 87 (125)
T d1a81a2 30 PWFHGKIS---------REESEQIVLIGSKTNGKFLIRARD----NNGSYALCLLHEG---------KVLHYRIDKDKTG 87 (125)
T ss_dssp TTEEEECC---------HHHHHHHHHSSCCCTTCEEEEECS----SSSCEEEEEEETT---------EEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCceEEEEecC----CCCCEEEEeeccc---------cceeEeeeEcCCC
Confidence 58888774 222333343334 5999999774 3578999998522 46899998765 4
Q ss_pred ceeee
Q 021253 86 NYSVS 90 (315)
Q Consensus 86 ~~~i~ 90 (315)
.|.+.
T Consensus 88 ~~~~~ 92 (125)
T d1a81a2 88 KLSIP 92 (125)
T ss_dssp CEECT
T ss_pred cEecc
Confidence 56654
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.88 E-value=0.082 Score=36.83 Aligned_cols=63 Identities=16% Similarity=0.235 Sum_probs=40.7
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC-
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~- 84 (315)
+=+||++.+. -.-+.......+ .|+|++++|.+ ..|.+++|++... .+.|+.|....
T Consensus 2 d~PWy~g~is---------R~~AE~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~ 60 (103)
T d1i3za_ 2 DLPYYHGCLT---------KRECEALLLKGGVDGNFLIRDSES---VPGALCLCVSFKK---------LVYSYRIFREKH 60 (103)
T ss_dssp CCTTEESSCC---------HHHHHHHHHTTCSTTEEEEEECSS---STTCEEEEEECSS---------SEEEEEEEECTT
T ss_pred CCCcccCCCC---------HHHHHHHHHhCCCCCeEEEEecCC---CCCCEEEEEEeCC---------eEEEEEeEEcCC
Confidence 4477877664 223333443333 49999998865 5689999999422 56899887554
Q ss_pred Cceeee
Q 021253 85 HNYSVS 90 (315)
Q Consensus 85 ~~~~i~ 90 (315)
+.|.+.
T Consensus 61 g~~~~~ 66 (103)
T d1i3za_ 61 GYYRIE 66 (103)
T ss_dssp SCEEEC
T ss_pred CcEEEe
Confidence 556653
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.59 E-value=0.1 Score=35.85 Aligned_cols=60 Identities=22% Similarity=0.183 Sum_probs=40.4
Q ss_pred CCccccccCccCCCCccccccHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc-
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN- 86 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~- 86 (315)
|||++.+. -.-+....+..+ .|+|+++.|.+ .+|.+++|++... .+.|+.|.....+
T Consensus 4 pWy~g~is---------R~~Ae~lL~~~~~~G~FLvR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~g~ 62 (96)
T d1jyra_ 4 AWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFGN---------DVQHFKVLRDGAGK 62 (96)
T ss_dssp TTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEETT---------EEEEEECEECTTSC
T ss_pred CccCCCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEEeCC---------ceEEEEEEECCCCe
Confidence 67777664 333444454433 49999998865 6788999999532 5689999877644
Q ss_pred eee
Q 021253 87 YSV 89 (315)
Q Consensus 87 ~~i 89 (315)
|.+
T Consensus 63 ~~~ 65 (96)
T d1jyra_ 63 YFL 65 (96)
T ss_dssp EES
T ss_pred EEe
Confidence 443
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.57 E-value=0.083 Score=36.97 Aligned_cols=65 Identities=17% Similarity=0.199 Sum_probs=43.6
Q ss_pred cccccC---CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCC
Q 021253 3 GKMVEG---PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPG 79 (315)
Q Consensus 3 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~ 79 (315)
|||..+ +||.+.+. -.-+....+....|+|+++.|.+ ..+ |++++.... .+.|+.
T Consensus 1 ~~~~~~~~~pWy~g~is---------R~eAe~lL~~~~~G~FLvR~S~~---~~~-y~Lsv~~~~---------~~~h~~ 58 (106)
T d2cs0a1 1 GQLAQDGVPEWFHGAIS---------REDAENLLESQPLGSFLIRVSHS---HVG-YTLSYKAQS---------SCCHFM 58 (106)
T ss_dssp SCCCSSSCCSSBCSSCC---------HHHHHHHHHTSCTTCEEEEECSS---SSS-EEEEECCSS---------SCEEEE
T ss_pred CCccCCCCCCCccCCCC---------HHHHHHHHcCCCCCcEEEEecCC---CCC-EEEEEEecC---------CceeEE
Confidence 677776 68887774 33345566655689999998753 233 999998432 457888
Q ss_pred CcccC-Cceee
Q 021253 80 LKPVR-HNYSV 89 (315)
Q Consensus 80 i~~~~-~~~~i 89 (315)
|.... +.|.+
T Consensus 59 I~~~~~g~~~~ 69 (106)
T d2cs0a1 59 VKLLDDGTFMI 69 (106)
T ss_dssp EEECTTSCEEC
T ss_pred EEEcCCCCEEE
Confidence 87666 44554
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.98 E-value=0.12 Score=35.57 Aligned_cols=59 Identities=14% Similarity=0.040 Sum_probs=41.5
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCcee
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~ 88 (315)
+||.+.+. -.-+....+....|+|+++.|.+ .+|.|++|++... .+.|+.|.....+++
T Consensus 7 ~Wy~g~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~g~~ 65 (97)
T d1r1qa_ 7 EWFHEGLS---------RHQAENLLMGKDIGFFIIRASQS---SPGDFSISVRHED---------DVQHFKVMRDTKGNY 65 (97)
T ss_dssp TTBCTTCC---------HHHHHHHHHTSCTTCEEEEECSS---STTCEEEEEECSS---------SEEEEECEECTTCCE
T ss_pred CccCCCCC---------HHHHHHHHhcCCCCCEEEeecCC---CCCCEEEEEEecC---------CeEEEEEEEcCCCeE
Confidence 57777664 33445556556689999998865 6789999998422 468999988774443
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=87.08 E-value=0.13 Score=34.47 Aligned_cols=63 Identities=16% Similarity=0.125 Sum_probs=40.1
Q ss_pred cccCCCccccccCccCCCCccccccHHHHHHhc---CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCc
Q 021253 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG---EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLK 81 (315)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~ 81 (315)
|-+-+||++.+. -.-+....+..| .|+|+++.|.+ ..|.+++|++... .+.|+.|.
T Consensus 2 l~~~pWyhg~is---------R~~Ae~lL~~~~~~~dG~FLvR~S~~---~~g~~~Lsv~~~~---------~v~h~~I~ 60 (86)
T d1rpya_ 2 LSDYPWFHGTLS---------RVKAAQLVLAGGPRSHGLFVIRQSET---RPGECVLTFNFQG---------KAKHLRLS 60 (86)
T ss_dssp GGGSTTBCTTCC---------HHHHHHHHHTTGGGGTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEC-
T ss_pred CccCcccCCCCC---------HHHHHHHHHhCCCCCCceEEEEecCC---CCCcEEEEEEECC---------ceEEEEEE
Confidence 345588888775 334444554434 59999998765 6788999999532 57889887
Q ss_pred ccCCcee
Q 021253 82 PVRHNYS 88 (315)
Q Consensus 82 ~~~~~~~ 88 (315)
....+++
T Consensus 61 ~~~~~~~ 67 (86)
T d1rpya_ 61 LNGHGQC 67 (86)
T ss_dssp ---CCCH
T ss_pred EcCCceE
Confidence 7665544
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.46 E-value=0.081 Score=37.49 Aligned_cols=62 Identities=24% Similarity=0.254 Sum_probs=43.3
Q ss_pred CCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCce
Q 021253 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (315)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~ 87 (315)
-+||++.+. -.-+....+....|+|++++|.+ ..|.+++|++... .+.|+.|....+.|
T Consensus 11 ~~Wy~g~is---------R~~Ae~lL~~~~~GtFLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~~~ 69 (112)
T d2izva2 11 NPCYWGVMD---------KYAAEALLEGKPEGTFLLRDSAQ---EDYLFSVSFRRYS---------RSLHARIEQWNHNF 69 (112)
T ss_dssp CTTEEEECC---------HHHHHHHHTTCCTTEEEEEECSS---TTCSEEEEEEETT---------EEEEEECEEETTEE
T ss_pred CCCcCCCCC---------HHHHHHHHccCCCCcEEEeecCC---CCCCeEEEEEecC---------CceEEEEEEeCCeE
Confidence 467777664 22344445444579999998765 5688999998532 56899998877777
Q ss_pred eee
Q 021253 88 SVS 90 (315)
Q Consensus 88 ~i~ 90 (315)
++.
T Consensus 70 ~l~ 72 (112)
T d2izva2 70 SFD 72 (112)
T ss_dssp ESC
T ss_pred EEe
Confidence 764
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=86.26 E-value=0.2 Score=35.01 Aligned_cols=60 Identities=22% Similarity=0.249 Sum_probs=39.1
Q ss_pred CCccccccCccCCCCccccccHHHHHHhcC-CCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccC
Q 021253 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (315)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~ 84 (315)
.||++.+. -.-+.......+. |+|++++|+ ..|.|+||++.......+ ..++|+.|....
T Consensus 7 ~Wy~g~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~~---~~i~h~~I~~~~ 67 (108)
T d1luia_ 7 EWYNKSIS---------RDKAEKLLLDTGKEGAFMVRDSR----TPGTYTVSVFTKAIISEN---PCIKHYHIKETN 67 (108)
T ss_dssp TTBCTTCC---------HHHHHHHHHHHCCTTEEEEEECC----TTTCEEEEEECSCCTTTC---SCEEEEECEECC
T ss_pred CCcCCCCC---------HHHHHHHHHhcCCCCeEEEEecC----CCCCEEEEEEecCCcccC---CceeEEEEEEec
Confidence 57777664 2334445544444 999999874 357899999865544332 367888886654
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.46 E-value=0.2 Score=34.84 Aligned_cols=59 Identities=15% Similarity=0.219 Sum_probs=34.6
Q ss_pred cHHHHHHhc-CCCCCCcccccccCCCCeEEEEEeeCCCCCCC-cccccccCCCCcccCCceeee
Q 021253 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSND-SLTHILSHPGLKPVRHNYSVS 90 (315)
Q Consensus 29 ~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~-~~~~~~~~~~i~~~~~~~~i~ 90 (315)
+....+..+ .|+|+++.|++ .+|.|++|+......... .....+.|+.+....+.|++.
T Consensus 12 Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 72 (108)
T d2shpa3 12 AEKLLTEKGKHGSFLVRESQS---HPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVG 72 (108)
T ss_dssp HHHHHHHTCCTTEEEEEECSS---STTCEEEEEEECC-----CCCCCEEEEEEEEEETTEEESS
T ss_pred HHHHHhhcCCCCeEEEEecCC---CCCCeEEEEEecCccccccccccceeeEEEEeCCCceEeC
Confidence 344554444 49999998875 678999999865433211 111234566666555666553
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.58 E-value=0.3 Score=35.94 Aligned_cols=39 Identities=15% Similarity=0.088 Sum_probs=28.8
Q ss_pred CCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCceee
Q 021253 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSV 89 (315)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~~~i 89 (315)
.|+|+++.|.+ ..|.|+||+.... .++|+.|.. ++.+++
T Consensus 55 dGsFLVR~S~~---~~g~y~LSv~~~~---------~v~H~~I~~-~g~~~~ 93 (141)
T d1xa6a2 55 EGAYILRESQR---QPGCYTLALRFGN---------QTLNYRLFH-DGKHFV 93 (141)
T ss_dssp TTBEEEEECSS---STTCEEEEEEETT---------EEEECCCEE-SSSEEC
T ss_pred CCeEEEEecCC---CCCCEEEEEEECC---------EEEEEEEEE-CCCEEE
Confidence 69999998864 6788999998532 578999875 344444
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=80.52 E-value=0.32 Score=34.01 Aligned_cols=64 Identities=13% Similarity=0.129 Sum_probs=42.8
Q ss_pred cCCCccccccCccCCCCccccccHHHHHHhcCCCCCCcccccccCCCCeEEEEEeeCCCCCCCcccccccCCCCcccCCc
Q 021253 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~i~~~~~~ 86 (315)
+-+||++.+. -.-+....+..+.|+|+++.|++ ..++.+++++.... .+.|+.|...++.
T Consensus 10 ~~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~--~~~~~~~ls~~~~~---------~~~H~~I~~~~~~ 69 (111)
T d1fu6a_ 10 DAEWYWGDIS---------REEVNEKLRDTADGTFLVRDAST--KMHGDYTLTLRKGG---------NNKSIKIFHRDGK 69 (111)
T ss_dssp CCSSCCSSCC---------SHHHHHHSSSCSSCCCCCBSSCC--SSSCCSBCEEEETT---------EEEECCCCCTTTC
T ss_pred cCcCCCCCCC---------HHHHHHHhCcCCCCEEEEEeccC--CCCccEEEEEecCC---------ceEEEEEEEcCCe
Confidence 3478887764 22333444445689999998864 24567888887532 5688999877777
Q ss_pred eeee
Q 021253 87 YSVS 90 (315)
Q Consensus 87 ~~i~ 90 (315)
|++.
T Consensus 70 ~~~~ 73 (111)
T d1fu6a_ 70 YGFS 73 (111)
T ss_dssp CCTT
T ss_pred EEEC
Confidence 7764
|